Citrus Sinensis ID: 007103
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 618 | 2.2.26 [Sep-21-2011] | |||||||
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | yes | no | 0.948 | 0.833 | 0.717 | 0.0 | |
| Q9C8M9 | 719 | Protein STRUBBELIG-RECEPT | no | no | 0.957 | 0.823 | 0.471 | 1e-145 | |
| Q9LUL4 | 717 | Protein STRUBBELIG-RECEPT | no | no | 0.966 | 0.832 | 0.459 | 1e-141 | |
| Q6R2K1 | 699 | Protein STRUBBELIG-RECEPT | no | no | 0.936 | 0.828 | 0.423 | 1e-134 | |
| Q6R2K2 | 687 | Protein STRUBBELIG-RECEPT | no | no | 0.933 | 0.839 | 0.427 | 1e-125 | |
| Q06BH3 | 775 | Protein STRUBBELIG-RECEPT | no | no | 0.951 | 0.758 | 0.426 | 1e-119 | |
| Q9FG24 | 735 | Protein STRUBBELIG-RECEPT | no | no | 0.938 | 0.789 | 0.397 | 1e-109 | |
| Q6R2K3 | 776 | Protein STRUBBELIG-RECEPT | no | no | 0.381 | 0.304 | 0.593 | 1e-74 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.818 | 0.424 | 0.326 | 3e-65 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.758 | 0.425 | 0.312 | 8e-63 |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 855 bits (2208), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/605 (71%), Positives = 492/605 (81%), Gaps = 19/605 (3%)
Query: 21 AFVLILSIFLT----LSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWK 76
A +L +F+ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWK
Sbjct: 7 AMFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWK 66
Query: 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
G+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNL
Sbjct: 67 GITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNL 126
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
A NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGDLP+S
Sbjct: 127 ARNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSS 186
Query: 197 FISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
++S +S LY+QNNQ+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSF
Sbjct: 187 LSTVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSF 246
Query: 257 DNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAV 313
DN PA P P + GS P GS+ SSD K L G + GIV G++
Sbjct: 247 DNVPASPQPERPG--------KKETPSGSKKPKIGSEEKSSDSGKGLSGGVVTGIVFGSL 298
Query: 314 FLVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPP 372
F+ + L LY C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL
Sbjct: 299 FVAGIIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSS 355
Query: 373 PAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA 432
PAEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF
Sbjct: 356 PAEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFP 415
Query: 433 NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492
NGKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGN
Sbjct: 416 NGKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGN 475
Query: 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
GNL D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+EL
Sbjct: 476 GNLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEEL 535
Query: 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG 612
NPHLSD GLAALTPNTERQVSTQ+VG+FGYSAPEFALSGIYTVKSDVY+FGVVMLELLTG
Sbjct: 536 NPHLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTG 595
Query: 613 RKPLD 617
RKPLD
Sbjct: 596 RKPLD 600
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C8M9|SRF6_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 6 OS=Arabidopsis thaliana GN=SRF6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 516 bits (1328), Expect = e-145, Method: Compositional matrix adjust.
Identities = 290/615 (47%), Positives = 388/615 (63%), Gaps = 23/615 (3%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
A + + L + TD+SD AL L++ ++SP+ LT W GDPCG++W+GV C
Sbjct: 9 ALFTLCIVGFELRFIHGATDASDTSALNTLFSGMHSPAQLTQWTAAAGDPCGQNWRGVTC 68
Query: 81 EGSAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN 139
GS V I +SGL LSGT+G Y+L L SL + DLS N++ +PYQ PPNL LNLA+N
Sbjct: 69 SGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPPNLQRLNLANN 128
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
F+G YS++ + L YLN+ N I F L L TLD SFN+F+ LP +F S
Sbjct: 129 QFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLPATFSS 188
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNG 259
L+++ SLYLQNNQ +G+++V +GLPL TLN+ANN F+GWIP L I T I DGNSF+ G
Sbjct: 189 LTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TLIKDGNSFNTG 247
Query: 260 PAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVALA 319
PAPPPPP T P G R+ S +++ S K + ++ ++ LV A
Sbjct: 248 PAPPPPPGTPPIRGSPSRKSGGRESRSSDESTRNGDSKKSGIGAGAIAGIIISL-LVVTA 306
Query: 320 LLALYFCIRKNRRKVSG----ARSSAGSFPVSTNNMNTEMHEQRVKSVAAVT-------D 368
LL +F R+ + K S ++ F +++N+ + Q SV +
Sbjct: 307 LLVAFFLFRRKKSKRSSPMDIEKTDNQPFTLASNDFHENNSIQSSSSVETKKLDTSLSIN 366
Query: 369 LTPPPAEKLVI----ERVAKSGSLKK--IKSPITATSYTVASLQTATNSFSQEFLIGEGS 422
L PPP ++ + K ++KK + P Y+VA LQ AT SFS + L+GEG+
Sbjct: 367 LRPPPIDRNKSFDDEDSTRKPIAVKKSTVVVPSNVRLYSVADLQIATGSFSVDNLLGEGT 426
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482
GRVYRAEF +GK++AVKKID++AL D+F+E VS ++ L HPN+ L GYCAEHGQ
Sbjct: 427 FGRVYRAEFDDGKVLAVKKIDSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQ 486
Query: 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542
L+VYE+ NG+LHD LH +++ SK L WN+RV++ALGTARALEYLHEVC PS+V +N K
Sbjct: 487 HLVVYEFHKNGSLHDFLHLSEEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIK 546
Query: 543 SANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602
SANILLD ELNPHLSD GLA+ P T ++ Q GYSAPE ++SG Y++KSD+YSF
Sbjct: 547 SANILLDSELNPHLSDSGLASFLP-TANELLNQT--DEGYSAPEVSMSGQYSLKSDIYSF 603
Query: 603 GVVMLELLTGRKPLD 617
GVVMLELLTGRKP D
Sbjct: 604 GVVMLELLTGRKPFD 618
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LUL4|SRF7_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 7 OS=Arabidopsis thaliana GN=SRF7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1291), Expect = e-141, Method: Compositional matrix adjust.
Identities = 289/629 (45%), Positives = 399/629 (63%), Gaps = 32/629 (5%)
Query: 13 FSTSRLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCG 72
+ +R++ A +++ + S + TDSSD AL ++++S+NSP L+ W + GDPCG
Sbjct: 1 MTENRVVLALLILCIVGFEPSFIHGATDSSDTSALNIMFSSMNSPGQLSQWTASGGDPCG 60
Query: 73 ESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLT 132
++WKG+ C GS V I + LGLSG++G++L L S+ +FD+S N++ +PYQLPPNL
Sbjct: 61 QNWKGITCSGSRVTQIKLPSLGLSGSLGFMLDKLTSVTEFDMSNNNLGGDLPYQLPPNLE 120
Query: 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192
LNLA+N F+G+ YSI+ M L YLN++ N L Q D F L L+ LDLS N F G
Sbjct: 121 RLNLANNQFTGSAQYSISMMAPLKYLNLAHNQLKQLAID-FTKLTSLSILDLSSNAFIGS 179
Query: 193 LPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
LPN+ SL++ S+YLQNNQ +G++++ + LPL LN+ANN F+GWIP L I D
Sbjct: 180 LPNTCSSLTSAKSIYLQNNQFSGTIDILATLPLENLNIANNRFTGWIPDSLKGI-NLQKD 238
Query: 253 GNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKE--LPAGAIVGIVL 310
GN ++GPAPPPPP T P S S +S +G+ S S +S + L AG + GIV+
Sbjct: 239 GNLLNSGPAPPPPPGTPPISKSSPTPKSGNRGNRSNGDSSNSKDSSKSGLGAGGVAGIVI 298
Query: 311 GAVFLVALALLALYFCIRKNRRKVSGARSSAGSF--PV--STNNMNTE--------MHEQ 358
+ + A+ L R R + + + P+ ++N+ + E + E
Sbjct: 299 SLIVVTAVIAFFLIKRKRSKRSSSTDIEKTDNNINQPIILASNDFHQENKSVQNPPLVET 358
Query: 359 RVKSVAAVTDLTPPPAEK----------LVIERVAKSGSLKKIKSPITATSYTVASLQTA 408
+ + +L PPP+E+ + VAK + + P +YTV+ LQ A
Sbjct: 359 KKLDTSLSMNLRPPPSERHKSFDDDDSTMRKPIVAKKAA---VVVPSNVNTYTVSDLQVA 415
Query: 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
TNSFS + L+GEG+ GRVYRA+F +GK++AVKKID++AL D+F E VS ++ L H
Sbjct: 416 TNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIVSKIAHLDHE 475
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N+ L GYC+EHGQ L+VYE+ NG+LHD LH A++ SK L WN RV++ALGTARALEYL
Sbjct: 476 NVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIALGTARALEYL 535
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
HEVC PS+VH+N KSANILLD ELNPHLSD GLA+ P T ++ Q GYSAPE +
Sbjct: 536 HEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFLP-TANELLNQ--NDEGYSAPETS 592
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+SG Y++KSDVYSFGVVMLELLTGRKP D
Sbjct: 593 MSGQYSLKSDVYSFGVVMLELLTGRKPFD 621
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K1|SRF5_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 5 OS=Arabidopsis thaliana GN=SRF5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 480 bits (1235), Expect = e-134, Method: Compositional matrix adjust.
Identities = 259/612 (42%), Positives = 369/612 (60%), Gaps = 33/612 (5%)
Query: 23 VLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG 82
++I+S+ +T++L+Q TD+ +V AL V++TSLNSPS L WK N GDPC +SW+GV C+G
Sbjct: 8 LVIVSLAITVTLLQAKTDNQEVSALNVMFTSLNSPSKLKGWKANGGDPCEDSWEGVKCKG 67
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
S+V + +SG L G+ GYLLS+L SL FDLS N++ IPYQLPPN+ +L+ + N
Sbjct: 68 SSVTELQLSGFELGGSRGYLLSNLKSLTTFDLSKNNLKGNIPYQLPPNIANLDFSENELD 127
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
GN+PYS++ M +L +N+ +N L + D+F L+ L TLD S N SG LP SF +L++
Sbjct: 128 GNVPYSLSQMKNLQSINLGQNKLNGELPDMFQKLSKLETLDFSLNKLSGKLPQSFANLTS 187
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+ L+LQ+N+ TG +NV L + LNV +N F GWIP EL I + + GN + AP
Sbjct: 188 LKKLHLQDNRFTGDINVLRNLAIDDLNVEDNQFEGWIPNELKDIDSLLTGGNDWSTETAP 247
Query: 263 PPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVAL---- 318
PPPP + R+ S S G ++ + AGA +G+++ + L+AL
Sbjct: 248 PPPPGV----------KYGRKSSGSKDGGGITAGTGMVIAGACLGVLVLIIVLIALVSKK 297
Query: 319 -ALLALYFCIRKNRRKVSGARS-----SAGSFPVSTNN-----MNTEMHEQRVKSVAA-- 365
+ L+ +F N +S SA V N + + ++ + + +
Sbjct: 298 KSSLSPHFIDEDNSHHTPKFKSLTSHGSAQELRVDFGNDYKDGKSGDSGDENIHRIGSKG 357
Query: 366 VTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGR 425
+ A + K+ S +A + ++ LQ+AT +FS L+GEGS+GR
Sbjct: 358 LKHYVSSRVMSFTDTEFANKLNAKRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGR 417
Query: 426 VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485
VYRA++++G+ +AVKKID+ + + V ++S++RH NI L GYC+E G +L
Sbjct: 418 VYRAKYSDGRTLAVKKIDSTLFDSGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNML 477
Query: 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545
VYEY NG+LH+ LH +D SK LTWN RVR+ALGTARA+EYLHE C PSV+H+N KS+N
Sbjct: 478 VYEYFRNGSLHEFLHLSDCFSKPLTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSN 537
Query: 546 ILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVV 605
ILLD +LNP LSD GL+ T +Q +G GY+APE YT KSDVYSFGVV
Sbjct: 538 ILLDADLNPRLSDYGLSKFYLRT-----SQNLGE-GYNAPEARDPSAYTPKSDVYSFGVV 591
Query: 606 MLELLTGRKPLD 617
MLELLTGR P D
Sbjct: 592 MLELLTGRVPFD 603
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K2|SRF4_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 4 OS=Arabidopsis thaliana GN=SRF4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1154), Expect = e-125, Method: Compositional matrix adjust.
Identities = 270/632 (42%), Positives = 366/632 (57%), Gaps = 55/632 (8%)
Query: 17 RLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWK 76
R++ F+ IF S+V TDS DV AL Y S+NSPS L W + GDPCG+SW
Sbjct: 7 RIVLVFIACFGIFT--SVVLAKTDSQDVSALNDAYKSMNSPSKLKGWSSSGGDPCGDSWD 64
Query: 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
G+ C+GS+V I +SG GLSG++GY L +L SL D+S N+++ +PYQLP LT L+
Sbjct: 65 GITCKGSSVTEIKVSGRGLSGSLGYQLGNLKSLTYLDVSKNNLNGNLPYQLPDKLTYLDG 124
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ N+F+GN+PYS++ M LSYLN+ RN+L + D+F L L T+DLS N +G LP S
Sbjct: 125 SENDFNGNVPYSVSLMNDLSYLNLGRNNLNGELSDMFQKLPKLETIDLSSNQLTGKLPQS 184
Query: 197 FISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNS 255
F +L+ + +L+LQ NQ GS+N LP + +NVANN F+GWIP EL +I GN
Sbjct: 185 FANLTGLKTLHLQENQFKGSINALRDLPQIDDVNVANNQFTGWIPNELKNIGNLETGGNK 244
Query: 256 FDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGI-VLGAVF 314
+ +G AP PPP G H +R+ S K L G I+ + +G +
Sbjct: 245 WSSGRAPSPPP------GTRHIDRNSS--------GGGGGSSKALTLGVIIAVSSIGGLI 290
Query: 315 LVALALLALYFCIRKNRRKVS-------GARSSAGSF-PVSTNNMNTEMHEQ--RVKSVA 364
L A L+AL RKN S G S F P S+ + + E+ K+V
Sbjct: 291 LFA-GLIAL-ISRRKNSNDSSHFFDDEKGTNRSKPLFTPQSSQMLQFDNMEEFKNQKTVD 348
Query: 365 AVTDLTPPPAEKLVIERVAKSG-----------------SLKKIKSPIT--ATSYTVASL 405
+ T L P+ K K+ S SP T ++++A L
Sbjct: 349 SNTSLETKPSVKRTSSVSFKNSPTFHLIPSTQVAATPDRSSTSQDSPDTRGVKAFSLADL 408
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
Q + FS L+GEG++GRVY+A+F +G+ AVK+ID++ L + F VS++S +
Sbjct: 409 QNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVKEIDSSLLGKGNPEEFSHIVSSISSI 468
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
H N+ L GYC+E G+ +LVYEY +G+LH LH +DD SK LTWN R+R+ALGTA+A+
Sbjct: 469 HHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLHLSDDFSKPLTWNTRIRIALGTAKAI 528
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
EYLHE C P +VH+N KS+NILLD+ELNP LSD GLA T + + GY+AP
Sbjct: 529 EYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYGLANFHHRTSQNL------GVGYNAP 582
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
E YT KSDVYSFGVVMLELLTGRKP D
Sbjct: 583 ECTDPSAYTQKSDVYSFGVVMLELLTGRKPYD 614
|
Acts as a direct positive regulator of leaf size but not leaf shape. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06BH3|SRF1_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 1 OS=Arabidopsis thaliana GN=SRF1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 429 bits (1104), Expect = e-119, Method: Compositional matrix adjust.
Identities = 288/676 (42%), Positives = 382/676 (56%), Gaps = 88/676 (13%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
+F LI L+L+L T+ DV A+ L+ +L SP +L W + GDPCGESW+GV C
Sbjct: 19 SFALISLPSLSLAL----TNPDDVAAINSLFLALESP-LLPGWVASGGDPCGESWQGVLC 73
Query: 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNN 140
S V +I + L G +G L+ SL+ D S N I +IP LP +L +L L+ NN
Sbjct: 74 NASQVETIILISANLGGELGVGLNMFTSLKAMDFSNNHIGGSIPSTLPVSLQNLFLSGNN 133
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
F+G +P S++S+ SLS ++++ N L+ I D+F +L + +DLS NN SG LP S +L
Sbjct: 134 FTGTIPESLSSLKSLSVMSLNNNLLSGKIPDVFQDLGLMINIDLSSNNLSGPLPPSMQNL 193
Query: 201 SNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260
S ++SL LQNN ++G L+V LPL LNV NN F+G IP +L+SI FI GN F+
Sbjct: 194 STLTSLLLQNNHLSGELDVLQDLPLKDLNVENNLFNGPIPEKLLSIPNFIKGGNLFNVTI 253
Query: 261 AP-------------------PPPPSTAPPSGRSHNN---RSHRQGSHSPSGSQSSSSDK 298
AP PP P+ + G++H H +P G + S + K
Sbjct: 254 APSPSPETPPSPTSPKRPFFGPPSPNASAGHGQAHVRSPPSDHHPSRPTPQGKEDSFTSK 313
Query: 299 ELPAGAIVGIVLGAVFLVALALLALYF---CIRKNR---------------RKVSGARSS 340
+ I +LGA V LAL+ L C+RK R G+RS+
Sbjct: 314 RI----IWISILGAFSFVVLALVCLLCGRKCLRKREDSEQLSKPHLTSEYGRAREGSRSN 369
Query: 341 AGSFPVS-TNNMNTE------------MHEQRVKSVAA--------------VTDLTPP- 372
A P S T N + E +H +SV + DL P
Sbjct: 370 ASMLPPSNTFNKDKEARPKERVGGASKLHGGAERSVGSESKQESHEIDMNGNAMDLMHPS 429
Query: 373 --PAEKLVIERVAK--SGSLKKIKS----PITATS-YTVASLQTATNSFSQEFLIGEGSL 423
P K VI + + SLK+ S P+TA +TVASLQ TNSFS E LIG G L
Sbjct: 430 SIPPIKRVIAKATEPAEASLKRTTSKSHGPLTAVKHFTVASLQQHTNSFSHENLIGTGML 489
Query: 424 GRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483
G VYRAE GK+ AV+K+D + + +EE FLE V+N+ R+RH NIV L G+C+EH QR
Sbjct: 490 GSVYRAELPGGKLFAVRKLDKKSPNHEEEGKFLELVNNIDRIRHANIVQLVGFCSEHSQR 549
Query: 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543
LL++EY NG LHD+LH D L+WN RVR+AL A+ALEYLHE+C P +HRNFKS
Sbjct: 550 LLIHEYCRNGTLHDLLHIDDRLKIELSWNVRVRIALEAAKALEYLHEICDPPSIHRNFKS 609
Query: 544 ANILLDDELNPHLSDCGLAAL-TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602
ANILLDD++ H+SDCGLA L + Q+S Q++ A+GY APEF GIYT+K DVYSF
Sbjct: 610 ANILLDDDIRVHVSDCGLAPLISSGAVSQLSGQLLAAYGYGAPEFEY-GIYTMKCDVYSF 668
Query: 603 GVVMLELLTGRKPLDR 618
GVVMLELLTGRK D+
Sbjct: 669 GVVMLELLTGRKSYDK 684
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FG24|SRF2_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 2 OS=Arabidopsis thaliana GN=SRF2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 250/629 (39%), Positives = 353/629 (56%), Gaps = 49/629 (7%)
Query: 21 AFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC 80
A +L+ +I L+ + TD +V ALQ LY SL +P L W+ GDPCGE+W G++C
Sbjct: 11 ATILLTTILFVLA--KTDTDPLEVLALQDLYKSLRNPEQLRGWRLEGGDPCGEAWLGISC 68
Query: 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNN 140
GS++V + + L L G++G L L +L+ D+S N++ IP+ LPPN T +N+A NN
Sbjct: 69 SGSSIVDLQLRELKLLGSLGNQLQHLHNLKILDVSFNNLEGEIPFGLPPNATHINMAYNN 128
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+ ++P+S+ M SL LN+S NSL+ +G++F L + +DLSFNN +GDLP+SF +L
Sbjct: 129 LTQSIPFSLPLMTSLQSLNLSHNSLSGPLGNVFSGLQ-IKEMDLSFNNLTGDLPSSFGTL 187
Query: 201 SNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGP 260
N++SLYLQNN++TGS+ + LPL LN+ +N FSG IP SI GN F P
Sbjct: 188 MNLTSLYLQNNRLTGSVIYLADLPLADLNIEDNQFSGIIPSHFQSIPHLWIWGNKFHVEP 247
Query: 261 APPP---PPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVF--- 314
P P P N + + S + + + GI G+ F
Sbjct: 248 NYKPWKFPLDVRP----LIQNDTGYPTTESSAIMNFPRPETQKVKKKKKGIGAGSTFLLV 303
Query: 315 ---LVALALLALYFCIRKNRRKVSGA-------RSSAGSFPVSTNN---MNTEMHEQRVK 361
+ AL F +R N R+ S A S PVST + TE + Q
Sbjct: 304 GGLALLGTFFAL-FAVRMNHRRAQNLAAIHRSNNSIAYSLPVSTGREYPVATEDNPQ--- 359
Query: 362 SVAAVTDLTPPPAEKL--------VIERVAKSGSLK-KIKSPITATSYTVASLQTATNSF 412
+ PPPA +L I++ A+ S + P A ++ A LQ ATN F
Sbjct: 360 ----IKRFQPPPAPQLRHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCF 415
Query: 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
S+E L+GEG LG VYRA+ +G+ V+ I ++LSL EE+ F E + S+LRHPNIVT
Sbjct: 416 SEENLLGEGPLGSVYRAKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVT 475
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G+C E+G+ LLVYEYVG+ +L++ +H D+ K L+W R+R+A+G ARAL+YLH
Sbjct: 476 LLGFCIENGEHLLVYEYVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSF 533
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV----STQMVGAFGYSAPEFA 588
P + H + K+ NILLD+EL P ++DCGLA+L P T V S + GY APE
Sbjct: 534 CPPIAHSDLKATNILLDEELTPRIADCGLASLRPLTSNSVKLRASEIAIQNTGYIAPEHG 593
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
G KSD Y+ GV++LELLTGRK D
Sbjct: 594 QPGSSGTKSDTYALGVLLLELLTGRKAFD 622
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K3|SRF3_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 3 OS=Arabidopsis thaliana GN=SRF3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (719), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 143/241 (59%), Positives = 174/241 (72%), Gaps = 5/241 (2%)
Query: 380 ERVAKSGSLKKIKSPITATS-YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMA 438
ER K S K++ P+T+ Y++ASLQ T SF+QE LIG G LG VYRA NGK+ A
Sbjct: 454 ERPVKKTSPKRL--PLTSVKHYSIASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFA 511
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
VKK+D A Q++ F+E V+N+ +RH NIV L GYCAEH QRLLVYEY NG L D
Sbjct: 512 VKKLDKRASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDG 571
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
LH D+ K L+WN RV +ALG ARALEYLHEVC P ++HRNFKSAN+LLDD+L+ +SD
Sbjct: 572 LHSDDEFKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSD 631
Query: 559 CGLAAL-TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
CGLA L + + Q+S Q++ A+GY APEF SGIYT +SDVYSFGVVMLELLTGR D
Sbjct: 632 CGLAPLISSGSVSQLSGQLLAAYGYGAPEFD-SGIYTWQSDVYSFGVVMLELLTGRMSYD 690
Query: 618 R 618
R
Sbjct: 691 R 691
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (638), Expect = 3e-65, Method: Compositional matrix adjust.
Identities = 178/546 (32%), Positives = 277/546 (50%), Gaps = 40/546 (7%)
Query: 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLAS 138
E +V I +S LSG + LS L +L DLSGN++ +IP ++ L LNLA+
Sbjct: 602 ECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLAN 661
Query: 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N +G++P S + SL LN+++N L + GNL L +DLSFNN SG+L +
Sbjct: 662 NQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELS 721
Query: 199 SLSNISSLYLQNNQVTGSLNVFSG--LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
++ + LY++ N+ TG + G L L+V+ N SG IP ++ + + +
Sbjct: 722 TMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAK 781
Query: 257 DN--GPAPP----PPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKEL-PAGAIVGIV 309
+N G P PS A SG +++ GS +L A I G++
Sbjct: 782 NNLRGEVPSDGVCQDPSKALLSG-------NKELCGRVVGSDCKIEGTKLRSAWGIAGLM 834
Query: 310 LGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDL 369
LG +V + + +L RR R P M E R+K +L
Sbjct: 835 LGFTIIVFVFVFSL-------RRWAMTKRVKQRDDP-------ERMEESRLKGFVD-QNL 879
Query: 370 TPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA 429
+ R S ++ + P+ + + AT+ FS++ +IG+G G VY+A
Sbjct: 880 YFLSGSR---SREPLSINIAMFEQPLLKVR--LGDIVEATDHFSKKNIIGDGGFGTVYKA 934
Query: 430 EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489
K +AVKK+ A Q F+ + + +++HPN+V+L GYC+ ++LLVYEY
Sbjct: 935 CLPGEKTVAVKKLSEA--KTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEY 992
Query: 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549
+ NG+L L + L W+ R+++A+G AR L +LH +P ++HR+ K++NILLD
Sbjct: 993 MVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLD 1052
Query: 550 DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLEL 609
+ P ++D GLA L E VST + G FGY PE+ S T K DVYSFGV++LEL
Sbjct: 1053 GDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLEL 1112
Query: 610 LTGRKP 615
+TG++P
Sbjct: 1113 VTGKEP 1118
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 171/547 (31%), Positives = 269/547 (49%), Gaps = 78/547 (14%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNN 140
+ +V +IS L+G + L +++++ DLSGN I +L L L L+ N
Sbjct: 523 TKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNR 582
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA-TLDLSFNNFSGDLPNSFIS 199
+G +P+S + L L + N L+++I G L L +L++S NN SG +P+S +
Sbjct: 583 LTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGN 642
Query: 200 LSNISSLYLQNNQVTGSLNVFSG--LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
L + LYL +N+++G + G + L N++NN+ G +P + R D ++F
Sbjct: 643 LQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRM---DSSNF- 698
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGA-------IVGIVL 310
A G ++ RSH Q P S S L G+ I IV+
Sbjct: 699 -----------AGNHGLCNSQRSHCQ----PLVPHSDSKLNWLINGSQRQKILTITCIVI 743
Query: 311 GAVFLVALALLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLT 370
G+VFL+ L L + I++ R + A+ D T
Sbjct: 744 GSVFLITF--LGLCWTIKR-----------------------------REPAFVALEDQT 772
Query: 371 PPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAE 430
P V S K +T L AT +FS++ ++G G+ G VY+AE
Sbjct: 773 KPD--------VMDSYYFPK-------KGFTYQGLVDATRNFSEDVVLGRGACGTVYKAE 817
Query: 431 FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490
+ G+++AVKK+++ +++F +S + ++RH NIV L G+C LL+YEY+
Sbjct: 818 MSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYM 877
Query: 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD 550
G+L + L + + L WNAR R+ALG A L YLH C P +VHR+ KS NILLD+
Sbjct: 878 SKGSLGEQLQRGEKNCL-LDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDE 936
Query: 551 ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610
H+ D GLA L + + + + G++GY APE+A + T K D+YSFGVV+LEL+
Sbjct: 937 RFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELI 996
Query: 611 TGRKPLD 617
TG+ P+
Sbjct: 997 TGKPPVQ 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 618 | ||||||
| 356555690 | 705 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.953 | 0.835 | 0.736 | 0.0 | |
| 356532229 | 706 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.943 | 0.825 | 0.741 | 0.0 | |
| 359494846 | 729 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.987 | 0.836 | 0.737 | 0.0 | |
| 297803912 | 703 | kinase [Arabidopsis lyrata subsp. lyrata | 0.953 | 0.837 | 0.721 | 0.0 | |
| 79481791 | 703 | STRUBBELIG-receptor family 8 protein [Ar | 0.948 | 0.833 | 0.717 | 0.0 | |
| 224117956 | 672 | predicted protein [Populus trichocarpa] | 0.912 | 0.839 | 0.771 | 0.0 | |
| 449455383 | 711 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.948 | 0.824 | 0.721 | 0.0 | |
| 255554777 | 640 | Serine/threonine-protein kinase PBS1, pu | 0.826 | 0.798 | 0.769 | 0.0 | |
| 449513527 | 647 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.870 | 0.831 | 0.686 | 0.0 | |
| 357138966 | 715 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.930 | 0.804 | 0.651 | 0.0 |
| >gi|356555690|ref|XP_003546163.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/599 (73%), Positives = 505/599 (84%), Gaps = 10/599 (1%)
Query: 23 VLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG 82
+L+ +F+ L L TD SDVQAL+V+Y +LNSP+ LT WK GDPCGESWKGV CEG
Sbjct: 10 ILLSLVFVALPLSLANTDPSDVQALEVMYNALNSPTQLTGWKIGGGDPCGESWKGVTCEG 69
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
SAVVSI +SGLGL GT+GYLLSDL+SLR+ DLS N IHDTIPYQLPPNLTSLN A NN S
Sbjct: 70 SAVVSIKLSGLGLDGTLGYLLSDLMSLRELDLSDNKIHDTIPYQLPPNLTSLNFARNNLS 129
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
GNLPYSI++MVSL+YLN+S N+L+ ++GDIF +L L TLDLSFNNFSGDLP SF++L+N
Sbjct: 130 GNLPYSISAMVSLNYLNLSNNALSMTVGDIFASLQDLGTLDLSFNNFSGDLPPSFVALAN 189
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+SSL+LQ NQ+TGSL V GLPL TLNVANN+FSGWIP EL SIR FIYDGNSF+N PAP
Sbjct: 190 LSSLFLQKNQLTGSLGVLVGLPLDTLNVANNNFSGWIPHELSSIRNFIYDGNSFENSPAP 249
Query: 263 PPPPSTAPPSGRSHNNRSHRQGSHSP---SGSQSSSSDKELPAGAIVGIVLGAVFLVALA 319
PP T+PP H GSH+ S ++ S K L GA+VGIVLG+V + A+
Sbjct: 250 LPPAFTSPPPNGPHGRHHSGSGSHNKTQVSDNEKSDGHKGLTVGAVVGIVLGSVLVAAIV 309
Query: 320 LLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVI 379
LLAL FCIRK + K GAR+ +GS P++ +M EQRVKS A VTDL P PAE + +
Sbjct: 310 LLALVFCIRKQKGK-KGARNFSGSLPLTP-----QMQEQRVKSAAVVTDLKPRPAENVTV 363
Query: 380 ERVA-KSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMA 438
ERVA KSGS+K++KSPIT+T YTVASLQ+ATNSFSQEF+IGEGSLGRVY+A+F NGK+MA
Sbjct: 364 ERVAVKSGSVKQMKSPITSTLYTVASLQSATNSFSQEFIIGEGSLGRVYKADFPNGKVMA 423
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
+KKIDN+ALSLQEEDNFLEAVSNMSRLRHP+IVTLAGYCAEHGQRLLVYEY+ NGNLHDM
Sbjct: 424 IKKIDNSALSLQEEDNFLEAVSNMSRLRHPSIVTLAGYCAEHGQRLLVYEYIANGNLHDM 483
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
LHFA+DSSK L+WNARVR+ALGTARALEYLHEVCLPSVVHRNFKSANILLD+ELNPHLSD
Sbjct: 484 LHFAEDSSKALSWNARVRIALGTARALEYLHEVCLPSVVHRNFKSANILLDEELNPHLSD 543
Query: 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
CGLAALTPNTERQVSTQMVG+FGYSAPEFALSG+YTVKSDVYSFGVVMLELLTGRKPLD
Sbjct: 544 CGLAALTPNTERQVSTQMVGSFGYSAPEFALSGVYTVKSDVYSFGVVMLELLTGRKPLD 602
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532229|ref|XP_003534676.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2272), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/596 (74%), Positives = 503/596 (84%), Gaps = 13/596 (2%)
Query: 28 IFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVS 87
IF+ L L TTD SDVQAL+V+Y LNSP+ LT WK GDPCGESWKGV CEGSAVVS
Sbjct: 15 IFVALPLSLATTDPSDVQALEVMYNVLNSPTQLTGWKIGGGDPCGESWKGVTCEGSAVVS 74
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY 147
I +SGLGL GT+GYLLSDL+SLR DLS N IHDTIPYQLPPNLTSLN A NN SGNLPY
Sbjct: 75 IKLSGLGLDGTLGYLLSDLMSLRDLDLSDNKIHDTIPYQLPPNLTSLNFARNNLSGNLPY 134
Query: 148 SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
SI++M SL+YLN+S N+L+ ++GDIF +L L TLDLSFNNFSGDLP S +L+N+SSL+
Sbjct: 135 SISAMGSLNYLNLSNNALSMTVGDIFASLQDLGTLDLSFNNFSGDLPPSVGALANLSSLF 194
Query: 208 LQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPS 267
LQ NQ+TGSL+ GLPL TLNVANN+FSGWIP EL SI FIYDGNSF+N PAP PP
Sbjct: 195 LQKNQLTGSLSALVGLPLDTLNVANNNFSGWIPHELSSIHNFIYDGNSFENRPAPLPPTV 254
Query: 268 TAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKE-----LPAGAIVGIVLGAVFLVALALLA 322
T+PP SH R H GS S + +Q+S ++K L GA++GIVLG+V + A+ LA
Sbjct: 255 TSPPPSGSH--RRHHSGSGSHNKTQASDNEKSNGHKGLTVGAVIGIVLGSVLVAAIVFLA 312
Query: 323 LYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV 382
L FCIRK + K GAR+ +GS P++ +M EQRVKS A VTDL P PAE + +ERV
Sbjct: 313 LVFCIRKQKGKKKGARNFSGSLPLTP-----QMQEQRVKSAAVVTDLKPRPAENVTVERV 367
Query: 383 A-KSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKK 441
A KSGS+K++KSPIT+TSYTVASLQ+ATNSFSQEF+IGEGSLGRVYRA+F NGK+MA+KK
Sbjct: 368 AVKSGSVKQMKSPITSTSYTVASLQSATNSFSQEFIIGEGSLGRVYRADFPNGKVMAIKK 427
Query: 442 IDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF 501
IDN+ALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY+ NGNLHDMLHF
Sbjct: 428 IDNSALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYIANGNLHDMLHF 487
Query: 502 ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
A+DSSK+L+WNARVR+ALGTARALEYLHEVCLPSVVHRNFKSANILLD+ELNPHLSDCGL
Sbjct: 488 AEDSSKDLSWNARVRIALGTARALEYLHEVCLPSVVHRNFKSANILLDEELNPHLSDCGL 547
Query: 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
AALTPNTERQVSTQMVG+FGYSAPEFALSG+YTVKSDVYSFGVVMLELLTGRKPLD
Sbjct: 548 AALTPNTERQVSTQMVGSFGYSAPEFALSGVYTVKSDVYSFGVVMLELLTGRKPLD 603
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494846|ref|XP_002267170.2| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Vitis vinifera] gi|297741762|emb|CBI32991.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 878 bits (2269), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/633 (73%), Positives = 519/633 (81%), Gaps = 23/633 (3%)
Query: 1 MAVQYTAVFPLPFSTSRLIDAFVLILS---IFLTLSLVQCTTDSSDVQALQVLYTSLNSP 57
MAV F S SR A +++ S I LS V TD SDVQ LQV+Y SLN P
Sbjct: 1 MAVNGALSFSCSHSHSRFFFALLVLFSFSAILPPLS-VYGATDPSDVQGLQVIYNSLNGP 59
Query: 58 SVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN 117
S LT W + GDPCGESWKGV CEGSAVVSI ISGLGL+GTMGYLLS+ LSLR D+S N
Sbjct: 60 SQLTGWTNSSGDPCGESWKGVTCEGSAVVSIQISGLGLNGTMGYLLSNFLSLRTLDMSDN 119
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IHDTIPYQLPPNLT+LNLASNN +G+ PYSI++MVSL+YLNVS NS++QSIGDIF LA
Sbjct: 120 NIHDTIPYQLPPNLTNLNLASNNLTGSFPYSISTMVSLNYLNVSHNSISQSIGDIFAKLA 179
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSG 237
GL LDLS NNF+GDLPNSF SLSN+S+LYLQNNQ+TG L+V +GLPLT LNVANN+FSG
Sbjct: 180 GLTILDLSVNNFTGDLPNSFTSLSNLSTLYLQNNQLTGPLSVLTGLPLTDLNVANNNFSG 239
Query: 238 WIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQS---- 293
WIP EL SIR FIYDGNSFDNGPAPPPPP T PP RS +NR+H SP +++
Sbjct: 240 WIPSELRSIRKFIYDGNSFDNGPAPPPPPYTPPPPSRSRSNRTH-----SPPEARTPSSS 294
Query: 294 -------SSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFPV 346
+ +K L G I+GIVLG++ LV +AL+AL FC+RK ++K +GAR S GS PV
Sbjct: 295 DGQSSNSDNGNKGLAIGPIIGIVLGSL-LVLVALIALVFCVRKAKKKGTGARPSVGSVPV 353
Query: 347 STNNMNTE-MHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVAS 404
T +NTE M EQR K A VTDL PPPAE L++ERV K+GS K++KSPITATSYTVAS
Sbjct: 354 VTEKVNTETMQEQRTKFTATVTDLKPPPAENLMVERVQGKNGSGKRVKSPITATSYTVAS 413
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQTATNSFSQEFLIGEGSLGRVYRA+F NGK MA+KKIDNAALSLQEEDNFLEAVSNMSR
Sbjct: 414 LQTATNSFSQEFLIGEGSLGRVYRADFPNGKTMAIKKIDNAALSLQEEDNFLEAVSNMSR 473
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
LRH NIVTL GYCAEHGQRLLVYEY+GNG+LHDMLHF DDS K LTWNARVRVALGTARA
Sbjct: 474 LRHQNIVTLVGYCAEHGQRLLVYEYIGNGSLHDMLHFTDDSGKTLTWNARVRVALGTARA 533
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LEYLHEVCLPS VHRNFKSANILLD+ELNPHLSDCGLAALTPNTERQVSTQMVG+FGYSA
Sbjct: 534 LEYLHEVCLPSTVHRNFKSANILLDEELNPHLSDCGLAALTPNTERQVSTQMVGSFGYSA 593
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD
Sbjct: 594 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 626
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297803912|ref|XP_002869840.1| kinase [Arabidopsis lyrata subsp. lyrata] gi|297315676|gb|EFH46099.1| kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2259), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/604 (72%), Positives = 494/604 (81%), Gaps = 15/604 (2%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
+ +L +++ S+V C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWKG
Sbjct: 8 MFTVLLLFIALISGFSIVSCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKG 67
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
+ CEGSAVVSIDIS LG+SGT+GYLLSDL+SLRK D+SGNSIHDT+PYQLPPNLTSLNLA
Sbjct: 68 ITCEGSAVVSIDISDLGVSGTLGYLLSDLMSLRKLDVSGNSIHDTLPYQLPPNLTSLNLA 127
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
NN SGNLPYSI++M SLSYLNVS NSLT SIGDIF + L+TLDLS NNFSGDLP+S
Sbjct: 128 RNNLSGNLPYSISAMGSLSYLNVSGNSLTMSIGDIFADHKSLSTLDLSHNNFSGDLPSSL 187
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
++S +S LY+QNNQ+TGS++V SGLPLTTLNVANNHF+G IP+EL SI+T IYDGNSFD
Sbjct: 188 STVSALSVLYVQNNQLTGSIDVLSGLPLTTLNVANNHFNGSIPKELSSIQTLIYDGNSFD 247
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAVF 314
N PA P P + GS P GS+ SSD K L G + GIV G++F
Sbjct: 248 NVPATPQPERPG--------KKGEPSGSKKPKIGSEKKSSDSGKGLSGGVVTGIVFGSLF 299
Query: 315 LVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPP 373
+ + L LY C+ K +RKV G+ R+S S P+S EM EQRVKSVA+V DL P
Sbjct: 300 VAGIIALVLYLCLHKKKRKVGGSTRASQRSLPLSGT---PEMQEQRVKSVASVADLKSSP 356
Query: 374 AEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFAN 433
AEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF N
Sbjct: 357 AEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPN 416
Query: 434 GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493
GKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGNG
Sbjct: 417 GKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNG 476
Query: 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553
NL DMLH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+ELN
Sbjct: 477 NLDDMLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELN 536
Query: 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
PHLSD GLAALTPNTERQVSTQ+VG+FGYSAPEFALSGIYTVKSDVY+FGVVMLELLTGR
Sbjct: 537 PHLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGR 596
Query: 614 KPLD 617
KPLD
Sbjct: 597 KPLD 600
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79481791|ref|NP_193944.2| STRUBBELIG-receptor family 8 protein [Arabidopsis thaliana] gi|75127758|sp|Q6R2J8.1|SRF8_ARATH RecName: Full=Protein STRUBBELIG-RECEPTOR FAMILY 8; AltName: Full=Leucine-rich repeat receptor kinase-like protein SRF8; Flags: Precursor gi|41323415|gb|AAR99876.1| strubbelig receptor family 8 [Arabidopsis thaliana] gi|224589624|gb|ACN59345.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332659160|gb|AEE84560.1| STRUBBELIG-receptor family 8 protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2208), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/605 (71%), Positives = 492/605 (81%), Gaps = 19/605 (3%)
Query: 21 AFVLILSIFLT----LSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWK 76
A +L +F+ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWK
Sbjct: 7 AMFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWK 66
Query: 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
G+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNL
Sbjct: 67 GITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNL 126
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
A NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGDLP+S
Sbjct: 127 ARNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSS 186
Query: 197 FISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
++S +S LY+QNNQ+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSF
Sbjct: 187 LSTVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSF 246
Query: 257 DNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS-GSQSSSSD--KELPAGAIVGIVLGAV 313
DN PA P P + GS P GS+ SSD K L G + GIV G++
Sbjct: 247 DNVPASPQPERPG--------KKETPSGSKKPKIGSEEKSSDSGKGLSGGVVTGIVFGSL 298
Query: 314 FLVALALLALYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPP 372
F+ + L LY C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL
Sbjct: 299 FVAGIIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSS 355
Query: 373 PAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA 432
PAEK+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF
Sbjct: 356 PAEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFP 415
Query: 433 NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492
NGKIMA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGN
Sbjct: 416 NGKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGN 475
Query: 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
GNL D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+EL
Sbjct: 476 GNLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEEL 535
Query: 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG 612
NPHLSD GLAALTPNTERQVSTQ+VG+FGYSAPEFALSGIYTVKSDVY+FGVVMLELLTG
Sbjct: 536 NPHLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTG 595
Query: 613 RKPLD 617
RKPLD
Sbjct: 596 RKPLD 600
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117956|ref|XP_002331522.1| predicted protein [Populus trichocarpa] gi|222873746|gb|EEF10877.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/573 (77%), Positives = 498/573 (86%), Gaps = 9/573 (1%)
Query: 50 LYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSL 109
+YTSLNSPS LT WK N GDPC ESWKG+ CEGSAVVSI ISGLGL GTMGYLL++L+SL
Sbjct: 1 MYTSLNSPSQLTTWKSNGGDPCAESWKGITCEGSAVVSIQISGLGLDGTMGYLLANLMSL 60
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R DLS N +HD+ PYQLPPNLTSLNLA NN SGN+PYS++SMVSLSYLN+SRNSL QSI
Sbjct: 61 RTLDLSDNHLHDSFPYQLPPNLTSLNLAKNNLSGNIPYSMSSMVSLSYLNISRNSLAQSI 120
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN 229
GD+F NL+ LAT+DLSFN+FSGDLP+SF SLSN+S+L +QNNQ+TGSLNV +GLPLTTLN
Sbjct: 121 GDVFLNLSLLATMDLSFNSFSGDLPSSFNSLSNLSTLNVQNNQLTGSLNVLTGLPLTTLN 180
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSP- 288
VANN+FSGWIP+EL SI FIYDGNSFDNGP+PPPPP T PP G+SH NR+H GS +P
Sbjct: 181 VANNNFSGWIPQELSSIPNFIYDGNSFDNGPSPPPPPYTPPPPGKSHRNRTH-PGSGAPV 239
Query: 289 ---SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSFP 345
S Q S SDK + GAIVG+ LG++ LV + LLAL FCI+K++ K G ++ GS P
Sbjct: 240 TPSSDGQPSQSDKGISVGAIVGVALGSLVLVLIVLLALVFCIKKHKSKEIGPLATRGSRP 299
Query: 346 VSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVAS 404
T++ M E RVK++AAVTDL PPPAEKLV+ER+ SGS+K++KSPITATSY+VAS
Sbjct: 300 ADTDD---NMQESRVKNMAAVTDLKPPPAEKLVVERLQGNSGSIKRMKSPITATSYSVAS 356
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQTATNSFSQEFLIGEGSLGRVYR EF NGK+MAVKKIDNAALSLQEEDNFLEAVSNMS
Sbjct: 357 LQTATNSFSQEFLIGEGSLGRVYRGEFPNGKMMAVKKIDNAALSLQEEDNFLEAVSNMSH 416
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
LRHPNIV+L GYC EHGQRLLVYEY+ NG++HD+LHFADD SK L+WNARVRVALGTARA
Sbjct: 417 LRHPNIVSLVGYCVEHGQRLLVYEYIANGSVHDILHFADDGSKTLSWNARVRVALGTARA 476
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LEYLHEVCLPSVVHRN KSANILLD+ELNPHLSDCGLAALTPNTERQVSTQMVG+FGYSA
Sbjct: 477 LEYLHEVCLPSVVHRNLKSANILLDEELNPHLSDCGLAALTPNTERQVSTQMVGSFGYSA 536
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD
Sbjct: 537 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 569
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455383|ref|XP_004145432.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 840 bits (2170), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/593 (72%), Positives = 499/593 (84%), Gaps = 7/593 (1%)
Query: 31 TLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDI 90
++ ++ TD+SDVQALQV+YTSL+SP LT W + GDPC ESWKGV CEGSAVVSI+I
Sbjct: 17 SIPFLRAHTDASDVQALQVMYTSLDSPPQLTGWIVSGGDPCAESWKGVTCEGSAVVSIEI 76
Query: 91 SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
SGLGL+GTMGY LS LSL+K D+S NSIHD +PYQLPPNLTSLN+A N+ GNLPYS++
Sbjct: 77 SGLGLNGTMGYALSSFLSLKKLDMSDNSIHDAVPYQLPPNLTSLNMAKNSLIGNLPYSLS 136
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+M SL+YLN+S N L+Q IGD+F NL L TLDLSFNNF+GDLP S +LSN+SSL+ QN
Sbjct: 137 TMASLNYLNMSHNLLSQVIGDVFTNLTTLETLDLSFNNFTGDLPKSLGTLSNVSSLFFQN 196
Query: 211 NQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAP 270
N++TGSLN+ LPLTTLNVANN+FSGWIP+EL S+ +FIYDGNSFDN PAPPPPP T P
Sbjct: 197 NRLTGSLNILIDLPLTTLNVANNNFSGWIPQELKSVESFIYDGNSFDNSPAPPPPPFTPP 256
Query: 271 PSGRSHNNRSH---RQGSHSP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYF 325
P GRS N+ H G+H+ S SS S+K LP AIVGIVLGA+ V + L+A
Sbjct: 257 PPGRSRNSPKHPGSSGGTHTAPSSEGSSSHSNKGLPVLAIVGIVLGAIIFVLIVLVAFAV 316
Query: 326 CIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AK 384
C +K +RK G R+S+G + T+ +N E+ E RVKSVAAV D+ P PAEK+ ER+ AK
Sbjct: 317 CFQKRKRKNIGLRASSGRLSIGTS-VNAEVQEHRVKSVAAVADIKPLPAEKMNPERLQAK 375
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDN 444
+GS+K+IK+PITATSYTVASLQ ATNSFSQE ++GEGSLGRVY+AEF NGK MA+KKIDN
Sbjct: 376 NGSVKRIKAPITATSYTVASLQAATNSFSQECIVGEGSLGRVYKAEFPNGKTMAIKKIDN 435
Query: 445 AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD 504
+ALSLQEEDNFLEAVSNMSRLRH NIVTL GYCAEHGQRLLVYE++G+G+LHDMLHFA++
Sbjct: 436 SALSLQEEDNFLEAVSNMSRLRHTNIVTLNGYCAEHGQRLLVYEFIGHGSLHDMLHFAEE 495
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564
SSK LTWNARVRVALGTARALEYLHEVCLPSVVHRN K+ANILLD++LNPHLSDCGLAAL
Sbjct: 496 SSKTLTWNARVRVALGTARALEYLHEVCLPSVVHRNLKTANILLDEDLNPHLSDCGLAAL 555
Query: 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
TPNTERQ+STQMVG+FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD
Sbjct: 556 TPNTERQISTQMVGSFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 608
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554777|ref|XP_002518426.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223542271|gb|EEF43813.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/524 (76%), Positives = 455/524 (86%), Gaps = 13/524 (2%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
L + DLS N+IHDTIPYQLPPNLTSLNLA NN SGNLPYSI++MVSL+YLN+S NS++
Sbjct: 14 LRFKGIDLSDNNIHDTIPYQLPPNLTSLNLARNNLSGNLPYSISTMVSLTYLNMSHNSIS 73
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLT 226
QS+GD+F NLA L TLDLSFNNFSG+LP+SF SLSN+S+ Y+QNNQ+TGSL+V +GLPLT
Sbjct: 74 QSVGDVFANLALLTTLDLSFNNFSGNLPSSFSSLSNLSTFYIQNNQLTGSLDVLAGLPLT 133
Query: 227 TLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHR-QGS 285
TLNVANNH +GWIPREL S+ FIYDGNSFDNGPAPPPPP T PP GRS NN SH G+
Sbjct: 134 TLNVANNHLTGWIPRELNSVPNFIYDGNSFDNGPAPPPPPYTPPPPGRSRNNHSHSGSGT 193
Query: 286 HSP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGS 343
+P S QSS SDK + GAIVGIVLG+V L+ +ALLA+ FC RK ++K GA S GS
Sbjct: 194 RTPPSSDDQSSESDKGMSVGAIVGIVLGSVLLIFIALLAVLFCTRKKKQKDGGAIVSQGS 253
Query: 344 FPVSTNNM---------NTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKS 393
T + +TEM EQRVKS+AAV DL PPPAEKLV++++ SGS+K++KS
Sbjct: 254 RSAGTTDSAKFSSVIAGDTEMQEQRVKSIAAVADLKPPPAEKLVVDKLQGHSGSVKRMKS 313
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
PITATSYTVASLQTATNSFSQEF+IGEGSLGRVYR EF+NGKIMA+KKIDNAALSLQEED
Sbjct: 314 PITATSYTVASLQTATNSFSQEFIIGEGSLGRVYRGEFSNGKIMAIKKIDNAALSLQEED 373
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
NFLEAVSNMSRLRHPNIV+LAGYCAEHGQRLLVYE++GNG+LHDMLHFA+D SK L+WNA
Sbjct: 374 NFLEAVSNMSRLRHPNIVSLAGYCAEHGQRLLVYEHIGNGSLHDMLHFAEDGSKTLSWNA 433
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
RVRVALGTARALEYLHEVCLPS+VHRNFKSANILLD+ELNPHLSDCGLAALTPNTERQVS
Sbjct: 434 RVRVALGTARALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDCGLAALTPNTERQVS 493
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
TQMVG+FGYSAPEFALSG+YTVKSDVYSFGVVMLELLTGRKPLD
Sbjct: 494 TQMVGSFGYSAPEFALSGVYTVKSDVYSFGVVMLELLTGRKPLD 537
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449513527|ref|XP_004164349.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/574 (68%), Positives = 456/574 (79%), Gaps = 36/574 (6%)
Query: 50 LYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSL 109
+YTSL+SP LT W + GDPC ESWKGV CEGSAVVSI+ISGLGL+GTMGY LS LSL
Sbjct: 1 MYTSLDSPPQLTGWIVSGGDPCAESWKGVTCEGSAVVSIEISGLGLNGTMGYALSSFLSL 60
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
+K D+S NSIHD +PYQLPPNLTSLN+A N+ GNLPYS+++M SL+YLN+S N L+Q I
Sbjct: 61 KKLDMSDNSIHDAVPYQLPPNLTSLNMAKNSLIGNLPYSLSTMASLNYLNMSHNLLSQVI 120
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN 229
GD+F NL L TLDLSFNNF+GDLP S +LSN+SSL+ QNN++TGSLN+ LPLTTLN
Sbjct: 121 GDVFTNLTTLETLDLSFNNFTGDLPKSLGTLSNVSSLFFQNNRLTGSLNILIDLPLTTLN 180
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSH---RQGSH 286
VANN+FSGWIP+EL S+ +FIYDGNSFDN PAPPPPP T PP GRS N+ H G+H
Sbjct: 181 VANNNFSGWIPQELKSVESFIYDGNSFDNSPAPPPPPFTPPPPGRSRNSPKHPGSSGGTH 240
Query: 287 SP--SGSQSSSSDKELPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKVSGARSSAGSF 344
+ S SS S+K LP AIVGIVLGA+ V + L+A C +K +RK G R+S+G
Sbjct: 241 TAPSSEGSSSHSNKGLPVLAIVGIVLGAIIFVLIVLVAFAVCFQKRKRKNIGLRASSGRL 300
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSGSLKKIKSPITATSYTVA 403
+ T+ +N E+ E RVKSVAAV D+ P PAEK+ ER+ AK+GS+K+IK+PITATSYTVA
Sbjct: 301 SIGTS-VNAEVQEHRVKSVAAVADIKPLPAEKMNPERLQAKNGSVKRIKAPITATSYTVA 359
Query: 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
SLQ ATNSFSQE ++GEGSLGRVY+AEF NGK MA+KKIDN+ALSLQEEDNFLEAVSNMS
Sbjct: 360 SLQAATNSFSQECIVGEGSLGRVYKAEFPNGKTMAIKKIDNSALSLQEEDNFLEAVSNMS 419
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
RLRH NIVTL ++SSK LTWNARVRVALGTAR
Sbjct: 420 RLRHTNIVTL-----------------------------NESSKTLTWNARVRVALGTAR 450
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
ALEYLHEVCLPSVVHRN K+ANILLD++LNPHLSDCGLAALTPNTERQ+STQMVG+FGYS
Sbjct: 451 ALEYLHEVCLPSVVHRNLKTANILLDEDLNPHLSDCGLAALTPNTERQISTQMVGSFGYS 510
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD
Sbjct: 511 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 544
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357138966|ref|XP_003571057.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/591 (65%), Positives = 458/591 (77%), Gaps = 16/591 (2%)
Query: 40 DSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTM 99
+SSD AL LYTS NSPS L W + GDPCG W+GV+C GS V I ++G GL+G++
Sbjct: 23 ESSDAAALGNLYTSWNSPSQLAGWSASGGDPCGAGWQGVSCNGSGVTEIKLAGTGLNGSL 82
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
GY LS+L SL+ DLS N+IH +IPYQLPPNLT LNLA+NNFSGNLPYSI++M S+ YLN
Sbjct: 83 GYELSNLYSLKTLDLSNNNIHGSIPYQLPPNLTYLNLATNNFSGNLPYSISNMASIEYLN 142
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+S NSL+Q IGD+F NL L+ LD+SFN +GDLPNS SLSNISSLY+QNNQ+TG +NV
Sbjct: 143 ISHNSLSQQIGDLFRNLNSLSELDISFNKLTGDLPNSIGSLSNISSLYMQNNQLTGPVNV 202
Query: 220 FSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNR 279
SGL LTTLN+ANN+FSGWIP+E SI I GNSF NGPAPPPPP PP R N
Sbjct: 203 LSGLGLTTLNIANNNFSGWIPKEFSSIPDVILGGNSFANGPAPPPPPFMPPPPRRPRNRP 262
Query: 280 SHRQGS-HSPSGSQSSSS--DKE--LPAGAIVGIVLGAVFLVALALLALYFCIRKNRRKV 334
++ GS ++P GS+SS+ DK+ L GA+VGI++G++ LL L CIR R++
Sbjct: 263 NNSGGSGNAPKGSESSTGQGDKKQGLQTGALVGIIVGSILAALCVLLVLVLCIRNARKRK 322
Query: 335 SGARSSAGSF--PVSTN-----NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERV-AKSG 386
+ S + F P+S N + H SVAA+ L PAEK+ ERV +G
Sbjct: 323 DDSSSESKDFVGPLSVNIQEASDREIAEHGHENTSVAAMKVL---PAEKMTPERVYGING 379
Query: 387 SLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAA 446
S++K K PITAT YTVASLQ ATNSF Q+ L+GEGSLGRVY+A+F NGK++AVKKID+AA
Sbjct: 380 SMRKAKVPITATPYTVASLQVATNSFCQDSLLGEGSLGRVYKADFPNGKVLAVKKIDSAA 439
Query: 447 LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS 506
LSLQEEDNFLE VS+MSRLRHPNIV L GYC EH QRLLVYEY+GNG LHDMLHF+D+ S
Sbjct: 440 LSLQEEDNFLEVVSSMSRLRHPNIVPLTGYCVEHAQRLLVYEYIGNGTLHDMLHFSDEMS 499
Query: 507 KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
+ LTWN RVR+ALGTARALEYLHEVCLPSVVHRNFKS+NILLD+E N HLSDCGLAALTP
Sbjct: 500 RKLTWNIRVRIALGTARALEYLHEVCLPSVVHRNFKSSNILLDEEHNAHLSDCGLAALTP 559
Query: 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
NTERQVST++VG+FGYSAPE+++SGIYTVKSDVYSFGVVMLELLTGRKPLD
Sbjct: 560 NTERQVSTEVVGSFGYSAPEYSMSGIYTVKSDVYSFGVVMLELLTGRKPLD 610
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 618 | ||||||
| TAIR|locus:2120683 | 703 | SRF8 "STRUBBELIG-receptor fami | 0.957 | 0.842 | 0.672 | 6e-206 | |
| TAIR|locus:2091015 | 717 | SRF7 "STRUBBELIG-receptor fami | 0.425 | 0.366 | 0.549 | 1.3e-124 | |
| TAIR|locus:2024837 | 720 | SRF6 "STRUBBELIG-receptor fami | 0.961 | 0.825 | 0.430 | 1.3e-123 | |
| TAIR|locus:2207280 | 699 | SRF5 "STRUBBELIG-receptor fami | 0.360 | 0.319 | 0.537 | 2.9e-114 | |
| TAIR|locus:2089210 | 687 | SRF4 "STRUBBELIG-receptor fami | 0.427 | 0.384 | 0.476 | 2.3e-112 | |
| TAIR|locus:2125566 | 776 | SRF3 "STRUBBELIG-receptor fami | 0.396 | 0.315 | 0.575 | 3e-112 | |
| TAIR|locus:2051404 | 775 | SRF1 "STRUBBELIG-receptor fami | 0.446 | 0.356 | 0.520 | 9e-111 | |
| TAIR|locus:2170219 | 735 | SRF2 "STRUBBELIG-receptor fami | 0.464 | 0.390 | 0.424 | 6e-99 | |
| TAIR|locus:2202084 | 768 | SUB "STRUBBELIG" [Arabidopsis | 0.357 | 0.287 | 0.535 | 2.9e-97 | |
| TAIR|locus:2154709 | 1036 | PSKR2 "phytosylfokine-alpha re | 0.347 | 0.207 | 0.451 | 1.9e-65 |
| TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1992 (706.3 bits), Expect = 6.0e-206, P = 6.0e-206
Identities = 404/601 (67%), Positives = 452/601 (75%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
+ +L ++ S+V+C TD SDVQALQVLYTSLNSPS LTNWK GDPCGESWKG
Sbjct: 8 MFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKG 67
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
+ CEGSAVV+IDIS LG+SGT+GYLLSDL SLRK D+SGNSIHDT+PYQLPPNLTSLNLA
Sbjct: 68 ITCEGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNLA 127
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDXXXXX 197
NN SGNLPYSI++M SLSY+NVS NSLT SIGDIF + LATLDLS NNFSGD
Sbjct: 128 RNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSSL 187
Query: 198 XXXXXXXXXXXXXXQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
Q+TGS++V SGLPL TLNVANNHF+G IP+EL SI+T IYDGNSFD
Sbjct: 188 STVSTLSVLYVQNNQLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSFD 247
Query: 258 NGXXXXXXXXXXXXXGRSHNNXXXXXXXXXXXXXXXXXXDKELPAGAXXXXXXXXXXXXX 317
N G+ K L G
Sbjct: 248 N----VPASPQPERPGKKETPSGSKKPKIGSEEKSSDSG-KGLSGGVVTGIVFGSLFVAG 302
Query: 318 XXXXXXYFCIRKNRRKVSGA-RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEK 376
Y C+ K +RKV G+ R+S S P+S E+ EQRVKSVA+V DL PAEK
Sbjct: 303 IIALVLYLCLHKKKRKVRGSTRASQRSLPLSGT---PEVQEQRVKSVASVADLKSSPAEK 359
Query: 377 LVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKI 436
+ ++RV K+GS+ +I+SPITA+ YTV+SLQ ATNSFSQE +IGEGSLGRVYRAEF NGKI
Sbjct: 360 VTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKI 419
Query: 437 MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLH 496
MA+KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV LAGYC EHGQRLLVYEYVGNGNL
Sbjct: 420 MAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLD 479
Query: 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556
D LH DD S NLTWNARV+VALGTA+ALEYLHEVCLPS+VHRNFKSANILLD+ELNPHL
Sbjct: 480 DTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHL 539
Query: 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
SD GLAALTPNTERQVSTQ+VG+FGYSAPEFALSGIYTVKSDVY+FGVVMLELLTGRKPL
Sbjct: 540 SDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPL 599
Query: 617 D 617
D
Sbjct: 600 D 600
|
|
| TAIR|locus:2091015 SRF7 "STRUBBELIG-receptor family 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 1.3e-124, Sum P(2) = 1.3e-124
Identities = 150/273 (54%), Positives = 190/273 (69%)
Query: 352 NTEMHEQRVKSVAAVTDLTPPPAEKLVI-----ERVAKSGSLKK--IKSPITATSYTVAS 404
N + E + + +L PPP+E+ + K KK + P +YTV+
Sbjct: 352 NPPLVETKKLDTSLSMNLRPPPSERHKSFDDDDSTMRKPIVAKKAAVVVPSNVNTYTVSD 411
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
LQ ATNSFS + L+GEG+ GRVYRA+F +GK++AVKKID++AL D+F E VS ++
Sbjct: 412 LQVATNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIVSKIAH 471
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L H N+ L GYC+EHGQ L+VYE+ NG+LHD LH A++ SK L WN RV++ALGTARA
Sbjct: 472 LDHENVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIALGTARA 531
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LEYLHEVC PS+VH+N KSANILLD ELNPHLSD GLA+ P T ++ Q GYSA
Sbjct: 532 LEYLHEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFLP-TANELLNQ--NDEGYSA 588
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
PE ++SG Y++KSDVYSFGVVMLELLTGRKP D
Sbjct: 589 PETSMSGQYSLKSDVYSFGVVMLELLTGRKPFD 621
|
|
| TAIR|locus:2024837 SRF6 "STRUBBELIG-receptor family 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 1.3e-123, P = 1.3e-123
Identities = 266/618 (43%), Positives = 355/618 (57%)
Query: 18 LIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKG 77
++ F L + F L + TD+SD AL L++ ++SP+ LT W GDPCG++W+G
Sbjct: 7 VVALFTLCIVGF-ELRFIHGATDASDTSALNTLFSGMHSPAQLTQWTAAAGDPCGQNWRG 65
Query: 78 VACEGSAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNL 136
V C GS V I +SGL LSGT+G Y+L L SL + DLS N++ +PYQ PPNL LNL
Sbjct: 66 VTCSGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPPNLQRLNL 125
Query: 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDXXXX 196
A+N F+G YS++ + L YLN+ N I F L L TLD SFN+F+
Sbjct: 126 ANNQFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLPAT 185
Query: 197 XXXXXXXXXXXXXXXQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
Q +G+++V +GLPL TLN+ANN F+GWIP L I T I DGNSF
Sbjct: 186 FSSLTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TLIKDGNSF 244
Query: 257 DNGXXXXXXXXXXXXXGRSHNNXXXXXXXXXXXXXXXXXXDKELPAGAXXXXXXXXXXXX 316
+ G G S + K+ GA
Sbjct: 245 NTGPAPPPPPGTPPIRG-SPSRKSGGRESRSSDESTRNGDSKKSGIGAGAIAGIIISLLV 303
Query: 317 XXXXXXXYFCIRKNRRKVSGA----RSSAGSFPVSTNNMNTEMHEQRVKSV-------AA 365
+F R+ + K S ++ F +++N+ + Q SV +
Sbjct: 304 VTALLVAFFLFRRKKSKRSSPMDIEKTDNQPFTLASNDFHENNSIQSSSSVETKKLDTSL 363
Query: 366 VTDLTPPPAEKLVI----ERVAKSGSLKK--IKSPITATSYTVASLQTATNSFSQEFLIG 419
+L PPP ++ + K ++KK + P Y+VA LQ AT SFS + L+G
Sbjct: 364 SINLRPPPIDRNKSFDDEDSTRKPIAVKKSTVVVPSNVRLYSVADLQIATGSFSVDNLLG 423
Query: 420 EGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479
EG+ GRVYRAEF +GK++AVKKID++AL D+F+E VS ++ L HPN+ L GYCAE
Sbjct: 424 EGTFGRVYRAEFDDGKVLAVKKIDSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAE 483
Query: 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHR 539
HGQ L+VYE+ NG+LHD LH +++ SK L WN+RV++ALGTARALEYLHEVC PS+V +
Sbjct: 484 HGQHLVVYEFHKNGSLHDFLHLSEEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDK 543
Query: 540 NFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDV 599
N KSANILLD ELNPHLSD GLA+ P T ++ Q GYSAPE ++SG Y++KSD+
Sbjct: 544 NIKSANILLDSELNPHLSDSGLASFLP-TANELLNQTDE--GYSAPEVSMSGQYSLKSDI 600
Query: 600 YSFGVVMLELLTGRKPLD 617
YSFGVVMLELLTGRKP D
Sbjct: 601 YSFGVVMLELLTGRKPFD 618
|
|
| TAIR|locus:2207280 SRF5 "STRUBBELIG-receptor family 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 2.9e-114, Sum P(2) = 2.9e-114
Identities = 123/229 (53%), Positives = 160/229 (69%)
Query: 389 KKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS 448
K+ S +A + ++ LQ+AT +FS L+GEGS+GRVYRA++++G+ +AVKKID+
Sbjct: 381 KRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLFD 440
Query: 449 LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN 508
+ + V ++S++RH NI L GYC+E G +LVYEY NG+LH+ LH +D SK
Sbjct: 441 SGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNMLVYEYFRNGSLHEFLHLSDCFSKP 500
Query: 509 LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
LTWN RVR+ALGTARA+EYLHE C PSV+H+N KS+NILLD +LNP LSD GL+ T
Sbjct: 501 LTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSNILLDADLNPRLSDYGLSKFYLRT 560
Query: 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+Q +G GY+APE YT KSDVYSFGVVMLELLTGR P D
Sbjct: 561 -----SQNLGE-GYNAPEARDPSAYTPKSDVYSFGVVMLELLTGRVPFD 603
|
|
| TAIR|locus:2089210 SRF4 "STRUBBELIG-receptor family 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 2.3e-112, Sum P(2) = 2.3e-112
Identities = 131/275 (47%), Positives = 177/275 (64%)
Query: 348 TNNMNTEMHEQ-RVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIK--SPIT--ATSYTV 402
T + NT + + VK ++V+ P + +VA + SP T ++++
Sbjct: 346 TVDSNTSLETKPSVKRTSSVSFKNSPTFHLIPSTQVAATPDRSSTSQDSPDTRGVKAFSL 405
Query: 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNM 462
A LQ + FS L+GEG++GRVY+A+F +G+ AVK+ID++ L + F VS++
Sbjct: 406 ADLQNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVKEIDSSLLGKGNPEEFSHIVSSI 465
Query: 463 SRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
S + H N+ L GYC+E G+ +LVYEY +G+LH LH +DD SK LTWN R+R+ALGTA
Sbjct: 466 SSIHHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLHLSDDFSKPLTWNTRIRIALGTA 525
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
+A+EYLHE C P +VH+N KS+NILLD+ELNP LSD GLA N + S Q +G GY
Sbjct: 526 KAIEYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYGLA----NFHHRTS-QNLGV-GY 579
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+APE YT KSDVYSFGVVMLELLTGRKP D
Sbjct: 580 NAPECTDPSAYTQKSDVYSFGVVMLELLTGRKPYD 614
|
|
| TAIR|locus:2125566 SRF3 "STRUBBELIG-receptor family 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 3.0e-112, Sum P(2) = 3.0e-112
Identities = 148/257 (57%), Positives = 181/257 (70%)
Query: 371 PPPA-EKLVI------ERVAKSGSLKKIKSPITATS-YTVASLQTATNSFSQEFLIGEGS 422
PPP EK+ + ER K S K++ P+T+ Y++ASLQ T SF+QE LIG G
Sbjct: 438 PPPLDEKVTVMPIISPERPVKKTSPKRL--PLTSVKHYSIASLQQYTESFAQENLIGSGM 495
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482
LG VYRA NGK+ AVKK+D A Q++ F+E V+N+ +RH NIV L GYCAEH Q
Sbjct: 496 LGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQ 555
Query: 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542
RLLVYEY NG L D LH D+ K L+WN RV +ALG ARALEYLHEVC P ++HRNFK
Sbjct: 556 RLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFK 615
Query: 543 SANILLDDELNPHLSDCGLAAL-TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYS 601
SAN+LLDD+L+ +SDCGLA L + + Q+S Q++ A+GY APEF SGIYT +SDVYS
Sbjct: 616 SANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYGYGAPEFD-SGIYTWQSDVYS 674
Query: 602 FGVVMLELLTGRKPLDR 618
FGVVMLELLTGR DR
Sbjct: 675 FGVVMLELLTGRMSYDR 691
|
|
| TAIR|locus:2051404 SRF1 "STRUBBELIG-receptor family 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 9.0e-111, Sum P(2) = 9.0e-111
Identities = 149/286 (52%), Positives = 186/286 (65%)
Query: 336 GARSSAGSFPVSTN-NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSP 394
G+ S S + N N MH + + V PAE + +KS P
Sbjct: 406 GSESKQESHEIDMNGNAMDLMHPSSIPPIKRVIAKATEPAEASLKRTTSKS------HGP 459
Query: 395 ITATS-YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
+TA +TVASLQ TNSFS E LIG G LG VYRAE GK+ AV+K+D + + +EE
Sbjct: 460 LTAVKHFTVASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLFAVRKLDKKSPNHEEEG 519
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
FLE V+N+ R+RH NIV L G+C+EH QRLL++EY NG LHD+LH D L+WN
Sbjct: 520 KFLELVNNIDRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHDLLHIDDRLKIELSWNV 579
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL-TPNTERQV 572
RVR+AL A+ALEYLHE+C P +HRNFKSANILLDD++ H+SDCGLA L + Q+
Sbjct: 580 RVRIALEAAKALEYLHEICDPPSIHRNFKSANILLDDDIRVHVSDCGLAPLISSGAVSQL 639
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
S Q++ A+GY APEF GIYT+K DVYSFGVVMLELLTGRK D+
Sbjct: 640 SGQLLAAYGYGAPEFEY-GIYTMKCDVYSFGVVMLELLTGRKSYDK 684
|
|
| TAIR|locus:2170219 SRF2 "STRUBBELIG-receptor family 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 6.0e-99, Sum P(2) = 6.0e-99
Identities = 133/313 (42%), Positives = 180/313 (57%)
Query: 325 FCIRKNRRKVSGA----RSS---AGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKL 377
F +R N R+ RS+ A S PVST E + + PPPA +L
Sbjct: 316 FAVRMNHRRAQNLAAIHRSNNSIAYSLPVSTGREYPVATEDNPQ----IKRFQPPPAPQL 371
Query: 378 -----VIERVAKSGSLKKIKS----PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYR 428
R+ KS K + P A ++ A LQ ATN FS+E L+GEG LG VYR
Sbjct: 372 RHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEGPLGSVYR 431
Query: 429 AEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488
A+ +G+ V+ I ++LSL EE+ F E + S+LRHPNIVTL G+C E+G+ LLVYE
Sbjct: 432 AKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENGEHLLVYE 491
Query: 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548
YVG+ +L++ +H D+ K L+W R+R+A+G ARAL+YLH P + H + K+ NILL
Sbjct: 492 YVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDLKATNILL 549
Query: 549 DDELNPHLSDCGLAALTPNTERQVSTQM----VGAFGYSAPEFALSGIYTVKSDVYSFGV 604
D+EL P ++DCGLA+L P T V + + GY APE G KSD Y+ GV
Sbjct: 550 DEELTPRIADCGLASLRPLTSNSVKLRASEIAIQNTGYIAPEHGQPGSSGTKSDTYALGV 609
Query: 605 VMLELLTGRKPLD 617
++LELLTGRK D
Sbjct: 610 LLLELLTGRKAFD 622
|
|
| TAIR|locus:2202084 SUB "STRUBBELIG" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
Identities = 122/228 (53%), Positives = 158/228 (69%)
Query: 391 IKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ 450
+ S +AT +T+ASLQ TN+FS+E +IGEGS+G VYRAE +GK +AVKK+ N Q
Sbjct: 476 LNSSSSATVFTIASLQQYTNNFSEENIIGEGSIGNVYRAELRHGKFLAVKKLSNTINRTQ 535
Query: 451 EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510
+ FL VSN+ +L+ +I+ L GYC E GQRLLVYEY NG+L D LH K LT
Sbjct: 536 SDGEFLNLVSNVLKLKRGHILELLGYCNEFGQRLLVYEYCPNGSLQDALHLDRKLHKKLT 595
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
WN R+ +ALG ++AL++LHEVC P VVH+NFKS+ +LLD +L+ ++D GLA + P R
Sbjct: 596 WNVRINIALGASKALQFLHEVCQPPVVHQNFKSSKVLLDGKLSVRVADSGLAYMLP--PR 653
Query: 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
S QM G Y+APE G YT +SDV+S GVVMLELLTGR+P DR
Sbjct: 654 PTS-QMAG---YAAPEVEY-GSYTCQSDVFSLGVVMLELLTGRRPFDR 696
|
|
| TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 1.9e-65, Sum P(2) = 1.9e-65
Identities = 98/217 (45%), Positives = 139/217 (64%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVS 460
+V L +TN+FSQ +IG G G VY+A F +G AVK++ ++ E F V
Sbjct: 743 SVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMERE--FQAEVE 800
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
+SR H N+V+L GYC RLL+Y ++ NG+L LH D + L W+ R+++A G
Sbjct: 801 ALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWDVRLKIAQG 860
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580
AR L YLH+VC P+V+HR+ KS+NILLD++ HL+D GLA L + V+T +VG
Sbjct: 861 AARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTTDLVGTL 920
Query: 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
GY PE++ S I T + DVYSFGVV+LEL+TGR+P++
Sbjct: 921 GYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPVE 957
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6R2J8 | SRF8_ARATH | No assigned EC number | 0.7173 | 0.9482 | 0.8335 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | scaffold_702155.1 | annotation not avaliable (703 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 618 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 1e-45
Identities = 72/200 (36%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G GS G VY+A+ GKI+AVK + + +++ + + RL HPNIV L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV EY G+L D L L+ + ++AL R LEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTV 595
+HR+ K NILLD+ ++D GLA T VG Y APE L G Y
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKK-LLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 596 KSDVYSFGVVMLELLTGRKP 615
K DV+S GV++ ELLTG+ P
Sbjct: 179 KVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 70/195 (35%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+GEG G VY A GK +A+K I S E+ E + + +L HPNIV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLRE-IEILKKLNHPNIVKLYGV 59
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV EY G+L D+L ++ L+ + +R+ L LEYLH +
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 537 VHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE-FALSGIYT 594
+HR+ K NILLD D L+D GL+ L + + + T VG Y APE G Y+
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYS 172
Query: 595 VKSDVYSFGVVMLEL 609
KSD++S GV++ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 71/202 (35%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEGS G+VY A + GK++A+K I + E E + + +L+HPNIV L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILRE-IKILKKLKHPNIVRLYD 64
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + LV EY G+L D+L L+ + ALEYLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHSKG--- 117
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+VHR+ K NILLD++ + L+D GLA E+ T VG Y APE L Y
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYGK 175
Query: 596 KSDVYSFGVVMLELLTGRKPLD 617
D++S GV++ ELLTG+ P
Sbjct: 176 AVDIWSLGVILYELLTGKPPFP 197
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 418 IGEGSLGRVYRA----EFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG+ G VY+ + + AVK + A + E+ FLE S M +L HPNIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIVR 65
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C + +V EY+ G+L D L + LT +++AL A+ +EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS-----APEF 587
+ VHR+ + N L+ + L +SD GL+ + G APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG----GKLPIKWMAPES 175
Query: 588 ALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
G +T KSDV+SFGV++ E+ T G +P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 9e-40
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G VY+ + GK AVK + A Q E+ FL M +L HPN+V
Sbjct: 7 LGEGAFGEVYKGK-LKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNVV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C E +V EY+ G+L L + L+ + + AL AR +EYL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+HR+ + N L+ + L +SD GL+ + + + APE G
Sbjct: 122 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 592 IYTVKSDVYSFGVVMLELLT-GRKP 615
+T KSDV+SFGV++ E+ T G +P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 69/205 (33%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G VY+ GK AVK + A Q E+ FL M +L HPNIV
Sbjct: 7 LGEGAFGEVYKGT-LKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNIV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C E ++V EY+ G+L D L K L+ + + AL AR +EYL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+HR+ + N L+ + L +SD GL+ + + + APE G
Sbjct: 123 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 592 IYTVKSDVYSFGVVMLELLT-GRKP 615
+T KSDV+SFGV++ E+ T G +P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 69/217 (31%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVT 472
+GEG+ G VY+ + AVK + A + +D FL EA M +L HPN+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARV-MKKLGHPNVVR 60
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEY 527
L G C E LV EY+ G+L D L F L+ + A+ A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--------MVGA 579
L VHR+ + N L+ ++L +SD GL+ + + M
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
APE GI+T KSDV+SFGV++ E+ T G P
Sbjct: 175 ----APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-38
Identities = 142/538 (26%), Positives = 238/538 (44%), Gaps = 87/538 (16%)
Query: 94 GLSGTMGYLLSDLLSLRKFDLSGNSIH---DTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
SG + + L + D+S N++ ++ + +P +L L+LA N F G LP S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP-SLQMLSLARNKFFGGLPDSFG 473
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
S L L++SRN + ++ G+L+ L L LS N SG++P+ S + SL L +
Sbjct: 474 SK-RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 211 NQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFD--NGPAPPPPP 266
NQ++G + FS +P L+ L+++ N SG IP+ L ++ + + S + +G P
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 267 STAPPSGRSHNNRSHRQGSHSPSGSQSSSS-------DKELPAGAIVGIVLGAVFLVALA 319
A N S G+ G ++S K + LGA ++AL
Sbjct: 593 FLAI-------NASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALV 645
Query: 320 LLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVI 379
F +N ++ + G++ + +
Sbjct: 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFD----------------------------- 676
Query: 380 ERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAV 439
+V+KS ++ I S S +E +I G G Y+ + + V
Sbjct: 677 SKVSKSITINDILS-----------------SLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499
K N S+ + +++M +L+HPNIV L G C L++EY+ NL ++L
Sbjct: 720 VKEINDVNSIPSSE-----IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559
+NL+W R ++A+G A+AL +LH C P+VV N I++D + PHL
Sbjct: 775 -------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS 827
Query: 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
L +T+ +S+ Y APE + T KSD+Y FG++++ELLTG+ P D
Sbjct: 828 LPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLA 474
L+G GS G VY A + G++MAVK ++ + +EE LE + +S L+HPNIV
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 475 GYC--AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G E + EYV G+L +L L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST-QMVGAFGYSAPEFALSG 591
+VHR+ K ANIL+D + L+D G A + E T + G + APE
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 592 IYTVKSDVYSFGVVMLELLTGRKP 615
Y +D++S G ++E+ TG+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G G V ++ K+ AVK + + + + Q FL S M+ LRHPN+V L G
Sbjct: 13 TIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQA---FLAEASVMTTLRHPNLVQLLGV 68
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ +V EY+ G+L D L + +T ++ AL +EYL E +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSGIYT 594
VHR+ + N+L+ ++L +SD GLA + Q G ++APE ++
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 595 VKSDVYSFGVVMLELLT-GRKPLDR 618
KSDV+SFG+++ E+ + GR P R
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
LIG G+ G VY+ G +A+K+I + + + ++ + + L+HPNIV G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ EY NG+L ++ ++L +V G L YLHE
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG----LAYLHE---QG 119
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE-FALSGIYT 594
V+HR+ K+ANIL + L+D G+ A N + +VG + APE +SG +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV-ATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-S 177
Query: 595 VKSDVYSFGVVMLELLTGRKP 615
SD++S G ++ELLTG P
Sbjct: 178 TASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 13/210 (6%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
F IG+GS G V++ A+ ++ A+K+ID + ++ +E + ++ +++L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDS--SKNLTWNARVRVALGTARALEYL 528
+ + G+ +V EY NG+LH +L ++ W +++ LG L +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEF 587
H ++HR+ KS N+ LD N + D G+A L+ NT + +VG Y +PE
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPEL 172
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y KSDV++ GVV+ E TG+ P D
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S E +G G G V+ + +AVK + +S + FL+ M +LRH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKLRHDK 62
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L C+E +V EY+ G+L D L K L V +A A + YL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPE 586
+ +HR+ + NIL+ + L ++D GLA L + E T GA ++APE
Sbjct: 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPE 174
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
A G +T+KSDV+SFG+++ E++T GR P
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAG 475
IG+G G VY+A GK +A+K I L +E+ + + + + +HPNIV
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHPNIVKY-- 62
Query: 476 YCA--EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
Y + + + +V E+ G+L D+L + + + A V + LEYLH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL-TESQIAYV--CKELLKGLEYLHSN-- 117
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ K+ANILL + L D GL+A L+ R MVG + APE
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKP 173
Query: 593 YTVKSDVYSFGVVMLELLTGRKPL 616
Y K+D++S G+ +EL G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+GS G+VY ++GK+ +K+ID + +S +E ++ L V + +L HPNI+
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 476 YCAEHGQRLL-VYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGTARALEYLHE 530
E +L V EY G+L + K + V++ L AL+YLH
Sbjct: 67 -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLHS 121
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K NI L L D G++ L+ ++ +VG Y +PE
Sbjct: 122 ---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQ 176
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
+ Y KSD++S G V+ EL T + P
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+GS G+V + GK+ A+K + + +E ++ L + +SR+ HP IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 476 YCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
+ A + LV EY G L L + R + AR AL
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL------------SKEGRFSEERARFYAAEIVLAL 106
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
EYLH + +++R+ K NILLD + + L+D GLA + + +T G Y AP
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAP 162
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E L Y D +S GV++ E+LTG+ P
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G VY+A + A GK +A+KK+ L Q ++ + + M +HPNIV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 477 CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G L +V EY+ G+L D++ + + V + LEYLH +
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEYLH---SQN 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V+HR+ KS NILL + + L+D G AA LT ++ S +VG + APE Y
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYG 194
Query: 595 VKSDVYSFGVVMLELLTGRKP 615
K D++S G++ +E+ G P
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+F +E +G G G V+ ++ +A+K I A+S ED+F+E M +L HPN+
Sbjct: 7 TFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C + +V EY+ NG L L++ + L + + A+EYL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCL---LNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+HR+ + N L+ ++ +SD GLA + + S ++ PE
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY 175
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKPLDR 618
++ KSDV+SFGV+M E+ + G+ P +R
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNIV 471
IG G+ G+VY A G++MAVK+I +Q+ D + + + L+HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI-----RIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 472 TLAGYCAE-HGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYL 528
Y E H +++ ++ EY G L ++L +++ +RV L L YL
Sbjct: 63 KY--YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-----IRVYTLQLLEGLAYL 115
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ--MVGAFGYSAP 585
H +VHR+ K ANI LD L D G A L NT + G Y AP
Sbjct: 116 HS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 586 EFALSGIYTVK---SDVYSFGVVMLELLTGRKP 615
E G +D++S G V+LE+ TG++P
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 4e-24
Identities = 72/212 (33%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDN-FLEAVSNMSRLRHP-NIVTLA 474
+GEGS G VY A + K++A+K + S +E FL + ++ L HP NIV L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ + G LV EYV G+L D+L L+ + + + ALEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHSKG-- 121
Query: 535 SVVHRNFKSANILLDDELN-PHLSDCGLAALTPNTE-----RQVSTQMVGAFGYSAPEFA 588
++HR+ K NILLD + L D GLA L P+ + + VG GY APE
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 589 LSGI---YTVKSDVYSFGVVMLELLTGRKPLD 617
L + SD++S G+ + ELLTG P +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 30/226 (13%)
Query: 412 FSQEFLIGEGSLGRVYRAEFA--NGKIM----AVKKI-DNAALSLQEEDNFLEAVSNMSR 464
F +E +GEG+ G+VY+ E N ++ A+K + +NA +Q+E F + MS
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE--FRQEAELMSD 64
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWN 512
L+HPNIV L G C + +++EY+ +G+LH+ L + +L +
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--R 570
+ +A+ A +EYL VHR+ + N L+ + L +SD GL+ + + R
Sbjct: 125 DFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
S ++ + PE L G +T +SD++SFGVV+ E+ + G +P
Sbjct: 182 VQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 418 IGEGSLGRVYRAEFANGK------IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ E + + ++AVK + A + +D F ++ +H NIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHENIV 71
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML-----HFA-----DDSSKNLTWNARVRVALGT 521
G C E ++V+EY+ +G+L+ L A D LT + +++A+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGA 579
A + YL VHR+ + N L+ +L + D G++ T + R M+
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-P 187
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + +T +SDV+SFGVV+ E+ T G++P
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +AVK + +S ++FLE M +LRH +V L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L D + L V +A A + Y+ + + +
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ +SANIL+ D L ++D GLA L + E ++APE AL G +T+KS
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ EL+T GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IG G+ VY A N + +A+K+ID ++ D + V MS+ HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-----DELRKEVQAMSQCNHPNVVK 63
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ LV Y+ G+L D++ + L V + LEYLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQ--VSTQMVGAFGYSAPEFAL 589
+HR+ K+ NILL ++ + ++D G++A L +R V VG + APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 590 SGI-YTVKSDVYSFGVVMLELLTGRKPL 616
Y K+D++SFG+ +EL TG P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-22
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 10/206 (4%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S + +G+G G V+ + +A+K + + + FL+ M +LRH +
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L +E +V E++G G+L D L D K L V +A A + Y+
Sbjct: 64 VPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+ + +HR+ ++ANIL+ D L ++D GLA L + E ++APE AL
Sbjct: 121 M---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
G +T+KSDV+SFG+++ EL+T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
F+ E +G G G V+ + N +A+K + + L Q++ F + V + RLRH +++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+L C+ ++ E + G+L L + L + + +A A + YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE- 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+ +HR+ + NIL+ ++L ++D GLA L S + + + ++APE A G
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPEAASHG 179
Query: 592 IYTVKSDVYSFGVVMLELLT 611
++ KSDV+SFG+++ E+ T
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+ QE IG G G V+ + + +A+K I A+S E++F+E M +L HP +
Sbjct: 7 TLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C E LV+E++ +G L D L + + + L + YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLES 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
V+HR+ + N L+ + +SD G+ + + ST +S+PE
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF 175
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKPLD 617
Y+ KSDV+SFGV+M E+ + G+ P +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S E +G+G G V+ + +A+K + +S + FL+ M +LRH +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L +E +V EY+ G+L D L + K L V +A A + Y+
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+ + VHR+ ++ANIL+ + L ++D GLA L + E ++APE AL
Sbjct: 121 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
G +T+KSDV+SFG+++ EL T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKK--IDNAALSLQEEDNFLEAVSNMSRLR 466
F +GEGS G VY+A G+++A+K ++ + +E +S + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE------ISILKQCD 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
P IV G ++ +V EY G G++ D++ ++K LT + T + LE
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLE 113
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
YLH +HR+ K+ NILL++E L+D G++ +T + +T ++G + APE
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPE 169
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y K+D++S G+ +E+ G+ P
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + N +AVK + ++ +D FL M +LRHP ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK--PGTMDPKD-FLAEAQIMKKLRHPKLIQLYAVC 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+V E + G+L + L + + L + +A A + YL + +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEA---QNYI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N+L+ + ++D GLA + + ++APE AL +++KS
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+GS G V + ++GKI+ K+ID ++ +E+ + V+ + L+HPNIV Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 477 CAE----HGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-- 529
Q L +V EY G+L ++ K + R+ AL H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V+HR+ K ANI LD N L D GLA + + + VG Y +PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGTPYYMSPEQLN 183
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
Y KSD++S G ++ EL P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +A+K + ++S + FL + M +L+HP +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG+L D L LT N + +A A + ++ + +
Sbjct: 71 TQE-PIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIER---KNYI 124
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ + L ++D GLA L + E ++APE G +T+KS
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ E++T GR P
Sbjct: 185 DVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G VY+A G+I+A+KKI S L + + L HPNI+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPS 535
G LV+E++ D+ D + L + ++ L + L + H
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHS---HG 118
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAAL-----TPNTERQVSTQMVGAFGYSAPEFAL- 589
++HR+ K N+L++ E L+D GLA P T V T+ Y APE L
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH-YVVTRW-----YRAPELLLG 172
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y+ D++S G + ELL+ R PL
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR-PL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 418 IGEGSLGRVYRAEFA-NGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G G V R GK +A+K + + S ++ +FL S M + HPNI+ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + +++ EY+ NG+L L D T V + G A ++YL E+
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG------YSAPEF 587
VHR+ + NIL++ L +SD GL+ ++E +T+ G ++APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWTAPEA 179
Query: 588 ALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+SFG+VM E+++ G +P
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IGEG+ G+VY+A G+++A+KKI E++ F + + + +LRHPNIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME----NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 473 LAGYCAEH--GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
L G +V+EY+ HD+ D T + L+YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL- 589
++HR+ K +NIL++++ L+D GLA T V Y PE L
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ Y + D++S G ++ EL G+
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + G+ +AVK + N + Q +F + + L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALEYL 528
G C + G R L+ EY+ +G+L D L D + K L + + + ++YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDYL 125
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG---AFGYSAP 585
+HR+ + NIL++ E +SD GLA + P + + G F Y AP
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLT 611
E + ++ SDV+SFGV + EL T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G+V + K+ A+K ++ + N L + L HP +V L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW- 66
Query: 476 YCAEHGQRL-LVYEYVGNGNL--H--DMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Y + + + LV + + G+L H + F+++ K W + ALEYLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVK--FWICEI------VLALEYLHS 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K NILLD++ + H++D +A +TP+T +T G GY APE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLC 172
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
Y+V D +S GV E L G++P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V + GKIMAVK I ++ + L + + + P IV G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVCLP 534
+G + EY+ G+L +L R+ ++A+ + L YLHE
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQG-----RIPERILGKIAVAVLKGLTYLHEKH-- 120
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV--------GAFGYSAPE 586
++HR+ K +NIL++ L D G VS Q+V G Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFG-----------VSGQLVNSLAKTFVGTSSYMAPE 169
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y+VKSD++S G+ ++EL TGR P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G VY+ GKI A+KKI + + L + + P +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVCLP 534
+ G+ +V EY+ G+L D+L K V +A + L+YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTK--R 119
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
++HR+ K +N+L++ + ++D G++ + NT Q +T VG Y +PE Y+
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQGESYS 178
Query: 595 VKSDVYSFGVVMLELLTGRKPL 616
+D++S G+ +LE G+ P
Sbjct: 179 YAADIWSLGLTLLECALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA----VSNMSRLRHPNIV 471
+G G+ Y+A + G +MAVK++ + E++ +EA + M+RL HP+I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ G E L E++ G++ +L + + + R L YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYLHE- 121
Query: 532 CLPSVVHRNFKSANILLDDE-LNPHLSDCGLAA-----LTPNTERQVSTQMVGAFGYSAP 585
++HR+ K AN+L+D ++D G AA T E Q Q++G + AP
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ--GQLLGTIAFMAP 177
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E Y DV+S G V++E+ T + P
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE---AVSNMSRLRHPNIVTL 473
IG G+ G VY+A + A G+++A+K I L+ D+F +S + RHPNIV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-----KLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + +V EY G G+L D+ L R L + L YLHE
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHET-- 120
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA---LS 590
+HR+ K ANILL ++ + L+D G++A T + + +G + APE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAAVERK 178
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y K D+++ G+ +EL + P+
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVK--KIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G GS G VY +G AVK + + + QE LE ++ +S+L+HPNIV
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 473 LAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G L ++ E V G+L +L + + ++ LG LEYLH+
Sbjct: 67 YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHD- 120
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ-----MVGAFGYSAPE 586
+ VHR+ K ANIL+D L+D G+A +QV G+ + APE
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPE 171
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKP 615
G Y + +D++S G +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALS-----LQEEDNFLEAVSNMS 463
F+ IG+GS G VY+A + +++A+K ID +Q+E FL S
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFL------S 54
Query: 464 RLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
+ R P I G G +L ++ EY G G+ D+L L +
Sbjct: 55 QCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVL 108
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
LEYLHE +HR+ K+ANILL +E + L+D G++ +T + +T VG +
Sbjct: 109 LGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFW 164
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE Y K+D++S G+ +EL G PL
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IGEG+ G VYRA + +G+I+A+KK+ E D L ++ + LRHPNIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMD----NERDGIPISSLREITLLLNLRHPNIVE 70
Query: 473 LAGYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEY 527
L G+ L LV EY D+ D+ + ++V+ + L R L+Y
Sbjct: 71 LKEVVV--GKHLDSIFLVMEYCE----QDLASLLDNMPTPFS-ESQVKCLMLQLLRGLQY 123
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LHE ++HR+ K +N+LL D+ ++D GLA + ++ ++V + Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW-YRAPEL 179
Query: 588 AL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
L YT D+++ G ++ ELL KPL
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED---NFLEA----VSNMSRLRHP 468
LIG GS G VY A +G++MAVK+++ ++S +D + L+A ++ + L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
NIV G + + EYV G++ +L+ + L N VR L + L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF-VRQIL---KGLNYL 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGL-----AALTPNTERQVSTQMVGAFGYS 583
H ++HR+ K ANIL+D++ +SD G+ A + G+ +
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE YT K+D++S G +++E+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I ++S ED F+E M +L H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +V EY+ NG L L++ + K + + + + YL +
Sbjct: 69 TKQRPIYIVTEYMSNGCL---LNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L+DD+ +SD GL+ + E S +S PE L ++ KS
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 598 DVYSFGVVMLELLT-GRKPLDR 618
DV++FGV+M E+ + G+ P +R
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+F +E +G G G V+ ++ +A+K I+ A+S E++F+E M +L HP +
Sbjct: 7 TFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKL 61
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G C + +V E++ NG L L++ L+ + + + +EYL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
S +HR+ + N L+ +SD G+ + E S+ +S PE
Sbjct: 119 ---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKPLDR 618
Y+ KSDV+SFGV+M E+ T G+ P ++
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAA---LSLQEEDNFLEAVSNMSRLRHPNIVT 472
+IGEG+ G+VY+A G+++A+K +D ++EE N L SN HPNI T
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN-----HPNIAT 67
Query: 473 LAG------YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
G Q LV E G G++ D++ K L + T R L
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
YLHE V+HR+ K NILL L D G++A +T + +T +G + APE
Sbjct: 128 YLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-FIGTPYWMAPE 183
Query: 587 F-----ALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y +SDV+S G+ +EL G+ PL
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQE-------EDNFLEAVSNMSRLRHPN 469
+G+G G V + GK+ A KK+D L ++ E LE VS+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-----VALGTAR 523
IV+LA Y E L LV + G+L H + AR + G
Sbjct: 55 IVSLA-YAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFP-EARAIFYAAQIICG--- 107
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
LE+LH+ +V+R+ K N+LLDD N +SD GLA + G GY
Sbjct: 108 -LEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGKKIKGRAGTPGYM 161
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE +Y D ++ G + E++ GR P
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 46/226 (20%)
Query: 417 LIGEGSLGRVYRAEF------ANGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL---- 465
+GEG+ G+V +AE +AVK + D+A E + + VS M +
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-----EKDLSDLVSEMEMMKMIG 73
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADD--SSKNLTWNA 513
+H NI+ L G C + G +V EY +GNL D L D + LT
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV- 572
V A AR +E+L +HR+ + N+L+ ++ ++D GLA R +
Sbjct: 134 LVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLA-------RDIH 183
Query: 573 -------STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+T + APE +YT +SDV+SFGV++ E+ T
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A + +++A+KK+ + E+ + ++ V + +LRHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + K L + G + L YLH
Sbjct: 83 CYLREH-TAWLVMEYC-LGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL-TPNTERQVSTQMVGAFGYSAPEFALS--- 590
+HR+ K+ NILL + L+D G A+L +P + VG + APE L+
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDE 188
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y K DV+S G+ +EL + PL
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 5e-19
Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEG+ G VY+A + G+I+A+KKI EE+ L +S + L+HPNIV
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD----NEEEGIPSTALREISLLKELKHPNIVK 62
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA--------RA 524
L + LV+EY +L L ++ R
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLD-----------KRPGPLSPNLIKSIMYQLLRG 110
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYS 583
L Y H ++HR+ K NIL++ + L+D GLA A T V Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYR 165
Query: 584 APEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L S Y+ D++S G + E++TG KPL
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+GS G VY+ + ++ + A+K++D ++S +E ++ + + ++ + HPNI+
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---S 63
Query: 476 YCAEH--GQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
Y G +L +V EY G+L + K + R+ + R L+ LHE
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ KSANILL + D G++ + + TQ +G Y APE
Sbjct: 123 --KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQ-IGTPHYMAPEVWKGRP 177
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLD 617
Y+ KSD++S G ++ E+ T P +
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG G V + E+ G+ +AVK I D A + FLE + M++L H N+V L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVRLLG 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+G + V E + GNL + L + ++ ++ +L A +EYL
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLES---KK 120
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+VHR+ + NIL+ ++ +SD GLA + V + ++APE ++
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL-PVKWTAPEALKHKKFSS 176
Query: 596 KSDVYSFGVVMLELLT-GRKP 615
KSDV+S+GV++ E+ + GR P
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPN 469
++GEG+ G V + A G+I+A+KK + ED+ L V + +LRH N
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF------KESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH-----FADDSSKNLTWNARVRVALGTARA 524
IV L G+ LV+EYV L ++L D+ ++ W +A
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQ--------LLQA 112
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
+ Y H +++HR+ K NIL+ + L D G A T V Y A
Sbjct: 113 IAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
PE + Y DV++ G +M ELL G PL
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGE-PL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ G VY+ +AVK + L + FL+ + + HPNIV L G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G+L L F LT ++++L A +EYL
Sbjct: 61 CVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG-AFGYSAPEFALSGIYTV 595
+HR+ + N L+ + +SD G++ VS + ++APE G YT
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 596 KSDVYSFGVVMLELLTG 612
+SDV+S+G+++ E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-NF--LEAVSNMSRLRHPNIVT 472
+GEG+ VY+A G+I+A+KKI ++ NF L + + L+HPNI+
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 473 L-AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYLH 529
L + H + LV+E++ D+ D S LT A ++ L T R LEYLH
Sbjct: 67 LLDVFG--HKSNINLVFEFMET----DLEKVIKDKSIVLT-PADIKSYMLMTLRGLEYLH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K N+L+ + L+D GLA + R+++ Q+V + Y APE
Sbjct: 120 SN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-YRAPELLF 175
Query: 590 -SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ Y V D++S G + ELL R P
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 9e-19
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 9/199 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + N +AVK + +S+Q FLE + M L+H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ G+L D L +D+ K + + + A + Y+ + +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK-SDEGGK-VLLPKLIDFSAQIAEGMAYIER---KNYI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++AN+L+ + L ++D GLA + + E ++APE G +T+KS
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ E++T G+ P
Sbjct: 186 DVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + +AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 70
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + +A + A+EYL + +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEK---KNF 125
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFALSGIY 593
+HR+ + N L+ + ++D GL+ L T GA ++APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 594 TVKSDVYSFGVVMLELLT 611
++KSDV++FGV++ E+ T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA--------VSNMSRLRH 467
LIG+G+ GRVY A G++MAVK+++ A D+ + + + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTAR 523
NIV G+ + EYV G++ L F + + T
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS-TQMVGAFGY 582
L YLH ++HR+ K+ N+L+D + +SD G++ + + M G+ +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 583 SAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKP 615
APE S Y+ K D++S G V+LE+ GR+P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 62/208 (29%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEGS G++Y A+ ++ + +K+ID + ++E++ + V +++++HPNIVT
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLH------FADDSSKNLTWNARVRVALGTARALEYLHE 530
E+G+ +V EY G+L ++ F++D + L+W V+++LG L+++H+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSW--FVQISLG----LKHIHD 119
Query: 531 VCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ KS NI L + L D G+A N +++ VG Y +PE
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+ Y K+D++S G V+ EL T + P +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV-TLAG 475
IGEG+ G V++A + G+ +A+KK+ L + L + + +HP +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYLHEVCL 533
+ HG LV EY+ + L ++L D + L A+V+ + + Y+H
Sbjct: 68 F--PHGSGFVLVMEYMPSD-LSEVLR---DEERPLP-EAQVKSYMRMLLKGVAYMHAN-- 118
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SGI 592
++HR+ K AN+L+ + ++D GLA L E ++ + V Y APE +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 593 YTVKSDVYSFGVVMLELLTGRKPL 616
Y D+++ G + ELL G PL
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS-PL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V ++ G +AVK I N A + FL S M++LRH N+V L G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 478 AE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E G +V EY+ G+L D L S L + ++ +L A+EYL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEA---NNF 123
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSGIYT 594
VHR+ + N+L+ ++ +SD GL T+ STQ G ++APE ++
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGL------TKEASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 595 VKSDVYSFGVVMLELLT-GRKPLDR 618
KSDV+SFG+++ E+ + GR P R
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 418 IGEGSLGRV----YRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G G+ G V Y + +AVK + + FL S M++L HP IV L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLH 529
G C +LV E G L L K L A A + YL
Sbjct: 62 IGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--------AHQVAMGMAYLE 112
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAF--GYSAPE 586
VHR+ + N+LL + +SD G++ AL ++ +T G + + APE
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPE 168
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
G ++ KSDV+S+GV + E + G KP
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 418 IGEGSLGR--VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+G+ G +YR + ++ K+++ LS +E + L + +S L+HPNI+
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVC 532
+ + L+ EY G L+D + + + W A+ Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKA- 120
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ K+ NI L L D G++ + +E ++ +VG Y +PE
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLD 617
Y KSD+++ G V+ ELLT ++ D
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 37/225 (16%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRL-RHPNI 470
+IGEGS V A E K A+K +D L +++ + V ++RL HP I
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY---VKIEKEVLTRLNGHPGI 64
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+ L Y + + L V EY NG L + S + R A ALEYLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE-ILLALEYLH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM------------- 576
++HR+ K NILLD +++ ++D G A + S +
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 577 ------VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
VG Y +PE SD+++ G ++ ++LTG+ P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
+ +++ +IG G G V+R G+ +A+K + Q +D FL S M +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQF 63
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
H NI+ L G + +++ EY+ NG L L D + +R G A +
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--YS 583
+YL ++ + VHR+ + NIL++ L +SD GL+ + + T G ++
Sbjct: 121 KYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
APE +T SDV+SFG+VM E+++ G +P
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 417 LIGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+IG+G G VY ++G+ + AVK + N L+E + FL+ M HPN+++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 473 LAGYC-AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C G L+V Y+ +G D+ +F + N T + L A+ +EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHG---DLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS- 116
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFA 588
VHR+ + N +LD+ ++D GLA + E GA + A E
Sbjct: 117 --KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 589 LSGIYTVKSDVYSFGVVMLELLT 611
+ +T KSDV+SFGV++ EL+T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 417 LIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
++GEG G V + + K+ AVK + + E + FL + M HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 472 TLAGYCAEHGQR------LLVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTAR 523
L G C E +++ ++ +G+LH L ++ + L ++ + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQ--VSTQMVGA 579
+EYL + +HR+ + N +L +++ ++D GL+ + + RQ ++ V
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 180
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ A E +YT KSDV++FGV M E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED--NFLEAVSNMSRLRH---PNI 470
LIG G+ G VYR G+++A+K I+ L ++D + V+ +S+LR PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
G G RL ++ EY G++ ++ + K ++ R AL+Y+H
Sbjct: 65 TKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIH 118
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V V+HR+ K+ANIL+ + N L D G+AAL + ST VG + APE
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVIT 174
Query: 590 SGI-YTVKSDVYSFGVVMLELLTGRKPL 616
G Y K+D++S G+ + E+ TG P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 418 IGEGSLGRVYRA----EFANGKI-MAVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G G+ G VY+ E KI +A+K + + + +E L+ M+ + HP++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE--ILDEAYVMASVDHPHVV 72
Query: 472 TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEY 527
L G C ++ L+ + + G L D + D S L W ++ A+ + Y
Sbjct: 73 RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--MVGAFGYSAP 585
L E L VHR+ + N+L+ + ++D GLA L E++ + V + A
Sbjct: 125 LEEKRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKWMAL 180
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617
E L IYT KSDV+S+GV + EL+T G KP +
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 412 FSQEFL-----IGEGSLGRV--YRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSN 461
F + +L +GEG G+V Y + AN G+++AVK + Q + + ++
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINI 59
Query: 462 MSRLRHPNIVTLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+ L H NIV G C+E G + L+ EYV G+L D L L + A
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQ 114
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG- 578
+ YLH +HR+ + N+LLD++ + D GLA P + G
Sbjct: 115 QICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 579 --AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
F Y A E ++ SDV+SFGV + ELLT
Sbjct: 172 SPVFWY-AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A + + G+ +AVKK+D L Q+ L V M +HPNIV +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + V L +AL +LH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA---QG 135
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V+HR+ KS +ILL + LSD G A ++ R+ S +VG + APE Y
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYG 193
Query: 595 VKSDVYSFGVVMLELLTGRKPL 616
+ D++S G++++E++ G P
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 417 LIGEGSLGRVYRAEF------ANGKI-MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
+G G+ G VY +G I +AVK + A + QE+ FL+ MS HPN
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPN 60
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTAR 523
IV L G C + + ++ E + G D+L + D+ LT + + L A+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNP-----HLSDCGLAA-LTPNTERQVSTQMV 577
YL ++ +HR+ + N L+ ++ + D GLA + + + + +
Sbjct: 118 GCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 578 GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ APE L G +T +SDV+SFGV+M E+LT G++P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ + A KI + ED +E + +S +HPNIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-IDILSECKHPNIVGLYEAY 71
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ E+ G L ++ + + LT V AL +LH V+
Sbjct: 72 FYENKLWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHS---HKVI 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGI 592
HR+ K+ NILL + + L+D G++A +T ++ T +G + APE
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNP 184
Query: 593 YTVKSDVYSFGVVMLELLTGRKP 615
Y K+D++S G+ ++EL P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G+ G V + G IMAVK+I + L+ V M P IV
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKF 68
Query: 474 AGYCAEHGQRLLVYEYVGNG--NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G G + E + + ++ + + ++A+ T +AL YL E
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVY--EVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE----F 587
++HR+ K +NILLD N L D G++ ++ + T+ G Y APE
Sbjct: 127 L--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPS 182
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
A G Y V+SDV+S G+ + E+ TG+ P
Sbjct: 183 ARDG-YDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 415 EFLIGEGSLGRVYRAEF-ANGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
E +IG G G V R GK +A+K + + Q D FL S M + HPNI
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L G + +++ E++ NG L L D T V + G A ++YL E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSE 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGA---FGYSAPE 586
+ + VHR+ + NIL++ L +SD GL+ L +T T +G ++APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+S+G+VM E+++ G +P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 20/220 (9%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQ-EEDNFLEA 458
T+ S+ +++ IG+G+ G VY A + A G+ +A+K+++ L Q +++ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINE 66
Query: 459 VSNMSRLRHPNIVT-LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M +HPNIV L Y G L +V EY+ G+L D++ + A R
Sbjct: 67 ILVMRENKHPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCR 122
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ 575
L +ALE+LH V+HR+ KS NILL + + L+D G A +TP E+ +
Sbjct: 123 ECL---QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRST 174
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
MVG + APE Y K D++S G++ +E++ G P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 55/218 (25%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GE + G++Y+ + +++A+K + + + Q+ F + S M+ L HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVC 71
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS-------------KNLTWNARVRVAL 519
L G + +++EY+ G+LH+ L S +L + +A+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVG 578
A +EYL VH++ + NIL+ ++L+ +SD GL+ + + +V + +
Sbjct: 132 QIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + G ++ SD++SFGVV+ E+ + G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 417 LIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIV 68
Query: 472 TLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
G C G+R LV EY+ G+L D L K+ R L + L Y
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYL------QKH-------RERLDHRKLLLYAS 115
Query: 530 EVC-----LPS--VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA--- 579
++C L S VHR+ + NIL++ E + D GL + P + + G
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
F Y APE ++V SDV+SFGVV+ EL T
Sbjct: 176 FWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
+G G+ G V + G IMAVK+I A ++ QE+ L + +M + P VT G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G + E V + +L D + + ++A+ +ALEYLH S
Sbjct: 68 ALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--S 124
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE-----FALS 590
V+HR+ K +N+L++ L D G++ ++ T G Y APE
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDAGCKPYMAPERINPELNQK 182
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLDR 618
G Y VKSDV+S G+ M+EL TGR P D
Sbjct: 183 G-YDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-16
Identities = 80/274 (29%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 24 LILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPS-VLTNWKGNEGDPCGESWKGVACEG 82
++ + L L + +++ L +S+N P L+NW + D C W+G+ C
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWN-SSADVC--LWQGITCNN 67
Query: 83 SA-VVSIDISGLGLSGTM---------------------GYLLSDLL----SLRKFDLSG 116
S+ VVSID+SG +SG + G + D+ SLR +LS
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 117 NSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
N+ +IP PNL +L+L++N SG +P I S SL L++ N L I + NL
Sbjct: 128 NNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLN---VANN 233
L L L+ N G +P + ++ +YL N ++G + G LT+LN + N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYN 246
Query: 234 HFSGWIPRELISIRT----FIYDGNSFDNGPAPP 263
+ +G IP L +++ F+Y N +GP PP
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQ-NKL-SGPIPP 278
|
Length = 968 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-16
Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 20/220 (9%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
T+ S+ +++ IG+G+ G V+ A + A G+ +A+K+I+ LQ++ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-----LQKQPKKELII 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M L++PNIV + +V EY+ G+L D++ + A R
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCR 122
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ 575
L +ALE+LH V+HR+ KS N+LL + + L+D G A +TP E+ +
Sbjct: 123 ECL---QALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRST 174
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
MVG + APE Y K D++S G++ +E++ G P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 418 IGEGSLGR-VYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEGS G+ + +GK +K+I+ + +S +E + + V+ +S ++HPNIV
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP-- 534
E+G +V +Y G+L+ + NA+ V + L++ ++CL
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKI------------NAQRGVLFPEDQILDWFVQICLALK 115
Query: 535 -----SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ KS NI L + L D G+A + +T T +G Y +PE
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICE 174
Query: 590 SGIYTVKSDVYSFGVVMLELLT 611
+ Y KSD+++ G V+ E+ T
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 417 LIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTL 473
+IGEG+ G+V +A ++ A K S + +F + + +L HPNI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADDSSKNLTWNAR--VRVALGT 521
G C G L EY +GNL D L FA +S T +++ + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG 581
AR ++YL + +HR+ + NIL+ + ++D GL+ + + +G
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRLP 174
Query: 582 --YSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ A E +YT SDV+S+GV++ E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 415 EFLIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
E +IGEG+ G+V RA K+ A K+ S + +F + + +L HPNI+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLH----------FADD--SSKNLTWNARVRVAL 519
L G C G + EY GNL D L FA + ++ LT ++ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
A ++YL E +HR+ + N+L+ + L ++D GL+ E + +G
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKKTMGR 179
Query: 580 FG--YSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ A E +YT KSDV+SFGV++ E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQE-------EDNFLEAVSNMSRLRHPN 469
+G+G G V + N GK+ A KK+D L + E LE V++ P
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS------PF 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
IV LA Y E L LV + G+L H + + L + + + +L
Sbjct: 55 IVNLA-YAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHL 111
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H + +V+R+ K N+LLDD+ N LSD GLA + + TQ G GY APE
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEIL 166
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y+ D ++ G + E++ GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-16
Identities = 57/163 (34%), Positives = 86/163 (52%), Gaps = 4/163 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+ G L G + L++L SL L+ N + IP +L +L + L NN SG +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
PY I + SL++L++ N+LT I GNL L L L N SG +P S SL + S
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 206 LYLQNNQVTGSLN--VFSGLPLTTLNVANNHFSGWIPRELISI 246
L L +N ++G + V L L++ +N+F+G IP L S+
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 417 LIGEGSLGRVYRA-----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
L+ EG+ GR++ + + + VK + + A S + L+ + L H NI+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNIL 71
Query: 472 TLAGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKN----LTWNARVRVALGTARALE 526
+ C E ++Y Y+ GNL L N L+ V +A+ A +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---------ALTPNTERQVSTQMV 577
YLH+ V+H++ + N ++D+EL ++D L+ L N R V
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184
Query: 578 GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ A E ++ Y+ SDV+SFGV++ EL+T
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 417 LIGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ + GK++ AVK + + LS +D FL+ + M L H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLIR 60
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G H ++V E G+L D L D+ + + A+ A + YL
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVST-QMVGAFGYSAPEFALS 590
+HR+ + NILL + + D GL AL N + V + F + APE +
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
++ SDV+ FGV + E+ T G +P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 28/210 (13%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI---DNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+GEG+ G V + G I A+K I N L Q L + + P IV
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSCKSPYIVKY 64
Query: 474 AG-YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARV------RVALGTARAL 525
G + E + + EY G+L + K R+ ++A + L
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
YLH ++HR+ K +NILL + L D G++ N+ ++ G Y AP
Sbjct: 119 SYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS---LAGTFTGTSFYMAP 172
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E Y++ SDV+S G+ +LE+ R P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY + G+ +AVK++ D + ++E N LE + + L+H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 473 LAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G C + L ++ EY+ G++ D L ++ +T ++ G +EYLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG----VEYLHS- 122
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAPEFA 588
+VHR+ K ANIL D N L D G A+ T T M G + +PE
Sbjct: 123 --NMIVHRDIKGANILRDSAGNVKLGDFG-ASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y K+DV+S G ++E+LT + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 68/227 (29%), Positives = 101/227 (44%), Gaps = 54/227 (23%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED---NFLEAVSNMSRLR---HPN 469
IGEG+ G VY+A + G+ +A+KK+ + L EE + L ++ + +L HPN
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 470 IVTLAGYCAEHGQRL-------LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR 516
IV L C HG R LV+E+V + +L L ++ K+L
Sbjct: 63 IVRLLDVC--HGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ---- 115
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------ALTPNTE 569
R +++LH +VHR+ K NIL+ + ++D GLA ALT
Sbjct: 116 ----LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS--- 165
Query: 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
V T Y APE L Y D++S G + EL R+PL
Sbjct: 166 -VVVTLW-----YRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A ++ +++AVKK+ + E+ + ++ V + +L+HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + + A + G + L YLH +
Sbjct: 89 CYLKEH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHNM- 142
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS---G 591
+HR+ K+ NILL + L+D G A+ + + VG + APE L+ G
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSASKS-----SPANSFVGTPYWMAPEVILAMDEG 195
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPL 616
Y K DV+S G+ +EL + PL
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIM---AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+GEG G V + + AVK + A + E ++FL M HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 475 GYCAEHGQR------LLVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTARALE 526
G C + + +++ ++ +G+LH L ++ D + L V+ A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQ--VSTQMVGAFGY 582
YL S +HR+ + N +L++ +N ++D GL+ N + RQ ++ V +
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK---W 180
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
A E +YT KSDV+SFGV M E+ T G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 37/215 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
I EG+ G VYRA + G+I+A+KK+ +E++ F L ++ + +L+HPNIVT
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKME----KEKEGFPITSLREINILLKLQHPNIVT 68
Query: 473 LA----GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ G + + +V EYV HD+ + + + + L + +L
Sbjct: 69 VKEVVVG--SNLDKIYMVMEYVE----HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGY 582
H+ ++HR+ K++N+LL++ + D GLA R+ TQ+V Y
Sbjct: 123 HD---NWILHRDLKTSNLLLNNRGILKICDFGLA-------REYGSPLKPYTQLVVTLWY 172
Query: 583 SAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L Y+ D++S G + ELLT +KPL
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 62/210 (29%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 418 IGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G G+V E G K V K A+ + E+ FL+ V L HPN++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
C E LLV E+ G+L + L A + K++ R+A A L +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMACEVASGLLWLHQ 118
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST--QMVGAFGYSAPEFA 588
+H + N L +L+ + D GL AL E T + APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGL-ALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 589 -------LSGIYTVKSDVYSFGVVMLELLT 611
L T KS+++S GV M EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLR 466
+F E IG+G VY+A +G+++A+KK+ + + + L+ + + +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-HFADDSS---KNLTWNARVRVALGTA 522
HPN++ E+ + +V E G+L M+ HF + W V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG- 581
ALE++H ++HR+ K AN+ + L D GL R S++ A
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLG-------RFFSSKTTAAHSL 166
Query: 582 -----YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y +PE Y KSD++S G ++ E+ + P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 418 IGEGSLGRVYRAEFANGKI-------MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + +A+K + N S++E FL S M ++
Sbjct: 14 LGQGSFGMVYEG-LAKGVVKGEPETRVAIKTV-NENASMRERIEFLNEASVMKEFNCHHV 71
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKNL----TWNARVRVALGTARA 524
V L G + L+V E + G+L L + + T +++A A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVSTQMVGAFGY 582
+ YL VHR+ + N ++ ++L + D G+ T+ R+ ++ +
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 187
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT 611
APE G++T KSDV+SFGVV+ E+ T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F Q ++G+G G V + A GK+ A KK++ +++L E+ LE V+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEK-QILEKVN- 58
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
SR +V+LA Y E L LV + G+L ++ ++
Sbjct: 59 -SRF----VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGEA------------GFE 100
Query: 521 TARALEYLHEVCL-------PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
RA+ Y E+C +V+R+ K NILLDD + +SD GLA P E Q
Sbjct: 101 EGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTI 158
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
VG GY APE + YT D ++ G ++ E++ G+ P +
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 35/213 (16%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAG 475
IGEG+ V +A GK A+K + SL E+ N L + + RL HPNI+ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIE 65
Query: 476 --YCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYL 528
+ + G+ LV+E + + NL++++ + K+ + ++L+++
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQ--------LLKSLDHM 116
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSD----CGLAALTPNTERQVSTQMVGAFGYSA 584
H + HR+ K NIL+ D++ L+D G+ + P TE +ST+ Y A
Sbjct: 117 HR---NGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTE-YISTRW-----YRA 166
Query: 585 PEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
PE L G Y K D+++ G V E+L+ PL
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS-LFPL 198
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSNMSRLRHPN 469
I +G+ GRV+ A+ + G I A+K I A + + E + L S+ + P
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDIL------SQAQSPY 54
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARA 524
+V L Y + + L LV EY+ G+L +L +D ++ + L A
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI----AEIVL----A 105
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------ALTPNTERQVSTQMV 577
LEYLH ++HR+ K NIL+D + L+D GL+ + N + + ++V
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 578 GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G Y APE L ++ D +S G ++ E L G P
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 418 IGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N ++AVK + A+ S +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD----DSSKN-----LTWNARVRVALG 520
G C E L+V+EY+ +G+L+ L H D ++ LT + +A
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGA 579
A + YL + VHR+ + N L+ L + D G++ +T+ +V + +
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE L +T +SD++SFGVV+ E+ T G++P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 418 IGEGSLGRVYRAEF--------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---- 465
+GEG G+V AE +AVK + + A E + + VS M +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIG 78
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--------HFADD----SSKNLTWNA 513
+H NI+ L G C + G ++ EY GNL + L ++ D + +T+
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QV 572
V AR +EYL +HR+ + N+L+ + ++D GLA N + +
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+T + APE +YT +SDV+SFGV+M E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-15
Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 5/167 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+S L+G + L +L K L NS+ IP L +L + L N+FSG L
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
P + + +L++S N+L I ++ L L L+ N F G LP+SF S + +
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLEN 479
Query: 206 LYLQNNQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPRELISIRTFI 250
L L NQ +G++ L L L ++ N SG IP EL S + +
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
|
Length = 968 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 52/229 (22%)
Query: 418 IGEGSLGRVYRAEFANG---------KIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL-- 465
+GEG G+V RAE A G +AVK + DNA + + + +S M +
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNAT-----DKDLADLISEMELMKL 73
Query: 466 --RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------FADDSSK----NLTW 511
+H NI+ L G C + G ++ EY GNL + L + D +K L++
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 512 NARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--------- 562
V A AR +EYL +HR+ + N+L+ ++ ++D GLA
Sbjct: 134 KDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
T N V + APE +YT +SDV+SFG++M E+ T
Sbjct: 191 KKTSNGRLPVK--------WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G VY+ + +++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
P I G + + ++ EY+G G+ D+L L + + L+
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLD 115
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
YLH +HR+ K+AN+LL ++ + L+D G+A +T+ + +T VG + APE
Sbjct: 116 YLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPE 171
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y K+D++S G+ +EL G P
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 46/219 (21%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAV--------SNMSRLRHP 468
IGEG+ G VY+A + G+I+A+KKI L+ ED E V S + L HP
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-----RLETED---EGVPSTAIREISLLKELNHP 58
Query: 469 NIVTLAGYCAEH-GQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
NIV L H +L LV+E++ D+ + D S L
Sbjct: 59 NIVRL--LDVVHSENKLYLVFEFLD----LDLKKYMDSSPL---------TGLDPPLIKS 103
Query: 527 YLHEVCLP-------SVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVG 578
YL+++ V+HR+ K N+L+D E L+D GLA A + T V
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVV 161
Query: 579 AFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L Y+ D++S G + E++ R+PL
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLR----HPN 469
+GEG G+V AE K A+ + ++D + + VS M ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------FADDSSK----NLTWNARVRV 517
I+ L G C + G ++ EY GNL + L ++ D+ K LT+ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQM 576
A AR +EYL +HR+ + N+L+ ++ ++D GLA N + + +T
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ APE +YT +SDV+SFGV++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSL--QEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G GRV + + A+K + + Q+E F E + HP IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKL- 58
Query: 475 GYCA----EHGQRLLVY---EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
Y ++ +Y EY G L +L + + AR +A A EY
Sbjct: 59 -YRTFKDKKY-----IYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEY 108
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LH +++R+ K N+LLD L D G A + ++ + G Y APE
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEI 163
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
L+ Y D +S G+++ ELLTGR P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G VY A + N +++A+KK+ + E+ + ++ V + +LRHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 476 -YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y EH LV EY G+ D+L + + A V G + L YLH
Sbjct: 83 CYLREH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS---H 134
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS---G 591
+++HR+ K+ NILL + L D G A++ + VG + APE L+ G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDEG 189
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPL 616
Y K DV+S G+ +EL + PL
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRL-----RHP 468
++G+GS G+V AE ++ AVK K D + LQ++D +E R+ +HP
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKD---VILQDDD--VECTMTEKRVLALAGKHP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+ L C + RL V EYV G+L M H S A L++
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDL--MFHI--QRSGRFDEPRARFYAAEIVLGLQF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LHE +++R+ K N+LLD E + ++D G+ ++ G Y APE
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEI 167
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D ++ GV++ E+L G+ P +
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 8/201 (3%)
Query: 417 LIGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++GEGS GR + N A+K+I S ED+ EAV +++++HPNIV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNIVAFKE 65
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G +V EY G+L M K + ++ + ++++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDL--MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KR 120
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ KS NI L L D G A L + T VG Y PE + Y
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWENMPYNN 179
Query: 596 KSDVYSFGVVMLELLTGRKPL 616
KSD++S G ++ EL T + P
Sbjct: 180 KSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 34/232 (14%)
Query: 408 ATNSFSQEFLIGEGSLGRVYRAEF---ANG---KIMAVKKI-DNAALSLQEEDNFLEAVS 460
+T F +E +GE G+VY+ A G + +A+K + D A L+EE F
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE--FKHEAM 60
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA----------DDSSKNLT 510
SRL+HPNIV L G + +++ Y + +LH+ L DD + T
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 511 WNAR--VRVALGTARALEYL--HEVCLPSVVHRNFKSANILLDDELNPHLSDCGL--AAL 564
V + A +E+L H V H++ + N+L+ D+LN +SD GL
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ + + ++ + +PE + G +++ SD++S+GVV+ E+ + G +P
Sbjct: 176 AADYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 35/225 (15%)
Query: 418 IGEGSLGRVYRAEFANGK----------------IMAVKKIDNAALSLQEEDNFLEAVSN 461
+GEG G V+ E N + ++ KI + ++FL+ V
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 462 MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKN----------- 508
+SRL+ PNI+ L G C + ++ EY+ NG+L+ L H DD +N
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 509 --LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LT 565
+++++ + VAL A ++YL + + VHR+ + N L+ + L ++D G++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610
++ + V + A E L G +T SDV++FGV + E+L
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
S E +G G G V+ A + +AVK + ++S++ FL + M L+H +
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKL 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L + ++ E++ G+L D L + S + L + + A + ++ +
Sbjct: 64 VKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 120
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+ +HR+ ++ANIL+ L ++D GLA + + E ++APE
Sbjct: 121 ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 177
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
G +T+KSDV+SFG++++E++T GR P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 415 EFLIGEGSLGRVYRAEFA-NGK---IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
E +IG G G V GK +A+K + Q D FL S M + HPNI
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L G + ++V EY+ NG+L L D T V + G A ++YL +
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSD 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--YSAPEFA 588
+ VHR+ + NIL++ L +SD GL+ + + T G ++APE
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+S+G+VM E+++ G +P
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
EFL GEG+ EF ++ K+ A ++ ++FL+ + MSRL++PNI+ L
Sbjct: 30 AEFL-GEGA------PEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSK--------NLTWNARVRVALGTARAL 525
G C ++ EY+ NG+L+ L + S +++ + +A+ A +
Sbjct: 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGM 142
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSA 584
+YL + + VHR+ + N L+ + ++D G++ L ++ + V + A
Sbjct: 143 KYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA 199
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLT 611
E L G +T SDV++FGV + E+ T
Sbjct: 200 WESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-AG 475
+G+GS G V +GK +KK++ S +E + +S+L+HPNIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ E G +V + G+L+ L + K L N V + A AL+YLHE
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLK--EQKGKLLPENQVVEWFVQIAMALQYLHE---KH 122
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++HR+ K+ N+ L + D G+A + N ST ++G Y +PE + Y
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNY 181
Query: 596 KSDVYSFGVVMLELLT 611
KSDV++ G + E+ T
Sbjct: 182 KSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N KI+ AVK + +A+ + +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD-------DSSKNLTWNARVRVALGTA 522
G C E ++V+EY+ +G+L+ L H D + LT + + +A A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVGAFG 581
+ YL VHR+ + N L+ + L + D G++ +T+ +V +
Sbjct: 131 AGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + +T +SDV+S GVV+ E+ T G++P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 20/220 (9%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
++ S+ +++ IG+G+ G VY A + A G+ +A+++ ++LQ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ-----MNLQQQPKKELII 65
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M ++PNIV + +V EY+ G+L D++ + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 120
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ 575
V +ALE+LH V+HR+ KS NILL + + L+D G A +TP E+ +
Sbjct: 121 VCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRST 175
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
MVG + APE Y K D++S G++ +E++ G P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 52/235 (22%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IG+G+ GRV++A A G ++AVK + A S + +F + M+ HPNI
Sbjct: 13 IGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNI 70
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL----TWNARVRVALGTARALE 526
V L G CA L++EY+ G+L++ L S + + R L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 527 YLHEVCLPS-------------VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
++C+ VHR+ + N L+ + + ++D GL S
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL-----------S 177
Query: 574 TQMVGAFGYSA------------PEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ A Y A PE YT +SDV+++GVV+ E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 417 LIGEGSLGRVYRAEFANG--KIMAVKKID--NAAL--SLQEED-NFLEAVSNMS----RL 465
+G G+ G VY+ N ++A+K+I+ N A +E D + + VS ++ +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGT 521
RHPNIV E+ + +V + + L + + + + T WN V++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG 581
AL YLH+ +VHR+ NI+L ++ ++D GLA T +VG
Sbjct: 125 --ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA--KQKQPESKLTSVVGTIL 178
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
YS PE + Y K+DV++FG ++ ++ T + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ G VY A + + +A+K+I + E ++ S L+H NIV G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLH--FADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
+E+G + E V G+L +L + T + L L+YLH+
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---EGLKYLHDN-- 127
Query: 534 PSVVHRNFKSANILLDDELNP-HLSDCG----LAALTPNTERQVSTQMVGAFGYSAPEFA 588
+VHR+ K N+L++ +SD G LA + P TE G Y APE
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE-----TFTGTLQYMAPEVI 181
Query: 589 LSGI--YTVKSDVYSFGVVMLELLTGRKP 615
G Y +D++S G ++E+ TG+ P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLR----HPN 469
+GEG G+V AE ++ A+ + + D + + +S M ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF------------ADDSSKNLTWNARVRV 517
I+ L G C + G ++ EY GNL + L + L++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQM 576
A AR +EYL +HR+ + N+L+ ++ ++D GLA + + + +T
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ APE IYT +SDV+SFGV++ E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 48/225 (21%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF-LEAVSNMSRLR---HPNI 470
IGEG+ G+VY+A + G+++A+KK+ DN E++ F + A+ + LR H NI
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDN------EKEGFPITAIREIKILRQLNHRNI 68
Query: 471 VTL----------AGYCAEHGQRLLVYEYVGNGNLHD--------MLHFADDSSKNLTWN 512
V L + + G LV+EY+ HD ++HF++D K+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSEDHIKSF--- 121
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
++ L L Y H+ + +HR+ K +NILL+++ L+D GLA L + E +
Sbjct: 122 --MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 573 STQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPL 616
T V Y PE L Y DV+S G ++ EL T +KP+
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ G VY A G+++A+KK+ S +E N E S HPNIV L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 477 CAEHGQRLLVYEYVGNGNLHDML------HFADDSSKNLTWNARVRVALGTARALEYLHE 530
E+ + V+EY+ GNL+ ++ F++ +++ + + L ++H+
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQ--------ILQGLAHIHK 117
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA----ALTPNTERQVSTQMVGAFGYSAPE 586
HR+ K N+L+ ++D GLA + P T+ VST+ Y APE
Sbjct: 118 HGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-YVSTRW-----YRAPE 168
Query: 587 FAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
L S Y+ D+++ G +M EL T R PL
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR-PL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 417 LIGEGSLGRVYRA------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ GRV+ + K+MA+ ++ + L++E + + + HP I
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEV----IRLKQEQHVHNEKRVLKEVSHPFI 63
Query: 471 VTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
+ L + EH QR L + EYV G L L R + T
Sbjct: 64 IRL--FWTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYASE 109
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580
ALEYLH +V+R+ K NILLD E + L+D G A R + + G
Sbjct: 110 IVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFA----KKLRDRTWTLCGTP 162
Query: 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y APE S + D ++ G+++ E+L G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-------HPN 469
+G G+ G+V A + K AV K+ A L+ + E + MS L+ H N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKV--AVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
IV L G C G L++ EY G+L + L LT + + A+ + +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF---GYSAPE 586
+ +HR+ + N+LL + D GLA N V A + APE
Sbjct: 159 S---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG--NARLPVKWMAPE 213
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT 611
+ +YT +SDV+S+G+++ E+ +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
L+G+G+ G V++ + +AVK L + + FL + + HPNIV L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G D L F L V+ AL A + YL +
Sbjct: 61 CTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG-------YSAPEFAL 589
+HR+ + N L+ + +SD G++ RQ + + G ++APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS-------RQEDDGIYSSSGLKQIPIKWTAPEALN 167
Query: 590 SGIYTVKSDVYSFGVVMLELLT 611
G Y+ +SDV+S+G+++ E +
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-14
Identities = 54/164 (32%), Positives = 76/164 (46%), Gaps = 29/164 (17%)
Query: 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCG---ESWKGVACEGSAVVSI-DISGLG 94
T +V ALQ L +SL P G GDPC W G C+ + I GLG
Sbjct: 369 TLLEEVSALQTLKSSLGLPLRF----GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLG 424
Query: 95 LS--GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
L G G++ +D+ LR L S+NL+ N+ GN+P S+ S+
Sbjct: 425 LDNQGLRGFIPNDISKLRH-------------------LQSINLSGNSIRGNIPPSLGSI 465
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
SL L++S NS SI + G L L L+L+ N+ SG +P +
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPN 469
F+ IG GS G VY A +++A+KK+ + E+ + ++ V + R++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 470 IVTLAG-YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ G Y EH LV EY G+ D+L + + A + G + L YL
Sbjct: 87 SIEYKGCYLREH-TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYL 141
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H +++HR+ K+ NILL + L+D G A++ + VG + APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVI 193
Query: 589 LS---GIYTVKSDVYSFGVVMLELLTGRKPL 616
L+ G Y K DV+S G+ +EL + PL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G V++ + +++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARAL 525
P + G + + ++ EY+G G+ D+L D + T + + L
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI------LKGL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+YLH +HR+ K+AN+LL ++ + L+D G+A +T+ + +T VG + AP
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAP 170
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E Y K+D++S G+ +EL G P
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 36/217 (16%)
Query: 418 IGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQE---------EDNFLEAVSNMSR 464
+G G+ G+V+ GK+ A+K + A + +Q+ E LEAV
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVR---- 62
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TA 522
R P +VTL Y + +L L+ +YV G L L+ ++ T + VRV +
Sbjct: 63 -RCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY----QREHFT-ESEVRVYIAEIV 115
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVSTQMVGAF 580
AL++LH++ +++R+ K NILLD E + L+D GL+ L ER S G
Sbjct: 116 LALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTI 170
Query: 581 GYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKP 615
Y APE G + D +S GV+ ELLTG P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLR 466
F++ IG+GS G V++ + K++A+K ID L+E ++ +E + +S+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD 60
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARAL 525
P + G + + ++ EY+G G+ D+L D ++ T + + L
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+YLH +HR+ K+AN+LL + L+D G+A +T+ + VG + AP
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAP 170
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E Y K+D++S G+ +EL G P
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 30/224 (13%)
Query: 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFANG------KIMAVKKIDNAALSLQEEDN-- 454
++LQ T +G G G V+ A+ ++ VK AL +++N
Sbjct: 5 SNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVK-----ALQKTKDENLQ 52
Query: 455 --FLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF---ADDSSK-- 507
F + +L H N+V L G C E ++ EY G+L L D+ K
Sbjct: 53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112
Query: 508 NLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
L+ +V + A +++L VHR+ + N L+ + +S L+ N
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169
Query: 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+E + + APE ++ KSDV+SFGV+M E+ T
Sbjct: 170 SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 9e-14
Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 20/220 (9%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN---FL 456
++ S+ +++ IG+G+ G VY A + A G+ +A+K+ ++LQ++ +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQ-----MNLQQQPKKELII 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
+ M ++PNIV + +V EY+ G+L D++ + +
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA 119
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQ 575
V +AL++LH V+HR+ KS NILL + + L+D G A +TP E+ +
Sbjct: 120 VCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRST 174
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
MVG + APE Y K D++S G++ +E++ G P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 418 IGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG G+V +A A +AVK + A S + D L + + ++ HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNHPHVI 66
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLH---------------------FADDSSKNLT 510
L G C++ G LL+ EY G+L L D + LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE-RALT 125
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+ A +R ++YL E+ +VHR+ + N+L+ + +SD GL+ +
Sbjct: 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 571 QVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
V ++ + A E IYT +SDV+SFGV++ E++T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV +GK A+K + A + L++ ++ L + +RHP +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ L LV EYV G L L F + ++ +V L ALEYLH
Sbjct: 69 -SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA----AQVVL----ALEYLHS 119
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFAL 589
+ +V+R+ K N+LLD + ++D G A + T T + G Y APE L
Sbjct: 120 L---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT----YT-LCGTPEYLAPEIIL 171
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
S Y D ++ G+++ E+L G P
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 418 IGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N ++AVK + + L+ +++ F ++ L+H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIV 70
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML--HFAD----------DSSKNLTWNARVRVAL 519
G C + ++V+EY+ +G+L+ L H D + L + + +A
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVG 578
A + YL VHR+ + N L+ L + D G++ +T+ +V +
Sbjct: 131 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + +T +SDV+SFGV++ E+ T G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V+ A+ +AVK L + FL+ + + HPNIV L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G D L F L +++ A +EYL
Sbjct: 62 CTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--------YSAPEFA 588
+HR+ + N L+ ++ +SD G++ R+ + + G ++APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMS-------REEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 589 LSGIYTVKSDVYSFGVVMLE 608
G Y+ +SDV+SFG+++ E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKID---NAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
L+G G+ G+VY+ G++ A+K +D + +++E N L+ S+ H NI T
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-----HRNIAT 67
Query: 473 LAGYCAEHG------QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV-RVALGTARAL 525
G + Q LV E+ G G++ D++ ++ W A + R L R L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGL 124
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+LH+ V+HR+ K N+LL + L D G++A T + +T +G + AP
Sbjct: 125 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 180
Query: 586 EFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPL 616
E Y KSD++S G+ +E+ G PL
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 418 IGEGSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G V + + + K +AVK + N +D L + M +L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C E +LV E G L+ L +K++T + + ++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE---T 114
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSGI 592
+ VHR+ + N+LL + +SD GL+ E + G + + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 593 YTVKSDVYSFGVVMLELLT-GRKP 615
++ KSDV+SFGV+M E + G+KP
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 417 LIGEGSLGRVYRA----EFANGKI-MAVKKIDNAA--LSLQEEDNFLEAVSNMSRLRHPN 469
L+G G G V++ E + KI +A+K I + + + QE + + A M L H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA---MGSLDHAY 70
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARALEY 527
IV L G C G L LV + G+L D + DS N V++A G + Y
Sbjct: 71 IVRLLGICP--GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG----MYY 124
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPE 586
L E + VHRN + NILL + ++D G+A L P+ ++ ++ + A E
Sbjct: 125 LEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 587 FALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
L G YT +SDV+S+GV + E+++ G +P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A ++GK++AVKK+D L Q+ L V M +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + + V L +AL LH
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QG 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ KS +ILL + LSD G A + E +VG + APE Y
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 596 KSDVYSFGVVMLELLTGRKP 615
+ D++S G++++E++ G P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPN 469
L+GEGS G V + + G+I+A+KK L+ ED+ + + + +LRH N
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF------LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L + LV+E+V + L D+ + + L + + R +E+ H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCH 117
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+++HR+ K NIL+ L D G A T +V T V Y APE +
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 590 SGI-YTVKSDVYSFGVVMLELLTGRKPL 616
Y D+++ G ++ E+LTG +PL
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG-EPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G VY+ G+I+A+KKI L+ E+ + +S + L+HPNIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + + L++E++ D+ + D K + YL+++
Sbjct: 63 CLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQY--------MDAELVKSYLYQI 110
Query: 532 CLP-------SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
V+HR+ K N+L+D++ L+D GLA R V T V Y A
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VYTHEVVTLWYRA 169
Query: 585 PEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
PE L S Y+ D++S G + E+ T +KPL
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNF---LEAVSNMSRLRHPNIVTL 473
IG G+ G VY+A N G++ A+K I L+ ++F + + M +H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-----KLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + + E+ G G+L D+ H S++ V+ T + L YLH
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQI----AYVSRETLQGLYYLHS--- 124
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFAL--- 589
+HR+ K ANILL D + L+D G++A +T ++ S +G + APE A
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVER 182
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y D+++ G+ +EL + P+
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V A + +GK +A+KKI +A L + + +H NI+ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 477 C---AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA-RALEYLHEVC 532
+ + V + +LH ++H S + LT +R L R L+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIH----SDQPLT-EEHIRYFLYQLLRGLKYIHSAN 127
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQ-VSTQMVGAFGYSAPEFAL 589
V+HR+ K +N+L++++ + D G+A + TE + T+ V Y APE L
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 590 S-GIYTVKSDVYSFGVVMLELLTGRKPL 616
S YT D++S G + E+L GR+ L
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F ++G+G G V + A GK+ A KK++ A++L E+ LE V++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-QILEKVNS 59
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNL----HDMLHFADDSSKNLTWNARVR 516
+V+LA Y E L LV + G+L ++M + D + + + A +
Sbjct: 60 ------RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI- 111
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM 576
G LE LH +V+R+ K NILLDD + +SD GLA P E
Sbjct: 112 -TCG----LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR 161
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
VG GY APE + YT D + G ++ E++ G+ P
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
IG+G+ G V++A +I+A+KK+ L E++ F L + + L+H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 473 LAGYC-----AEHGQR---LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L C + + LV+E+ HD+ L N V+ L +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCE----HDL--------AGLLSNKNVKFTLSEIKK 123
Query: 525 --------LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVS 573
L Y+H ++HR+ K+ANIL+ + L+D GLA +L+ N++
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 574 TQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
T V Y PE L Y D++ G +M E+ T R P+
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A E GK +AVKK+D L Q+ L V M H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V E++ G L D++ + + + V L RAL YLH
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QG 138
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ KS +ILL + LSD G A + E +VG + APE Y
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 596 KSDVYSFGVVMLELLTGRKP 615
+ D++S G++++E++ G P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 418 IGEGSLGRVYR-AEFANGKIMAVKKID---NAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+G+ G+VY+ +G + AVK +D + ++ E N L+++ N HPN+V
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN-----HPNVVKF 84
Query: 474 AG--YCAEH---GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
G Y A+ GQ LV E G++ +++ + L + G L++L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF- 587
H ++HR+ K NILL E L D G++A +T + +T VG + APE
Sbjct: 145 HN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVI 200
Query: 588 ----ALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y + DV+S G+ +EL G PL
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVT 472
+IGEG+ G+V +A +G M A+K++ A S + +F + + +L HPNI+
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLH------------FADDSSKNLTWNARVRVALG 520
L G C G L EY +GNL D L A+ ++ L+ + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580
AR ++YL + +HR+ + NIL+ + ++D GL+ E V M G
Sbjct: 133 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM-GRL 185
Query: 581 G--YSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ A E +YT SDV+S+GV++ E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 44/221 (19%)
Query: 418 IGEGSLGRVYRA---EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIV 471
IG G+ GRVY+A +GK A+KK Q A ++ LR H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK--GDKEQYTGISQSACREIALLRELKHENVV 65
Query: 472 TLAGYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL---- 525
+L EH + L+++Y HD+ + RV + ++L
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQ----AKRVSIPPSMVKSLLWQI 117
Query: 526 ----EYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAAL------TPNTERQ 571
YLH V+HR+ K ANIL+ E + D GLA L
Sbjct: 118 LNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 572 VSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLT 611
V V Y APE L + YT D+++ G + ELLT
Sbjct: 175 V----VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V E +I A+K I ++ +Q E + E SN HP
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN-----HP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+V L C + RL V E+V G+L M H K +AR A + AL +
Sbjct: 57 FLVGLHS-CFQTESRLFFVIEFVSGGDL--MFHM-QRQRKLPEEHARFYSA-EISLALNF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSAP 585
LHE +++R+ K N+LLD E + L+D G+ + P ++ G Y AP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DTTSTFCGTPNYIAP 165
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
E Y D ++ GV+M E++ GR P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 418 IGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G G+ G VY + A +AVK + + S Q+E +FL MS+ H NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIV 72
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G E R ++ E + G D+ F ++ LT + A A+
Sbjct: 73 RLIGVSFERLPRFILLELMAGG---DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNP----HLSDCGLAALTPNTE--RQVSTQMVGA 579
+YL E +HR+ + N LL + P ++D G+A R+ M+
Sbjct: 130 KYLEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAML-P 184
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE L GI+T K+DV+SFGV++ E+ + G P
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF---LEAVSNMSRLRHPNIVTL 473
+G G+ G VY+A G++ AVK I L+ D+F + + + +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII-----KLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSK-NLTWNARVRVALGTARALEYLHEVC 532
G + + EY G G+L D+ H S+ + + R T + L YLH
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHS-- 124
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFAL-- 589
+HR+ K ANILL D + L+D G+AA +T ++ S +G + APE A
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVE 181
Query: 590 -SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+G Y D+++ G+ +EL + P+
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ ++A K+ + S +E ++++ + ++ HPNIV L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ E+ G + ++ + + LT V T AL YLHE ++
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI----- 592
HR+ K+ NIL + + L+D G++A T Q +G + APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 593 YTVKSDVYSFGVVMLEL 609
Y K+DV+S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE-------EDNFLEAVSNM 462
+F Q ++G+G G V + A GK+ A K+++ + ++ E LE V+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-- 58
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGT 521
S+ +V LA Y E L LV + G+L H + + + A
Sbjct: 59 SQF----VVNLA-YAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEI 111
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG 581
LE LH + V+R+ K NILLDD + +SD GLA P E + VG G
Sbjct: 112 LCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRVGTVG 166
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE + YT+ D + G ++ E++ G+ P
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V + + G +MA K + A S++++ L + M R P IV+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ--ILRELQIMHECRSPYIVSFYG 70
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ E++ G+L + + ++A+ L YL+ V
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNV--HR 124
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++HR+ K +NIL++ L D G++ N+ ++ VG Y +PE G YTV
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKYTV 181
Query: 596 KSDVYSFGVVMLELLTGRKPLD 617
KSDV+S G+ ++EL G+ P
Sbjct: 182 KSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 418 IGEGSLGRVYRAEFANG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G VY+A+ +G + A+K+I+ +S+ ++ + L+HPN+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISLQ 64
Query: 475 GYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY----- 527
H R L+++Y HD+ H + V++ G ++L Y
Sbjct: 65 KVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPH-----LSDCGLAALTPNTERQVS--TQMVGAF 580
+H + V+HR+ K ANIL+ E P ++D G A L + + ++ +V F
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 581 GYSAPEFALSGI-YTVKSDVYSFGVVMLELLT 611
Y APE L YT D+++ G + ELLT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 417 LIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH----P 468
++G G+ G+V+ G K+ A+K + AAL +Q+ + + L H P
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSP 65
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALE 526
+VTL Y + +L L+ +YV G + L+ D+ S+ VR G ALE
Sbjct: 66 FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEIILALE 119
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
+LH++ +V+R+ K NILLD E + L+D GL+ + E++ + G Y APE
Sbjct: 120 HLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
G + D +S G+++ ELLTG P
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 50/162 (30%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 463 SRLRHPNIVTL--AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
+RL HPNIV L +G G V+EYV L ++L A D + L R+ L
Sbjct: 33 ARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL--AADGA--LPAGETGRLMLQ 87
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQ------ 571
AL H +VHR+ K NI++ + + D G+ L P
Sbjct: 88 VLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
+T+++G Y APE T SD+Y++G++ LE LTG+
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-13
Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 4/159 (2%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
++S+D+S LSG + L+ L +L L N+ IP L P L L L SN FS
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
G +P ++ +L+ L++S N+LT I + + L L L N+ G++P S + +
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405
Query: 203 ISSLYLQNNQVTGSLNV-FSGLPLTT-LNVANNHFSGWI 239
+ + LQ+N +G L F+ LPL L+++NN+ G I
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 61/176 (34%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM 152
LSG + Y + L SL DL N++ IP L NL L L N SG +P SI S+
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L L++S NSL+ I ++ L L L L NNF+G +P + SL + L L +N+
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 213 VTGSL--NVFSGLPLTTLNVANNHFSGWIPRELIS---IRTFIYDGNSFDNGPAPP 263
+G + N+ LT L+++ N+ +G IP L S + I NS + G P
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE-GEIPK 398
|
Length = 968 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 417 LIGEGSLGRVYRAEF---ANGKI-MAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG G VY+ + N KI +AVK K + S++E FL+ M + HP+I
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVRE--KFLQEAYIMRQFDHPHI 69
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L G E+ +V E G L + + +L + + + + AL YL
Sbjct: 70 VKLIGVITEN-PVWIVMELAPLGELR---SYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
VHR+ + N+L+ L D GL+ + +++ + APE
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+ FGV M E+L G KP
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 61/233 (26%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEG+ G VY+A + G+++A+KKI L E+D F L + + +L+HPN+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKILKKLKHPNVVP 71
Query: 473 LAGYCAEHG-----QRLLVY---EYVGNGNLHD---MLHFADDSSKNLTWNARVRVALGT 521
L E +R VY Y+ HD +L N V++
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMD----HDLSGLLE-----------NPSVKLTESQ 116
Query: 522 AR--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA----------- 562
+ + YLHE ++HR+ K+ANIL+D++ ++D GLA
Sbjct: 117 IKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 563 -ALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGR 613
T + T +V Y PE L YT D++ G V E+ T R
Sbjct: 174 GGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHP 468
+F E IG G VYRA +G +A+KK+ L + + ++ + + +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-HFADDSS---KNLTWNARVRVALGTARA 524
N++ E + +V E G+L M+ HF + W V++ A
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LE++H V+HR+ K AN+ + L D GL +++ + +VG Y +
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
PE Y KSD++S G ++ E+ + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 59/238 (24%)
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNF-----LEAV 459
N IG G+ G+VY+ F G +MAVK++ + +E+N L+ V
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVV 67
Query: 460 SNMSRLRH--PNIVTLAGY----------------CAEHGQRLLVYEYVGNGNLHDMLHF 501
S H P IV GY C + +LL + + D+L
Sbjct: 68 L-KS---HDCPYIVKCYGYFITDSDVFICMELMSTCLD---KLL--KRIQGPIPEDILG- 117
Query: 502 ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561
++ + +AL YL E V+HR+ K +NILLD N L D G+
Sbjct: 118 --------------KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161
Query: 562 AALTPNTERQVSTQMVGAFGYSAPEF----ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ + + T+ G Y APE + Y +++DV+S G+ ++EL TG+ P
Sbjct: 162 SGRL--VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 417 LIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G+G G V A E + + +AVK + S + + FL + M HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 473 LAGYC--AEHGQRL----LVYEYVGNGNLHDMLHFA--DDSSKNLTWNARVRVALGTARA 524
L G + RL ++ ++ +G+LH L + + L VR + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVSTQMVGAFGY 582
+EYL + +HR+ + N +L++ + ++D GL+ + + RQ + +
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-PVKW 181
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
A E +YT SDV++FGV M E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY + G+ +A K++ D + +E + LE + + L+H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 473 LAGYCAEHGQRLLV--YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ L EY+ G++ D L ++++T ++ G + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG----MSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAPEF 587
+VHR+ K ANIL D N L D G A+ T T + G + +PE
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFG-ASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y K+DV+S G ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+IG+GS G V A + G+ +A+KKI++ + + L + + LRHP+IV +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 476 YCAEHGQR-----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+R +V+E + + +LH ++ DD LT RAL+Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHT 121
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN-TERQVS-TQMVGAFGYSAPEFA 588
+V HR+ K NIL + + + D GLA + N T + T V Y APE
Sbjct: 122 A---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 589 LS--GIYTVKSDVYSFGVVMLELLTGRKPL 616
S YT D++S G + E+LTG KPL
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V +I A+K + ++ +Q E + E SN HP
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HP 56
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+V L + V EYV G+L M H K +AR A + AL YL
Sbjct: 57 FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHM-QRQRKLPEEHARFYSA-EISLALNYL 112
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSAPE 586
HE +++R+ K N+LLD E + L+D G+ L P ++ G Y APE
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPE 166
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D ++ GV+M E++ GR P D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 418 IGEGSLGRVYRAE----------------FANGKIM-AVKKI-DNAALSLQEEDNFLEAV 459
+GEG G V+ E A+ ++ AVK + +A+ + +E+ FL+ V
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED--FLKEV 70
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDS-----SKNLTWN 512
+SRL PNI L G C ++ EY+ NG+L+ L H A+ S SK+L+++
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQ 571
+ +A A + YL + VHR+ + N L+ ++D G++ L + +
Sbjct: 131 TLLYMATQIASGMRYLESLNF---VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
V + + A E L G +T KSDV++FGV + E+LT
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTLA 474
IG+GS G+V A+ A+GK AVK + A+ ++E + A N + ++HP +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLH 529
Y + +L V +YV G L L F + ++ + A + ALG YLH
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--FYAAEIASALG------YLH 113
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ ++++R+ K NILLD + + L+D GL + ST G Y APE
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLR 169
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
Y D + G V+ E+L G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 418 IGEGSLGRVYRAEFANG-KIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+GS G+V + + +I A+K I A + S E + L + ++++ P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ LV ++ G L H + AR A ALE LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTA-ELLCALENLHKF---N 113
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V++R+ K NILLD + + L D GL L + + +T G Y APE L YT
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTK 172
Query: 596 KSDVYSFGVVMLELLTGRKP 615
D ++ GV++ E+LTG P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLRHPNIVTL 473
IGEG+ G VY+A G+++A+KKI L + E + +S + L HPNIV L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-- 531
+ LV+E++ D+ F D S + + YL ++
Sbjct: 65 LDVIHTENKLYLVFEFLH----QDLKKFMDASPLS---------GIPLPLIKSYLFQLLQ 111
Query: 532 ----CLP-SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
C V+HR+ K N+L++ E L+D GLA R + ++V Y APE
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 170
Query: 587 FAL-SGIYTVKSDVYSFGVVMLELLTGR 613
L Y+ D++S G + E++T R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTLAG 475
IGEGS G V A E +G+ +AVK +D L Q+ L V M +H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ ++ E++ G L D++ S L V +AL YLH
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHS---QG 137
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V+HR+ KS +ILL + LSD G A ++ + ++ S +VG + APE Y
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYG 195
Query: 595 VKSDVYSFGVVMLELLTGRKP 615
+ D++S G++++E++ G P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 55/155 (35%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIAS 151
LSG + + L L DLS NS+ IP QL NL L+L SNNF+G +P ++ S
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ-NLEILHLFSNNFTGKIPVALTS 330
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L L + N + I G L LDLS NN +G++P S N+ L L +N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 212 QVTG----SLNVFSGLPLTTLNVANNHFSGWIPRE 242
+ G SL L L +N FSG +P E
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQ--DNSFSGELPSE 423
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 3/139 (2%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNL 145
+D+S SG + L L L + LS N + IP +L L SL+L+ N SG +
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISS 205
P S + M LS L++S+N L+ I GN+ L +++S N+ G LP++ L+ +S
Sbjct: 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS 599
Query: 206 LYLQNNQVTGSLNVFSGLP 224
N + G + SGLP
Sbjct: 600 AVAGNIDLCGG-DTTSGLP 617
|
Length = 968 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 52/234 (22%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----------NF--LEAVSNMSR 464
+GEG+ G+V +A GKI+A+KK+ +S +F L + M+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA------ 518
++H NI+ L E LV + + A D K + + ++R+
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-----------ASDLKKVV--DRKIRLTESQVKC 123
Query: 519 --LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------------A 563
L L LH+ +HR+ ANI ++ + ++D GLA
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 564 LTPNTERQVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
R+ T V Y APE + + Y D++S G + ELLTG KPL
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 418 IGEGSLGRVYRA-EFANG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR------HPN 469
IGEG+ G+V++A + NG + +A+K++ + EE L + ++ LR HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 470 IVTLAGYCA-----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTAR 523
+V L C + LV+E+V D+ + D + ++ + R
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
L++LH VVHR+ K NIL+ L+D GLA + + + T +V Y
Sbjct: 122 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYR 176
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
APE L Y D++S G + E+ RKPL R
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 28/231 (12%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKID---NAALSLQEEDNFLE 457
+++L+ F ++G G+ G+VY+ G++ A+K +D + ++ E N L+
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 458 AVSNMSRLRHPNIVTLAGYCAEHG------QRLLVYEYVGNGNLHDMLHFADDSSKNLTW 511
S+ H NI T G + Q LV E+ G G++ D++ ++ W
Sbjct: 68 KYSH-----HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122
Query: 512 NARV-RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
A + R L R L +LH V+HR+ K N+LL + L D G++A T
Sbjct: 123 IAYICREIL---RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 571 QVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ +T +G + APE Y +SD++S G+ +E+ G PL
Sbjct: 177 RRNT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 415 EFL--IGEGSLGRVYRA-EFANGKIMAVKKI----DNAALS--LQEEDNFLEAVSNMSRL 465
E L +G+G+ G VY+ G MA+K+I D + + + E D +AVS
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS----- 58
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
P IV G G + EY+ G+L D L+ +++ + + R+ + L
Sbjct: 59 --PYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
++L E +++HR+ K N+L++ L D G++ N ++ +G Y AP
Sbjct: 116 KFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG---NLVASLAKTNIGCQSYMAP 170
Query: 586 EFALSG------IYTVKSDVYSFGVVMLELLTGRKP 615
E SG YTV+SDV+S G+ +LE+ GR P
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKI----DNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G+G+ G VY G+++AVK++ N + +E + E V + L+H NIV
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G C + + E+V G++ +L+ + + ++ G A YLH C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA-----ALTPNTERQVSTQMVGAFGYSAPEF 587
VVHR+ K N++L L D G A T + M G + APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y KSD++S G + E+ TG+ PL
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 412 FSQEFL-----IGEGSLGRV----YRAEFAN-GKIMAVKKIDNAALSLQEED------NF 455
F + FL +GEG G+V Y E N G+ +AVK SL+ E +
Sbjct: 1 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-------SLKPESGGNHIADL 53
Query: 456 LEAVSNMSRLRHPNIVTLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKN-LTWN 512
+ + + L H NIV G C E G L+ E++ +G+L + L +KN +
Sbjct: 54 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLK 109
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER- 570
+++ A+ + ++YL VHR+ + N+L++ E + D GL A+ + E
Sbjct: 110 QQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166
Query: 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
V + + APE + + + SDV+SFGV + ELLT
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 31/214 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQE------EDNFLEAVSNMSRLRHPNI 470
+G+G+ G V++A + +++A+KKI +A + + E FL+ + + HPNI
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD-----HPNI 69
Query: 471 VTL-AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEY 527
V L AE+ + + LV+EY+ +LH ++ N+ + R + +AL+Y
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-ETDLHAVIR------ANILEDVHKRYIMYQLLKALKY 122
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA----ALTPNTERQVSTQMVGAFGYS 583
+H +V+HR+ K +NILL+ + L+D GLA L N E V T V Y
Sbjct: 123 IHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 584 APEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L S YT D++S G ++ E+L G KPL
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 36/216 (16%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEED--------NFLEAVSNMSR 464
++G+G G+V++ GKI A+K + A + ++D N LEAV
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV----- 57
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVAL 519
+HP IV L Y + G +L L+ EY+ G L L F +D++ + + + +AL
Sbjct: 58 -KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTAC--FYLSEISLAL 113
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
E+LH+ +++R+ K NILLD + + L+D GL + + E V+ G
Sbjct: 114 ------EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGT 163
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y APE + + D +S G +M ++LTG P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 28/211 (13%)
Query: 417 LIGEGSLGRVY--RAEFA--NGKIMAVKKIDNAALSLQE------EDNFLEAVSNMSRLR 466
++G+GS G+V+ R G++ A+K + A L +++ E + L V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------ 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR-VRVALGT-ARA 524
HP IV L G+ L+ +++ G+L L SK + + V+ L A A
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALA 110
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
L++LH + +++R+ K NILLD+E + L+D GL+ + + E++ + G Y A
Sbjct: 111 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMA 166
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +T +D +SFGV+M E+LTG P
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIV 471
+IG G G VY A+ GK+ A+K +D + +++ + N +S +S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYL 528
+ + + + + G+LH H + S K + + A + LG LE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYA-TEIILG----LEHM 113
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H VV+R+ K ANILLD+ + +SD GLA + S VG GY APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 589 LSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
G Y +D +S G ++ +LL G P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 39/225 (17%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNA--------ALSLQEEDNFLEAVSN 461
+F ++G+G G V + A GK+ A KK++ A++L E+ LE V+
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-RILEKVN- 58
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
SR +V+LA Y E L LV + G+L ++ +
Sbjct: 59 -SRF----VVSLA-YAYETKDALCLVLTIMNGGDLKFHIYNMGNP------------GFD 100
Query: 521 TARALEYLHEVCL-------PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
RA+ Y E+C +V+R+ K NILLDD + +SD GLA P E +
Sbjct: 101 EQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETV 158
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
VG GY APE + YT D + G ++ E++ G+ P +
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 410 NSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRH 467
F + L+G G G V E A G I A+K + + L QE +F E + +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARAL 525
P I L Y + L LV EY G+L +L+ +D +++ + L A +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-----AQFYL--AELV 112
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+H V VHR+ K N+L+D + L+D G AA + S VG Y AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
Query: 586 EF--ALSG----IYTVKSDVYSFGVVMLELLTGRKP 615
E ++G Y V+ D +S GV+ E++ GR P
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIV 471
+IG G G VY A+ GK+ A+K +D + +++ + N +S +S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 472 TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEY 527
++ Y +L + + + G+LH H + S + + A + LG LE+
Sbjct: 61 CMS-YAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRFYA-AEIILG----LEH 112
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
+H VV+R+ K ANILLD+ + +SD GLA + S VG GY APE
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEV 166
Query: 588 ALSGI-YTVKSDVYSFGVVMLELLTGRKP 615
G+ Y +D +S G ++ +LL G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 417 LIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G G+ G VY+ E KI KI N + F++ M+ + HP++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLH-FADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C +L V + + +G L D +H D+ L N V++A G + YL E
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG----MMYLEER 128
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP--EFAL 589
L VHR+ + N+L+ + ++D GLA L E++ + A G P AL
Sbjct: 129 RL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN-----ADGGKMPIKWMAL 180
Query: 590 SGI----YTVKSDVYSFGVVMLELLT-GRKPLD 617
I +T +SDV+S+GV + EL+T G KP D
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V A +G++ AVK + + LQ++D +E R+ HP +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDD--VECTMTEKRILSLARNHPFL 58
Query: 471 VTLAGYCAEHGQRLL-VYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYL 528
L C + RL V E+V G+L M H S+ AR R A AL +L
Sbjct: 59 TQLY-CCFQTPDRLFFVMEFVNGGDL--MFHI--QKSRRFD-EARARFYAAEITSALMFL 112
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H+ +++R+ K N+LLD E + L+D G+ + ST G Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEIL 168
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+Y D ++ GV++ E+L G P +
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 418 IGEGSLGRVYRAEFANGKI---MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G VY+A+ +GK A+K+I+ +S+ ++ + L+HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIALQ 64
Query: 475 GYCAEHGQR--LLVYEYVGNGNLHDM-LHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
H R L+++Y + H + H A ++K R V + L+ +H +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 532 CLPSVVHRNFKSANILLDDELNPH-----LSDCGLAALTPNTERQVS--TQMVGAFGYSA 584
V+HR+ K ANIL+ E P ++D G A L + + ++ +V F Y A
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLT 611
PE L YT D+++ G + ELLT
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V+ AE + A+K + + + D+ +E R+ HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFL 58
Query: 471 VTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFAD----DSSKNLTWNARVRVALGTARA 524
L YC + L V EY+ G+L M H D + + A + L
Sbjct: 59 THL--YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL----- 109
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
++LH +V+R+ K NILLD + + ++D G+ + + T G Y A
Sbjct: 110 -QFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIA 164
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
PE L Y D +SFGV++ E+L G+ P
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV A+ G+ A+K + L +++ + + S + L HP IV +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ + + E+V G L L F +D +K ++A + +A EYLH
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK--FYHAELVLAF------EYLHSK 137
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+++R+ K N+LLD++ + ++D G A P +R + + G Y APE S
Sbjct: 138 ---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT--LCGTPEYLAPEVIQSK 190
Query: 592 IYTVKSDVYSFGVVMLELLTGRKP 615
+ D ++ GV++ E + G P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 65/209 (31%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 418 IGEGSLGRVYRAEFANGK----IMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPN 469
+G G G+V AE+ I A+KK D + SL E E + RHP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPF 63
Query: 470 IVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALE 526
+V L C + + V EY G+L M+H D S + A V LG L+
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYA-ACVVLG----LQ 115
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
YLHE +V+R+ K N+LLD E ++D GL + ST G + APE
Sbjct: 116 YLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPE 171
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
YT D + GV++ E+L G P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G+G+ GRVY A+ G+ +AVK++ D + +E N LE + + L H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + +R L E++ G++ D L S LT N + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAPEF 587
+VHR+ K ANIL D N L D G A+ T T M G + +PE
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFG-ASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y K+D++S G ++E+LT + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN------FLEAVSNMSRLRHPNI 470
IGEGS G V++ G+I+A+KK ++ ED+ L + + +L+HPN+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF------VESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALE 526
V L + LV+EY + L+++ + K + W T +A+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVN 114
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
+ H+ + +HR+ K NIL+ + L D G A + T V Y APE
Sbjct: 115 FCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPE 170
Query: 587 FALSG--IYTVKSDVYSFGVVMLELLTGRKPL 616
L G Y DV++ G V ELLTG +PL
Sbjct: 171 L-LVGDTQYGPPVDVWAIGCVFAELLTG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 412 FSQEFLIGEGSLGRVYRA----EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
F + ++G G+ G VY+ E KI K A S + L+ M+ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARA 524
P++ L G C +L + + + G L D + D S L W ++ A+
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FG 581
+ YL E L VHR+ + N+L+ + ++D GLA L E++ + G
Sbjct: 122 MNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE--GGKVPIK 176
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617
+ A E L IYT +SDV+S+GV + EL+T G KP D
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKI--DNAALSLQEEDNFLEA-VSNMSRLRHPNIVT 472
L+G G+ G VY A+ G+ +AVK++ D + +E N LE + + LRH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ L EY+ G++ D L + LT N R + + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAPEF 587
+VHR+ K ANIL D N L D G A+ T T + G + +PE
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFG-ASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y K+DV+S ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 417 LIGEGSLGRVYRAEFANGK----IMAVKK----IDNAALSLQEEDNFLEAVSNMSRLRHP 468
++G+GS G+V AE I A+KK D+ E L HP
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-----EHP 56
Query: 469 NIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFAD----DSSKNLTWNARVRVALGTA 522
+ L +C + L V EY+ G+L M H D ++ + A + L
Sbjct: 57 FLTHL--FCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGL--- 109
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
++LH+ +++R+ K N+LLD + + ++D G+ N E + ST G Y
Sbjct: 110 ---QFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDY 162
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE Y D +SFGV++ E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G VY+A + + +A+KKI L++ED + +S + ++H NIV
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-----RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR-VRVAL-GTARALEYLH 529
L + LV+EY+ +L H DSS + N R ++ L R + Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYL---DLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 530 EVCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
V+HR+ K N+L+D N L+D GLA R + ++V Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEIL 175
Query: 589 L-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
L S Y+ D++S G + E++ +KPL
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V A + +A+KKI NA + + L + + L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 477 CAEHGQR-----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHE 530
+ +VYE + + +LH ++ SS+ L+ + + L R L+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-DTDLHQIIR----SSQTLS-DDHCQYFLYQLLRGLKYIHS 126
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+V+HR+ K +N+LL+ + + D GLA T + + T+ V Y APE L+
Sbjct: 127 A---NVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 591 -GIYTVKSDVYSFGVVMLELLTGRKPL 616
YT DV+S G + ELL GRKPL
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 418 IGEGSLGRVYRAEFANG------KIMAVKKIDN-----AALSLQEEDN------FLEAVS 460
+GEG G V+ E A G K ++ N A L+E+ N FL+ +
Sbjct: 13 LGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-------HFADDSSKNLTWNA 513
MSRL+ PNI+ L C ++ EY+ NG+L+ L ++++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQV 572
+ +A A ++YL + + VHR+ + N L+ ++D G++ L ++
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ V + + E L G +T SDV++FGV + E+LT
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ G V+ A+ K++ +K+I ++ E + L HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY-------L 528
E ++V EY G L + + R L L + L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI------------QKRCNSLLDEDTILHFFVQILLAL 114
Query: 529 HEVCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
H V ++HR+ K+ NILLD + D G++ + +++ + T +VG Y +PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT-VVGTPCYISPEL 172
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y KSD+++ G V+ EL + ++ +
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 65/241 (26%), Positives = 108/241 (44%), Gaps = 31/241 (12%)
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKID---NAALSL 449
P++ + S ++++ IG+G+ G+V++ NG AVK +D + +
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYC----AEHGQRL-LVYEYVGNGNLHD----MLH 500
+ E N L+A+S+ HPN+V G ++G +L LV E G++ D L
Sbjct: 62 EAEYNILKALSD-----HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK 116
Query: 501 FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+ + + +G L++LH +HR+ K NILL E L D G
Sbjct: 117 RGERMEEPIIAYILHEALMG----LQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFG 169
Query: 561 LAALTPNTERQVSTQMVGAFGYSAPEF-----ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
++A +T + +T VG + APE L Y + DV+S G+ +EL G P
Sbjct: 170 VSAQLTSTRLRRNTS-VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
Query: 616 L 616
L
Sbjct: 229 L 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNA--ALSLQEE----DNFLEAVSNMSRLRHPNIV 471
+G G+ G V + + M K+ID A L + E D + M +L +P IV
Sbjct: 3 LGSGNFGCVKKGVYK----MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ G C E +LV E G L+ L D +T + V + + ++YL
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEG- 113
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFAL 589
+ VHR+ + N+LL ++ +SD GL+ + + G + + APE
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
++ +SDV+S+G+ M E + G+KP
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 6/208 (2%)
Query: 411 SFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHP 468
+F E IG G VYRA + K +A+KK+ + + + ++ + + +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N++ E + +V E G+L M+ + + + + + A+E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H V+HR+ K AN+ + L D GL +++ + +VG Y +PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERI 178
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y KSD++S G ++ E+ + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 69/224 (30%), Positives = 98/224 (43%), Gaps = 50/224 (22%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI------DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IG G+ G VY+A + +G +A+K + D LS E L+ + HPNI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLK---RLEAFDHPNI 64
Query: 471 VTLAGYCA-----EHGQRLLVYEYVGNGNLHDMLHFAD------DSSKNLTWNARVRVAL 519
V L CA + LV+E+V + +L L ++ K+L +R L
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDL-----MRQFL 118
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-------ALTPNTERQV 572
R L++LH C +VHR+ K NIL+ L+D GLA ALTP
Sbjct: 119 ---RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP------ 166
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+V Y APE L Y D++S G + E+ RKPL
Sbjct: 167 ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 55/179 (30%), Positives = 81/179 (45%), Gaps = 27/179 (15%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPP--NLTSLNLASNNFSGNLPYSIASM 152
+G + L+ L L+ L N IP L NLT L+L++NN +G +P + S
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L L + NSL I G L + L N+FSG+LP+ F L + L + NN
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 213 VTGSLN------------------VFSGLP-------LTTLNVANNHFSGWIPRELISI 246
+ G +N F GLP L L+++ N FSG +PR+L S+
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
|
Length = 968 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-- 473
IG G+ G V A G+ +A+KKI N L + L + + LRH NI+ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 474 ---AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV----ALGTARALE 526
+ +V E + +LH ++ S + LT + ++ L R L+
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQPLT-DDHIQYFLYQIL---RGLK 117
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSA 584
YLH +V+HR+ K +NIL++ + + D GLA E+ T+ V Y A
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
PE LS YT D++S G + ELLT RKPL
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G+ G+VY+A+ +A K+ S +E ++++ + ++ HP IV L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
G+ ++ E+ G + ++ D R L AL+YLH + ++
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---EALQYLHSM---KII 132
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI----- 592
HR+ K+ N+LL + + L+D G++A T Q +G + APE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 593 YTVKSDVYSFGVVMLEL 609
Y K+D++S G+ ++E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A+GK A+K + + ++E + L + RHP + +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLH 529
Y + RL V EYV G L L F++D ++ + A + AL+YLH
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR--FYGAEI------VSALDYLH 112
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V+R+ K N++LD + + ++D GL T+ G Y APE
Sbjct: 113 S---GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLE 168
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + GVVM E++ GR P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 42/224 (18%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLR 466
+F Q +GEG+ VY+ G+I+A+K+I A EE + +S M L+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA----EEGTPSTAIREISLMKELK 56
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFAD----------DSSKNLTWNARVR 516
H NIV L + +LV+EY+ D+ + D ++ K+ T+
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQ---- 108
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVS 573
+ + + HE V+HR+ K N+L++ L+D GLA + NT S
Sbjct: 109 ----LLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT---FS 158
Query: 574 TQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
++V Y AP+ L S Y+ D++S G +M E++TGR PL
Sbjct: 159 NEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A+ ++G AVK + + ++E N + A N + L+HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYLHEV 531
Y + ++L V +YV G L H + R R A A A+ YLH +
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGEL--FFHL---QRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
++++R+ K NILLD + + L+D GL E ST G Y APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKE 171
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNF-LEAVSNMSRLRHPNIVTLA 474
I +G+ G VY A+ + G A+K + + + + + N E M + P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLH 529
Y + L LV EY+ G+ ++ +D +K V LG +E LH
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYI----AEVVLG----VEDLH 114
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ ++HR+ K N+L+D + L+D GL+ + + VG Y APE L
Sbjct: 115 Q---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETIL 166
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
SD +S G V+ E L G P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ VY+ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV+EY+ D+ + DD ++ + R L Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SG 591
V+HR+ K N+L+++ L+D GLA + S ++V Y P+ L S
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGST 180
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPL 616
Y+ + D++ G + E+ TGR PL
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR-PL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
S E ++G G G + R + ++ A S ++ FL + + H
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
NIV L G ++V EY+ NG L L L + + G A ++Y
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKY 122
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG--AFGYSAP 585
L E+ VH+ + +L++ +L +S G L + + T M G ++AP
Sbjct: 123 LSEM---GYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
E ++ SDV+SFG+VM E+++ G +P
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSR 464
+S+ + +GEGS VY+ + NGK++A+K I LQEE+ + S +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-----RLQEEEGTPFTAIREASLLKG 59
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
L+H NIV L LV+EYV D+ + D L R
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRG 115
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
L Y+H+ ++HR+ K N+L+ D L+D GLA S ++V Y
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRP 171
Query: 585 PEFAL-SGIYTVKSDVYSFGVVMLELLTG 612
P+ L S Y+ D++ G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLRHP 468
+IG GS +V N +I A+K + + +Q E + E S+ +P
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-----NP 56
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+V L C + RL LV EYV G+L M H K +AR A AL +
Sbjct: 57 FLVGLHS-CFQTTSRLFLVIEYVNGGDL--MFHM-QRQRKLPEEHARFYAA-EICIALNF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSAP 585
LHE +++R+ K N+LLD + + L+D G+ L P ++ G Y AP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAP 165
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
E Y D ++ GV+M E++ GR P D
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A G+ A+K + + ++E + + + RHP + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F ++ ++ + A + ALEYLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR--FYGAEI------VSALEYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
VV+R+ K N++LD + + ++D GL + + T G Y APE
Sbjct: 114 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLED 169
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + GVVM E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G+ G V + + ++ +K+ + + + + + + P IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
G+ + E++ G+L +L +K + +V++ R L YL E ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIM 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ K +NIL++ L D G++ ++ ++ VG Y +PE Y+V+S
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 598 DVYSFGVVMLELLTGRKPL 616
D++S G+ ++EL GR P+
Sbjct: 184 DIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN---MSRLRHPNIVTL 473
+G+G G V + A GK+ A KK++ L++ + A+ ++++ IV+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKK--RLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
A Y + L LV + G+L ++ D+ + LE+LH+
Sbjct: 59 A-YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ-MVGAFGYSAPEFALSG 591
+++R+ K N+LLD++ N +SD GLA + Q T+ G G+ APE
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLDR 618
Y D ++ GV + E++ R P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 65/223 (29%), Positives = 90/223 (40%), Gaps = 44/223 (19%)
Query: 423 LGRVYRAEFANGKIMAVKKIDNAALSLQEEDN------------------FLEAVSNMSR 464
LGR R + G + K D+ E F E S M +
Sbjct: 3 LGRGTRTQIYAGILN--YKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
+ H +IV L G C + ++V E+V G L +H S LT + +VA A A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASA 117
Query: 525 LEYLHEVCLPSVVHRNFKSANILL-----DDELNP--HLSDCGLAALTPNT--ERQVSTQ 575
L YL + +VH N + NILL D E P LSD G+ P T RQ +
Sbjct: 118 LSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQ---E 167
Query: 576 MVGAFGYSAPE-FALSGIYTVKSDVYSFGVVMLEL-LTGRKPL 616
V + APE S ++ +D +SFG + E+ G PL
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEED-----NFLEAVSNMSRLRHPNIV 471
IGEG+ G V++A+ +I+A+K++ L ++D + L + + L+H NIV
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 472 TLAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
L Y H + LV+EY D+ + D + ++ + L + H
Sbjct: 63 RL--YDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V+HR+ K N+L++ L+D GLA R S ++V Y P+
Sbjct: 117 S---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 172
Query: 590 SG-IYTVKSDVYSFGVVMLELLTGRKPL 616
+Y+ D++S G + EL +PL
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G VY+A +I+AVK I + + LQ++ + + + + P I+ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQ--IMSELEILYKCDSPYIIGFYG 66
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + E++ G+L D + + + R+A+ + L YL +
Sbjct: 67 AFFVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLWSL---K 115
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++HR+ K +N+L++ L D G++ N+ ++ VG Y APE Y +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGI 172
Query: 596 KSDVYSFGVVMLELLTGRKP 615
SDV+S G+ +EL GR P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNI 470
++G+GS G+V AE ++ A+K + + LQ++D ++ R+ +HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDD--VDCTMTEKRILALAAKHPFL 58
Query: 471 VTLAGYCAEHGQRLL-VYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEY 527
L C + RL V EYV G+L + + D ++ + A V +AL +
Sbjct: 59 TALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MF 111
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGYSAP 585
LH V++R+ K NILLD E + L+D G+ + +T G Y AP
Sbjct: 112 LHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYIAP 165
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
E Y D ++ GV+M E++ G+ P +
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 57/246 (23%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRL 465
F + L+G+G +GRV+ GK+ A+K +D + + N ++ V ++ L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM---IKRNKVKRVLTEQEILATL 58
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH------FADDSSKNLTWNARVRVAL 519
HP + TL LV +Y G L +L +++ AR A
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV-------ARFYAAE 111
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQM- 576
ALEYLH L +V+R+ K NILL + + H LSD L+ + VS +
Sbjct: 112 VLL-ALEYLH---LLGIVYRDLKPENILLHE--SGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 577 ---------------------------VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLEL 609
VG Y APE + D ++ G+++ E+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
Query: 610 LTGRKP 615
L G P
Sbjct: 226 LYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ V++ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-----RLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEV 531
L LV+EY+ + D+ + D+ NL V++ + R L Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS----DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-S 590
++HR+ K N+L++++ L+D GLA + S ++V Y P+ L S
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 178
Query: 591 GIYTVKSDVYSFGVVMLELLTGR 613
Y+ D++ G ++ E+ TGR
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 417 LIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH----P 468
++G G+ G+V+ +G K+ A+K + A + +Q+ + L H P
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSP 65
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALE 526
+VTL Y + +L L+ +Y+ G L L + + V++ G ALE
Sbjct: 66 FLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EVQIYSGEIVLALE 119
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVSTQMVGAFGYSA 584
+LH++ +++R+ K NILLD + L+D GL+ ER S G Y A
Sbjct: 120 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEYMA 174
Query: 585 PEFALSGI--YTVKSDVYSFGVVMLELLTGRKPL 616
P+ G + D +S GV+M ELLTG P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A GK A+K + + ++E + L + RHP + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F++D ++ + A + AL YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--FYGAEI------VSALGYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
VV+R+ K N++LD + + ++D GL + + T G Y APE
Sbjct: 114 C---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLED 169
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKP 615
Y D + GVVM E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A A K AVK + A+ ++E+ + + N + ++HP +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYLHEV 531
+ + +L V +Y+ G L F + R R A A AL YLH +
Sbjct: 62 H-FSFQTADKLYFVLDYINGGEL-----FYHLQRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA--LTPNTERQVSTQMVGAFGYSAPEFAL 589
++V+R+ K NILLD + + L+D GL + N ++ G Y APE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTFCGTPEYLAPEVLH 169
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + G V+ E+L G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 418 IGEGSLGRVYRAEFANGKI--MAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
+G GS GRV A + N +A+K+ + + + Q++ D+ ++ + HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G + LV E+V G L +K + A EYL +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL--- 150
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
++V+R+ K N+LLD + ++D G A + + + T + G Y APE L+ +
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGHG 206
Query: 595 VKSDVYSFGVVMLELLTGRKPL 616
+D ++ G+ + E+L G P
Sbjct: 207 KAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIMA---VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G G+V +E +A VK++ A S +E++ FL+ L+HPNI+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKEL-KANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C E LLV+EY G+L L +N R+A A + ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--- 118
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--MVGAFGYSAPEFA---- 588
+ +H + N L +L + D G+ + E + T+ + APE
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI-GPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 589 ---LSGIYTVKSDVYSFGVVMLELL 610
++ T S+V++ GV + EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEGS VY+ G+++A+K+I L+ E+ + S + L+H NIVT
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-----RLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 473 LAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
L H ++ L V+EY+ D+ + DD L+ + VR+ L R L Y H
Sbjct: 68 LHDII--HTKKTLTLVFEYLDT----DLKQYMDDCGGGLSMH-NVRLFLFQLLRGLAYCH 120
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ V+HR+ K N+L+ + L+D GLA + S ++V + Y P+ L
Sbjct: 121 Q---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW-YRPPDVLL 176
Query: 590 -SGIYTVKSDVYSFGVVMLELLTGR 613
S Y+ D++ G + E+ TGR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 418 IGEGSLGRVYRAEFANGKI-------MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + +A+K ++ AA S++E FL S M ++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHV 71
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARA 524
V L G ++ L++ E + G+L L +N + +++A A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVSTQMVGAFGY 582
+ YL+ VHR+ + N ++ ++ + D G+ T+ R+ ++ +
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 187
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+PE G++T SDV+SFGVV+ E+ T
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIMA---VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G G+V E +G A VK++ +A S+QE+ FLE L+H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV--RVALGTARALEYLHEVC 532
G C E LLV E+ G+L L + ++ +T + R+A A L +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLR-SCRKAELMTPDPTTLQRMACEIALGLLHLHK-- 118
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFA--- 588
+ +H + N LL +L + D GL+ + V Q+ + APE
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 589 ----LSGIYTVKSDVYSFGVVMLELLT-GRKP 615
L T +S+V+S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEED----NFLEAVSNMSRLRHPNIVT 472
+GEG+ V++ ++A+K+I L+ E+ + VS + L+H NIVT
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI-----RLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV+EY+ D+ + DD ++ + R L Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK----DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-- 122
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SG 591
V+HR+ K N+L+++ L+D GLA + S ++V Y P+ L S
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPL 616
Y+ + D++ G + E+ +GR PL
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR-PL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 418 IGEGSLGRVYRA---------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
+G+G+ ++++ E +++ +K +D + + E +F EA S MS+L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVL-LKVLDKSHRNYSE--SFFEAASMMSQLSHK 59
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
++V G C + ++V EYV G+L D + + N++W ++ VA A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 529 HEVCLPSVVHRNFKSANILLDDEL-----NP---HLSDCGLAALTPNTERQVSTQMVGAF 580
+ + H N + N+LL E NP LSD G++ E ++
Sbjct: 117 ED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----ILLERI 168
Query: 581 GYSAPE-FALSGIYTVKSDVYSFGVVMLELLTG-RKPL 616
+ PE ++ +D +SFG + E+ +G KPL
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
+IG+GS G+V A+ +GK AVK + + ++E + A N + ++HP +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV-ALGTARALEYLHEV 531
Y + ++L V ++V G L H + S R R A A AL YLH +
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLHSI 115
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
++V+R+ K NILLD + + L+D GL + +T G Y APE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + G V+ E+L G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLA 474
L+G+G+ G+V E A G+ A+K + + ++E + L + RHP + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYLHE 530
H + V EY G L L F++D ++ + A + AL+YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--FYGAEI------VSALDYLHS 113
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+VV+R+ K N++LD + + ++D GL + T G Y APE
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLED 170
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D + GVVM E++ GR P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 409 TNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
TN + +G G+ G V A + G+ +A+KKI + + + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 468 PNIVTLAG-YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
NI++L+ + + V E +G +LH +L +S+ L R L+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGT-DLHRLL-----TSRPLEKQFIQYFLYQILRGLK 122
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT-PNTERQVSTQMVGAFGYSAP 585
Y+H VVHR+ K +NIL+++ + + D GLA + P VST+ Y AP
Sbjct: 123 YVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174
Query: 586 EFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
E L+ Y V+ D++S G + E+L G KPL
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 418 IGEGSLGRVYRA---EFANGKI---MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+GS G VY + G+ +AVK ++ +A SL+E FL S M ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G ++ L+V E + +G+L L ++N T +++A A +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQVSTQMVGAFGYS 583
YL+ VHR+ + N ++ + + D G+ T+ R+ ++ +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWM 188
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLT 611
APE G++T SD++SFGVV+ E+ +
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVK-----KIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
LI E +Y+ F N K + ++ + L D + N+ R+ NI+
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLI----DITENEIKNLRRIDSNNIL 81
Query: 472 TLAGYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+ G+ + L L+ EY G L ++L D K+L++ ++ +A+ + L
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYN 137
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
L++ + ++N S + L+ + + GL + V Y + +
Sbjct: 138 LYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLE----KILSSPPFKNVNFMVYFSYKM 191
Query: 588 ALSGI---YTVKSDVYSFGVVMLELLTGRKPLD 617
L+ I YT+K D+YS GVV+ E+ TG+ P +
Sbjct: 192 -LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
++G G+ G VY+ + N KI K+ S + L+ M+ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLH 529
L G C +L V + + G L D + D S L W ++ A+ + YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVSTQMVGAFGYSAPEF 587
EV L VHR+ + N+L+ + ++D GLA L TE V + A E
Sbjct: 127 EVRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALES 182
Query: 588 ALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617
L +T +SDV+S+GV + EL+T G KP D
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+GS G+V AE G+ AVK + + + ++ + L N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 476 YCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR---ALEYLHE 530
YC + L V E++ G+L M H D +L R A L++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDL-----YRATFYAAEIVCGLQFLHS 114
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+++R+ K N++LD + + ++D G+ + + ST G Y APE
Sbjct: 115 ---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
YT D +SFGV++ E+L G+ P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTL 473
++G+GS G+V AE ++ A+K I + +Q++D V ++ P +T
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
C + RL V EYV G+L M H V A + L +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDL--MYHI--QQVGKFKEPQAVFYAAEISVGLFFLHR-- 119
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ-MVGAFGYSAPEFALSG 591
+++R+ K N++LD E + ++D G+ + V+T+ G Y APE
Sbjct: 120 -RGIIYRDLKLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D +++GV++ E+L G+ P D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 417 LIGEGSLGR----VYRAEFANGKIMAVKKIDNAALSLQEEDNFLE---AVSNMSRLRHPN 469
LIG+ + + + ++AVKKI+ L +++ + +L+HPN
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKIN---LDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVAL---GTARA 524
I+ + +V + G+ D+L HF + + +A A
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA-------IAFILKDVLNA 113
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--- 581
L+Y+H +HR+ K+++ILL + LS GL + ++V F
Sbjct: 114 LDYIHSK---GFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 582 -----YSAPEF---ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ +PE L G Y KSD+YS G+ EL G P
Sbjct: 169 VKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 9/208 (4%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGK-IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
N F ++GEG+ G V + K I+A+KK ++ + + ++ L + + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
NIV L G+ LV+EYV +ML ++ + +A+ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEK----NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H+ +VHR+ K N+L+ L D G A T+ V Y +PE
Sbjct: 117 HK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPL 616
L Y D++S G ++ EL G +PL
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + G +AVKK+ S+ + + ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 474 ---AGYCAEHGQRLLVYEYVGN--GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
A E LV +G N+ DD + L + R L+Y+
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 136
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSAP 585
H ++HR+ K +N+ ++++ + D GLA R +M G Y AP
Sbjct: 137 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGYVATRWYRAP 186
Query: 586 EFALSGI-YTVKSDVYSFGVVMLELLTGR 613
E L+ + Y D++S G +M ELLTGR
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKI---DNAALSLQEEDNFLEAVSNMSRLRH 467
+ IGEG+ G V A G +A+KKI ++ + L + + R +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIKILRRFKH 62
Query: 468 PNIVTL-----AGYCAEHGQRLLVYEYVGNGNLHDML---HFADDSSKNLTWNARVRVAL 519
NI+ + +V E + +L+ ++ H ++D + +
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQ------- 114
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS--TQMV 577
R L+Y+H +V+HR+ K +N+LL+ + + D GLA + T+ V
Sbjct: 115 -ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 578 GAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L S YT D++S G ++ E+L+ R PL
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 418 IGEGSLGRVYRAEFA---NGKIMAVKKIDNA---ALSLQEEDNFLEAVSNMSRLR-HPNI 470
+G+G+ G V A A + +A+KKI N + + L + + R H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA---LRELKLLRHFRGHKNI 64
Query: 471 VTL-----AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
L + L +YE + +LH ++ S + LT +A + +
Sbjct: 65 TCLYDMDIVFPGNFNE--LYLYEELMEADLHQIIR----SGQPLT-DAHFQSFIYQILCG 117
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVS--TQMVGAFG 581
L+Y+H +V+HR+ K N+L++ + + D GLA + N T+ V
Sbjct: 118 LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 582 YSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE LS YT DV+S G ++ ELL GRKP+
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 15/98 (15%)
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG- 581
R L+Y+H ++HR+ K +NI ++++ + D GLA R +M G
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA-------RHTDDEMTGYVAT 178
Query: 582 --YSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L+ + Y D++S G +M ELLTG K L
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-KTL 215
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 418 IGEGSLGRVYR-AEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V+ + +GK +A+KK+ N +L + + +H N+ L+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV--LSAL 65
Query: 477 CAEHGQRLLVYE--YVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCL 533
+ +E YV + LH S + L+ + V+V L R L+YLH
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA-- 122
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SGI 592
++HR+ K N+L++ + D GLA + E + TQ V Y APE + S
Sbjct: 123 -GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181
Query: 593 YTVKSDVYSFGVVMLELLTGR 613
YT D++S G + ELL R
Sbjct: 182 YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 417 LIGEGSLGRVY-------RAEFANGKIMAVKKIDNAALSL--QEEDNFLEAVSNMSRLRH 467
LI G+ G VY R FA +KKI+ L L Q + F+E ++ +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFA------MKKINKQNLILRNQIQQVFVER-DILTFAEN 60
Query: 468 PNIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525
P +V++ +C+ +R L V EYV G+ +L ++ AR+ A T AL
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM---ARMYFA-ETVLAL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-----ALTPN---------TERQ 571
EYLH +VHR+ K N+L+ + L+D GL+ +LT N T
Sbjct: 115 EYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ Q+ G Y APE L Y D ++ G+++ E L G P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 1/91 (1%)
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT-ERQVSTQMVGAFGYSAPE 586
+H V ++HR+ KSANILL L D G + + T V G Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y+ K+D++S GV++ ELLT ++P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 44/199 (22%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G+ G V++ ++ +K+ + + + + + + P IV G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
G+ + E++ G+L +L A + + +V++ + L YL E ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG----KVSIAVIKGLTYLREK--HKIM 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ K +NIL++ L D G++ ++ ++ VG Y +PE Y+V+S
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 598 DVYSFGVVMLELLTGRKPL 616
D++S G+ ++E+ GR P+
Sbjct: 184 DIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE---DNFLEAVSNMSRLRH-PNIVT 472
IGEG+ G+VY+A + GK++A+KK L + EE L +S + L IV
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 473 LAGYCAEH-------GQRLLVYEYVGNGNLHDMLHFADD----SSKNLTWNARVRVALGT 521
L EH LV+EY+ + D+ F D + L
Sbjct: 66 L--LDVEHVEEKNGKPSLYLVFEYLDS----DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNP-HLSDCGLA-ALTPNTERQVSTQMVGA 579
+ + + H+ V+HR+ K N+L+D + ++D GL A + + T +
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174
Query: 580 FGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L Y+ D++S G + E+ ++PL
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 55/173 (31%), Positives = 78/173 (45%), Gaps = 24/173 (13%)
Query: 455 FLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR 514
F E S MS+L H ++V L G C ++V EYV G L LH ++ +L W +
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHRE-KNNVSLHW--K 103
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNP---HLSDCGLA-ALTP 566
+ VA A AL YL + L VH N NIL+ +E LSD G+ +
Sbjct: 104 LDVAKQLASALHYLEDKKL---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160
Query: 567 NTERQVSTQMVGAFGYSAPEF--ALSGIYTVKSDVYSFGVVMLELLT-GRKPL 616
ER + APE T+ +D +SFG +LE+ + G +PL
Sbjct: 161 REERVERIPWI------APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 30/101 (29%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
++++ R L YL E ++HR+ K +NIL++ L D G++ ++ ++
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
VG Y +PE YTV+SD++S G+ ++E+ GR P+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF-- 580
+ L+Y+H ++HR+ K N+ ++++ + D GLA RQ ++M G
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA-------RQTDSEMTGYVVT 178
Query: 581 -GYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L+ + YT D++S G +M E+LTG KPL
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-08
Identities = 16/43 (37%), Positives = 21/43 (48%), Gaps = 4/43 (9%)
Query: 40 DSSDVQALQVLYTSLNSPS--VLTNWKGNEGDPCGESWKGVAC 80
+ D AL +SLN L++W + DPC SW GV C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSN--MSRLRHPNIVTLA 474
++G+GS G+V AE + KI + +Q++D V ++ P +T
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFAD----DSSKNLTWNARVRVALGTARALEYLH 529
C + RL V EYV G+L M + + A + + L +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGL------FFLH 118
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ-MVGAFGYSAPEFA 588
+++R+ K N++LD E + ++D G+ N V+T+ G Y APE
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEII 173
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D ++FGV++ E+L G+ P +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 18/223 (8%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFL-EAV 459
+ LQ + +IG G+ G V ++ K+ A+K + + + + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
M+ P +V L +CA + L V EY+ G+L +++ D K W A+
Sbjct: 95 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---W-AKFYT 148
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV 577
A AL+ +H + L +HR+ K N+LLD + L+D G T V
Sbjct: 149 A-EVVLALDAIHSMGL---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 578 GAFGYSAPEFALS----GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y +PE S G Y + D +S GV + E+L G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 47/137 (34%), Positives = 69/137 (50%), Gaps = 6/137 (4%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L +LL L DL+ N + I L NLTSL+L +NN + P +L L+
Sbjct: 87 ENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELD 146
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+S N + + NL L LDLSFN+ S DLP +LSN+++L L N+++ L
Sbjct: 147 LSDNKIESLPSPL-RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 220 FSGLP--LTTLNVANNH 234
L L L+++NN
Sbjct: 204 EIELLSALEELDLSNNS 220
|
Length = 394 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 49/273 (17%)
Query: 358 QRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQ-EF 416
QR S+A L PP + S +++S S +A S S+ E
Sbjct: 36 QRDPSLAVPLPLPPPSSS-----------------SSSSSSSSASGSAPSAAKSLSELER 78
Query: 417 L--IGEGSLGRVYRA-EFANGKIMAVKKI-----DNAALSLQEEDNFLEAVSNMSRLRHP 468
+ IG G+ G VY+ G++ A+K I D + E L V+ HP
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN------HP 132
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N+V +G+ ++ E++ G+L + H AD+ VA + YL
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQ-------FLADVARQILSGIAYL 184
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
H +VHR+ K +N+L++ N ++D G++ + T ++ VG Y +PE
Sbjct: 185 HR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERI 240
Query: 589 LS----GIYT-VKSDVYSFGVVMLELLTGRKPL 616
+ G Y D++S GV +LE GR P
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-07
Identities = 22/59 (37%), Positives = 29/59 (49%)
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L L++S N LT F L L LDLS NN + P +F L ++ SL L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 418 IGEG--SLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLA 474
IG G +L VY A + +I + +E L+ +S RHPNI+T
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
++ ++ G+ + +L +F + S+ L N + G R L YLH+
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQ-- 119
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCG-LAALTPNTER--------QVSTQMVGAFGYS 583
+HRN K+++IL+ + LS L +L N ++ Q ST ++
Sbjct: 120 -NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
L G Y VKSD+YS G+ EL TGR P
Sbjct: 179 LLRQDLYG-YNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNM----SRLRHPNIVT 472
IG+G+ G+VY+ + +I A+K + + ++E N+ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARALEYL 528
L LV +Y+ G L L F++D A+ +A ALE+L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-------RAKFYIA-ELVLALEHL 112
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN-TERQVSTQMVGAFGYSAPEF 587
H+ +V+R+ K NILLD H++ C N T+ + + G Y APE
Sbjct: 113 HKY---DIVYRDLKPENILLD--ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167
Query: 588 ALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
L YT D +S GV++ E+ G P
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + + +AVKK+ SL + + ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 474 ---AGYCAEHGQRLLVYEYVGNGNLHDMLHF---ADDSSKNLTWNARVRVALGTARALEY 527
A + LV +G +L++++ +D+ + L + R L+Y
Sbjct: 83 FTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLIYQ--------LLRGLKY 133
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG---YSA 584
+H ++HR+ K +N+ ++++ + D GLA RQ +M G Y A
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA-------RQADDEMTGYVATRWYRA 183
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGR 613
PE L+ + Y D++S G +M ELL G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL----RHPNIVT 472
++G+GS G+V AE + KI + +Q++D +E R+ P +T
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD--VECTMVEKRVLALPGKPPFLT 64
Query: 473 LAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVRVALGTARAL 525
C + RL V EYV G+L M H F + + V A A L
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHA--------VFYAAEIAIGL 114
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+LH +++R+ K N++LD E + ++D G+ + T G Y AP
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAP 170
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
E Y D ++FGV++ E+L G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 433 NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVG 491
G+ + V++I+ A + E FL+ ++S+L HPNIV + +V ++
Sbjct: 24 TGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 492 NGNLHDML--HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549
G+ D++ HF D S+ A + G +AL+Y+H + VHR+ K+++IL+
Sbjct: 83 YGSAKDLICTHFMDGMSEL----AIAYILQGVLKALDYIHHM---GYVHRSVKASHILIS 135
Query: 550 DELNPHLSDCGLAALTPNTERQVSTQMVGAF-GYSA-------PEFALSGI--YTVKSDV 599
+ +LS GL + ++V F YS PE + Y KSD+
Sbjct: 136 VDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 193
Query: 600 YSFGVVMLELLTGRKPL 616
YS G+ EL G P
Sbjct: 194 YSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 33/122 (27%), Positives = 52/122 (42%), Gaps = 5/122 (4%)
Query: 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555
D+ + D S L + + AL YLH ++HR+ K+ NI LD+ N
Sbjct: 170 CDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAV 225
Query: 556 LSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRK 614
L D G A L + + G ++PE Y K+D++S G+V+ E+
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
Query: 615 PL 616
L
Sbjct: 286 TL 287
|
Length = 392 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 9/196 (4%)
Query: 418 IGEGSLGRVY----RAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G+GS G VY + A ++ +K+I L+ E + +S+L HP IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
E ++ EY +L L + K L+ N + + Y+H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--- 124
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
++HR+ K+ NI L + L + D G++ L + ++T G Y +PE Y
Sbjct: 125 RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEALKHQGY 182
Query: 594 TVKSDVYSFGVVMLEL 609
KSD++S G ++ E+
Sbjct: 183 DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G+G G+V+ A+ + G+I+A+K++ + L L E + L ++ + +V L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA-RALEYLHEVCL 533
Y + + L L EYV G+ +L ++ + R + A++ LHE+
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL-----NNLGVLSEDHARFYMAEMFEAVDALHEL-- 120
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
+HR+ K N L+D + L+D GL+ + +VG+ Y APE Y
Sbjct: 121 -GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGY 175
Query: 594 TVKSDVYSFGVVMLELLTGRKPLD 617
D +S G ++ E L G P
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 41/232 (17%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRHPNIVTLA 474
+IG G+ G V+ + G++ A+K + + + + + + A + ++ P IV L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 475 GYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
Y + + L V EY+ G+L ++L D + AR +A AL+ +H++
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVL-ALDSVHKL- 120
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAA------------------------LTPNT 568
+HR+ K NIL+D + + L+D GL L
Sbjct: 121 --GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 569 ERQVSTQM----VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ + VG Y APE Y ++ D +S GV++ E+L G P
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 455 FLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR 514
F E S MS++ H ++ + G C + ++V E+V +G L D+ + + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--K 119
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANIL-----LDDELNP--HLSDCGLAALTPN 567
+ VA A AL YL + ++VH N + NIL L + +P LSD G++ +
Sbjct: 120 ITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 568 TERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLEL-LTGRKPL 616
E +V + APE G + +D +SFG +LE+ G PL
Sbjct: 177 REERVER-----IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 46/198 (23%), Positives = 79/198 (39%), Gaps = 32/198 (16%)
Query: 421 GSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480
GS GRV+ A V KI Q+ +EA+ + + HP+++ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIG------QKGTTLIEAML-LQNVNHPSVIRMKDTLVSG 129
Query: 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA--------RALEYLHEVC 532
+V + H++ D LT +R + + A L YLH
Sbjct: 130 AITCMV-----------LPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQ- 176
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ K+ NI ++D + D G A + + G +APE
Sbjct: 177 --RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVETNAPEVLARDK 232
Query: 593 YTVKSDVYSFGVVMLELL 610
Y K+D++S G+V+ E+L
Sbjct: 233 YNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 37/232 (15%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKI-----DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
LIG+G +G VY A + + +A+KKI +N L + FL + L HP I
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL----KKRFLREAKIAADLIHPGI 64
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARV----RVALGTAR 523
V + C++ Y+ L +L + SK L V +
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-----------ALTPNTERQV 572
+EY+H V+HR+ K NILL + D G A + +
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 573 STQM------VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
+ M VG Y APE L + +D+Y+ GV++ ++LT P R
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 30/119 (25%), Positives = 53/119 (44%), Gaps = 22/119 (18%)
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
++D + L + L+Y+H ++HR+ K N+ ++++ + D
Sbjct: 112 HPLSEDKVQYLVYQ--------MLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160
Query: 559 CGLAALTPNTERQVSTQMVGAF---GYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGR 613
GLA R +M G Y APE L+ + Y D++S G +M E+LTG+
Sbjct: 161 FGLA-------RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 43/243 (17%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP 468
+ F +IG G+ G V + + G I A+K + A + +E+ + A ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 469 NIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
V Y + + L L+ E++ G++ +L D S+ T + +A T A++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEAT---QFYIA-ETVLAIDA 116
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-------------LTPN------- 567
+H++ +HR+ K N+LLD + + LSD GL LT N
Sbjct: 117 IHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 568 --------------TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
RQ++ VG Y APE + Y D +S GV+M E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 614 KPL 616
P
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGY 582
AL+ +H + +HR+ KSANI L L D G + + + V++ G Y
Sbjct: 181 ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE Y+ K+D++S GV++ ELLT +P
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 19/210 (9%)
Query: 417 LIGEGSLGRVYRAEFANG-KIMAVKKIDN-AALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + N K+ A+K ++ L E F E + + I TL
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML-HFADDSSKNLT--WNARVRVALGTARALEYLHEV 531
+ LV +Y G+L +L F D +++ + A + +A+ + L Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS- 590
VHR+ K NIL+D + L+D G S+ VG Y +PE +
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 591 ----GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y + D +S GV M E+L G P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 406 QTATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
++ S+ +IG GS G VY A + +A+KK+ LQ+ + M
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKN 115
Query: 465 LRHPNIVTLAGY----CAEHGQRLL----VYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
L H NI+ L Y C + ++ + V E++ +H + ++ L
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL 174
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVS 573
+ RAL Y+H + HR+ K N+L+D N H L D G A +R VS
Sbjct: 175 YSYQLCRALAYIHS---KFICHRDLKPQNLLIDP--NTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 574 TQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTG 612
+ + Y APE L YT D++S G ++ E++ G
Sbjct: 230 --YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA---LTPNTERQVSTQMVG 578
A+ +E+L +HR+ + NILL + + D GLA P+ R+ ++
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ APE +YT++SDV+SFGV++ E+ + G P
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 3/135 (2%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
LLS+L +L DLSGN I D P + SNN L S++++ +LS L +S
Sbjct: 181 LLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELS 240
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N L + GNL+ L TLDLS NN + S SL+N+ L L N ++ +L + +
Sbjct: 241 NNKLEDLP-ESIGNLSNLETLDLS-NNQISSIS-SLGSLTNLRELDLSGNSLSNALPLIA 297
Query: 222 GLPLTTLNVANNHFS 236
L L + N +
Sbjct: 298 LLLLLLELLLNLLLT 312
|
Length = 394 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 67/254 (26%), Positives = 103/254 (40%), Gaps = 64/254 (25%)
Query: 410 NSFSQEFLIGEGSLGRVYR--AEFANGKIMAVKKIDNAALSLQE-------EDNFLEAVS 460
+ F +IG G+ G V R + G I A+KK+ + + +E E + L
Sbjct: 1 DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD 59
Query: 461 NMSRLRHPNIVTLAGYCA-EHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518
N P +V L Y + + L L+ EY+ G++ +L D ++ T R +A
Sbjct: 60 N------PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---RFYIA 108
Query: 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---------------- 562
T A++ +H++ +HR+ K N+LLD + + LSD GL
Sbjct: 109 -ETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 563 -ALTPNTERQVSTQM--------------------VGAFGYSAPEFALSGIYTVKSDVYS 601
AL N +S M VG Y APE L Y + D +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 602 FGVVMLELLTGRKP 615
GV+M E+L G P
Sbjct: 225 LGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 41/151 (27%), Positives = 62/151 (41%), Gaps = 21/151 (13%)
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNL----HDMLHFADDSSKNLTWNARVRVALGTAR 523
PN+V L Y LV ++ G L L+ ++ K W A + VAL
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR--WAAEMVVAL---- 98
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD-CGLAALTPNTERQVSTQMVGAFGY 582
+ LH +V R+ NILLDD + L+ + + + + + M Y
Sbjct: 99 --DALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
APE T D +S G ++ ELLTG+
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 3/94 (3%)
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
RA++YLHE ++HR+ K+ NI ++ + L D G A + G
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+APE Y D++S G+V+ E+ T L
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 43/236 (18%)
Query: 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+IG G+ G V + + G + A+K + A + +E+ + A ++ V
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y + L L+ E++ G++ +L D LT T A++ +H++
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL--- 120
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGL--------------------------------- 561
+HR+ K N+LLD + + LSD GL
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 562 -AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
A RQ++ VG Y APE + Y D +S GV+M E+L G P
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 20/223 (8%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDN--FLEA 458
+ L+ F +IG G+ G V ++ ++ A+K + + ++ D+ F E
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAFFWEE 93
Query: 459 VSNMSRLRHPNIVTLAGYCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
M+ IV L + A + L V EY+ G+L +++ D K W AR
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---W-ARFY 147
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM 576
A AL+ +H + +HR+ K N+LLD + L+D G
Sbjct: 148 TA-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 577 VGAFGYSAPEFALS----GIYTVKSDVYSFGVVMLELLTGRKP 615
VG Y +PE S G Y + D +S GV + E+L G P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 70/262 (26%), Positives = 104/262 (39%), Gaps = 71/262 (27%)
Query: 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVK--------KIDNAALSLQEEDNFLEAVS 460
F +IG+G+ G V + GKI A+K K D A E D E+ S
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
P +V+L Y + Q L L+ E++ G+L ML D S+++T R +A
Sbjct: 61 -------PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---RFYMA- 108
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA---------------- 563
A+E +H++ +HR+ K NIL+D + LSD GL+
Sbjct: 109 ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 564 --------------------LTPNTERQVST----------QMVGAFGYSAPEFALSGIY 593
LT +++ Q++T VG Y APE L Y
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 594 TVKSDVYSFGVVMLELLTGRKP 615
+ D +S G +M E L G P
Sbjct: 226 GQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 417 LIGEGSLGRV--YRAEFANGKIMAVKKIDNAALSLQEEDNFL-EAVSNMSRLRHPNIVTL 473
+IG G+ G V R + K+ A+K + + + + F E M+ P +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
+ +V EY+ G+L +++ D K W AR A AL+ +H +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---W-ARFYTA-EVVLALDAIHSM-- 161
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM-VGAFGYSAPEFALS-- 590
+HR+ K N+LLD + L+D G + N E V VG Y +PE S
Sbjct: 162 -GFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 591 --GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y + D +S GV + E+L G P
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+GEGS VY+ NG+++A+K I S++ E+ + S + L+H NIV
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI-----SMKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL-TWNARVRVALGTARALEYLHEV 531
L V+EY+ D+ + L +N R+ R L Y+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG- 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
++HR+ K N+L+ L+D GLA + S+++V Y P+ L
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGA 178
Query: 592 I-YTVKSDVYSFGVVMLELLTGR 613
Y+ D++ G + +E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA---LTPNTERQVSTQMVG 578
AR +E+L +HR+ + NILL + + D GLA P+ R+ S ++
Sbjct: 184 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ APE +YT +SDV+SFGV++ E+ + G P
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-05
Identities = 21/60 (35%), Positives = 33/60 (55%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189
NL SL+L++N + + + +L L++S N+LT + F L L +LDLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA---LTPNTERQVSTQMVG 578
AR +E+L +HR+ + NILL + + D GLA P+ R+ ++
Sbjct: 183 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ APE +YT +SDV+SFGV++ E+ +
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNA--ALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + + + + KI N L E F E + + I TL
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML-HFADDSSKNLT--WNARVRVALGTARALEYLHEV 531
+ LV +Y G+L +L F D +++ + A + +A+ + L Y
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY---- 123
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALS 590
VHR+ K N+LLD + L+D G + L N + V S+ VG Y +PE +
Sbjct: 124 -----VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 591 -----GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y + D +S GV M E+L G P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 4/112 (3%)
Query: 501 FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560
+DD S+ LT + AR +E+L + VHR+ + N+LL + D G
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFG 282
Query: 561 LAALTPNTERQVST-QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
LA + VS + APE +YT SDV+S+G+++ E+ +
Sbjct: 283 LARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 8e-05
Identities = 19/60 (31%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 108 SLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+L+ DLS N + PNL L+L+ NN + P + + + SL L++S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 22/60 (36%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHF 235
L +LDLS N + +F L N+ L L N +T S FSGLP L +L+++ N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 29/164 (17%)
Query: 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-------SLQEEDNFLEAVSNMSRLRHPN 469
I G+ G+VY N K+ AVK + A + +Q E + L A+S + P
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALS-----KSPF 65
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH----FADDSSKNLTWNARVRVALGTARAL 525
IV L LV EY+ G++ +LH F ++ + V+ A AL
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA--------VKYISEVALAL 117
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+YLH ++HR+ K N+L+ +E + L+D GL+ +T N E
Sbjct: 118 DYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 404 SLQTATNSFS------QEFLIGEGSLGRVYRA-EFANGKIMAVKKI------DNAALSLQ 450
S+Q A ++F+ Q IG G+ G V A + G +AVKK+ A
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 68
Query: 451 EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510
E L+ V++ + + N+ T E LV E + + NL ++H D
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELD------ 121
Query: 511 WNARVRVALGTAR-ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
+ R+ L +++LH ++HR+ K +NI++ + + D GLA T T
Sbjct: 122 -HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TACTN 176
Query: 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG 612
++ +V + Y APE L Y D++S G +M EL+ G
Sbjct: 177 FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 34/134 (25%), Positives = 50/134 (37%), Gaps = 45/134 (33%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL---------------------- 561
A+E +H++ +HR+ K NIL+D + + L+D GL
Sbjct: 113 AIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 562 -------------AALTPNTERQVSTQM-------VGAFGYSAPEFALSGIYTVKSDVYS 601
L P R+ VG Y APE L YT D +S
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 602 FGVVMLELLTGRKP 615
GV++ E+L G+ P
Sbjct: 230 VGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLA-ALTPNTERQ--VSTQMVG 578
R L+Y+H +V+HR+ K AN+ ++ ++L + D GLA + P+ + +S +V
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 579 AFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGR 613
+ Y +P LS YT D+++ G + E+LTG+
Sbjct: 182 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 17/139 (12%)
Query: 485 LVYEYVGNGNLHDML-HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543
LV +Y G+L +L F D +++ AR +A A++ +H++ VHR+ K
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLA-EMVLAIDSVHQL---GYVHRDIKP 130
Query: 544 ANILLDDELNPHLSDCG--LAALTPNTERQVSTQMVGAFGYSAPEFALS-----GIYTVK 596
N+LLD + L+D G L L T + S VG Y +PE + G Y +
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQ--SNVAVGTPDYISPEILQAMEDGKGRYGPE 188
Query: 597 SDVYSFGVVMLELLTGRKP 615
D +S GV M E+L G P
Sbjct: 189 CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
+++LH ++HR+ K +NI++ + + D GLA T T ++ +V + Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRY-YR 184
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGR 613
APE L Y D++S G +M E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 27/103 (26%), Positives = 46/103 (44%), Gaps = 4/103 (3%)
Query: 509 LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
L R + A+EY+H+ L +HR+ K NI L+ + L D G A
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
VG ++PE Y +D++S G+++L++L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 24/225 (10%)
Query: 418 IGEGSLGRVYRAEFANGK-IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT-LAG 475
IG G G V+ + + K I L +E+ + V+ M L+H NIV +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV--- 531
+ + Q+L ++ E+ G+L + + +A V + AL Y H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 532 -CLPSVVHRNFKSANILLD-------------DELNPH-LSDCGLAALTPNTE-RQVSTQ 575
V+HR+ K NI L + LN ++ G L+ N ++
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS 200
Query: 576 MVGAFGYSAPEFAL--SGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
VG Y +PE L + Y KSD+++ G ++ EL +G+ P +
Sbjct: 201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 10/91 (10%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ GRV A A+G +AVK + + A S E+ + + MS L H N
Sbjct: 45 LGSGAFGRVVEAT-AHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLN 102
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH 500
IV L G C + G ++ EY G+L D LH
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
+++LH ++HR+ K +NI++ + + D GLA T T ++ +V + Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRY-YR 192
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGR 613
APE L Y D++S G +M E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPN-TERQVSTQMVGAFGYSAPEFALSGIYTV 595
+HR+ + N+LL D + D GLA N + V + APE +YTV
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 596 KSDVYSFGVVMLELLT-GRKP 615
+SDV+S+G+++ E+ + G+ P
Sbjct: 294 QSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
+++LH ++HR+ K +NI++ + + D GLA T T ++ +V + Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRY-YR 185
Query: 584 APEFALSGIYTVKSDVYSFGVVMLE------LLTGRKPLDR 618
APE L Y D++S G +M E L GR +D+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 32/99 (32%), Positives = 38/99 (38%), Gaps = 17/99 (17%)
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM 576
V L AL LH R KS NILL + L D +A TP R
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLTWDGLLKL-DGSVAFKTPEQSRP--DPY 69
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
A PE YT K+D+YS G+ + E L P
Sbjct: 70 FMA-----PEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 618 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.98 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.62 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.62 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.58 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.5 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.49 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.39 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.27 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.25 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.25 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 99.05 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.01 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.0 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.36 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-57 Score=530.81 Aligned_cols=465 Identities=29% Similarity=0.444 Sum_probs=314.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
..++.|+|++|++++.+|..+.+++.|+.|+|++|.+++.+|..+. ++|+.|+|++|++.+.+|..+ .+++|+.|+|
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~l 482 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDL 482 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEEC
Confidence 4678888888888888888888888888888888888887776543 778888888888887777655 3577888888
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc-CC-CCccEEEccccccccc
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLNVANNHFSGW 238 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~L~l~~N~l~g~ 238 (618)
++|++++.+|..|.++++|+.|+|++|++.|.+|..+..+++|++|+|++|.++|.+|.. .. .+|+.|||++|+++|.
T Consensus 483 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 562 (968)
T PLN00113 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGE 562 (968)
T ss_pred cCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccccc
Confidence 888888888877888888888888888888788887878888888888888888766542 22 3478888888888888
Q ss_pred Cchhhhc---ccchhccCCcCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCcceeehhHHHH
Q 007103 239 IPRELIS---IRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQG---SHSPSGSQSSSSDKELPAGAIVGIVLGA 312 (618)
Q Consensus 239 ip~~~~~---l~~l~~~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~s~~~~~~~~~~~~~~~~~i~~~~~~~ 312 (618)
+|..+.+ |+.|++++|++.+.............+....+...+... ..+++.. ........+++++++++
T Consensus 563 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~----~~~~~~~~~~~~~~~~~ 638 (968)
T PLN00113 563 IPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR----VRKTPSWWFYITCTLGA 638 (968)
T ss_pred CChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc----ccccceeeeehhHHHHH
Confidence 8876543 556677777776532211111111111111111111000 0001110 00111223344444444
Q ss_pred HHHHHHHHHHHHHHHHhccccccCCCCCCCCCCCCCCcccccccccccccccccccCCCCchhhhHHHHHhhcCCCcccc
Q 007103 313 VFLVALALLALYFCIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIK 392 (618)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (618)
++++++++++++++++|++++.+......+ .. .. .....
T Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~---~~--~~~~~---------------- 677 (968)
T PLN00113 639 FLVLALVAFGFVFIRGRNNLELKRVENEDG--------------------TW---EL--QFFDS---------------- 677 (968)
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccc--------------------cc---cc--ccccc----------------
Confidence 333333333333222222111100000000 00 00 00000
Q ss_pred CCCcccceehhhhhhhhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCccc
Q 007103 393 SPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (618)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (618)
......+ .+.....|...+.||+|+||.||+|.. .+|+.||+|+++..... ..+|++.+++++||||+
T Consensus 678 --~~~~~~~---~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv 746 (968)
T PLN00113 678 --KVSKSIT---INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIV 746 (968)
T ss_pred --ccchhhh---HHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcc
Confidence 0000011 122234566778999999999999987 47899999998643321 12457888999999999
Q ss_pred ccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
++++++.+++..++||||+++|+|.++++ .++|..+.+++.|+++||+|||..+.++|+||||||+||+++.+
T Consensus 747 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~ 819 (968)
T PLN00113 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819 (968)
T ss_pred eEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC
Confidence 99999999999999999999999999995 37899999999999999999996655599999999999999999
Q ss_pred CCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.+++. ||........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 820 ~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 820 DEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred CceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 888875 6655332211 22368899999999999999999999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=365.01 Aligned_cols=202 Identities=29% Similarity=0.487 Sum_probs=184.7
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+|...+.||+|+|++||+|++. ++.+||||.+..........+.+..|+++++.++|||||.+++++..++..++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467888888999999999999876 489999999988776777788899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC------CCcEEeecc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE------LNPHLSDCG 560 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~------~~~kl~Dfg 560 (618)
||||.+|+|.++++ ..+.+++.+++.++.|++.||++||++ +||||||||.|||++.. -.+||+|||
T Consensus 88 MEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999998 456899999999999999999999999 99999999999999854 458999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
+|+...+ .......+|++-|||||+++..+|+.|+|+||+|+|+|+|++|+.||+.
T Consensus 161 fAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 161 FARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9998863 4455678999999999999999999999999999999999999999983
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=372.21 Aligned_cols=218 Identities=52% Similarity=0.904 Sum_probs=193.3
Q ss_pred cccceehhhhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccce
Q 007103 396 TATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475 (618)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 475 (618)
....|++.++..++++|.....||+|+||.||+|...+|+.||||++....... ..+|..|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 445689999999999999999999999999999999999999999887544322 456999999999999999999999
Q ss_pred EEeeCC-eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCc
Q 007103 476 YCAEHG-QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 476 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
||.+.+ +.+||+|||++|+|.++++..... .++|..+.+|+.++|+||+|||+.+.|.||||||||+|||+|+++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 999998 599999999999999999843222 88999999999999999999999988889999999999999999999
Q ss_pred EEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+|||+|+..+.......+...||.+|+|||++..+..+.|+|||||||++.||+||+.|.+
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d 279 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD 279 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence 999999997665422221111179999999999999999999999999999999999999876
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=344.00 Aligned_cols=202 Identities=28% Similarity=0.439 Sum_probs=183.0
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccH-HHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..++||+|+||.||.++..+ ++.||+|++++..... .+.+..+.|..++.+++||+||+++-.|.+.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35679999999999999999997665 8999999998776533 356788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|+||+.||.|..+++ ..+.+++..+.-++..|+.||.|||+. +||||||||+|||+|++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999997 467899999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ..+..++||+.|||||++.+..|+..+|+||+|+++|||++|.+||.
T Consensus 176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 176 LKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred ccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 4332 23345899999999999999999999999999999999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=334.17 Aligned_cols=207 Identities=27% Similarity=0.425 Sum_probs=187.2
Q ss_pred hcCCcccceeccCccceEEEEE-EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceE-EeeCC-eEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY-CAEHG-QRLL 485 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~-~~~l 485 (618)
..+|.+.+.||+|.||+||++. ..+|+.+|.|.++-...+.+..++...|+.++++++|||||+++++ +.++. .+++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3467888899999999999995 5689999999999888888889999999999999999999999983 44444 4899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
||||++.|+|.+.++..+.....+++.++++++.|+++||.++|+.. ++ |+||||||.||+++.+|.+|+.|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999988888899999999999999999999999942 25 8999999999999999999999999999
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....+.+|||.||+||.+.+..|++|+||||+||++|||+.=+.||.
T Consensus 177 ~l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 177 FLSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred Hhcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 88654 445567899999999999999999999999999999999999999996
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=354.37 Aligned_cols=203 Identities=37% Similarity=0.622 Sum_probs=179.2
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-eEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 488 (618)
..+...+.+|+|+||+||+|.+.....||||++..........+.|.+|+.++.+++|||||+++|+|.+.. ...+|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 334455569999999999999985555999999877766666789999999999999999999999999987 7999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCCCCeeecCCC-CcEEeeccccccCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-VVHRNFKSANILLDDEL-NPHLSDCGLAALTP 566 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~ 566 (618)
|+++|+|.++++.. ....+++..+.+++.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++...
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999743 367899999999999999999999999 7 99999999999999997 99999999998765
Q ss_pred CCCcccccceeccccccCccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFAL--SGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
... ...+...||++|||||++. ...|+.|+||||||+++|||+||+.||+.
T Consensus 196 ~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 196 ISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred ccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 332 2233468999999999999 66999999999999999999999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=337.42 Aligned_cols=197 Identities=28% Similarity=0.492 Sum_probs=177.7
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-eEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 488 (618)
+++....||+|..|+||++.++ +++.+|+|.+. ........+++.+|++++++.+||+||.+||.|..++ ...++||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 4555678999999999999886 58899999994 3345667789999999999999999999999999999 5999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
||++|+|.+++. ..+++++....+|+.++++||.|||+.+ +||||||||+|||++..|+|||+|||.+....+.
T Consensus 159 YMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999997 3477999999999999999999999632 9999999999999999999999999999876543
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||-
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCC
Confidence 5567899999999999999999999999999999999999999984
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=351.75 Aligned_cols=201 Identities=27% Similarity=0.490 Sum_probs=183.0
Q ss_pred cCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.+|...+.||+|||+.+|+++. ..|+.||+|++.+... +....+.+.+|+++.+.++|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999987 6799999999976543 3345677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
|+|..++|.++++ ..+.+++.+++.+..||+.||.|||++ +|||||||-.|++++++.+|||+|||+|.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999986 467899999999999999999999999 999999999999999999999999999988764
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
++. .....+|||.|.|||++.....+..+||||+||+||.|++|++||+.
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 422 22357999999999999999999999999999999999999999973
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=340.62 Aligned_cols=202 Identities=28% Similarity=0.432 Sum_probs=176.1
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHH-----HHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQ-----EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+...... ......+|+++|++++|||||+++++++.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456688889999999999999954 5799999999986654332 2234579999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC---CCcEEee
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSD 558 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~D 558 (618)
..|+||||++||+|.+.+- ..+.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999985 456677888889999999999999999 99999999999999765 7899999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
||+|+... +...+...+|||.|.|||++.+.. +..++|+||+||++|-+++|.+||.+
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 99998875 455667789999999999998654 34588999999999999999999964
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=315.87 Aligned_cols=198 Identities=28% Similarity=0.431 Sum_probs=180.8
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
-.+|+..+.||.|+||+|.+++.+ +|..+|+|.+.+... .....+...+|..+++.+.||+++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 457888899999999999999876 488999999986543 444567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|.|..+++ ..+++++..++-++.||+.||+|||+. +|++|||||+|||+|.+|++||+|||+|+...
T Consensus 123 meyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999998 467899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ....+|||.|+|||++.+..|+.++|+|||||++|||+.|.+||-
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 32 446899999999999999999999999999999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.27 Aligned_cols=199 Identities=25% Similarity=0.376 Sum_probs=177.9
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
+.|+....+|+|+||.||++++++ |+.||||++.....+....+-.++|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 357788899999999999999876 9999999998877666677778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|++..-|.++-+ ....++...+.+++.|++.|+.|+|++ ++|||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 ~~dhTvL~eLe~----~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHELER----YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHHHHh----ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 998754544433 566789999999999999999999999 9999999999999999999999999999988754
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
.. ..+.++.|..|+|||.+.+ .+|+..+||||+||++.||++|++-|
T Consensus 155 gd-~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~ 202 (396)
T KOG0593|consen 155 GD-NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW 202 (396)
T ss_pred cc-hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence 33 3355788999999999998 78999999999999999999999866
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=336.60 Aligned_cols=204 Identities=30% Similarity=0.448 Sum_probs=182.9
Q ss_pred hhhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQR 483 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 483 (618)
...+.|+.++.||+|.||.||+|+. .+|+.||+|++...........-..+||.+++++.||||+++.+...+. +.+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 4456789999999999999999965 5699999999987776666677789999999999999999999998876 689
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
|+|+|||+. ||.-++. ...-.+++.++..++.|++.||+|+|++ +|+|||||.+|||||++|.+||+|||+|+
T Consensus 194 YlVFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 999999987 8887775 3455799999999999999999999999 99999999999999999999999999999
Q ss_pred cCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+........+..+-|..|+|||.+.+. .|+.++|+||.||||.||++|++.|.
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 8876666556778889999999999885 59999999999999999999999885
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=340.75 Aligned_cols=203 Identities=31% Similarity=0.499 Sum_probs=181.0
Q ss_pred hhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+.+...+.||+|.||.||.|.+.....||+|.++.... ..+.|.+|+++|++++|+|||+++++|..++.++||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 33445566778999999999999999888999999986543 357789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
||||+.|+|.++++. ..+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...
T Consensus 280 tE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 999999999999984 3567789999999999999999999999 99999999999999999999999999999665
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++.........-+..|.|||.+....++.|||||||||+||||+| |+.|+.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 555545555556779999999999999999999999999999999 999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=303.75 Aligned_cols=199 Identities=26% Similarity=0.393 Sum_probs=177.9
Q ss_pred cCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.+|...+.+|+|.||.||+|+. ..|+.||||+++.......-.....+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999965 469999999999876665556778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
||+. +|+..++ .....++..++..++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9986 9999986 4567799999999999999999999999 8999999999999999999999999999988766
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
...... .+-|..|+|||.+.| +.|+..+||||.|||+.||+-|.+-|
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f 202 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF 202 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence 554433 377899999999987 56999999999999999999987655
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.96 Aligned_cols=198 Identities=31% Similarity=0.476 Sum_probs=184.3
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|...+.||+|.||+||||+.+ +.+.||+|.+.+.....++.+.+++|+++++.++||||+.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999766 48899999998887787888999999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+.+ +|++++. ..+.++++.+..++.+++.||.|||+. +|+|||+||.|||++.++++|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 9999997 578899999999999999999999999 999999999999999999999999999998754
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
....-+.+.|||-|||||.+.+..|+..+|+||+|||+||+++|++||
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc
Confidence 445556788999999999999999999999999999999999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=347.97 Aligned_cols=206 Identities=31% Similarity=0.517 Sum_probs=178.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
...+....+.||+|+||.||+|+.. +...||||.+++.. ..+..++|++|++++..++|||||+++|+|.+++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 4455666778999999999999754 34679999998765 5557889999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccC------C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADD------S----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
.+++|+|||..|||.+|++.... . ..+++..+.+.|+.|||.||+||-++ .+|||||.++|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999975322 1 23488999999999999999999999 89999999999999999
Q ss_pred CCcEEeeccccccCCCCCcccc-cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTERQVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..|||+|||+++..-..+.+.. ....-..+|||||.|..++|+.+||||||||+|||+++ |+.|+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 9999999999986544433322 23456789999999999999999999999999999999 999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=330.27 Aligned_cols=206 Identities=27% Similarity=0.428 Sum_probs=180.5
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHH-HHHHHHHHHHhhcC-CCCcccccceEEeeCCe
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQE-EDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 482 (618)
.....+|...++||+|+|++|++|+.. .+++||||++.+.....+. .+....|-+.|.++ .||.|++++-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345578999999999999999999654 5999999999766543332 34566778888888 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
+|+|+||+++|+|.++++ ..+.+++...+.++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999997 457899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc------------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 563 ALTPNTERQ------------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 563 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
..+...... ....++||..|.+||++.....++.+|+|+||||+|+|+.|++||..
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 866432111 12458999999999999999999999999999999999999999963
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.31 Aligned_cols=204 Identities=26% Similarity=0.379 Sum_probs=178.7
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
...++|+....||+|+||.||+|+-+ .|+.+|+|++++... ...+.+..+.|-.+|....+|.||+++-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35678999999999999999999765 499999999987643 4445677888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
|||||++||++..+|. ..+.+++..++.++.+++-|++-+|+. |+|||||||+|+|||..|++||+||||+..
T Consensus 218 LiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999996 467899999999999999999999999 999999999999999999999999999842
Q ss_pred CCC-----------------------CCc-----------------------ccccceeccccccCccccccCCCCcccc
Q 007103 565 TPN-----------------------TER-----------------------QVSTQMVGAFGYSAPEFALSGIYTVKSD 598 (618)
Q Consensus 565 ~~~-----------------------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 598 (618)
... +.. ......+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 110 000 0011358999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCC
Q 007103 599 VYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 599 vwslG~il~elltg~~Pf~ 617 (618)
+||||||||||+.|.+||.
T Consensus 371 wWSLG~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFC 389 (550)
T ss_pred HHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999995
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.11 Aligned_cols=204 Identities=33% Similarity=0.512 Sum_probs=179.4
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc---HHHHHHHHHHHHHhhcCC-CCcccccceEEeeCC
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG 481 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 481 (618)
...+.|...+.||+|+||.|++|.+. .|+.||+|.+...... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568899999999999999999664 5899999977654221 123556678999999999 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-CCcEEeecc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCG 560 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg 560 (618)
.+++||||+.+|+|.+++. ..+++.+.++.+++.|++.|++|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999997 357888999999999999999999999 99999999999999998 999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGI-YT-VKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~Pf~~ 618 (618)
++.... .........+||+.|+|||++.+.. |. .++||||+||++|.|++|+.||++
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 998774 2334455689999999999999977 85 789999999999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=317.66 Aligned_cols=207 Identities=28% Similarity=0.445 Sum_probs=178.8
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.+.+.....+.+.||+|.||+|.+++...+..||||.++... ......+|.+|+++|.+++||||++++|+|..++.++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 345566778888999999999999999888999999998765 3345689999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+|+|||++|+|.+|+...... ..+-....+|+.||+.|++||.+. ++|||||.++|+|++.++++||+|||+++.
T Consensus 612 mI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 999999999999999754322 245556677999999999999999 999999999999999999999999999986
Q ss_pred CCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCC
Q 007103 565 TPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~Pf~ 617 (618)
.-..+.+. ....+-+.+|||+|.+.-++++.++|||+||+.+||+++ .+.||.
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 54443333 233466789999999999999999999999999999887 778875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=319.90 Aligned_cols=198 Identities=26% Similarity=0.423 Sum_probs=174.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCC-eEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG-QRLL 485 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 485 (618)
.++|...+.||.|.||.||+|+.. .|+.||||+++......++. .-++|++.+++++ ||||+++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 467888999999999999999765 58999999999887775444 3467899999998 999999999999988 9999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|||||+. +|+++++. .+..+++..++.|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+||..
T Consensus 88 VfE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999987 99999973 367899999999999999999999999 9999999999999998889999999999987
Q ss_pred CCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
.+...+ +.++.|..|+|||++.. +.|+.+.||||+|||++|+.+=++-|
T Consensus 161 ~SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 161 RSKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred ccCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 654433 55789999999999865 67899999999999999999876655
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.08 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=178.4
Q ss_pred hhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (618)
...++|....+||+|.||.|+++..+. ++.+|||.+++... ...+.+..+.|..++... +||.+++++..|.+.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345689999999999999999998874 88999999987654 444566677777777665 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+.||++..+.+ ...+++..+.-++..++.||.|||++ +||+||||-+|||+|.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999655443 57899999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..-..+. .+..++|||.|||||++.+..|+..+|+|||||+||||+.|+.||.
T Consensus 517 e~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 517 EGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred ccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence 6543333 4556899999999999999999999999999999999999999996
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=290.13 Aligned_cols=202 Identities=28% Similarity=0.411 Sum_probs=181.7
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|++.+.||+|.||.||.|+.+ ++-.||+|++.+... ..+.+.++++|+++.+.++||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4567899999999999999999765 578999999876543 44457889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
++||...|.+...++.. ....+++.....++.|+|.|+.|+|.. +||||||||+|+|++.++.+||+|||++...
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999743 345688889999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+ ...+...+||..|.+||+..+..++..+|+|++|++.||++.|.+||+
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe 223 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE 223 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh
Confidence 5 233456899999999999999999999999999999999999999996
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.93 Aligned_cols=198 Identities=27% Similarity=0.462 Sum_probs=177.4
Q ss_pred hhcCCcccceeccCccceEEEEE-EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
....|..-..||+|+.|.||.|. ...++.||||++.... ....+-+.+|+.+|+..+|+|||.+++.|...+.+|.|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 34567777889999999999995 4568999999997543 22456678999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
||||++|+|.+.+. ...+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.
T Consensus 349 MEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999995 45699999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
.... .+...+|||+|||||++....|++|+||||||++++||+-|++||
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY 469 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY 469 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc
Confidence 4433 445679999999999999999999999999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=307.39 Aligned_cols=205 Identities=27% Similarity=0.430 Sum_probs=179.0
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
-.++|+..+.||.|..++||+|+. +.++.||||++........ .+.+++|+..|+.++||||++++..|..+..+|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 456799999999999999999965 4689999999987664433 68899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|.||.+|++.++++..- ...+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999997543 34599999999999999999999999 99999999999999999999999999875443
Q ss_pred CCCc--ccc-cceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 567 NTER--QVS-TQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 567 ~~~~--~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.... ... ..++||+.|||||+++. ..|+.|+||||||+...||.+|+.||.+
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 3221 112 45689999999999754 4599999999999999999999999974
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=306.60 Aligned_cols=202 Identities=27% Similarity=0.433 Sum_probs=183.3
Q ss_pred hhcCCcccceeccCccceEEEEE-EcCCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...+|++.+.||+|.||.|-+|. +..|+.||||.+++... +.++.-.+++|+++|+.++||||+.++++|+..+.+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 44578888999999999999995 47799999999987665 44456678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||..+|.|++++. ..+.+++.+++.++.||+.|+.|+|++ +++|||||.+|||+|.++++||+|||++-.+
T Consensus 131 vMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999997 467899999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
... ..-..++|++-|.+||++.+..| ++.+|-|||||++|.|+.|..|||.
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 543 34456899999999999999998 6889999999999999999999983
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.98 Aligned_cols=201 Identities=32% Similarity=0.498 Sum_probs=171.5
Q ss_pred hcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC--eEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLL 485 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 485 (618)
..+|...+.||+|+||.||++...+ |+.+|||.+...... ..+.+.+|+.++.+++|||||+++|...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 3457778899999999999998765 899999998765211 2667899999999999999999999855544 6899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-CCCcEEeecccccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAAL 564 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~ 564 (618)
.|||+++|+|.+++... ++.+++..++.+..||++||+|||++ ||+||||||+|||++. ++.+||+|||++..
T Consensus 94 ~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999999732 22799999999999999999999999 9999999999999999 79999999999987
Q ss_pred CCC--CCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPN--TERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ..........||+.|||||++..+ ...+++|||||||++.||+||+.||.
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 653 222233457899999999999964 34469999999999999999999985
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=298.95 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=175.7
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (618)
..++|+....|++|+||.||+|+.+ +++.||+|+++-......-.-.-++|+.++.+++|||||.+.++.... +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3456888899999999999999775 589999999986553333344568999999999999999999988654 5799
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+|||||+. +|..+++. ..+++...++..+..|+++|++|||.+ .|+||||||+|+|+++.|.+||+|||+||.
T Consensus 154 ~VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence 99999987 99999973 457899999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.++... .+..+-|..|+|||.+.+. .|++.+|+||+|||+.||+++++-|.
T Consensus 227 ygsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 227 YGSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred hcCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 8766443 3456789999999999885 59999999999999999999988774
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=321.91 Aligned_cols=200 Identities=30% Similarity=0.452 Sum_probs=178.8
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcc-cccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNA-ALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.-|...+.||+|+.|.|-+|++. .|+..|||++.+. .........+.+|+-+|+.+.||||+++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34677889999999999999765 6999999999765 333334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|-|++++. ..+++.+.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+.+||+|||+|....+
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999996 467899999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
+..-...||.|.|.|||++++..| +.++||||.|||||.|+||+.||++
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 333455799999999999999998 6899999999999999999999985
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.04 Aligned_cols=190 Identities=28% Similarity=0.504 Sum_probs=169.2
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+.....+.||.|+.|.||+|++. ++.||||+++.- -..+|+-+++++||||+.+.|+|.....++|||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 33445667999999999999986 788999988522 22457889999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
|..|-|.++++ .+..+.......+..+||.|+.|||.. .|||||||.-||||+.+..|||+|||-++...+.
T Consensus 194 Ca~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 194 CAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred cccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 99999999997 567889999999999999999999999 9999999999999999999999999998766443
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
...-.++||..|||||++.....++|+||||||||||||+||+.||.+
T Consensus 266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 223357999999999999999999999999999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.46 Aligned_cols=207 Identities=29% Similarity=0.487 Sum_probs=181.3
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
..+++...+++.+.+.||+|.||+||+|+|- ..||||.+.......+..+.|+.|+..+++-+|.||+-+.|+|..++
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3566777788888999999999999999985 46899999988888888999999999999999999999999999887
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
. .+|+.+|++.+|+.++|.. ...++..+.+.|+.||++|+.|||.+ +|||||||+.||++.++++|||.|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 7 9999999999999999854 46789999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-CcccccceeccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNT-ERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.....- ......+..|..-|||||+++. ..|++.+||||||+|+|||+||..||.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 8643211 1111223457888999999974 358999999999999999999999985
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=319.69 Aligned_cols=201 Identities=25% Similarity=0.373 Sum_probs=174.3
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|++++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999765 588999999975432 2233457788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999986 345789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 007103 568 TER----------------------------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613 (618)
Q Consensus 568 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 613 (618)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0112357999999999999999999999999999999999999
Q ss_pred CCCC
Q 007103 614 KPLD 617 (618)
Q Consensus 614 ~Pf~ 617 (618)
.||.
T Consensus 234 ~Pf~ 237 (363)
T cd05628 234 PPFC 237 (363)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=325.38 Aligned_cols=201 Identities=28% Similarity=0.488 Sum_probs=176.3
Q ss_pred hcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.....++++||.|.||+|++|+++- ...||||.++... ......+|+.|+.+|.++.||||+++-|+.......+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 3456678899999999999998763 4569999998665 4456788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+|+|||++|+|..|++. ..+.+++.+...+.++|+.|+.||-++ ++|||||.++|||++.+..+|++|||++|.
T Consensus 707 IiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999999985 456799999999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCcccccce--eccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 007103 565 TPNTERQVSTQM--VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPL 616 (618)
Q Consensus 565 ~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf 616 (618)
..++.....+.. --..+|.|||.+..++++.++||||||++|||.++ |++||
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 754432222222 23469999999999999999999999999999887 99997
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=319.04 Aligned_cols=205 Identities=24% Similarity=0.352 Sum_probs=176.3
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
+....++|+..+.||+|+||.||+++.. +++.+|+|.+.+... .......+.+|+++++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999876 478999999864322 22345567889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++|+|.++++ ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999985 23578889999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...............||+.|+|||++.+.. ++.++||||+||++|||++|+.||.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 766433322234567999999999997543 7889999999999999999999996
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.99 Aligned_cols=204 Identities=27% Similarity=0.391 Sum_probs=173.2
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCc-ccccceEEeeCC-----
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHG----- 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 481 (618)
...|...++||+|+||.||+|+.. +|+.||+|++..............+|+.+++.++|+| |+++++++.+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345667778999999999999765 5899999999765543233455689999999999999 999999998877
Q ss_pred -eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 482 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
..++|+||++. +|..++.........++...+..++.||++||+|||++ +|+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78999999976 99999975443325677789999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+|+...-+... .+..++|..|+|||++.+. .|+...||||+|||++||++++.-|.
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp 222 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP 222 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence 99866533222 2346789999999999986 68999999999999999999988774
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=295.99 Aligned_cols=192 Identities=31% Similarity=0.490 Sum_probs=161.1
Q ss_pred CcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhh--cCCCCcccccceEEeeCC----eEEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS--RLRHPNIVTLAGYCAEHG----QRLL 485 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~l 485 (618)
....+++|+|.||.||+|.+. ++.||||++. .++.+.|..|-++.+ .++|+||++++++-.... +++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 345568999999999999986 5999999996 456777887766655 468999999999876554 8899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeecCCCCcEEeec
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------LPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
|+||.+.|+|.+++. ...++|....+++..+++||+|||+.. .|+|+|||||++||||.+|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999995 567999999999999999999999763 478999999999999999999999999
Q ss_pred cccccCCCCC-cccccceeccccccCccccccCCC------CcccchhhHHHHHHHHHhCCC
Q 007103 560 GLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIY------TVKSDVYSFGVVMLELLTGRK 614 (618)
Q Consensus 560 gl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslG~il~elltg~~ 614 (618)
|+|..+.... .......+||.+|||||++.+..- -.+.||||+|.|+|||+++-.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 9997765332 222334799999999999987542 246999999999999998543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=301.57 Aligned_cols=198 Identities=28% Similarity=0.401 Sum_probs=168.2
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 481 (618)
..-.|...+++|.|+||.||+|...+ ++.||||++-... +.-.+|+++|+++.|||||++.-+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 34467788899999999999998764 7899999985432 23347899999999999999988876532
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-CCcEEeecc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCG 560 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg 560 (618)
...+|||||+. +|.++++.....+..++.-.+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||+|||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 23589999987 99999986655678888889999999999999999998 99999999999999965 999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.|+.....+.. .++..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.
T Consensus 172 SAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 172 SAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred cceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 99887655444 456789999999999885 59999999999999999999998774
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.04 Aligned_cols=197 Identities=26% Similarity=0.368 Sum_probs=174.0
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999876 589999999865432 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++ ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999986 345688999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 21 23568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.38 Aligned_cols=200 Identities=24% Similarity=0.320 Sum_probs=172.4
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999765 588999999975432 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999862 35688999999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cccccceeccccccCccccccCCCCcccchhhH
Q 007103 569 E----------------------------------------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602 (618)
Q Consensus 569 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 602 (618)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 001123579999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCC
Q 007103 603 GVVMLELLTGRKPLD 617 (618)
Q Consensus 603 G~il~elltg~~Pf~ 617 (618)
||++|||+||+.||.
T Consensus 235 G~il~elltG~~Pf~ 249 (381)
T cd05626 235 GVILFEMLVGQPPFL 249 (381)
T ss_pred hhHHHHHHhCCCCCc
Confidence 999999999999995
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.69 Aligned_cols=198 Identities=25% Similarity=0.398 Sum_probs=175.3
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.++|+..+.||+|+||.||+|... +|+.||+|.++.... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357888999999999999999876 588999999875432 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999986 345688899999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 322 23579999999999999999999999999999999999999995
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.24 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=172.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|...+.||+|+||.||++... +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999765 689999999865432 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999986 245688999999999999999999999 999999999999999999999999999863321
Q ss_pred CCcc----------------------------------------------cccceeccccccCccccccCCCCcccchhh
Q 007103 568 TERQ----------------------------------------------VSTQMVGAFGYSAPEFALSGIYTVKSDVYS 601 (618)
Q Consensus 568 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 601 (618)
.... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCC
Q 007103 602 FGVVMLELLTGRKPLD 617 (618)
Q Consensus 602 lG~il~elltg~~Pf~ 617 (618)
|||++|||+||+.||.
T Consensus 234 lGvil~elltG~~Pf~ 249 (377)
T cd05629 234 LGAIMFECLIGWPPFC 249 (377)
T ss_pred cchhhhhhhcCCCCCC
Confidence 9999999999999995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.80 Aligned_cols=201 Identities=26% Similarity=0.409 Sum_probs=174.0
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+|+.. +|+.||||++..... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999876 589999999975432 2234456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999986 245689999999999999999999999 999999999999999999999999999865422
Q ss_pred CCcc-------------------------------------cccceeccccccCccccccCCCCcccchhhHHHHHHHHH
Q 007103 568 TERQ-------------------------------------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610 (618)
Q Consensus 568 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 610 (618)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 111246999999999999999999999999999999999
Q ss_pred hCCCCCC
Q 007103 611 TGRKPLD 617 (618)
Q Consensus 611 tg~~Pf~ 617 (618)
+|+.||.
T Consensus 234 ~G~~Pf~ 240 (364)
T cd05599 234 VGYPPFC 240 (364)
T ss_pred cCCCCCC
Confidence 9999995
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.69 Aligned_cols=200 Identities=24% Similarity=0.324 Sum_probs=171.9
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.|+..+.||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999765 588999999875432 22345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999862 34688899999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cccccceeccccccCccccccCCCCcccchhhH
Q 007103 569 E----------------------------------------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602 (618)
Q Consensus 569 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 602 (618)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 001123479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCC
Q 007103 603 GVVMLELLTGRKPLD 617 (618)
Q Consensus 603 G~il~elltg~~Pf~ 617 (618)
||++|||++|+.||.
T Consensus 235 Gvil~elltG~~Pf~ 249 (382)
T cd05625 235 GVILYEMLVGQPPFL 249 (382)
T ss_pred hHHHHHHHhCCCCCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.66 Aligned_cols=206 Identities=23% Similarity=0.340 Sum_probs=176.9
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
.+....++|+..+.||+|+||.||+++.. +++.+|+|.+..... .......+.+|+.+++.++||||+++++.+.+.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34555688999999999999999999876 478999999864322 2233456788999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+++|+|.++++ ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999986 23578888999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSG----IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 976644333333456799999999999754 37899999999999999999999996
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.42 Aligned_cols=197 Identities=26% Similarity=0.395 Sum_probs=175.2
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+|+.. +++.||+|+++..... ......+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 4889999999754322 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999996 345688999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence 2234579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.69 Aligned_cols=199 Identities=25% Similarity=0.400 Sum_probs=174.5
Q ss_pred hhcCCcccceeccCccceEEEEEEcC--CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
..++|...+.||+|+||.||+|.+.+ +..||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578889999999999999997653 36899999865432 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999996 345689999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence 5432 124579999999999999889999999999999999999999995
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.18 Aligned_cols=194 Identities=27% Similarity=0.391 Sum_probs=169.5
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
+.||+|+||.||+|... +|+.||+|+++.... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999765 689999999875432 2234466788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccc
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 573 (618)
+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 9999886 345789999999999999999999999 99999999999999999999999999987543222 122
Q ss_pred cceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence 34679999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=302.02 Aligned_cols=199 Identities=27% Similarity=0.400 Sum_probs=172.9
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
|+..+.||+|+||.||+|... +|+.||+|.+...... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999764 6899999998754332 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998887532 234689999999999999999999999 99999999999999999999999999997654322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 1 234578999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=299.53 Aligned_cols=206 Identities=26% Similarity=0.395 Sum_probs=170.6
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHH------------HHHHHHHHHHHhhcCCCCccc
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ------------EEDNFLEAVSNMSRLRHPNIV 471 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv 471 (618)
.....++|++...||+|.||.|-+|+.. +++.||||++.+.....+ ..+..++|+.+|+++.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3445688999999999999999999765 699999999975543221 135788999999999999999
Q ss_pred ccceEEeeC--CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec
Q 007103 472 TLAGYCAEH--GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (618)
Q Consensus 472 ~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~ 549 (618)
+++++..+. +.+|+|+|||..|.+...- .....+++.++++++.+++.||+|||.+ |||||||||+|+|++
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence 999998774 5789999999988775322 2223399999999999999999999999 999999999999999
Q ss_pred CCCCcEEeeccccccCCCCC----cccccceeccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 550 DELNPHLSDCGLAALTPNTE----RQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 550 ~~~~~kl~Dfgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++|++||+|||.+...+... ...-...+|||.|+|||...++. .+.+.||||+||+||-|+.|+.||-
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 99999999999997653221 11112368999999999998733 3678999999999999999999995
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.94 Aligned_cols=200 Identities=24% Similarity=0.336 Sum_probs=171.9
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
+|+..+.||+|+||.||+|+.. +++.||+|.+..... .......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999865 489999999865432 22234667889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999962 45688889999999999999999999 9999999999999999999999999997432100
Q ss_pred ------------------------------------------CcccccceeccccccCccccccCCCCcccchhhHHHHH
Q 007103 569 ------------------------------------------ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVM 606 (618)
Q Consensus 569 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 606 (618)
........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00011235799999999999999999999999999999
Q ss_pred HHHHhCCCCCC
Q 007103 607 LELLTGRKPLD 617 (618)
Q Consensus 607 ~elltg~~Pf~ 617 (618)
|||++|+.||.
T Consensus 235 yell~G~~Pf~ 245 (376)
T cd05598 235 YEMLVGQPPFL 245 (376)
T ss_pred eehhhCCCCCC
Confidence 99999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=292.49 Aligned_cols=203 Identities=29% Similarity=0.395 Sum_probs=176.6
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
+.|+..+.||.|.-|+||+++..+ +..+|+|++.+.... .....+...|-++|+.++||.++.+|..++.++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456777889999999999999875 589999999876543 344566778899999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
|||+||+|..+.+. .....+++..++-++..++-||+|||.. |||.|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999998874 3567899999999999999999999999 999999999999999999999999998842110
Q ss_pred ---------------------------------C-C---------------------cccccceeccccccCccccccCC
Q 007103 568 ---------------------------------T-E---------------------RQVSTQMVGAFGYSAPEFALSGI 592 (618)
Q Consensus 568 ---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 592 (618)
. . ...+..++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 01223468999999999999999
Q ss_pred CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 593 YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 593 ~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+.++|+|+|||++|||+.|+.||.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFK 336 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFK 336 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcC
Confidence 9999999999999999999999996
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=302.23 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=175.2
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|+||.||+|+.. +++.||+|+++.........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999886 57899999997654444456678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|++++.+..+.+ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999877765543 245689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 3323334578999999999999899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.04 Aligned_cols=203 Identities=23% Similarity=0.333 Sum_probs=174.3
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
...++|+..+.||+|+||.||+|+.. +++.||+|.+..... .......+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999876 588999999864322 2233456788999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999986 23578888999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSG----IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 543332223346799999999998653 37899999999999999999999996
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=309.46 Aligned_cols=207 Identities=26% Similarity=0.457 Sum_probs=171.8
Q ss_pred hhhcCCcccceeccCccceEEEEEE------cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
...++|+..+.||+|+||.||+|.+ ..++.||+|+++... .....+.+.+|++++.++ +||||+++++++..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 3456788999999999999999964 235689999987543 334456789999999999 89999999998876
Q ss_pred C-CeEEEEEEecCCCChhhhhhcccCC-----------------------------------------------------
Q 007103 480 H-GQRLLVYEYVGNGNLHDMLHFADDS----------------------------------------------------- 505 (618)
Q Consensus 480 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 505 (618)
. +..++||||+++|+|.++++..+..
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4689999999999999998643210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc-ccceecc
Q 007103 506 -----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQMVGA 579 (618)
Q Consensus 506 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt 579 (618)
...+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++......... .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13478889999999999999999999 99999999999999999999999999997654322221 1223567
Q ss_pred ccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~ 278 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 278 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence 78999999999999999999999999999997 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=291.61 Aligned_cols=202 Identities=29% Similarity=0.444 Sum_probs=176.5
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-----CC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-----HG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 481 (618)
....|...+.||+|+||.|..|... +|+.||||++..........++-.+|+++++.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999765 58999999998777777778889999999999999999999998865 34
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..|+|+|+|+. +|.+.++ .+..++...+..++.|+++||.|+|+. +|+||||||.|++++.+..+||+|||+
T Consensus 100 DvYiV~elMet-DL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHhh-HHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 68999999954 9999997 445599999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNT-ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+..... .....+.++.|..|+|||++.. ..|+.+.||||.|||+.||++|++-|-
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 9987542 2333467889999999999865 679999999999999999999998774
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=302.68 Aligned_cols=201 Identities=30% Similarity=0.472 Sum_probs=178.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
...|...+.||+|.||.||+|... .++.||+|++...... .+..++.+|+..+.+++++||.++|+.+..+..++++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 345777789999999999999654 5899999999866533 35567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
|||.+|++.+.++ ....+++..+.-++.++..|+.|||++ +.+|||||+.|||+..+|.+|++|||.+.....
T Consensus 91 ey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999996 344458888888999999999999999 999999999999999999999999999977655
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.... ...++||+.|||||++.+..|+.|+||||||++++||.+|.+|+.+
T Consensus 164 ~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 164 TVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred hhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 4333 3678999999999999998999999999999999999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.21 Aligned_cols=202 Identities=29% Similarity=0.486 Sum_probs=172.9
Q ss_pred hcCCcccceeccCccceEEEEEEcC--C--cE-EEEEEcCc-ccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN--G--KI-MAVKKIDN-AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
-.+....+.||+|+||.||+|.+.. + .. ||+|..+. .........+|+.|+++|++++|||||++||++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3444555799999999999997753 2 23 89999986 33566778899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
+++|||+|.||+|.++++. ....++..++..++.++|+||+|||++ ++|||||.++|+|++.++.+||+|||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999973 334699999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+........ .....-+.+|+|||.+....|++++|||||||++||+++ |..||.
T Consensus 310 ~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~ 364 (474)
T KOG0194|consen 310 RAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP 364 (474)
T ss_pred cCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence 755411111 111234579999999999999999999999999999999 888985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.60 Aligned_cols=192 Identities=30% Similarity=0.422 Sum_probs=168.4
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
||+|+||.||+|... +++.||+|+++.... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 488999999865432 333456788899999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccc
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 575 (618)
.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99986 245689999999999999999999999 99999999999999999999999999987543222 22334
Q ss_pred eeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence 679999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.89 Aligned_cols=202 Identities=26% Similarity=0.345 Sum_probs=173.6
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccc-ccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+++.. +++.||+|.+.... ......+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999876 48999999986432 22334566888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999863 245688999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccccceeccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 33322333579999999999873 457889999999999999999999995
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.26 Aligned_cols=206 Identities=32% Similarity=0.549 Sum_probs=177.5
Q ss_pred hhcCCcccceeccCccceEEEEEEcC--Cc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN--GK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
.....+..+.||+|.||.||+|...+ |. .||+|.++... +.++..+|++|..+|++++|||||+++|++.+.+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 34556677789999999999997764 43 48999887554 6678899999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDS---SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
..++++|||++|+|..|++..+.. ...++..+.+.++.|||+|++||+++ ++|||||.++|+|+++...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999865432 45688999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccce-eccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 559 CGLAALTPNTERQVSTQM-VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
||+|+.+-..+.+..... .-..+|||||.+..+.++.|+|||||||++||++| |..||-
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 999995433333322222 34469999999999999999999999999999999 999984
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.89 Aligned_cols=194 Identities=27% Similarity=0.385 Sum_probs=168.6
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
+.||+|+||.||++... +|+.||+|.++.... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999765 589999999875432 2234556788999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccc
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 573 (618)
+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++........ ..
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 9998886 345689999999999999999999999 999999999999999999999999999875322221 12
Q ss_pred cceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 34579999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.11 Aligned_cols=201 Identities=25% Similarity=0.376 Sum_probs=176.8
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH-HHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|...+.||+|+||.||+|... +|+.||+|+++...... .....+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999876 68999999997543322 34567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999963 36789999999999999999999998 999999999999999999999999999976543
Q ss_pred CC----------------------------cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TE----------------------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 32 112234579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=307.67 Aligned_cols=202 Identities=26% Similarity=0.332 Sum_probs=173.9
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|...+.||+|+||.||+++.. +++.||+|.+..... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999876 478899999865322 2334456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999963 235688999999999999999999999 999999999999999999999999999976644
Q ss_pred CCcccccceeccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 33322334579999999999876 467889999999999999999999995
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=288.71 Aligned_cols=196 Identities=29% Similarity=0.452 Sum_probs=164.0
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhc--CCCCcccccceEEeeCC-
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEHG- 481 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~- 481 (618)
-.+..++....+.||+|.||.||+|+|. |+.||||++.. .+++.+.+|.++.+. ++|+||+.+++.-..+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 3456677888999999999999999997 89999999953 245667777777654 59999999999875543
Q ss_pred ---eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCceecCCCCCCeeecCCCC
Q 007103 482 ---QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-----VCLPSVVHRNFKSANILLDDELN 553 (618)
Q Consensus 482 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~iiH~Dlkp~Nill~~~~~ 553 (618)
+++||++|.+.|||+|++. ...++....++++..+|.||+|||. ++.|.|.|||||+.||||..++.
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 6899999999999999996 4678999999999999999999994 46689999999999999999999
Q ss_pred cEEeeccccccCCCCCcc---cccceeccccccCccccccCC------CCcccchhhHHHHHHHHHh
Q 007103 554 PHLSDCGLAALTPNTERQ---VSTQMVGAFGYSAPEFALSGI------YTVKSDVYSFGVVMLELLT 611 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~ellt 611 (618)
+.|+|+|+|.......+. .....+||.+|||||++.... ....+||||||.|+||+.-
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999999999776544322 234569999999999996542 2246999999999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.56 Aligned_cols=194 Identities=26% Similarity=0.390 Sum_probs=169.1
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
+.||+|+||.||+++.. +|+.||+|++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999765 589999999975432 2334567888999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccc
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 573 (618)
+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9998885 345689999999999999999999999 99999999999999999999999999987543221 122
Q ss_pred cceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence 34579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=312.22 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=173.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||++... +++.||+|++..... .......+.+|++++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999876 589999999875332 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999986 345689999999999999999999999 999999999999999999999999999864421
Q ss_pred CCc----------------------------------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 007103 568 TER----------------------------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613 (618)
Q Consensus 568 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 613 (618)
... ......+||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 0112357999999999999999999999999999999999999
Q ss_pred CCCC
Q 007103 614 KPLD 617 (618)
Q Consensus 614 ~Pf~ 617 (618)
.||.
T Consensus 234 ~Pf~ 237 (360)
T cd05627 234 PPFC 237 (360)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.04 Aligned_cols=202 Identities=26% Similarity=0.343 Sum_probs=172.6
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+++... ++.+|+|.+.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368888999999999999998764 77899999864322 2233455788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999963 235689999999999999999999999 999999999999999999999999999875533
Q ss_pred CCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 3322233457999999999986 3457899999999999999999999996
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=308.94 Aligned_cols=202 Identities=28% Similarity=0.381 Sum_probs=175.8
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|...+.||+|+||.||+|... +|+.||+|+++.... ..+..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999775 589999999976543 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999632 35789999999999999999999999 999999999999999999999999999976654
Q ss_pred CCcccccceeccccccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFAL------SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 4333333457999999999987 4567899999999999999999999996
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.36 Aligned_cols=200 Identities=28% Similarity=0.398 Sum_probs=171.6
Q ss_pred CCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccc--cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (618)
+|+..+.||+|+||.||+++.. .++.||+|++..... .....+.+..|++++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999753 578999999865432 122345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999886 345689999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..............||+.|+|||++.+. .++.++|||||||++|||+||+.||+
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 6544333333446799999999999875 47889999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.20 Aligned_cols=203 Identities=27% Similarity=0.432 Sum_probs=185.5
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe-EEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ-RLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 487 (618)
++|...+.+|+|+||.++..+++ +++.+++|++........+.+....|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888899999999999999765 57899999998887777777788999999999999999999999999998 89999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
+|++||++.+.+...+ +..+++..+..++.|++.|+.|||++ +|.|||||+.||+++.++.|||.|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999997543 56799999999999999999999988 999999999999999999999999999998865
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.. ....+++||+.||.||++.+..|+.|+|||||||++|||++=+++|+.
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 54 344568999999999999999999999999999999999999999973
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.54 Aligned_cols=194 Identities=27% Similarity=0.427 Sum_probs=167.7
Q ss_pred ceeccCccceEEEEEEc----CCcEEEEEEcCcccc--cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 416 FLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+.||+|+||.||+++.. .++.||+|.++.... .......+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999753 578999999875432 122345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++ ..+.+.+..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999886 345678888999999999999999999 99999999999999999999999999986543222
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~ 201 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCC
Confidence 22234579999999999999889999999999999999999999996
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=301.55 Aligned_cols=199 Identities=24% Similarity=0.376 Sum_probs=170.0
Q ss_pred CCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCC-cccccceEEeeCCeEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHP-NIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 487 (618)
+|+..+.||+|+||.||+|...+ ++.||+|++..... .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788899999999999998764 78899999875432 223456678888888888765 5888999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999886 345688999999999999999999999 999999999999999999999999999864322
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||+
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 211 2234579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.70 Aligned_cols=194 Identities=25% Similarity=0.405 Sum_probs=164.2
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhc-CCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+.. +++.||+|.++.... .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 478899999875432 12233444555666554 4899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999886 245689999999999999999999999 99999999999999999999999999997543222 22
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 234579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.35 Aligned_cols=194 Identities=26% Similarity=0.391 Sum_probs=167.9
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
+.||+|+||.||++... +|+.||+|.++.... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 689999999975432 2234456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9998885 34568999999999999999999997 6 999999999999999999999999999875432221 2
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCC
Confidence 233579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.70 Aligned_cols=197 Identities=27% Similarity=0.425 Sum_probs=167.6
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHH---hhcCCCCcccccceEEeeCCeEEEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSN---MSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+.+|+++ ++.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999765 589999999975432 22233456666554 4567899999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|..+++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998875 35689999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~ 202 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 222 22234679999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.94 Aligned_cols=199 Identities=23% Similarity=0.371 Sum_probs=169.0
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 487 (618)
+|...+.||+|+||.||+|+.. +++.||+|.+..... .......+..|..++... .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778889999999999999876 478999999875432 222334556677777666 5899999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999998886 235688999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence 21 12234579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=301.39 Aligned_cols=194 Identities=26% Similarity=0.414 Sum_probs=168.0
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+.. +++.||+|.++..... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999875 5889999999764332 22345678888988888 799999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++....... ..
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 99998885 245789999999999999999999999 99999999999999999999999999986432221 12
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 234579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=293.45 Aligned_cols=196 Identities=24% Similarity=0.387 Sum_probs=169.3
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
||+|+||+||++... +|+.||+|.+...... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 6889999998754322 22335677899999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccc
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 575 (618)
.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988754433456789999999999999999999999 999999999999999999999999999876543322 2234
Q ss_pred eeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=300.66 Aligned_cols=194 Identities=26% Similarity=0.419 Sum_probs=167.0
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|... +++.||+|.++.... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999876 478999999975432 223445677888887766 899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 99998885 345689999999999999999999999 999999999999999999999999999875332221 2
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 234579999999999999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=300.04 Aligned_cols=194 Identities=25% Similarity=0.409 Sum_probs=166.3
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+.. +++.||+|+++.... .......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 488999999875432 223345667778877765 699999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999886 345689999999999999999999999 99999999999999999999999999986542221 12
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 234579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=300.49 Aligned_cols=194 Identities=26% Similarity=0.401 Sum_probs=166.7
Q ss_pred ceeccCccceEEEEEEcC-CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+..+ ++.||+|+++.... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998764 78999999875432 223345677788888765 799999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99998886 345688999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~ 197 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCC
Confidence 234579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=314.64 Aligned_cols=211 Identities=25% Similarity=0.358 Sum_probs=181.1
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG- 481 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 481 (618)
......++|.+.+.||+|+||.||+|+.. +|+.||+|.+............+.+|+..+..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445678999999999999999999754 6899999999766656666778889999999999999999887765432
Q ss_pred -------eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCc
Q 007103 482 -------QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 482 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
..++||||+++|+|.++++........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 36899999999999999975444556789999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCC-cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 555 HLSDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999997654321 222334679999999999999999999999999999999999999996
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=301.94 Aligned_cols=199 Identities=29% Similarity=0.450 Sum_probs=168.9
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----CeEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQRL 484 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 484 (618)
+|+..+.||+|+||.||+|... +|+.||+|++............+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778889999999999999865 589999999875444444556788999999999999999999988543 2579
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||++ ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 68988886 345689999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCC--cccccceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTE--RQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 43221 112234579999999999876 678999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.54 Aligned_cols=194 Identities=29% Similarity=0.442 Sum_probs=170.2
Q ss_pred ceeccCccceEEEEEE----cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecC
Q 007103 416 FLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
+.||+|+||.||+++. .+|+.||+|+++...........+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4799999999999865 358899999997655444445667889999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc
Q 007103 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (618)
Q Consensus 492 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 571 (618)
+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 999999885 345689999999999999999999999 999999999999999999999999999876543321
Q ss_pred cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 199 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCC
Confidence 2234579999999999999889999999999999999999999996
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.99 Aligned_cols=202 Identities=22% Similarity=0.268 Sum_probs=174.6
Q ss_pred CCcccceeccCccceEEEEEEc-C-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-N-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.|...+.||+|++|.||+|... + ++.||+|.+.... ......+++|+.+++.++||||+++++++...+..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3888899999999999999654 3 6778888765432 3345677889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++|+|.++++........+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999998864433456789999999999999999999999 9999999999999999999999999999865432
Q ss_pred Cc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 21 22334579999999999999999999999999999999999999986
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=299.10 Aligned_cols=194 Identities=28% Similarity=0.437 Sum_probs=164.5
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHH-HhhcCCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999875 589999999875432 1222344445544 56788999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.++++ ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 99999886 345788999999999999999999999 99999999999999999999999999986543222 22
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence 234579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=294.14 Aligned_cols=199 Identities=24% Similarity=0.389 Sum_probs=169.6
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|...+.||+|+||.||+|... +++.||+|+++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46888899999999999999775 588999999875432 2234567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 89888863 234578899999999999999999999 9999999999999999999999999998765432
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....+++.|+|||++.+ ..++.++||||+||++|||+||+.||.
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 157 TKT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred Ccc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 221 233568999999999876 568999999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.90 Aligned_cols=200 Identities=26% Similarity=0.392 Sum_probs=170.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 467899999999999999999876 6889999998754322 22345678999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 83 EYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred ECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9996 588887752 345688999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 22 12233568999999999875 457889999999999999999999995
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.57 Aligned_cols=193 Identities=21% Similarity=0.311 Sum_probs=168.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+|+..+.||+|+||.||++... .++.||+|... ...+.+|++++++++||||+++++++......++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 3457999999999999999999765 58899999653 23467899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+|++. ++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 162 ~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 162 LPRYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EecCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 99996 68888875 235688999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
...........||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 32222333467999999999999999999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.22 Aligned_cols=202 Identities=24% Similarity=0.392 Sum_probs=171.8
Q ss_pred hcCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|+..+.||+|+||.||+|.+. .+..||+|.++... .......+.+|+..+++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 456888899999999999999764 36789999998653 3344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999863 235689999999999999999999999 999999999999999999999999998755
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 42221111112345678999999999999999999999999999875 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.32 Aligned_cols=199 Identities=26% Similarity=0.429 Sum_probs=175.2
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||++... +|..+|+|.+.... .......+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 467899999999999999999876 58889999887543 3344577999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999863 346889999999999999999999863 699999999999999999999999999875533
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 157 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred c---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 2 1234578999999999999999999999999999999999999995
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.93 Aligned_cols=194 Identities=28% Similarity=0.413 Sum_probs=163.3
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHH-HHhhcCCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAV-SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+.. +++.||+|++..... .......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 478899999875432 122233444444 456778999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.++++ ....+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 99999886 345678888999999999999999999 99999999999999999999999999987543222 12
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence 234579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.47 Aligned_cols=194 Identities=28% Similarity=0.425 Sum_probs=164.0
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHH-HHhhcCCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAV-SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+.. +|+.||+|++..... .......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 588999999875432 222334455554 457889999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.+.+. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99988875 345688899999999999999999998 99999999999999999999999999987532222 12
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCC
Confidence 234579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=291.86 Aligned_cols=203 Identities=28% Similarity=0.420 Sum_probs=180.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..+.|..-++||+|+||.||-++.. .|+.||+|++.+...+ .+.+...+.|-.++++++.+.||.+.-.|++.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456788889999999999999765 5999999998766543 3345667889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|+..|.||+|.-++... ....+++..++-++.+|+.||++||++ +||.|||||+|||+|+.|+++|+|.|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999998777533 345799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+..... .+.+||.+|||||++.+..|+...|+||+||++|||+.|+.||.
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 765444 34589999999999999999999999999999999999999996
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.26 Aligned_cols=194 Identities=25% Similarity=0.421 Sum_probs=164.4
Q ss_pred ceeccCccceEEEEEEcC-CcEEEEEEcCccccc-HHHHHHHHHHHHHhhc-CCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+..+ ++.||+|.++..... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999998764 789999998754321 1233445566677665 5899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.++++ ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++........ .
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 99999986 235688999999999999999999999 999999999999999999999999999865322211 2
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 234579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.49 Aligned_cols=200 Identities=23% Similarity=0.362 Sum_probs=169.5
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 487 (618)
+|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999875 588999999875432 2233456777888888775 577888999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999886 345689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 21 122345699999999999998999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.63 Aligned_cols=194 Identities=23% Similarity=0.388 Sum_probs=164.8
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhc-CCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+.. +|+.||+|.++..... ......+..|..++.. .+||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999876 5889999999754321 1233455666777664 4899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 99999886 245688999999999999999999999 99999999999999999999999999986432211 22
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 234679999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.83 Aligned_cols=199 Identities=26% Similarity=0.388 Sum_probs=171.7
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----eEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRL 484 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 484 (618)
+|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778889999999999999864 6899999998765444445677889999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+|+||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 57887775 345789999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.............+++.|+|||++.+. .++.++||||+||++|||++|+.||+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 543333333445788999999999874 47899999999999999999999995
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.22 Aligned_cols=200 Identities=30% Similarity=0.468 Sum_probs=173.5
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC------eE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------QR 483 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~ 483 (618)
.|...+.||+|+||.||+|+++ .|+.||||.+.... .....+...+|++++++++|+|||+++++-++.. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3556778999999999999865 59999999998654 4446678899999999999999999999866544 56
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec--CCC--CcEEeec
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DEL--NPHLSDC 559 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~--~~kl~Df 559 (618)
.+|||||.+|||...++.- ++...+++.+.+.+..+++.||.|||++ +|+||||||.||++- ++| .-||+||
T Consensus 93 vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred eEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 8999999999999999743 3456799999999999999999999998 999999999999984 333 3599999
Q ss_pred cccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|.|+..++.. ...+.+||..|.+||++.. +.|+..+|.|||||++||+.||..||.
T Consensus 169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9999886544 5567899999999999984 889999999999999999999999995
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.79 Aligned_cols=194 Identities=26% Similarity=0.413 Sum_probs=167.7
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|... +++.||+|+++..... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 4789999999765432 23445678888888887 699999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99998885 235689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 234679999999999999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.36 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=165.1
Q ss_pred cCCcccceeccCccceEEEEEEc--CCcEEEEEEcCcccccHHHHHHHHHHHHHhhc---CCCCcccccceEEee-----
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR---LRHPNIVTLAGYCAE----- 479 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~----- 479 (618)
++|+..+.||+|+||.||+|+.. +|+.||+|+++...........+.+|+..++. ++||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999763 46889999987544333233445566666554 479999999998853
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
....++||||++ ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 356899999997 5899988632 234589999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 999765432 22234578999999999998899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.09 Aligned_cols=192 Identities=23% Similarity=0.409 Sum_probs=165.6
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccHH-HHHHHHHHHHHhhcCCCCcccccceEEee----CCeEEEEEEec
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ-EEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVYEYV 490 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 490 (618)
..||+|++|.||+|.+ +|+.||+|+++....... ..+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 589999999976543222 24678899999999999999999999876 34689999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
++|+|.++++ ....+++....+++.|++.||+|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999996 3456889999999999999999999742 78899999999999999999999999987654321
Q ss_pred ccccceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||+.
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~ 224 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence 23468899999999976 6799999999999999999999999963
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.86 Aligned_cols=197 Identities=28% Similarity=0.469 Sum_probs=176.1
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
-|.+.+.||+|+||.||+|.++ .|.++|||.+... ...+++..|+.+|++++.|+||++||.+.....+|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 3667788999999999999765 5999999998643 2567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
|..|++.+.++. ....+++.++..+....+.||+|||-. .-||||||+.|||++.+|++|++|||.+....+.
T Consensus 110 CGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT- 182 (502)
T KOG0574|consen 110 CGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT- 182 (502)
T ss_pred cCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-
Confidence 999999999974 456899999999999999999999998 7799999999999999999999999998655322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
-..+..+.||+-|||||++..-.|..++||||||+...||..|++||.+
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 1223467899999999999999999999999999999999999999974
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.46 Aligned_cols=194 Identities=28% Similarity=0.417 Sum_probs=164.7
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHH-HhhcCCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999765 589999999875432 2223344555544 46778999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 99998886 345789999999999999999999999 999999999999999999999999999865322221 2
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence 234579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=292.91 Aligned_cols=205 Identities=28% Similarity=0.480 Sum_probs=171.1
Q ss_pred hcCCcccceeccCccceEEEEEEcC-----------------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCccc
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-----------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (618)
..+|...+.||+|+||.||+|.+.+ +..||+|.+.... ......++.+|++++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4578888999999999999997542 3469999987543 334466799999999999999999
Q ss_pred ccceEEeeCCeEEEEEEecCCCChhhhhhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 007103 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD---------------SSKNLTWNARVRVALGTARALEYLHEVCLPSV 536 (618)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 536 (618)
++++++.+.+..++||||+++|+|.+++..... ....+++..+.+++.|++.||+|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 999999999999999999999999998854211 113478889999999999999999999 99
Q ss_pred eecCCCCCCeeecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh--CC
Q 007103 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GR 613 (618)
Q Consensus 537 iH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~ 613 (618)
+||||||+|||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999765433221 1222345788999999998899999999999999999987 66
Q ss_pred CCCC
Q 007103 614 KPLD 617 (618)
Q Consensus 614 ~Pf~ 617 (618)
.||.
T Consensus 240 ~p~~ 243 (304)
T cd05096 240 QPYG 243 (304)
T ss_pred CCCC
Confidence 7774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=284.01 Aligned_cols=199 Identities=28% Similarity=0.469 Sum_probs=172.7
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
++|+..+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 45777889999999999999998888999998874432 245688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 81 MENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999998863 234688999999999999999999999 99999999999999999999999999987654332
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........++..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~ 203 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence 222223345678999999998889999999999999999999 999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=294.11 Aligned_cols=194 Identities=24% Similarity=0.396 Sum_probs=166.8
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|+.. +++.||+|+++.... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 478999999975432 223345667788888777 699999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 99998886 345789999999999999999999999 99999999999999999999999999986532221 12
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 234579999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=296.65 Aligned_cols=196 Identities=24% Similarity=0.403 Sum_probs=165.7
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..+|+..+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+++++.++|+||+++++++...+..++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 356777889999999999999865 58999999986443 3334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 152 e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 152 EFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred ecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999999986532 345677889999999999999999 999999999999999999999999999976543
Q ss_pred CCcccccceeccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......||..|+|||++.. ...+.++|||||||++|||++|+.||.
T Consensus 221 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 221 1234579999999998853 224568999999999999999999995
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=288.44 Aligned_cols=200 Identities=28% Similarity=0.408 Sum_probs=172.9
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.|+..+.||+|+||.||++... +++.||+|++...... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999865 5899999998754322 2234567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999887532 235689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .....|++.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence 21 123478999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=274.32 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=176.6
Q ss_pred hcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.+.|++.+.||+|.|+.||+..+ ..|+.+|+|.+.....+....+++.+|+.+-+.++||||+++.+.+.+.+..++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45788888999999999999854 46999999999877766667788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCcEEeecccccc
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAAL 564 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl~~~ 564 (618)
|+|.|++|..-+- .....++..+..++.||+++|+|+|.+ +|||||+||+|+++.. .--+|++|||++..
T Consensus 90 e~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999976553 124578888999999999999999999 9999999999999963 34589999999987
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......+.+|||+|||||++...+|+..+|||+-|||+|-|+.|.+||-
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 76 3334456799999999999999999999999999999999999999994
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.43 Aligned_cols=201 Identities=29% Similarity=0.413 Sum_probs=179.3
Q ss_pred hhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccH-HHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 483 (618)
.....|+..+.||+|.||.||++..+. |+.+|+|.+.+..... .....+.+|+++|+++. ||||+.+++++++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345568888999999999999998775 9999999997665432 24568899999999998 99999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC----CCcEEeec
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLSDC 559 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~Df 559 (618)
++|||++.+|.|.+.+... .+++.++..++.|++.+++|||+. ||+||||||+|+|+... +.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999998633 399999999999999999999998 99999999999999633 47999999
Q ss_pred cccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|++..... .......+||+.|+|||++....|+..+||||+||++|.|+.|..||.
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~ 239 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW 239 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc
Confidence 99988765 344556899999999999999999999999999999999999999996
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=315.86 Aligned_cols=205 Identities=26% Similarity=0.369 Sum_probs=174.1
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+|... .|+.||+|++..... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999876 489999999875432 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 488 EYVGNGNLHDMLHFADD-------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
||+++|+|.++++.... .....++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123456778899999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCc-----------------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTER-----------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 9976521110 01112469999999999999999999999999999999999999996
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=293.88 Aligned_cols=199 Identities=25% Similarity=0.426 Sum_probs=174.3
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||++.+. +++.+|+|.+.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 467899999999999999999876 58889999886543 3344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999863 346888999999999999999999752 799999999999999999999999999875532
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2 1223568999999999999899999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=300.24 Aligned_cols=207 Identities=28% Similarity=0.464 Sum_probs=172.6
Q ss_pred hhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
...++|+..+.||+|+||.||+|... +++.||+|+++... .......+.+|+++++.+ +|+||+++++++..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 44567889999999999999998742 24579999997544 233456788999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccC-------------------------------------------------------
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADD------------------------------------------------------- 504 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 504 (618)
.+..++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998863211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc-c
Q 007103 505 -----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ-V 572 (618)
Q Consensus 505 -----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~ 572 (618)
....+++..+.+++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 113478889999999999999999998 9999999999999999999999999999765432221 1
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 122345678999999999999999999999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=299.46 Aligned_cols=207 Identities=28% Similarity=0.451 Sum_probs=172.7
Q ss_pred hhhcCCcccceeccCccceEEEEEE------cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
...++|+..+.||+|+||.||+|.+ ..+..||+|+++... .....+.+.+|++++..+ +||||+++++++..
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 3455788899999999999999963 235689999987543 233456788999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccC-------------------------------------------------------
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADD------------------------------------------------------- 504 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 504 (618)
.+..++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999864221
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 505 ----------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 505 ----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
....+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 112578889999999999999999998 9999999999999999999999999999765433
Q ss_pred Cccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 569 ERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 569 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 2211 112345678999999999999999999999999999998 899985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.89 Aligned_cols=209 Identities=28% Similarity=0.334 Sum_probs=185.6
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCccc-ccHHHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
+..+.....+|++.++||+|+||.|..++++. +++||+|++.+-. ....+...|.+|-++|.--..+=|++++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34456667899999999999999999998864 8999999997532 234456788999999988888889999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
+.++|+|||||+||+|-.++.. ..++++..++.++..|+-||.-+|+. |+|||||||+|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999963 23799999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccceeccccccCccccc----c-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFAL----S-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|.+-.+..++...+...+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||-
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 999888777777777789999999999995 3 579999999999999999999999993
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=264.31 Aligned_cols=208 Identities=26% Similarity=0.403 Sum_probs=176.3
Q ss_pred hhcCCcccceeccCccceEEEEE-EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----C
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----G 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 481 (618)
-.++|.+.+.||+|||.-||.++ ..+++.||+|++.-.. .++.+..++|++..++++||||++++++...+ .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 34679999999999999999996 4568999999986543 45677889999999999999999999886433 3
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
+.|++++|...|+|.+.++..+..+..+++.+++.|+.++++||++||+.. |+++||||||.|||+++++.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 589999999999999999877777778999999999999999999999983 3599999999999999999999999999
Q ss_pred cccCCCCCcccc--------cceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 562 AALTPNTERQVS--------TQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 562 ~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
++..+-...... .....|..|+|||.+. +...++++|||||||++|+|+.|.-||++
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 876542211110 1235788899999985 44578999999999999999999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=274.80 Aligned_cols=202 Identities=25% Similarity=0.379 Sum_probs=178.2
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
.-++|+..++||+|.||.|.+++-+ .|+.||+|++++... ...+...-+.|-.+++..+||.+..+.-.|...+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888899999999999999655 599999999987654 34445666788899999999999999989999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||..||.|.-++. ....+++...+-+...|+.||.|||++ +||.||||.+|.|+|.+|++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999998885 345688888889999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .....++|||.|+|||++....|+..+|+|.+||+||||+.|+.||-
T Consensus 319 I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 319 IKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred cccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 4433 33456899999999999999999999999999999999999999984
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.20 Aligned_cols=206 Identities=23% Similarity=0.341 Sum_probs=171.0
Q ss_pred hhcCCcccceeccCccceEEEEEEcCC-cEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceE-Eee-----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGY-CAE----- 479 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~----- 479 (618)
...++++++.|.+|||+.||.|....+ ..||+|++... +......+++|+++|++++ |+|||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 345677888999999999999988766 99999998755 4556788999999999996 9999999993 221
Q ss_pred -CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 480 -HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 480 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
.-+.+|.||||.+|.|-|++.... ...+++.++++|+.|+++|+++||.. .|+|||||||-+||||+.+++.||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 136789999999999999997433 33499999999999999999999987 46799999999999999999999999
Q ss_pred ccccccCC-CCCccc-----c--cceeccccccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 559 CGLAALTP-NTERQV-----S--TQMVGAFGYSAPEFA---LSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 559 fgl~~~~~-~~~~~~-----~--~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
||.+.-.. ...... . -....|+.|+|||++ .+..+++|+|||||||+||-|+....||++
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 99985322 111110 0 113578999999998 466789999999999999999999999984
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=286.52 Aligned_cols=203 Identities=27% Similarity=0.420 Sum_probs=181.2
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...-|..++.||+|.|..|-+|++- .|++||||++.+..........+..|+..|+.++|||||++|++......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 3456888889999999999999654 699999999998888877788899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCcEEeeccccccC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALT 565 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~ 565 (618)
+|.=++|+|++|+-. ....+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-||+.|||++-.+
T Consensus 96 LELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999963 345688999999999999999999999 899999999999764 6789999999999766
Q ss_pred CCCCcccccceeccccccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.+... -+..+|...|.|||++.+..|. +++||||||||+|-|+.|++||++
T Consensus 170 ~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 170 QPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred CCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 54332 3457999999999999999995 789999999999999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=283.86 Aligned_cols=193 Identities=28% Similarity=0.426 Sum_probs=165.9
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEcCcccccH-HHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
||+|+||.||+++.. +|+.||+|++....... .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999775 58999999987543322 2334556799999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccc
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 575 (618)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........ ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence 9888532 234588999999999999999999999 999999999999999999999999999876543221 123
Q ss_pred eeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..|+..|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 468999999999999889999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=282.34 Aligned_cols=202 Identities=26% Similarity=0.455 Sum_probs=175.4
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..++|+..+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 346788889999999999999998888999999986533 23567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 81 EYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred ecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999998632 345688899999999999999999998 999999999999999999999999999976654
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..........++..|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence 32222223346778999999998889999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.82 Aligned_cols=198 Identities=25% Similarity=0.322 Sum_probs=169.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 481 (618)
..++|+..+.||+|+||.||++... .|+.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999765 5899999999765544555677889999999999999999999986543
Q ss_pred -eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 482 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
..++||||+++ ++.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999976 5666654 2478888999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 99754322 12234578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.49 Aligned_cols=201 Identities=28% Similarity=0.474 Sum_probs=169.8
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
..+|+..+.||+|+||.||+|.+. +|+ .||+|.++... .....+++.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 356888999999999999999764 333 38999987432 334567788999999999999999999998764 57
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++|+||+++|+|.++++. ....+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 84 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 799999999999999873 234688999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 765433222 122335678999999999999999999999999999998 999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=279.83 Aligned_cols=202 Identities=26% Similarity=0.460 Sum_probs=174.1
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..++|+..+.||+|++|.||+|...+++.||+|.++.... ..+++.+|++.+++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3456888899999999999999988888999999875432 2466889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999998632 235689999999999999999999999 999999999999999999999999999976653
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
...........+..|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 206 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 22221122233457999999999899999999999999999999 999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.37 Aligned_cols=199 Identities=28% Similarity=0.459 Sum_probs=172.2
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
++|...+.||+|+||.||+|++.++..+|+|.++..... .+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 457788899999999999999887778999998754332 45688999999999999999999999988899999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+.+|+|.++++.. ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++......
T Consensus 81 ~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 81 MSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999998632 33689999999999999999999999 99999999999999999999999999987654332
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 203 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 222222345678999999998889999999999999999999 999986
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=303.17 Aligned_cols=198 Identities=26% Similarity=0.378 Sum_probs=164.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (618)
..++|...+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3467999999999999999999875 58899999885322 2234689999999999999999886432
Q ss_pred --CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEe
Q 007103 481 --GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLS 557 (618)
Q Consensus 481 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~ 557 (618)
...++||||+++ ++.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 246789999985 78777765444567799999999999999999999999 999999999999999654 79999
Q ss_pred eccccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|||+++....... .....||+.|+|||++.+. .|+.++|||||||++|||++|++||.
T Consensus 214 DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 214 DFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred ccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999986543322 2235789999999998764 68999999999999999999999995
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.69 Aligned_cols=211 Identities=24% Similarity=0.372 Sum_probs=176.2
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CC
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HG 481 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 481 (618)
.+...++|.+.+.||+|+||.||+|.... ++.+|+|.+............+..|+.++++++||||+++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34556789999999999999999998764 7789999987665555567789999999999999999999998854 35
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCceecCCCCCCeeecCC------
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL----PSVVHRNFKSANILLDDE------ 551 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~iiH~Dlkp~Nill~~~------ 551 (618)
..++||||+++|+|.+++.........+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999997544445679999999999999999999998521 259999999999999642
Q ss_pred -----------CCcEEeeccccccCCCCCcccccceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 552 -----------LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 552 -----------~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 348999999997654321 2234579999999999864 458899999999999999999999996
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=283.28 Aligned_cols=199 Identities=28% Similarity=0.425 Sum_probs=171.9
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
|+..+.||+|+||.||++... +++.||+|.+...... ......+..|+.++++++|++|+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999765 5889999998754332 22345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988532 234689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 2 123478999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.80 Aligned_cols=207 Identities=27% Similarity=0.424 Sum_probs=173.4
Q ss_pred hhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 479 (618)
...++|.+.+.||+|+||.||+|.+. .+..||+|+++... .....+.+.+|+++++++. ||||+++++++.+
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 34568889999999999999999753 13579999997543 3344577999999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccC-------------------------------------------------------
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADD------------------------------------------------------- 504 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 504 (618)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998864211
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 007103 505 -------------------------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (618)
Q Consensus 505 -------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 547 (618)
....+++..+.+++.|+++||+|||+. +|+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 013478888999999999999999998 9999999999999
Q ss_pred ecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 548 LDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 548 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 999999999999999765432221 1223457788999999999999999999999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.43 Aligned_cols=199 Identities=29% Similarity=0.455 Sum_probs=172.8
Q ss_pred CcccceeccCccceEEEEEE-cCCc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEF-ANGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
....++||+|+||+||+|.| ++|+ +||||++.... ..+..+++++|+..|.+++|||+++++++|.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 44567899999999999965 4454 57888876543 4456788999999999999999999999998775 8899
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
++||+.|+|.+++++ .+.++..+..+.+..|||+||.|||++ +++||||.++||||..-.++||.|||+++...
T Consensus 776 tq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999986 456788889999999999999999999 99999999999999999999999999999887
Q ss_pred CCCccccc-ceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 567 NTERQVST-QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 567 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
.++..+.. ...-.+.|||-|.+....|+.++|||||||.+||++| |..|+++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 66554432 3345678999999999999999999999999999999 9999874
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=279.64 Aligned_cols=199 Identities=29% Similarity=0.460 Sum_probs=170.9
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
.+|+..+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 45778889999999999999988788899999865432 245678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...+..
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 81 MANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 999999999863 234689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence 221122234567999999999999999999999999999999 899985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=268.37 Aligned_cols=199 Identities=31% Similarity=0.470 Sum_probs=171.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHH--H----HHHHHHHHHHhhcC-CCCcccccceEEeeC
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ--E----EDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 480 (618)
...|...++||+|..++|-++.++ .|+++|+|++.......+ . .+.-++|+.+++++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456778889999999999988654 588999999864432211 1 23346789999887 799999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++|+|.|+.|.|+|++. ..-.++++...+|+.|+.+|++|||.+ +|+||||||+|||++++..+||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999996 455789999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFAL------SGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
+++.....+.- ...+|||+|+|||.+. ...|+..+|+||.|||||.|+.|-+||
T Consensus 169 Fa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 169 FACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred eeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 99888655433 4579999999999985 345888999999999999999999998
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=276.77 Aligned_cols=201 Identities=29% Similarity=0.480 Sum_probs=177.6
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|...+.||+|++|.||+|... +++.|++|.+..........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999875 589999999876555566678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999742 245789999999999999999999998 99999999999999999999999999987664332
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 2 2234568899999999999989999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=282.00 Aligned_cols=199 Identities=27% Similarity=0.401 Sum_probs=171.7
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH-HHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
|+..+.||+|+||.||+|.+. +++.+|+|.+....... .....+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566678999999999999775 58899999986543322 2345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888632 234689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....|+..|+|||++.+..++.++|+|||||++|||++|+.||.
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 1 123578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=277.87 Aligned_cols=201 Identities=27% Similarity=0.388 Sum_probs=173.2
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc---HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
+.|...+.||+|++|.||+|... +++.+++|.+...... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888899999999999999764 5899999998654322 2234578889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998862 35688899999999999999999999 9999999999999999999999999998755
Q ss_pred CCCCcccc--cceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ ....|+..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 43221111 23467889999999999989999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=293.94 Aligned_cols=192 Identities=28% Similarity=0.396 Sum_probs=160.7
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcC---CCCcccccceEEeeCCeEEEEEEecCC
Q 007103 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
||+|+||.||+|+.. +|+.||+|++...... ......+..|..++... .||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 5899999998654321 22233445566665554 699999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.++++ ....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99998886 345689999999999999999999999 99999999999999999999999999986543222 12
Q ss_pred ccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 2345799999999999765 47999999999999999999999985
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=278.70 Aligned_cols=204 Identities=24% Similarity=0.405 Sum_probs=176.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccc-ccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.+|++.+.||+|+||.||+|... +++.||+|.++... ........+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999765 68999999876432 23445567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.+++.........+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865444455688999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 221 1223468889999999998889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.76 Aligned_cols=205 Identities=29% Similarity=0.440 Sum_probs=185.4
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
..+.....|.+...||+|.|+.|..|++. .+..||||.+.+........+.+.+|+++|..+.|||||+++.+.+....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 34556678999999999999999999765 59999999999888777777779999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
+|+||||+.+|.+++++. ..+.+.+..+..++.|+.+|++|||++ .|+|||||++|||++.+..+||+|||++
T Consensus 130 lylV~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred eEEEEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccc
Confidence 999999999999999997 455666788899999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..+.. .......+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..|||
T Consensus 203 ~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 203 TFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred eeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 87752 334456799999999999999887 689999999999999999999998
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=292.24 Aligned_cols=198 Identities=23% Similarity=0.308 Sum_probs=169.8
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (618)
..++|...+.||+|+||.||+|... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999765 588999999976554445567788999999999999999999987543
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 7777664 2478889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 99765332 12234578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=276.78 Aligned_cols=202 Identities=30% Similarity=0.474 Sum_probs=173.3
Q ss_pred hcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|+..+.||+|+||.||+|.+.. ...||+|.++... .......+.+|+..+++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 3568888999999999999998753 4578999887543 3345567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++++|.+++.. ..+.+++..+.+++.|++.|++|||++ +|+||||||+||++++++.++|+|||+++.
T Consensus 82 iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 82 IITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999999863 234789999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 6522221 1222345678999999999999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=280.15 Aligned_cols=207 Identities=25% Similarity=0.403 Sum_probs=172.6
Q ss_pred hhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
...++|+..+.||+|+||.||+|.+. .++.||+|++.... ......++.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35677999999999999999999753 25679999986433 334456788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDS------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
+..++||||+++++|.++++..+.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 9999999999999999998643221 23467888999999999999999998 99999999999999999999
Q ss_pred EEeeccccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 555 HLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999987553322211 112345778999999999889999999999999999999 788885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=294.61 Aligned_cols=192 Identities=30% Similarity=0.444 Sum_probs=168.6
Q ss_pred eeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 417 LIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
+||+|.||+||-|+..+ ...+|||.+.... .+..+-+.+|+.+.++++|.|||+++|.+.+++..-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 69999999999998765 4568999987554 34566789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCcEEeeccccccCCCCCccc
Q 007103 496 HDMLHFADDSSKNL--TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 496 ~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
.++++. .-+++ .+.++-.+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||-++....- +..
T Consensus 660 SsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 660 SSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred HHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 999973 33455 7788889999999999999999 999999999999997 6789999999999877543 334
Q ss_pred ccceeccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...+.||..|||||++..+. |+.++|||||||.+.||.||++||-
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 55678999999999997654 8999999999999999999999994
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.82 Aligned_cols=204 Identities=26% Similarity=0.372 Sum_probs=171.3
Q ss_pred eehhhhhhhhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-C-----Ccccc
Q 007103 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-H-----PNIVT 472 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~ 472 (618)
|.+..-+....+|++.+.||+|+||+|.+|.. ..++.||||+++.... ...+-..|+.++..++ | -|+|+
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr 252 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVR 252 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence 33333344445899999999999999999965 4599999999986542 3445567788887775 3 47999
Q ss_pred cceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC--
Q 007103 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-- 550 (618)
Q Consensus 473 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-- 550 (618)
++++|.-.++.+||+|.++. +|+++++..+ -..++...++.|+.||+.||.+||+. +|||+||||+|||+.+
T Consensus 253 m~d~F~fr~HlciVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 253 MLDYFYFRNHLCIVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPK 326 (586)
T ss_pred eeeccccccceeeeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCC
Confidence 99999999999999999976 9999998543 45589999999999999999999999 9999999999999974
Q ss_pred CCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 551 ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 551 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
...+||+|||.++....... .++-+..|+|||++.+..|+.+.||||||||++||++|.+-|
T Consensus 327 r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred cCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 34799999999987643322 567788999999999999999999999999999999997665
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=291.90 Aligned_cols=198 Identities=23% Similarity=0.306 Sum_probs=170.1
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (618)
..++|...+.||+|+||.||++... .++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999765 588999999976554555567788899999999999999999988643
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++||||+++ ++.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999975 6766664 2478889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99765332 12234578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=280.72 Aligned_cols=205 Identities=27% Similarity=0.495 Sum_probs=174.0
Q ss_pred hcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
..+|...+.||+|+||.||+|...+ ++.||+|.++... ..+..+.+.+|++++++++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 3467788899999999999997643 4789999987543 23345789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 483 RLLVYEYVGNGNLHDMLHFAD----------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
.++||||+++++|.++++... .....+++..+..++.|++.|++|||+. +++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 999999999999999997432 1234578899999999999999999999 999999999999999999
Q ss_pred CcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 553 NPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 999999999875432221 11223356788999999999999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=280.32 Aligned_cols=204 Identities=29% Similarity=0.537 Sum_probs=173.1
Q ss_pred cCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
++|+..+.||+|+||.||+|.... .+.+++|.+.... .......+.+|++.+++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 467888899999999999997643 2579999987543 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 484 LLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
+++|||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999964321 114688899999999999999999999 99999999999999999
Q ss_pred CCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999976533221 22233467889999999998999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=270.27 Aligned_cols=204 Identities=27% Similarity=0.405 Sum_probs=173.0
Q ss_pred cCCcccceeccCccceEEEEEEcC-----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-CCeE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQR 483 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 483 (618)
..|+....||+|.||.||+|.-++ .+.+|+|+++.............+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888899999999999995432 3479999998765444445567789999999999999999998877 7889
Q ss_pred EEEEEecCCCChhhhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC----CCcEEee
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSS-KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLSD 558 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~D 558 (618)
++++||.+. +|...+++.+... ..++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 9999998765433 4688899999999999999999999 68999999999999876 9999999
Q ss_pred ccccccCCCCCccc--ccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQV--STQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+|+++.+.+.-... ...++-|+.|+|||.+.+. .||.+.||||+|||+.||+|-++-|.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999886554332 3457889999999999885 58999999999999999999877664
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=285.10 Aligned_cols=199 Identities=23% Similarity=0.395 Sum_probs=168.6
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|...+.||+|+||.||+|... +++.||+|.++..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56888899999999999999875 5788999998754322 233457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9985 88887753 234578899999999999999999999 9999999999999999999999999998754332
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....+++.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 158 TKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred ccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 221 223467899999999865 458899999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=277.01 Aligned_cols=200 Identities=32% Similarity=0.524 Sum_probs=171.1
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.++|++.+.||+|+||.||+|.+.++..||+|+++..... ...+.+|++++++++||||+++++++. ....++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 4568899999999999999998877778999999754332 356889999999999999999999874 456799999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++|+|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999632 234678999999999999999999999 9999999999999999999999999999766443
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.........++..|+|||+..+..++.++||||||+++|||+| |+.||.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~ 205 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 205 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 3222223456778999999998899999999999999999999 888985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=276.28 Aligned_cols=204 Identities=24% Similarity=0.414 Sum_probs=178.0
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|++|.||+|... +|+.||+|.++.... .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 789999998864332 3334678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.+++.........+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875444456689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .....++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 2221 223568889999999999889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=288.80 Aligned_cols=197 Identities=23% Similarity=0.386 Sum_probs=169.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (618)
..++|...+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4567999999999999999999764 588999999976544444556678899999999999999999987543
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++++|++ +++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 678988774 35689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99765432 234578999999999977 568999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=277.17 Aligned_cols=201 Identities=26% Similarity=0.466 Sum_probs=172.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..+|+..+.||+|++|.||+|... .++.||+|.+.... .....+.+|++.+++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 345778889999999999999765 48899999987543 23567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 82 EFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999998632 235689999999999999999999998 999999999999999999999999999976654
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..........++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 32222222334668999999999999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=278.65 Aligned_cols=199 Identities=34% Similarity=0.562 Sum_probs=174.4
Q ss_pred CcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
|+..+.||+|+||.||++.... ++.||+|.+..............+|+..+++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999998875 678999999877655545445566999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
++++|.+++. ....+++..+..++.|+++||++||+. +|+|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999997 346789999999999999999999999 99999999999999999999999999987541 122
Q ss_pred ccccceeccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.......++..|+|||++. +..++.++||||+|+++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2333467899999999998 78899999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=276.14 Aligned_cols=201 Identities=28% Similarity=0.505 Sum_probs=173.3
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..++|+..+.||+|+||.||+|...+++.||+|.+...... ..++.+|++++++++|+||+++++++. .+..+++|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 45678889999999999999999888999999998754433 457889999999999999999999874 45789999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+.+++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999988632 345689999999999999999999998 999999999999999999999999999976653
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 32222223456778999999999899999999999999999999 999995
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=277.24 Aligned_cols=203 Identities=28% Similarity=0.497 Sum_probs=176.9
Q ss_pred hhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
+...+|+..+.||+|+||.||+|...+++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4566788899999999999999999889999999987544 22356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 81 TELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred EeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 9999999999999742 345689999999999999999999999 99999999999999999999999999997664
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.
T Consensus 156 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 156 EDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred Ccccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 33221 223346778999999998889999999999999999998 899985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=287.30 Aligned_cols=207 Identities=27% Similarity=0.455 Sum_probs=171.5
Q ss_pred hhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
.+.++|++.+.||+|+||.||+|... .++.||+|+++... .....+.+..|++++.++ +|+||+++++++..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 34567899999999999999999642 25789999987543 333456778899999999 79999999998865
Q ss_pred C-CeEEEEEEecCCCChhhhhhcccCC-----------------------------------------------------
Q 007103 480 H-GQRLLVYEYVGNGNLHDMLHFADDS----------------------------------------------------- 505 (618)
Q Consensus 480 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 505 (618)
. ...++++||+++++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5688999999999999988632210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc-ccceeccc
Q 007103 506 ----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAF 580 (618)
Q Consensus 506 ----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~ 580 (618)
...+++..+.+++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 13678999999999999999999999 99999999999999999999999999997654332222 22345677
Q ss_pred cccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~ 277 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence 8999999999999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=275.91 Aligned_cols=201 Identities=32% Similarity=0.529 Sum_probs=172.1
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..++|+..+.||+|+||.||+|...++..+|+|.+...... .+.+.+|+.++++++|+|++++++++. ....+++|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 34578888999999999999999888889999998764433 456889999999999999999999875 45688999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 80 EYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999998632 234689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 205 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCC
Confidence 33222222345678999999988889999999999999999999 999985
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.88 Aligned_cols=197 Identities=32% Similarity=0.482 Sum_probs=172.6
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
+.+.|...+.||.|+||.||-|+.. +.+.||||++..... +.+.+.+++.|+..+++++|||++.+.|+|-.+...||
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 3445777788999999999999654 688999999875433 44557899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|||||-| +-.|++... ..++.+.++..|..+.+.||+|||+. +.||||||+.|||+++.|.||++|||.+...
T Consensus 104 VMEYClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 104 VMEYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence 9999964 777877643 46788999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
.+. ..++|||.|||||++. .+.|+-|+||||||++..||..+++|+
T Consensus 177 ~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 177 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred Cch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 433 4579999999999985 578999999999999999999999995
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=280.85 Aligned_cols=199 Identities=28% Similarity=0.408 Sum_probs=163.1
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhc---CCCCcccccceEEeeC-----C
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR---LRHPNIVTLAGYCAEH-----G 481 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~-----~ 481 (618)
+|+..+.||+|+||.||+|... +|+.||+|.++...........+.+|++.++. ++||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999776 58899999987543222223344556655554 4799999999988642 4
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+++ +|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999985 888888632 234589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++...... ......||..|+|||++.+..++.++||||+||++|||++|++||.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 97654322 1223568899999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=272.10 Aligned_cols=195 Identities=26% Similarity=0.442 Sum_probs=167.3
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
++||+|+||.||+|...+++.+|+|.+.... .......+.+|++.+++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999998889999999987543 333455788999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccc
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 575 (618)
.+++.. ....+++..+..++.|++.||.|+|+. +++||||||+||++++++.+||+|||++.............
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 998863 234578999999999999999999998 99999999999999999999999999986543222111112
Q ss_pred eeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..++..|+|||++.+..++.++||||||+++||+++ |..||.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 244678999999998999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=276.60 Aligned_cols=192 Identities=25% Similarity=0.425 Sum_probs=168.4
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 5777889999999999999764 68899999986543 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 367888899999999999999999 99999999999999999999999999987654322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 194 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence 233578999999999999999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=278.58 Aligned_cols=197 Identities=30% Similarity=0.464 Sum_probs=174.3
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|++|.||++... +++.+|+|.++.... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999876 589999999865432 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999863 36789999999999999999999998 999999999999999999999999999876644
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 3 223468899999999988888999999999999999999999985
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=277.79 Aligned_cols=199 Identities=40% Similarity=0.643 Sum_probs=167.2
Q ss_pred ccceeccCccceEEEEEEc-----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 414 QEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 414 ~~~~Lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
..+.||+|.||.||+|.+. .+..|+||.++.. ......+.+.+|++.+++++||||++++|++...+..++|+|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4568999999999999887 2678999999653 344457889999999999999999999999998888999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++|+|.++++.. ....+++..+..++.||++||+|||++ +++|+||+++||++++++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999743 246789999999999999999999999 9999999999999999999999999999766322
Q ss_pred Cc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 569 ER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 569 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
.. .......+...|+|||.+....++.++||||||+++|||++ |+.||.+
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11 22233457788999999999999999999999999999999 7899863
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=283.77 Aligned_cols=194 Identities=25% Similarity=0.449 Sum_probs=159.4
Q ss_pred ceeccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCeEEEEEEec
Q 007103 416 FLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVYEYV 490 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 490 (618)
+.||+|+||.||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++|+||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 47999999999999865 467899999875432 2446789999999999999999998854 45688999998
Q ss_pred CCCChhhhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----cCCCCcEEeeccc
Q 007103 491 GNGNLHDMLHFADD-----SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCGL 561 (618)
Q Consensus 491 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfgl 561 (618)
++ +|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 88887753221 123588999999999999999999999 99999999999999 4567899999999
Q ss_pred cccCCCCCc--ccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTER--QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 986643321 11234578999999999977 458999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=292.46 Aligned_cols=195 Identities=25% Similarity=0.411 Sum_probs=167.4
Q ss_pred ccceeccCccceEEEEEEc-CCcEEEEEEcCcccc--cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC--eEEEEEE
Q 007103 414 QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLVYE 488 (618)
Q Consensus 414 ~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 488 (618)
...+||+|+|-+||+|.+. +|.+||--.++.... +....++|.+|+.+++.++||||++++.++.+.. ...+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3457999999999999765 477777654443332 3445589999999999999999999999998765 4889999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCcEEeeccccccCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPN 567 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~~ 567 (618)
.+..|+|..|.+. .+.++...+..++.||++||.|||++ .|+|||||||-+||+|+ ..|.|||.|+|+|.....
T Consensus 124 L~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999973 45678889999999999999999997 57999999999999998 669999999999987753
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ....++|||.|||||++. ..|++.+||||||+.|+||.|+.+||.
T Consensus 199 s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 199 S---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred c---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 2 223489999999999987 789999999999999999999999985
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=292.25 Aligned_cols=194 Identities=22% Similarity=0.284 Sum_probs=168.0
Q ss_pred hcCCcccceeccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..+|...+.||+|+||.||++... .++.|++|.+... ....+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 457999999999999999999654 3578999988643 234578999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|||++. ++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999996 58888874 346789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 43322 12234579999999999999999999999999999999999999984
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=277.92 Aligned_cols=204 Identities=27% Similarity=0.477 Sum_probs=172.4
Q ss_pred hcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
..+|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 456888899999999999999742 34668999886543 3345678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC
Q 007103 483 RLLVYEYVGNGNLHDMLHFAD---------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 553 (618)
.++||||+++++|.++++... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999999986432 1223589999999999999999999998 9999999999999999999
Q ss_pred cEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 554 PHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999765432221 1122345778999999999899999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=274.90 Aligned_cols=203 Identities=25% Similarity=0.465 Sum_probs=170.1
Q ss_pred CcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe-----
Q 007103 412 FSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ----- 482 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 482 (618)
|.+.+.||+|+||.||+|.... +..||+|+++...........+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567789999999999997653 3679999998665555556789999999999999999999998866554
Q ss_pred -EEEEEEecCCCChhhhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 483 -RLLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 483 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
.++++||+++|+|.+++...+ .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999885432 2234689999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 560 GLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~ 217 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP 217 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 9997654332221 112235678999999988889999999999999999999 999985
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=271.76 Aligned_cols=195 Identities=25% Similarity=0.431 Sum_probs=165.6
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGN 494 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 494 (618)
+.||+|+||.||+|... +++.+|+|.+.... ..+....+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999775 68999999886443 33455678999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc-c
Q 007103 495 LHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-S 573 (618)
Q Consensus 495 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~ 573 (618)
|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......... .
T Consensus 80 L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 80 FLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999862 234688999999999999999999999 99999999999999999999999999987543221111 1
Q ss_pred cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 574 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....++..|+|||.+.+..++.++||||||+++|||++ |..||+
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 11123457999999999999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=277.12 Aligned_cols=204 Identities=26% Similarity=0.512 Sum_probs=171.6
Q ss_pred cCCcccceeccCccceEEEEEE-----cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.+|+..+.||+|+||.||+|.+ ..++.+++|.++... ..+....+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4677788999999999999974 246789999997543 3344567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 485 LVYEYVGNGNLHDMLHFADD-------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
+||||+++++|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853211 123578889999999999999999999 99999999999999999
Q ss_pred CCcEEeeccccccCCCCC-cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999997653322 112233446778999999998889999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=273.76 Aligned_cols=202 Identities=32% Similarity=0.527 Sum_probs=175.1
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..++|.+.+.||+|+||.||+|...+++.+|+|.+...... .+++.+|++.+++++|+||+++++++......++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678889999999999999999888889999998754432 456889999999999999999999999889999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++.. ....+++..+..++.|++.|++|||++ +++|+||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999632 235689999999999999999999999 999999999999999999999999999876643
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..........++..|+|||.+.+..++.++||||+|+++|||++ |+.||.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 206 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 22222222335568999999999889999999999999999999 999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=272.53 Aligned_cols=193 Identities=30% Similarity=0.452 Sum_probs=165.0
Q ss_pred eeccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 417 LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.||+|+||.||+|.+. +++.+|+|+++.........+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 5788999998766555556678999999999999999999999875 45678999999999
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccc
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 573 (618)
+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999986 234689999999999999999999998 999999999999999999999999999976643332211
Q ss_pred --cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 574 --TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 574 --~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....++..|+|||.+....++.++|||||||++|||++ |+.||+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 200 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 12234578999999988889999999999999999998 999996
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=276.31 Aligned_cols=200 Identities=28% Similarity=0.420 Sum_probs=166.8
Q ss_pred cCCcccceeccCccceEEEEEEc-CCc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.+|+..+.||+|+||.||+|.+. +|+ .+++|.+.... ......++..|+..++++.||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46778889999999999999874 344 47778775432 23344677788888999999999999998754 4678
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+++||+++|+|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 89999999999999963 235689999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
...... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 543322 12233457788999999999999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=277.45 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=172.1
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|++|.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788889999999999999876 58999999987544333344567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|++++.|..+.+ ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887764 344689999999999999999999998 9999999999999999999999999999766543
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 32 1223457889999999876 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=274.95 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=176.5
Q ss_pred cCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.+|+..+.||+|++|.||+|.. .+++.+++|.+..... ......++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577888999999999999986 4789999998865332 3334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++........+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875444456789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 322 1223468899999999998889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.50 Aligned_cols=198 Identities=23% Similarity=0.355 Sum_probs=160.0
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC------CCCcccccceEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL------RHPNIVTLAGYC 477 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~ 477 (618)
+....++|++.+.||+|+||.||+|... .++.||||+++... .....+..|+++++.+ .|.+++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3445678999999999999999999765 47889999986432 1223344455555544 455688888888
Q ss_pred eeC-CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeeecCCC---
Q 007103 478 AEH-GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDEL--- 552 (618)
Q Consensus 478 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~--- 552 (618)
... +..++|||++ +++|.+++. ..+.+++..+..++.||+.||+|||+ . +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 764 5788999988 568888875 23578999999999999999999997 5 899999999999998765
Q ss_pred -------------CcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 553 -------------NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 553 -------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 49999999875432 12234689999999999999999999999999999999999999996
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=277.30 Aligned_cols=201 Identities=26% Similarity=0.401 Sum_probs=170.4
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||+|... +++.||+|+++...........+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999875 589999999875443333446778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
++ ++|.++++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58888886432 235689999999999999999999999 99999999999999999999999999987553322
Q ss_pred cccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......+++.|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1 12234678899999988754 47889999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=273.69 Aligned_cols=199 Identities=29% Similarity=0.412 Sum_probs=170.8
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 457889999999999999999864 688999999864432 23456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 86 EYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 9999999999886 235688999999999999999999998 999999999999999999999999999976542
Q ss_pred CCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .......|++.|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 159 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 159 TI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 22 1123356889999999985 3447889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=250.50 Aligned_cols=207 Identities=26% Similarity=0.392 Sum_probs=175.2
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhh-cCCCCcccccceEEeeCCe
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMS-RLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~ 482 (618)
++...++......||+|++|.|-+.++. +|+.+|+|++.... ..++.++++.|+.+.. ...+|.+|.++|.....+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 5566677777888999999999888664 69999999998654 3456677777777654 4579999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++.||.|.. +|..+.+..-..++.+++..+-+|+..+.+||+|||++. .+||||+||+|||++.+|++||+|||.+
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999975 888888766667888999999999999999999999985 8999999999999999999999999998
Q ss_pred ccCCCCCcccccceeccccccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALS----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....+.- ..+...|...|||||.+.. ..|+-|+||||||+.+.||.+++.||+
T Consensus 197 G~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 197 GYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred eeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 7654321 1222467888999999853 368999999999999999999999986
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=270.81 Aligned_cols=201 Identities=24% Similarity=0.401 Sum_probs=177.0
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|+||.||.++.. +++.+++|.+.....+....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778889999999999999754 588999999876655556677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999998632 245689999999999999999999998 99999999999999999999999999987664433
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 2 2234578999999999998889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=278.78 Aligned_cols=198 Identities=26% Similarity=0.417 Sum_probs=172.6
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|+||.||++... +++.+|+|.++... ......++.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888899999999999999765 57889999886432 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++. ...+++..+..++.|+++||+|||+.+ +++||||||+||++++++.+||+|||++......
T Consensus 80 y~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 80 HMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999999963 356889999999999999999999742 8999999999999999999999999998654322
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 1234578899999999988889999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=283.22 Aligned_cols=205 Identities=29% Similarity=0.471 Sum_probs=177.8
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcC---Cc--EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN---GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~---g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
.+.........++||+|.||.||+|.+.+ |+ .||||..+... .....+.|+.|..+|+.++||||++++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34445556677889999999999997643 33 48888887654 44557889999999999999999999999975
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
. ..|+|||.++.|.|..+++. +...++......++.||+.||+|||+. ++|||||..+|||+....-||++||
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred c-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 4 78999999999999999974 456788899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+++.+.++..+......-+..|||||.+.-++++.++|||-|||.|||++. |..||.
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 9999987766555554556779999999999999999999999999999887 999996
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=277.91 Aligned_cols=202 Identities=31% Similarity=0.484 Sum_probs=167.8
Q ss_pred cCCcccceeccCccceEEEEEEcC-Cc--EEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
++|+..+.||+|+||.||+|...+ +. .+++|.++... .....+.+.+|++++.++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578888999999999999998754 33 46888876432 334456788999999998 79999999999999999999
Q ss_pred EEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC
Q 007103 486 VYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 553 (618)
|+||+++++|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999964321 123588999999999999999999998 9999999999999999999
Q ss_pred cEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 158 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred EEECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999864321111 111223557999999998889999999999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.11 Aligned_cols=206 Identities=25% Similarity=0.409 Sum_probs=174.7
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-CC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 481 (618)
..++|...+.||+|+||.||+|.+.+ +..|++|++.... .......+.+|+.++++++||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 35678888999999999999998766 7889999887443 44456778899999999999999999998776 46
Q ss_pred eEEEEEEecCCCChhhhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEe
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDS----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 557 (618)
..++++||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998654322 25689999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 558 DCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 99999765433221 1222346778999999998889999999999999999999 999996
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=276.80 Aligned_cols=204 Identities=26% Similarity=0.480 Sum_probs=172.5
Q ss_pred hcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
..+|...+.||+|+||.||+|+.. ++..+++|.+.... ....+.+.+|++.+++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 346778889999999999999743 35678999886443 3345678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC
Q 007103 483 RLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD 550 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~ 550 (618)
.++||||+++++|.++++.... ....+++..++.++.|++.|++|||++ +|+||||||+||++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 9999999999999999964321 224589999999999999999999999 9999999999999999
Q ss_pred CCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 551 ELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 551 ~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999975543221 11223456788999999999999999999999999999999 999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=279.74 Aligned_cols=203 Identities=29% Similarity=0.476 Sum_probs=168.9
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCc--EEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
.++|+..+.||+|+||.||+|.+. ++. .+++|.++... .......+.+|++++.++ +||||+++++++...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 457888899999999999999875 344 45777765432 334567788999999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 485 LVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
+||||+++++|.++++.... ....+++.+++.++.|++.||+|||++ +|+||||||+|||+++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 99999999999999974321 123588999999999999999999999 999999999999999999
Q ss_pred CcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 162 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred cEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 99999999986332111 1111234668999999988889999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=282.18 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=166.2
Q ss_pred ccceeccC--ccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 414 QEFLIGEG--SLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 414 ~~~~Lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
..++||+| +|++||++... +|+.||+|++............+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34679999 68899999764 6899999999765544445567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998632 234589999999999999999999998 999999999999999999999999986543221111
Q ss_pred ------ccccceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 ------QVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 ------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 01122356778999999976 458999999999999999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=272.37 Aligned_cols=199 Identities=31% Similarity=0.541 Sum_probs=169.6
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
++|...+.||+|++|.||+|...++..+|+|++..... ..+.+.+|++++++++|||++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 46788889999999999999988777899998865432 2456888999999999999999998875 4568899999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999632 234578999999999999999999999 99999999999999999999999999997654332
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........++..|+|||...+..++.++||||||+++|||+| |+.||.
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 222223346778999999998899999999999999999999 999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=273.23 Aligned_cols=200 Identities=27% Similarity=0.410 Sum_probs=172.7
Q ss_pred CCcccceeccCccceEEEEEEcCCcEEEEEEcCcccc----cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL----SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
+|...+.||+|+||.||+|...+|+.+|+|.+..... .......+.+|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999888899999998864432 122345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999862 34678999999999999999999998 99999999999999999999999999987542
Q ss_pred CCC-----cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTE-----RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ........|+..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 111 111223568899999999999889999999999999999999999995
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=276.64 Aligned_cols=211 Identities=26% Similarity=0.369 Sum_probs=175.7
Q ss_pred eehhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
..+..+..+.++|+..+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 455667778899999999999999999999775 57899999876432 1235677888988888 699999999987
Q ss_pred e-----eCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 478 A-----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 478 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
. ..+..++||||+++++|.++++........+++..+..++.|++.||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4 34568999999999999998864333456788999999999999999999998 999999999999999999
Q ss_pred CcEEeeccccccCCCCCcccccceeccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+||+|||++....... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||.
T Consensus 162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 162 GVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred CEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 99999999987654322 12223468999999999853 447889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.45 Aligned_cols=193 Identities=23% Similarity=0.304 Sum_probs=165.9
Q ss_pred hcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
...|.+.+.||+|+||.||+|.+.. ++.||+|... ...+.+|++++++++|+||+++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999998764 7889999643 223567999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
|++. ++|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 240 e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 240 PKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9995 688888752 234689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 568 TER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 568 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
... .......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 221 1223457999999999999999999999999999999999987653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=272.23 Aligned_cols=201 Identities=26% Similarity=0.354 Sum_probs=169.8
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc---cHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQR 483 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 483 (618)
.+|+..+.||+|+||.||+|... +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 489999998753321 223456788899999999999999999988764 467
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++++|.+++.. ...+++..+.+++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999998862 34578888999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 54322111 1123468899999999988889999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=273.38 Aligned_cols=202 Identities=28% Similarity=0.477 Sum_probs=167.7
Q ss_pred cccceeccCccceEEEEEEcCC-c--EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------CeE
Q 007103 413 SQEFLIGEGSLGRVYRAEFANG-K--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQR 483 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~~g-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 483 (618)
.+.+.||+|+||.||+|.+.+. . .+|+|.++.........+.+.+|++.++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999987653 2 589999876655555677889999999999999999999987532 246
Q ss_pred EEEEEecCCCChhhhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 484 LLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
+++|||+++|+|.+++...+ .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874322 2234589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 562 AALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 216 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 98664332211 122346778999999999999999999999999999999 899985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=277.91 Aligned_cols=208 Identities=29% Similarity=0.490 Sum_probs=175.0
Q ss_pred hhhhcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEe
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (618)
....++|+..+.||+|+||.||++...+ ...+|+|.+.... ..+....+.+|++++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3455678888999999999999997642 3679999987543 334456788999999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Ni 546 (618)
.++..+++|||+++|+|.++++... .....+++..+++++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999986422 2345789999999999999999999998 999999999999
Q ss_pred eecCCCCcEEeeccccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 547 LLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 547 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 99999999999999998664332211 122235678999999998899999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=277.44 Aligned_cols=199 Identities=27% Similarity=0.431 Sum_probs=173.6
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+|+..+.||+|++|.||+|... +++.+++|.+...... ....+.+|+++++.++|+||+++++.+......++|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4467888899999999999999764 5889999988754422 356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred ecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999999885 24578899999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 168 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~ 217 (296)
T cd06654 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (296)
T ss_pred cccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 3221 1223468899999999998889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=275.61 Aligned_cols=206 Identities=26% Similarity=0.407 Sum_probs=173.9
Q ss_pred hhcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
..++|...+.||+|+||.||+|...+ +..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 34678888999999999999997643 4689999986543 3344567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcE
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDS------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 555 (618)
..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999998643221 23478899999999999999999998 999999999999999999999
Q ss_pred EeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 556 LSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 556 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 9999998765433221 1223456789999999998889999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=263.35 Aligned_cols=194 Identities=26% Similarity=0.411 Sum_probs=164.2
Q ss_pred cceeccCccceEEEEE-EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEEecCC
Q 007103 415 EFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
.++||+|+|+.|--+. +..|.+||||++.+.. .....+..+|++++.+. .|+||++++++|+++...|||||.|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 3579999999999884 5679999999998764 33567788999999888 599999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC---cEEeeccccccCCCCC
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGLAALTPNTE 569 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfgl~~~~~~~~ 569 (618)
|+|..+++ ....+++.++.++.++|+.||.|||.+ ||.||||||+|||-....+ +||+||.++.-.....
T Consensus 161 GplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 161 GPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred chHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 99999997 456789999999999999999999999 9999999999999975544 7999998875432111
Q ss_pred c--cc----ccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 R--QV----STQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~--~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .. -...+|+..|||||+.. ...|+.+.|.||||||+|-|+.|.+||.
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 1 11 12357899999999874 3458899999999999999999999995
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=284.05 Aligned_cols=204 Identities=25% Similarity=0.462 Sum_probs=177.8
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
++-...+....+.||-|.||.||.|.|+. .-.||||.++.. ..+..+|+.|..+|+.++|||+|+++|+|..+...
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 34445566677899999999999999975 567999999754 34578899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
|||+|||..|+|.++++.+. ...++.-..+.++.||..|++||..+ ++|||||.++|+|+.++..|||+|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999998653 45677778889999999999999999 99999999999999999999999999999
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPL 616 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf 616 (618)
.+..+......+.--.+.|.|||.+....++.|+|||+|||+|||+.| |-.||
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY 467 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 467 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC
Confidence 987654433334445678999999999999999999999999999998 66665
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=272.71 Aligned_cols=201 Identities=28% Similarity=0.466 Sum_probs=170.9
Q ss_pred cCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
.+|.+.+.||+|+||.||+|.+. .+..+|+|.++... .....+.+.+|+..+++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778889999999999999764 23479999987543 23445688999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.++++. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999863 235689999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCccccc--ceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 566 PNTERQVST--QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 443322211 1233568999999999899999999999999999887 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=271.07 Aligned_cols=199 Identities=29% Similarity=0.523 Sum_probs=171.9
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+...... ...+.+|++++++++|||++++++++......++|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 467778899999999999998877889999998754433 45688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 81 MEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999998863 234688999999999999999999999 99999999999999999999999999987554322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........++.+|+|||.+.+..++.++||||||+++|||++ |+.||+
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 222222345678999999998899999999999999999998 999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=274.60 Aligned_cols=206 Identities=29% Similarity=0.439 Sum_probs=171.2
Q ss_pred hhcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
..++|...+.||+|++|.||+|.+.+ +..|++|.+.... .......+..|+.++++++|+||+++++++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 34678888999999999999998754 5678999876433 3344567899999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC---CcE
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPH 555 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~k 555 (618)
..++||||+++++|.++++..+. ....+++..+.+++.||+.||+|||+. +++||||||+||++++++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 99999999999999999975432 123589999999999999999999999 999999999999998654 589
Q ss_pred EeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 556 LSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 556 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999765322111 1112234568999999999999999999999999999997 999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=270.27 Aligned_cols=192 Identities=25% Similarity=0.424 Sum_probs=162.2
Q ss_pred eccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCC
Q 007103 418 IGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGN 494 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 494 (618)
||+|+||.||+|.+. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 899999999999764 35679999987543 3344567899999999999999999999875 457899999999999
Q ss_pred hhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccc-
Q 007103 495 LHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS- 573 (618)
Q Consensus 495 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~- 573 (618)
|.++++. ....+++..+.+++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999863 245689999999999999999999998 999999999999999999999999999975543322211
Q ss_pred -cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 574 -TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 574 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 11234578999999988889999999999999999996 999996
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=244.09 Aligned_cols=197 Identities=25% Similarity=0.381 Sum_probs=172.9
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|...+.||+|.||+||+|+.. .++.||+|++.............++|+.+++.++|.|||+++++.+.+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4677889999999999999765 489999999987766666677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
|.. +|..+.. .-.+.++...+..++.|+++||.|+|++ ++.||||||.|.||+.+|++|++|||+++-+.-..
T Consensus 83 cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 976 7776664 4567899999999999999999999999 99999999999999999999999999998776555
Q ss_pred cccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKP 615 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~P 615 (618)
..++. .+-|..|++|.++.+.+ |+...|+||-|||+.|+.....|
T Consensus 156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 44433 45689999999999876 89999999999999999985554
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=272.38 Aligned_cols=197 Identities=29% Similarity=0.393 Sum_probs=163.1
Q ss_pred eeccCccceEEEEEEcC---CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 417 LIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.||+|+||.||+|.+.+ +..+|+|+++... .......+.+|+..+++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997653 4578999887554 2344567889999999999999999999999989999999999999
Q ss_pred ChhhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 494 NLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 494 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
+|.++++..+. .....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999974332 223567778889999999999999999 99999999999999999999999999986543322111
Q ss_pred -ccceeccccccCccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 573 -STQMVGAFGYSAPEFALSG-------IYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 573 -~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 211 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 1234577889999998642 35789999999999999996 999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=273.16 Aligned_cols=197 Identities=28% Similarity=0.385 Sum_probs=161.0
Q ss_pred eeccCccceEEEEEEcC---CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 417 LIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.||+|+||.||+|...+ ...+++|.+.... .......+.+|++.++.++||||+++++.+...+..++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 3568888876433 3445567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc-
Q 007103 494 NLHDMLHFADDS-SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ- 571 (618)
Q Consensus 494 sL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 571 (618)
+|.++++..... ....++.....++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999754322 23456788899999999999999999 9999999999999999999999999998654322111
Q ss_pred cccceeccccccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 572 VSTQMVGAFGYSAPEFALS-------GIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......++..|+|||++.. ..++.++|||||||++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 1123356778999998753 356889999999999999999 888885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=275.61 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=171.7
Q ss_pred hhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
...++|++.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+..+++++||||+++++++.+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34578899999999999999999654 24579999886543 233445688899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDS------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
+..++||||+++|+|.++++..... ....++..+.+++.|++.||+|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999743211 23456778899999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 555 HLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999987553322211 122345678999999999899999999999999999998 788885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=271.32 Aligned_cols=201 Identities=26% Similarity=0.377 Sum_probs=170.3
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc---cHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCeE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQR 483 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 483 (618)
.+|+..+.||+|+||.||+|... .++.|++|++..... ..+....+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999775 588999998864432 22344678899999999999999999998875 3577
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++++||+++++|.+++. ....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999986 234588999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCC--cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTE--RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 553211 111123458899999999999889999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=270.59 Aligned_cols=200 Identities=26% Similarity=0.407 Sum_probs=173.5
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|+||.||++... +++.+|+|.++... .....+.+.+|+.+++.++|+||+++++.+.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4777889999999999999775 58899999986443 233456788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 80 CDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999999988632 245678999999999999999999999 99999999999999999999999999987654322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||+
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence 2 2233568899999999999889999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=277.91 Aligned_cols=207 Identities=29% Similarity=0.485 Sum_probs=173.4
Q ss_pred hhhcCCcccceeccCccceEEEEEEc--------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
....+|.+.+.||+|+||.||+|++. ++..||+|.+.... .....+.+.+|+..++.+ +||||+++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 44567888899999999999999642 24579999887543 334557788999999999 899999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 545 (618)
...+..++||||+++|+|.+++...+. ....+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999975321 124578889999999999999999999 99999999999
Q ss_pred eeecCCCCcEEeeccccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 546 ILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 546 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|++++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999997664332221 122345678999999999899999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=270.61 Aligned_cols=201 Identities=26% Similarity=0.464 Sum_probs=172.6
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..++|...+.||+|+||.||+|...++..+++|.++... ...+.+.+|++++++++|+||+++++++.. ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 456788899999999999999998888889999887432 235678899999999999999999999877 7789999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999632 245678889999999999999999998 999999999999999999999999999876543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..........++..|+|||++....++.++|+|||||++||++| |+.||.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 32222223345678999999998889999999999999999999 999985
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=273.88 Aligned_cols=201 Identities=26% Similarity=0.437 Sum_probs=168.7
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|+..+.||+|+||.||+|.+. +|+ .||+|.++... .......+.+|+..++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 356788899999999999999754 444 48999886543 33445678899999999999999999999875 457
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++++||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 84 ~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 899999999999999863 245689999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 664332221 122345678999999999899999999999999999998 999986
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=273.78 Aligned_cols=202 Identities=28% Similarity=0.478 Sum_probs=170.0
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeC----
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH---- 480 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---- 480 (618)
.+.+.|+..+.||+|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45667888899999999999999775 48889999986443 2345678889998888 699999999998753
Q ss_pred --CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 481 --GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 481 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
...++||||+++++|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 4589999999999999998742 234688999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||+
T Consensus 155 fg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 155 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred CCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999876543221 223457899999999986 3457889999999999999999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=270.11 Aligned_cols=198 Identities=28% Similarity=0.488 Sum_probs=175.2
Q ss_pred hcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|...+ ++.+++|.+.... ..+++.+|++.+++++||||+++++++......++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 4678889999999999999998875 7899999986432 2678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++. ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999863 245689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~ 200 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS 200 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 321 2233458889999999999899999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=269.97 Aligned_cols=200 Identities=30% Similarity=0.471 Sum_probs=175.4
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|...+.||+|+||.||+|... +++.+++|.++.........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999765 689999999886655545678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++ ....+++..+..++.|+++||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999986 234578899999999999999999999 99999999999999999999999999987665433
Q ss_pred ccccc---ceeccccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVST---QMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ...++..|+|||++.+.. ++.++||||||+++|||++|+.||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~ 207 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 22211 346788999999998766 8899999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=286.80 Aligned_cols=208 Identities=28% Similarity=0.446 Sum_probs=172.9
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEe
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCA 478 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 478 (618)
+...++|...+.||+|+||.||+|.+. .++.||+|+++.... ....+.+.+|++++.++. ||||+++++++.
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 334556888899999999999999864 246899999976532 233457889999999997 999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccC------------------------------------------------------
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------------------------------------------------ 504 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 504 (618)
..+..++||||+++|+|.++++..+.
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999974321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 505 ----------------------------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 505 ----------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
....+++..+.+++.|++.||+|||+. +|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112367788899999999999999998 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999976532221 11123457789999999998889999999999999999998 899985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=275.23 Aligned_cols=203 Identities=29% Similarity=0.483 Sum_probs=170.0
Q ss_pred CCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
+|+..+.||+|+||.||+|... ....+++|.+.... ......++.+|+..++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3667789999999999999753 23578888887543 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 485 LVYEYVGNGNLHDMLHFADD--------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
+++||+.+++|.+++...+. ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 99999999999999864321 123578999999999999999999998 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999997653322211 122345678999999988889999999999999999999 999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=276.47 Aligned_cols=200 Identities=26% Similarity=0.407 Sum_probs=172.5
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999886 48999999987654443445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++.+ ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988765 234589999999999999999999999 9999999999999999999999999998765433
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 32 2233568899999999876 447889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=274.30 Aligned_cols=202 Identities=30% Similarity=0.435 Sum_probs=167.2
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHH-hhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+|... +|+.||+|+++....... ...+..|+.. ++..+||||+++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36888899999999999999876 599999999876543332 3445555554 56678999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||++ |+|.++++........+++..++.++.|++.||+|||++. +++||||||+||++++++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9997 6888888654444567899999999999999999999853 799999999999999999999999999876533
Q ss_pred CCcccccceeccccccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALS----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||+
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence 21 1223468889999998865 446889999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=281.25 Aligned_cols=196 Identities=27% Similarity=0.425 Sum_probs=174.7
Q ss_pred cceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.++||+|.||+||-|.++ .|+.||||++.+-......+.++++|+.+++.+.||.||.+--.|++.+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 568999999999999764 699999999998888777789999999999999999999999999999999999999976
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC---CCcEEeeccccccCCCCCc
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfgl~~~~~~~~~ 570 (618)
++.+.+-. .+.+++++.....++.||+.||+|||-+ +|+|+||||+|||+.+. -.+||+|||+|+...+ .
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--k 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--K 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--h
Confidence 55454432 3567889888888999999999999999 99999999999999743 4689999999998864 4
Q ss_pred ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
..+..++|||.|+|||++....|...-|+||+|||+|-=++|..||++
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 455678999999999999999999999999999999999999999974
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=278.52 Aligned_cols=206 Identities=29% Similarity=0.478 Sum_probs=171.7
Q ss_pred hhcCCcccceeccCccceEEEEEEcC--------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (618)
..++|.+.+.||+|+||.||+|...+ +..+|+|.++... .......+.+|+++++++ +||||+++++++.
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34678899999999999999997532 3579999997543 334456788899999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Ni 546 (618)
..+..++||||+++|+|.++++.... ....+++.++.+++.|++.||+|||+. +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999975332 123588999999999999999999998 999999999999
Q ss_pred eecCCCCcEEeeccccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 547 LLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 547 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++++++.+||+|||.++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999987654322111 111234568999999999999999999999999999998 888885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=279.70 Aligned_cols=194 Identities=26% Similarity=0.450 Sum_probs=159.1
Q ss_pred ceeccCccceEEEEEEcC---CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCeEEEEEEec
Q 007103 416 FLIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVYEYV 490 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 490 (618)
..||+|+||.||+|...+ ++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++|+||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 479999999999998653 57899998865432 2456789999999999999999998854 45789999998
Q ss_pred CCCChhhhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----cCCCCcEEeeccc
Q 007103 491 GNGNLHDMLHFADD-----SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCGL 561 (618)
Q Consensus 491 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfgl 561 (618)
++ +|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 78777753221 223588999999999999999999999 99999999999999 4667899999999
Q ss_pred cccCCCCCcc--cccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQ--VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 9866433221 1234578999999999976 457999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=275.20 Aligned_cols=200 Identities=29% Similarity=0.397 Sum_probs=174.7
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||+|... +++.|++|+++.........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888899999999999999876 488999999876554444567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
++++.+..+.+ ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99877766554 345589999999999999999999999 99999999999999999999999999997765444
Q ss_pred cccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3233345788999999999888 78999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=273.03 Aligned_cols=198 Identities=27% Similarity=0.429 Sum_probs=169.3
Q ss_pred CCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
.|+..+.||+|+||.||+|.... +..+++|.+.... ......+.+|+++++.++||||+++++++...+..++|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 36677889999999999998764 7788999886433 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 84 CAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred cCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999988752 235689999999999999999999999 99999999999999999999999999986553322
Q ss_pred cccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......+++.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 158 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred c-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 1 223356899999999984 3457889999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=272.92 Aligned_cols=199 Identities=29% Similarity=0.425 Sum_probs=171.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 357788889999999999999765 58899999986543 223456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++ ..+.+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 86 EFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred eccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999999886 345789999999999999999999999 999999999999999999999999999865532
Q ss_pred CCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .......|+..|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 159 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 21 1223457899999999985 4558899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=268.63 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=173.6
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-CCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 488 (618)
.|+..+.||+|++|.||++... +++.+|+|++..........+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999765 47889999997655555566778899999999999999999988764 446799999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++.. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999988632 234689999999999999999999999 9999999999999999999999999999766433
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......+++.|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 22 2234568899999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=277.28 Aligned_cols=199 Identities=25% Similarity=0.401 Sum_probs=168.3
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|...+.||+|+||.||+|... +++.||+|.++..... .....+.+|+..+++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 56888899999999999999775 5889999998644322 223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 85 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 588888753 234688999999999999999999999 9999999999999999999999999998754322
Q ss_pred CcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....+++.|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 211 1234578899999998764 47889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=270.43 Aligned_cols=200 Identities=29% Similarity=0.472 Sum_probs=170.9
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH-------HHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-------QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
+|.....||+|++|.||+|... +++.+|+|.+....... +..+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667788999999999999765 58899999886543221 123568889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++|+||+++++|.++++. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999963 35688899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc-----ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTER-----QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+....... .......|+..|+|||.+.+..++.++||||+||++|||++|+.||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 76542111 11123458889999999999889999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=269.25 Aligned_cols=200 Identities=30% Similarity=0.451 Sum_probs=174.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|... +++.+++|.+...... ..+.+.+|++++++++||||+++++++...+..+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 357888899999999999999875 4788999998754322 4577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 80 EYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred eCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999998863 235689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcccccceeccccccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSG---IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||.
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 221 12335688899999999877 78999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=277.18 Aligned_cols=203 Identities=28% Similarity=0.402 Sum_probs=174.6
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccH-HHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|++|.||+|...+ ++.||+|.+....... ...+.+.+|++.++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888899999999999998764 8999999997654332 35567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+.+++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998632 345789999999999999999999999 999999999999999999999999999865432
Q ss_pred CCc----------------------------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TER----------------------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 111 01113468899999999999889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=273.60 Aligned_cols=197 Identities=28% Similarity=0.443 Sum_probs=166.7
Q ss_pred CcccceeccCccceEEEEEE-----cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (618)
|...+.||+|+||.||++.. .+++.||+|.++... .......+.+|++.+++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 47788999999999988643 357889999987543 233456788999999999999999999988654 4678
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 85 LIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999985 24589999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCccc--ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ .....++..|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 211 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCC
Confidence 65332211 122345667999999998899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=271.09 Aligned_cols=201 Identities=28% Similarity=0.500 Sum_probs=169.6
Q ss_pred cCCcccceeccCccceEEEEEEcC-C---cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
.+|+..+.||+|+||.||+|.... + ..||+|.++... ......+|..|+..+++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 357778899999999999998753 3 369999987543 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.++++. ..+.+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 83 ITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999863 235689999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccc--ccce--eccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 566 PNTERQV--STQM--VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 566 ~~~~~~~--~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....... .... ..+..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~ 213 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence 4322211 1111 12457999999999999999999999999999887 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.90 Aligned_cols=206 Identities=17% Similarity=0.238 Sum_probs=162.4
Q ss_pred hhhhcCCcccceeccCccceEEEEEEcC--CcEEEEEEc---------------CcccccHHHHHHHHHHHHHhhcCCCC
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKI---------------DNAALSLQEEDNFLEAVSNMSRLRHP 468 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~--g~~vavK~~---------------~~~~~~~~~~~~~~~e~~~l~~l~h~ 468 (618)
.....+|++.+.||+|+||.||++.+.. +...+.|.+ +...........+.+|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456789999999999999999986542 222222211 00011222345688999999999999
Q ss_pred cccccceEEeeCCeEEEEEEecCCCChhhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 007103 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (618)
Q Consensus 469 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 547 (618)
||+++++++...+..++|+|++.+ +|.+++..... .........+..++.|++.||+|||++ +|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 999999999999999999999864 77776642211 122334566788999999999999999 9999999999999
Q ss_pred ecCCCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 007103 548 LDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615 (618)
Q Consensus 548 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P 615 (618)
++.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999987654443334456799999999999999999999999999999999998754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=273.06 Aligned_cols=199 Identities=26% Similarity=0.441 Sum_probs=171.0
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
+.|+..+.||+|+||.||+|.... ++.+++|.+... .....+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 568888999999999999998764 889999998644 34456778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|..++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999888753 235689999999999999999999998 9999999999999999999999999998654322
Q ss_pred CcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .......+++.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 1 1123456889999999985 3457889999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=274.31 Aligned_cols=203 Identities=26% Similarity=0.452 Sum_probs=169.7
Q ss_pred CCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
+|...+.||+|+||.||+|...+ ++.||+|+++... .......+.+|+.++..++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 46677789999999999997642 5789999997543 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 485 LVYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985211 1123578889999999999999999999 999999999999999999
Q ss_pred CcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 553 NPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999876543221 11223346788999999998889999999999999999998 888885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=273.59 Aligned_cols=211 Identities=28% Similarity=0.413 Sum_probs=176.0
Q ss_pred eehhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
+++..+..+.++|...+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 455666777889999999999999999999775 58899999986432 1235567888888888 799999999998
Q ss_pred eeC-----CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 478 AEH-----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 478 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
... +..++|+||+++++|.++++........+++..++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 754 358999999999999998864433456789999999999999999999998 999999999999999999
Q ss_pred CcEEeeccccccCCCCCcccccceeccccccCccccccCC-----CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-----YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+||+|||++........ ......|+..|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 999999999876543221 122346889999999986433 6889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=275.75 Aligned_cols=205 Identities=28% Similarity=0.433 Sum_probs=173.3
Q ss_pred hhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
...++|...+.||+|+||.||+|... .+..+|+|.++... .....+.+.+|+++++++ +||||+++++++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 34567888999999999999999642 35579999987543 233456789999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
.+..++||||+.+|+|.++++.. ....+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+|++||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999998632 223489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 560 GLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|++......... ......++..|+|||.+.+..++.++||||+||++|||++ |+.||.
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~ 245 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence 999765433221 1222346778999999999999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=274.82 Aligned_cols=205 Identities=26% Similarity=0.452 Sum_probs=170.9
Q ss_pred hcCCcccceeccCccceEEEEEEc-----------------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCccc
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-----------------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (618)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.... ......++.+|++.++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 467889999999999999998543 23468999987543 334457889999999999999999
Q ss_pred ccceEEeeCCeEEEEEEecCCCChhhhhhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDS-------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
++++++...+..++||||+++++|.+++...... ...+++.++..++.|++.||+|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 9999999999999999999999999998643211 13477889999999999999999999 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~Pf~ 617 (618)
||++++++.++|+|||+++........ ......+++.|+|||...++.++.++|||||||++|||++ |..||.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999998765332211 1122344678999999988889999999999999999998 778885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=268.06 Aligned_cols=198 Identities=29% Similarity=0.428 Sum_probs=172.3
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc---cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
+|+..+.||+|++|.||+|... +++.|++|.+..... ..+..+.+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999876 789999998864332 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+||+++++|.++++. ...+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999862 34688999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~ 203 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 332 223456889999999998776 8999999999999999999999995
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=274.27 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=173.8
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+|+..+.||.|++|.||+|.. .+|+.|++|.+..... ...+.+.+|++.++.++||||+++++++...+..++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 345688889999999999999975 4689999999865432 2356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+||+++++|.+++. ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||++....
T Consensus 95 ~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 95 MEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 99999999999885 34589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred cccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3222 2233468899999999999889999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=272.93 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=173.3
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||+|... +|+.|++|++............+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999875 689999999876554444567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+ +++|.++++.. ...+++..++.++.|+++||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998632 35689999999999999999999999 99999999999999999999999999997765433
Q ss_pred cccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........|+..|+|||++.+. .++.++||||+|+++|||+||++||.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 2222345689999999998764 46899999999999999999988874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=268.49 Aligned_cols=195 Identities=29% Similarity=0.457 Sum_probs=168.0
Q ss_pred ceeccCccceEEEEEEcC--C--cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecC
Q 007103 416 FLIGEGSLGRVYRAEFAN--G--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
+.||+|++|.||+|.+.+ + ..+|+|.+...... ...+.+.+|+..+++++||||+++++++.. ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998753 3 36899999876544 567789999999999999999999999988 88999999999
Q ss_pred CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc
Q 007103 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (618)
Q Consensus 492 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 571 (618)
+++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 9999999874321 5689999999999999999999999 9999999999999999999999999999766443222
Q ss_pred c--ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 572 V--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 572 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
. .....++..|+|||++.+..++.++|||||||++|||++ |+.||+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 1 123457788999999999899999999999999999999 999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=275.01 Aligned_cols=206 Identities=26% Similarity=0.446 Sum_probs=171.0
Q ss_pred hhcCCcccceeccCccceEEEEEEcC---------------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccc
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN---------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 472 (618)
..++|+..+.||+|+||.||++...+ ...||+|.++... .......+.+|++.+++++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 34678889999999999999987642 2358999987543 3345567899999999999999999
Q ss_pred cceEEeeCCeEEEEEEecCCCChhhhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD--------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 473 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
+++++...+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 99999999999999999999999999864211 112468889999999999999999999 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~Pf~ 617 (618)
||++++++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||+
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 999999999999999998755332211 1122345678999999999999999999999999999998 677875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=275.02 Aligned_cols=199 Identities=27% Similarity=0.426 Sum_probs=174.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+|...+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 4567889999999999999999864 6999999998754322 346688899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 95 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred ecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999885 34578899999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 3222 2233468899999999999889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=272.26 Aligned_cols=204 Identities=28% Similarity=0.495 Sum_probs=171.3
Q ss_pred hcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
.++|...+.||+|+||.||++... ++..+++|.+.... ......+.+|++.+++++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 456778889999999999999642 35688999886443 3456689999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 483 RLLVYEYVGNGNLHDMLHFADD-----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
.+++|||+++++|.++++.... ....+++..+..++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 9999999999999999874321 113578999999999999999999999 99999999999999999
Q ss_pred CCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999875532221 11122345788999999999999999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=268.99 Aligned_cols=203 Identities=29% Similarity=0.424 Sum_probs=176.7
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCeEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLVY 487 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 487 (618)
+|+..+.||+|+||.||+|... +|+.+|+|.+..........+.+..|++.+++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999764 58899999987665566667788999999999999999999998754 45679999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-----EVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
||+++++|.++++........+++..++.++.|++.||+||| +. +++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765555678999999999999999999999 66 9999999999999999999999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ ......+++.|+|||++.+..++.++||||||+++|+|++|+.||+
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 211 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCccc
Confidence 87654332 1233568999999999999889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=275.83 Aligned_cols=198 Identities=24% Similarity=0.376 Sum_probs=167.8
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|+||.||+|... +|+.+|+|+++...........+.+|++.+++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999875 589999999875443333345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++ +|.+++.. ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 974 78777752 245689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf 616 (618)
.. .....+++.|+|||++.+.. ++.++|||||||++|||+||+.||
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 21 12346788999999987754 789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=272.93 Aligned_cols=200 Identities=28% Similarity=0.426 Sum_probs=172.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|++.+.||+|+||.||+|... +++.+|+|.+... .....+.+..|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 456888899999999999999875 5889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 82 EFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999863 235689999999999999999999999 999999999999999999999999999865433
Q ss_pred CCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~ 209 (280)
T cd06611 156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209 (280)
T ss_pred ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence 221 223457899999999985 3446789999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=267.86 Aligned_cols=198 Identities=33% Similarity=0.543 Sum_probs=171.9
Q ss_pred ceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecC
Q 007103 416 FLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
+.||+|+||.||+|.... +..+++|.++...... ..+.+.+|++.++.++|+||+++++++...+..++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 369999999999998764 7889999998655433 56788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 492 NGNLHDMLHFADDS-----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 492 ~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+++|.++++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999743211 36789999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 567 NTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 567 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.... .......++..|+|||.+....++.++||||+|+++|||++ |+.||+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 4321 11233467889999999998889999999999999999999 699986
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=268.31 Aligned_cols=201 Identities=27% Similarity=0.372 Sum_probs=170.6
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccc---ccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA---LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQR 483 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 483 (618)
.+|+..+.||+|+||.||+|... +|+.||+|.+.... ...+....+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999765 58999999875321 1234456788999999999999999999998764 468
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++++||+++++|.+++. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999886 234578899999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCc--ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTER--QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 6532111 11123568899999999998889999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=271.03 Aligned_cols=197 Identities=30% Similarity=0.450 Sum_probs=173.8
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||.|++|.||+|... +++.+|+|.+.... .......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 5778889999999999999876 58899999987543 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++. ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999862 3789999999999999999999998 99999999999999999999999999997765432
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......+++.|+|||.+.+..++.++||||||+++|||+||+.||+
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 1 2233568889999999999889999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=268.88 Aligned_cols=197 Identities=26% Similarity=0.396 Sum_probs=159.5
Q ss_pred eeccCccceEEEEEEcCC---cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 417 LIGEGSLGRVYRAEFANG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.||+|+||.||+|+..++ ..+++|.+.... .....+.+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999976543 345666665432 2345678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC-ccc
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQV 572 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 572 (618)
+|.++++.........++..+..++.|+++||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975433344567778889999999999999998 99999999999999999999999999985432111 111
Q ss_pred ccceeccccccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 573 STQMVGAFGYSAPEFALS-------GIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 223567889999999853 245789999999999999997 577875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=276.31 Aligned_cols=207 Identities=28% Similarity=0.487 Sum_probs=171.8
Q ss_pred hhhcCCcccceeccCccceEEEEEEc--------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
....+|.+.+.||+|+||.||+|... .+..+|+|.++... .......+..|+++++++ +||||+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34567888899999999999999652 24578999987543 334466788999999999 699999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 545 (618)
...+..++||||+++|+|.++++.... ....+++.++.+++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 999999999999999999999965321 124588999999999999999999998 99999999999
Q ss_pred eeecCCCCcEEeeccccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 546 ILLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 546 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 999999999999999997654322111 111234467999999999899999999999999999999 899885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=272.20 Aligned_cols=200 Identities=26% Similarity=0.424 Sum_probs=170.4
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|+||.||++... +|+.||+|.++... .......+.+|++++++++||||+++++.+...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 5778889999999999999876 68999999886542 333456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++... ....+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999886321 2347899999999999999999999642 8999999999999999999999999998655322
Q ss_pred cccccceeccccccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGI------YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 122346788999999986543 5889999999999999999999995
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=269.50 Aligned_cols=202 Identities=27% Similarity=0.480 Sum_probs=170.7
Q ss_pred hcCCcccceeccCccceEEEEEEcC-C---cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|+..+.||+|+||.||+|.... + ..+++|.++... .....+.+..|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 3467788899999999999998753 3 378999886543 3334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++++|.++++. ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999863 235689999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccc--cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 543222111 11223457999999998889999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=281.54 Aligned_cols=190 Identities=21% Similarity=0.313 Sum_probs=162.8
Q ss_pred hcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
...|...+.||+|+||.||+|.... ++.||+|...... ...|+.++++++||||+++++++...+..++|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4579999999999999999998764 6789999754322 345888999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+. ++|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 588888753 345789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P 615 (618)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 21 12345799999999999999999999999999999999985544
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=274.18 Aligned_cols=201 Identities=26% Similarity=0.372 Sum_probs=171.2
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||++.... ++.|++|.+...... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 367888999999999999998764 789999998755322 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++. .+.+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999962 35689999999999999999999998 999999999999999999999999999863211
Q ss_pred CC--------------cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TE--------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 00 001112457889999999998889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=269.72 Aligned_cols=198 Identities=28% Similarity=0.397 Sum_probs=174.7
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
+|+..+.||.|+||.||+|... +++.||+|.+..... .....+.+.+|++.+++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999999999876 589999999875433 22456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+.+++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999862 35789999999999999999999998 9999999999999999999999999998765433
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||+
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 200 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCC
Confidence 2 1233568889999999998889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=268.22 Aligned_cols=203 Identities=29% Similarity=0.432 Sum_probs=175.4
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|+||+||+|... ++..+++|++....... ..+.+.+|++.++.++|+||+++++.+...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 46888899999999999999865 57889999987544333 56788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
++++++|.++++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999996422 124689999999999999999999998 9999999999999999999999999998765433
Q ss_pred Ccc---cccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQ---VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......|+..|+|||++... .++.++|+|||||++|||++|+.||+
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 222 22334688999999999877 78999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-33 Score=285.21 Aligned_cols=200 Identities=26% Similarity=0.448 Sum_probs=171.8
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEE-EEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~v-avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.+.|+++..||.|+||.||+|..++.... |.|++... +.++..+|+-|++++..+.||+||++++.|..++.+++..
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 44577888899999999999988765544 45555422 4556788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
|||+||....++- .-+..+.+.++..+++|++.||.|||++ +|||||||+.|||++-+|.++++|||.+.....
T Consensus 109 EFC~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 109 EFCGGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred eecCCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 9999999988775 2467899999999999999999999999 999999999999999999999999999854432
Q ss_pred CCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......++|||+|||||+.+ ...|+.++||||||+.|.||..+.+|-.
T Consensus 183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 223445789999999999875 4569999999999999999999999954
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=273.17 Aligned_cols=205 Identities=29% Similarity=0.465 Sum_probs=172.9
Q ss_pred hcCCcccceeccCccceEEEEEEcC-----------------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCccc
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-----------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (618)
..+|+..+.||+|+||.||+|...+ +..||+|.+.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4678889999999999999997653 2458999987543 234567889999999999999999
Q ss_pred ccceEEeeCCeEEEEEEecCCCChhhhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADD-------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
++++++..++..++|+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999874331 123689999999999999999999998 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT--GRKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~Pf~ 617 (618)
||++++++.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999999999999999875533221 12223456788999999998889999999999999999998 778875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=267.04 Aligned_cols=193 Identities=27% Similarity=0.424 Sum_probs=163.9
Q ss_pred ceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecC
Q 007103 416 FLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
+.||+|+||.||+|.+.. +..+|+|.+...... ...+++.+|+++++++.||||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 369999999999997543 268999999866543 45678899999999999999999999876 446799999999
Q ss_pred CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc
Q 007103 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (618)
Q Consensus 492 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 571 (618)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 79 LGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999963 34689999999999999999999998 9999999999999999999999999999766433322
Q ss_pred ccc--ceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 572 VST--QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 572 ~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~ 200 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence 211 1223567999999999999999999999999999998 999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=276.40 Aligned_cols=205 Identities=23% Similarity=0.310 Sum_probs=176.5
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (618)
+......|++.+.||+||.+.||++...+.+.||+|++.....+.+..+-|..|++.|.++ .|.+|+++++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3444567999999999999999999998899999999988888888899999999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
|+||||= ..+|..+++... ..+....++.+..||+.|+.++|+. ||||.||||.|+|+-.+ .+||+|||+|.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~ 507 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIAN 507 (677)
T ss_pred EEEeecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhc
Confidence 9999974 459999997432 2233237888999999999999999 99999999999999654 89999999998
Q ss_pred cCCCCC-cccccceeccccccCccccccCC-----------CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTE-RQVSTQMVGAFGYSAPEFALSGI-----------YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+..+. .......+||+.||+||.+.... .++++||||+|||+|+|+.|+.||.
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 776554 34456679999999999995332 5678999999999999999999996
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=268.87 Aligned_cols=201 Identities=28% Similarity=0.412 Sum_probs=168.6
Q ss_pred hcCCcccceeccCccceEEEEEEcCC----cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|...+.||+|+||.||+|.+.+. ..+++|...... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34577888999999999999976532 468899886543 23455688999999999999999999998875 4678
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 99999999999999963 234589999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.............++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 54432222222345568999999988889999999999999999996 999985
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=268.44 Aligned_cols=196 Identities=30% Similarity=0.496 Sum_probs=162.4
Q ss_pred ceeccCccceEEEEEEcC-Cc--EEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEEecC
Q 007103 416 FLIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
+.||+|+||.||+|...+ +. .+++|.++... .....+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998764 43 46888886432 334456788999999999 79999999999999999999999999
Q ss_pred CCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 492 NGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 492 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
+|+|.++++..+. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999864321 123578999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|++........ ......+..|+|||++....++.++|||||||++|||++ |+.||.
T Consensus 157 gl~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 157 GLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred CCccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99853321111 111234567999999988889999999999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=265.71 Aligned_cols=196 Identities=31% Similarity=0.522 Sum_probs=171.7
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 457888899999999999999875 78899999975542 46778999999999999999999999999899999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 81 YMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999998632 223689999999999999999999999 9999999999999999999999999999766322
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.. ...++..|+|||++....++.++||||||+++|||++ |+.||.
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence 21 2234567999999998899999999999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=278.76 Aligned_cols=206 Identities=27% Similarity=0.460 Sum_probs=169.0
Q ss_pred hhcCCcccceeccCccceEEEEEE------cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 480 (618)
..++|+..+.||+|+||.||+|.+ .+++.||||+++... .......+.+|++++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 456789999999999999999964 347889999997543 233456788999999999 689999999988654
Q ss_pred -CeEEEEEEecCCCChhhhhhcccC-------------------------------------------------------
Q 007103 481 -GQRLLVYEYVGNGNLHDMLHFADD------------------------------------------------------- 504 (618)
Q Consensus 481 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 504 (618)
...++||||+++|+|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999864221
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc-ccc
Q 007103 505 --------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQ 575 (618)
Q Consensus 505 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~ 575 (618)
....+++..+.+++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.......... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 012467888899999999999999999 99999999999999999999999999987653222211 122
Q ss_pred eeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 283 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 283 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 345678999999999999999999999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=269.06 Aligned_cols=198 Identities=26% Similarity=0.439 Sum_probs=172.9
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
..|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+++++++.||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 34667788999999999999875 58899999887543 23456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++ ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 83 YLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999885 24688889999999999999999998 9999999999999999999999999999765433
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......++..|+|||++.+..++.++|+|||||++|||+||+.||+
T Consensus 155 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 155 QI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 21 2233468889999999998889999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=267.90 Aligned_cols=200 Identities=26% Similarity=0.445 Sum_probs=171.4
Q ss_pred CCcccceeccCccceEEEEEE-cCCcEEEEEEcCccccc----HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS----LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
+|+..+.||+|++|.||+|.. .+++.+|+|.+...... ....+.+.+|++.+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999976 46899999998643321 2235678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEeecccccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~ 564 (618)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999863 34688999999999999999999999 999999999999998765 599999999876
Q ss_pred CCCCCc---ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTER---QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... .......|+..|+|||.+.+..++.++||||+|+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 543321 11223568899999999988889999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=269.06 Aligned_cols=201 Identities=28% Similarity=0.471 Sum_probs=170.1
Q ss_pred hcCCcccceeccCccceEEEEEEcC-Cc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
..+|+..+.||+|+||.||+|.+.+ |+ .+|+|...... .......+.+|+..+++++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 3567888899999999999998653 33 58999886553 24455778899999999999999999999987 788
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++|+||+++|+|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++
T Consensus 84 ~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 84 QLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999999863 234589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCcccc-cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.......... ....++..|+|||.+....++.++||||||+++||+++ |+.||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 6653332221 11234568999999988889999999999999999999 999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=270.98 Aligned_cols=197 Identities=27% Similarity=0.449 Sum_probs=171.3
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
.|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4666778999999999999765 578899998875432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++ ...+++..+..++.|+++|++|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999885 35688999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 12223468889999999999889999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=272.93 Aligned_cols=196 Identities=30% Similarity=0.432 Sum_probs=169.8
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
.|.....||+|+||.||++... +++.||+|++.... ....+.+.+|+..++.++|+||+++++.+...+..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3444567999999999999765 58899999986433 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 101 ~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 101 LEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 99999999885 34588999999999999999999999 99999999999999999999999999987554322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 173 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 173 P-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred c-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2 2233578999999999998889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=268.69 Aligned_cols=204 Identities=25% Similarity=0.406 Sum_probs=172.2
Q ss_pred cCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
++|+..+.||+|+||.||+|... +.+.+++|.+.... .....+.+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 56888889999999999999864 24678999886433 222456789999999999999999999999998999
Q ss_pred EEEEEecCCCChhhhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 484 LLVYEYVGNGNLHDMLHFADDS-----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
++||||+++|+|.++++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999743321 12689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
||++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99986543332222334467788999999988889999999999999999999 888885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=272.11 Aligned_cols=198 Identities=27% Similarity=0.427 Sum_probs=172.4
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|+||.||++... +|+.||+|.+.... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 56788889999999999999765 58899999876443 23345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++. .+.+++..+..++.+++.||.|||+.+ +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999998863 356899999999999999999999742 8999999999999999999999999998654222
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....|+..|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~ 203 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 1 123568999999999988899999999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=271.57 Aligned_cols=200 Identities=24% Similarity=0.349 Sum_probs=167.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|...+.||+|+||.||+|... +|+.|++|++..... ......+.+|++.++.++|+||+++++++...+..++|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467888999999999999999765 588999999865432 223345678999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+. +++.+++.. ....+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 677776642 234577888899999999999999999 999999999999999999999999999875432
Q ss_pred CCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||+
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2211 1234578999999998764 47889999999999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=269.81 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=166.8
Q ss_pred cCCcccceeccCccceEEEEEEc-----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQ 482 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 482 (618)
.+|+..+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 46788889999999999999753 57899999987543 3345678899999999999999999998754 346
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++|+||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred eEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 8999999999999999863 234689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccc--ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 563 ALTPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 563 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
+......... .....++..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 8765432211 11123445699999999889999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=265.77 Aligned_cols=194 Identities=32% Similarity=0.518 Sum_probs=166.2
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEe-eCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 488 (618)
++|...+.||+|+||.||++... |..+++|.++... ..+.+.+|+.++++++|+|++++++++. .++..++|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888899999999999999775 7889999886432 3457889999999999999999999764 4567899999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999998632 233588999999999999999999998 9999999999999999999999999998754332
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2 12334568999999998889999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=265.33 Aligned_cols=201 Identities=26% Similarity=0.426 Sum_probs=175.0
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|+||.||++... +|+.|++|++............+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778889999999999999765 589999999876544555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+.+++|.++++.. ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988632 234578899999999999999999998 99999999999999999999999999997654322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 1 1223468889999999999889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=268.65 Aligned_cols=203 Identities=24% Similarity=0.367 Sum_probs=170.9
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCccccc-HHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
...+|....+||+|+||.|.+|+.+. .+.||||++++...- ....+--+.|-+++..- +-|.+++++..+.+-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34578888899999999999997764 677999999876542 22222234455555554 5788999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+.+|+|--.+++ -+.+.+..+.-++..||-||-+||++ |||.||||.+|||+|.+|++||+|||++..
T Consensus 427 FVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999888873 46678888899999999999999999 999999999999999999999999999975
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
..-. ......++|||.|+|||++....|+.++|+||+||+||||+.|++||+.
T Consensus 500 ni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 500 NIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred cccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 4322 2334568999999999999999999999999999999999999999973
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=264.25 Aligned_cols=195 Identities=28% Similarity=0.458 Sum_probs=167.5
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
+.||+|+||.||++...+++.|++|.+...... .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999998877999999998765433 4567889999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccc-c
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS-T 574 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~ 574 (618)
.++++. ....+++..+..++.+++.||+|||++ +++||||||+||+++.++.+||+|||++........... .
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999863 234678899999999999999999999 999999999999999999999999999875542211111 1
Q ss_pred ceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 575 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~ 197 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence 1234567999999998899999999999999999999 888885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=270.31 Aligned_cols=200 Identities=25% Similarity=0.433 Sum_probs=168.8
Q ss_pred cCCcccceeccCccceEEEEEE-----cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--Ce
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQ 482 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 482 (618)
+.|...+.||+|+||.||++.+ .+++.||+|.++... .......+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3467788999999999999974 247889999987543 334456789999999999999999999998775 56
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++++|.+++.. ....+++.++..++.|++.||+|||++ +++||||||+||++++++.+||+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 8999999999999999863 234689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 563 ALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 563 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
+........ ......++..|+|||++.+..++.++||||||+++|||+|++.|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 765433221 122345677899999999888999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=269.63 Aligned_cols=201 Identities=25% Similarity=0.378 Sum_probs=172.5
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLV 486 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 486 (618)
++|+..+.||.|++|.||++... +++.+|+|.+..... ......+.+|++.+++++||||+++++++... +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 35778889999999999999875 588999998875432 24567788999999999999999999988653 468999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999998765444456789999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ....++..|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2211 23457889999999999999999999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=271.96 Aligned_cols=199 Identities=25% Similarity=0.405 Sum_probs=168.0
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|++|.||+|... +++.||+|.+...... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57888899999999999999876 5899999998654322 123456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9985 89988863 234688999999999999999999999 9999999999999999999999999998654322
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||.
T Consensus 157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 111 122356889999999876 458899999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=271.20 Aligned_cols=206 Identities=28% Similarity=0.469 Sum_probs=172.5
Q ss_pred hhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
..++|+..+.||+|+||.||+|... ++..||+|.+.... ......++.+|++++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 3567888999999999999999764 46789999987543 3345577899999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhccc------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 007103 482 QRLLVYEYVGNGNLHDMLHFAD------------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp 543 (618)
..++|+||+++|+|.++++... .....+++..++.++.|++.||+|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 9999999999999999996321 1123478889999999999999999998 999999999
Q ss_pred CCeeecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 544 ANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 544 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+||++++++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999998754322211 1122345678999999998999999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=266.14 Aligned_cols=203 Identities=26% Similarity=0.386 Sum_probs=169.5
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
+.+++.+.....||+|+||.||+|... ++..|++|.+.... ....+.+.+|++++++++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 344555666678999999999999765 57789999886543 334567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-CCCcEEeeccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNL--TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGL 561 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl 561 (618)
+|+||+++++|.++++.. ...+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||.
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999998632 2334 7888889999999999999998 9999999999999986 67999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+........ ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 876533221 122345889999999987643 7889999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=268.92 Aligned_cols=197 Identities=29% Similarity=0.444 Sum_probs=173.2
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||++... +++.+++|++..... .....++.+|++.+++++||||+++++++...+..++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999876 589999999876542 34567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
+++++|.+++... ...+++..+..++.|++.|++|||+ . +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999742 2678899999999999999999999 7 9999999999999999999999999998655322
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 200 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 11 12568889999999999999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=271.69 Aligned_cols=199 Identities=30% Similarity=0.407 Sum_probs=169.4
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc---HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
+|+..+.||+|++|.||+|... +|+.|++|++...... ......+..|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999875 5899999999765433 23345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+ +++|.++++.. ...+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 88999999632 23689999999999999999999999 99999999999999999999999999997665
Q ss_pred CCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ....+++.|+|||.+.+ ..++.++|||||||++|||++|..||.
T Consensus 154 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 154 SPNRKM-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred CCCccc-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 432221 22356788999999865 457899999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=265.62 Aligned_cols=188 Identities=30% Similarity=0.409 Sum_probs=157.7
Q ss_pred eeccCccceEEEEEEcC-------------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 417 LIGEGSLGRVYRAEFAN-------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.||+|+||.||+|.+.. ...+++|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 58999999999997542 2358888876433 23445788899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC-------cEE
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-------PHL 556 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-------~kl 556 (618)
++||||+++|+|..+++. ....+++..+.+++.||++||+|||++ +|+||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999988752 235689999999999999999999999 9999999999999986654 899
Q ss_pred eeccccccCCCCCcccccceeccccccCccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCC
Q 007103 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELL-TGRKPLD 617 (618)
Q Consensus 557 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~Pf~ 617 (618)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||.
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999998654322 2245788899999987 466899999999999999997 5888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=263.63 Aligned_cols=200 Identities=23% Similarity=0.399 Sum_probs=173.9
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||++... +++.+|+|.+............+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999999765 588999999876655555677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-CCcEEeeccccccCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCGLAALTPNT 568 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfgl~~~~~~~ 568 (618)
+++++|.++++.. ....+++..+.+++.|++.||+|||++ +++|+||+|+||+++++ +.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999632 234589999999999999999999999 99999999999999855 46899999999766433
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||+
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 202 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 22 123468889999999998889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=276.00 Aligned_cols=206 Identities=29% Similarity=0.485 Sum_probs=171.2
Q ss_pred hhcCCcccceeccCccceEEEEEEcC--------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (618)
...+|.+.+.||+|+||.||+|+..+ +..+|+|.++... .....+.+.+|+++++++ +||||+++++++.
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34568888999999999999997531 2368999887432 334567889999999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Ni 546 (618)
..+..++++||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 99999999999999999999864321 223578899999999999999999998 999999999999
Q ss_pred eecCCCCcEEeeccccccCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 547 LLDDELNPHLSDCGLAALTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 547 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999997654322111 122234567999999999999999999999999999998 889885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=267.92 Aligned_cols=204 Identities=33% Similarity=0.507 Sum_probs=173.3
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCC---
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG--- 481 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~--- 481 (618)
.++++|+..+.||+|++|.||+|... +++.+++|.+.... ...+++.+|+++++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45688999999999999999999875 57889999886543 2346788999999998 6999999999997644
Q ss_pred ---eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 482 ---QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 482 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
..++||||+++++|.++++........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999999875443456789999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccceeccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred Cccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 999876543222 2233568899999998854 346789999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=266.81 Aligned_cols=200 Identities=28% Similarity=0.436 Sum_probs=169.4
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc--------HHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS--------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
+|...+.||+|++|.||+|... +|+.+|+|.++..... ....+.+.+|++.+++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999765 5899999988643211 112346788999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+++++|.++++. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999863 35788999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcc-cccceeccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQ-VSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++........ ......|+..|+|||.+.... ++.++||||||+++||+++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 9765432211 123346889999999987654 7899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=272.43 Aligned_cols=195 Identities=28% Similarity=0.404 Sum_probs=168.8
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
|+....||+|+||.||+|... +++.||+|.+..... ...+.+.+|+..++.++||||+++++++..++..++|+||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 334457999999999999765 689999999864332 23466888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
++++|.+++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 101 QGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999998774 34688999999999999999999999 999999999999999999999999999875543221
Q ss_pred ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2234578999999999998889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=269.38 Aligned_cols=200 Identities=26% Similarity=0.391 Sum_probs=169.1
Q ss_pred CCcccceeccCccceEEEEEE----cCCcEEEEEEcCcccc--cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (618)
+|+..+.||+|+||.||+|+. .+|+.||+|++..... .....+.+.+|+++++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999976 3689999999875432 122346678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999863 34678899999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCcccccceeccccccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 6543322222345688999999998753 46789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=266.74 Aligned_cols=203 Identities=25% Similarity=0.412 Sum_probs=172.1
Q ss_pred CCcccceeccCccceEEEEEEcC--CcEEEEEEcCccc--------ccHHHHHHHHHHHHHhhc-CCCCcccccceEEee
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKIDNAA--------LSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAE 479 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 479 (618)
.|+..+.||+|+||.||+|.... ++.+|+|.+.... .......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778889999999999998765 6889999875332 122344567778887764 799999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
++..++||||+++++|.+++.........+++..+++++.|++.||.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988654445567899999999999999999999631 8999999999999999999999999
Q ss_pred cccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 9997655433 2234578899999999999889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=269.32 Aligned_cols=200 Identities=28% Similarity=0.420 Sum_probs=170.2
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||+|... +|+.||+|++............+.+|++.+++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999875 589999999875544444456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+. ++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 5898888642 245689999999999999999999998 99999999999999999999999999987554322
Q ss_pred cccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .....+++.|+|||++.+.. ++.++||||||+++|||+||+.||.
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 21 12335788999999887654 5889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=264.42 Aligned_cols=198 Identities=27% Similarity=0.468 Sum_probs=175.6
Q ss_pred CCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||+|...+ ++.|++|++...... .....+.+|++.+.+++|+||+++++++...+..++|+||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 57788999999999999998774 999999998765432 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
+++++|.+++.. ...+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999963 3678999999999999999999999 8 9999999999999999999999999998766433
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....++..|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 201 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL 201 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 322 123568899999999999999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=268.23 Aligned_cols=191 Identities=29% Similarity=0.418 Sum_probs=158.0
Q ss_pred eeccCccceEEEEEEc-CCcEEEEEEcCcccccHH-HHHHHHHHHHH---hhcCCCCcccccceEEeeCCeEEEEEEecC
Q 007103 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ-EEDNFLEAVSN---MSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
+||+|+||.||++... +++.+|+|.+........ ....+.+|..+ +....||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865433222 22333444333 334479999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc
Q 007103 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (618)
Q Consensus 492 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 571 (618)
+++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999886 235689999999999999999999999 999999999999999999999999999865433221
Q ss_pred cccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 572 VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 23468999999999864 558899999999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=266.91 Aligned_cols=191 Identities=31% Similarity=0.443 Sum_probs=158.7
Q ss_pred eeccCccceEEEEEEc-CCcEEEEEEcCcccccH-HHHHHHHHH---HHHhhcCCCCcccccceEEeeCCeEEEEEEecC
Q 007103 417 LIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEA---VSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
.||+|+||.||+|... +++.||+|.+....... .....+..| .+.++...||+|+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999765 48899999987543321 122223333 334455689999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc
Q 007103 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (618)
Q Consensus 492 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 571 (618)
+++|.+++. ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999998885 345789999999999999999999998 999999999999999999999999999875533221
Q ss_pred cccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 572 VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 234689999999999754 68999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=267.29 Aligned_cols=193 Identities=27% Similarity=0.404 Sum_probs=166.0
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
||+|+||.||++... +|+.||+|.+...... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 5899999998654322 22345667899999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccc
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 575 (618)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.+....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99886322 24689999999999999999999999 99999999999999999999999999987654321 1223
Q ss_pred eeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..++..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 467889999999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=264.47 Aligned_cols=187 Identities=30% Similarity=0.459 Sum_probs=158.9
Q ss_pred ceeccCccceEEEEEEcCCc-----------EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 416 FLIGEGSLGRVYRAEFANGK-----------IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36899999999999886533 5777876543321 5778899999999999999999999988 7789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-------CcEEe
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-------NPHLS 557 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-------~~kl~ 557 (618)
+||||+++|+|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 77 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999998732 23689999999999999999999998 999999999999999887 79999
Q ss_pred eccccccCCCCCcccccceeccccccCccccccC--CCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||.
T Consensus 151 Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~ 208 (259)
T cd05037 151 DPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208 (259)
T ss_pred CCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence 9999876543 1234567789999999876 78999999999999999999 588775
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=263.41 Aligned_cols=195 Identities=31% Similarity=0.496 Sum_probs=159.5
Q ss_pred ceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-CCeEEEEEEec
Q 007103 416 FLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVYEYV 490 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 490 (618)
+.||+|+||.||+|.+.+ +..+|+|++.... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999997642 4579999885432 33445678899999999999999999998754 55688999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
.+|+|.++++. .....++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999863 234567788899999999999999998 999999999999999999999999999875532211
Q ss_pred c---cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCC
Q 007103 571 Q---VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG-RKPLD 617 (618)
Q Consensus 571 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~Pf~ 617 (618)
. ......++..|+|||.+.+..++.++|||||||++|||++| .+||.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1 11123467789999999888999999999999999999994 56664
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=270.89 Aligned_cols=201 Identities=27% Similarity=0.465 Sum_probs=167.3
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|+..+.||+|+||.||+|.+. +|+ .+|+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 456778889999999999999764 344 47888886543 233445688999999999999999999998754 56
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++++||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 799999999999999863 234688999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 664332221 122345778999999999999999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=266.21 Aligned_cols=188 Identities=27% Similarity=0.386 Sum_probs=156.4
Q ss_pred eeccCccceEEEEEEcC-------------------------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCccc
Q 007103 417 LIGEGSLGRVYRAEFAN-------------------------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 471 (618)
.||+|+||.||+|.+.. ...|++|.+.... ......+.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999997521 1358888886443 23346788899999999999999
Q ss_pred ccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
++++++......++||||+++|+|.++++. ....+++..+..++.|+++||+|||++ +|+||||||+||++++.
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999998862 345688999999999999999999998 99999999999999764
Q ss_pred C-------CcEEeeccccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHH-hCCCCCC
Q 007103 552 L-------NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELL-TGRKPLD 617 (618)
Q Consensus 552 ~-------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~Pf~ 617 (618)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred CcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3 3799999987543221 12357788999998876 56899999999999999985 7999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=262.09 Aligned_cols=199 Identities=33% Similarity=0.531 Sum_probs=170.3
Q ss_pred cccceeccCccceEEEEEEcC-----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 413 SQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
+..+.||+|+||.||++...+ +..+|+|.+.... .....+.+..|++.+..++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999998764 4889999996553 2235678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999986321 12289999999999999999999999 999999999999999999999999999976654
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 32222212337789999999988889999999999999999998 888886
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=263.25 Aligned_cols=201 Identities=26% Similarity=0.437 Sum_probs=177.6
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||++... +++.+++|.+............+.+|++.+++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999765 688999999876655555667788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999875444456789999999999999999999999 9999999999999999999999999999776543
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2223468889999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=306.39 Aligned_cols=206 Identities=29% Similarity=0.408 Sum_probs=176.6
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
+...+-+|.....||.|.||.||.|... +|+..|+|.++.........+...+|+.++..++|||+|+++|+-...+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 4455667888889999999999999654 599999999876655555567788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
+|.||||++|+|.++++ .+...++.....+..|++.|++|||+. |||||||||.||+++.+|.+|..|||.|.
T Consensus 1310 ~IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccccee
Confidence 99999999999999997 344566667777899999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccc---ccceeccccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQV---STQMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...+..... -....||+.|||||++.+.. -..++||||+|||+.||+||++||+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 765443221 12468999999999997644 4678999999999999999999986
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=265.65 Aligned_cols=197 Identities=29% Similarity=0.512 Sum_probs=169.3
Q ss_pred CCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC---CCcccccceEEeeCCeEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 486 (618)
.|+..+.||+|+||.||+|.+ .+++.+++|.+.... ......++.+|++++++++ |||++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467778899999999999986 468999999986543 2234456788888888886 99999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++ ...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 81 MEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999885 23688999999999999999999999 99999999999999999999999999987665
Q ss_pred CCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||+
T Consensus 153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 203 (277)
T cd06917 153 QNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203 (277)
T ss_pred CCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence 43322 2334688999999998754 46899999999999999999999996
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=280.91 Aligned_cols=200 Identities=30% Similarity=0.463 Sum_probs=173.3
Q ss_pred CCcccceeccCccceEEEEEEcC--Cc--EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN--GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~--g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
+....+.||+|.||.|++|.|.. |+ .||||.++...... ...+|++|+..|.+++|||++++||++.+ ....+|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34456689999999999998863 44 58999998766443 67899999999999999999999999987 688999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+|.++.|+|.+.++. .....+-......++.|||.||.||.++ ++|||||..+|+|+-..-.|||+|||+.+-..
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999985 3456678888999999999999999999 99999999999999988899999999999876
Q ss_pred CCCcccc--cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 567 NTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 567 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..++++. ...--.+.|+|||.+....++.++|||+|||.+|||+| |+.||-
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 5554432 22345568999999999999999999999999999999 888873
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=263.31 Aligned_cols=191 Identities=26% Similarity=0.393 Sum_probs=168.2
Q ss_pred eccCccceEEEEEEcC-CcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
||+|++|.||+|.... ++.+++|.+...... ....+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999998764 899999998754432 33457789999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccc
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 575 (618)
.++++. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999963 34588999999999999999999998 99999999999999999999999999997665432 1223
Q ss_pred eeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..|+..|+|||.+.+..++.++|+||+|+++|||++|+.||.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 193 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcC
Confidence 468899999999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=275.72 Aligned_cols=203 Identities=23% Similarity=0.330 Sum_probs=172.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..-|..++.||-|+||.|.+++-. ....||.|.+.+... ........+.|-++|.....+=||++|-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 345888899999999999999544 467799999876543 333445677888899998999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC-
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT- 565 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~- 565 (618)
|||++||++-.++- .-+-+.+..++.++..+..|+++.|+. |+|||||||+|||||.+|++||.|||++.-+
T Consensus 708 MdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999885 346788888899999999999999999 9999999999999999999999999998521
Q ss_pred --------CCCC--------------------------------cccccceeccccccCccccccCCCCcccchhhHHHH
Q 007103 566 --------PNTE--------------------------------RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVV 605 (618)
Q Consensus 566 --------~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 605 (618)
.+.+ .......+||+.|+|||++....|+...|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1000 011223589999999999999999999999999999
Q ss_pred HHHHHhCCCCCCC
Q 007103 606 MLELLTGRKPLDR 618 (618)
Q Consensus 606 l~elltg~~Pf~~ 618 (618)
||||+.|+.||.+
T Consensus 861 l~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLA 873 (1034)
T ss_pred HHHHhhCCCCccC
Confidence 9999999999963
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=260.27 Aligned_cols=203 Identities=30% Similarity=0.490 Sum_probs=179.8
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|...+.||+|++|.||++... +++.+++|++..........+.+.+|++.++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999876 589999999987655556677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++........+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999975443457899999999999999999999999 99999999999999999999999999997664432
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 204 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCC
Confidence 22334578899999999999889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=271.89 Aligned_cols=203 Identities=28% Similarity=0.408 Sum_probs=168.1
Q ss_pred CCcccceeccCccceEEEEEEcC---CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN---GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (618)
+|+..+.||+|++|.||+|.... ++.||+|.+..... .......+.+|++++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999998754 78999999976331 112235677899999999999999999999888 7899
Q ss_pred EEEEecCCCChhhhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC----CCCcEEeec
Q 007103 485 LVYEYVGNGNLHDMLHFADDSS-KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD----ELNPHLSDC 559 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~kl~Df 559 (618)
+||||+++ ++.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7777775433333 3789999999999999999999999 9999999999999999 899999999
Q ss_pred cccccCCCCCc--ccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTER--QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|++........ .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 99876543322 112335688999999988764 57899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=266.41 Aligned_cols=208 Identities=26% Similarity=0.463 Sum_probs=171.7
Q ss_pred ehhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEe
Q 007103 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (618)
Q Consensus 401 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (618)
++.++..+.+.|+..+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 34445556778999999999999999999875 58899999875432 2345677888888888 6999999999985
Q ss_pred e------CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 479 E------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 479 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
. ....+++|||+++|+|.+++...+ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 3 457899999999999999986432 34578888999999999999999999 999999999999999999
Q ss_pred CcEEeeccccccCCCCCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 999999999875532221 123356899999999986 3457889999999999999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=267.53 Aligned_cols=199 Identities=28% Similarity=0.436 Sum_probs=173.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+|...+.||+|+||.||++... +++.+++|.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 3468888999999999999999764 57899999986432 22346788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+||+++++|.+++. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 95 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 99999999999985 24578889999999999999999999 99999999999999999999999999886554
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......|++.|+|||.+.+..++.++||||||+++||+++|+.||.
T Consensus 167 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred cccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3322 2223468889999999988889999999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=263.79 Aligned_cols=198 Identities=27% Similarity=0.448 Sum_probs=172.1
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
+-|+..+.||+|+||.||+|... +++.+|+|.+..... ....+.+.+|++.+++++||||+++++++..++..++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 34667788999999999999764 688999998865432 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++ ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 83 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999999885 34688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 155 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred hh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 21 1223468889999999988888999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=266.24 Aligned_cols=197 Identities=31% Similarity=0.501 Sum_probs=164.6
Q ss_pred eeccCccceEEEEEEcC-------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 417 LIGEGSLGRVYRAEFAN-------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
.||+|+||.||+|...+ ++.+++|.+.... .......+.+|++.++.++||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 68999999999997653 2578999886432 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-----CcEEeeccc
Q 007103 490 VGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-----NPHLSDCGL 561 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-----~~kl~Dfgl 561 (618)
+++++|.++++.... ....+++.++..++.|++.||+|||+. +++|+||||+||++++++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964322 224578899999999999999999998 999999999999999877 899999999
Q ss_pred cccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 562 AALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+......... ......++..|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 8755332211 1122345678999999999999999999999999999998 999985
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=268.68 Aligned_cols=200 Identities=28% Similarity=0.399 Sum_probs=169.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLV 486 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 486 (618)
++|+..+.||+|+||.||+|... +++.+++|.++...........+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888889999999999999876 588999999975543333344667899999999999999999998877 889999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+||+++ +|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 998888632 23689999999999999999999999 99999999999999999999999999987665
Q ss_pred CCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||.
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 43221 1234578899999998764 46889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=261.81 Aligned_cols=201 Identities=27% Similarity=0.453 Sum_probs=173.1
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|+||.||+|... +|..+|+|.+..........+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999876 488999999876544444567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEeeccccccCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNT 568 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~ 568 (618)
+++++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999988632 234579999999999999999999998 999999999999999875 4699999998766433
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22 2223468899999999988889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=266.13 Aligned_cols=202 Identities=29% Similarity=0.418 Sum_probs=176.0
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
+..++.|+....||+|++|.||+|.+. +++.+++|++..... ....+.+|++.+++++|+||+++++.+...+..+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 345667888889999999999999876 688999999875432 4567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+|+||+++++|.++++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 92 VVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 999999999999999732 13789999999999999999999998 999999999999999999999999998865
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 166 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~ 217 (286)
T cd06614 166 LTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL 217 (286)
T ss_pred hccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 543221 1223457889999999998889999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=267.69 Aligned_cols=203 Identities=23% Similarity=0.331 Sum_probs=167.5
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCe-----
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQ----- 482 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 482 (618)
++|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|+++++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999875 5899999998755433333456788999999995 6999999999877665
Q ss_pred EEEEEEecCCCChhhhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-CCCcEEeecc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDS-SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCG 560 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg 560 (618)
.++||||+++ +|.+++...... ...+++..+..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 898888643322 35689999999999999999999999 9999999999999998 8899999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++......... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 98755332211 122356888999998865 457899999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=261.87 Aligned_cols=193 Identities=30% Similarity=0.496 Sum_probs=165.3
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
++|...+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++++++|||++++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4578888999999999999975 57889999986432 345788999999999999999999998655 47999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 9999999998642 234688999999999999999999998 99999999999999999999999999987543221
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 12234567999999998899999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=274.19 Aligned_cols=198 Identities=23% Similarity=0.329 Sum_probs=169.7
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (618)
..++|+..+.||+|+||.||+|... +|+.||+|.+............+.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577999999999999999999765 689999999875544444556778899999999999999999988643
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 356999999964 88887741 288889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 9976543221 233468899999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=247.40 Aligned_cols=202 Identities=27% Similarity=0.446 Sum_probs=167.6
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
...++.+....||.|..|.|+++++. .|..+|||.+.... ..++.++++..+.++.+- ..|+||+.+|+|..+...+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 33456667778999999999999776 48999999998665 344556666667766554 4899999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+.||.|.. .++.+++. ..+++++..+-++...++.||.||.+++ +|||||+||+|||+|+.|.+|++|||++..
T Consensus 168 IcMelMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccce
Confidence 99999864 56666652 4567899989999999999999999997 999999999999999999999999999866
Q ss_pred CCCCCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+-+...+ +.-+|.+.|||||.+. ...|+.++||||||+.++||.||+.||.
T Consensus 242 lvdSkAh--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~ 295 (391)
T KOG0983|consen 242 LVDSKAH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK 295 (391)
T ss_pred eeccccc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence 5433222 2347889999999995 3468999999999999999999999996
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=266.60 Aligned_cols=201 Identities=25% Similarity=0.361 Sum_probs=167.4
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|++|.||+|... +|+.||+|++..........+.+.+|++.+++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999876 58899999987554333345678889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-CCCcEEeeccccccCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPN 567 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~ 567 (618)
|++ ++|.+++... ....+++..+..++.||+.||+|||++ +++||||+|+||++++ ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 4788777522 233467888899999999999999999 9999999999999985 56799999999975533
Q ss_pred CCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......+++.|+|||++.+. .++.++||||+||++|+|+||+.||.
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 221 11234578899999998764 57899999999999999999999985
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=263.13 Aligned_cols=203 Identities=25% Similarity=0.464 Sum_probs=167.6
Q ss_pred CcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC------
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (618)
|...+.||+|+||.||+|.+. .++.+|+|+++.........+++.+|++.+++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999754 3688999999766555556778899999999999999999999886532
Q ss_pred eEEEEEEecCCCChhhhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 482 QRLLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
..++++||+.+|+|.+++.... .....+++..+.+++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875322 1223578899999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 560 GLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~ 217 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence 998765432211 1122345678999999998889999999999999999999 889985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=264.94 Aligned_cols=199 Identities=28% Similarity=0.405 Sum_probs=168.4
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
|+..+.||+|++|.||+|... +|+.||+|++............+.+|++.+++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999765 6999999998755433334466888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
+ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999886322 24689999999999999999999998 999999999999999999999999999875533222
Q ss_pred ccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1 1223568899999988764 46889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=268.70 Aligned_cols=204 Identities=27% Similarity=0.391 Sum_probs=170.5
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC----
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG---- 481 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 481 (618)
...++|++.+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678899999999999999999886 4889999998755433334456788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcE
Q 007103 482 ------QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (618)
Q Consensus 482 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 555 (618)
..++|+||+++ ++.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 67676642 234689999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 556 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999997664433222223456788999998865 457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.90 Aligned_cols=198 Identities=32% Similarity=0.482 Sum_probs=169.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..+.|...+.||+|+||.||+|... +|+.||+|.+..... ..+..+++.+|+++++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4456888899999999999999875 589999999864432 33445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|+||+. |++.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++...
T Consensus 93 v~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999997 577776652 234689999999999999999999998 9999999999999999999999999998755
Q ss_pred CCCCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ....++..|+|||++. ...++.++||||||+++|||+||+.||.
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 432 2346788999999884 4568899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=265.51 Aligned_cols=199 Identities=28% Similarity=0.445 Sum_probs=169.8
Q ss_pred CcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEEEEEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLVYE 488 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 488 (618)
|+..+.||+|++|.||+|...+ |+.+|+|++............+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5667889999999999998764 88999999986543334456788999999999999999999999888 88999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 88888752 225789999999999999999999998 9999999999999999999999999999766544
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||+
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 3222233467888999998765 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=269.81 Aligned_cols=202 Identities=31% Similarity=0.436 Sum_probs=168.8
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (618)
..++|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3467889999999999999999875 589999999875443322334567899999999999999999998765 5689
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 99999975 888888632 35689999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 6533222 222346788999999876 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=257.74 Aligned_cols=199 Identities=28% Similarity=0.451 Sum_probs=176.6
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||+|... +++.|++|.+..........+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999765 578999999987765545677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++.. ...+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999862 36789999999999999999999999 99999999999999999999999999997665433
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 22 233568899999999988888999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=257.64 Aligned_cols=214 Identities=26% Similarity=0.419 Sum_probs=179.1
Q ss_pred ehhhhhhhhcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccc
Q 007103 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474 (618)
Q Consensus 401 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 474 (618)
+..++.....+++....+-+|.||+||+|.|.+ .+.|.+|.++... +......++.|.-++..+.|||+.++.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 455666667778888899999999999996653 4567778777655 444556788888888889999999999
Q ss_pred eEEeeC-CeEEEEEEecCCCChhhhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec
Q 007103 475 GYCAEH-GQRLLVYEYVGNGNLHDMLHFADDS----SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (618)
Q Consensus 475 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~ 549 (618)
+++.++ ...+.++.++..|+|+.|++.++.. .+.++..+...++.|++.|++|||+. +|||.||.++|++||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 998664 5678999999999999999865532 23467778889999999999999999 999999999999999
Q ss_pred CCCCcEEeeccccccC-CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 550 DELNPHLSDCGLAALT-PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 550 ~~~~~kl~Dfgl~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
+...+||+|=.++|.. +.+..........+..||+||.+....|+.++|||||||+||||+| |+.|+.+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 9999999999999854 4444455555667789999999999999999999999999999999 9999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=265.16 Aligned_cols=201 Identities=26% Similarity=0.439 Sum_probs=170.7
Q ss_pred cCCcccceeccCccceEEEEEEc-----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQ 482 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 482 (618)
+.|...+.||+|+||.||+|.+. .++.+|+|.++..... ...+.+.+|++.++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45677789999999999999764 3688999999765433 456789999999999999999999999877 557
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred eEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 89999999999999999632 33689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCccc--ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......... .....++..|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 8765322211 112245567999999998899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=256.81 Aligned_cols=197 Identities=31% Similarity=0.523 Sum_probs=174.7
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|++.+++++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4677789999999999999876 688999999976543 3567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 79 CSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999998632 25789999999999999999999998 99999999999999999999999999987665433
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+
T Consensus 153 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 153 A--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred c--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 2 234578899999999998889999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=265.88 Aligned_cols=202 Identities=20% Similarity=0.246 Sum_probs=153.7
Q ss_pred hhcCCcccceeccCccceEEEEEEcCC----cEEEEEEcCcccccHHHH---------HHHHHHHHHhhcCCCCcccccc
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEE---------DNFLEAVSNMSRLRHPNIVTLA 474 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~l~ 474 (618)
..++|.+.+.||+|+||.||+|...++ ..+++|...........+ .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346799999999999999999987653 455666533222111111 1122334456677999999999
Q ss_pred eEEeeCC----eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC
Q 007103 475 GYCAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD 550 (618)
Q Consensus 475 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~ 550 (618)
+.+.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8766543 34678887754 66666642 23356788899999999999999999 9999999999999999
Q ss_pred CCCcEEeeccccccCCCCCc------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 551 ELNPHLSDCGLAALTPNTER------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 551 ~~~~kl~Dfgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++.++|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999976532211 11123469999999999999999999999999999999999999996
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=272.68 Aligned_cols=201 Identities=26% Similarity=0.395 Sum_probs=169.7
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee----CCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 483 (618)
..+|+..+.||+|++|.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999765 58999999987654443445677889999999999999999998763 3468
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+. ++|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 58988885 345589999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc---ccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTER---QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 5533221 12234578899999999866 458899999999999999999999995
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=261.34 Aligned_cols=193 Identities=30% Similarity=0.444 Sum_probs=167.4
Q ss_pred eccCccceEEEEEEcC-CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
||+|+||.||+++..+ |+.+++|.+..... .....+.+.+|++.+++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998875 99999999875433 223456788899999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc-----
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER----- 570 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 570 (618)
.++++. ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999963 23689999999999999999999999 999999999999999999999999999875432211
Q ss_pred --ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 --QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......++..|+|||...+..++.++||||||+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 12233568889999999998889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=259.49 Aligned_cols=190 Identities=25% Similarity=0.348 Sum_probs=160.1
Q ss_pred ceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHH-hhcCCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|... +|+.||+|.+...... ......+..|... ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999775 5899999998754322 1222333444443 4455899999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
++|.++++. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999963 34688999999999999999999998 999999999999999999999999999875432
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence 123468889999999998889999999999999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=262.79 Aligned_cols=196 Identities=30% Similarity=0.436 Sum_probs=169.3
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
.|...+.||+|++|.||++... +++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 3445568999999999999864 68899999885432 23456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.+.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 98 LEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999999862 4688999999999999999999999 99999999999999999999999999886544322
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 170 P-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred c-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 1 1223568899999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-33 Score=256.71 Aligned_cols=201 Identities=28% Similarity=0.411 Sum_probs=164.5
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhh-cCCCCcccccceEEeeCCeEEEEEEe
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMS-RLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
.+....||.|+||+|++-.++ .|+.+|||++..... ..+.++++.|.+... .-+.||||+++|.+..++..|+.||.
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 334557999999999999765 599999999987664 345667777777644 45799999999999999999999999
Q ss_pred cCCCChhhhhhc-ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 490 VGNGNLHDMLHF-ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 490 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+- +|..+... +.-....+++...-+|....+.||.||.+.. .|||||+||+|||++..|.+|++|||++....+
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~- 220 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD- 220 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence 965 77665532 2223457888888899999999999999885 899999999999999999999999999865432
Q ss_pred CcccccceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
....+..+|...|||||.+.. ..|..++||||||+.|||+.||+.|+++
T Consensus 221 -SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 221 -SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred -HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 222234578889999999964 3489999999999999999999999863
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=272.58 Aligned_cols=201 Identities=23% Similarity=0.331 Sum_probs=178.3
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCc-EEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGK-IMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
.-.++.....||-|+||.|-++.....+ .+|+|.+++... .....+....|-.+|...+.|.||++|.-|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3445666778999999999999876543 488888876543 34455677888899999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
.||-|-||.|...++ ..+.++..+..-++..+++|++|||++ +||.|||||+|.+++.+|.+||.|||+|+..
T Consensus 498 LmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 999999999999997 567899999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... +..++|||.|.|||++.....+.++|.||||+++|||+||.+||.
T Consensus 571 ~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs 620 (732)
T KOG0614|consen 571 GSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS 620 (732)
T ss_pred ccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC
Confidence 65443 457899999999999999999999999999999999999999996
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-33 Score=256.06 Aligned_cols=197 Identities=26% Similarity=0.403 Sum_probs=172.6
Q ss_pred cccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----eEEEE
Q 007103 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRLLV 486 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 486 (618)
+..+.||-|+||.||.+.+. +|+.||.|++..-.......+.+-+|++++.-++|.||+..++...-.. ++|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34567999999999999665 6999999999877666667788999999999999999999988765432 56789
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+|.|.. +|...+- ..+.++...+.-+..||++||.|||+. +|.||||||.|.|++.+..+||+|||+++.-.
T Consensus 136 TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 998865 8887774 678899999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.++...+++.+-|.+|+|||++++. .|+.++||||+|||+.||+.++.-|+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 6666667778889999999999985 58999999999999999999887765
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=263.42 Aligned_cols=200 Identities=28% Similarity=0.432 Sum_probs=169.0
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+|+..+.||+|++|.||+|... +|+.||+|+++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4778889999999999999876 5889999998754322 2345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++ +|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 80 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 80 MDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred CCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 985 8888876332 235689999999999999999999998 99999999999999999999999999987554322
Q ss_pred cccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 155 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 155 NT-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred cc-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 1234578899999998664 57889999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=270.74 Aligned_cols=199 Identities=26% Similarity=0.410 Sum_probs=166.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----Ce
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (618)
.++|+..+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 467899999999999999999764 58999999986432 223456678899999999999999999987654 35
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++|+||+++ +|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 7999999975 8887774 35689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc--cccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQ--VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 765432221 1123578999999998755 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.09 Aligned_cols=203 Identities=25% Similarity=0.392 Sum_probs=171.2
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
...+....++|...+.||+|+||.||+|.. .+|+.||+|+++.........+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445566778999999999999999999975 4689999999976544444456788899999999999999999988643
Q ss_pred ------CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCc
Q 007103 481 ------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 481 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
...+++++++ +++|.++++ ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3467888876 679988775 34589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999998754322 223467889999999876 467889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=265.65 Aligned_cols=201 Identities=29% Similarity=0.432 Sum_probs=165.8
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 488 (618)
+|...+.||+|+||.||++... +|+.+|+|.+...... .....+.+|+..+.++. |+||+++++++..++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4556678999999999999765 5899999998754433 45567889999999986 9999999999999999999999
Q ss_pred ecCCCChhhhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 489 YVGNGNLHDMLHFA-DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 489 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
|+.. ++.++.... ......+++..+..++.|++.||+|||+.. +|+||||||+||++++++.+||+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 665544321 122467899999999999999999999742 899999999999999999999999999875533
Q ss_pred CCcccccceeccccccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSG---IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ....|++.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 161 SIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred CCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 2211 223688899999999876 68999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=263.70 Aligned_cols=207 Identities=27% Similarity=0.397 Sum_probs=170.7
Q ss_pred hhhhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHH-----HHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE-----EDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
....++|-...+||+|||+.||+|.. .+.+.||||+-.......++ .+...+|..+.+.+.||.||++|+++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34456788888999999999999954 45677888876543322222 2345788999999999999999999865
Q ss_pred -CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec---CCCCcE
Q 007103 480 -HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPH 555 (618)
Q Consensus 480 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~k 555 (618)
.+..+.|+|||+|.+|.-+++ ...-+++.+++.|+.||+.||.||.+. .|+|||-||||.|||+. .-|.+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred ccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 567889999999999988886 345689999999999999999999987 46899999999999995 457899
Q ss_pred EeeccccccCCCCCcc------cccceeccccccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 556 LSDCGLAALTPNTERQ------VSTQMVGAFGYSAPEFALSG----IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 556 l~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|.|||+++.++++... ...+.+||..|++||.+.-+ +.+.|+||||+|||+|..+.|+.||-
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 9999999988655332 23456899999999998533 47889999999999999999999994
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=270.89 Aligned_cols=201 Identities=29% Similarity=0.430 Sum_probs=168.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeC--CeE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH--GQR 483 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 483 (618)
..++|+..+.||+|+||.||+|... +|+.+|+|++............+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999876 588999999865433334455677899999999 999999999998654 368
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||++ ++|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599888852 2678899999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCc----ccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTER----QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 6543322 12233578999999998865 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=261.72 Aligned_cols=189 Identities=26% Similarity=0.411 Sum_probs=157.5
Q ss_pred ceeccCccceEEEEEEcC--------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 416 FLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
+.||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 369999999999997642 2347788775432 234567888999999999999999999999989999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC--------cEEeec
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--------PHLSDC 559 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~--------~kl~Df 559 (618)
||+++|+|.++++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. ++++||
T Consensus 79 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999963 234688999999999999999999999 9999999999999987765 599999
Q ss_pred cccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCC-CCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGR-KPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~-~Pf~ 617 (618)
|++...... ....+++.|+|||++.+. .++.++||||||+++|||++|. .||.
T Consensus 153 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 153 GISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred ccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 988654322 234678899999999874 5789999999999999999984 5653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=256.97 Aligned_cols=200 Identities=30% Similarity=0.434 Sum_probs=176.4
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLLVY 487 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 487 (618)
+|...+.||+|++|.||+|... +++.+++|++..........+.+.+|++.+++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999876 689999999876655455678899999999999999999999999988 8999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999863 23789999999999999999999998 999999999999999999999999999876654
Q ss_pred CCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3321 1233568889999999998889999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=266.76 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=166.9
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (618)
.++|+..+.||+|+||.||+|... +++.||+|.+............+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457888999999999999999875 5899999998654433333445678999999999999999999987654
Q ss_pred --eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 482 --QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 482 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
..++||||+.+ +|.+++.. ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999975 78877752 234689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcc---cccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQ---VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 999765432211 12234678899999988764 47889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=263.20 Aligned_cols=200 Identities=28% Similarity=0.402 Sum_probs=169.6
Q ss_pred CCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccc--cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (618)
+|+..+.||+|++|.||++... +++.||+|.++.... .....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999753 578899999875432 122346688899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.+++. ....+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999886 235688999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcccccceeccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 65433332233456889999999987765 7889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=252.10 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=173.5
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHH-HHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQE-EDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
..++|....+||+|+|..|..+++. ..+.||+|++++......+ .+-...|-.+..+. +||.+|-+...|.++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3467888999999999999999876 4789999999876554333 23344555555544 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+|.||+++|+|--+++ ....+++..++-+...|.-||.|||++ |||.||||.+|||+|..|++|+.|+|+++.
T Consensus 328 fvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999987776 345688999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...+.+ ....++|||.|.|||++.+..|+..+|+|++||+|+||+.|+.||+
T Consensus 401 ~l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 GLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 544333 3456899999999999999999999999999999999999999997
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=262.19 Aligned_cols=201 Identities=28% Similarity=0.418 Sum_probs=174.5
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 486 (618)
++|...+.||+|++|.||+|... +|+.|++|++..... .....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888889999999999999775 689999999875432 3334567888999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999963 34799999999999999999999998 99999999999999999999999999987554
Q ss_pred CCCc-------------------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTER-------------------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .......++..|+|||.+.+..++.++||||||+++|++++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 3221 11223467899999999988889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=269.73 Aligned_cols=200 Identities=28% Similarity=0.427 Sum_probs=169.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----Ce
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (618)
.++|...+.||+|+||.||+|... +++.||+|.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999765 589999999876443344456677899999999999999999988654 34
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++|+||+. ++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 68888875 345689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 7664332 22234568889999998865 468899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=262.65 Aligned_cols=193 Identities=30% Similarity=0.434 Sum_probs=167.8
Q ss_pred ccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 414 QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 414 ~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
....||+|+||.||++... +|+.||+|++.... ......+.+|+..++.++|+||+++++++...+..++||||+++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3457999999999999775 68999999886432 33566788999999999999999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
++|.+++. ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........ .
T Consensus 102 ~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 102 GALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 99999874 34578999999999999999999999 999999999999999999999999999865543221 1
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....|++.|+|||.+.+..++.++|+||+|+++|||++|+.||.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 233568899999999988889999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=264.02 Aligned_cols=196 Identities=31% Similarity=0.482 Sum_probs=167.2
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
+.|...+.||+|+||.||+|... +++.+|+|++..... .......+.+|++.+++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777889999999999999865 588999999864422 3334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+.+ ++.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99974 77777652 245689999999999999999999999 999999999999999999999999999865432
Q ss_pred CCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ....|++.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 2 2346888999999984 4568899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.68 Aligned_cols=199 Identities=31% Similarity=0.425 Sum_probs=172.0
Q ss_pred CCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----eEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-----QRL 484 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 484 (618)
+|...+.||+|++|.||+|...+ |+.+|+|++..........+.+.+|++.++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788899999999999998764 899999999765433445678899999999999999999999988765 789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++ +|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999984 8888886 234789999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCc--ccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTER--QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 654321 112335678899999999887 78999999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=257.23 Aligned_cols=190 Identities=23% Similarity=0.341 Sum_probs=158.5
Q ss_pred hcCCccccee--ccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhh-cCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLI--GEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMS-RLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~L--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|+..+.+ |+|+||.||++... +++.+|+|.+........ |+.... ..+||||+++++.+...+..+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 4455555555 99999999999765 588899999865432211 111111 126999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEeeccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAA 563 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~ 563 (618)
+||||+++++|.++++. ...+++.++..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||++.
T Consensus 86 iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999962 34789999999999999999999999 999999999999999888 99999999987
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ...++..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 159 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 159 IIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred ecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 554221 2458899999999999899999999999999999999999995
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=267.81 Aligned_cols=197 Identities=23% Similarity=0.369 Sum_probs=168.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 481 (618)
..++|...+.||+|+||.||+|... +|+.||+|++............+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567999999999999999999754 6899999998654434444567889999999999999999999887653
Q ss_pred -eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 482 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 668988875 34689999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++....... ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 987654321 23467889999999876 457899999999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=288.37 Aligned_cols=199 Identities=30% Similarity=0.422 Sum_probs=163.5
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC----
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH---- 480 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 480 (618)
.+...+|+..+.||+||||.||+++.+ ||+.||||++.... +......+.+|++.+++++|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 456678999999999999999999876 89999999998876 666677889999999999999999987654100
Q ss_pred --------------------------------------------------------------------------------
Q 007103 481 -------------------------------------------------------------------------------- 480 (618)
Q Consensus 481 -------------------------------------------------------------------------------- 480 (618)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHH
Q 007103 481 -----------------------------------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL 525 (618)
Q Consensus 481 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L 525 (618)
..+||-||||+...+.++++.. ...-.....++++.+|++||
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHH
Confidence 1236888888887777777621 11115778899999999999
Q ss_pred HHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC-----------------CCCcccccceeccccccCcccc
Q 007103 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP-----------------NTERQVSTQMVGAFGYSAPEFA 588 (618)
Q Consensus 526 ~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~ 588 (618)
+|+|++ |||||||||.||+++++..|||.|||++.... .......++.+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999997511 1111133567999999999999
Q ss_pred ccCC---CCcccchhhHHHHHHHHHh
Q 007103 589 LSGI---YTVKSDVYSFGVVMLELLT 611 (618)
Q Consensus 589 ~~~~---~~~~~DvwslG~il~ellt 611 (618)
.+.. |+.|+|+||+|||++||+.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc
Confidence 7654 9999999999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=258.68 Aligned_cols=195 Identities=28% Similarity=0.391 Sum_probs=161.7
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeC--CeEEEEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEH--GQRLLVY 487 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 487 (618)
|+..+.||+|+||.||+|... +++.||+|+++....... .....+|+..+.++. |+||+++++++.+. +..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 556778999999999999765 589999999876543322 233456788888885 99999999999887 8899999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||++ +++.+++.. ....+++.++..++.|++.||+|||+. +++||||+|+||++++ +.+||+|||+++....
T Consensus 80 e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 9997 588887753 235689999999999999999999999 9999999999999999 9999999999976543
Q ss_pred CCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ....++..|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 152 KPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred CCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 2221 23457889999997754 557889999999999999999999995
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=265.61 Aligned_cols=202 Identities=29% Similarity=0.417 Sum_probs=166.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (618)
.++|+..+.||+|+||.||+|... +++.+|+|++............+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999875 5899999998654433333456678999999999999999999875433
Q ss_pred --eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 482 --QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 482 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
..++|+||++. ++.+.+.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999975 67666642 345799999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcc----------cccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQ----------VSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 999755322211 11234678899999988654 57899999999999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=266.13 Aligned_cols=196 Identities=25% Similarity=0.357 Sum_probs=162.9
Q ss_pred eeccC--ccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCC
Q 007103 417 LIGEG--SLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 417 ~Lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.||+| +||+||+|.+. +|+.||+|.+..........+.+.+|+.+++.++||||+++++++...+..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999875 6999999998765545555678899999999999999999999999999999999999999
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc-
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV- 572 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 572 (618)
++.++++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999887432 34588999999999999999999998 99999999999999999999999998653322111100
Q ss_pred -----ccceeccccccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 -----STQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0112355679999999764 47899999999999999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=267.05 Aligned_cols=195 Identities=23% Similarity=0.379 Sum_probs=165.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------C
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 481 (618)
.++|...+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 467888999999999999999865 589999999875443333445678999999999999999999998654 2
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++|+||+.. +|.++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999974 676654 23588999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 8765322 123567889999999876 468899999999999999999999996
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=263.92 Aligned_cols=196 Identities=22% Similarity=0.298 Sum_probs=162.8
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
+.+|.|+++.||++.. +++.||+|++..........+.+.+|++.+++++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455555555555544 589999999976544555667899999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc-----
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER----- 570 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 570 (618)
.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999743 234588899999999999999999999 999999999999999999999999998864432211
Q ss_pred -ccccceeccccccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 -QVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 112234577889999998763 58899999999999999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=264.72 Aligned_cols=199 Identities=29% Similarity=0.424 Sum_probs=169.2
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-CCeE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQR 483 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 483 (618)
....++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345778999999999999999999765 68999999987544444455678889999999999999999998866 4578
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++|+||+. ++|.++++ ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.+.
T Consensus 86 ~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELLG-TDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehhc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999984 58988875 34578888889999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||.
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 54321 123467889999999866 568999999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=258.70 Aligned_cols=198 Identities=29% Similarity=0.424 Sum_probs=164.9
Q ss_pred CcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC---CCCcccccceEEeeCCe-----
Q 007103 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCAEHGQ----- 482 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 482 (618)
|+..+.||+|+||.||+|+... ++.||+|+++...........+.+|+.++.++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667889999999999998875 89999999975443333334556676665544 69999999999988776
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.+++|||+.+ +|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8988886322 23689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......... ....++..|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 766433221 22357889999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=258.92 Aligned_cols=198 Identities=29% Similarity=0.417 Sum_probs=170.6
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
|+..+.||+|++|.||+|... +|+.+++|++............+.+|++.+++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999875 6889999998766544445677888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
++ ++.+++.. ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 88888763 235789999999999999999999999 999999999999999999999999999876654331
Q ss_pred ccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||.
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 11234578899999999876 78999999999999999999999984
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=284.11 Aligned_cols=209 Identities=29% Similarity=0.480 Sum_probs=176.8
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc--------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccce
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAG 475 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 475 (618)
++...++..+.+.||+|.||.|++|... ....||||.++..... .+.+.+..|+++|+.+ +|+||+.++|
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3444455556669999999999999643 1457999999887766 6788999999999988 5999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhccc---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 007103 476 YCAEHGQRLLVYEYVGNGNLHDMLHFAD---D-------SS--KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543 (618)
Q Consensus 476 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp 543 (618)
+|...+..++|+||+..|+|.++++..+ . .. ..++..+.+.++.|||.|++||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998655 0 01 1388999999999999999999999 999999999
Q ss_pred CCeeecCCCCcEEeeccccccCCCCCccccccee--ccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 544 ANILLDDELNPHLSDCGLAALTPNTERQVSTQMV--GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 544 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+|||++++..+||+|||+++............-. -...|||||.+....|+.|+|||||||++|||+| |..|+-
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999876554444322222 2457999999999999999999999999999999 888874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=263.32 Aligned_cols=199 Identities=27% Similarity=0.350 Sum_probs=164.3
Q ss_pred CCcccceeccCccceEEEEEEc-C--CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeC----Ce
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-N--GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEH----GQ 482 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 482 (618)
+|+..+.||+|+||.||++... . ++.||+|++..........+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999875 3 67899999875443333456788899999988 599999999875432 45
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++++||++ ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899886 58988885 345689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCc---ccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTER---QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ .......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 76543221 11233578999999998766 468999999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=247.17 Aligned_cols=194 Identities=24% Similarity=0.321 Sum_probs=162.1
Q ss_pred hcCCcc-cceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhc-CCCCcccccceEEee----CC
Q 007103 409 TNSFSQ-EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAE----HG 481 (618)
Q Consensus 409 ~~~~~~-~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~ 481 (618)
+++|.+ .++||-|-.|.|..+..+ .|+++|+|++.+. ...++|++..-. -.|||||.++++|+. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 344443 247999999999999765 5899999988632 345677776433 379999999998865 35
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec---CCCCcEEee
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSD 558 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~D 558 (618)
.+.+|||.|+||.|++.++.. ..+.+++.++..|+.||+.|+.|||+. +|.||||||+|+|.+ .+-.+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 788999999999999988743 456799999999999999999999999 999999999999997 456799999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
||+|+..... ......+-||.|.|||++...+|+...|+||+||+||-|+.|.+||
T Consensus 208 fGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 208 FGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred cccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 9999876532 2233467899999999999999999999999999999999999998
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=257.78 Aligned_cols=201 Identities=28% Similarity=0.465 Sum_probs=165.3
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|++|.||+|.+.+ ++.||+|.++..... .....+..|++.+.+. .||||+++++++.+....++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 34678888999999999999998875 899999998754322 2344556677666665 59999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++ ++.+++.. ....+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++...
T Consensus 92 v~e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 92 CMELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EeeccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999864 77776653 2347899999999999999999999742 8999999999999999999999999998765
Q ss_pred CCCCcccccceeccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.
T Consensus 166 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 166 VDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred cCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 432221 2235788999999997654 7889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=257.54 Aligned_cols=194 Identities=31% Similarity=0.493 Sum_probs=165.0
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
|...+.||+|+||.||+|... +|+.|++|++..... .....+.+.+|++.++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999765 588999999865432 233446788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+. |++.+++.. ....+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 577777752 245689999999999999999999999 9999999999999999999999999988543221
Q ss_pred cccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....|+..|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2356889999999984 4568889999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=254.17 Aligned_cols=202 Identities=23% Similarity=0.335 Sum_probs=167.6
Q ss_pred CCcccceeccCccceEEEEEEcC-CcEEEEEEcCc---ccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDN---AALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
+|.+.+.||+|+||.||++.... +..+++|.++. .........++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788899999999999997654 34444444432 222333445677889999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+||+++++|.++++........+++..+..++.|++.||+|||+. +++|+||+|+||++++ +.+||+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875544567899999999999999999999998 9999999999999976 469999999987654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3222 2223467889999999988888999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=265.40 Aligned_cols=197 Identities=24% Similarity=0.406 Sum_probs=168.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ---- 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 482 (618)
..++|+..+.||+|++|.||+|... +++.||+|++............+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567899999999999999999876 57899999987654344445667889999999999999999998766554
Q ss_pred --EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 483 --RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 483 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
.++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 569999885 35689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99765432 223467889999999865 367899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=250.01 Aligned_cols=192 Identities=31% Similarity=0.451 Sum_probs=167.8
Q ss_pred eccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCCh
Q 007103 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNL 495 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 495 (618)
||+|+||.||++... +++.+++|.+...... ......+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 4899999998755432 23456788999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccc
Q 007103 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575 (618)
Q Consensus 496 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 575 (618)
.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 999862 34689999999999999999999998 99999999999999999999999999987654332 12234
Q ss_pred eeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 568889999999998888999999999999999999999995
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=262.95 Aligned_cols=197 Identities=22% Similarity=0.370 Sum_probs=169.6
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHH------HHHHHHHHHhhcCC---CCcccccceEEee
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEE------DNFLEAVSNMSRLR---HPNIVTLAGYCAE 479 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~------~~~~~e~~~l~~l~---h~niv~l~~~~~~ 479 (618)
.+|...+.+|+|+||.|+.|.++. ..+|+||.+.+.+.-...+ -..-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358899999999999999998764 6788999887665422221 12345888888886 9999999999999
Q ss_pred CCeEEEEEEecCCC-ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 480 HGQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 480 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
++.+||+||-...| +|++++.+ ...+++.++..|+.|++.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999997654 99999973 56799999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf 616 (618)
||.+....+.. ...++||..|.|||++.+.+| +..-|||++|+++|.++..+.||
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99997765433 245789999999999999998 56689999999999999999997
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=258.99 Aligned_cols=197 Identities=33% Similarity=0.491 Sum_probs=166.7
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccc-ccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.+.|...+.||+|+||.||+|... +++.+++|.+.... .......++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345777788999999999999875 57889999886432 2333456788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+||+. |++.+++.. ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99997 588777652 234588999999999999999999999 99999999999999999999999999987554
Q ss_pred CCCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ....+++.|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 32 2346788999999985 3567889999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=256.07 Aligned_cols=198 Identities=30% Similarity=0.433 Sum_probs=169.7
Q ss_pred CcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
|+..+.||+|++|.||+|.... ++.+++|.+..........+.+..|++.+++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999998764 899999999865433334567788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
+ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.+........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 5899999732 24689999999999999999999999 999999999999999999999999999876543322
Q ss_pred ccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1 2234567789999999776 78999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=254.90 Aligned_cols=197 Identities=28% Similarity=0.438 Sum_probs=166.1
Q ss_pred CcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEEEEe
Q 007103 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
|+..+.||+|++|.||+|...+ ++.|++|++...... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 5667889999999999998864 788999998755432 23334556888899998 99999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+ +|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9 779998886322 35789999999999999999999998 99999999999999999999999999997654322
Q ss_pred cccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ....++..|+|||++.+ ..++.++|+||||+++|||++|+.||.
T Consensus 154 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 154 PY--TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred Cc--CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 21 23467889999998854 557899999999999999999999984
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=262.19 Aligned_cols=200 Identities=27% Similarity=0.380 Sum_probs=164.9
Q ss_pred cCCc-ccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHH------------HHHHHHHHHHHhhcCCCCcccccce
Q 007103 410 NSFS-QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ------------EEDNFLEAVSNMSRLRHPNIVTLAG 475 (618)
Q Consensus 410 ~~~~-~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~ 475 (618)
++|. ..+.||+|+||.||+|... +++.||+|++........ ....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3567999999999999865 589999999865432210 0124678999999999999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcE
Q 007103 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (618)
Q Consensus 476 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 555 (618)
++...+..++||||++ |+|.+++. ....+++.....++.|++.||+|||+. +|+||||+|+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 58998885 345689999999999999999999998 999999999999999999999
Q ss_pred EeeccccccCCCC-------------CcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 556 LSDCGLAALTPNT-------------ERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 556 l~Dfgl~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+|||++...... .........++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999998755411 01111223568889999999764 46899999999999999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=280.93 Aligned_cols=147 Identities=27% Similarity=0.399 Sum_probs=131.3
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|.+.+.||+|+||.||+|... +++.||+|+++.... .......+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999876 589999999875432 3334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
||+.+++|.++++. .+.+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999963 34688899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=261.88 Aligned_cols=197 Identities=27% Similarity=0.379 Sum_probs=163.1
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--------
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-------- 480 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 480 (618)
.+|...+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 57888999999999999999775 588999999865432 3456788899999999999999999876554
Q ss_pred ------CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCC
Q 007103 481 ------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELN 553 (618)
Q Consensus 481 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~ 553 (618)
...++|+||++ ++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 35789999997 58888774 34688999999999999999999999 999999999999998 5567
Q ss_pred cEEeeccccccCCCCCccc--ccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 554 PHLSDCGLAALTPNTERQV--STQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+||+|||.+.......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 8999999987653322111 122357889999998755 557889999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=243.87 Aligned_cols=201 Identities=25% Similarity=0.411 Sum_probs=165.8
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--------
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-------- 480 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 480 (618)
..|+....+|+|.||.||+|+..+ |+.||+|++--...........++|++++..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456677789999999999998764 77888887643332333345567899999999999999999988542
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++|+.+|+. +|.-++. +...+++..++.+++.++..||.|+|.. .|+|||+||.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 357999999986 8888885 3346799999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCc---ccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTER---QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++.+..... ...+..+-|..|++||.+.+ +.|+++.|||+-|||+.||.||.+-|+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 9976543222 22344567999999999987 569999999999999999999987654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=267.44 Aligned_cols=208 Identities=27% Similarity=0.461 Sum_probs=175.7
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
+..+...+..|++.+.||.|.+|.||+++.. +|+..|+|+...... ..+++..|..+++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445556778999999999999999999654 688889988764432 344556677777766 69999999999864
Q ss_pred -----CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCc
Q 007103 480 -----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 480 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
++++|||||||.+|+..|+++... +..+.|..+..|+..+++|+.+||.. .++|||+|-.|||++.++.|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 468999999999999999998654 77899999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcccccceeccccccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-----IYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
|++|||.+........ .+...+|||.|||||++... .|+.++|+||||++..||--|.+|+.+
T Consensus 163 KLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred EEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 9999999977654433 33456899999999999643 377889999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=244.53 Aligned_cols=179 Identities=23% Similarity=0.272 Sum_probs=151.5
Q ss_pred CccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCChhhhh
Q 007103 421 GSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499 (618)
Q Consensus 421 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 499 (618)
|.+|.||++... +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999765 58999999987542 1223334444557999999999999999999999999999999988
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccceecc
Q 007103 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579 (618)
Q Consensus 500 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 579 (618)
.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....++
T Consensus 77 ~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~ 145 (237)
T cd05576 77 SK----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVE 145 (237)
T ss_pred HH----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcC
Confidence 63 34589999999999999999999998 99999999999999999999999999876543321 223456
Q ss_pred ccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 580 ~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..|+|||.+.+..++.++||||+|+++|||++|+.||+
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 78999999988889999999999999999999998865
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=260.85 Aligned_cols=208 Identities=18% Similarity=0.260 Sum_probs=154.1
Q ss_pred hhhcCCcccceeccCccceEEEEEE-----------------cCCcEEEEEEcCcccccHH------------HHHHHHH
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEF-----------------ANGKIMAVKKIDNAALSLQ------------EEDNFLE 457 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~------------~~~~~~~ 457 (618)
...++|++.++||+|+||.||+|.. ..++.||||++........ ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3567899999999999999999964 2356899999864321110 1112334
Q ss_pred HHHHhhcCCCCcc-----cccceEEee--------CCeEEEEEEecCCCChhhhhhcccC--------------------
Q 007103 458 AVSNMSRLRHPNI-----VTLAGYCAE--------HGQRLLVYEYVGNGNLHDMLHFADD-------------------- 504 (618)
Q Consensus 458 e~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 504 (618)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 5666666766554 677777753 3568999999999999999863211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccceeccccccC
Q 007103 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584 (618)
Q Consensus 505 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 584 (618)
....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112356788899999999999999999 99999999999999999999999999997554322221122345789999
Q ss_pred ccccccCC--------------------CC--cccchhhHHHHHHHHHhCCC-CCC
Q 007103 585 PEFALSGI--------------------YT--VKSDVYSFGVVMLELLTGRK-PLD 617 (618)
Q Consensus 585 PE~~~~~~--------------------~~--~~~DvwslG~il~elltg~~-Pf~ 617 (618)
||.+.... |+ .+.||||+||++|||++|.. ||+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 99986432 11 24799999999999999986 664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=258.55 Aligned_cols=191 Identities=29% Similarity=0.357 Sum_probs=160.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 486 (618)
+..|.....+|.|+|+.|-.+... .++..++|++.+.... -.+|+.++... +||||+++.+.+.+..+.++|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence 567788888999999999998665 5888999999765322 23455444443 799999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee-cCCCCcEEeeccccccC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL-DDELNPHLSDCGLAALT 565 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill-~~~~~~kl~Dfgl~~~~ 565 (618)
||.+.++-+.+.+.. ...+. ..+..|+.+|+.|++|||++ ||+||||||+|||+ ++.++++|+|||.++..
T Consensus 395 ~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999988777752 22233 67778999999999999998 99999999999999 59999999999999877
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ....+-|..|.|||++....|++++||||||++||+|++|+.||+
T Consensus 467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 544 223466889999999999999999999999999999999999996
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=233.20 Aligned_cols=199 Identities=32% Similarity=0.491 Sum_probs=171.2
Q ss_pred CcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 412 FSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
|...+.||+|++|.||++...+ ++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4566789999999999998875 899999999765433 24678889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
++++|.+++.... ..+++..+..++.++++++.+||+. +++|+|++|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 80 EGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999986321 1178999999999999999999999 999999999999999999999999999977654321
Q ss_pred ccccceeccccccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFA-LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......++..|++||.+ ....++.++|||+||+++|||++|+.||+
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 122335678889999998 66778889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=239.62 Aligned_cols=205 Identities=23% Similarity=0.374 Sum_probs=169.2
Q ss_pred eehhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCC--Cc----ccc
Q 007103 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PN----IVT 472 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~ 472 (618)
+.+.......++|.+...+|+|.||.|-.+... .+..||+|+++... ...+.-+-|+++++++.+ |+ ++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 444455566889999999999999999999654 37889999987432 223445667888888832 22 788
Q ss_pred cceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC--
Q 007103 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-- 550 (618)
Q Consensus 473 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-- 550 (618)
+.+||+-.++.++|+|.++ -++.+++.. +...+++...++.++.|++++++|||+. +++|-||||+|||+.+
T Consensus 156 m~~wFdyrghiCivfellG-~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELLG-LSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE 229 (415)
T ss_pred eehhhhccCceEEEEeccC-hhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence 8999999999999999884 499999973 3456788999999999999999999999 9999999999999831
Q ss_pred ------------------CCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhC
Q 007103 551 ------------------ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG 612 (618)
Q Consensus 551 ------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 612 (618)
+..+||+|||.|+...... ...+.|..|+|||++.+-.++.++||||+||||+|++||
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 3458999999997654332 457889999999999999999999999999999999999
Q ss_pred CCCCC
Q 007103 613 RKPLD 617 (618)
Q Consensus 613 ~~Pf~ 617 (618)
..-|.
T Consensus 306 ~~LFq 310 (415)
T KOG0671|consen 306 ETLFQ 310 (415)
T ss_pred ceecc
Confidence 98774
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=262.16 Aligned_cols=201 Identities=21% Similarity=0.277 Sum_probs=144.6
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceE------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY------ 476 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------ 476 (618)
..++|+..+.||+|+||.||+|.+.+ +..||+|++..... .+.+..+ .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 45689999999999999999998754 68999998764221 1111111 1122223333322221
Q ss_pred EeeCCeEEEEEEecCCCChhhhhhcccCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 007103 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDS----------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRN 540 (618)
Q Consensus 477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D 540 (618)
.......++|+||+++++|.++++..... ........+..++.|++.||+|||++ +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 23456889999999999999988632110 01112344668999999999999999 999999
Q ss_pred CCCCCeeecC-CCCcEEeeccccccCCCCCcccccceeccccccCccccccC----------------------CCCccc
Q 007103 541 FKSANILLDD-ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG----------------------IYTVKS 597 (618)
Q Consensus 541 lkp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 597 (618)
|||+|||+++ ++.+||+|||+++..............+++.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 57999999999986654444444557899999999976422 234567
Q ss_pred chhhHHHHHHHHHhCCCCCC
Q 007103 598 DVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 598 DvwslG~il~elltg~~Pf~ 617 (618)
|||||||++|||+++..|++
T Consensus 361 DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc
Confidence 99999999999999887764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=221.44 Aligned_cols=191 Identities=21% Similarity=0.400 Sum_probs=162.6
Q ss_pred hcCCcccceeccCccceEEEEE-EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCC--eEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG--QRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~ 484 (618)
.++|++.+.+|+|.|++||.|. ..+.++++||.++.. ..+.+.+|+++++.+. ||||++++++..+.. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4678999999999999999995 456888999998743 3667889999999996 999999999998754 568
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-CCCcEEeeccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAA 563 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~ 563 (618)
+|+||+++.+...+.. .++..++..++.+++.||.|+|++ ||+|||+||.|++||. .-+++|+|+|+|.
T Consensus 112 LiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 9999999988877663 577788999999999999999999 9999999999999994 5679999999998
Q ss_pred cCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
.+...... ...+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||
T Consensus 182 FYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 182 FYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred hcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence 77543222 22456778999999976 45889999999999999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=232.59 Aligned_cols=197 Identities=23% Similarity=0.313 Sum_probs=168.4
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 481 (618)
...+|.....+|.|.- .|-.|.+ -.++.||+|+...+.......++..+|..++..+.|+||++++.++.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456777888999988 5555533 35899999999877666667788889999999999999999999986543
Q ss_pred -eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 482 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
..|+|||+|.. +|.+.++ -+++..++..+..|++.|++|||+. +|+||||||+||++..+..+||.|||
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 56999999965 8988886 4578889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++.-... -..+.++.|..|.|||++.+-.|.+.+||||+||++.||++|+.-|.
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 99765432 34566789999999999999889999999999999999999987653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=228.86 Aligned_cols=186 Identities=37% Similarity=0.567 Sum_probs=163.4
Q ss_pred ccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCChhhhhh
Q 007103 422 SLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH 500 (618)
Q Consensus 422 ~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 500 (618)
+||.||+|...+ |+.+++|++........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999998874 89999999976543321 6788999999999999999999999999999999999999999999986
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccceeccc
Q 007103 501 FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580 (618)
Q Consensus 501 ~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~ 580 (618)
. ...+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++.
T Consensus 80 ~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 80 K----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred h----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 3 22388999999999999999999999 99999999999999999999999999997765432 223456888
Q ss_pred cccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 581 GYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 581 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.|++||.+.+..++.++||||||+++|+|++|+.||+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~ 187 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFP 187 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999998889999999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-28 Score=256.48 Aligned_cols=198 Identities=26% Similarity=0.367 Sum_probs=161.5
Q ss_pred CCcccceeccCccc-eEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLG-RVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 488 (618)
-|...+++|.|+.| .||+|... |+.||||++-.. ..+...+|+..++.- .|||||++++.-.++...|++.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 46667789999998 57999885 889999998532 345567899988876 69999999999888999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---C--CCcEEeeccccc
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---E--LNPHLSDCGLAA 563 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~--~~~kl~Dfgl~~ 563 (618)
.|.. +|.+++...............+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9976 99999975311111111144577889999999999998 9999999999999975 3 468999999999
Q ss_pred cCCCCCcccc--cceeccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCC
Q 007103 564 LTPNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG-RKPLDR 618 (618)
Q Consensus 564 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~Pf~~ 618 (618)
..+....... ....||-+|+|||++....-+.++||||+||++|+.++| ..||.+
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 8875544333 356899999999999998888899999999999999995 999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=275.05 Aligned_cols=220 Identities=30% Similarity=0.530 Sum_probs=145.6
Q ss_pred hccCCChHHHHHHHHHHHhCCCCC-CCCCCCCCCCCCCCCCCceeEeeC-CCEEEEEcCCCCCcccccccccCCCCCCEE
Q 007103 35 VQCTTDSSDVQALQVLYTSLNSPS-VLTNWKGNEGDPCGESWKGVACEG-SAVVSIDISGLGLSGTMGYLLSDLLSLRKF 112 (618)
Q Consensus 35 ~~~~~~~~~~~al~~~~~~~~~~~-~~~~w~~~~~~~c~~~w~gv~c~~-~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L 112 (618)
..+..+++|.+||++||+++++|. .+.+|+. ..++| .|.||.|+. ++|+.|+|++|+++|.++..|..+++|+.|
T Consensus 22 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c--~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L 98 (968)
T PLN00113 22 NFSMLHAEELELLLSFKSSINDPLKYLSNWNS-SADVC--LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTI 98 (968)
T ss_pred HccCCCHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCC--cCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEE
Confidence 334457799999999999998764 6789974 34666 899999974 689999999999998888888888888888
Q ss_pred EecCCCccCCCCCCCC---CCccEEecccccccc----------------------cCCccccCCCCccEEEeecCCCCC
Q 007103 113 DLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG----------------------NLPYSIASMVSLSYLNVSRNSLTQ 167 (618)
Q Consensus 113 ~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~~----------------------~~p~~~~~l~~L~~L~L~~N~l~~ 167 (618)
+|++|+++|.+|..+. ++|++|+|++|++++ .+|..++++++|++|+|++|.+++
T Consensus 99 ~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~ 178 (968)
T PLN00113 99 NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178 (968)
T ss_pred ECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc
Confidence 8888888877775432 455555555555554 455555555555555555555555
Q ss_pred ccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cC-CCCccEEEcccccccccCchhhh-
Q 007103 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS-GLPLTTLNVANNHFSGWIPRELI- 244 (618)
Q Consensus 168 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-~~~L~~L~l~~N~l~g~ip~~~~- 244 (618)
.+|..++++++|++|+|++|++.+.+|..++++++|++|+|++|++++.+|. +. ..+|+.|+|++|+++|.+|..+.
T Consensus 179 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 258 (968)
T PLN00113 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258 (968)
T ss_pred cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhC
Confidence 5555555555555555555555555555555555556666665555554433 12 13466666666666666665543
Q ss_pred --cccchhccCCcCC
Q 007103 245 --SIRTFIYDGNSFD 257 (618)
Q Consensus 245 --~l~~l~~~~N~~~ 257 (618)
+|+.|.+.+|.+.
T Consensus 259 l~~L~~L~L~~n~l~ 273 (968)
T PLN00113 259 LKNLQYLFLYQNKLS 273 (968)
T ss_pred CCCCCEEECcCCeee
Confidence 3445555665543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=218.21 Aligned_cols=196 Identities=22% Similarity=0.375 Sum_probs=158.8
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceE-EeeCCeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY-CAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~ 484 (618)
..+.|.+.+.||+|.||.+-+++++. .+.+++|-+..+.. ..++|.+|..---.+ .|.||+.-|++ |...+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 45678999999999999999998875 67889998876543 356788887653334 58999988775 56678889
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec--CCCCcEEeecccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLA 562 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfgl~ 562 (618)
+++||++.|+|.+-+. ...+-+....+++.|+++|++|||+. ++||||||.+||||- +...+|++|||++
T Consensus 99 F~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 9999999999998774 35677888899999999999999999 999999999999994 4458999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSG-----IYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
+........ ...+..|.+||..... ...+.+|||.||+++|.++||+.||++
T Consensus 171 ~k~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 171 RKVGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred cccCceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 766433222 2345679999987532 246789999999999999999999974
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-27 Score=242.52 Aligned_cols=199 Identities=29% Similarity=0.454 Sum_probs=172.4
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
....+|+..+.+|.|.||.||||+.. .++..|+|.++..... ..+-...|+-+++..+||||+.++|.+...+..++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 45678999999999999999999765 5889999999865533 34556778888999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
+|||+.+|+|.+..+ ..+.+++.++..+.+...+|++|||++ +-+|||||-.||++++.|.+|++|||.+..+
T Consensus 90 cMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence 999999999999987 567899999999999999999999999 8899999999999999999999999988554
Q ss_pred CCCCcccccceeccccccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFA---LSGIYTVKSDVYSFGVVMLELLTGRKP 615 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~P 615 (618)
... -..+..+.||++|||||+. +.+.|..++|||++|+...|+-.-+.|
T Consensus 163 tat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 163 TAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred hhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 322 2234567999999999987 356689999999999999998777666
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=203.91 Aligned_cols=184 Identities=36% Similarity=0.594 Sum_probs=159.0
Q ss_pred eccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCChh
Q 007103 418 IGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLH 496 (618)
Q Consensus 418 Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 496 (618)
||+|.+|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998865 8999999997654322 3577899999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-CCCcEEeeccccccCCCCCcccccc
Q 007103 497 DMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTPNTERQVSTQ 575 (618)
Q Consensus 497 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~ 575 (618)
+++... ...+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 80 DLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 998632 14688999999999999999999999 9999999999999999 89999999999976654321 1223
Q ss_pred eeccccccCccccccC-CCCcccchhhHHHHHHHH
Q 007103 576 MVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLEL 609 (618)
Q Consensus 576 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el 609 (618)
..+...|++||.+... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4577889999999887 788999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=224.40 Aligned_cols=207 Identities=25% Similarity=0.307 Sum_probs=170.1
Q ss_pred ceehhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC------CCccc
Q 007103 399 SYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR------HPNIV 471 (618)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv 471 (618)
.|.+...+..-.+|......|+|-|+.|.+|... .|..||||++.....- .+.=+.|+++|.++. --|++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 3555556667778888889999999999999765 4889999999865432 223357888888884 34799
Q ss_pred ccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
+++..|....++++|+|.+.. +|.++++.... .-.+....+..++.|+.-||..|... +|+|.||||+|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 999999999999999999865 89999975543 34577889999999999999999998 99999999999999865
Q ss_pred -CCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 552 -LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 552 -~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
..+||||||.|......+ . +.+.-+.-|.|||++.+-.|....|+||+||.||||+||+.-|
T Consensus 573 k~iLKLCDfGSA~~~~ene--i-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE--I-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cceeeeccCcccccccccc--c-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 568999999997654332 1 2234456799999999999999999999999999999999877
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=215.16 Aligned_cols=131 Identities=22% Similarity=0.440 Sum_probs=109.3
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-----C---CcccccceEEeeC
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----H---PNIVTLAGYCAEH 480 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~ 480 (618)
.+|...++||-|.|++||++... +.+.||+|+.+.+. ...+..+.||+++++++ | ..||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 78999999999999999999654 56789999987443 23455678899988873 3 3599999999764
Q ss_pred C----eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 007103 481 G----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (618)
Q Consensus 481 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill 548 (618)
+ +.++|+|++.. +|..++... ..+.++...+.+|++||+.||.|||+.+ +|||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvLGd-nLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGD-NLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhhhh-HHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 3 78999999955 888888754 4567888999999999999999999998 99999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=217.40 Aligned_cols=198 Identities=27% Similarity=0.399 Sum_probs=164.4
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
+....+.|...++||+|.|++||++.+. ..+.||+|.+.... ....+..|++++..+ .+.||+++.+.+..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3445677889999999999999999654 36789999986433 456688999999988 59999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCcEEee
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSD 558 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~D 558 (618)
++...+|+||++.....+++. .++..++..++..+..||+++|++ |||||||||.|+|.+ ..+.-.|+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 999999999999988888875 356788999999999999999999 999999999999998 456789999
Q ss_pred ccccccCC-----------------C-C---------------Ccc----------cccceeccccccCccccccC-CCC
Q 007103 559 CGLAALTP-----------------N-T---------------ERQ----------VSTQMVGAFGYSAPEFALSG-IYT 594 (618)
Q Consensus 559 fgl~~~~~-----------------~-~---------------~~~----------~~~~~~gt~~y~aPE~~~~~-~~~ 594 (618)
||++.... . . ... .....+||++|+|||++... ..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99996110 0 0 000 01124799999999999764 468
Q ss_pred cccchhhHHHHHHHHHhCCCCC
Q 007103 595 VKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 595 ~~~DvwslG~il~elltg~~Pf 616 (618)
+++||||.|||+.-+++++.||
T Consensus 257 taiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred Cccceeeccceeehhhcccccc
Confidence 9999999999999999999998
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=216.84 Aligned_cols=169 Identities=17% Similarity=0.154 Sum_probs=130.5
Q ss_pred hhhcCCcccceeccCccceEEEEEEc--CCcEEEEEEcCcccc---cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
....+|...+.||+|+||.||+|.+. +++.+|||++..... .......+.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34567999999999999999999765 578889998753311 23345678999999999999999863322 25
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCCeeecCCCCcEEeecc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF-KSANILLDDELNPHLSDCG 560 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfg 560 (618)
..++||||+++++|... . ... ...++.|+++||+|||+. +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 68999999999999632 1 111 145788999999999999 9999999 9999999999999999999
Q ss_pred ccccCCCCCccc-------ccceeccccccCccccccCC
Q 007103 561 LAALTPNTERQV-------STQMVGAFGYSAPEFALSGI 592 (618)
Q Consensus 561 l~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~ 592 (618)
+++......... -+...+++.|+|||.+...+
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 998664332111 13457889999999986543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-23 Score=187.01 Aligned_cols=199 Identities=23% Similarity=0.323 Sum_probs=164.8
Q ss_pred hcCCcccceeccCccceEEEEE-EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCC-CcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 486 (618)
...|...+.||.|+||.+|.|. ..+|++||||.-...... .++..|.++...+++ ..|..+..+..+.....+|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 4678899999999999999995 457999999987655433 346677777777764 5677777777888889999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCcEEeeccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl~~ 563 (618)
|+.+. -+|+++..++. ..++..+++-.+-|++.-++|+|.+ ++|||||||+|+|+.- ...+.++|||+++
T Consensus 90 MdLLG-PsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLLG-PSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeccC-ccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 99985 49999998763 5688999999999999999999999 9999999999999973 3568899999998
Q ss_pred cCCCCCcc------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 564 LTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 564 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.+.+.... ......||.+|.+-....+.+.+.+.|+-|+|.++.+...|..||+.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 76533221 12345799999999999999999999999999999999999999973
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=205.95 Aligned_cols=199 Identities=22% Similarity=0.260 Sum_probs=159.5
Q ss_pred CCcccceeccCccceEEEEEEcCC--cEEEEEEcCcccccHHHHHHHHHHHHHhhcCC----CCcccccceEE-eeCCeE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFANG--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR----HPNIVTLAGYC-AEHGQR 483 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~~ 483 (618)
+|.+.+.||+|+||.||++..... +.+|+|......... . ..+..|..++..+. -+++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 789999999999999999987653 477887765432221 1 14566667666665 25888888888 477788
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-----CCcEEee
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-----LNPHLSD 558 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-----~~~kl~D 558 (618)
++||+.+ +.+|.++..... .+.++..+..+++.|++.+|++||+. |++||||||.|+++... ..+.|.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 9999987 559999775432 57899999999999999999999999 99999999999999854 4689999
Q ss_pred ccccc--cCCCCCc----cc---ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAA--LTPNTER----QV---STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+++ ....... .. .....||.+|++++...+...+++.|+||++.++.|++.|..||.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCc
Confidence 99998 3322211 11 123569999999999999999999999999999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-23 Score=236.76 Aligned_cols=146 Identities=16% Similarity=0.193 Sum_probs=113.9
Q ss_pred CCC-CcccccceEE-------eeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 007103 465 LRH-PNIVTLAGYC-------AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536 (618)
Q Consensus 465 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 536 (618)
++| +||.++++++ ...+..+.++||+ +++|.++++. ....+++.++..++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 345 5888888877 2234677889987 5599999962 245689999999999999999999999 99
Q ss_pred eecCCCCCCeeecC-------------------CCCcEEeeccccccCCCCCc---------------ccccceeccccc
Q 007103 537 VHRNFKSANILLDD-------------------ELNPHLSDCGLAALTPNTER---------------QVSTQMVGAFGY 582 (618)
Q Consensus 537 iH~Dlkp~Nill~~-------------------~~~~kl~Dfgl~~~~~~~~~---------------~~~~~~~gt~~y 582 (618)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566667776653211000 001113588999
Q ss_pred cCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 583 ~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||||++.+..|+.++|||||||++|||++|..|+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 99999999999999999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-21 Score=197.10 Aligned_cols=200 Identities=36% Similarity=0.568 Sum_probs=170.6
Q ss_pred CcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHH-HHHHHHHHHHHhhcCCCC-cccccceEEeeCCeEEEEEEe
Q 007103 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ-EEDNFLEAVSNMSRLRHP-NIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 489 (618)
|...+.||.|+||.||++... ..+++|.+........ ....+.+|+..++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999886 8889999987665443 577889999999999988 799999999777778999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEeeccccccCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNT 568 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~ 568 (618)
+.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777522111 3788999999999999999999999 899999999999999888 7999999999755443
Q ss_pred Ccc-----cccceeccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQ-----VSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 322 2345689999999999988 578899999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=187.32 Aligned_cols=197 Identities=20% Similarity=0.324 Sum_probs=164.8
Q ss_pred cCCcccceeccCccceEEEEE-EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 487 (618)
-.|...+.||+|.||+++.|. +-+++.||||.-.... +..+++.|....+.+ ..++|..++-+........||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 468888999999999999995 4579999999754322 344566777766666 5789999888878888889999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-----CCcEEeecccc
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-----LNPHLSDCGLA 562 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-----~~~kl~Dfgl~ 562 (618)
|.+. -+|+|+...+ +..++.+++..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|
T Consensus 104 dLLG-PSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLLG-PSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhC-cCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9985 4999988755 46799999999999999999999999 89999999999999743 45789999999
Q ss_pred ccCCCCCccc------ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQV------STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.+.+..... .....||.+||+-....+++.+++.|+-|||-++.+.+.|..||+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccc
Confidence 8776554321 234579999999999999999999999999999999999999996
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=183.54 Aligned_cols=142 Identities=20% Similarity=0.234 Sum_probs=109.5
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccHHH------------------------HHHHHHHHHHhhcCCCCcc
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE------------------------EDNFLEAVSNMSRLRHPNI 470 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni 470 (618)
...||+|++|.||+|...+|+.||+|+++........ ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754321111 1122458889999988877
Q ss_pred cccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCceecCCCCCCeeec
Q 007103 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL-HEVCLPSVVHRNFKSANILLD 549 (618)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~Dlkp~Nill~ 549 (618)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|+|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54433322 23489999999887765432 235688999999999999999999 687 999999999999998
Q ss_pred CCCCcEEeeccccccCC
Q 007103 550 DELNPHLSDCGLAALTP 566 (618)
Q Consensus 550 ~~~~~kl~Dfgl~~~~~ 566 (618)
+ +.++|+|||++....
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 4 789999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=183.73 Aligned_cols=175 Identities=13% Similarity=0.163 Sum_probs=135.4
Q ss_pred hhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHH-H------HHHHHHHHhhcCCCCcccccceEEe
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEE-D------NFLEAVSNMSRLRHPNIVTLAGYCA 478 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~-~------~~~~e~~~l~~l~h~niv~l~~~~~ 478 (618)
....++|...+++|.|+||.||++.. ++..+|+|.+.......+.. . .+.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 44567899999999999999999876 57789999997654333221 2 2578899999999999999988865
Q ss_pred eC--------CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC
Q 007103 479 EH--------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD 550 (618)
Q Consensus 479 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~ 550 (618)
.. +..++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||++|+||++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 35789999999999987642 222 2455899999999999 9999999999999999
Q ss_pred CCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHH
Q 007103 551 ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610 (618)
Q Consensus 551 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 610 (618)
++ ++|+|||........... ..++....|..++|+||||+.+....
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988655322111 11344556778999999999876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-22 Score=185.17 Aligned_cols=195 Identities=21% Similarity=0.375 Sum_probs=157.3
Q ss_pred CcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecC
Q 007103 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
....-+|.+...|+.|+|+|+. ..+++|++..........++|.+|.-.++.+.||||++++|.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 3344468899999999999984 445568877666666667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEe--eccccccCCCCC
Q 007103 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS--DCGLAALTPNTE 569 (618)
Q Consensus 492 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~--Dfgl~~~~~~~~ 569 (618)
.|+|+..++.. ..-..+..++.+++.+|++|++|||+.. |-|.--.|.+..|++|++.+++|+ |-.++.. .
T Consensus 271 ~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq--e-- 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--E-- 343 (448)
T ss_pred chHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee--c--
Confidence 99999999843 3345788899999999999999999974 233444799999999999998875 3222211 1
Q ss_pred cccccceeccccccCccccccCCC---CcccchhhHHHHHHHHHhCCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIY---TVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.+..-.|.||+||.+...+. -+++|+|||++++|||.|++.||.+
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 12234578999999987653 3579999999999999999999975
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=208.83 Aligned_cols=136 Identities=38% Similarity=0.607 Sum_probs=84.1
Q ss_pred cCCChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC---CCCceeEeeCC------CEEEEEcCCCCCcccccccccCCC
Q 007103 37 CTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCG---ESWKGVACEGS------AVVSIDISGLGLSGTMGYLLSDLL 107 (618)
Q Consensus 37 ~~~~~~~~~al~~~~~~~~~~~~~~~w~~~~~~~c~---~~w~gv~c~~~------~v~~l~l~~~~l~~~~~~~l~~l~ 107 (618)
..+.+.|.+||+++|++++++.. .+|.+ |+|. +.|.||.|... .|+.|+|++|+|.|.+|..++.|+
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~-~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR-FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc-CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 45677899999999999977542 48964 4553 47999999631 255556655555555555555555
Q ss_pred CCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccC
Q 007103 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFN 187 (618)
Q Consensus 108 ~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 187 (618)
+|+.|+|++|+|+ |.+|..++.+++|+.|+|++|+|+|.+|+.++++++|+.|+|++|
T Consensus 443 ~L~~L~Ls~N~l~----------------------g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 443 HLQSINLSGNSIR----------------------GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred CCCEEECCCCccc----------------------CcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence 5544444444443 344455555556666666666666666666666666666666666
Q ss_pred cCCCCCCCCcc
Q 007103 188 NFSGDLPNSFI 198 (618)
Q Consensus 188 ~l~g~~p~~~~ 198 (618)
+|+|.+|..+.
T Consensus 501 ~l~g~iP~~l~ 511 (623)
T PLN03150 501 SLSGRVPAALG 511 (623)
T ss_pred cccccCChHHh
Confidence 66666655543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=175.82 Aligned_cols=142 Identities=20% Similarity=0.234 Sum_probs=111.4
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccH------------------------HHHHHHHHHHHHhhcCCCCcc
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL------------------------QEEDNFLEAVSNMSRLRHPNI 470 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~h~ni 470 (618)
...||+|++|.||+|...+|+.||||++....... .....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999988789999999987542110 002234578889999999987
Q ss_pred cccceEEeeCCeEEEEEEecCCCChhhh-hhcccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeee
Q 007103 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDM-LHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILL 548 (618)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dlkp~Nill 548 (618)
.....+... ..++||||++++++... +. ...++..+..+++.|++.++.++|+ . ||+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 555444333 34899999998755432 32 3457788899999999999999999 8 99999999999999
Q ss_pred cCCCCcEEeeccccccCCC
Q 007103 549 DDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 549 ~~~~~~kl~Dfgl~~~~~~ 567 (618)
+ ++.++|+|||++...+.
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999976653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=170.66 Aligned_cols=184 Identities=16% Similarity=0.129 Sum_probs=137.6
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEEcCcccccH--HHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEEEEec
Q 007103 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL--QEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 414 ~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
....|++|+||+||.+.. .+.+++.+.+.....-. -....+.+|+++++++. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 345799999999998866 57888878776544321 12336789999999995 5789988886 4579999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF-KSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
.+.+|.+... .. ...++.|++++|+++|+. ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~-----~~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPP-----RG------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhh-----hh------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9988865432 11 134678999999999999 9999999 7999999999999999999997554322
Q ss_pred cc----c--------ccceeccccccCccccccC-CCC-cccchhhHHHHHHHHHhCCCCC
Q 007103 570 RQ----V--------STQMVGAFGYSAPEFALSG-IYT-VKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 570 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltg~~Pf 616 (618)
.. . ......++.|++|+...-- ..+ ...++++-|.-+|.++||..|+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 0 0112356777888754322 223 5679999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=176.02 Aligned_cols=105 Identities=31% Similarity=0.345 Sum_probs=93.1
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.++++. ....+++.+++.++.|++.||+|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999863 245699999999999999999999998 5 999999999999999 99987654322
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 105 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 258899999999999999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-21 Score=208.69 Aligned_cols=197 Identities=25% Similarity=0.308 Sum_probs=158.3
Q ss_pred cccceeccCccceEEEEEEc-CCcEEEEEEcC----cccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKID----NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
....++|.|++|.|+.+... ..+.++.|.+. ......+....+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45668999999988777433 34444444433 22212222233677888888999999998888887777766679
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++ +|..++. ....+...++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999885 235788899999999999999999999 999999999999999999999999999976643
Q ss_pred CCc---ccccceeccccccCccccccCCCCc-ccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TER---QVSTQMVGAFGYSAPEFALSGIYTV-KSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......+|+-.|+|||.+.+.+|.+ ..||||.|+++..|.+|+.||.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 332 4556789999999999999999975 5999999999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-21 Score=198.98 Aligned_cols=187 Identities=26% Similarity=0.394 Sum_probs=156.2
Q ss_pred eeccCccceEEEEE----EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEEEEecC
Q 007103 417 LIGEGSLGRVYRAE----FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
.+|+|.||.|++++ ...|..+|.|..++.............|..++...+ ||.++++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999763 234788999988766543333334555666777776 9999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc
Q 007103 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571 (618)
Q Consensus 492 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 571 (618)
+|++...+. ....+++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999988775 445677777888888999999999999 999999999999999999999999999976543322
Q ss_pred cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 572 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+||..|||||++. .....+|.||||++++||+||..||.
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 28999999999998 45678999999999999999999995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=164.11 Aligned_cols=139 Identities=16% Similarity=0.215 Sum_probs=105.6
Q ss_pred CcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-----CCCcccccceEEeeCC---eE
Q 007103 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNIVTLAGYCAEHG---QR 483 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~ 483 (618)
+...+.||+|+||.||. +++....+||++..... ...+.+.+|++.++.+ .||||++++|+++++. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999996 44333347888865432 2456789999999999 5799999999998873 43
Q ss_pred E-EEEEe--cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCceecCCCCCCeeecC----CCCcE
Q 007103 484 L-LVYEY--VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARAL-EYLHEVCLPSVVHRNFKSANILLDD----ELNPH 555 (618)
Q Consensus 484 ~-lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~k 555 (618)
+ +|+|| +.+|+|.+++.. ..+++. ..++.|++.++ +|||+. +|+||||||+|||++. ++.++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 3 78999 557999999962 235554 35577778777 999999 9999999999999974 34799
Q ss_pred Eee-cccccc
Q 007103 556 LSD-CGLAAL 564 (618)
Q Consensus 556 l~D-fgl~~~ 564 (618)
|+| ||....
T Consensus 150 LiDg~G~~~~ 159 (210)
T PRK10345 150 VCDNIGESTF 159 (210)
T ss_pred EEECCCCcce
Confidence 999 454433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=192.83 Aligned_cols=200 Identities=22% Similarity=0.245 Sum_probs=156.9
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHH-HHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ-EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.+.....|.+.+.+|+|+||.||+|...+|+.||+|.=+......- -..+++..++ ..--+-|..+...+.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCCcc
Confidence 3444567888899999999999999988899999998775542210 1122222222 00123455555555667788
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-------CCCcEE
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-------ELNPHL 556 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-------~~~~kl 556 (618)
++|+||.+.|+|.+++. ..+.++|..++.++.|+++.+++||.. +|||+||||+|+|+.. ...++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999997 677899999999999999999999999 9999999999999952 345899
Q ss_pred eeccccccCCCC-CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 007103 557 SDCGLAALTPNT-ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRK 614 (618)
Q Consensus 557 ~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 614 (618)
+|||.+..+.-. +.......++|-.+-.+|+..++.++.++|.|.++-+++-|+.|++
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999998544211 2234456788999999999999999999999999999999999974
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-20 Score=163.31 Aligned_cols=173 Identities=25% Similarity=0.381 Sum_probs=152.1
Q ss_pred eCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEE
Q 007103 81 EGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (618)
Q Consensus 81 ~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (618)
+..+++.|.|++|.|+ .+|+.+..|.+|+.|++++|+|+ .+|.++. ++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3467999999999997 57888999999999999999999 7887877 89999999999999 899999999999999
Q ss_pred EeecCCCC-CccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEccccccc
Q 007103 159 NVSRNSLT-QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFS 236 (618)
Q Consensus 159 ~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~ 236 (618)
||.+|++. ..+|..|-.++.|+.|+|++|.|. .+|..++++++|+.|.+..|.+-..+..... ..|++|++.+|+++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee
Confidence 99999998 467888889999999999999999 8999999999999999999998876554443 35999999999999
Q ss_pred ccCchhhhccc------chhccCCcCCC
Q 007103 237 GWIPRELISIR------TFIYDGNSFDN 258 (618)
Q Consensus 237 g~ip~~~~~l~------~l~~~~N~~~~ 258 (618)
.+|++++++. .+.+..|||-.
T Consensus 187 -vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 187 -VLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred -ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 8998887764 45566777754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=163.06 Aligned_cols=145 Identities=18% Similarity=0.156 Sum_probs=111.3
Q ss_pred CCcccceeccCccceEEEEE--EcCCcEEEEEEcCcccccH----------------------HHHHHHHHHHHHhhcCC
Q 007103 411 SFSQEFLIGEGSLGRVYRAE--FANGKIMAVKKIDNAALSL----------------------QEEDNFLEAVSNMSRLR 466 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~ 466 (618)
.|.+.+.||+|++|.||+|. ..+|+.||+|.+....... .....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 5679999999987432100 01234568899998887
Q ss_pred CCc--ccccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCC
Q 007103 467 HPN--IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-VVHRNFKS 543 (618)
Q Consensus 467 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~Dlkp 543 (618)
+.. +.+++++ ...++||||+++++|..... ........+...++.|++.++++||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3333332 24589999999988876542 223456667789999999999999999 8 99999999
Q ss_pred CCeeecCCCCcEEeeccccccCCC
Q 007103 544 ANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 544 ~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
+||+++ ++.++|+|||.+.....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 78999999999875543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=156.65 Aligned_cols=138 Identities=21% Similarity=0.307 Sum_probs=114.4
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccH------HHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL------QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
+.||+|++|.||+|.+ +|..+++|+........ .....+.+|++.+..+.|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 57788899765432211 1234678899999999999998888887778889999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
+++++|.+++... .. .+..++.+++.+|+++|+. +++|||++|+||+++ ++.++|+|||.+....
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988521 11 7788999999999999999 999999999999999 7889999999987543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-18 Score=186.95 Aligned_cols=197 Identities=26% Similarity=0.283 Sum_probs=152.6
Q ss_pred CCcccceeccCccceEEEEEEcCCcEEEEEEcCccc--ccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAA--LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++...+.||++.|=.|.+|++.+|. |+||++-+.. .+.....+.++|++ ...++|||++++..+-..+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677788999999999999998888 7788875443 34444455555566 566799999999888777888899999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc--CC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TP 566 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~--~~ 566 (618)
|+.. +|+|.+. .+.-+...+..=|+.|++.||..+|+. ||+|||||.+||||+.-.=+.|+||..-+. .+
T Consensus 102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9876 8999885 445567777788999999999999999 999999999999999988899999976542 22
Q ss_pred CCCcccccce----eccccccCccccccCC-----------CCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 567 NTERQVSTQM----VGAFGYSAPEFALSGI-----------YTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~----~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.+.......+ ..-..|.|||.+.... .+++-||||+||++.||++ |++||+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 2221111111 2223699999886421 4678999999999999998 788885
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=162.58 Aligned_cols=200 Identities=22% Similarity=0.330 Sum_probs=131.8
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCccc-ccHHHHHHHHHHHHHhhcCCC----------CcccccceEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH----------PNIVTLAGYC 477 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~ 477 (618)
..+...+.||.|+++.||.+.+.+ |+.+|+|.+.... ......+++++|.-....+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 345567789999999999998875 8999999975433 233356677777665555433 1222222222
Q ss_pred e---------eC---C-----eEEEEEEecCCCChhhhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 007103 478 A---------EH---G-----QRLLVYEYVGNGNLHDMLHFAD---DSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537 (618)
Q Consensus 478 ~---------~~---~-----~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii 537 (618)
. .. . ..+++|+-+. +||.+++.... .....+....+..+..|+++.+++||+. |++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 1 11 1 2367888774 58888765311 1112244455667789999999999999 999
Q ss_pred ecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccceeccccccCccccccC--------CCCcccchhhHHHHHHHH
Q 007103 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG--------IYTVKSDVYSFGVVMLEL 609 (618)
Q Consensus 538 H~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslG~il~el 609 (618)
|+||+|+|++++++|.++|.||+........... ...+..|.+||..... .++.+.|.|++|+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999877654322111 2345779999977442 478899999999999999
Q ss_pred HhCCCCCC
Q 007103 610 LTGRKPLD 617 (618)
Q Consensus 610 ltg~~Pf~ 617 (618)
..|+.||+
T Consensus 244 WC~~lPf~ 251 (288)
T PF14531_consen 244 WCGRLPFG 251 (288)
T ss_dssp HHSS-STC
T ss_pred HHccCCCC
Confidence 99999997
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=177.32 Aligned_cols=143 Identities=17% Similarity=0.303 Sum_probs=114.2
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCccccc-----HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS-----LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
...|...+.||+|+||.||+|.+.+...++.+++.+.... ....+.+.+|++.+..++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445667899999999999998865444333333221111 12245688999999999999999888887777788
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++++|.+++. ....++.+++++|+|||+. +++||||||+|||+ +++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999999884 3467899999999999999 99999999999999 67799999999997
Q ss_pred cCCC
Q 007103 564 LTPN 567 (618)
Q Consensus 564 ~~~~ 567 (618)
....
T Consensus 476 ~~~~ 479 (535)
T PRK09605 476 YSDL 479 (535)
T ss_pred cCCc
Confidence 6543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.9e-17 Score=154.66 Aligned_cols=139 Identities=18% Similarity=0.133 Sum_probs=107.6
Q ss_pred CCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccH--------------------HHHHHHHHHHHHhhcCCCCc-
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL--------------------QEEDNFLEAVSNMSRLRHPN- 469 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~n- 469 (618)
.|...+.||+|+||.||++...+|+.||||++....... ........|+..+..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 366778899999999999998889999999865432110 01123567888888887774
Q ss_pred -ccccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 007103 470 -IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (618)
Q Consensus 470 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill 548 (618)
+.+.++ ....++||||+++++|.++... .....++.+++.++.++|+. +|+||||||+||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 333333 3456899999999998765420 23457889999999999998 99999999999999
Q ss_pred cCCCCcEEeeccccccCC
Q 007103 549 DDELNPHLSDCGLAALTP 566 (618)
Q Consensus 549 ~~~~~~kl~Dfgl~~~~~ 566 (618)
++++.++|+|||.+....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=155.30 Aligned_cols=134 Identities=21% Similarity=0.332 Sum_probs=108.2
Q ss_pred eeccCccceEEEEEEcCCcEEEEEEcCccccc------HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
.||+|++|.||+|.+ +|..+++|........ .....++.+|++.+..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 4778899986533211 112356788999999999888766666666677789999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
++++|.+++... .. .++.+++.+|++||+. +++|||++|+||+++ ++.++++|||++....
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999999887521 10 7899999999999999 999999999999999 7899999999987654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-18 Score=178.00 Aligned_cols=185 Identities=25% Similarity=0.306 Sum_probs=160.5
Q ss_pred ceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCC
Q 007103 76 KGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMV 153 (618)
Q Consensus 76 ~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~ 153 (618)
+|++....++..|+|+.|+++..-...+.+|+.|+.|+||+|.|...-+..+. ++|+.|||++|+|+..-+.+|..|.
T Consensus 262 DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~ 341 (873)
T KOG4194|consen 262 DGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS 341 (873)
T ss_pred CcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence 46665566899999999999988888999999999999999999977776554 9999999999999988899999999
Q ss_pred CccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCC---CcccCCCcCeeeecccccccccc-ccCCC-CccEE
Q 007103 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN---SFISLSNISSLYLQNNQVTGSLN-VFSGL-PLTTL 228 (618)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~---~~~~l~~L~~L~l~~N~l~~~~~-~~~~~-~L~~L 228 (618)
.|+.|+|++|+++..-...|..+++|+.|||++|.|++.|-+ .|..|++|+.|+|.+|+|..... .|.+. .|+.|
T Consensus 342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL 421 (873)
T ss_pred HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence 999999999999988888999999999999999999987754 47789999999999999997653 45554 49999
Q ss_pred EcccccccccCchhhh--cccchhccCCcCCCCC
Q 007103 229 NVANNHFSGWIPRELI--SIRTFIYDGNSFDNGP 260 (618)
Q Consensus 229 ~l~~N~l~g~ip~~~~--~l~~l~~~~N~~~~~~ 260 (618)
||.+|.|...-|..|. .|+.|-++.-.|.|.+
T Consensus 422 dL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 422 DLGDNAIASIQPNAFEPMELKELVMNSSSFLCDC 455 (873)
T ss_pred cCCCCcceeecccccccchhhhhhhcccceEEec
Confidence 9999999988888775 4567777777787764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-17 Score=177.58 Aligned_cols=164 Identities=28% Similarity=0.429 Sum_probs=121.1
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+|+.++.+..|+||.||.++++. .+.+|+| +.+... +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee---------------
Confidence 45689999999999999999998875 5677773 332211 1110 22222333333
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|+-.+.+. ..+.++. +++.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||++....
T Consensus 136 ------gDc~tllk----~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ------GDCATLLK----NIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ------chhhhhcc----cCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 55555564 2333332 237789999999 99999999999999999999999999986321
Q ss_pred C---------CCc-----ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 N---------TER-----QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~---------~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ... -...+++||+.|.|||++....|+..+|+|++|+|+||.+.|..||.
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 0 000 11235699999999999999999999999999999999999999986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-16 Score=155.80 Aligned_cols=143 Identities=24% Similarity=0.340 Sum_probs=107.9
Q ss_pred CCCcccccceEEee---------------------------CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHH
Q 007103 466 RHPNIVTLAGYCAE---------------------------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518 (618)
Q Consensus 466 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 518 (618)
+|||||++.++|.+ ...+|+||..++. +|.+++. ....+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 69999999887742 2256899998876 8999885 3345666777889
Q ss_pred HHHHHHHHHHhhcCCCCceecCCCCCCeeec--CCC--CcEEeeccccccCCCC-----CcccccceeccccccCccccc
Q 007103 519 LGTARALEYLHEVCLPSVVHRNFKSANILLD--DEL--NPHLSDCGLAALTPNT-----ERQVSTQMVGAFGYSAPEFAL 589 (618)
Q Consensus 519 ~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~--~~kl~Dfgl~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~ 589 (618)
.|+++|+.|||++ ||.|||+|++|||+. +|+ .+.|+|||.+---... .....-..-|....||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999984 443 3678999987321110 001111235677789999986
Q ss_pred cCC------CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 590 SGI------YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 590 ~~~------~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ...|+|.|+.|-+.||+++...||=
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 432 2458999999999999999999983
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=141.82 Aligned_cols=138 Identities=21% Similarity=0.253 Sum_probs=96.3
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHH----------------------HHHHHHhhcCCCCc--c
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNF----------------------LEAVSNMSRLRHPN--I 470 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~n--i 470 (618)
.+.||+|+||.||+|...+|+.||||++............+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999998889999999886543221111111 23444444443332 3
Q ss_pred cccceEEeeCCeEEEEEEecCCCChhh-hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeee
Q 007103 471 VTLAGYCAEHGQRLLVYEYVGNGNLHD-MLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILL 548 (618)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dlkp~Nill 548 (618)
.+.++. ...++||||++++.+.. .+... ... .....++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 34689999999854321 11100 011 5677899999999999999 7 99999999999999
Q ss_pred cCCCCcEEeeccccccCC
Q 007103 549 DDELNPHLSDCGLAALTP 566 (618)
Q Consensus 549 ~~~~~~kl~Dfgl~~~~~ 566 (618)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.5e-17 Score=157.21 Aligned_cols=192 Identities=26% Similarity=0.332 Sum_probs=137.6
Q ss_pred CCCCCCC---ceeEeeCC-----------CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCcc
Q 007103 69 DPCGESW---KGVACEGS-----------AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLT 132 (618)
Q Consensus 69 ~~c~~~w---~gv~c~~~-----------~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~ 132 (618)
.+|.|+= .-|.|+.. ..+.|+|..|+|+.+.+.+|..+++|+.||||+|+|+.+-|..|. ++|.
T Consensus 39 ~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~ 118 (498)
T KOG4237|consen 39 APCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLL 118 (498)
T ss_pred CCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhh
Confidence 5666654 34889753 467899999999999999999999999999999999988887775 4444
Q ss_pred EE-ecccccccccCCccccCCCCccE------------------------EEeecCCCCCcc------------------
Q 007103 133 SL-NLASNNFSGNLPYSIASMVSLSY------------------------LNVSRNSLTQSI------------------ 169 (618)
Q Consensus 133 ~L-~L~~N~l~~~~p~~~~~l~~L~~------------------------L~L~~N~l~~~~------------------ 169 (618)
+| ++++|+|+..--..|++|.+|+. |.|..|.+..+-
T Consensus 119 ~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~n 198 (498)
T KOG4237|consen 119 SLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQN 198 (498)
T ss_pred HHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcC
Confidence 43 44557777433334444444433 333333222100
Q ss_pred -------------------------------------------------------------------c-hhhcCCCCCCe
Q 007103 170 -------------------------------------------------------------------G-DIFGNLAGLAT 181 (618)
Q Consensus 170 -------------------------------------------------------------------p-~~~~~l~~L~~ 181 (618)
| ..|..|++|+.
T Consensus 199 p~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ 278 (498)
T KOG4237|consen 199 PFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRK 278 (498)
T ss_pred ccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceE
Confidence 0 12345778888
Q ss_pred EEcccCcCCCCCCCCcccCCCcCeeeecccccccccc-ccCCC-CccEEEcccccccccCchhh---hcccchhccCCcC
Q 007103 182 LDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGL-PLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSF 256 (618)
Q Consensus 182 L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~-~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~ 256 (618)
|+|++|+|++.-+.+|.++..|++|+|..|+|...-. .|.+. .|+.|+|.+|+|+-.-|-.| .+|..|++.+|||
T Consensus 279 lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 279 LNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 8888888887778888888888888888888875433 34443 49999999999998888665 5677899999999
Q ss_pred CCCC
Q 007103 257 DNGP 260 (618)
Q Consensus 257 ~~~~ 260 (618)
+|.+
T Consensus 359 ~CnC 362 (498)
T KOG4237|consen 359 NCNC 362 (498)
T ss_pred cCcc
Confidence 9976
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-16 Score=160.07 Aligned_cols=174 Identities=22% Similarity=0.244 Sum_probs=148.0
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
.+..||+++|.|+.+-+..|.+|++|+.++|.+|.++ .||.... .+|+.|+|.+|.|+..-.+++..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3566999999999999999999999999999999999 7886555 679999999999998888899999999999999
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cC-CCCccEEEcccccccc--
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS-GLPLTTLNVANNHFSG-- 237 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-~~~L~~L~l~~N~l~g-- 237 (618)
.|.|+.+.-+.|..-.++++|+|++|+|+..-...|.++.+|..|.|+.|+|+..+.. |. ...|+.|+|..|+|.-
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 9999977777888888999999999999977778899999999999999999986543 44 3459999999999862
Q ss_pred -cCchhhhcccchhccCCcCCC
Q 007103 238 -WIPRELISIRTFIYDGNSFDN 258 (618)
Q Consensus 238 -~ip~~~~~l~~l~~~~N~~~~ 258 (618)
.--..+.+|++|.+..|.+..
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~k 259 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISK 259 (873)
T ss_pred hhhhcCchhhhhhhhhhcCccc
Confidence 223455677788888887543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.2e-15 Score=158.66 Aligned_cols=151 Identities=29% Similarity=0.507 Sum_probs=126.3
Q ss_pred hhcCCCCcccccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc-eecC
Q 007103 462 MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV-VHRN 540 (618)
Q Consensus 462 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-iH~D 540 (618)
|+.+.|.|+.+++|.+.+....+.|.+|+..|+|.|.+.. ....+++.-...++.+|+.||+|+|.- .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3567899999999999999999999999999999999973 466789999999999999999999987 44 9999
Q ss_pred CCCCCeeecCCCCcEEeeccccccCCCC-CcccccceeccccccCccccccCC-------CCcccchhhHHHHHHHHHhC
Q 007103 541 FKSANILLDDELNPHLSDCGLAALTPNT-ERQVSTQMVGAFGYSAPEFALSGI-------YTVKSDVYSFGVVMLELLTG 612 (618)
Q Consensus 541 lkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~elltg 612 (618)
+++.|+++|..+.+||+|||+....... .........-..-|.|||.+.... .+.+.||||||++++|++++
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998766421 111111122345699999997642 36679999999999999999
Q ss_pred CCCCCC
Q 007103 613 RKPLDR 618 (618)
Q Consensus 613 ~~Pf~~ 618 (618)
+.||+.
T Consensus 155 ~~~~~~ 160 (484)
T KOG1023|consen 155 SGPFDL 160 (484)
T ss_pred cCcccc
Confidence 999973
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.8e-15 Score=134.08 Aligned_cols=135 Identities=19% Similarity=0.200 Sum_probs=112.3
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCC--CcccccceEEeeCCeEEEEEEecCC
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4579999999999998864 7889999865442 4568888888888876 5888888888888889999999998
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
+.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 766543 45566778999999999999864447999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.8e-17 Score=166.81 Aligned_cols=172 Identities=27% Similarity=0.324 Sum_probs=133.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC---CCccEEecccccccccCCccccCCCCccEEE
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
..++.|||++|+|. ..|..+..-+++-.|+||+|+|. .||..+. +.|-.||||+|++. .+|+.+..|..|+.|+
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 45788888888886 46777777888888888888887 6776665 56667888888888 6777778888888888
Q ss_pred eecCCCC-------------------------CccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccc
Q 007103 160 VSRNSLT-------------------------QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (618)
Q Consensus 160 L~~N~l~-------------------------~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (618)
|++|.|. ..+|.++..|.+|..+|||+|+|. .+|+.+.++.+|..|+||+|+|+
T Consensus 180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 8887543 136677778889999999999999 89999999999999999999998
Q ss_pred ccccc-cCCCCccEEEcccccccccCchhhhc---ccchhccCCcCCCC
Q 007103 215 GSLNV-FSGLPLTTLNVANNHFSGWIPRELIS---IRTFIYDGNSFDNG 259 (618)
Q Consensus 215 ~~~~~-~~~~~L~~L~l~~N~l~g~ip~~~~~---l~~l~~~~N~~~~~ 259 (618)
..--. -.-.+|++|+||.|+++ .+|+.+.+ |+.|+.++|.++..
T Consensus 259 eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~Fe 306 (1255)
T KOG0444|consen 259 ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFE 306 (1255)
T ss_pred eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccccc
Confidence 63221 11235899999999999 88987654 45677888876653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.4e-15 Score=143.08 Aligned_cols=139 Identities=15% Similarity=0.181 Sum_probs=106.9
Q ss_pred cceec-cCccceEEEEEEcCCcEEEEEEcCcccc-----------cHHHHHHHHHHHHHhhcCCCCcc--cccceEEeeC
Q 007103 415 EFLIG-EGSLGRVYRAEFANGKIMAVKKIDNAAL-----------SLQEEDNFLEAVSNMSRLRHPNI--VTLAGYCAEH 480 (618)
Q Consensus 415 ~~~Lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 480 (618)
..+|| .|+.|+||+++.. +..+++|++..... .......+.+|++.+.++.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34687 8999999999885 77889998854211 11234567889999999998885 6666664432
Q ss_pred C----eEEEEEEecCC-CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcE
Q 007103 481 G----QRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555 (618)
Q Consensus 481 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 555 (618)
. ..++|||++++ .+|.+++.. ..++.. .+.+++.++++||+. ||+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 699888752 334443 356899999999999 999999999999999988999
Q ss_pred EeeccccccCC
Q 007103 556 LSDCGLAALTP 566 (618)
Q Consensus 556 l~Dfgl~~~~~ 566 (618)
|+|||.+....
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999987654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.1e-15 Score=162.95 Aligned_cols=211 Identities=20% Similarity=0.284 Sum_probs=131.6
Q ss_pred hhhccCCChHHHHHHHHHHHhCCCCCCCCC----CCCCCCCCCCCCC--------------ceeEeeCCCE---------
Q 007103 33 SLVQCTTDSSDVQALQVLYTSLNSPSVLTN----WKGNEGDPCGESW--------------KGVACEGSAV--------- 85 (618)
Q Consensus 33 ~~~~~~~~~~~~~al~~~~~~~~~~~~~~~----w~~~~~~~c~~~w--------------~gv~c~~~~v--------- 85 (618)
......+..+|.+.+.++.+.+..|.++.+ |++. .++|.-.- ..|.|.+..|
T Consensus 54 ~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~-~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~ 132 (754)
T PRK15370 54 CHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGA-DQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESE 132 (754)
T ss_pred hCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCC-CcccccCCcchhhheeeecCCceEEecCCCccccccccccc
Confidence 344456778999999999999999988877 9864 57885322 2377755443
Q ss_pred ------------------------------------------------EEEEcCCCCCcccccccccCCCCCCEEEecCC
Q 007103 86 ------------------------------------------------VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN 117 (618)
Q Consensus 86 ------------------------------------------------~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N 117 (618)
+.|++++++|+. +|..+. ++|+.|+|++|
T Consensus 133 ~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N 209 (754)
T PRK15370 133 QASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNN 209 (754)
T ss_pred ccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCC
Confidence 345666666654 344332 46777777777
Q ss_pred CccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCc
Q 007103 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197 (618)
Q Consensus 118 ~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 197 (618)
+|+ .+|..+.++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. .+|+.|+|++|+|+ .+|..+
T Consensus 210 ~Lt-sLP~~l~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l 281 (754)
T PRK15370 210 ELK-SLPENLQGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENL 281 (754)
T ss_pred CCC-cCChhhccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cccccc
Confidence 777 566666677777777777777 4555443 35777777777776 4555543 46777777777777 466655
Q ss_pred ccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCch-hhhcccchhccCCcCCCC
Q 007103 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR-ELISIRTFIYDGNSFDNG 259 (618)
Q Consensus 198 ~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~-~~~~l~~l~~~~N~~~~~ 259 (618)
. .+|+.|+|++|+|++.+..+ ...|+.|+|++|+|++ +|. ...+|+.|.+++|.+.+.
T Consensus 282 ~--~sL~~L~Ls~N~Lt~LP~~l-p~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt~L 340 (754)
T PRK15370 282 P--EELRYLSVYDNSIRTLPAHL-PSGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALTSL 340 (754)
T ss_pred C--CCCcEEECCCCccccCcccc-hhhHHHHHhcCCcccc-CCccccccceeccccCCccccC
Confidence 3 36777777777776533221 2235555666665553 332 223455555555555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2e-16 Score=161.20 Aligned_cols=123 Identities=26% Similarity=0.418 Sum_probs=108.0
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++.|+++...+|+++++.. ......++.....++.|++.|++| + +.+|||+||.||....+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999633 345667888999999999999999 5 889999999999999999999999999
Q ss_pred cccCCCCC-----cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh
Q 007103 562 AALTPNTE-----RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611 (618)
Q Consensus 562 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 611 (618)
........ ....+...||..||+||.+.+..|+.|+||||||+|++|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 97766554 223455689999999999999999999999999999999987
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-16 Score=139.15 Aligned_cols=155 Identities=30% Similarity=0.486 Sum_probs=137.9
Q ss_pred cccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCC
Q 007103 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (618)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (618)
.+.++.+.+.|.||+|+++ .+|..+. .+|+.|++++|++. .+|.+++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4567888999999999999 6777776 89999999999999 89999999999999999999998 889999999999
Q ss_pred CeEEcccCcCCC-CCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccccCchhhh---cccchhccCC
Q 007103 180 ATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPRELI---SIRTFIYDGN 254 (618)
Q Consensus 180 ~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~ip~~~~---~l~~l~~~~N 254 (618)
+.|||.+|+++. .+|..|..|..|..|+|+.|.+.-.++.... .+|+.|.+..|.+- .+|.+++ .|+.|...||
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 999999999964 6899999999999999999999987776655 46999999999998 7887765 5667889999
Q ss_pred cCCCCC
Q 007103 255 SFDNGP 260 (618)
Q Consensus 255 ~~~~~~ 260 (618)
.+.-.|
T Consensus 184 rl~vlp 189 (264)
T KOG0617|consen 184 RLTVLP 189 (264)
T ss_pred eeeecC
Confidence 987654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-16 Score=163.05 Aligned_cols=170 Identities=23% Similarity=0.347 Sum_probs=98.3
Q ss_pred EEEEEcCCCCCc-ccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEee
Q 007103 85 VVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 85 v~~l~l~~~~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
|..+|+++|.++ +..|.....+++++.|-|...++. .+|.+++ .+|+.|.+++|++. .+-..++.|+.|+.+++.
T Consensus 9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR 86 (1255)
T ss_pred eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence 555666666666 355666666666666666666665 5565555 56666666666666 444555666666666666
Q ss_pred cCCCC-CccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCCC-CccEEEccccccccc
Q 007103 162 RNSLT-QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGL-PLTTLNVANNHFSGW 238 (618)
Q Consensus 162 ~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~-~L~~L~l~~N~l~g~ 238 (618)
+|+|. .-||..+-.|..|+.||||+|+|. ..|..+..-.++-+|+||+|+|..++.. +... .|-.||||+|++. .
T Consensus 87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~ 164 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-M 164 (1255)
T ss_pred ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-h
Confidence 66664 224555555666666666666666 5666666666666666666666654432 2222 2556666666666 4
Q ss_pred Cchhh---hcccchhccCCcCCC
Q 007103 239 IPREL---ISIRTFIYDGNSFDN 258 (618)
Q Consensus 239 ip~~~---~~l~~l~~~~N~~~~ 258 (618)
+|+.+ ..|+.|.+++||+.-
T Consensus 165 LPPQ~RRL~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 165 LPPQIRRLSMLQTLKLSNNPLNH 187 (1255)
T ss_pred cCHHHHHHhhhhhhhcCCChhhH
Confidence 44443 334555666666443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=9e-16 Score=167.34 Aligned_cols=202 Identities=26% Similarity=0.334 Sum_probs=161.4
Q ss_pred cCCcccceeccCccceEEEEEEcC--CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN--GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 486 (618)
..|...+.||+|+|+.|-...... ...+|.|.+...............|..+-..+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345666679999999998886643 345666666554423333445556777777776 99999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCC-CCCHHHHHHHHHHHHHHHHHHh-hcCCCCceecCCCCCCeeecCCC-CcEEeeccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSK-NLTWNARVRVALGTARALEYLH-EVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~ 563 (618)
+||..++++.+-+. .... ..+......++.|+..++.|+| +. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999998873 1222 5566677889999999999999 77 999999999999999999 99999999998
Q ss_pred cCCC--CCcccccceec-cccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPN--TERQVSTQMVG-AFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+.. .........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|++
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence 7655 22233344578 99999999998854 4778999999999999999999986
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-16 Score=155.45 Aligned_cols=169 Identities=23% Similarity=0.342 Sum_probs=138.8
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC-CCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+..++..+|+++ ..|+.++++.+|..|++.+|++....|..+. +.|+.||+..|-+. .+|+.++.+.+|.-|||.+
T Consensus 138 ~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 138 DLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhh
Confidence 3566777788886 5688889999999999999999855555444 88999999999888 8899999999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcc-cCCCcCeeeeccccccccccccCC-CCccEEEcccccccccCc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~ip 240 (618)
|+|. ..| +|+++..|.+|+++.|+|. .+|.+.. ++++|.+|||..|+++..+..... .+|+.||||+|.++ .+|
T Consensus 216 Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp 291 (565)
T KOG0472|consen 216 NKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLP 291 (565)
T ss_pred cccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCC
Confidence 9998 455 7889999999999999999 7887776 889999999999999976654433 45999999999999 677
Q ss_pred hhhhcc--cchhccCCcCCC
Q 007103 241 RELISI--RTFIYDGNSFDN 258 (618)
Q Consensus 241 ~~~~~l--~~l~~~~N~~~~ 258 (618)
.+++++ ++|.+.|||+..
T Consensus 292 ~sLgnlhL~~L~leGNPlrT 311 (565)
T KOG0472|consen 292 YSLGNLHLKFLALEGNPLRT 311 (565)
T ss_pred cccccceeeehhhcCCchHH
Confidence 777765 477788998654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=4e-14 Score=157.46 Aligned_cols=163 Identities=26% Similarity=0.350 Sum_probs=99.7
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
+++.|+|++|+|+. +|..+. .+|+.|+|++|++. .+|..+.++|+.|+|++|+|+ .+|..+. ++|+.|+|++|
T Consensus 221 nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N 293 (754)
T PRK15370 221 NIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLPSALQSLDLFHNKIS-CLPENLP--EELRYLSVYDN 293 (754)
T ss_pred CCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHhCCCCEEECcCCccC-ccccccC--CCCcEEECCCC
Confidence 57888888888874 454443 36777778877777 567666677777777777777 4566553 46777777777
Q ss_pred CCCCccchhhc-------------------CCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCC
Q 007103 164 SLTQSIGDIFG-------------------NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP 224 (618)
Q Consensus 164 ~l~~~~p~~~~-------------------~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 224 (618)
+|++ +|..+. -.++|+.|++++|.|+ .+|..+. ++|+.|+|++|+|+..+ ......
T Consensus 294 ~Lt~-LP~~lp~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~~LP-~~lp~~ 368 (754)
T PRK15370 294 SIRT-LPAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQITVLP-ETLPPT 368 (754)
T ss_pred cccc-CcccchhhHHHHHhcCCccccCCccccccceeccccCCccc-cCChhhc--CcccEEECCCCCCCcCC-hhhcCC
Confidence 7774 333221 1134555555555555 3454442 46666666666666422 222245
Q ss_pred ccEEEcccccccccCchhh-hcccchhccCCcCCCC
Q 007103 225 LTTLNVANNHFSGWIPREL-ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 225 L~~L~l~~N~l~g~ip~~~-~~l~~l~~~~N~~~~~ 259 (618)
|+.|+|++|+|+ .+|+.+ ..|+.|++++|.+...
T Consensus 369 L~~LdLs~N~Lt-~LP~~l~~sL~~LdLs~N~L~~L 403 (754)
T PRK15370 369 ITTLDVSRNALT-NLPENLPAALQIMQASRNNLVRL 403 (754)
T ss_pred cCEEECCCCcCC-CCCHhHHHHHHHHhhccCCcccC
Confidence 667777777776 455444 3566666666666543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=151.89 Aligned_cols=33 Identities=21% Similarity=0.332 Sum_probs=19.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCcc
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIH 120 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~ 120 (618)
+++.|++.+|+|+. +|. .+++|++|+|++|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt 255 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT 255 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC
Confidence 45666666666654 332 2356666666666666
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.6e-13 Score=143.70 Aligned_cols=143 Identities=22% Similarity=0.260 Sum_probs=99.7
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccHH--------------------------------------HHHHHH
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ--------------------------------------EEDNFL 456 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 456 (618)
.+.||.|++|+||+|++.+|+.||||+.+......- .+-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 357999999999999999999999999865421100 011344
Q ss_pred HHHHHhhcC----CCCcccccceEE-eeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 007103 457 EAVSNMSRL----RHPNIVTLAGYC-AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-ALEYLHE 530 (618)
Q Consensus 457 ~e~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~ 530 (618)
.|...+.++ +|.+-+.+-.++ ......++||||++|++|.++..... ...+ ..+++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 555555444 222222222222 23456799999999999988764211 1122 3456666665 4788898
Q ss_pred cCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 531 ~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
. |++|+|++|.||++++++.++++|||++....
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 99999999999999999999999999997665
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.3e-13 Score=150.60 Aligned_cols=162 Identities=22% Similarity=0.348 Sum_probs=101.4
Q ss_pred EeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEE
Q 007103 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158 (618)
Q Consensus 79 ~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (618)
.|....-..|+|++++|+ .+|+.+. .+|+.|+|++|+|+ .+|. +.++|++|+|++|+|+ .+|.. .++|+.|
T Consensus 197 ~Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~-lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L 267 (788)
T PRK15387 197 ACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-LPPELRTLEVSGNQLT-SLPVL---PPGLLEL 267 (788)
T ss_pred HHhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC-CCCCCcEEEecCCccC-cccCc---cccccee
Confidence 454455667999999998 5777775 48999999999999 4664 4689999999999999 45643 3567777
Q ss_pred EeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc------------------
Q 007103 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF------------------ 220 (618)
Q Consensus 159 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~------------------ 220 (618)
+|++|.|+. +|.. +.+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++.+...
T Consensus 268 ~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~ 339 (788)
T PRK15387 268 SIFSNPLTH-LPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPT 339 (788)
T ss_pred eccCCchhh-hhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCccccCCCCcccccccccccCccccccc
Confidence 777777663 3322 133444555555554 33331 234444555555444421100
Q ss_pred CCCCccEEEcccccccccCchhhhcccchhccCCcCCC
Q 007103 221 SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDN 258 (618)
Q Consensus 221 ~~~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~~N~~~~ 258 (618)
...+|+.|+|++|+|+ .+|....++..|.+.+|.+..
T Consensus 340 lp~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~ 376 (788)
T PRK15387 340 LPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS 376 (788)
T ss_pred cccccceEecCCCccC-CCCCCCcccceehhhcccccc
Confidence 1124667777777776 355555566666666666654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.8e-15 Score=152.02 Aligned_cols=170 Identities=30% Similarity=0.427 Sum_probs=147.9
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
..+..||+.|++. .+|..+..+..|+.|.|+.|.|. .+|..+. ..|++|||+.|+++ .+|..++.|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 4566788999886 67888888999999999999998 7777766 78999999999999 8888888876 8999999
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCch
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~ 241 (618)
+|+++ .+|+.++.++.|..||.+.|++. .+|..++.+.+|+.|.+..|++...++.+...+|..||+|+|+++ .||-
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPV 228 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecch
Confidence 99998 67888888899999999999999 899999999999999999999999888877888999999999999 8998
Q ss_pred hhhcc---cchhccCCcCCCCC
Q 007103 242 ELISI---RTFIYDGNSFDNGP 260 (618)
Q Consensus 242 ~~~~l---~~l~~~~N~~~~~~ 260 (618)
.|.++ +.|.+.+||+.-.|
T Consensus 229 ~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred hhhhhhhheeeeeccCCCCCCh
Confidence 77654 57788999987654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.1e-15 Score=143.69 Aligned_cols=153 Identities=25% Similarity=0.362 Sum_probs=136.2
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
+++.+++.+|.+....|..+. ++.|++||...|-++ .+|.+++ .+|..|||..|+|. .+| +|.+|..|++|+++
T Consensus 161 ~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g 236 (565)
T KOG0472|consen 161 KLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVG 236 (565)
T ss_pred HHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhc
Confidence 456789999999876666655 999999999999998 8888887 89999999999999 777 99999999999999
Q ss_pred cCCCCCccchh-hcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc
Q 007103 162 RNSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 162 ~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip 240 (618)
.|+|. .+|.+ ...+++|..|||.+|++. ..|+.++-+.+|+.||||+|.|++.+.....+.|+.|-|.+|.+. .|-
T Consensus 237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr-TiR 313 (565)
T KOG0472|consen 237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR-TIR 313 (565)
T ss_pred ccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH-HHH
Confidence 99999 55554 459999999999999999 899999999999999999999999999888889999999999997 444
Q ss_pred hhh
Q 007103 241 REL 243 (618)
Q Consensus 241 ~~~ 243 (618)
.++
T Consensus 314 r~i 316 (565)
T KOG0472|consen 314 REI 316 (565)
T ss_pred HHH
Confidence 443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3e-14 Score=153.22 Aligned_cols=171 Identities=25% Similarity=0.318 Sum_probs=138.1
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCC----------------------------CCCccEEec
Q 007103 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL----------------------------PPNLTSLNL 136 (618)
Q Consensus 85 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----------------------------~~~L~~L~L 136 (618)
++.|+...|.+. .+|+.+..++.|+.|+|..|+|. ..|..+ .+.|+.|+|
T Consensus 289 L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lyl 366 (1081)
T KOG0618|consen 289 LVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYL 366 (1081)
T ss_pred HHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHH
Confidence 445566666664 45667777777777777777776 333211 146888999
Q ss_pred ccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccc
Q 007103 137 ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (618)
Q Consensus 137 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (618)
.+|.|+...-+.+.+..+|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..+..|++|...+|+|...
T Consensus 367 anN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f 445 (1081)
T KOG0618|consen 367 ANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF 445 (1081)
T ss_pred hcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec
Confidence 999999887788899999999999999999666668899999999999999999 8999999999999999999999987
Q ss_pred ccccCCCCccEEEcccccccc-cCchhh--hcccchhccCCcCCC
Q 007103 217 LNVFSGLPLTTLNVANNHFSG-WIPREL--ISIRTFIYDGNSFDN 258 (618)
Q Consensus 217 ~~~~~~~~L~~L~l~~N~l~g-~ip~~~--~~l~~l~~~~N~~~~ 258 (618)
+.......|+.+|||.|+|+- .+|..+ .+|+.|+++||.+.-
T Consensus 446 Pe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 446 PELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred hhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 755556679999999999975 566554 589999999999644
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.5e-13 Score=142.15 Aligned_cols=148 Identities=16% Similarity=0.190 Sum_probs=94.3
Q ss_pred hcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccH--------------------------------HHH---
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSL--------------------------------QEE--- 452 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~--------------------------------~~~--- 452 (618)
-.+|+. +.||+|++|+||+|.+.+ |+.||||+.+...... +..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 689999999999999987 9999999997542110 011
Q ss_pred ---HHHHHHHHHhhcCC----CCcccccceEEee-CCeEEEEEEecCCCChhhhhhcccC--CCCCCCHHHHHHHHHHHH
Q 007103 453 ---DNFLEAVSNMSRLR----HPNIVTLAGYCAE-HGQRLLVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTA 522 (618)
Q Consensus 453 ---~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~ 522 (618)
-++.+|+..+.+++ +.+.+.+=.++.+ ....++||||++|+.+.++...... ....+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 12344444433332 3333333333322 4567899999999999875321110 0012223333333333
Q ss_pred HHHHHHhhcCCCCceecCCCCCCeeecCCC----CcEEeeccccccCCC
Q 007103 523 RALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDCGLAALTPN 567 (618)
Q Consensus 523 ~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfgl~~~~~~ 567 (618)
+... |++|+|+||.||+++.++ .++++|||++.....
T Consensus 276 -----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3445 999999999999999888 999999999976643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.7e-13 Score=138.21 Aligned_cols=178 Identities=25% Similarity=0.386 Sum_probs=132.5
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCC---CCEEEecCCCccCCCC-------CCCCCCccEEeccccccccc----CCc
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLS---LRKFDLSGNSIHDTIP-------YQLPPNLTSLNLASNNFSGN----LPY 147 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~---L~~L~L~~N~l~~~~p-------~~~~~~L~~L~L~~N~l~~~----~p~ 147 (618)
..+++.|+|++|.+.+..+..+..+.+ |++|+|++|++++... ....++|+.|+|++|++++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 358999999999998777777776666 9999999999883211 12227899999999999943 345
Q ss_pred cccCCCCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeecccccccc-c-
Q 007103 148 SIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGS-L- 217 (618)
Q Consensus 148 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~-~- 217 (618)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|++++|.+++. +
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 567788999999999999853 344566678999999999998743 334566788999999999999862 1
Q ss_pred c---cc--CCCCccEEEccccccc--c--cCchh---hhcccchhccCCcCCCC
Q 007103 218 N---VF--SGLPLTTLNVANNHFS--G--WIPRE---LISIRTFIYDGNSFDNG 259 (618)
Q Consensus 218 ~---~~--~~~~L~~L~l~~N~l~--g--~ip~~---~~~l~~l~~~~N~~~~~ 259 (618)
. .+ ....|+.|++++|.++ | .+... +.+++.+++++|.+...
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 1 11 1246999999999997 2 22233 35678888888887753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-11 Score=114.87 Aligned_cols=132 Identities=20% Similarity=0.142 Sum_probs=94.7
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCccc-ccceEEeeCCeEEEEEEecCCC
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV-TLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.+.++.|.++.||+++.. ++.+++|....... ....+..|++.++.+.+.+++ +++.+. ....++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 346889999999999875 77899998764431 123456777777777655544 344433 33458999999998
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC--LPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
++.+.. . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+...
T Consensus 77 ~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 77 ELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 775420 0 11235678999999999982 11259999999999999 668999999998643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.1e-12 Score=140.82 Aligned_cols=107 Identities=26% Similarity=0.339 Sum_probs=85.5
Q ss_pred CccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc-CC-CCccEEEcc
Q 007103 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLNVA 231 (618)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~L~l~ 231 (618)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|.|.+|..++.+++|+.|+|++|+|+|.+|.. .. .+|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3778888888888888888888888888888888888888888888888888888888888877653 22 358888888
Q ss_pred cccccccCchhhhc----ccchhccCCcCCCCC
Q 007103 232 NNHFSGWIPRELIS----IRTFIYDGNSFDNGP 260 (618)
Q Consensus 232 ~N~l~g~ip~~~~~----l~~l~~~~N~~~~~~ 260 (618)
+|+|+|.+|..+.. +..+.+.+|+..|+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 88888889987754 346788899988863
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.4e-11 Score=113.08 Aligned_cols=138 Identities=16% Similarity=0.183 Sum_probs=97.2
Q ss_pred ceeccCccceEEEEEEcC-------CcEEEEEEcCccccc--------------------HHHHHHH----HHHHHHhhc
Q 007103 416 FLIGEGSLGRVYRAEFAN-------GKIMAVKKIDNAALS--------------------LQEEDNF----LEAVSNMSR 464 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~--------------------~~~~~~~----~~e~~~l~~ 464 (618)
..||.|.-+.||.|...+ +..+|+|..+..... ....+.+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997553 478999987432110 0011222 378888887
Q ss_pred CCC--CcccccceEEeeCCeEEEEEEecCCCChhh-hhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCceecC
Q 007103 465 LRH--PNIVTLAGYCAEHGQRLLVYEYVGNGNLHD-MLHFADDSSKNLTWNARVRVALGTARALEYL-HEVCLPSVVHRN 540 (618)
Q Consensus 465 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~D 540 (618)
+.. -++.+++++ ...++||||+++..+.. .++ ...++..+...+..+++.+|..| |+. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 753 345555653 56789999998754421 222 12344556677889999999999 787 999999
Q ss_pred CCCCCeeecCCCCcEEeeccccccCC
Q 007103 541 FKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 541 lkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|++.||++++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 689999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.8e-11 Score=127.38 Aligned_cols=166 Identities=22% Similarity=0.261 Sum_probs=124.9
Q ss_pred EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCC
Q 007103 431 FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510 (618)
Q Consensus 431 ~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~ 510 (618)
..++..|.|...+.... .......+.++.++.++||||+++++.++.++..|+|+|-+. .|..++.. +.
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LG 102 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hH
Confidence 34577777777765442 334556777889999999999999999999999999999986 46666652 22
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccceeccccccCcccccc
Q 007103 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590 (618)
Q Consensus 511 ~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 590 (618)
.....-.+.||+.||.|||..+ +++|++|.-+.|+|++.|+.||.+|.++........ ......--..|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 4556667889999999999775 899999999999999999999999998755432221 1111222234667776543
Q ss_pred CCCCcccchhhHHHHHHHHHhC
Q 007103 591 GIYTVKSDVYSFGVVMLELLTG 612 (618)
Q Consensus 591 ~~~~~~~DvwslG~il~elltg 612 (618)
.. -..|.|-|||++||++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 33 346999999999999998
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.2e-11 Score=144.82 Aligned_cols=79 Identities=19% Similarity=0.135 Sum_probs=34.8
Q ss_pred CCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCCCCccEEEcccccccccCchhhhcccchhccCCcC
Q 007103 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256 (618)
Q Consensus 178 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~~N~~ 256 (618)
+|+.|+|++|...+.+|.+++++++|+.|+|++|...+.+|. ....+|+.|+|++|..-..+|....+++.|++.+|.+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i 858 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGI 858 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCccccccccccccCEeECCCCCC
Confidence 444555555544445555555666666666655432222222 1122244444444333333333333444444444433
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-13 Score=145.56 Aligned_cols=174 Identities=21% Similarity=0.266 Sum_probs=125.0
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
..++.+|++.|++++.. +.++.+.+|+.|+..+|+|+ .+|..+. ++|+.|++.+|.+. .+|+....++.|+.|+|
T Consensus 241 ~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 35677888888888654 88889999999999999996 6776665 67888888888888 77777788888888888
Q ss_pred ecCCCCCccchhhc-------------------------CCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc
Q 007103 161 SRNSLTQSIGDIFG-------------------------NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 161 ~~N~l~~~~p~~~~-------------------------~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
..|+|....+..|. .++.|+.|+|.+|.|+...-..+.+..+|++|+|++|+|..
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 88888744332221 12346677778888877666667777788888888888776
Q ss_pred cccccCC--CCccEEEcccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 216 SLNVFSG--LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 216 ~~~~~~~--~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
.+..... ..|+.|+||+|.|+ .+|+.+ ..|+.|...+|.+.|.|
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP 446 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP 446 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech
Confidence 5543222 23778888888887 677655 44556667777766654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.4e-12 Score=133.88 Aligned_cols=175 Identities=22% Similarity=0.234 Sum_probs=123.8
Q ss_pred CCEEEEEcCCCCCc------ccccccccCCCCCCEEEecCCCccCCCCCCCC-----CCccEEecccccccc----cCCc
Q 007103 83 SAVVSIDISGLGLS------GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNFSG----NLPY 147 (618)
Q Consensus 83 ~~v~~l~l~~~~l~------~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~~L~~L~L~~N~l~~----~~p~ 147 (618)
..++.|+++++.+. ..++..+..+++|+.|+|++|.+.+..+..+. ++|++|++++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 34778888887776 23455677888999999999988765443332 349999999998883 3344
Q ss_pred cccCC-CCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeeccccccccc-
Q 007103 148 SIASM-VSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL- 217 (618)
Q Consensus 148 ~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~- 217 (618)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 56667 8899999999998853 344567778899999999998852 3344556678999999999887532
Q ss_pred ---c-cc-CCCCccEEEcccccccccCch----hh----hcccchhccCCcCC
Q 007103 218 ---N-VF-SGLPLTTLNVANNHFSGWIPR----EL----ISIRTFIYDGNSFD 257 (618)
Q Consensus 218 ---~-~~-~~~~L~~L~l~~N~l~g~ip~----~~----~~l~~l~~~~N~~~ 257 (618)
. .+ ...+|+.|++++|.+++.... .+ ..|+.|++.+|.+.
T Consensus 211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 1 11 124599999999998863332 22 46778888887664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.9e-11 Score=141.12 Aligned_cols=166 Identities=17% Similarity=0.200 Sum_probs=114.5
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC-C---------------------CccEEecccccc
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-P---------------------NLTSLNLASNNF 141 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~---------------------~L~~L~L~~N~l 141 (618)
+++.|+|+++..-..+|..+.+|++|+.|+|++|..-+.+|..+. + +|+.|+|++|.+
T Consensus 658 ~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i 737 (1153)
T PLN03210 658 NLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI 737 (1153)
T ss_pred cccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence 455566666555456666777777777777777544345554331 3 444455555554
Q ss_pred cccCCccc------------------------------cCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCC
Q 007103 142 SGNLPYSI------------------------------ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191 (618)
Q Consensus 142 ~~~~p~~~------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 191 (618)
. .+|..+ ...++|+.|+|++|...+.+|..++++++|+.|+|++|..-+
T Consensus 738 ~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~ 816 (1153)
T PLN03210 738 E-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE 816 (1153)
T ss_pred c-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC
Confidence 4 334321 012467888888888888899999999999999999976555
Q ss_pred CCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCchhhh---cccchhccC
Q 007103 192 DLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELI---SIRTFIYDG 253 (618)
Q Consensus 192 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~~~---~l~~l~~~~ 253 (618)
.+|..+ ++++|+.|+|++|.....++.. ..+|+.|+|++|.++ .+|.++. +|..|++.+
T Consensus 817 ~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 817 TLPTGI-NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred eeCCCC-CccccCEEECCCCCcccccccc-ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence 888876 7899999999998655544432 246999999999998 7887654 556666766
|
syringae 6; Provisional |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-11 Score=128.89 Aligned_cols=199 Identities=24% Similarity=0.279 Sum_probs=155.1
Q ss_pred hcCCcccceecc--CccceEEEEEE---cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGE--GSLGRVYRAEF---ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 482 (618)
...+...+.+|. |.+|.||.+.. .++..+|+|+-+......+....-.+|+....++ .|+|.++.+..++..+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345666778999 99999999976 3588899998665554444444555667666666 49999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCceecCCCCCCeeecCC-CCcEEe
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----ALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLS 557 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~ 557 (618)
.++-+|++. .+|.++.+. ...-++....+.+..+..+ |+.++|+. +++|-|+||.||....+ ...++.
T Consensus 193 lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 999999986 577777652 2233677778888888888 99999999 99999999999999988 889999
Q ss_pred eccccccCCCCCcccc----cceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 007103 558 DCGLAALTPNTERQVS----TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615 (618)
Q Consensus 558 Dfgl~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P 615 (618)
|||+...+.+..-... ....|...|++||...+ -++..+|+|++|.++.+..++-.+
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccc
Confidence 9999987755432211 11257778999998754 468899999999999998876544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-10 Score=103.00 Aligned_cols=135 Identities=22% Similarity=0.316 Sum_probs=101.7
Q ss_pred eeccCccceEEEEEEcCCcEEEEEE-cCcccccHHH-----HHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 417 LIGEGSLGRVYRAEFANGKIMAVKK-IDNAALSLQE-----EDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
.+++|+-+.+|.+.+.+.. +++|. +++....++- ..+-.+|+.++.+++--.|.-..=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999876444 44443 3333322222 234567888888887666666666777888889999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
++..|.+.+... ...++..+-+-+.-||.. +|+|+||.++||++..+. +.++|||++.....
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 999999888622 234666777888899999 999999999999998775 99999999976543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.1e-11 Score=116.07 Aligned_cols=154 Identities=25% Similarity=0.401 Sum_probs=118.6
Q ss_pred HHHhhcCCCCcccccceEEeeCC-----eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 007103 459 VSNMSRLRHPNIVTLAGYCAEHG-----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533 (618)
Q Consensus 459 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 533 (618)
+..+-.+.|.||++++.|+.+.. +..+++|||..|++.++++..+.....+......+++-||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34445567999999999986643 56899999999999999998777777888899999999999999999985 6
Q ss_pred CCceecCCCCCCeeecCCCCcEEeeccccccCCCCC--ccc-ccceeccccccCccccccCCCCcccchhhHHHHHHHHH
Q 007103 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE--RQV-STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELL 610 (618)
Q Consensus 534 ~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 610 (618)
|.|+|+++.-+-|++..+|-+||.----......-. ... .....+-++|.|||+=.....+..+|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 799999999999999999888874211111000000 000 01124668899999877777788999999999999987
Q ss_pred hCC
Q 007103 611 TGR 613 (618)
Q Consensus 611 tg~ 613 (618)
-++
T Consensus 277 ilE 279 (458)
T KOG1266|consen 277 ILE 279 (458)
T ss_pred Hhe
Confidence 664
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-12 Score=133.12 Aligned_cols=152 Identities=26% Similarity=0.372 Sum_probs=95.4
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC-CCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 85 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
+..+.|..|.+. .+|..+.+|..|++|||+.|+++ .+|..++ --|+.|-+++|+++ .+|..++.+..|..||.+.|
T Consensus 100 Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~n 176 (722)
T KOG0532|consen 100 LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKN 176 (722)
T ss_pred HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCccc-cCCcccccchhHHHhhhhhh
Confidence 444555666654 46666777777777777777776 5555554 45677777777776 66666666677777777777
Q ss_pred CCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCC-ccEEEcccccccccCchh
Q 007103 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE 242 (618)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~L~l~~N~l~g~ip~~ 242 (618)
.+. .+|..++.+.+|+.|.+..|++. .+|..++.| .|..||+|+|+++..+-.|..+. |++|-|.+|.|+ .-|..
T Consensus 177 ei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq-SPPAq 252 (722)
T KOG0532|consen 177 EIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ-SPPAQ 252 (722)
T ss_pred hhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC-CChHH
Confidence 766 45566666666666666666666 566666644 46666666666665444444443 666666666666 33443
Q ss_pred h
Q 007103 243 L 243 (618)
Q Consensus 243 ~ 243 (618)
+
T Consensus 253 I 253 (722)
T KOG0532|consen 253 I 253 (722)
T ss_pred H
Confidence 3
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-11 Score=109.45 Aligned_cols=111 Identities=25% Similarity=0.301 Sum_probs=31.7
Q ss_pred ccCCCCCCEEEecCCCccCCCCCCC-CCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCe
Q 007103 103 LSDLLSLRKFDLSGNSIHDTIPYQL-PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181 (618)
Q Consensus 103 l~~l~~L~~L~L~~N~l~~~~p~~~-~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 181 (618)
+.+..+++.|+|++|.|+....-.. ..+|+.|||++|.|+.. +.+..+++|+.|+|++|+|+...+.....+++|+.
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred cccccccccccccccccccccchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 3445567777777777774332221 25677777777777743 35666777777777777777543322235677777
Q ss_pred EEcccCcCCCCC-CCCcccCCCcCeeeeccccccc
Q 007103 182 LDLSFNNFSGDL-PNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 182 L~ls~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
|+|++|+|...- -..+..+++|++|+|.+|.++.
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 777777776311 1234455666666666666653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.8e-10 Score=109.21 Aligned_cols=144 Identities=22% Similarity=0.286 Sum_probs=108.6
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCC--cccccceEEeeC---CeEEEEEEec
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP--NIVTLAGYCAEH---GQRLLVYEYV 490 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~ 490 (618)
+.|+.|..+.||++...+|+.+++|........ .....+..|++.++.+.+. ++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 468999999999998877789999998654321 1345678888888888653 456677776653 3668999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-------------------------------------- 532 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 532 (618)
++.++.+.+. ...++......++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9988876542 134667777788888888888888531
Q ss_pred ---------------CCCceecCCCCCCeeecC--CCCcEEeeccccccC
Q 007103 533 ---------------LPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (618)
Q Consensus 533 ---------------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~ 565 (618)
...++|+|+.|.||+++. ++.+.|+||+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 135799999999999998 667899999987543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.3e-11 Score=109.95 Aligned_cols=121 Identities=23% Similarity=0.254 Sum_probs=53.6
Q ss_pred CEEEEEcCCCCCccccccccc-CCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccc-cCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLS-DLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~ 161 (618)
+++.|+|.+|.|+.+ +.++ .+++|+.|+|++|.|+........++|+.|+|++|+|+. +.+.+ ..+++|+.|+|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-T
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECc
Confidence 578999999999754 4566 689999999999999976655556999999999999994 44445 479999999999
Q ss_pred cCCCCCcc-chhhcCCCCCCeEEcccCcCCCCCCC----CcccCCCcCeeee
Q 007103 162 RNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPN----SFISLSNISSLYL 208 (618)
Q Consensus 162 ~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~l 208 (618)
+|+|...- -..+..+++|+.|+|.+|.++. .+. .+..+++|+.||-
T Consensus 97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 97 NNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp TS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEETT
T ss_pred CCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeCC
Confidence 99998542 2567889999999999999983 343 2457889998873
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1e-09 Score=97.84 Aligned_cols=147 Identities=18% Similarity=0.252 Sum_probs=106.5
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEE-cCcccccHH-----HHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 414 QEFLIGEGSLGRVYRAEFANGKIMAVKK-IDNAALSLQ-----EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 414 ~~~~Lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
....+.+|+-+.|+++.+. |+...||. +.+....+. ..++...|++.+.++.--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568999999999999886 66655553 332222221 3456678889888887666666566677777888999
Q ss_pred EecCC-CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC---CcEEeeccccc
Q 007103 488 EYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAA 563 (618)
Q Consensus 488 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfgl~~ 563 (618)
||+++ .++.+++..... ..........++.+|-+.+.-||.. +|||+||.++||++.+++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 478888864321 1222223367888899999999999 999999999999997554 34799999986
Q ss_pred cCC
Q 007103 564 LTP 566 (618)
Q Consensus 564 ~~~ 566 (618)
...
T Consensus 165 ~s~ 167 (229)
T KOG3087|consen 165 VSR 167 (229)
T ss_pred ccc
Confidence 543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.1e-11 Score=124.43 Aligned_cols=199 Identities=20% Similarity=0.193 Sum_probs=152.6
Q ss_pred hhhhhcCCcccceeccCccceEEEEEE--cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCC
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 481 (618)
......+|.....||.|.|+.|++... .++..|++|.+.+..........-..|+.+...+ .|.+++.++..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 344556788889999999999999854 3588999999887665544444445566655555 5899999888888888
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-CCcEEeecc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCG 560 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg 560 (618)
..++-.||+++++...... ....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 8889999999998876652 345678888999999999999999998 99999999999999876 788999999
Q ss_pred ccccCCCCCcccccceecccccc--CccccccCCCCcccchhhHHHHHHHHHhCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYS--APEFALSGIYTVKSDVYSFGVVMLELLTGRK 614 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~ 614 (618)
.+..+.-.. ....++-+++ +++......+..+.|++|||.-+.|..+|..
T Consensus 413 ~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 413 CWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccceec----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 885432111 1112233444 4555556678899999999999999888753
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-11 Score=129.25 Aligned_cols=127 Identities=25% Similarity=0.329 Sum_probs=107.8
Q ss_pred CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCC-cccCCCcCeee
Q 007103 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLY 207 (618)
Q Consensus 129 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~ 207 (618)
..|.+.+.++|+|. .+..++.-++.|+.|+|++|+++... .+..++.|++|||++|.|. .+|.. ...+ +|+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence 57889999999999 77788999999999999999999664 7889999999999999999 67753 2334 499999
Q ss_pred eccccccccccccCCCCccEEEcccccccc---cCc-hhhhcccchhccCCcCCCCC
Q 007103 208 LQNNQVTGSLNVFSGLPLTTLNVANNHFSG---WIP-RELISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 208 l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g---~ip-~~~~~l~~l~~~~N~~~~~~ 260 (618)
|++|-++.........+|..|||+.|-|++ ..| ..+..|..|++.|||++|.+
T Consensus 239 lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 239 LRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999999987666666679999999999987 233 45688999999999999975
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-10 Score=123.02 Aligned_cols=121 Identities=34% Similarity=0.453 Sum_probs=58.8
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC-C-CccEEecccccccccCCccccCCCCccEEEeecCCC
Q 007103 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-P-NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165 (618)
Q Consensus 88 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 165 (618)
+++..+.+... ...+..++.++.|++.+|.++...|.... + +|+.|++++|++. .+|..+..+++|+.|++++|++
T Consensus 98 l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l 175 (394)
T COG4886 98 LDLNLNRLRSN-ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL 175 (394)
T ss_pred eeccccccccC-chhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchh
Confidence 44554444221 12233345555555555555533322222 1 5555555555555 4444555555555555555555
Q ss_pred CCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccc
Q 007103 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212 (618)
Q Consensus 166 ~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~ 212 (618)
+ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|.
T Consensus 176 ~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 176 S-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred h-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 5 33333334555555555555555 455444444445555555553
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-11 Score=115.23 Aligned_cols=127 Identities=24% Similarity=0.289 Sum_probs=83.1
Q ss_pred CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeee
Q 007103 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYL 208 (618)
Q Consensus 129 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l 208 (618)
+-|+.||||+|.|+ .+.++..-+++++.|++|+|.|+.+ . .+..+++|+.||||+|.++ .+-.+-..+-|++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 46777777777777 6667777777788888888877733 2 2666777888888888777 55555556777778888
Q ss_pred ccccccccccccCCCCccEEEcccccccccCc-h---hhhcccchhccCCcCCCC
Q 007103 209 QNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R---ELISIRTFIYDGNSFDNG 259 (618)
Q Consensus 209 ~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~---~~~~l~~l~~~~N~~~~~ 259 (618)
++|.|...-..-..-+|..||+++|+|...-- . .++.|..+.+.+||+...
T Consensus 360 a~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 360 AQNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 87776643222222347777888887763111 1 233445667777777654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=7e-11 Score=129.60 Aligned_cols=204 Identities=24% Similarity=0.270 Sum_probs=140.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..+.+.+.+-+-+|.++.++.+.-. .|...++|....... .....+..+.+-...-...+|-++...--+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455666667888999999877433 244444444432211 11111112222222222234555544444445667899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
+++|+.+++|...++. .+..+..........+..+++|||.. .+.|||++|.|.+...+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999983 33455555666777888999999998 7899999999999999999999999843211
Q ss_pred C-------C--------------C---------CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 007103 566 P-------N--------------T---------ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615 (618)
Q Consensus 566 ~-------~--------------~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P 615 (618)
. . . +........||+.|.+||...+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 0 0 00112235799999999999999999999999999999999999999
Q ss_pred CCC
Q 007103 616 LDR 618 (618)
Q Consensus 616 f~~ 618 (618)
|+.
T Consensus 1035 ~na 1037 (1205)
T KOG0606|consen 1035 FNA 1037 (1205)
T ss_pred CCC
Confidence 974
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.2e-11 Score=113.02 Aligned_cols=104 Identities=23% Similarity=0.248 Sum_probs=44.7
Q ss_pred CCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc-CCCCccEEE
Q 007103 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-SGLPLTTLN 229 (618)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~ 229 (618)
....|+.||||+|.|+ .+.++..-+|.++.|++|+|.|. .+-. +..+++|+.||||+|.++.....- ..-+++.|.
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLK 358 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeee
Confidence 3344555555555554 33334444455555555555554 2222 444555555555555544322211 112344555
Q ss_pred cccccccccCc-hhhhcccchhccCCcCC
Q 007103 230 VANNHFSGWIP-RELISIRTFIYDGNSFD 257 (618)
Q Consensus 230 l~~N~l~g~ip-~~~~~l~~l~~~~N~~~ 257 (618)
|++|.|....- .-+.+|.+|++.+|.+.
T Consensus 359 La~N~iE~LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 359 LAQNKIETLSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhhhHhhhhhhHhhhhheeccccccchh
Confidence 55554432111 22333444445555443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.7e-10 Score=122.09 Aligned_cols=172 Identities=31% Similarity=0.461 Sum_probs=137.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCC-CCCEEEecCCCccCC-CCCCCCCCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDT-IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~-~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
..++.|++.+|+++. +++....+. +|+.|++++|++... .+....++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 116 ~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 116 TNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred cceeEEecCCccccc-CccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 468999999999975 566677775 999999999999944 25566699999999999999 77777779999999999
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccccC
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWI 239 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~i 239 (618)
++|+++ .+|.....+..|+.|.+++|.+. .++..+..+.++..|.+++|++...+..... ..++.|++++|.++ .+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i 270 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SI 270 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-cc
Confidence 999999 56665556677999999999755 5777888999999999999998875444333 34999999999998 44
Q ss_pred ch--hhhcccchhccCCcCCCC
Q 007103 240 PR--ELISIRTFIYDGNSFDNG 259 (618)
Q Consensus 240 p~--~~~~l~~l~~~~N~~~~~ 259 (618)
+. .+.+++.|++++|.+...
T Consensus 271 ~~~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 271 SSLGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred ccccccCccCEEeccCcccccc
Confidence 43 456677888888887654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.3e-11 Score=117.32 Aligned_cols=174 Identities=22% Similarity=0.238 Sum_probs=126.2
Q ss_pred CCEEEEEcCCCCCcc--cccccccCCCCCCEEEecCCCccCCCCC---CCCCCccEEecccccccc-cCCccccCCCCcc
Q 007103 83 SAVVSIDISGLGLSG--TMGYLLSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSG-NLPYSIASMVSLS 156 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~p~---~~~~~L~~L~L~~N~l~~-~~p~~~~~l~~L~ 156 (618)
.+|+.|||+.|=+.. ++......|++|+.|+|+.|++.-.... ...+.|+.|.|+.+.|+- .+-..+..+++|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 578999999997764 3345567899999999999998733322 233889999999999983 2334456789999
Q ss_pred EEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCC--CCcccCCCcCeeeecccccccc-cccc-------CCCCcc
Q 007103 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGS-LNVF-------SGLPLT 226 (618)
Q Consensus 157 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~-~~~~-------~~~~L~ 226 (618)
.|+|..|...+........++.|+.|||++|++- ..+ ...+.++.|..|+++.+.|+.. .+.. ...+|+
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~ 304 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE 304 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence 9999999744444455666889999999999988 444 4567889999999999988863 2221 123599
Q ss_pred EEEcccccccccCc-----hhhhcccchhccCCcCCC
Q 007103 227 TLNVANNHFSGWIP-----RELISIRTFIYDGNSFDN 258 (618)
Q Consensus 227 ~L~l~~N~l~g~ip-----~~~~~l~~l~~~~N~~~~ 258 (618)
.|+++.|++.. .+ ..+.+++.|.+.+|.++.
T Consensus 305 ~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 305 YLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred eeecccCcccc-ccccchhhccchhhhhhcccccccc
Confidence 99999999963 22 234556666666666664
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.8e-10 Score=84.66 Aligned_cols=61 Identities=43% Similarity=0.573 Sum_probs=37.6
Q ss_pred CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcC
Q 007103 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (618)
Q Consensus 129 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 189 (618)
++|+.|+|++|+|+...+..|.++++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3556666666666644445666666666666666666655556666666666666666654
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.6e-09 Score=98.19 Aligned_cols=128 Identities=23% Similarity=0.292 Sum_probs=83.2
Q ss_pred eEEEEEEcCCcEEEEEEcCcccc------------------------cHHHHHHHHHHHHHhhcCCCC--cccccceEEe
Q 007103 425 RVYRAEFANGKIMAVKKIDNAAL------------------------SLQEEDNFLEAVSNMSRLRHP--NIVTLAGYCA 478 (618)
Q Consensus 425 ~Vy~~~~~~g~~vavK~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 478 (618)
.||.|...+|+.+|+|..+.... .........+|.+.|.++... ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999999999999998743211 111234557899999998766 45555544
Q ss_pred eCCeEEEEEEecC--CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCceecCCCCCCeeecCCCCcE
Q 007103 479 EHGQRLLVYEYVG--NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY-LHEVCLPSVVHRNFKSANILLDDELNPH 555 (618)
Q Consensus 479 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~iiH~Dlkp~Nill~~~~~~k 555 (618)
...++||||++ +..+..+... .++......++.+++..+.. +|+. ||+|+||.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24579999998 6555444331 11133455677788885555 5677 99999999999999988 999
Q ss_pred EeeccccccCC
Q 007103 556 LSDCGLAALTP 566 (618)
Q Consensus 556 l~Dfgl~~~~~ 566 (618)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.5e-08 Score=99.89 Aligned_cols=143 Identities=15% Similarity=0.092 Sum_probs=99.8
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccHH---------HHHHHHHHHHHhhcCCCCcc--cccceEEee-----
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ---------EEDNFLEAVSNMSRLRHPNI--VTLAGYCAE----- 479 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~----- 479 (618)
+.+-+.....|++.++ +|+.|.||+......... ....+.+|...+.++...+| ++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444455556777766 578899997743321110 01136677777776643333 344455443
Q ss_pred CCeEEEEEEecCCC-ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-------C
Q 007103 480 HGQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-------E 551 (618)
Q Consensus 480 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-------~ 551 (618)
....++|+|++++. +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999986 8998875221 23455667788999999999999999 9999999999999975 4
Q ss_pred CCcEEeecccccc
Q 007103 552 LNPHLSDCGLAAL 564 (618)
Q Consensus 552 ~~~kl~Dfgl~~~ 564 (618)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6789999998854
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.7e-10 Score=83.68 Aligned_cols=61 Identities=43% Similarity=0.557 Sum_probs=56.4
Q ss_pred CCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccc
Q 007103 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213 (618)
Q Consensus 153 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l 213 (618)
++|++|+|++|+|+...+..|..+++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999988778999999999999999999977778999999999999999986
|
... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.5e-10 Score=109.58 Aligned_cols=141 Identities=26% Similarity=0.334 Sum_probs=111.5
Q ss_pred CCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEccc-CcCCCCCCCCcccC
Q 007103 122 TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF-NNFSGDLPNSFISL 200 (618)
Q Consensus 122 ~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l 200 (618)
.+|..+++.-+.|+|..|+|+...|..|+.+++|+.||||+|+|+-+-|++|.++++|..|-+.+ |+|+..-...|++|
T Consensus 60 eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL 139 (498)
T KOG4237|consen 60 EVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGL 139 (498)
T ss_pred cCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhH
Confidence 67888888888999999999977778889999999999999999988899999999888776655 88984444568889
Q ss_pred CCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCch----hhhcccchhccCCcCCCCCCCC
Q 007103 201 SNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDNGPAPP 263 (618)
Q Consensus 201 ~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip~----~~~~l~~l~~~~N~~~~~~~~~ 263 (618)
..|+.|.+.-|++.-.... +.. .++..|.|-+|.+. .|+. .+..++.+.+..|++-|.+..+
T Consensus 140 ~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 140 SSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred HHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccc
Confidence 9999999999988865532 333 34778888888887 5554 4466678889999988876543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.3e-08 Score=99.87 Aligned_cols=169 Identities=19% Similarity=0.262 Sum_probs=126.4
Q ss_pred ccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee----CCeEEEEEEecCC-CCh
Q 007103 422 SLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVYEYVGN-GNL 495 (618)
Q Consensus 422 ~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL 495 (618)
.-.+.|++.. .||..|++|+++.... +.......-+++++++.|+|||++.+++.. +..+++|++|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3457899954 4799999999943322 122223355788999999999999998863 4478999999986 477
Q ss_pred hhhhhcc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 496 HDMLHFA-----------DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 496 ~~~l~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
.++.-.. -..+...++..+|.++.|+..||.++|+. |+.-+-|.+++|+++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 7654211 11234578899999999999999999999 889999999999999998999999998876
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 613 (618)
...+.. |-+.+ -.+-|.=.||.++..|.||.
T Consensus 443 l~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 443 LQEDPT---------------EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred ecCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 654331 11111 13568889999999999984
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.4e-09 Score=115.43 Aligned_cols=169 Identities=24% Similarity=0.241 Sum_probs=82.9
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
.+..|++.+|.|..... .+..+++|++|+|++|.|+...+....+.|+.|++++|.|+.. ..+..++.|+.+++++|
T Consensus 96 ~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n 172 (414)
T KOG0531|consen 96 SLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYN 172 (414)
T ss_pred ceeeeeccccchhhccc-chhhhhcchheeccccccccccchhhccchhhheeccCcchhc--cCCccchhhhcccCCcc
Confidence 45555566655544321 1455555666666666665555544445556666666655533 33444555566666666
Q ss_pred CCCCccc-hhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCC--ccEEEccccccccc--
Q 007103 164 SLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVANNHFSGW-- 238 (618)
Q Consensus 164 ~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~--L~~L~l~~N~l~g~-- 238 (618)
+++...+ . ...+.+|+.+++++|.+. ....+..+..+..+++..|.++-.-+...... |+.+++++|+++-.
T Consensus 173 ~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~~~ 249 (414)
T KOG0531|consen 173 RIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISRSPE 249 (414)
T ss_pred hhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccccccc
Confidence 5554333 1 344555555555555554 11223333344444555555443222222222 55666666666521
Q ss_pred CchhhhcccchhccCCcCCC
Q 007103 239 IPRELISIRTFIYDGNSFDN 258 (618)
Q Consensus 239 ip~~~~~l~~l~~~~N~~~~ 258 (618)
....+..+..+.+..|....
T Consensus 250 ~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 250 GLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred cccccccccccchhhccccc
Confidence 22334444555555555443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.5e-08 Score=91.46 Aligned_cols=137 Identities=18% Similarity=0.148 Sum_probs=96.0
Q ss_pred cccceeccCccceEEEEEEcCCcEEEEEEcCcccc------------------c--HHHHHHHHHHHHHhhcCCCC--cc
Q 007103 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL------------------S--LQEEDNFLEAVSNMSRLRHP--NI 470 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~--~~~~~~~~~e~~~l~~l~h~--ni 470 (618)
.+...||.|.-+.||.|..+.|.++|+|.=+.... + ........+|.+.|+++.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45568999999999999999999999995422211 1 11123456788888888644 56
Q ss_pred cccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC
Q 007103 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD 550 (618)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~ 550 (618)
.+.+++ +...+||||+++--|...- ++....-.++..|++-++-+-+. ||||+|+++-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 666654 5678999999985554322 12223333444555555555566 9999999999999999
Q ss_pred CCCcEEeeccccccC
Q 007103 551 ELNPHLSDCGLAALT 565 (618)
Q Consensus 551 ~~~~kl~Dfgl~~~~ 565 (618)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.4e-09 Score=113.67 Aligned_cols=170 Identities=24% Similarity=0.274 Sum_probs=128.2
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCC-CCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+..+++..|.+.. +-..+..+++|..|+|.+|+|.+... ....++|++|+|++|+|+.. ..+..++.|+.|++++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccc--cchhhccchhhheecc
Confidence 34555677777654 34458889999999999999997776 56669999999999999966 4577788899999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCC-cccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCch
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~ 241 (618)
|.|+.. ..+..+++|+.+++++|++. .+... ...+.+|+.+++.+|.+...-..-....+..+++..|.++-.-+.
T Consensus 150 N~i~~~--~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~~~l 226 (414)
T KOG0531|consen 150 NLISDI--SGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKLEGL 226 (414)
T ss_pred Ccchhc--cCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceeccCc
Confidence 999854 34555899999999999998 44442 577889999999999988655444444466668899998754432
Q ss_pred h-hhc--ccchhccCCcCCCC
Q 007103 242 E-LIS--IRTFIYDGNSFDNG 259 (618)
Q Consensus 242 ~-~~~--l~~l~~~~N~~~~~ 259 (618)
. ... ++.+++.+|+..-.
T Consensus 227 ~~~~~~~L~~l~l~~n~i~~~ 247 (414)
T KOG0531|consen 227 NELVMLHLRELYLSGNRISRS 247 (414)
T ss_pred ccchhHHHHHHhcccCccccc
Confidence 2 222 78889999988765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.6e-07 Score=90.81 Aligned_cols=193 Identities=18% Similarity=0.231 Sum_probs=126.6
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceE-----E-ee-CCeEEEE
Q 007103 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY-----C-AE-HGQRLLV 486 (618)
Q Consensus 414 ~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-----~-~~-~~~~~lv 486 (618)
....||+|+.+.+|-..-- +.. +.|++....... ..+...|+. ..-.||-+-.-+.| + -. .....+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~--~aqk~a~la--~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAA--QAQKVAELA--ATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCchH--HHHHHHHhc--cCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3456999999999965221 222 347766544222 222222222 12245543221111 1 11 2236678
Q ss_pred EEecCCC-Chhhhhhc--ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 487 YEYVGNG-NLHDMLHF--ADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
|..+.+- -+..+++- .+..-....|.-.++.+..++.+.+-||+. |.+-+|+.++|+|+.+++.+.+.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 8877653 23333321 112234578999999999999999999999 99999999999999999999999765433
Q ss_pred cCCCCCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTG-RKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~Pf~ 617 (618)
...+ .......+|...|.+||... +...+...|-|.||+++++++.| +.||.
T Consensus 166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 3322 22223457899999999765 34457789999999999999986 99985
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.9e-07 Score=84.46 Aligned_cols=141 Identities=16% Similarity=0.135 Sum_probs=103.0
Q ss_pred eeccCccceEEEEEEcCCcEEEEEEcCcc-ccc---HHHHHHHHHHHHHhhcCCCCc--ccccceEEee-----CCeEEE
Q 007103 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNA-ALS---LQEEDNFLEAVSNMSRLRHPN--IVTLAGYCAE-----HGQRLL 485 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~-~~~---~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~~~~~l 485 (618)
--|+||.+-|++..+. |+.+-+|+-... ..+ +-....|.+|+..+.++...+ +.++. ++.. .-..+|
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 4578999999998875 557888886521 111 224567888988888775332 44444 3321 124689
Q ss_pred EEEecCC-CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC--cEEeecccc
Q 007103 486 VYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfgl~ 562 (618)
|+|-+++ -+|.+++... ...+.+...+..++.+++..++-||.. |+.|+|+.+.||+++.++. ++++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9998764 4888887521 223557777889999999999999999 9999999999999986666 999999877
Q ss_pred cc
Q 007103 563 AL 564 (618)
Q Consensus 563 ~~ 564 (618)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 54
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.61 E-value=8.3e-09 Score=103.26 Aligned_cols=176 Identities=20% Similarity=0.191 Sum_probs=126.8
Q ss_pred CEEEEEcCCCCCccccc-ccccCCCCCCEEEecCCCccCCCCC----CCCCCccEEecccccccccCCcccc-CCCCccE
Q 007103 84 AVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPY----QLPPNLTSLNLASNNFSGNLPYSIA-SMVSLSY 157 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~----~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~ 157 (618)
.++.+.|.+..+.-... .....|++++.||||.|-|....|. +-.++|+.|+|+.|++.-....... .++.|+.
T Consensus 122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 45666666665532211 4667899999999999998854441 2238999999999999855444433 5789999
Q ss_pred EEeecCCCCCc-cchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccc--cccCC-CCccEEEcccc
Q 007103 158 LNVSRNSLTQS-IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSG-LPLTTLNVANN 233 (618)
Q Consensus 158 L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~-~~L~~L~l~~N 233 (618)
|.|+.+.|+.. +...+..+|+|+.|+|..|...+.-.....-+..|+.|||++|++.... +.... ..|+.|+++.+
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~t 281 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSST 281 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcccc
Confidence 99999999943 3344567899999999999644344444556788999999999988644 32222 34888888888
Q ss_pred cccc-cCch--------hhhcccchhccCCcCCCC
Q 007103 234 HFSG-WIPR--------ELISIRTFIYDGNSFDNG 259 (618)
Q Consensus 234 ~l~g-~ip~--------~~~~l~~l~~~~N~~~~~ 259 (618)
.++. .+|+ .+.+|+.|....|+..-.
T Consensus 282 gi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w 316 (505)
T KOG3207|consen 282 GIASIAEPDVESLDKTHTFPKLEYLNISENNIRDW 316 (505)
T ss_pred CcchhcCCCccchhhhcccccceeeecccCccccc
Confidence 8865 3343 467888999999987543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.1e-07 Score=88.77 Aligned_cols=108 Identities=22% Similarity=0.292 Sum_probs=81.4
Q ss_pred HHHHHHHHHHhhcCCCCc--ccccceEEeeC----CeEEEEEEecCCC-ChhhhhhcccCCCCCCCHHHHHHHHHHHHHH
Q 007103 452 EDNFLEAVSNMSRLRHPN--IVTLAGYCAEH----GQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARA 524 (618)
Q Consensus 452 ~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~ 524 (618)
.....+|...+.++.... +.+.+++.+.. ...++|+|++++. +|.+++... ...+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 345666776666654333 44556665542 2458999999874 799988632 225666778899999999
Q ss_pred HHHHhhcCCCCceecCCCCCCeeecCCC---CcEEeeccccccCC
Q 007103 525 LEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAALTP 566 (618)
Q Consensus 525 L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfgl~~~~~ 566 (618)
++-||+. ||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 999999999999999887 89999999886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.8e-07 Score=98.43 Aligned_cols=143 Identities=23% Similarity=0.280 Sum_probs=93.3
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccH--------------------------------------HHHHHHHH
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL--------------------------------------QEEDNFLE 457 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--------------------------------------~~~~~~~~ 457 (618)
+.|+.++-|+||+|++++|+.||||+.+...... ..+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4799999999999999999999999875432110 01123344
Q ss_pred HHHHhhcCC-----CCcccccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHH-HHHHhhc
Q 007103 458 AVSNMSRLR-----HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA-LEYLHEV 531 (618)
Q Consensus 458 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~ 531 (618)
|...+.+++ .++|.=..=|++-.+..+++|||++|-.+.+.... .....+... ++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 544444442 23332222233345678999999999888877431 123344333 33333322 2333334
Q ss_pred CCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 532 ~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
|++|.|..|.||+++.+|++.+.|||+....+.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.5e-07 Score=64.66 Aligned_cols=39 Identities=49% Similarity=1.026 Sum_probs=29.1
Q ss_pred hHHHHHHHHHHHhCCC-C-CCCCCCCCCC-CCCCCCCCceeEee
Q 007103 41 SSDVQALQVLYTSLNS-P-SVLTNWKGNE-GDPCGESWKGVACE 81 (618)
Q Consensus 41 ~~~~~al~~~~~~~~~-~-~~~~~w~~~~-~~~c~~~w~gv~c~ 81 (618)
++|++||++||+++.+ + ..+.+|+.+. .+|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C--~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC--SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC--CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe--eeccEEeC
Confidence 5799999999999985 4 5899999764 6778 79999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.8e-09 Score=88.16 Aligned_cols=125 Identities=28% Similarity=0.345 Sum_probs=77.6
Q ss_pred EEEEcCCCCCcccccc---cccCCCCCCEEEecCCCccCCCCCCCC---CCccEEecccccccccCCccccCCCCccEEE
Q 007103 86 VSIDISGLGLSGTMGY---LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 86 ~~l~l~~~~l~~~~~~---~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
-.+||++..|- .++. .+....+|+..+|++|.|. ..|..|. +.++.|+|++|.|+ .+|.+++.++.|+.|+
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34556655552 2332 3445556666677777776 4444443 46777777777777 6677777777777777
Q ss_pred eecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc
Q 007103 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
++.|.|. ..|..+..|.+|..|+..+|.+. .+|..+..-+++-..++.++.+.+
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccc
Confidence 7777777 55666666777777777777777 566554333333333444455444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.9e-08 Score=103.21 Aligned_cols=191 Identities=18% Similarity=0.126 Sum_probs=135.3
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCc-ccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~ 483 (618)
++..++-+..-+-.++|+++.++|.+-.-.+....+.+.. . ....-+++++.+++||| .+..++-+..+...
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----T--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----c--hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 3444444555566889999999998754333333444322 1 34456788999999999 77777777777888
Q ss_pred EEEEEecCCC-ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 484 LLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 484 ~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
+++++++..+ +-..... .....+...+...+...-.++++|+|+. .=+||| ||+..+ +..|..||+..
T Consensus 310 ~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred chhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCC
Confidence 9999999877 2222111 1222344444555666677899999987 458998 777666 58899999988
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P 615 (618)
..+.... ......+|+.|+|||+.....+....|+|++|+-..++--|-+|
T Consensus 379 ~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 379 PQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 6654332 33456899999999999999999999999999877777666655
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.9e-06 Score=78.09 Aligned_cols=141 Identities=15% Similarity=0.192 Sum_probs=92.9
Q ss_pred hhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHH-------HHHHHHHHHhhcCC---CCcccccceE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEE-------DNFLEAVSNMSRLR---HPNIVTLAGY 476 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~-------~~~~~e~~~l~~l~---h~niv~l~~~ 476 (618)
...++|...+++-......|.+.+. +|+.+++|.........+.. ....+++..+.+++ -.....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456788888888877777777766 47899999887654322111 11223333333332 2333333333
Q ss_pred Eee-----CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 477 CAE-----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 477 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
.+. ....+++|||++|..|.++.. +++ .++..+++++.-+|+. |+.|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 322 235579999999987776542 222 2445677889999999 99999999999999966
Q ss_pred CCcEEeecccccc
Q 007103 552 LNPHLSDCGLAAL 564 (618)
Q Consensus 552 ~~~kl~Dfgl~~~ 564 (618)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=4e-06 Score=80.99 Aligned_cols=141 Identities=13% Similarity=0.181 Sum_probs=84.3
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCc--ccccceEEeeCCeEEEEEEecCCC
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
..||+|..+.||+. .|..+++|...... ......+|.+.++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 46899999999984 25567788876432 2234577888887775433 466777777777888999999986
Q ss_pred C-hhhhh---------------------hcccCCCCCCCHHHHHHHHHHH----------HH-HHHHHhhc-CCCCceec
Q 007103 494 N-LHDML---------------------HFADDSSKNLTWNARVRVALGT----------AR-ALEYLHEV-CLPSVVHR 539 (618)
Q Consensus 494 s-L~~~l---------------------~~~~~~~~~l~~~~~~~i~~~i----------~~-~L~~LH~~-~~~~iiH~ 539 (618)
+ +...+ |........+... ..++..++ .+ ..++|.+. ..+.++|+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 3 21111 1100001111100 00010000 01 12222211 12357899
Q ss_pred CCCCCCeeecCCCCcEEeeccccccC
Q 007103 540 NFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 540 Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|+.|.||++++++ +.|+||+.+..-
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCcC
Confidence 9999999999888 999999987543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.6e-08 Score=96.23 Aligned_cols=174 Identities=18% Similarity=0.258 Sum_probs=129.6
Q ss_pred CEEEEEcCCCCCcccccc----cccCCCCCCEEEecCCCccCCC----CC-----------CCCCCccEEeccccccccc
Q 007103 84 AVVSIDISGLGLSGTMGY----LLSDLLSLRKFDLSGNSIHDTI----PY-----------QLPPNLTSLNLASNNFSGN 144 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~----~l~~l~~L~~L~L~~N~l~~~~----p~-----------~~~~~L~~L~L~~N~l~~~ 144 (618)
+++.||||+|-+.-.-+. .+..++.|++|.|.||.+.-.- .. ...++|+++...+|++-..
T Consensus 93 ~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred ceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccc
Confidence 799999999988644433 4567899999999999986111 11 1127899999999999743
Q ss_pred ----CCccccCCCCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeecccc
Q 007103 145 ----LPYSIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQ 212 (618)
Q Consensus 145 ----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~ 212 (618)
+...|...+.|+.+.+..|.|... +-..|..+++|+.|||.+|-|+-. +...+..+++|++|+++.+.
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 334566789999999999998732 345678899999999999999742 34556778899999999999
Q ss_pred cccc--c---cccC--CCCccEEEccccccccc----Cch---hhhcccchhccCCcCC
Q 007103 213 VTGS--L---NVFS--GLPLTTLNVANNHFSGW----IPR---ELISIRTFIYDGNSFD 257 (618)
Q Consensus 213 l~~~--~---~~~~--~~~L~~L~l~~N~l~g~----ip~---~~~~l~~l~~~~N~~~ 257 (618)
+... . ..+. .++|+.|.|.+|.++.. +-. ..+.|..|++++|.+.
T Consensus 253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9752 2 2222 34699999999999742 111 2356778999999985
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.9e-06 Score=78.85 Aligned_cols=138 Identities=20% Similarity=0.265 Sum_probs=89.9
Q ss_pred eeccCccceEEEEEEcCCcEEEEEEcCcccccHHH----------------------HHHHHHHHHHhhcCC--CCcccc
Q 007103 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE----------------------EDNFLEAVSNMSRLR--HPNIVT 472 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~--h~niv~ 472 (618)
.|.+|.-+.||+|...++..+|+|+++.....-.. ..-..+|+..|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 46678888999999888999999998643221111 011134555555442 223333
Q ss_pred cceEEeeCCeEEEEEEecCCCCh-hhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 473 LAGYCAEHGQRLLVYEYVGNGNL-HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 473 l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
.+++ ....|||||++.... .=.| ..-.+...+...+..++++.++-|-... ++||+||+.-|||+. +
T Consensus 135 Pi~~----~~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 135 PIAF----RNNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-D 202 (268)
T ss_pred ceee----cCCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-C
Confidence 3333 245799999976411 0011 1112233356677788888888888732 999999999999999 7
Q ss_pred CCcEEeeccccccCC
Q 007103 552 LNPHLSDCGLAALTP 566 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~ 566 (618)
+.+.|+|+|-+....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 799999999886554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.1e-09 Score=110.57 Aligned_cols=122 Identities=25% Similarity=0.282 Sum_probs=91.0
Q ss_pred CCCEEEecCCCccCCCCCC--CCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccch-hhcCCCCCCeEEc
Q 007103 108 SLRKFDLSGNSIHDTIPYQ--LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGD-IFGNLAGLATLDL 184 (618)
Q Consensus 108 ~L~~L~L~~N~l~~~~p~~--~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l 184 (618)
.|...+.++|.++ .+..+ +.+.|+.|||++|+++.. +.+..|++|++|||++|.|+. +|. .-..+ .|+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhh-hheeeee
Confidence 4666777777776 33323 337899999999999865 378889999999999999984 333 22233 3899999
Q ss_pred ccCcCCCCCCCCcccCCCcCeeeecccccccc---ccccCCCCccEEEccccccc
Q 007103 185 SFNNFSGDLPNSFISLSNISSLYLQNNQVTGS---LNVFSGLPLTTLNVANNHFS 236 (618)
Q Consensus 185 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---~~~~~~~~L~~L~l~~N~l~ 236 (618)
++|.++ .+ ..+.+|.+|..|||+.|-|.+. .|.+..+.|..|+|.+|.+.
T Consensus 240 rnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 999988 33 3477888999999999998873 24455566899999999886
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 618 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 1e-97
Identities = 84/222 (37%), Positives = 133/222 (59%), Gaps = 3/222 (1%)
Query: 397 ATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ-EEDNF 455
+++ LQ A+++FS + ++G G G+VY+ A+G ++AVK++ Q E F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGELQF 74
Query: 456 LEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV 515
V +S H N++ L G+C +RLLVY Y+ NG++ L +S L W R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
R+ALG+AR L YLH+ C P ++HR+ K+ANILLD+E + D GLA L + V+T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+ G G+ APE+ +G + K+DV+ +GV++LEL+TG++ D
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 2e-92
Identities = 81/226 (35%), Positives = 132/226 (58%), Gaps = 6/226 (2%)
Query: 394 PITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEED 453
P + + L+ ATN+F +FLIG G G+VY+ +G +A+K+ S Q +
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIE 80
Query: 454 NFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
F + +S RHP++V+L G+C E + +L+Y+Y+ NGNL L+ +D + +++W
Sbjct: 81 EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QV 572
R+ + +G AR L YLH +++HR+ KS NILLD+ P ++D G++ ++ +
Sbjct: 141 RLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
ST + G GY PE+ + G T KSDVYSFGVV+ E+L R + +
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 3e-86
Identities = 81/229 (35%), Positives = 128/229 (55%), Gaps = 15/229 (6%)
Query: 399 SYTVASLQTATNSFSQEF------LIGEGSLGRVYRAEFANGKIMAVKKIDNAAL--SLQ 450
S++ L+ TN+F + +GEG G VY+ + N +AVKK+ + +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEE 72
Query: 451 EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT 510
+ F + + M++ +H N+V L G+ ++ LVY Y+ NG+L D L D + L+
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLS 131
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
W+ R ++A G A + +LHE +HR+ KSANILLD+ +SD GLA + +
Sbjct: 132 WHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 571 Q-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618
+++++VG Y APE AL G T KSD+YSFGVV+LE++TG +D
Sbjct: 189 TVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-62
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 30/232 (12%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL-EA-VSNM 462
L + + G G V++A+ + +AVK +Q++ ++ E V ++
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKI-----FPIQDKQSWQNEYEVYSL 72
Query: 463 SRLRHPNIVTLAGYCAE----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518
++H NI+ G L+ + G+L D L + ++WN +A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIA 127
Query: 519 LGTARALEYLHE-------VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER 570
AR L YLHE P++ HR+ KS N+LL + L ++D GLA
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 571 QVSTQMVGAFGYSAPEFALSGI-----YTVKSDVYSFGVVMLELLTGRKPLD 617
+ VG Y APE I ++ D+Y+ G+V+ EL + D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-57
Identities = 73/198 (36%), Positives = 105/198 (53%), Gaps = 4/198 (2%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG GS G V+RAE+ +G +AVK + + + FL V+ M RLRHPNIV G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +V EY+ G+L+ +LH + + L R+ +A A+ + YLH P +V
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HRN KS N+L+D + + D GL+ L +T S G + APE KS
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 598 DVYSFGVVMLELLTGRKP 615
DVYSFGV++ EL T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 7e-55
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G+ G V +A++ K +A+K+I++ E F+ + +SR+ HPNIV L G C
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
LV EY G+L+++LH + T + L ++ + YLH + +++
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 538 HRNFKSANILLDDELN-PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVK 596
HR+ K N+LL + D G A T G+ + APE Y+ K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 597 SDVYSFGVVMLELLTGRKP 615
DV+S+G+++ E++T RKP
Sbjct: 184 CDVFSWGIILWEVITRRKP 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-54
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEE--DNFLEAVSNMSRLRHPNIVTLAG 475
IG G G+VYRA + G +AVK + + +N + + L+HPNI+ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
C + LV E+ G L+ +L K + + V A+ AR + YLH+ +
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 536 VVHRNFKSANILLDDELNPH--------LSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
++HR+ KS+NIL+ ++ ++D GLA T + GA+ + APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEV 185
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ +++ SDV+S+GV++ ELLTG P
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-53
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKI-----DNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
IG+G G V++ + ++A+K + + +++ F V MS L HPNIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G +V E+V G+L+ L D + + W+ ++R+ L A +EY+
Sbjct: 87 KLYGLMHN--PPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN- 140
Query: 532 CLPSVVHRNFKSANILLD-----DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
P +VHR+ +S NI L + ++D GL+ + ++ + ++G F + APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPE 196
Query: 587 --FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
A YT K+D YSF +++ +LTG P
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-53
Identities = 45/204 (22%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+ E G +++ + G + VK + S ++ +F E + HPN++ + G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 478 AE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
L+ ++ G+L+++LH + ++ + + V+ AL AR + +LH P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG---- 591
+ S ++++D+++ +S + Q S + A + APE AL
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVK-----FSFQ-SPGRMYAPAWVAPE-ALQKKPED 186
Query: 592 IYTVKSDVYSFGVVMLELLTGRKP 615
+D++SF V++ EL+T P
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-51
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG GS G VY+ ++ +G + AVK ++ A + Q+ F V + + RH NI+ GY
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
Q +V ++ +L+ LH S + +A TAR ++YLH S++
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPE---FALSGIY 593
HR+ KS NI L ++ + D GLA Q+ G+ + APE S Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 594 TVKSDVYSFGVVMLELLTGRKP 615
+ +SDVY+FG+V+ EL+TG+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-51
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G G+ + G++M +K++ + + FL+ V M L HPN++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ + + EY+ G L ++ W+ RV A A + YLH + ++
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTE-------------RQVSTQMVGAFGYS 583
+HR+ S N L+ + N ++D GLA L + + R+ +VG +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE Y K DV+SFG+V+ E++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 8e-49
Identities = 54/243 (22%), Positives = 86/243 (35%), Gaps = 38/243 (15%)
Query: 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLE--A 458
+ ++ LIG G G VY+ + + +AVK S NF+
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV-----FSFANRQNFINEKN 57
Query: 459 VSNMSRLRHPNIVTLAGYCAE-----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
+ + + H NI + LLV EY NG+L L W +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 514 RVRVALGTARALEYLHE------VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567
R+A R L YLH P++ HR+ S N+L+ ++ +SD GL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 568 TERQ-------VSTQMVGAFGYSAPEFALSGI-------YTVKSDVYSFGVVMLELLTGR 613
+ VG Y APE + + D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 614 KPL 616
L
Sbjct: 233 TDL 235
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G+VY + +G++ A++ ID + + F V + RH N+V G C
Sbjct: 41 IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ L+ ++ D+ L N ++A + + YLH ++
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNT-ERQVSTQMVGAFG---YSAPE------- 586
H++ KS N+ D+ ++D GL +++ + ++ G + APE
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 587 --FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
++ SDV++ G + EL P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLE--AVSNMSRLRHPNIVTLA 474
+G+G G V+R + G+ +AVK S ++E ++ + N LRH NI+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 475 GYC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Q L+ Y G+L+D L L + +R+ L A L +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL---TPNTERQVSTQMVGAFGY 582
P++ HR+ KS NIL+ ++D GLA + + N + VG Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 583 SAPE------FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE + D+++FG+V+ E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-46
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 31/219 (14%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL-EA-VSNMSRLRHPNIVTLA 474
IG+G G V+ ++ G+ +AVK EE ++ E + +RH NI+
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 475 GYC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
Q L+ +Y NG+L+D L S L + +++A + L +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL---TPNTERQVSTQMVGAFGY 582
P++ HR+ KS NIL+ ++D GLA N VG Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 583 SAPE------FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE + +D+YSFG+++ E+
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL-EA-VSNMSRLRHPNIVTLA 474
IG+G G V+R ++ G+ +AVK S +EE ++ EA + LRH NI+
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 475 GYCAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+ Q LV +Y +G+L D L+ +T +++AL TA L +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 531 -----VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL---TPNTERQVSTQMVGAFGY 582
P++ HR+ KS NIL+ ++D GLA +T VG Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 583 SAPEFALSGI------YTVKSDVYSFGVVMLELLTGRKP 615
APE I ++D+Y+ G+V E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-40
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 16/234 (6%)
Query: 42 SDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGY 101
++ L L ++L +W N+ +PC ++ GV C V SID+S L+
Sbjct: 12 REIHQLISFKDVLPDKNLLPDWSSNK-NPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSA 68
Query: 102 L---LSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLP--YSIASMVSL 155
+ L L L LS + I+ ++ ++ +LTSL+L+ N+ SG + S+ S L
Sbjct: 69 VSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128
Query: 156 SYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL---YLQNN 211
+LNVS N+L L L LDLS N+ SG ++ L + N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 212 QVTGSLNVFSGLPLTTLNVANNHFSGWIP--RELISIRTFIYDGNSFDNGPAPP 263
+++G ++V + L L+V++N+FS IP + +++ GN +G
Sbjct: 189 KISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKL-SGDFSR 241
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNL 145
+DISG LSG +S L+ ++S N IP +L L+LA N F+G +
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEI 285
Query: 146 PYSIA-SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS-LSNI 203
P ++ + +L+ L++S N ++ FG+ + L +L LS NNFSG+LP + + +
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345
Query: 204 SSLYLQNNQVTGSL-NVFSGLP--LTTLNVANNHFSGWIPRELI-----SIRTFIYDGNS 255
L L N+ +G L + L L TL++++N+FSG I L +++ N
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405
Query: 256 FDNGPAPP 263
F G PP
Sbjct: 406 F-TGKIPP 412
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-30
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 14/188 (7%)
Query: 86 VSIDISGLGLSGTMGY-LLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASN 139
+++S L L SL DLS NSI L L ++ N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
SG++ ++ V+L +L+VS N+ + I + G+ + L LD+S N SGD + +
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGIPFL-GDCSALQHLDISGNKLSGDFSRAIST 245
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELI----SIRTFIYDGNS 255
+ + L + +NQ G + L L++A N F+G IP L ++ GN
Sbjct: 246 CTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 256 FDNGPAPP 263
F G PP
Sbjct: 306 F-YGAVPP 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 6/164 (3%)
Query: 86 VSIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNF 141
+++D+S SG + + +L++ L N IP L L SL+L+ N
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 142 SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
SG +P S+ S+ L L + N L I + L TL L FN+ +G++P+ + +
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490
Query: 202 NISSLYLQNNQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPREL 243
N++ + L NN++TG + L L L ++NN FSG IP EL
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 51/212 (24%), Positives = 80/212 (37%), Gaps = 29/212 (13%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
+ L G L+ L + +++ ++ L+++
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N SG +P I SM L LN+ N ++ SI D G+L GL LDLS N G +P +
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTF---IYDGN 254
+L+ LT ++++NN+ SG IP TF + N
Sbjct: 701 SALTM----------------------LTEIDLSNNNLSGPIPEMGQ-FETFPPAKFLNN 737
Query: 255 SFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSH 286
G P P + G +H+ RSH H
Sbjct: 738 PGLCGY-PLPRCDPSNADGYAHHQRSHHHHHH 768
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 36/159 (22%), Positives = 62/159 (38%), Gaps = 2/159 (1%)
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM 152
L G + L + +L L N + IP L NL ++L++N +G +P I +
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L+ L +S NS + +I G+ L LDL+ N F+G +P + S + +
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGK 573
Query: 213 VTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIY 251
+ F G +L + T
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-22
Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 13/186 (6%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
+ ++ + L+G + LS+ +L LS N + IP + NL L L+
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+N+FSGN+P + SL +L+++ N +I + ++ N +G
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYI 578
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGL----PLTTLNVANNHFSGWIPRELISIRTFIY-- 251
+ + N + L N+ + + G + + ++
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 252 -DGNSF 256
N
Sbjct: 639 MSYNML 644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS VY+ + +A ++ + L+ E F E + L+HPNIV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 476 YC---AEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ + +++ E + +G L L K + + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 532 CLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
P ++HR+ K NI + + + D GLA L + + ++G + APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKP 615
Y DVY+FG+ MLE+ T P
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP 228
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 36/237 (15%)
Query: 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVAC----EGSAVVSIDISGLG 94
+ D QAL + L +P+ L++W D C +W GV C + V ++D+SGL
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 95 LSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLAS-NNFSGNLPYSIAS 151
L IP L P L L + NN G +P +IA
Sbjct: 62 LPKPY----------------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L YL ++ +++ +I D + L TLD S+N SG LP S SL N+ + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 212 QVTGSL-NVFSGLP--LTTLNVANNHFSGWIPREL--ISIRTFIYDGNSFDNGPAPP 263
+++G++ + + T++ ++ N +G IP +++ N G A
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML-EGDASV 215
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 35/142 (24%), Positives = 55/142 (38%), Gaps = 4/142 (2%)
Query: 95 LSGTMGYLLSDLLSLRKF-DLSGNSIHDTIPYQL-PPNLTSLNLASNNFSGNLPYSIASM 152
+SG + L +S N + IP NL ++L+ N G+ S
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ +++++NSL +G + G L LDL N G LP L + SL + N
Sbjct: 221 KNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 213 VTGSLNVFSGLP-LTTLNVANN 233
+ G + L ANN
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 31/106 (29%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGN 144
+D+S L G L + +K L+ NS+ + L NL L+L +N G
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNN 188
LP + + L LNVS N+L G+I GNL + N
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLC---GEIPQGGNLQRFDVSAYANNK 302
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 16/204 (7%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG G+ G V+ + AVK L + FL+ + + HPNIV L G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C + +V E V G+ L L +++ A +EYL
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY----SAPEFALSGI 592
+HR+ + N L+ ++ +SD G++ + G +APE G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGR 291
Query: 593 YTVKSDVYSFGVVMLELLT-GRKP 615
Y+ +SDV+SFG+++ E + G P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 6/204 (2%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL-A 474
IG GS GR + ++GKI+ K++D +++ E+ + V+ + L+HPNIV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
L +V EY G+L ++ + L +RV AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 534 PS--VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
V+HR+ K AN+ LD + N L D GLA + + T VG Y +PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNRM 191
Query: 592 IYTVKSDVYSFGVVMLELLTGRKP 615
Y KSD++S G ++ EL P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 10/200 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + + AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 284
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVK 596
+HRN + N L+ + ++D GL+ L ++APE +++K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 597 SDVYSFGVVMLELLT-GRKP 615
SDV++FGV++ E+ T G P
Sbjct: 400 SDVWAFGVLLWEIATYGMSP 419
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIM---AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G G+ G V + + K++ AVK + N A +D L + M +L +P IV +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G C +LV E G L+ L ++++ + + + ++YL E
Sbjct: 85 GICEAE-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSGI 592
VHR+ + N+LL + +SD GL+ E Q G + + APE
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 593 YTVKSDVYSFGVVMLELLT-GRKP 615
++ KSDV+SFGV+M E + G+KP
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A E + I+A+K + A L E V S LRHPNI+ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
GY + + L+ EY G ++ L F + + A AL Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANALSYCHS 127
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
V+HR+ K N+LL ++D G + P++ R + G Y PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEG 181
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLD 617
++ K D++S GV+ E L G+ P +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G VY + + AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLGV 77
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALSGIYT 594
+HR+ + N L+ + ++D GL+ L F +APE ++
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTAPESLAYNKFS 190
Query: 595 VKSDVYSFGVVMLELLT-GRKP 615
+KSDV++FGV++ E+ T G P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 7/200 (3%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEGS G+ + +G+ +K+I+ + +S +E + V+ ++ ++HPNIV
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
E+G +V +Y G+L ++ + + + AL+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVHD---RK 145
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++HR+ KS NI L + L D G+A + +T +G Y +PE + Y
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKPYNN 204
Query: 596 KSDVYSFGVVMLELLTGRKP 615
KSD+++ G V+ EL T +
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V + G +AVK I N A FL S M++LRH N+V L G
Sbjct: 29 IGKGEFGDVMLGD-YRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFALSGIY 593
VHR+ + N+L+ ++ +SD GL ++ S+ ++APE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKKF 191
Query: 594 TVKSDVYSFGVVMLELLT-GRKP 615
+ KSDV+SFG+++ E+ + GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 23/213 (10%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPE------- 586
+VH + K AN L+ D L D G+A + P+T V VG Y PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 587 ----FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ KSDV+S G ++ + G+ P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 23/213 (10%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPE------- 586
+VH + K AN L+ D L D G+A + P+T V VG Y PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 587 ----FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ KSDV+S G ++ + G+ P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G+ G VY+ + KI A+K++ A S + L+ M+ + +P++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C L+ + + G L D + + N+ + + A+ + YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFAL 589
L VHR+ + N+L+ + ++D GLA L E++ + G + A E L
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESIL 192
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
IYT +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG+G G V ++ G +AVK I N A FL S M++LRH N+V L G
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA-FGY--SAPEFALSGIY 593
VHR+ + N+L+ ++ +SD GL ++ S+ +APE +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKKF 363
Query: 594 TVKSDVYSFGVVMLELLT-GRKP 615
+ KSDV+SFG+++ E+ + GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG G G V+ + N +A+K I A E++F+E M +L HP +V L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
E LV E++ +G L D L + + L + YL E V+
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L+ + +SD G+ + + ST +++PE Y+ KS
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFGV+M E+ + G+ P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP 205
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 14/205 (6%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G VYRA +G +A+KK+ L + + ++ + + +L HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT----WNARVRVALGTARALEYLHE 530
E + +V E G+L M+ + + W V++ ALE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHS 154
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
V+HR+ K AN+ + L D GL + + +VG Y +PE
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHE 210
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKP 615
Y KSD++S G ++ E+ + P
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 30/210 (14%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS G V+R + G AVKK+ ++E + + L P IV L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE-------LVACAGLSSPRIVPLYG 117
Query: 476 YCAEHGQRLLVY-EYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
G + ++ E + G+L ++ +D + AL LEYLH
Sbjct: 118 -AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL-----GQAL---EGLEYLHT 168
Query: 531 VCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNTERQVSTQ----MVGAFGYSAP 585
++H + K+ N+LL + + L D G A S + G + AP
Sbjct: 169 RR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E + K D++S +ML +L G P
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 23/245 (9%)
Query: 387 SLKKIKSPITATSYTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEF---ANG 434
K + A +T A SF++E +IG G G V
Sbjct: 17 QGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 435 KIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNG 493
+ A+K + A + ++ +FL S M + HPNI+ L G ++V EY+ NG
Sbjct: 77 DVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553
+L L T V + G + YL ++ VHR+ + N+L+D L
Sbjct: 136 SLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189
Query: 554 PHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+SD GL+ + + T G +APE ++ SDV+SFGVVM E+L
Sbjct: 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 612 -GRKP 615
G +P
Sbjct: 250 YGERP 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ A + +AVK + ++S++ FL + M L+H +V L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 252
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ E++ G+L D L D + + A + ++ + + +
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ L ++D GLA + + E ++APE G +T+KS
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG++++E++T GR P
Sbjct: 367 DVWSFGILLMEIVTYGRIP 385
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-32
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G G V+ + +A+K + +S + FL+ M +LRH +V L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L ++ K L V +A A + Y+ + + V
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ + L ++D GLA L + E ++APE AL G +T+KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ EL T GR P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLA 474
IG G +V++ +I A+K ++ Q D++ ++ +++L+ + I+ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
Y +V E GN +L+ L K++ R A+ +H+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFALSGI- 592
+VH + K AN L+ D L D G+A + P+T V VGA Y PE A+ +
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMS 232
Query: 593 -----------YTVKSDVYSFGVVMLELLTGRKP 615
+ KSDV+S G ++ + G+ P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A E N IMA+K + + L E + S LRHPNI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHE 530
Y + + L+ E+ G L+ L F + S A AL Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCHE 132
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
V+HR+ K N+L+ + ++D G + P+ R+ T M G Y PE
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEG 186
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPLD 617
+ K D++ GV+ E L G P D
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFD 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +AVK I + ED F + M +L HP +V G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
++ +V EY+ NG L + L K L + + + + +L +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L+D +L +SD G+ + + S +SAPE Y+ KS
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV++FG++M E+ + G+ P
Sbjct: 187 DVWAFGILMWEVFSLGKMP 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V+ + +AVK + ++S FL + M +L+H +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 77
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG+L D L S LT N + +A A + ++ E + +
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ D L+ ++D GLA L + E ++APE G +T+KS
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ E++T GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 28/216 (12%)
Query: 412 FSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL- 465
F Q F +G GS G V++ +G++ AVK+ + ++ L V + ++
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALG 520
+HP V L E G L E G +L + +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRD-------- 165
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGA 579
T AL +LH +VH + K ANI L L D GL L +V G
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGD 219
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y APE L G Y +DV+S G+ +LE+ +
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I ++ ED F+E M L H +V L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG L + L + + + A+EYL +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFALSGIYT 594
HR+ + N L++D+ +SD GL+ + E S G+ +S PE + ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLMYSKFS 199
Query: 595 VKSDVYSFGVVMLELLT-GRKP 615
KSD+++FGV+M E+ + G+ P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G G V++ + + KI +K I++ + + + + + L H +IV
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGSLDHAHIVR 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C LV +Y+ G+L D + L + + A+ + YL E
Sbjct: 80 LLGLCPGS-SLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFAL 589
+ VHRN + N+LL ++D G+A L P ++Q+ A + A E
Sbjct: 136 M---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALESIH 190
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
G YT +SDV+S+GV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 415 EFLIGEGSLGRVYRAEF--ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+ +G G+ G V + + +I A+K + E+ + M +L +P IV
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIV 73
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C +LV E G G LH L + + + + + ++YL E
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFAL 589
VHR+ + N+LL + +SD GL+ + + + G + + APE
Sbjct: 130 NF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
++ +SDV+S+GV M E L+ G+KP
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + N AVK + + D + + + L H NIV
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVK 87
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C E G L+ E++ +G+L + L + + +++ A+ + ++YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFA 588
VHR+ + N+L++ E + D GL + + + + APE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ + + SDV+SFGV + ELLT
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-31
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G+G G V+ + +A+K + +S + FL+ M +LRH +V L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 331
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+E +V EY+ G+L D L ++ K L V +A A + Y+ + + V
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ ++ANIL+ + L ++D GLA L + E ++APE AL G +T+KS
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 598 DVYSFGVVMLELLT-GRKP 615
DV+SFG+++ EL T GR P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 48/227 (21%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG G V AVK K+DN+ S +E + FL + M HPN++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVI 99
Query: 472 TLAGYCAEHGQR-----LLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTARA 524
L G C E + +++ ++ G+LH L + K++ ++ + A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--------- 575
+EYL + +HR+ + N +L D++ ++D GL+ +++ +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------KKIYSGDYYRQGRIA 209
Query: 576 ------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ A E +YT KSDV++FGV M E+ T G P
Sbjct: 210 KMPVKWI-------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRAEFA----NGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G G+ G VY+ + KI A+K++ A S + L+ M+ + +P++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G C L+ + + G L D + + N+ + + A+ + YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA---FGYSAPEFAL 589
L VHR+ + N+L+ + ++D GLA L E++ + G + A E L
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESIL 192
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
IYT +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 418 IGEGSLGRVYRAEFANGKIM-----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IG G G VY+ A+K + A + ++ +FL M + H NI+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +++ +++ EY+ NG L L + + V + G A ++YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALS 590
VHR+ + NIL++ L +SD GL+ + + T G +APE
Sbjct: 168 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+SFG+VM E++T G +P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 418 IGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG G G VY +GK + AVK ++ + E FL M HPN+++L
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 474 AGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G C G L+V Y+ +G+L + + + + N T + L A+ ++YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK- 147
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQ--------MVGAFGY 582
VHR+ + N +LD++ ++D GLA + M
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM------ 199
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
A E + +T KSDV+SFGV++ EL+T G P
Sbjct: 200 -ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 418 IGEGSLGRVYRAEF--ANGKIM--AVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ +GK + AVK + LS E D+F+ V+ M L H N++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +V E G+L D L + R A+ A + YL
Sbjct: 86 LYGVVLTP-PMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALS 590
+HR+ + N+LL + D GL P + Q + APE +
Sbjct: 142 F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 591 GIYTVKSDVYSFGVVMLELLT-GRKP 615
++ SD + FGV + E+ T G++P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 51/232 (21%), Positives = 93/232 (40%), Gaps = 36/232 (15%)
Query: 406 QTATNSFSQEF----LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVS 460
T F +F LIG G G+V++A+ +GK +K++ + E V
Sbjct: 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE------VK 56
Query: 461 NMSRLRHPNIV---------------TLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADD 504
+++L H NIV + + L + E+ G L +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KR 114
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-A 563
+ L + + + ++Y+H +++R+ K +NI L D + D GL +
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
L + +R T+ G Y +PE S Y + D+Y+ G+++ ELL
Sbjct: 172 LKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 45/226 (19%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G+G G V A+ AVK + ++ + + FL + M HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 474 AGYCAEHGQR------LLVYEYVGNGNLHDML--HFADDSSKNLTWNARVRVALGTARAL 525
G + +++ ++ +G+LH L ++ NL VR + A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ---------- 575
EYL + +HR+ + N +L +++ ++D GL+ R++ +
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------RKIYSGDYYRQGCASK 200
Query: 576 -----MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ A E +YTV SDV++FGV M E++T G+ P
Sbjct: 201 LPVKWL-------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+G G VY E+ A +I A+K + + +Q+ + FL M L HPN++ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 474 AGYC-AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G G ++ Y+ +G+L + +N T + L AR +EYL E
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF---GYSAPEFAL 589
VHR+ + N +LD+ ++D GLA + E Q A ++A E
Sbjct: 145 F---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 590 SGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ +T KSDV+SFGV++ ELLT G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 106
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C G+R L+ EY+ G+L D L + + ++ + +EYL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFA 588
+HR+ + NIL+++E + D GL + P + + G + APE
Sbjct: 164 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 589 LSGIYTVKSDVYSFGVVMLELLT 611
++V SDV+SFGVV+ EL T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+G G G V + +I A+K + + ++ +FL S M + HPNI+ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + ++V EY+ NG+L L T V + G A ++YL ++
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY--SAPEFALSG 591
VHR+ + NIL++ L +SD GL + + T G ++PE
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 592 IYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+S+G+V+ E+++ G +P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 418 IGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + G+++AVKK+ ++ + F + + L+H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 75
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C G+R L+ EY+ G+L D L + + ++ + +EYL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFA 588
+HR+ + NIL+++E + D GL + P + + G + APE
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 589 LSGIYTVKSDVYSFGVVMLELLT 611
++V SDV+SFGVV+ EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
+G G + VY AE +A+K I + +E++ L E + S+L H NI
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIF---IPPREKEETLKRFEREVHN-SSQLSHQNI 73
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V++ E LV EY+ L + + S L+ + + +++ H+
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ +VHR+ K NIL+D + D G+A AL+ + Q + ++G Y +PE A
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAK 185
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
+D+YS G+V+ E+L G P
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 67/299 (22%), Positives = 117/299 (39%), Gaps = 17/299 (5%)
Query: 326 CIRKNRRKVSGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKS 385
C+++ S + +S + P + +T H QR TP PA ++
Sbjct: 249 CLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPM 308
Query: 386 GSLKKIKSPITATSYTVASLQTA---TNSFSQEFLIGEGSLGRVYRAEF--ANGKIM-AV 439
+ + + + N + +G G+ G V + + +I A+
Sbjct: 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML 499
K + E+ + M +L +P IV L G C +LV E G G LH L
Sbjct: 369 KVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL 426
Query: 500 HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559
+ + + + + ++YL E VHRN + N+LL + +SD
Sbjct: 427 V---GKREEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDF 480
Query: 560 GLAALTPNTERQVSTQMVGAFGY--SAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
GL+ + + + G + APE ++ +SDV+S+GV M E L+ G+KP
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+GEG+ G+V+ AE N AVK + + +L +F ++ L+H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIV 80
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVAL 519
G C + ++V+EY+ +G+L+ L + L + + +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ---- 575
A + YL VHR+ + N L+ L + D G++ R V +
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-------RDVYSTDYYR 190
Query: 576 -----------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
M PE + +T +SDV+SFGV++ E+ T G++P
Sbjct: 191 VGGHTMLPIRWM-------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 44/231 (19%), Positives = 81/231 (35%), Gaps = 34/231 (14%)
Query: 411 SFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL 465
++ EF IG G G V++ + +G I A+K+ +E N L V + L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 466 -RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
+H ++V AE L+ EY G+L D + + L R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPH-------------------LSDCGLAALT 565
L Y+H S+VH + K +NI + P+ + D G
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 566 PNTERQVSTQMVGAFGYSAPE-FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ + + + A E + + K+D+++ + ++
Sbjct: 185 SSPQVEEGDSR-----FLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 418 IGEGSLGRVYRAEFANGKIM--------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
+G+G+ ++++ +K +D A + E F EA S MS+L H +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSKLSHKH 73
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V G C + +LV E+V G+L L + + ++ VA A A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 530 EVCLPSVVHRNFKSANILLDDELNPH--------LSDCGLAALTPNTERQVSTQMVGAF- 580
E L +H N + NILL E + LSD G++ V + +
Sbjct: 131 ENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITVLPKDILQER 180
Query: 581 -GYSAPE-FALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ PE + +D +SFG + E+ + G KP
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G+GS G VY A G + A+K + N A S++E FL S M ++
Sbjct: 33 LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML------HFADDSSKNLTWNARVRVALGTARA 524
V L G ++ L++ E + G+L L + + + +++A A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--------- 575
+ YL+ VHR+ + N ++ ++ + D G+ R +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-------RDIYETDYYRKGGKG 200
Query: 576 ------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
M +PE G++T SDV+SFGVV+ E+ T +P
Sbjct: 201 LLPVRWM-------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
L+G+GS VYRA G +A+K ID A+ V +L+HP+I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLT-WNARVRVALGTARALEYLHEVCL 533
Y + LV E NG ++ L + K + AR + YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEAR-HFMHQIITGMLYLHSHG- 132
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
++HR+ +N+LL +N ++D GLA + T + G Y +PE A +
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 594 TVKSDVYSFGVVMLELLTGRKPLD 617
++SDV+S G + LL GR P D
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFD 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL----SLQEEDNFLEAVSNMSRLRHPNIV 471
++G+G+ G VY + +N +A+K+I L EE ++ L+H NIV
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE------IALHKHLKHKNIV 82
Query: 472 TLAGYCAEHGQRLLVY-EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA---RALEY 527
G + ++ E V G+L +L L N + + T L+Y
Sbjct: 83 QYLG-SFSENGFIKIFMEQVPGGSLSALLR---SKWGPLKDNEQT-IGFYTKQILEGLKY 137
Query: 528 LHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
LH+ +VHR+ K N+L++ +SD G + T G Y APE
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE 193
Query: 587 FALSGI--YTVKSDVYSFGVVMLELLTGRKP 615
G Y +D++S G ++E+ TG+ P
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 418 IGEGSLGRVYRAEF----ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+G+G+ G V + N + AVK++ ++ Q + F + + L IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQILKALHSDFIVK 88
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G G++ LV EY+ +G L D L L + + + + +EYL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAF--GYSAPEF 587
VHR+ + NIL++ E + ++D GLA L + + V + G + APE
Sbjct: 146 RRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP-GQSPIFWYAPES 201
Query: 588 ALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
I++ +SDV+SFGVV+ EL T K
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 56/205 (27%), Positives = 83/205 (40%), Gaps = 17/205 (8%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IGEG G V++ + N + A+K S + FL+ M + HP+IV L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E+ ++ E G L L +L + + A + AL YL
Sbjct: 82 IGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFALSG 591
VHR+ + N+L+ L D GL+ ++ G + APE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFR 192
Query: 592 IYTVKSDVYSFGVVMLELLT-GRKP 615
+T SDV+ FGV M E+L G KP
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 418 IGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+GEG G+V + G+++AVK + A + + + + L H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG-WKQEIDILRTLYHEHIIK 97
Query: 473 LAGYCAEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
G C + G LV EYV G+L D L ++ + A + YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF--GYSAPEFA 588
+HR+ + N+LLD++ + D GLA P + G + APE
Sbjct: 153 QHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 589 LSGIYTVKSDVYSFGVVMLELLT-GRKP 615
+ SDV+SFGV + ELLT
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 43/234 (18%)
Query: 412 FSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
++ +F ++G+G+ G+V +A + + A+KKI + ++ L V ++ L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLN 60
Query: 467 HPNIVTL------------AGYCAEHGQRL-LVYEYVGNGNLHDMLHFAD-DSSKNLTWN 512
H +V + L + EY NG L+D++H + + ++ W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
++ AL Y+H ++HR+ K NI +D+ N + D GLA + +
Sbjct: 121 LFRQILE----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 573 S-------------TQMVGAFGYSAPE-FALSGIYTVKSDVYSFGVVMLELLTG 612
T +G Y A E +G Y K D+YS G++ E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
L+G G +G VY AE +I+A+K + +L + F EA + RL+ P++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMS---ETLSSDPVFRTRMQREART-AGRLQEPHV 96
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V + + GQ + + +L ML L V + AL+ H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFAL 589
HR+ K NIL+ + +L D G+A A T Q+ VG Y APE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFS 208
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
T ++D+Y+ V+ E LTG P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 13/203 (6%)
Query: 418 IGEGSLGRVYRAEFANGKIM----AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
+GEG G VY + N K AVK +L ++ F+ M L HP+IV L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E ++ E G L L + +L V +L +A+ YL +
Sbjct: 79 IGIIEEE-PTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VHR+ NIL+ L D GL+ + + ++ + +PE +
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 594 TVKSDVYSFGVVMLELLT-GRKP 615
T SDV+ F V M E+L+ G++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 30/232 (12%), Positives = 55/232 (23%), Gaps = 41/232 (17%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+ G V+ + + A+K A S E + EA +RL +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 475 GYC--------------------------AEHGQRLLVYEYVGNGNLHDMLHFADDSSKN 508
LL+ +L + D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 509 ---LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
A + R L +VH +F N+ + + L D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 566 PNTERQVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKP 615
Y+ EF + +T + + G+ + + P
Sbjct: 245 GTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 417 LIGEGSLGRVYRAEFANGKIM---AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
+IGEG+ G+V +A + A+K++ + A S + +F + + +L HPNI+
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNII 89
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVAL 519
L G C G L EY +GNL D L A+ ++ L+ + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
AR ++YL + +HR+ + NIL+ + ++D GL+ R +
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-------RGQEVYVKKT 199
Query: 580 FG-----YSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
G + A E +YT SDV+S+GV++ E+++ G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 37/301 (12%)
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAE--------KLVIERVAKSGSLKKIKSPIT 396
P+ + H +R SVAA + +L K+GS
Sbjct: 3 PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62
Query: 397 ATSYTVASLQTATNSFSQEFL-------------IGEGSLGRVYRAEF--ANGKIM--AV 439
+++L Q + IG G G VY +GK + AV
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 440 KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-GQRLLVYEYVGNGNLHDM 498
K + N + E FL M HPN+++L G C G L+V Y+ +G+L +
Sbjct: 123 KSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 499 LHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558
+ + + N T + L A+ +++L VHR+ + N +LD++ ++D
Sbjct: 182 IR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVAD 235
Query: 559 CGLAALTPNTERQVSTQMVGAF---GYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRK 614
GLA + E GA + A E + +T KSDV+SFGV++ EL+T G
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
Query: 615 P 615
P
Sbjct: 296 P 296
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 63/275 (22%), Positives = 105/275 (38%), Gaps = 61/275 (22%)
Query: 383 AKSGSLKKIKSPITATSYTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEFAN 433
+ S + + + Q +++ +GEG+ G+V+ AE N
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64
Query: 434 GKIM------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487
AVK + A S +F ++ L+H +IV G C E L+V+
Sbjct: 65 LLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122
Query: 488 EYVGNGNLHDML-----------HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
EY+ +G+L+ L D + L + VA A + YL +
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HF 179
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ---------------MVGAFG 581
VHR+ + N L+ L + D G++ R + + M
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMS-------RDIYSTDYYRVGGRTMLPIRWM----- 227
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
PE L +T +SDV+SFGVV+ E+ T G++P
Sbjct: 228 --PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 54/233 (23%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+GE G+VY+ G A+K + + A + F +RL+HPN+
Sbjct: 17 LGEDRFGKVYKGH-LFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNV 74
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARVRVA 518
V L G + +++ Y +G+LH+ L L V +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ--- 575
A +EYL VVH++ + N+L+ D+LN +SD GL R+V
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF-------REVYAADYY 184
Query: 576 ------------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
M APE + G +++ SD++S+GVV+ E+ + G +P
Sbjct: 185 KLLGNSLLPIRWM-------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 60/234 (25%), Positives = 93/234 (39%), Gaps = 53/234 (22%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A A G I AVK + +A L E + + + +S L H
Sbjct: 31 LGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHM 87
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------HFADDSSKNLTWNAR 514
NIV L G C G L++ EY G+L + L +D L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
+ + A+ + +L + +HR+ + NILL + D GLA R +
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-------RDIKN 197
Query: 575 QMVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
Y APE + +YT +SDV+S+G+ + EL + G P
Sbjct: 198 DSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPNI 470
++G G + V+ A + + +AVK + L + +F EA + + L HP I
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLR---ADLARDPSFYLRFRREAQN-AAALNHPAI 74
Query: 471 VTLAGYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
V + +V EYV L D++H + +T + V +AL
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALN 130
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMV-GAFGYSA 584
+ H+ ++HR+ K ANI++ + D G+A A+ + T V G Y +
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE A +SDVYS G V+ E+LTG P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/215 (26%), Positives = 83/215 (38%), Gaps = 21/215 (9%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG V E +G A+K+I Q+ + HPNI+ L
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 476 YCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
YC L+ + G L + + D LT + + + LG R LE +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA---LTPNTERQVST-----QMVGAFGYS 583
HR+ K NILL DE P L D G + RQ T Y
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 584 APE-FALSG--IYTVKSDVYSFGVVMLELLTGRKP 615
APE F++ + ++DV+S G V+ ++ G P
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/219 (23%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV---- 471
+G G G V+ A+ + A+K+I L E E V +++L HP IV
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLEHPGIVRYFN 70
Query: 472 -----TLAGYCAEHGQRLLVY---EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
++ +Y + NL D ++ + + + + + L A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFLQIAE 129
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-----------LTPNTERQV 572
A+E+LH ++HR+ K +NI + + D GL LTP
Sbjct: 130 AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
T VG Y +PE Y+ K D++S G+++ ELL
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 55/220 (25%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G VY + +G AVK + S Q+E +FL +S+ H NI
Sbjct: 38 LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARVRVALGTARALEY 527
V G + R ++ E + G+L L +L + VA A +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHL---SDCGLAALTPNTE---RQVSTQ-----M 576
L E +HR+ + N LL + D G+A + M
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
PE + GI+T K+D +SFGV++ E+ + G P
Sbjct: 213 -------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 5e-28
Identities = 37/250 (14%), Positives = 75/250 (30%), Gaps = 32/250 (12%)
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMA 438
L IK Q + L+GEG+ +VY A N +
Sbjct: 48 QCKLPAIK--------PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFV 99
Query: 439 VKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDM 498
+K A + E + + + + +LV E G L +
Sbjct: 100 LKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNA 157
Query: 499 L-HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH-- 555
+ + + K + + A+ +E +H+ ++H + K N +L +
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214
Query: 556 ---------LSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVV 605
L D G + + + + T G+ E + + + D +
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 606 MLELLTGRKP 615
+ +L G
Sbjct: 275 VYCMLFGTYM 284
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 46/224 (20%), Positives = 83/224 (37%), Gaps = 52/224 (23%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G + + + ++ A K + + L + + +S L H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
G+ ++ +V E +L ++ R + AR +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH------------KRRKALTEPEARYYLRQIVLGCQ 155
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL-------------TPNTERQVS 573
YLH V+HR+ K N+ L+++L + D GLA TPN
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------ 206
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y APE ++ + DV+S G +M LL G+ P +
Sbjct: 207 --------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 46/224 (20%), Positives = 83/224 (37%), Gaps = 52/224 (23%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G + + + ++ A K + + L + + +S L H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
G+ ++ +V E +L ++ R + AR +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH------------KRRKALTEPEARYYLRQIVLGCQ 129
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL-------------TPNTERQVS 573
YLH V+HR+ K N+ L+++L + D GLA TPN
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------ 180
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y APE ++ + DV+S G +M LL G+ P +
Sbjct: 181 --------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 45/230 (19%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG+ G+V AE A G AVK + D+A + ++ + + + M + +
Sbjct: 43 LGEGAFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK 99
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + +T+
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
V AR +EYL +HR+ + N+L+ + ++D GLA N + T
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 575 Q--------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
M APE +YT +SDV+SFGV+M E+ T G P
Sbjct: 217 TNGRLPVKWM-------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 38/226 (16%), Positives = 83/226 (36%), Gaps = 37/226 (16%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEA---------------VSNM 462
+ +G ++ E + K A+KK + + L + + + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 463 SRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
+ +++ +T G + + ++YEY+ N ++ L N + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE----YFFVLDKNYTCFIPIQVI 153
Query: 523 R--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
+ + Y+H ++ HR+ K +NIL+D LSD G + + + +
Sbjct: 154 KCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--G 209
Query: 575 QMVGAFGYSAPEFALSG---IYTVKSDVYSFGVVMLELLTGRKPLD 617
G + + PEF S K D++S G+ + + P
Sbjct: 210 -SRGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 405 LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAV 459
+ + S+ + +G G+ G V A+K I ++S LE V
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 460 SNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARV 515
+ + L HPNI+ L + + LV E G L D + F + + + +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----I 142
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQV 572
+ L + YLH+ ++VHR+ K N+LL + + + D GL+A+ N ++
Sbjct: 143 KQVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM- 195
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ +G Y APE L Y K DV+S GV++ LL G P
Sbjct: 196 -KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 58/239 (24%)
Query: 418 IGEGSLGRVYRAEFANGKIM-------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A A G AVK + + A E + + + M++L H
Sbjct: 53 LGSGAFGKVMNAT-AYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHE 109
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDML-------------------HFADDSSKNL 509
NIV L G C G L++EY G+L + L ++ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 510 TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569
T+ + A A+ +E+L S VHR+ + N+L+ + D GLA
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA------- 219
Query: 570 RQVSTQMVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
R + + Y APE GIYT+KSDV+S+G+++ E+ + G P
Sbjct: 220 RDIMSDSN----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 13/203 (6%)
Query: 418 IGEGSLGRVYRAEF---ANGKIM-AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473
IGEG G V++ + N + A+K S + FL+ M + HP+IV L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G E+ ++ E G L L S L + + A + AL YL
Sbjct: 457 IGVITEN-PVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRF 512
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VHR+ + N+L+ L D GL+ ++ +++ + APE +
Sbjct: 513 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 594 TVKSDVYSFGVVMLELLT-GRKP 615
T SDV+ FGV M E+L G KP
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP 592
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 47/229 (20%)
Query: 418 IGEGSLGRVYRAEFA-----NGKIM-AVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ G+V A + + AVK + A E++ + + MS L +H N
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHEN 111
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML----------HFADDSSKNLTWNARVRVAL 519
IV L G C G L++ EY G+L + L ++ + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA 579
A+ + +L + +HR+ + N+LL + + D GLA R +
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLA-------RDIMNDSN-- 219
Query: 580 FGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
Y APE +YTV+SDV+S+G+++ E+ + G P
Sbjct: 220 --YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 56/238 (23%)
Query: 418 IGEGSLGRVYRAEFA-----NGKIM-AVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+GEG G+V +A G AVK + +NA S E + L + + ++ HP++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHV 88
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------------HFADDSSKNLT 510
+ L G C++ G LL+ EY G+L L + LT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+ A ++ ++YL E+ +VHR+ + NIL+ + +SD GL+ R
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS-------R 198
Query: 571 QVSTQMVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
V + Y A E IYT +SDV+SFGV++ E++T G P
Sbjct: 199 DVYEEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 52/233 (22%)
Query: 418 IGEGSLGRVYRAEFANG-------KIMAVKKI-DNAALSLQEEDNFLEAVSNMSRL-RHP 468
+G G+ G+V A+ A G + +AVK + + A + E + + + + H
Sbjct: 35 LGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHL 91
Query: 469 NIVTLAGYCAEHGQ-RLLVYEYVGNGNLHDML------------HFADDSSKNLTWNARV 515
N+V L G C + G +++ E+ GNL L D LT +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
+ A+ +E+L +HR+ + NILL ++ + D GLA R +
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA-------RDIYKD 201
Query: 576 MVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
Y APE +YT++SDV+SFGV++ E+ + G P
Sbjct: 202 PD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 62/263 (23%), Positives = 101/263 (38%), Gaps = 46/263 (17%)
Query: 387 SLKKIKSPITATSY---TVASLQTATNSFSQEF---------LIGEGSLGRVYRAEFANG 434
L K+++ T Y + +T++ S +E +G G+ G VY + +G
Sbjct: 36 KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQ-VSG 94
Query: 435 KIM-------AVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487
AVK + S Q+E +FL +S+ H NIV G + R ++
Sbjct: 95 MPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153
Query: 488 EYVGNGNLHDMLH---FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544
E + G+L L +L + VA A +YL E +HR+ +
Sbjct: 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAAR 210
Query: 545 NILLDDELNPHL---SDCGLAALTPNTE---RQVSTQ-----MVGAFGYSAPEFALSGIY 593
N LL + D G+A + M PE + GI+
Sbjct: 211 NCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM-------PPEAFMEGIF 263
Query: 594 TVKSDVYSFGVVMLELLT-GRKP 615
T K+D +SFGV++ E+ + G P
Sbjct: 264 TSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-27
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G G V R G+ +A+K+ LS + + + + M +L HPN+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 474 ---AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
A + LL EY G+L L+ ++ L + + AL YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 531 VCLPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
++HR+ K NI+L + D G A E + T+ VG Y APE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPEL 194
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
YTV D +SFG + E +TG +P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
IG+GS G V++ + K++A+K ID L+E ++ +E + +S+ P +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 473 LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
G +L ++ EY+G G+ D+L L + + L+YLH
Sbjct: 85 YYG-SYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE 138
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+HR+ K+AN+LL + L+D G+A +T+ + +T VG + APE
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 194
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPL 616
Y K+D++S G+ +EL G P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPH 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 45/230 (19%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG+ G+V AE A G AVK + +A + ++ + + + M + +
Sbjct: 77 LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGK 133
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + + + + L+
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
V A AR +EYL +HR+ + N+L+ ++ ++D GLA + + T
Sbjct: 194 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 575 Q--------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
M APE IYT +SDV+SFGV++ E+ T G P
Sbjct: 251 TNGRLPVKWM-------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 53/234 (22%)
Query: 418 IGEGSLGRVYRAEFANGKIM---------AVKKI-DNAALSLQEEDNFLEAVSNMSRL-R 466
+GEG G+V AE A G AVK + D+A + ++ + + + M + +
Sbjct: 89 LGEGCFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK 145
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML------------HFADDSSKNLTWNAR 514
H NI+ L G C + G ++ EY GNL + L + +T+
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
V AR +EYL +HR+ + N+L+ + ++D GLA R ++
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA-------RDINN 255
Query: 575 QMVGAFGYS------------APEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615
Y APE +YT +SDV+SFGV+M E+ T G P
Sbjct: 256 IDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G VY A + A G+ +A+++++ L Q + + + + M ++PNIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G L +V EY+ G+L D++ + V +ALE+LH
Sbjct: 85 -SYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
V+HR+ KS NILL + + L+D G A +TP ++ + MVG + APE Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 193
Query: 594 TVKSDVYSFGVVMLELLTGRKPL 616
K D++S G++ +E++ G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 38/213 (17%)
Query: 417 LIGEGSLGRVYRAE--FANGKIMAVKKIDNAALSLQEEDNFL-----EAVSNMSRLRHPN 469
I G LG +Y A NG+ + +K L + E ++ + HP+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLK-----GLVHSGDAEAQAMAMAERQF-LAEVVHPS 140
Query: 470 IVTLAGYCAEHGQRL------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
IV + + EH R +V EYVG +L + L + L
Sbjct: 141 IVQIFNF-VEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILP 193
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGY 582
AL YLH + +V+ + K NI+L +E L D G + + G G+
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGF 243
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE +G TV +D+Y+ G + L
Sbjct: 244 QAPEIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 22/213 (10%)
Query: 418 IGEG--SLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG+G L V A G+ + V++I+ A S + + HPNIV
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY- 91
Query: 475 GYCA-EHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARV-RVALGTARALEYLHEV 531
L +V ++ G+ D++ N A + + L +AL+Y+H +
Sbjct: 92 -RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHM 147
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-----NTERQVSTQMVGAFGYSAP 585
VHR+ K+++IL+ + +LS + V + +P
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 586 EFALSGI--YTVKSDVYSFGVVMLELLTGRKPL 616
E + Y KSD+YS G+ EL G P
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 12/206 (5%)
Query: 412 FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
F +GEGS G VY+A G+I+A+K++ + ++ E +S M + P++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKE-ISIMQQCDSPHV 86
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V G ++ +V EY G G++ D++ +K LT + + T + LEYLH
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
+ +HR+ K+ NILL+ E + L+D G+A +T + +T ++G + APE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQE 199
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
Y +D++S G+ +E+ G+ P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 11/166 (6%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNL-PYSIASMVSLSYL 158
+ L +L D+S +L L +A N+F N P + +L++L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-L 217
++S+ L Q F +L+ L L++S NNF + L+++ L N + S
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 218 NVFSGLP--LTTLNVANNHFSG-----WIPRELISIRTFIYDGNSF 256
P L LN+ N F+ + + R + +
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM 581
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 10/165 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L D +++ + + NL L+++ + + SL L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL- 217
++ NS ++ DIF L L LDLS P +F SLS++ L + +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRELI----SIRTFIYDGNSFD 257
+ L L L+ + NH +EL S+ N F
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 38/195 (19%), Positives = 64/195 (32%), Gaps = 32/195 (16%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140
+ ++D+S L Y L+ DLS I +L++L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF-SGDLPNSFIS 199
+ + + SL L +L G+L L L+++ N S LP F +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 200 LSNISSLYLQNNQVTG-----------------------------SLNVFSGLPLTTLNV 230
L+N+ L L +N++ F + L L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 231 ANNHFSGWIPRELIS 245
NN S + + I
Sbjct: 208 RNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 3/129 (2%)
Query: 111 KFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
+ + + IP LP + +L+L+ N YS S L L++SR +
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTL 228
+ +L+ L+TL L+ N +F LS++ L + N L L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 229 NVANNHFSG 237
NVA+N
Sbjct: 130 NVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 34/159 (21%), Positives = 60/159 (37%), Gaps = 9/159 (5%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIH--DTIPYQL--PPNLTSLNLASNNFSGNLPYS 148
G + DL SL DLS N + +L L+L+ N + +
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 149 IASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
+ L +L+ ++L Q +F +L L LD+S + F LS++ L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 208 LQNNQVTGSL--NVFSGLP-LTTLNVANNHFSGWIPREL 243
+ N + ++F+ L LT L+++ P
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 32/136 (23%), Positives = 51/136 (37%), Gaps = 4/136 (2%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
+DIS + + L SL ++GNS + + NLT L+L+
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-SN 202
P + S+ SL LN+S N+ + L L LD S N+ S+
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544
Query: 203 ISSLYLQNNQVTGSLN 218
++ L L N +
Sbjct: 545 LAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-22
Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 28/182 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS------------------- 142
L + L ++ F L +I + L L + F
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
Query: 143 GNLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
G +S + SL +L++SRN L+ L LDLSFN + ++F+ L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395
Query: 201 SNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPRE---LISIRTFIYDGN 254
+ L Q++ + +VF L L L++++ H L S+ GN
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 255 SF 256
SF
Sbjct: 456 SF 457
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 30/135 (22%), Positives = 60/135 (44%), Gaps = 6/135 (4%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
+ ++L +L DLS + P +L LN++ NNF + + SL L
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523
Query: 159 NVSRNSLTQSIGDIFGNLAG-LATLDLSFNNFSGDLPNS-FIS-LSNISSLYLQNNQVTG 215
+ S N + S + LA L+L+ N+F+ + F+ + + L ++ ++
Sbjct: 524 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMEC 583
Query: 216 SL-NVFSGLPLTTLN 229
+ + G+P+ +LN
Sbjct: 584 ATPSDKQGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 35/186 (18%), Positives = 60/186 (32%), Gaps = 15/186 (8%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKF----DLSGNSIHDTIPYQL-PPNLTSLNLASNNFS 142
+D+S + L L + DLS N ++ P L L L +N S
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDS 213
Query: 143 GNLPY-SIASMVSLSYLNVSRNSLTQSI---GDIFGNLAGLATLDLSFNNFS------GD 192
N+ I + L + L GL L + + D
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 193 LPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
+ + F L+N+SS L + + + L + N F + +L S++ +
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT 333
Query: 253 GNSFDN 258
N N
Sbjct: 334 SNKGGN 339
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 62/241 (25%)
Query: 418 IGEGSLGRVYRAEFANGKIM------AVKKI-DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG+ GRV++A AVK + + A S + +F + M+ +PNI
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNI 112
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML--------------------HFADDSSKNLT 510
V L G CA L++EY+ G+L++ L + L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
++ +A A + YL E VHR+ + N L+ + + ++D GL+ R
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS-------R 222
Query: 571 QVSTQ---------------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRK 614
+ + M PE YT +SDV+++GVV+ E+ + G +
Sbjct: 223 NIYSADYYKADGNDAIPIRWM-------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 615 P 615
P
Sbjct: 276 P 276
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 24/245 (9%)
Query: 382 VAKSGSLKKIKSPITATSYTVASLQTATNS------FSQEFLIGEGSLGRVYRA-EFANG 434
V +S + A+L+ + IGEGS G V A E +G
Sbjct: 11 VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70
Query: 435 KIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGN 492
+ +AVK +D L Q+ L V M +H N+V + G+ L ++ E++
Sbjct: 71 RQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQG 126
Query: 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
G L D++ L V +AL YLH V+HR+ KS +ILL +
Sbjct: 127 GALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDG 178
Query: 553 NPHLSDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
LSD G A ++ + ++ S +VG + APE +Y + D++S G++++E++
Sbjct: 179 RVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 612 GRKPL 616
G P
Sbjct: 237 GEPPY 241
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 49/214 (22%), Positives = 82/214 (38%), Gaps = 22/214 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ V+R G + A+K +N + + D + + +L H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
E R L+ E+ G+L+ +L ++ L + + V + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 534 PSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSAPE--- 586
+VHRN K NI+ + L+D G A + E + G Y P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYE 188
Query: 587 -----FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y D++S GV TG P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 27/224 (12%)
Query: 405 LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEE-DNFLEA 458
+Q +T FS + ++G+GS G V + G+ AVK I + + + ++ L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 459 VSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNAR 514
V + +L HPNI+ L + + G LV E G L D + F++ + +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI----- 131
Query: 515 VRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQ 571
+R L + Y+H+ +VHR+ K N+LL + N + D GL+ +++
Sbjct: 132 IRQVLS---GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+G Y APE L G Y K DV+S GV++ LL+G P
Sbjct: 186 --KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 24/229 (10%)
Query: 402 VASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVS 460
+++L+ F L+G G+ G+VY+ G++ A+K +D ++ EE+ + ++
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEIN 72
Query: 461 NMSRL-RHPNIVT-----LAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNA 513
+ + H NI T + +L LV E+ G G++ D++ ++ W A
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 514 RV-RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ R L R L +LH+ V+HR+ K N+LL + L D G++A T +
Sbjct: 133 YICREIL---RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 573 STQMVGAFGYSAPE-----FALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+T +G + APE Y KSD++S G+ +E+ G PL
Sbjct: 187 NT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 418 IGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
IG G+ G V + +G+IMAVK+I ++ E++ ++ M P IV
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G G + E + + + ++ L T +AL +L E
Sbjct: 87 YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE----FAL 589
++HR+ K +NILLD N L D G++ ++ + T+ G Y APE A
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSAS 202
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y V+SDV+S G+ + EL TGR P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYP 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 44/217 (20%), Positives = 81/217 (37%), Gaps = 25/217 (11%)
Query: 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRL-RHP 468
SF + ++G G+ G + + + +AVK+I S E V + HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE------VQLLRESDEHP 78
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
N++ + + + E L + + D + L + + T L +L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHL 134
Query: 529 HEVCLPSVVHRNFKSANILL-----DDELNPHLSDCGLAALTPNTER--QVSTQMVGAFG 581
H + ++VHR+ K NIL+ ++ +SD GL + + G G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 582 YSAPE---FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ APE T D++S G V +++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G V + + + AVK I+ A+ ++ L V + +L HPNI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +V E G L D + F++ + + ++ + Y+H+
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYMHKH- 140
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++VHR+ K NILL + + + + D GL+ + +G Y APE L
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VL 195
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
G Y K DV+S GV++ LL+G P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
+G G+ G V + +G+IMAVK+I ++ ++ ++ +M + P VT
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G G + E + +L D + + + ++A+ +ALE+LH
Sbjct: 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL- 129
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE----FAL 589
SV+HR+ K +N+L++ + D G++ + + G Y APE
Sbjct: 130 -SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPYMAPERINPELN 186
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y+VKSD++S G+ M+EL R P D
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+GS G V + + + AVK I+ A+ ++ L V + +L HPNI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +V E G L D + F++ + + ++ + Y+H+
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYMHKH- 140
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++VHR+ K NILL + + + + D GL+ + +G Y APE L
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VL 195
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
G Y K DV+S GV++ LL+G P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 22/214 (10%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G+G+ V+R G + A+K +N + + D + + +L H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
E R L+ E+ G+L+ +L ++ L + + V + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 534 PSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSAPE--- 586
+VHRN K NI+ + L+D G A + E+ VS + G Y P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188
Query: 587 -----FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y D++S GV TG P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 60/247 (24%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 389 KKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAAL 447
+ I Y + QE +IG G+ V A + +A+K+I+
Sbjct: 6 SALPWSINRDDYEL-----------QE-VIGSGATAVVQAAYCAPKKEKVAIKRIN---- 49
Query: 448 SLQEEDNFLEAVSN----MSRLRHPNIVTLAGYCA-EHGQRL-LVYEYVGNGNLHDMLHF 501
L++ ++ + MS+ HPNIV+ Y + L LV + + G++ D++
Sbjct: 50 -LEKCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSVLDIIKH 106
Query: 502 ADDSSKNLTWNAR-------VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554
++ + +R L LEYLH+ +HR+ K+ NILL ++ +
Sbjct: 107 IVAKGEHKSGVLDESTIATILREVL---EGLEYLHKN---GQIHRDVKAGNILLGEDGSV 160
Query: 555 HLSDCGLAA-LTPNTERQVSTQ---MVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLEL 609
++D G++A L + + VG + APE Y K+D++SFG+ +EL
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
Query: 610 LTGRKPL 616
TG P
Sbjct: 221 ATGAAPY 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/202 (28%), Positives = 83/202 (41%), Gaps = 11/202 (5%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V+ E ++G +K I+ + E E + + L HPNI+ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE-IEVLKSLDHPNIIKIFEV 88
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ +V E G L + + A K L+ + AL Y H V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 537 VHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VH++ K NIL + D GLA L + ST G Y APE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPE-VFKRDV 202
Query: 594 TVKSDVYSFGVVMLELLTGRKP 615
T K D++S GVVM LLTG P
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLP 224
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 34/138 (24%), Positives = 58/138 (42%), Gaps = 3/138 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S D S + +P LP N+T LNL N + L+ L+V N++++
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-L 225
++ L L L+L N S +F +N++ L+L +N + N F L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 226 TTLNVANNHFSGWIPREL 243
TL++++N S
Sbjct: 124 ITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 6/169 (3%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
+ ++++ L + L D+ N+I P P L LNL N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ A +L+ L++ NS+ + + F L TLDLS N S + + L N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 203 ISSLYLQNNQVTG----SLNVFSGLPLTTLNVANNHFSGWIPRELISIR 247
+ L L NN++ L++F+ L L +++N + P +I
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 39/167 (23%), Positives = 60/167 (35%), Gaps = 6/167 (3%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNN 140
S + S+D+ +S L L L+ +L N + NLT L+L SN+
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+L L++S N L+ + L L L LS N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 201 SNIS--SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+N S L L +NQ+ S F + L L + N + +L
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 36/188 (19%), Positives = 66/188 (35%), Gaps = 18/188 (9%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG 143
I +S + + SL++ L ++ + P NLT L+L++NN +
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQ--------SIGDIFGNLAGLATLDLSFNNFSGDLPN 195
+ + L L++ N+L + L+ L L+L N F
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 196 SFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIP----RELISIRTF 249
F L + + L N + +VF+ L +LN+ N + ++
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 250 IYDGNSFD 257
N FD
Sbjct: 615 DMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 15/169 (8%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
++++ +S S L L DL N I + Q N+ + L+ N +
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 144 NLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
S A + SL L + R +L S F L L LDLS NN + + L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 202 NISSLYLQNNQVT---------GSLNVFSGLP-LTTLNVANNHFSGWIP 240
+ L LQ+N + G + GL L LN+ +N F
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 33/177 (18%), Positives = 67/177 (37%), Gaps = 19/177 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNF 141
+++S + + L L+ + ++ +L ++ +L+L+++
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234
Query: 142 SGNLPYSIASM--VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFIS 199
S + + +L+ L++S N+L D F L L L +NN +S
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294
Query: 200 LSNISSLYLQNNQVTGSL----------NVFSGLP-LTTLNVANNHFSGWIPRELIS 245
L N+ L L+ + S+ F L L LN+ +N G I + +
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFT 350
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 40/149 (26%), Positives = 61/149 (40%), Gaps = 13/149 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS--------GNLPYSIAS 151
L +L DLS N+I + L L L+L NN + G Y +
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ L LN+ N + ++F +L L +DL NN + + F + ++ SL LQ N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 212 QVTG-SLNVFSGLP--LTTLNVANNHFSG 237
+T VF LT L++ N F
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 34/172 (19%), Positives = 62/172 (36%), Gaps = 15/172 (8%)
Query: 87 SIDISGLGLSGTM-GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG 143
+D+ + + G L ++ + LS N P+L L L
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 144 --NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--------GDL 193
+ P + +L+ L++S N++ D+ L L LDL NN + G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 194 PNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LS++ L L++N + VF L L +++ N+ +
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 34/153 (22%), Positives = 57/153 (37%), Gaps = 11/153 (7%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM--VSLSY 157
+L DLS N + T NL L L++N + SL
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---ISLSNISSLYLQNNQVT 214
L +S N + + F + L L L+ L ++ ++I +L L N+Q++
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 215 G-SLNVFSGLP---LTTLNVANNHFSGWIPREL 243
S F GL LT L+++ N+ +
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 35/183 (19%), Positives = 69/183 (37%), Gaps = 17/183 (9%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-----------QLP 128
+ + + +D+S L+ + L L F L N+I + L
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
+ T +++ + +S + L +LN+ N + ++F L L L LS +
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 189 FSGD--LPNSFISLSNIS--SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE 242
S +F+SL++ L L N+++ + FS L L L++ N + +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 243 LIS 245
Sbjct: 425 EWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 39/200 (19%), Positives = 77/200 (38%), Gaps = 21/200 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-QLP----------PNLTSLN 135
+ + + L L ++R +L + +I LP L LN
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 136 LASNNFSGNLPYSIASMVSLSYLNVSRN--SLTQSIGDIFGNLA--GLATLDLSFNNFSG 191
+ N+ G +++L YL++S + SL + F +LA L L+L+ N S
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 192 DLPNSFISLSNISSLYLQNNQVTGSLN--VFSGLP-LTTLNVANNHFSGWIP---RELIS 245
++F L ++ L L N++ L + GL + + ++ N + + S
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 246 IRTFIYDGNSFDNGPAPPPP 265
++ + + N + P P
Sbjct: 456 LQRLMLRRVALKNVDSSPSP 475
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
VS + S LTQ D+ N + L+L+ N +F S ++SL + N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 213 VTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
++ + LP L LN+ +N S + + +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFA 94
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 36/198 (18%), Positives = 73/198 (36%), Gaps = 34/198 (17%)
Query: 45 QALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLS 104
+ L++L N+ + L WK KG+ S + +++ G +
Sbjct: 504 EKLEILDLQHNNLARL--WKHANPGGPIYFLKGL----SHLHILNLESNGFDEIPVEVFK 557
Query: 105 DLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164
DL L+ DL N+++ + VSL LN+ +N
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVF----------------------NNQVSLKSLNLQKNL 595
Query: 165 LTQSIGDIFG-NLAGLATLDLSFNNFSGDLPN-----SFISLSNISSLYLQNNQVTGSLN 218
+T +FG L LD+ FN F + ++I+ ++ + L ++ + +
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 219 VFSGLPLTTLNVANNHFS 236
+ G P+ + ++ S
Sbjct: 656 HYHGFPVRLFDTSSCKDS 673
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVTLAG 475
+G+G+ G+VY+A G + A K I+ +EE ++++ + ++ HP IV L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
H +L ++ E+ G + ++ D + LT V AL +LH
Sbjct: 84 -AYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-- 592
++HR+ K+ N+L+ E + L+D G++A T ++ + +G + APE +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195
Query: 593 ---YTVKSDVYSFGVVMLELLTGRKPL 616
Y K+D++S G+ ++E+ P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G+ G V++ +G +MA K I L+ + + + P IV
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIH-----LEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
G G+ + E++ G+L +L A + +V++ + L YL E
Sbjct: 96 FYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
++HR+ K +NIL++ L D G++ ++ ++ VG Y +PE
Sbjct: 152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH 206
Query: 593 YTVKSDVYSFGVVMLELLTGRKPL 616
Y+V+SD++S G+ ++E+ GR P+
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 28/235 (11%), Positives = 64/235 (27%), Gaps = 39/235 (16%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID--------------------------NAALSL 449
++G+ A G+ V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLVYEYVG--NGNLHDMLHFADDS 505
+ F+ + + ++ + + R +Y + ++L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 506 SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
K+L +AR+++ L R L LH +VH + +I+LD L+
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 566 PNTERQVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKP 615
+ + +A + T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 59/255 (23%), Positives = 95/255 (37%), Gaps = 39/255 (15%)
Query: 384 KSGSLKKIKSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMA 438
SG I ++ + + +G G+ G V + A
Sbjct: 8 SSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 439 VKKIDNAALS-----------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487
+K I + + + +S + L HPNI+ L + LV
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125
Query: 488 EYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543
E+ G L + + F + + N+ ++ L + YLH+ ++VHR+ K
Sbjct: 126 EFYEGGELFEQIINRHKFDECDAANI-----MKQILS---GICYLHKH---NIVHRDIKP 174
Query: 544 ANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVY 600
NILL + LN + D GL++ + +G Y APE L Y K DV+
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 601 SFGVVMLELLTGRKP 615
S GV+M LL G P
Sbjct: 232 SCGVIMYILLCGYPP 246
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDN---FLEAVSNMSRLRHPNIVTL 473
+G G+ G+V++ F G ++AVK++ S +E+N ++ + P IV
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
G + + E +G + ++ + +AL YL E
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEK-- 143
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE-----FA 588
V+HR+ K +NILLD+ L D G++ + + + + G Y APE
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDP 201
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y +++DV+S G+ ++EL TG+ P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYK 230
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 10/181 (5%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSG 143
S+++S + L DL+ + Q L LNL+ +
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIG---DIFGNLAGLATLDLSFNNFSGDLPNSFISL 200
+ + +L +LN+ N + + L L L LSF + S ++F SL
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 201 SNISSLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIP---RELISIRTFIYDGNSF 256
++ + L +N++T S+ S L LN+A+NH S +P L RT N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
Query: 257 D 257
D
Sbjct: 560 D 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 31/161 (19%), Positives = 49/161 (30%), Gaps = 7/161 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN 144
+ + LGL+ G L + L + S N + NLT L+L
Sbjct: 16 TYNCENLGLNEIPGTLPNSTECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ S L L ++ N L L L S + +
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
SLYL +N ++ L L L+ NN ++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 34/156 (21%), Positives = 59/156 (37%), Gaps = 8/156 (5%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI- 149
+ S L +L L+ +LS N P L L+LA S
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG---DLPNSFISLSNISSL 206
++ L LN+S + L S +F L L L+L N+F NS +L + L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIP 240
L ++ + F+ L + +++++N +
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-22
Identities = 22/130 (16%), Positives = 50/130 (38%), Gaps = 3/130 (2%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
+ ++ ++ IP LP + L + N + + +++L++L+++R +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTT 227
D F + L TL L+ N + + L+ ++ L +
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 228 LNVANNHFSG 237
L + +NH S
Sbjct: 134 LYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-22
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 8/168 (4%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS 142
V SI++ L++ DL+ + +P L L L L++N F
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGD-IFGNLAGLATLDLSFNN--FSGDLPNSFIS 199
S ++ SL++L++ N+ +G NL L LDLS ++ S +
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
Query: 200 LSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
LS++ SL L N+ F P L L++A +
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-21
Identities = 28/147 (19%), Positives = 51/147 (34%), Gaps = 9/147 (6%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+S+ +L + + L L+L + + S LP + + +L L +S N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDL-PNSFISLSNISSLYLQNNQVTGS---LNV 219
N L L + N +L +L N+ L L ++ + S
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 220 FSGLP-LTTLNVANNHFSGWIPRELIS 245
L L +LN++ N + E
Sbjct: 372 LRNLSHLQSLNLSYNEPLS-LKTEAFK 397
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 28/163 (17%), Positives = 54/163 (33%), Gaps = 10/163 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
S L++L DL+ I+ L +L L +N +++ +L +L
Sbjct: 53 FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT----GS 216
+ ++ N L +L L N+ S + L QNN +
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
Query: 217 LNVFSGLPLTTLNVANNHFSGWIPRE---LISIRTFIYDGNSF 256
++ +LN+ N +G I ++ + G
Sbjct: 173 MSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQN 214
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-20
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 8/143 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN---LPYSIASMVSLS 156
+L L+ +LS + + + P L LNL N+F S+ ++ L
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L +S L+ F +L + +DLS N + + L I L L +N ++
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISII 538
Query: 216 SLNVFSGLP-LTTLNVANNHFSG 237
++ L T+N+ N
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 25/141 (17%), Positives = 49/141 (34%), Gaps = 8/141 (5%)
Query: 104 SDLLSLRKFDLSGNSIHD----TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
S + SL D ++ S+NL + F + L L+
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-- 217
++ L++ + L+ L L LS N F S + +++ L ++ N L
Sbjct: 285 LTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 218 NVFSGLP-LTTLNVANNHFSG 237
L L L+++++
Sbjct: 344 GCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 25/143 (17%), Positives = 43/143 (30%), Gaps = 9/143 (6%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
LS +L+ I L L SL L SN+ S L L+
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159
Query: 160 VSRNSLTQSIGDIFGNLAGLA--TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N++ + +L +L+L+ N+ +G + + SL Q +
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVI 218
Query: 218 ---NVFSGLP-LTTLNVANNHFS 236
S + L +
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDE 241
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 24/164 (14%), Positives = 54/164 (32%), Gaps = 11/164 (6%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN 144
+ G+S L + +L L N I + L L+ +N
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 145 LPYSIASMVSLS--YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN--SFISL 200
++S+ + LN++ N + I + A +L+ + ++
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
Query: 201 SNISSLYLQNNQVTG-SLNVFSGLP---LTTLNVANNHFSGWIP 240
++ ++ S VF GL + ++N+ ++F
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 57/206 (27%), Positives = 83/206 (40%), Gaps = 24/206 (11%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS G V A A KKI + + E + M L HPNI+ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQE-IEIMKSLDHPNIIRLYET 74
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
++ LV E G L + + F + + + ++ L A+ Y H++
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL- 125
Query: 533 LPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+V HR+ K N L + L D GLAA + VG Y +P+ L
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ-VL 180
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
G+Y + D +S GV+M LL G P
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ +V A G+ +A+K ID L+ V M L HPNIV L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 477 -CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
E + L L+ EY G + D L A R+ AR A++
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLV------------AHGRMKEKEARSKFRQIVSAVQ 128
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
Y H+ +VHR+ K+ N+LLD ++N ++D G + ++ GA Y+APE
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDAF-CGAPPYAAPE 183
Query: 587 FALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
Y + DV+S GV++ L++G P D
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAG 475
IG GS G VY A + N +++A+KK+ + E+ + V + +LRHPN + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
C LV EY G+ D+L K L V G + L YLH
Sbjct: 122 -CYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH--- 173
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAA-LTP-NTERQVSTQMVGAFGYSAPEFALS-- 590
+++HR+ K+ NILL + L D G A+ + P N+ VG + APE L+
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------FVGTPYWMAPEVILAMD 226
Query: 591 -GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y K DV+S G+ +EL + PL
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 48/222 (21%), Positives = 92/222 (41%), Gaps = 27/222 (12%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLA 474
++ EG VY A+ +G+ A+K++ + ++ ++ V M +L HPNIV
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 475 GYCAEHGQR-------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
+ + L+ + G L + L +S L+ + +++ T RA+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVSTQMVGAFG----- 581
+H P ++HR+ K N+LL ++ L D G A ++ + S Q
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 582 -----YSAPE-FALSG--IYTVKSDVYSFGVVMLELLTGRKP 615
Y PE L K D+++ G ++ L + P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 31/241 (12%), Positives = 67/241 (27%), Gaps = 50/241 (20%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID--------------------------NAALSL 449
++G+ A + G+ V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRLLVYEYVG--NGNLHDMLHFADDS 505
+ F+ + + ++ + + R +Y + ++L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 506 SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565
K+L +AR+++ L R L LH +VH + +I+LD L+
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL--- 253
Query: 566 PNTERQVSTQMVGAFGYSAPEFALS-----------GIYTVKSDVYSFGVVMLELLTGRK 614
+ G+ PE + T D ++ G+V+ +
Sbjct: 254 --VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 615 P 615
P
Sbjct: 312 P 312
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 35/180 (19%), Positives = 66/180 (36%), Gaps = 10/180 (5%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSG 143
+D+S G M L L+ D +++ + L L+++ N
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ + SL+ L ++ NS + ++F N L LDLS F +L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 203 ISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSG---WIPRELISIRTFIYDGNSFD 257
+ L + +N + + ++ L L+TL+ + N + S+ F NS
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 37/167 (22%), Positives = 59/167 (35%), Gaps = 8/167 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGN 144
+D+S + L L L+GN I P +L +L +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 145 LPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNI 203
+ I +++L LNV+ N + + F NL L +DLS+N N L
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 204 S----SLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
SL + N + F G+ L L + N S I + +
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 27/133 (20%), Positives = 53/133 (39%), Gaps = 3/133 (2%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
+ + + +P +P + +++L+ N YS ++ L +L++SR +
Sbjct: 11 VPNITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP- 224
+ L L+ L L+ N P SF L+++ +L ++ L
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 225 LTTLNVANNHFSG 237
L LNVA+N
Sbjct: 130 LKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 38/147 (25%), Positives = 57/147 (38%), Gaps = 6/147 (4%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVS 161
DL L+ L+ N + P+L+ L+L+ N S G YS SL +L++S
Sbjct: 325 LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL-NV 219
N + F L L LD + S F+SL + L + +
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 220 FSGLP-LTTLNVANNHFSGWIPRELIS 245
F GL L TL +A N F + +
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFA 470
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 32/143 (22%), Positives = 53/143 (37%), Gaps = 9/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
S+ L+ DLS I +L++L L N P S + + SL L
Sbjct: 52 FSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTG-SLN 218
L G L L L+++ N LP F +L+N+ + L N + ++N
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171
Query: 219 VFSGLP-----LTTLNVANNHFS 236
L +L+++ N
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPID 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 46/205 (22%), Positives = 75/205 (36%), Gaps = 32/205 (15%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD---------------------TIPY 125
++ L ++ L+G SI P
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 126 QLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAG--LATLD 183
P L SL L N S + + ++ SLSYL++SRN+L+ S + +L L LD
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 184 LSFNNFSGDLPNSFISLSNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIP 240
LSFN + +F+ L + L Q++ + + F L L L+++ +
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 241 RE---LISIRTFIYDGNSFDNGPAP 262
L S+ T GNSF +
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 25/175 (14%), Positives = 58/175 (33%), Gaps = 19/175 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSG 143
++ L+ + + L++L+K +++ N IH +P NL ++L+ N
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 144 NLPYSIASMVSLS----YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFI 198
+ + L++S N + F + L L L N S ++
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQ 226
Query: 199 SLSNISSLYLQNNQVTG-------SLNVFSGLP---LTTLNVANNHFSGWIPREL 243
+L+ + L + ++ GL + + + +
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 35/211 (16%), Positives = 62/211 (29%), Gaps = 44/211 (20%)
Query: 90 ISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY------QLPPNLTSLNLASNNFSG 143
I L S+L +L DLS N I + P SL+++ N
Sbjct: 140 IHSCKLPAY----FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID- 194
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLA---------------------- 180
+ + L L + N + +I NLAGL
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 181 ----------TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNV 230
L++ N D F L+N+S++ L + +V +L++
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314
Query: 231 ANNHFSGWIPRELISIRTFIYDGNSFDNGPA 261
+ +L +++ N
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLTMNKGSISFK 345
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 31/156 (19%), Positives = 60/156 (38%), Gaps = 15/156 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
++ + N++ + L L L N G LP + S + L+ LN
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTG-SL 217
++ N +T+ + G + L + N S+S +S++ N++
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 218 NVFSGLP--------LTTLNVANNHFSGWIPRELIS 245
F L ++++N++NN S P+EL S
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFS 454
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 27/169 (15%), Positives = 70/169 (41%), Gaps = 23/169 (13%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG-------NLPYSIA 150
+ + N + IP +++++ + N L +
Sbjct: 372 FCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-------DLPNSFISLSNI 203
+++S +N+S N +++ ++F + L++++L N + D +F + +
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 204 SSLYLQNNQVTGSLN--VFSGLP-LTTLNVANNHFSGWIPRELISIRTF 249
+S+ L+ N++T + + LP L ++++ N FS P + ++ T
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 35/277 (12%), Positives = 73/277 (26%), Gaps = 43/277 (15%)
Query: 43 DVQALQVLYTSLNSPS---------VLTNWKGNEGDPCGESWKGVAC-EGSAVVSIDISG 92
D AL+ ++ +LN + NW N+ + GV+ V + + G
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL------NLASNNFSGNLP 146
G SG + + L L L + P +++ ++
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 147 YSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
L ++ + +SI + NN + + + + L+ +
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 205 SLYLQNNQVTGS-------------LNVFSGLP--------LTTLNVANNHFSGWIPRE- 242
Y+ N+ + LT + V N +P
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 243 --LISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHN 277
L ++ N +G +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 23/178 (12%), Positives = 60/178 (33%), Gaps = 15/178 (8%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD--------TIPYQLP--PNLTSLNL 136
+++ + L L ++ +++ N P + + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 137 ASNNF-SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN 195
NN + + S+ M L L N L + FG+ LA+L+L++N + N
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPAN 371
Query: 196 SFISLSNISSLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFI 250
+ +L +N++ ++ + ++ ++ + N + +
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 29/169 (17%), Positives = 52/169 (30%), Gaps = 17/169 (10%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNF---- 141
+ T +L L ++ +P L P + +N+A N
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL-PEMQLINVACNRGISGE 289
Query: 142 ----SGNLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ + + N+L + + L L+ +N G +
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPA 348
Query: 197 FISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
F S ++SL L NQ+T N + L+ A+N IP
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIF 396
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 30/182 (16%), Positives = 59/182 (32%), Gaps = 32/182 (17%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---------PNLTSLNLA 137
SI++S +S L S L +L GN + + L LTS++L
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 138 SNNFSGNLPYSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL------DLSFNNF 189
N + L ++ L +++S NS + N + L D N
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 190 SGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHFSGWIPREL 243
+ P +++ L + +N + ++ L++ +N +
Sbjct: 555 LREWPEGITLCPSLTQLQIGSND-------IRKVNEKITPNISVLDIKDNPNISIDLSYV 607
Query: 244 IS 245
Sbjct: 608 CP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 18/149 (12%), Positives = 38/149 (25%), Gaps = 14/149 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L LR+F + + + N ++ L+ + V
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENI---CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNF--------SGDLPNSFISLSNISSLYLQNNQ-V 213
+ L + ++++ N I +Y+ N
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 214 TGSL-NVFSGLP-LTTLNVANNHFSGWIP 240
T + + L L N G +P
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 23/118 (19%), Positives = 35/118 (29%), Gaps = 12/118 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSL------NLASNNFSGNLPYSIASMVS 154
+ L L DLS NS P Q L + N P I S
Sbjct: 509 ATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L+ L + N + + I N ++ LD+ N + L ++
Sbjct: 568 LTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 10/78 (12%), Positives = 25/78 (32%), Gaps = 1/78 (1%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYS 148
D G ++ SL + + N I + ++ PN++ L++ N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNISIDLSY 606
Query: 149 IASMVSLSYLNVSRNSLT 166
+ + + +
Sbjct: 607 VCPYIEAGMYMLFYDKTQ 624
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAG 475
++G GS G V G+ +AVK++ + D L + ++ HPN++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDHPNVIRY-- 74
Query: 476 YCAEHGQRL--LVYEYVGNGNLHDML---HFADDSSKNLTWNARVRVALGTARALEYLHE 530
YC+E R + E NL D++ + +D++ K + + A + +LH
Sbjct: 75 YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 531 VCLPSVVHRNFKSANILLDDELNPH-------------LSDCGLAALTPNTERQVSTQM- 576
+ ++HR+ K NIL+ +SD GL + + T +
Sbjct: 134 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 577 --VGAFGYSAPE-------FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G G+ APE T D++S G V +L+ K
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSN 461
+ F ++G G G V+ + A GK+ A KK++ L E L V
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWN-ARVR--- 516
IV+LA Y E L LV + G++ H + N + R
Sbjct: 244 -----SRFIVSLA-YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYT 295
Query: 517 --VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST 574
+ LE+LH+ ++++R+ K N+LLDD+ N +SD GLA + +
Sbjct: 296 AQIVS----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G G+ APE L Y D ++ GV + E++ R P
Sbjct: 349 -YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 409 TNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
+ FS + +G+G+ V R G A K I+ LS ++
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVAL 519
+L+HPNIV L E LV++ V G L + + +++ + + ++ L
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQIL 115
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVSTQM 576
++ Y H +VHRN K N+LL + L+D GLA + +
Sbjct: 116 E---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGF 167
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G GY +PE Y+ D+++ GV++ LL G P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/242 (23%), Positives = 95/242 (39%), Gaps = 25/242 (10%)
Query: 386 GSLKKIKSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVK 440
G + + A+ FS + +G+G+ V R G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 441 KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML- 499
I+ LS ++ +L+HPNIV L E LV++ V G L + +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 500 ---HFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH- 555
+++ + + ++ L ++ Y H +VHRN K N+LL +
Sbjct: 121 AREFYSEADASHC-----IQQILE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169
Query: 556 --LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR 613
L+D GLA ++ + G GY +PE Y+ D+++ GV++ LL G
Sbjct: 170 VKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227
Query: 614 KP 615
P
Sbjct: 228 PP 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-22
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ V R + G+ A I+ LS ++ L+HPNIV L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 477 CAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+E G L+++ V G L + + ++++ + + ++ L A+ + H++
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILE---AVLHCHQM- 129
Query: 533 LPSVVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
VVHRN K N+LL +L L+D GLA E+Q G GY +PE
Sbjct: 130 --GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSPEVLR 186
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
Y D+++ GV++ LL G P
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG+ G V A + +AVK +D E+ E + L H N+V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
+ E + L EY G L D + + + A+ + Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP--NTERQVSTQMVGAFGYSAP 585
LH + + HR+ K N+LLD+ N +SD GLA + N ER ++ M G Y AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 586 EFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
E + DV+S G+V+ +L G P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ V+ + GK+ A+K I + + + ++ + +++H NIVTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLED 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
LV + V G L D + + + + + ++ L A++YLHE
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS---AVKYLHEN 125
Query: 532 CLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
+VHR+ K N+L ++ ++D GL+ + N + + G GY APE
Sbjct: 126 ---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEVL 179
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y+ D +S GV+ LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 5e-22
Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-------SLQEEDNFLEAVSN 461
N FS +IG G G VY GK+ A+K +D + E L VS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH----FADDSSKNLTWNARVR 516
P IV ++ Y +L + + + G+LH L F++ +R
Sbjct: 249 G---DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---------DMR 295
Query: 517 -----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ 571
+ L LE++H VV+R+ K ANILLD+ + +SD GLA +++
Sbjct: 296 FYAAEIIL----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKK 346
Query: 572 VSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKP 615
VG GY APE G+ Y +D +S G ++ +LL G P
Sbjct: 347 PHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 27/152 (17%), Positives = 62/152 (40%), Gaps = 5/152 (3%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP 146
I ++ + ++ G + +++ ++ + P NL L + + + +
Sbjct: 48 YITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKI 105
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+++ + SL+ L++S ++ SI L + ++DLS+N D+ +L + SL
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSL 164
Query: 207 YLQNNQVTGSLNVFSGLP-LTTLNVANNHFSG 237
+Q + V P L L + G
Sbjct: 165 NIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-18
Identities = 25/134 (18%), Positives = 52/134 (38%), Gaps = 3/134 (2%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+ + SL L+ ++ D + N+ L + + + + P I+ + +L L +
Sbjct: 41 AQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL 223
+T L L LD+S + + +L ++S+ L N + L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTL 158
Query: 224 P-LTTLNVANNHFS 236
P L +LN+ +
Sbjct: 159 PELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 18/127 (14%), Positives = 46/127 (36%), Gaps = 22/127 (17%)
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ------------------SIG 170
+ S + A M SL+Y+ ++ ++T
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHAT 79
Query: 171 DI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNVFSGLP-LT 226
+ L+ L L + + + D + L++++ L + ++ S L + LP +
Sbjct: 80 NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
Query: 227 TLNVANN 233
+++++ N
Sbjct: 140 SIDLSYN 146
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEG+ G V A + +AVK +D E+ E + L H N+V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYG 72
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
+ E + L EY G L D + + + A+ + Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP--NTERQVSTQMVGAFGYSAP 585
LH + + HR+ K N+LLD+ N +SD GLA + N ER ++ M G Y AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 586 EFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
E + DV+S G+V+ +L G P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 36/231 (15%)
Query: 408 ATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNM 462
+T+ F + + ++G G V R K AVK ID + E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 463 SR----LR----HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLT 510
+ LR HPNI+ L + LV++ + G L D L ++ ++ +
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI- 129
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+R L + LH++ ++VHR+ K NILLDD++N L+D G +
Sbjct: 130 ----MRALLE---VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PG 177
Query: 571 QVSTQMVGAFGYSAPE------FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ ++ G Y APE Y + D++S GV+M LL G P
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 64/220 (29%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSN 461
N+F Q ++G+G G V + A GK+ A KK+ E LE V+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 242
Query: 462 MSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVR---- 516
+V+LA Y E L LV + G+L H AR
Sbjct: 243 -----SRFVVSLA-YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFP-EARAVFYAA 293
Query: 517 -VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
+ LE LH +V+R+ K NILLDD + +SD GLA E Q
Sbjct: 294 EICC----GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKG 344
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
VG GY APE + YT D ++ G ++ E++ G+ P
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 40/298 (13%)
Query: 345 PVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVAS 404
+ + + R + A + L P++ + AK + + K ++
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79
Query: 405 -----LQTATNSFSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED- 453
A F Q++ +IG G V R A G AVK ++ A L E
Sbjct: 80 EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 454 -NFLEAVSN----MSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFAD 503
EA + ++ HP+I+TL LV++ + G L D L ++
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 504 DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563
++++ +R L A+ +LH ++VHR+ K NILLDD + LSD G +
Sbjct: 200 KETRSI-----MRSLLE---AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 564 LTPNTERQVSTQMVGAFGYSAPE------FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E+ ++ G GY APE Y + D+++ GV++ LL G P
Sbjct: 249 HLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-21
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 48/229 (20%)
Query: 416 FLIGEGSLGRVYRA---EFANGKIMAVKKI--DNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G VY+A + + K A+K+I ++S E L L+HPN+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALL------RELKHPNV 80
Query: 471 VTLAGYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA------ 522
++L H R L+++Y HD+ H + V++ G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 523 --RALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLA--------ALTPNT 568
+ YLH V+HR+ K ANIL+ E ++D G A L +
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA-DL 192
Query: 569 ERQVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ V T F Y APE L + YT D+++ G + ELLT +P+
Sbjct: 193 DPVVVT-----FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 28/204 (13%), Positives = 58/204 (28%), Gaps = 39/204 (19%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
G + ++A A + +A+ +D L L +SR+ P + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
L+V E++ G+L ++ + + +R A A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V + + + + G ++
Sbjct: 149 GVALSIDHPSRVRVSID--------GDV-------------VLAYPATMPDA-------N 180
Query: 595 VKSDVYSFGVVMLELLTGRKPLDR 618
+ D+ G + LL R PL
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPE 204
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 58/227 (25%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRHPNIV 471
+G G+ G+V E G +AVK ++ + + + + N+ RHP+I+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHII 74
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-------- 523
L + +V EYV G L D + RV AR
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQQILS 122
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL------------TPNTERQ 571
A++Y H VVHR+ K N+LLD +N ++D GL+ + +PN
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---- 175
Query: 572 VSTQMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
Y+APE +Y + D++S GV++ LL G P D
Sbjct: 176 ----------YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 56/240 (23%), Positives = 91/240 (37%), Gaps = 25/240 (10%)
Query: 392 KSPITATSYTVASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAA 446
I+ + + F + +IG+G V R G+ AVK +D A
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 447 LSLQEEDNFLEAVSN----MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFA 502
+ E + L+HP+IV L + G +V+E++ +L +
Sbjct: 62 FT-SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 503 DDSSKNLTWNARVRVALGTAR----ALEYLHEVCLPSVVHRNFKSANILLDDELNPH--- 555
D+ + VA R AL Y H+ +++HR+ K +LL + N
Sbjct: 121 ADAGFVYS----EAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVK 173
Query: 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
L G+A V+ VG + APE Y DV+ GV++ LL+G P
Sbjct: 174 LGGFGVAIQLGE-SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
IG+G+ G V++A G+ +A+KK+ +N E++ F L + + L+H N+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMEN------EKEGFPITALREIKILQLLKHENV 78
Query: 471 VTLAGYCAEHGQRL--------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTA 522
V L C LV+++ HD+ + T + RV
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVSTQMVGA 579
L Y+H ++HR+ K+AN+L+ + L+D GLA +L N++ T V
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 580 FGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y PE L Y D++ G +M E+ T R P+
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSR 464
++ + +GEG+ VY+ + ++A+K+I L+ E+ + VS +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKD 56
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TAR 523
L+H NIVTL LV+EY+ D+ + DD + V++ L R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIIN-MHNVKLFLFQLLR 111
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMV 577
L Y H V+HR+ K N+L+++ L+D GLA R S V
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLA-------RAKSIPTKTYDNEV 161
Query: 578 GAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y P+ L S Y+ + D++ G + E+ T +PL
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPL 200
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 31/215 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQE--EDNFLEAVSN----MSRLRHPNI 470
+G G+ G V A E K +A++ I ++ E + V + +L HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALE 526
+ + + + +V E + G L D + + + K + A++
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------MLLAVQ 253
Query: 527 YLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
YLHE ++HR+ K N+LL +++ ++D G + + E + + G Y
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYL 308
Query: 584 APE---FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE + Y D +S GV++ L+G P
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 62/249 (24%), Positives = 106/249 (42%), Gaps = 35/249 (14%)
Query: 383 AKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKI 442
K L I + + + +++ +IG GS G V++A+ +A+KK+
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 443 DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL------LVYEYVGNGNLH 496
LQ++ + M ++HPN+V L + +G + LV EYV ++
Sbjct: 73 ------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 497 DMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPSVVHRNFKSANILLD---DEL 552
+ + +++ + R+L Y+H + + HR+ K N+LLD L
Sbjct: 126 RASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVL 181
Query: 553 NPHLSDCGLA----ALTPNTERQVSTQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVML 607
L D G A A PN + ++ Y APE + YT D++S G VM
Sbjct: 182 K--LIDFGSAKILIAGEPNVS-YICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMA 233
Query: 608 ELLTGRKPL 616
EL+ G +PL
Sbjct: 234 ELMQG-QPL 241
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/224 (26%), Positives = 85/224 (37%), Gaps = 24/224 (10%)
Query: 402 VASLQTATNSFSQEF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFL 456
V L + F+ + IG GS R A AVK ID + EE
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---- 65
Query: 457 EAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARV 515
+ + R +HPNI+TL + +V E + G L D + K +
Sbjct: 66 --IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREAS 119
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQ 571
V + +EYLH VVHR+ K +NIL DE + D G A
Sbjct: 120 AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ T + APE Y D++S GV++ +LTG P
Sbjct: 177 LMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++ H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +++ + + ++ L + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSA 584
H + H + K NI+L D+ P L D GLA + + G + A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVA 186
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +++D++S GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 29/211 (13%), Positives = 68/211 (32%), Gaps = 21/211 (9%)
Query: 90 ISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFS----- 142
I G + + ++ LS N I ++++ L++N +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 143 --GNLPYSIASMVSLSYLNVSRNSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFIS 199
+ + L+ +++ N LT D L L+ +D+S+N FS P ++
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN 774
Query: 200 LSNISSLYLQNNQVTGSLNVFSGLP--------LTTLNVANNHFSGWIPRELI-SIRTFI 250
S + + +++ + + P L L + +N + +L +
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILD 833
Query: 251 YDGNSFDNGPAPPPPPSTAPPSGRSHNNRSH 281
N + P +++
Sbjct: 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-20
Identities = 29/171 (16%), Positives = 50/171 (29%), Gaps = 17/171 (9%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG- 143
+ S+L L +L +P L P L SLN+A N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 144 --------NLPYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP 194
L + + + N+L + + L LD N
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--L 588
Query: 195 NSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+F + ++ L L NQ+ + + + L ++N IP
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 4e-19
Identities = 25/161 (15%), Positives = 61/161 (37%), Gaps = 21/161 (13%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGN-----LPYSIASM 152
+ + S N + IP + S++ + N
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-------GDLPNSFISLSNISS 205
++ S + +S N + + ++F + ++T+ LS N + ++ + +++
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 206 LYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSGWIPREL 243
+ L+ N++T + LP L+ ++V+ N FS P +
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQP 772
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 28/179 (15%), Positives = 60/179 (33%), Gaps = 19/179 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-----QLP------PNLTSLN 135
+++ + L DL L+ +++ N +L P +
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 136 LASNNFSG-NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP 194
+ NN S+ MV L L+ N + + + FG L L L +N +P
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HL-EAFGTNVKLTDLKLDYNQIEE-IP 611
Query: 195 NS-FISLSNISSLYLQNNQVTGSLNVFS--GLP-LTTLNVANNHFSGWIPRELISIRTF 249
+ L +N++ N+F+ + + +++ + N S+ +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 32/202 (15%), Positives = 62/202 (30%), Gaps = 37/202 (18%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN---SIHDTIPYQLP------PNLTSLNL 136
++ +S + L + + LS N SI + LT+++L
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 137 ASNNFSGNLPYSIA--SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF------NN 188
N + L ++ LS ++VS N + S N + L + N
Sbjct: 736 RFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNR 793
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHF-----SG 237
P + ++ L + +N + L L++A+N +
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSND-------IRKVDEKLTPQLYILDIADNPNISIDVTS 846
Query: 238 WIPRELISIRTFIYDGNSFDNG 259
P + +YD G
Sbjct: 847 VCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 22/144 (15%), Positives = 48/144 (33%), Gaps = 13/144 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLA------SNNFSGNLPYSIASMVSL 155
L L DL ++I+ + + ++L N + +I + L
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKL 450
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
+ + + T + + + + S+ +L +++ + L N
Sbjct: 451 QIIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 216 SL-NVFSGLP-LTTLNVANNHFSG 237
L + LP L +LN+A N
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 25/189 (13%), Positives = 49/189 (25%), Gaps = 34/189 (17%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPN--LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
F+ + D L N +T L+LA G +P +I + L L+ +
Sbjct: 298 HSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTH 357
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-----------------------NSFISL 200
S T S + + +
Sbjct: 358 SETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417
Query: 201 SNISSLYLQNNQVTGSLNVFSGLP--------LTTLNVANNHFSGWIPRELISIRTFIYD 252
S + L++ Q+ N + + L + AN+ F+ +
Sbjct: 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDY 476
Query: 253 GNSFDNGPA 261
++N
Sbjct: 477 AKQYENEEL 485
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 58/244 (23%), Positives = 96/244 (39%), Gaps = 37/244 (15%)
Query: 385 SGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKID 443
+GSL+ + P F ++GEGS V A E A + A+K ++
Sbjct: 12 AGSLQHAQPPPQPRKKRP-------EDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 444 NAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML-- 499
+ + MSRL HP V L + + ++L Y NG L +
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRK 123
Query: 500 --HFADDSSKNLTWNARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552
F + R + ALEYLH ++HR+ K NILL++++
Sbjct: 124 IGSFDET---------CTRFYTAEIVS----ALEYLHGK---GIIHRDLKPENILLNEDM 167
Query: 553 NPHLSDCGLAALTPNTERQVSTQ-MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611
+ ++D G A + +Q VG Y +PE SD+++ G ++ +L+
Sbjct: 168 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
Query: 612 GRKP 615
G P
Sbjct: 228 GLPP 231
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 34/213 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
IGEG+ G V++A +I+A+K++ D+ +++ L + + L+H NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNI 63
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V L + LV+E+ D+ + D + +L + L + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGYSA 584
V+HR+ K N+L++ L++ GLA R + V Y
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLA-------RAFGIPVRCYSAEVVTLWYRP 169
Query: 585 PEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
P+ + +Y+ D++S G + EL +PL
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 46/202 (22%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G+ G V+R E A G++ K I+ ++ +S M++L HP ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ + +L+ E++ G L D + ++ + L+++HE S+
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SI 170
Query: 537 VHRNFKSANILLDDELNPHL--SDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VH + K NI+ + + + D GLA L P+ ++ ++APE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPV 227
Query: 594 TVKSDVYSFGVVMLELLTGRKP 615
+D+++ GV+ LL+G P
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 59/246 (23%), Positives = 83/246 (33%), Gaps = 52/246 (21%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTL 473
IG+GS G V A E I A+K ++ + + ++ + V M +L HPNI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR---------- 523
+ LV E G+L D L+ D S V+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 524 --------------------------ALEYLHEVCLPSVVHRNFKSANILL--DDELNPH 555
AL YLH + HR+ K N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 556 LSDCGLAALTPNTERQVSTQMVGAFG---YSAPEFALSGI---YTVKSDVYSFGVVMLEL 609
L D GL+ M G + APE L+ Y K D +S GV++ L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 610 LTGRKP 615
L G P
Sbjct: 270 LMGAVP 275
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-----VSNMSRLRHPNIV 471
IGEGS G V++ G+I+A+KK E+D ++ + + +L+HPN+V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + LV+EY H +LH D + + + + T +A+ + H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTER---QVSTQMVGAFGYSAPEF 587
+ +HR+ K NIL+ L D G A LT ++ +V+T+ Y +PE
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-----YRSPEL 173
Query: 588 AL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ Y DV++ G V ELL+G PL
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV-PL 202
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 53/224 (23%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLE-AVSNMSRLRHPNIVTLA 474
+GEGS G+V A + + +A+K I L + +E +S + LRHP+I+ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALE 526
++V EY G G L D + + R+ R A+E
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYI------------VEKKRMTEDEGRRFFQQIICAIE 122
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL------------TPNTERQVST 574
Y H +VHR+ K N+LLDD LN ++D GL+ + +PN
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------- 172
Query: 575 QMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
Y+APE +Y + DV+S G+V+ +L GR P D
Sbjct: 173 -------YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++ HPNI+T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +++ + + ++ L + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSA 584
H + H + K NI+L D+ P L D GLA + + G + A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVA 186
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +++D++S GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 36/219 (16%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRH--PN 469
L+G G G VY ++ +A+K ++ +S E V + ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 470 IVTLAGYCAEHGQRLLVYEYV-GNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
++ L + +L+ E +L D + R + AR
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT------------ERGALQEELARSFFWQ 157
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVSTQMVGA 579
A+ + H V+HR+ K NIL+D + L D G AL +T G
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGT 211
Query: 580 FGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
YS PE+ Y + V+S G+++ +++ G P +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA-----VSNMSRLRHPNIV 471
+GEGS G V + G+I+A+KK ++D ++ + + +LRH N+V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L C + + LV+E+V H +L + L + + + + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGYSAP 585
+++HR+ K NIL+ L D G A R ++ V Y AP
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFA-------RTLAAPGEVYDDEVATRWYRAP 193
Query: 586 EFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
E + Y DV++ G ++ E+ G PL
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PL 224
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 54/233 (23%), Positives = 83/233 (35%), Gaps = 62/233 (26%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQE--EDNFLEAVSNMSRLRHPNIVTL 473
L+GEGS G+V AVK + L E N + + + RLRH N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 474 AGY---CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR------ 523
E Q++ +V EY G + +ML R + A
Sbjct: 72 --VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV----------PEKRFPVCQAHGYFCQL 118
Query: 524 --ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL---------------TP 566
LEYLH +VH++ K N+LL +S G+A +P
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 567 NTERQVSTQMVGAFGYSAPE-FALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
+ PE ++ K D++S GV + + TG P +
Sbjct: 176 A--------------FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 53/211 (25%), Positives = 82/211 (38%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + + GK A K I LS E + + +RHPNI+T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L +D + ++ L + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYL 124
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSA 584
H + H + K NI+L D+ P+ L D G+A + G + A
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVA 179
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +++D++S GV+ LL+G P
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 9/178 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L DL+ N I + P LT L L +N S P +A + +L+ L ++
Sbjct: 239 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 296
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N L NL L L L FNN S P SL+ + L+ NN+V+ ++ +
Sbjct: 297 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLAN 351
Query: 223 LP-LTTLNVANNHFSGWIP-RELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNN 278
L + L+ +N S P L I + ++ N P + P + ++
Sbjct: 352 LTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 36/139 (25%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L + N I D P + NL L+L N ++ ++AS+ +L+ L+++
Sbjct: 195 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLAN 252
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ L L L L N S ++ L+ +++L L NQ+ ++ S
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQIS-NISP-LAGLTALTNLELNENQLE-DISPISN 307
Query: 223 LP-LTTLNVANNHFSGWIP 240
L LT L + N+ S P
Sbjct: 308 LKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 30/136 (22%), Positives = 57/136 (41%), Gaps = 8/136 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L K L ++ DT+ +T+L ++ + + +L+ +N S
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 77
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N LT NL L + ++ N + +L+N++ L L NNQ+T ++
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQIT-DIDPLKN 132
Query: 223 LP-LTTLNVANNHFSG 237
L L L +++N S
Sbjct: 133 LTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-16
Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 9/136 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L++L +L L N I D P + NL L L+SN S +++ + SL L+
Sbjct: 108 LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG- 164
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL L LD+S N S + L+N+ SL NNQ++ +
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS-DITPLGI 219
Query: 223 LP-LTTLNVANNHFSG 237
L L L++ N
Sbjct: 220 LTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 39/162 (24%), Positives = 61/162 (37%), Gaps = 7/162 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L +L+ N + D P NLT L L NN S P ++S+ L L
Sbjct: 283 LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ NL + L N S DL +L+ I+ L L + T + +
Sbjct: 341 NKVSDV--SSLANLTNINWLSAGHNQIS-DLTP-LANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPP 264
++ N N I IS + + N P+
Sbjct: 397 N-VSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTN 437
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 23/128 (17%), Positives = 45/128 (35%), Gaps = 8/128 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I+ L N + + + ++ L R + SI +
Sbjct: 9 TQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGV- 64
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L L ++ S N + D+ +L+ + + + NNQ+ + + L LT L + N
Sbjct: 65 EYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFN 121
Query: 233 NHFSGWIP 240
N + P
Sbjct: 122 NQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 10/120 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L++L ++ N I D P +T L L ++ N P + + VS+ +
Sbjct: 349 LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNV 407
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ I + D+++N S + +S + Q + FSG
Sbjct: 408 TGALIAPATI-SDGGSYTEPDITWNLPS--------YTNEVSYTFSQPVTIGKGTTTFSG 458
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 9/90 (10%)
Query: 154 SLSYLNVSRNSLTQSIGDIFG--NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
L ++++ I IF LA L N + + L +++L
Sbjct: 2 PLGSATITQD---TPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL 56
Query: 212 QVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
+ S++ L LT +N +NN + P
Sbjct: 57 GIK-SIDGVEYLNNLTQINFSNNQLTDITP 85
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 9e-20
Identities = 38/166 (22%), Positives = 57/166 (34%), Gaps = 8/166 (4%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNL 145
+D+S + L L L+GN I +L L N +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 146 PYSIASMVSLSYLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ I + +L LNV+ N + + + F NL L LDLS N L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 205 ----SLYLQNNQVTG-SLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
SL L N + F + L L + NN S + + I
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 38/145 (26%), Positives = 64/145 (44%), Gaps = 6/145 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN--NFSGNLPYSIASMVSLSYLNVSRN 163
L SL++ + N + P+L L+L+ N +F G S SL YL++S N
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLN-VFS 221
+ ++ F L L LD +N + F+SL N+ L + + + N +F+
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 222 GLP-LTTLNVANNHFSGWIPRELIS 245
GL L L +A N F ++ +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 37/156 (23%), Positives = 63/156 (40%), Gaps = 7/156 (4%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSG 143
+D+S G+ TM L L D +++ + NL L+++ +
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ SL L ++ NS ++ DIF L L LDLS P +F SLS+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 203 ISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+ L + +NQ+ +F L L + + N +
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 9e-19
Identities = 31/128 (24%), Positives = 51/128 (39%), Gaps = 3/128 (2%)
Query: 111 KFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
+ + + IP LP + +L+L+ N YS S L L++SR +
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTL 228
+ +L+ L+TL L+ N +F LS++ L + L L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 229 NVANNHFS 236
NVA+N
Sbjct: 130 NVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 33/142 (23%), Positives = 59/142 (41%), Gaps = 9/142 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHD----TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
DL SL DLS N + + +L L+L+ N + + + L +L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 159 NVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++L Q S +F +L L LD+S + F LS++ L + N +
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 218 --NVFSGLP-LTTLNVANNHFS 236
++F+ L LT L+++
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 27/113 (23%), Positives = 44/113 (38%), Gaps = 3/113 (2%)
Query: 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTS---LNLASNNFS 142
+ +DIS + + L SL ++GNS + + L + L+L+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN 195
P + S+ SL LN++ N L IF L L + L N + P
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 29/178 (16%), Positives = 57/178 (32%), Gaps = 18/178 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD-TIPYQLP--PNLTSLNLASNNFSG 143
+ L+ + + L +L++ +++ N I +P NL L+L+SN
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 144 NLPYSIASMVSLSY----LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFI 198
+ + + L++S N + F + L L L N S ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQ 222
Query: 199 SLSNISSLYL-------QNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTF 249
L+ + L + N + G L L + + I F
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEG--LCNLTIEEFRLAYLDYYLDDIIDLF 278
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 38/206 (18%), Positives = 66/206 (32%), Gaps = 41/206 (19%)
Query: 96 SGTMGYLLSDLLSLRKFDLSGNSIHDTIP------YQLPPNLTSLNLASNNFSGNLPYSI 149
S + S+L +L DLS N I +Q+P SL+L+ N + +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196
Query: 150 ASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSG----------------- 191
+ L L + N + ++ LAGL L F
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 192 ----------------DLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHF 235
D+ + F L+N+SS L + + + L + N F
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 236 SGWIPRELISIRTFIYDGNSFDNGPA 261
+ +L S++ + N N +
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFS 342
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
+G G+ G V A E K +A+K I ++ A + + +L HP I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALE 526
+ + + + +V E + G L D + + + K L A++
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQ 128
Query: 527 YLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
YLHE ++HR+ K N+LL +++ ++D G + + E + + G Y
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYL 183
Query: 584 APE---FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE + Y D +S GV++ L+G P
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 60/292 (20%), Positives = 116/292 (39%), Gaps = 25/292 (8%)
Query: 335 SGARSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSP 394
SG + + + + + + A E++ ++ S I +P
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 395 ITATSYTVASLQTATNS----FSQEFLIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSL 449
+ + + + + S+ ++G G G+V++ E A G +A K I +
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GM 127
Query: 450 QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL 509
++++ +S M++L H N++ L +LV EYV G L D + D S NL
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNL 184
Query: 510 T-WNAR--VRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL--SDCGLAA- 563
T + ++ + ++H++ ++H + K NIL + + D GLA
Sbjct: 185 TELDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
Query: 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
P + G + APE + +D++S GV+ LL+G P
Sbjct: 239 YKPR---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNIV 471
+GEG+ G VY+A+ + G+I+A+K+I D E++ + +S + L HPNIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDA------EDEGIPSTAIREISLLKELHHPNIV 82
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+L LV+E++ D+ D++ L + R + + H+
Sbjct: 83 SLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGYSAP 585
++HR+ K N+L++ + L+D GLA R T V Y AP
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLA-------RAFGIPVRSYTHEVVTLWYRAP 188
Query: 586 EFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ + S Y+ D++S G + E++T KPL
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPL 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 56/253 (22%), Positives = 99/253 (39%), Gaps = 19/253 (7%)
Query: 371 PPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFLIGE----GSLGRV 426
+ ++ S Y ++ + + I E G+ G V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 427 YRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485
+R E A G A K + +++ + + MS LRHP +V L + + ++
Sbjct: 174 HRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231
Query: 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545
+YE++ G L + + D ++ + V + L ++HE + VH + K N
Sbjct: 232 IYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPEN 285
Query: 546 ILLDDELNPHL--SDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSF 602
I+ + + L D GL A L P Q G ++APE A +D++S
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 603 GVVMLELLTGRKP 615
GV+ LL+G P
Sbjct: 343 GVLSYILLSGLSP 355
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 48/211 (22%), Positives = 79/211 (37%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSN----MSRLRHPNIVT 472
+G G V + E + G A K I E + + ++HPN++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYL 528
L +L+ E V G L D L ++ + ++ L + YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVYYL 130
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGAFGYSA 584
H + + H + K NI+L D P + D GLA + G + A
Sbjct: 131 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVA 185
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE +++D++S GV+ LL+G P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 58/227 (25%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLRHPNIV 471
+G G+ G+V + G +AVK ++ + + + + N+ RHP+I+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKI---RSLDVVGKIRREIQNLKLFRHPHII 79
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR-------- 523
L + +V EYV G L D + R+ +R
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQQILS 127
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL------------TPNTERQ 571
++Y H VVHR+ K N+LLD +N ++D GL+ + +PN
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---- 180
Query: 572 VSTQMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
Y+APE +Y + D++S GV++ LL G P D
Sbjct: 181 ----------YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 50/218 (22%), Positives = 81/218 (37%), Gaps = 36/218 (16%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDN-------FLEAVSNMSRLRHPN 469
+G G+ G V+ A K + VK I + LE ++ +SR+ H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE-IAILSRVEHAN 90
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGN-LHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
I+ + G LV E G+G L + + R+ A
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFI------------DRHPRLDEPLASYIFRQ 138
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAF 580
A+ YL ++HR+ K NI++ ++ L D G AA + T G
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTF-CGTI 193
Query: 581 GYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
Y APE + Y + +++S GV + L+ P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 36/273 (13%)
Query: 355 MHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQ 414
MH S E L + ++ + + Y + + ++ S
Sbjct: 1 MHHHHHHSSGV-----DLGTENLYFQSMSSVTASAAPGTASLVPDYWI--DGSNRDALSD 53
Query: 415 EF----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
F +G G+ VYR + K A+K + ++ + + RL HPN
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPN 109
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARAL 525
I+ L + LV E V G L D + ++++ + + V+ L A+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILE---AV 161
Query: 526 EYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGY 582
YLHE +VHR+ K N+L + ++D GL+ + + + + G GY
Sbjct: 162 AYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGY 216
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
APE Y + D++S G++ LL G +P
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 35/164 (21%), Positives = 62/164 (37%), Gaps = 9/164 (5%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LS L L L +I+ Y L L ++ + + + ++L+ L
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+++ +LT +L L L+LS+N S + L + + L Q+
Sbjct: 230 SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSF 256
F GL L LNV+ N + + + ++ T I D N
Sbjct: 290 YAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 27/145 (18%), Positives = 57/145 (39%), Gaps = 7/145 (4%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
+ DL +L+ ++ N + I ++ +L L L N + +++ + L L
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVL 181
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ ++ F L L L++S + + + + N++SL + + +T
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPR 241
L L LN++ N S I
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEG 265
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 6/146 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
++L +LR L N + IP + NLT L+++ N L Y + +L L
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
V N L F L L L L N + + L + L L++ +
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 219 VFSGLP-LTTLNVANNHFSGWIPREL 243
F L L L +++ + +
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 42/185 (22%), Positives = 66/185 (35%), Gaps = 13/185 (7%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137
C ++ + ++ L DL N I + P+L L L
Sbjct: 9 CSAQDR-AVLCHRKRFVAVPEGIPTETRLL---DLGKNRIKTLNQDEFASFPHLEELELN 64
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N S P + ++ +L L + N L +F L+ L LD+S N L F
Sbjct: 65 ENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMF 124
Query: 198 ISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIY 251
L N+ SL + +N + S FSGL L L + + + IP E L +
Sbjct: 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRL 183
Query: 252 DGNSF 256
+
Sbjct: 184 RHLNI 188
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 28/129 (21%), Positives = 50/129 (38%), Gaps = 4/129 (3%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
++IS TM L+L ++ ++ +PY L LNL+ N S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNI 203
+ ++ L + + L F L L L++S N + + F S+ N+
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322
Query: 204 SSLYLQNNQ 212
+L L +N
Sbjct: 323 ETLILDSNP 331
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 4/115 (3%)
Query: 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLN 135
G + S+ I+ L+ + L+ LR +LS N I TI + L +
Sbjct: 220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQ 278
Query: 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS 190
L + PY+ + L LNVS N LT +F ++ L TL L N +
Sbjct: 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNI 470
+GEG+ G VY+A + + +A+K+I ++ EE+ + VS + L+H NI
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH------EEEGVPGTAIREVSLLKELQHRNI 95
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALEYLH 529
+ L + + L++EY +D+ + D + +++ ++ L + + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAE----NDLKKYM-DKNPDVS-MRVIKSFLYQLINGVNFCH 149
Query: 530 EVCLPSVVHRNFKSANILLDDELNPH-----LSDCGLAALTPNTERQVS------TQMVG 578
+HR+ K N+LL + D GLA R T +
Sbjct: 150 S---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-------RAFGIPIRQFTHEII 199
Query: 579 AFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y PE L S Y+ D++S + E+L + PL
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPL 237
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 8/142 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+++L L L+ N I D P +L N + ++ +A+M L+ L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQIT-DIT-PVANMTRLNSLKIGN 230
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL+ L L++ N S N+ L+ + L + +NQ++ ++V +
Sbjct: 231 NKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-DISVLNN 285
Query: 223 LP-LTTLNVANNHFSGWIPREL 243
L L +L + NN +
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 31/135 (22%), Positives = 61/135 (45%), Gaps = 6/135 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++++ L + N I D P LT L + +N S ++ ++ + L LNV
Sbjct: 217 VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGS 274
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ I + NL+ L +L L+ N + L+N+++L+L N +T + +
Sbjct: 275 NQIS-DI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPLAS 331
Query: 223 LP-LTTLNVANNHFS 236
L + + + AN
Sbjct: 332 LSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 28/159 (17%), Positives = 63/159 (39%), Gaps = 25/159 (15%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS-----GNLPY---------- 147
+L S+ K ++G + + NL LNL N + NL
Sbjct: 40 QEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNK 99
Query: 148 -----SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
++ ++ +L L ++ ++++ NL + +L+L N+ DL +++
Sbjct: 100 ITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTG 156
Query: 203 ISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
++ L + ++V + + L L +L++ N P
Sbjct: 157 LNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L SL F N I D P L SL + +N + +L +A++ L++L +
Sbjct: 195 LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKIT-DLS-PLANLSQLTWLEIGT 252
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNVFS 221
N ++ I + +L L L++ N S D+ +LS ++SL+L NNQ+ + V
Sbjct: 253 NQIS-DI-NAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 222 GLP-LTTLNVANNHFSGWIP-RELISIRTFIYDGN 254
GL LTTL ++ NH + P L + + +
Sbjct: 309 GLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 7e-17
Identities = 30/139 (21%), Positives = 63/139 (45%), Gaps = 8/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + L S+ D + + ++T L +A + ++ I + +L YLN++
Sbjct: 18 DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNG 75
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T NL L L + N + ++ +L+N+ LYL + ++ ++ +
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNIS-DISPLAN 130
Query: 223 LP-LTTLNVANNHFSGWIP 240
L + +LN+ NH +
Sbjct: 131 LTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 24/130 (18%), Positives = 49/130 (37%), Gaps = 8/130 (6%)
Query: 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
I+ P L + + + + S++ L V+ + S
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTT 227
I I L L L+L+ N + D+ +L +++LY+ N++T ++ L L
Sbjct: 59 IQGI-EYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKIT-DISALQNLTNLRE 114
Query: 228 LNVANNHFSG 237
L + ++ S
Sbjct: 115 LYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 14/67 (20%), Positives = 31/67 (46%), Gaps = 4/67 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L++L L L+ N + + + NLT+L L+ N+ + P +AS+ + +
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 161 SRNSLTQ 167
+ + +
Sbjct: 341 ANQVIKK 347
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 36/224 (16%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH 467
S++ +IG GS G VY+A+ +G+++A+KK+ LQ++ + M +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDH 106
Query: 468 PNIVTLAGYCAEHGQRL------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-G 520
NIV L + G++ LV +YV ++ + + + L V++ +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQ 164
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLA-ALT---PNTERQVS 573
R+L Y+H + HR+ K N+LLD L L D G A L PN +
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLK--LCDFGSAKQLVRGEPNVS-YIC 218
Query: 574 TQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
++ Y APE + YT DV+S G V+ ELL G+ P+
Sbjct: 219 SRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 14/166 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157
L LR+ L N I +IP P+L L+L + + + +L Y
Sbjct: 142 AFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY 200
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
LN+ ++ + + L GL L++S N+F P SF LS++ L++ N+QV+
Sbjct: 201 LNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
N F GL L LN+A+N+ S +P + L + N ++
Sbjct: 259 RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 30/139 (21%), Positives = 46/139 (33%), Gaps = 7/139 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L L NSI I +L +L L N + + + L L
Sbjct: 95 FRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLN 218
+ N + F + L LDL + +F L N+ L L + +
Sbjct: 154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP 212
Query: 219 VFSGLP-LTTLNVANNHFS 236
+ L L L ++ NHF
Sbjct: 213 NLTPLVGLEELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 9/139 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
Y + + SL + DL I + L NL LNL N ++P ++ +V L
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLF-NLKYLNLGMCNIK-DMP-NLTPLVGLE 221
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L +S N + F L+ L L + + S N+F L+++ L L +N ++
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL 281
Query: 216 SLNVFSGLP-LTTLNVANN 233
++F+ L L L++ +N
Sbjct: 282 PHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 34/128 (26%), Positives = 53/128 (41%), Gaps = 3/128 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K + + +P +P N LNL NN + + L L + RNS+ Q
Sbjct: 55 QFSKVVCTRRGL-SEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ 113
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
F LA L TL+L N + +F LS + L+L+NN + F+ +P L
Sbjct: 114 IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSL 173
Query: 226 TTLNVANN 233
L++
Sbjct: 174 MRLDLGEL 181
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 39/207 (18%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G V+R E ++ K K + ++ + +S ++ RH NI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHES 69
Query: 477 CAEHGQRLLVYEYVGNGNLHDML-----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ ++++E++ ++ + + + + V AL++LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---ALQFLHSH 121
Query: 532 CLPSVVHRNFKSANILLDDELNPHL--SDCGLAA-LTPNTERQVSTQMVGAFGYSAPEFA 588
++ H + + NI+ + + + G A L P + A Y APE
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVH 175
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ + +D++S G ++ LL+G P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS--------RLRHP 468
+GEG VY+A + +I+A+KKI L + ++ + L HP
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-----KLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARALEY 527
NI+ L LV++++ D+ D+S LT + ++ + T + LEY
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFM----ETDLEVIIKDNSLVLT-PSHIKAYMLMTLQGLEY 127
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFG 581
LH+ ++HR+ K N+LLD+ L+D GLA + T V
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLA-------KSFGSPNRAYTHQVVTRW 177
Query: 582 YSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE + +Y V D+++ G ++ ELL R P
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPF 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 12/203 (5%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAG 475
+G G V + + G+ A K + L ++ + + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +L+ EY G + + + ++ ++ N +R+ + YLH+ +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQILEGVYYLHQN---N 151
Query: 536 VVHRNFKSANILLDDELNPH---LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
+VH + K NILL + D G++ +++G Y APE
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYDP 209
Query: 593 YTVKSDVYSFGVVMLELLTGRKP 615
T +D+++ G++ LLT P
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSP 232
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 6e-19
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI--DNAALSLQEEDNF----LEAVSNMSRLRHPNIV 471
IGEG+ G VY+A+ G+ A+KKI + E++ + +S + L+H NIV
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK------EDEGIPSTTIREISILKELKHSNIV 63
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L + +LV+E++ D+ D L L + Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFGYSAP 585
V+HR+ K N+L++ E ++D GLA R T + Y AP
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLA-------RAFGIPVRKYTHEIVTLWYRAP 169
Query: 586 EFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ + S Y+ D++S G + E++ PL
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPL 200
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 36/205 (17%), Positives = 72/205 (35%), Gaps = 6/205 (2%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
+S + L+ +++ + D S NSI + + + LT L L NN + + + +
Sbjct: 191 ANVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNNLT-DTA-WLLNY 247
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L +++S N L + + F + L L +S N L + + L L +N
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 213 VTG-SLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ N L L + +N +++ N +D + A P
Sbjct: 307 LLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARP 366
Query: 272 SGRSHNNRSHRQGSHSPSGSQSSSS 296
+ ++ + G S
Sbjct: 367 AV-DDADQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA----------- 150
SL+ LS N + + L P+L N++ N S L IA
Sbjct: 160 TFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSI 217
Query: 151 ------SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
V L+ L + N+LT + N GL +DLS+N + + F+ + +
Sbjct: 218 NVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275
Query: 205 SLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LY+ NN++ +P L L++++NH + R
Sbjct: 276 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 7/139 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LL + +L+ I I + + L + N P+ ++ L+ L
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ RN L+ IF N L TL +S NN ++F + +++ +L L +N++T L
Sbjct: 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL 182
Query: 218 NVFSGLPLTTLNVANNHFS 236
++ L NV+ N S
Sbjct: 183 SLIPS--LFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 27/154 (17%), Positives = 56/154 (36%), Gaps = 6/154 (3%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGN 144
+ I G+ L + + +++ +P L + LNL
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEI 84
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
Y+ A ++ L + N++ +F N+ L L L N+ S F + ++
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+L + NN + + F L L +++N +
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 22/130 (16%), Positives = 50/130 (38%), Gaps = 6/130 (4%)
Query: 113 DLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
D+ + + + N + ++ + S + LN++ + +
Sbjct: 25 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 84
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LT 226
F + L + FN P+ F ++ ++ L L+ N ++ +F P LT
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 227 TLNVANNHFS 236
TL+++NN+
Sbjct: 145 TLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 31/140 (22%), Positives = 60/140 (42%), Gaps = 14/140 (10%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ +++K + N+I +P + P LT L L N+ S +LP I + L+
Sbjct: 88 AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 145
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
L++S N+L + D F L L LS N + + S + ++ + N L
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNL----L 198
Query: 218 NVFSGLP-LTTLNVANNHFS 236
+ + + L+ ++N +
Sbjct: 199 STLAIPIAVEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 12/86 (13%), Positives = 24/86 (27%), Gaps = 4/86 (4%)
Query: 155 LSYLNVSRNSLTQSIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ +V + TQ + F L + + S + L L + Q
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 213 VTG-SLNVFSGLP-LTTLNVANNHFS 236
+ F+ + L + N
Sbjct: 81 IEEIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+GEGS + + + AVK I + Q+E L+ HPNIV L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG-----HPNIVKLHE 73
Query: 476 YCAEHGQRLLVYEYVGNGNLHDML----HFADDSSKNLTWNARVRVALGTARALEYLHEV 531
+ LV E + G L + + HF++ + + +R + A+ ++H+V
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVS---AVSHMHDV 125
Query: 532 CLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
VVHR+ K N+L +D L + D G A L P + + T Y+APE
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELL 181
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y D++S GV++ +L+G+ P
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 44/220 (20%), Positives = 82/220 (37%), Gaps = 36/220 (16%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAV----SNMSRLR----H 467
L+G+G G V+ + +A+K I + + + + ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR---- 523
P ++ L + +LV E D+ + + + G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQ--DLFDYIT---------EKGPLGEGPSRCFFG 146
Query: 524 ----ALEYLHEVCLPSVVHRNFKSANILLDDELNP-HLSDCGLAALTPNTERQVSTQMVG 578
A+++ H VVHR+ K NIL+D L D G AL + G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DG 200
Query: 579 AFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617
YS PE+ Y + + V+S G+++ +++ G P +
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH 467
+ F IG+GS G+V + K+ A+K ++ + E N + + M L H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVR-----V 517
P +V L Y + + + +V + + G+L L HF ++ V+ +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---------TVKLFICEL 124
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV 577
+ AL+YL ++HR+ K NILLD+ + H++D +AA+ P + + M
Sbjct: 125 VM----ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA 175
Query: 578 GAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKP 615
G Y APE S Y+ D +S GV ELL GR+P
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 49/242 (20%), Positives = 91/242 (37%), Gaps = 61/242 (25%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKID--------------------NAALSLQEEDNF 455
IG+GS G V A + A+K + A +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 456 LEAV----SNMSRLRHPNIVTLAGY----CAEHGQRLLVYEYVGNGNLHDMLHFADDSSK 507
+E V + + +L HPN+V L +V+E V G + ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVP-------- 129
Query: 508 NLTWNARVRVALGTAR--------ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559
++ AR +EYLH ++HR+ K +N+L+ ++ + ++D
Sbjct: 130 -----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV----KSDVYSFGVVMLELLTGRKP 615
G++ ++ +S VG + APE +LS + DV++ GV + + G+ P
Sbjct: 182 GVSNEFKGSDALLSNT-VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 616 LD 617
Sbjct: 240 FM 241
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 28/154 (18%), Positives = 58/154 (37%), Gaps = 6/154 (3%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIH----DTIPYQLPPNLTSLNLASNNFSGN 144
+S + + L + ++I +T ++ L+L+
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
++ L LN++ N + + + F L L L+LS+N ++F L ++
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
+ LQ N + F L L TL++ +N +
Sbjct: 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-18
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 12/155 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L+ +L TI L PNL L+L S+ P + + L L
Sbjct: 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNL-PNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102
Query: 159 NVSRNSLTQSI--GDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVT- 214
+ L+ ++ F NL L LDLS N L SF L+++ S+ +NQ+
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162
Query: 215 ---GSLNVFSGLPLTTLNVANNHFSGWIPRELISI 246
L G L+ ++A N + +
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 31/156 (19%), Positives = 54/156 (34%), Gaps = 12/156 (7%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNL- 145
L+ + L + + LS N I P L L L S +
Sbjct: 10 FYRFCNLT----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL--PNSFISLSNI 203
+ ++ +L L++ + + D F L L L L F S + F +L +
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125
Query: 204 SSLYLQNNQVT--GSLNVFSGLP-LTTLNVANNHFS 236
+ L L NQ+ F L L +++ ++N
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 47/252 (18%), Positives = 79/252 (31%), Gaps = 22/252 (8%)
Query: 87 SIDISGLGLSG-TMGYLLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFS 142
I +S L + Y L + L+ L+ N P+L L L N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 143 GNLPYSI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+ + L L ++ N L +F +L L L L+ N + N
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
+N+ L + NQ+ + N + L+ L++ +N F + TFI + +
Sbjct: 525 --PANLEILDISRNQLL-APNPDVFVSLSVLDITHNKFI-----CECELSTFI-NWLNHT 575
Query: 258 NGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPSGSQSSSSDKELPAGAIVGIVLGAVFLVA 317
N PP S + S S S + + IV +
Sbjct: 576 NVTIAGPPADIYCVYPDSFSGVSLF----SLSTEGCDEEEVLKSLKFSLFIVCTVTLTLF 631
Query: 318 LALLALYFCIRK 329
L + R
Sbjct: 632 LMTILTVTKFRG 643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 17/159 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNL--PYSIASMVSLSY 157
+L +LR DL + I+ + +L L L S + ++ +L+
Sbjct: 69 FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 158 LNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS--SLYLQNNQVT 214
L++S+N + + FG L L ++D S N + L + L N +
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 215 --------GSLNVFSGLPLTTLNVANNHFSGWIPRELIS 245
+N F + L L+V+ N ++ I +
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 42/210 (20%), Positives = 73/210 (34%), Gaps = 24/210 (11%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140
S+V +D+S + + L L+ +L+ N I+ NL LNL+ N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLP---- 194
+ + ++Y+++ +N + F L L TLDL N + +P
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPD 385
Query: 195 -----NSFISLSNIS----SLYLQNNQVTG--SLNVFSGLP-LTTLNVANNHFSG----W 238
N ++L I+ ++L N++ L +P L L + N FS
Sbjct: 386 IFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ 445
Query: 239 IPRELISIRTFIYDGNSFDNGPAPPPPPST 268
P E S+ N
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDV 475
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 34/179 (18%), Positives = 67/179 (37%), Gaps = 29/179 (16%)
Query: 87 SIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL---NLASNNF 141
+ + GLS + +L +L + DLS N I + L SL + +SN
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 142 SGNLPYSIAS--MVSLSYLNVSRNSLTQSIGDIFGNLAG------LATLDLSFNNFSGDL 193
+ + +LS+ +++ NSL + +G L LD+S N ++ D+
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 194 PNSFIS------------LSNISSLYLQNNQVTG-SLNVFSGLP---LTTLNVANNHFS 236
+F + +I + + N F+GL + L++++
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 28/150 (18%), Positives = 48/150 (32%), Gaps = 18/150 (12%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSG-NLPYSIASMVSLS 156
L L + L + D + LT L+L+ N L S + SL
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151
Query: 157 YLNVSRNSLTQSIGDIFGNLAG--LATLDLSFNNFSGDLPNSFISLSN------ISSLYL 208
++ S N + L G L+ L+ N+ + + N + L +
Sbjct: 152 SIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211
Query: 209 QNNQVTG-----SLNVFSGLPLTTLNVANN 233
N T N S +L +A++
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHH 241
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 19/87 (21%), Positives = 30/87 (34%), Gaps = 7/87 (8%)
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+LTQ + L L LSFN +SF L + L L +
Sbjct: 4 FDGRIAFYRFCNLTQ----VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQY 59
Query: 213 VTGSL--NVFSGLP-LTTLNVANNHFS 236
++ F LP L L++ ++
Sbjct: 60 TPLTIDKEAFRNLPNLRILDLGSSKIY 86
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 43/222 (19%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVS-----------NMSRL 465
IG G+ G VY+A + +G +A+K + + + +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-----RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 466 RHPNIVTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
HPN+V L A + ++ LV+E+V D+ + D + ++ +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 521 -TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS-----T 574
R L++LH C +VHR+ K NIL+ L+D GLA R S T
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA-------RIYSYQMALT 177
Query: 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+V Y APE L Y D++S G + E+ RKPL
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 3e-18
Identities = 37/210 (17%), Positives = 73/210 (34%), Gaps = 6/210 (2%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
+S + L+ +++ + D S NSI+ + + LT L L NN + + + +
Sbjct: 197 ANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNY 253
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L +++S N L + + F + L L +S N L + + L L +N
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 213 VTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ L L + +N +++ N +D + A P
Sbjct: 313 LLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARP 372
Query: 272 SGRSHNNRSHRQGSHSPSGSQSSSSDKELP 301
+ ++ + G SDK
Sbjct: 373 AV-DDADQHCKIDYQLEHGLCCKESDKPYL 401
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 2e-16
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA----------- 150
SL+ LS N + + L P+L N++ N S L IA
Sbjct: 166 TFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSI 223
Query: 151 ------SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
V L+ L + N+LT + N GL +DLS+N + + F+ + +
Sbjct: 224 NVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281
Query: 205 SLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
LY+ NN++ +P L L++++NH + R
Sbjct: 282 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 320
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 7e-16
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 7/139 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
LL + +L+ I I + + L + N P+ ++ L+ L
Sbjct: 70 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ RN L+ IF N L TL +S NN ++F + +++ +L L +N++T L
Sbjct: 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL 188
Query: 218 NVFSGLPLTTLNVANNHFS 236
++ L NV+ N S
Sbjct: 189 SLIPS--LFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 8e-15
Identities = 30/181 (16%), Positives = 61/181 (33%), Gaps = 6/181 (3%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGN 144
+ I G+ L + + +++ +P L + LNL
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
Y+ A ++ L + N++ +F N+ L L L N+ S F + ++
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 205 SLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAP 262
+L + NN + + F L L +++N + + S+ N P
Sbjct: 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIP 210
Query: 263 P 263
Sbjct: 211 I 211
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 31/139 (22%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI-ASMVSLSYL 158
+ +++K + N+I +P + P LT L L N+ S +LP I + L+ L
Sbjct: 95 FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 152
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN 218
++S N+L + D F L L LS N + + S + ++ + N L+
Sbjct: 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNL----LS 205
Query: 219 VFSGLP-LTTLNVANNHFS 236
+ + L+ ++N +
Sbjct: 206 TLAIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 22/130 (16%), Positives = 50/130 (38%), Gaps = 6/130 (4%)
Query: 113 DLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
D+ + + + N + ++ + S + LN++ + +
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LT 226
F + L + FN P+ F ++ ++ L L+ N ++ +F P LT
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 227 TLNVANNHFS 236
TL+++NN+
Sbjct: 151 TLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 28/197 (14%), Positives = 58/197 (29%), Gaps = 18/197 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L + +S N + + P L L+L+ N+ ++ + L L
Sbjct: 273 PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+ NS+ ++ L L LS N++ + + N++ + + +
Sbjct: 331 LDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA----DQHC 381
Query: 220 FSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNR 279
L ++ R L I S +A + S +
Sbjct: 382 KIDYQLEHGLCCKESDKPYLDRLLQYIAL-----TSVVEKVQRAQGRCSATDTINSVQSL 436
Query: 280 SHRQGSHSPSGSQSSSS 296
SH Q +
Sbjct: 437 SHYITQQGGVPLQGNEQ 453
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 14/110 (12%), Positives = 27/110 (24%), Gaps = 8/110 (7%)
Query: 135 NLASNNFSGNLPYSIASMVSLSYLNVSRN-SLTQSIGDIFG-----NLAGLATLDLSFNN 188
N P +L Y V + + D++ L + +
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
S + L L + Q+ F+ + L + N
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 14/165 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLP-YSIASMVSLSYL 158
L L++ L N I +IP P+L L+L + + + +L YL
Sbjct: 132 FVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
N++ +L I + L L LDLS N+ S P SF L ++ L++ +Q+
Sbjct: 191 NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
N F L L +N+A+N+ + +P + L + N ++
Sbjct: 249 NAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 34/145 (23%), Positives = 50/145 (34%), Gaps = 8/145 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L L LS N I TI NL +L L N + + + L L
Sbjct: 84 FKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLN 218
+ N + F + L LDL + +F LSN+ L L + +
Sbjct: 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201
Query: 219 VFSGLP-LTTLNVANNHFSGWIPRE 242
+ L L L+++ NH S I
Sbjct: 202 NLTPLIKLDELDLSGNHLS-AIRPG 225
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 9/139 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
Y + + SLR+ DL I + L NL LNLA N +P ++ ++ L
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLS-NLRYLNLAMCNLR-EIP-NLTPLIKLD 210
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L++S N L+ F L L L + + N+F +L ++ + L +N +T
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270
Query: 216 SLNVFSGLP-LTTLNVANN 233
++F+ L L +++ +N
Sbjct: 271 PHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 3/128 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K ++ +P + N LNL N S + L L +SRN +
Sbjct: 44 QFSKVICVRKNL-REVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT 102
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
F LA L TL+L N + +F+ LS + L+L+NN + F+ +P L
Sbjct: 103 IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSL 162
Query: 226 TTLNVANN 233
L++
Sbjct: 163 RRLDLGEL 170
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 34/149 (22%), Positives = 55/149 (36%), Gaps = 10/149 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L +L +L N + TIP L L L +N Y+ + SL L+
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166
Query: 160 VSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ L+ F L+ L L+L+ N ++P + L + L L N ++
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP 224
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRELIS 245
F GL L L + + I R
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQ-VIERNAFD 252
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 23/92 (25%), Positives = 42/92 (45%), Gaps = 2/92 (2%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L+ L+ L + DLSGN + P +L L + + + ++ SL +N+
Sbjct: 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192
+ N+LT D+F L L + L N ++ +
Sbjct: 263 AHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 56/214 (26%), Positives = 82/214 (38%), Gaps = 34/214 (15%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G+ G +++AVK I+ A ++N + N LRHPNIV
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKE 83
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------ALEY 527
++ EY G L++ + R + AR + Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHL--SDCGLAALTPNTERQVSTQMVGAFGYSAP 585
H + + HR+ K N LLD P L D G + + + ST VG Y AP
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAP 186
Query: 586 EFALSGI-YT-VKSDVYSFGVVMLELLTGRKPLD 617
E L Y +DV+S GV + +L G P +
Sbjct: 187 E-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 14/166 (8%)
Query: 103 LSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ L L + DLS N S+ + L L +L+L L + + +L Y
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L + N+L D F +L L L L N S +F L ++ L L N+V
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
+ F L L TL + N+ S +P E L +++ + N +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 30/128 (23%), Positives = 48/128 (37%), Gaps = 6/128 (4%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
+ +P +P + L N S S + +L+ L + N L +
Sbjct: 17 SCPQQGL-QAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 173 FGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTL 228
F LA L LDLS N + +F L + +L+L + L +F GL L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 229 NVANNHFS 236
+ +N
Sbjct: 135 YLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 32/141 (22%), Positives = 54/141 (38%), Gaps = 9/141 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+L L N + I L L L+L+ N ++ + + L
Sbjct: 52 FRACRNLTILWLHSNVLA-RIDAAAFTGL-ALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L++ R L + +F LA L L L N ++F L N++ L+L N+++
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169
Query: 217 LNVFSGLP-LTTLNVANNHFS 236
F GL L L + N +
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 30/113 (26%), Positives = 44/113 (38%), Gaps = 4/113 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L +L+ L N++ +P NLT L L N S + + SL L
Sbjct: 124 LFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ +N + F +L L TL L NN S + L + L L +N
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNF----LEAVSNMSRLRHPNIVT 472
+G G+ VY+ G +A+K++ L E+ + +S M L+H NIV
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWN----ARVRVALG-TARALEY 527
L + LV+E++ +D+ + D + T V+ + L +
Sbjct: 68 LYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS------TQMVGAFG 581
HE ++HR+ K N+L++ L D GLA R + V
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-------RAFGIPVNTFSSEVVTLW 173
Query: 582 YSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y AP+ + S Y+ D++S G ++ E++T KPL
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPL 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 408 ATNSFSQEF---------LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE 457
+T+SFS F ++GEG+ RV + AVK I+ F E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFRE 60
Query: 458 AVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR 516
V + + + H N++ L + E + LV+E + G++ +H ++
Sbjct: 61 -VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASV 115
Query: 517 VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH---LSDCGLA------ALTPN 567
V A AL++LH + HR+ K NIL + + D L
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 568 TERQVSTQMVGAFGYSAPE-----FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G+ Y APE + IY + D++S GV++ LL+G P
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 36/182 (19%), Positives = 59/182 (32%), Gaps = 9/182 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSG-NLPYSIASMVSLSYLN 159
S + L+ N I + L+L N N AS +L +LN
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
+ N + G + A L TLDLS N + + F S + ++ + L+NN++
Sbjct: 176 LQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA 232
Query: 220 FSGLP-LTTLNVANNHFSGWIPRELISIRTFIY--DGNSFDNGPAPPPPPSTAPPSGRSH 276
L ++ N F R+ S + + T P G
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 277 NN 278
Sbjct: 293 AY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 31/143 (21%), Positives = 59/143 (41%), Gaps = 10/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L +LR DL+ N + + + P++ +L+ A+NN S + S + ++
Sbjct: 76 LESLSTLRTLDLNNNYVQ-ELL--VGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N +T G + + LDL N + S + L LQ N + +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
Query: 222 GLP-LTTLNVANNHFSGWIPREL 243
L TL++++N + ++ E
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 31/147 (21%), Positives = 58/147 (39%), Gaps = 13/147 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ + + ++ +S+ + N+ L+L+ N S +A L LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
+S N L D +L+ L TLDL+ N +L +I +L+ NN ++ S +
Sbjct: 65 LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISRVSCS 117
Query: 219 VFSGLPLTTLNVANNHFSGWIPRELIS 245
G + +ANN + +
Sbjct: 118 RGQG--KKNIYLANNKITM-LRDLDEG 141
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 31/152 (20%), Positives = 58/152 (38%), Gaps = 14/152 (9%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146
++ L + L ++++ DLSGN + L L LNL+SN
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL 74
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+ S+ +L L+++ N + + + TL + NN S + S ++
Sbjct: 75 -DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVSCS--RGQGKKNI 125
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFS 236
YL NN++T + L++ N
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 26/127 (20%), Positives = 49/127 (38%), Gaps = 4/127 (3%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L + +L +L N I+D + L +L+L+SN + + S +++++
Sbjct: 162 AELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD-LPNSFISLSNISSLYLQNNQ-VTGSL 217
+ N L I L DL N F L + F + ++ Q + +TG
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 218 NVFSGLP 224
+P
Sbjct: 280 EEECTVP 286
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 29/120 (24%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IH+ Q + ++ L S ++ L++S N L+Q
Sbjct: 1 AIHEIK--QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236
L L+LS N + SLS + +L L NN + P + TL+ ANN+ S
Sbjct: 59 KLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS 112
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 48/226 (21%), Positives = 86/226 (38%), Gaps = 29/226 (12%)
Query: 404 SLQTATNSFSQEF-----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLE 457
+ + + ++ ++G G G+V G+ A+K + ++ + QE
Sbjct: 18 GPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE------ 71
Query: 458 AVSNMSRL-RHPNIVTLAGYC--AEHGQR--LLVYEYVGNGNLHDMLHFADDSSKNLTWN 512
V + + P+IV + HG+R L++ E + G L + + T
Sbjct: 72 -VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTER 128
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAALTPNTE 569
+ A+++LH ++ HR+ K N+L + + L+D G A T
Sbjct: 129 EAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-- 183
Query: 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y APE Y D++S GV+M LL G P
Sbjct: 184 -NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 4/136 (2%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S +IP L + SL+L+ N + + + +L L + + + GD
Sbjct: 11 DGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F +L L LDLS N+ S + F LS++ L L N G ++F L L TL
Sbjct: 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 230 VANNHFSGWIPRELIS 245
+ N I R +
Sbjct: 130 IGNVETFSEIRRIDFA 145
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 13/166 (7%)
Query: 78 VACEGSAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTIPYQLP--PNLTSL 134
++C+ S V D + + S L +++ DLS N I L NL L
Sbjct: 2 LSCDASGVC--DGRSRSFT----SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVL 55
Query: 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DL 193
L S+ + + S+ SL +L++S N L+ FG L+ L L+L N + +
Sbjct: 56 ILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 194 PNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
+ F +L+N+ +L + N + + F+GL L L +
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 34/196 (17%), Positives = 66/196 (33%), Gaps = 13/196 (6%)
Query: 103 LSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L +L+ L + +I Y L +L L+L+ N+ S + SL YLN
Sbjct: 46 LRACANLQVLILKSSRINTIEGDAFYSL-GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104
Query: 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTG-S 216
+ N + +F NL L TL + ++ F L++++ L ++ +
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 217 LNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNGPAPPPPPSTAPP 271
+ + L + + + ++ L S+R + P P
Sbjct: 165 SQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 272 SGRSHNNRSHRQGSHS 287
+ R S
Sbjct: 224 PMKKLAFRGSVLTDES 239
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 14/141 (9%)
Query: 99 MGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLS 156
G +L L +L D+S N+ H +P P + LNL+S + I +L
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLE 434
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG- 215
L+VS N+L L L L +S N LP++ + + + + NQ+
Sbjct: 435 VLDVSNNNLD----SFSLFLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSV 488
Query: 216 SLNVFSGLP-LTTLNVANNHF 235
+F L L + + N +
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 38/165 (23%), Positives = 63/165 (38%), Gaps = 19/165 (11%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSY 157
SL+ LS N + NLTSL+++ N F +P S + +
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
LN+S + I L LD+S NN + + L + LY+ N++ +L
Sbjct: 415 LNLSSTGIRVVKTCIPQT---LEVLDVSNNNLD----SFSLFLPRLQELYISRNKLK-TL 466
Query: 218 NVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
S P L + ++ N +P L S++ N +D
Sbjct: 467 PDASLFPVLLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 25/139 (17%), Positives = 47/139 (33%), Gaps = 6/139 (4%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSL---NLASNNFSGNLPY-SIASMVSLSY 157
L SL+ +L GN L PNLT+L + + + A + SL+
Sbjct: 93 WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L + SL ++ + L L + + L LS++ L L++ +
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212
Query: 217 LNVFSGLP-LTTLNVANNH 234
+ + +
Sbjct: 213 FSPLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 23/138 (16%), Positives = 50/138 (36%), Gaps = 7/138 (5%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L L F+ S + + + + L++ +L + + + + V + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDL---PNSFISLSNISSLYLQNNQVT---GSLNV 219
+L L LDLS N + + ++ +L L N + + +
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 220 FSGLP-LTTLNVANNHFS 236
L LT+L+++ N F
Sbjct: 383 LLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 19/143 (13%), Positives = 44/143 (30%), Gaps = 7/143 (4%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L +L +L+ + I +L L + + + S+ S+ + +L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT---- 214
+ + + L+ + L+L N + + S + + +
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 215 GSLNVFSGLPLTTLNVANNHFSG 237
S N L L ++ F
Sbjct: 238 ESFNELLKLLRYILELSEVEFDD 260
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 27/199 (13%), Positives = 62/199 (31%), Gaps = 28/199 (14%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGN--- 144
+ + + + L S+R +L ++ LP + S + F G+
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 145 ---------LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT--------LDLSFN 187
L I + + + + + N L ++ L L +
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 188 NFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRE--- 242
DL + L + + ++N++V + L L L+++ N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 243 ---LISIRTFIYDGNSFDN 258
S++T + N +
Sbjct: 357 KGAWPSLQTLVLSQNHLRS 375
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 23/87 (26%), Positives = 35/87 (40%), Gaps = 4/87 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+L D+S N++ D+ LP L L ++ N LP + L + +SRN L
Sbjct: 430 PQTLEVLDVSNNNL-DSFSLFLP-RLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQL 485
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGD 192
IF L L + L N +
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 26/158 (16%), Positives = 49/158 (31%), Gaps = 8/158 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
+ L SL + ++ S+ + L ++ L L + + L + S+ YL +
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
+L + + + S SF L + L+ ++V F
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-----F 258
Query: 221 SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDN 258
L L N S + EL + T
Sbjct: 259 DDCTLNGLGDFNPSESDVVS-ELGKVETVTIRRLHIPQ 295
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 4/78 (5%)
Query: 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY 147
+D+S L L L++ +S N + L P L + ++ N
Sbjct: 436 LDVSNNNLD----SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDG 491
Query: 148 SIASMVSLSYLNVSRNSL 165
+ SL + + N
Sbjct: 492 IFDRLTSLQKIWLHTNPW 509
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 43/221 (19%)
Query: 418 IGEGSLGRVYRA--EFANGKIMAVKKI--DNAALSLQEEDNF----LEAVS---NMSRLR 466
IGEG+ G+V++A G+ +A+K++ E+ + V+ ++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMPLSTIREVAVLRHLETFE 72
Query: 467 HPNIVTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG- 520
HPN+V L + +L LV+E+V D+ + D + ++ +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS-----TQ 575
R L++LH VVHR+ K NIL+ L+D GLA R S T
Sbjct: 129 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA-------RIYSFQMALTS 178
Query: 576 MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+V Y APE L Y D++S G + E+ RKPL
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 71/289 (24%), Positives = 110/289 (38%), Gaps = 50/289 (17%)
Query: 350 NMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTAT 409
+ E E+R + A+ + ++ E +SGS T
Sbjct: 87 TFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVT 146
Query: 410 -NSFSQEFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEA 458
N F E+L +G+G+ G+V + A G+ A+K + + E+ L+
Sbjct: 147 MNEF--EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 459 VSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTW 511
RHP + L Y + RL V EY G L H F++D
Sbjct: 205 S------RHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED------- 248
Query: 512 NARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
R R + AL+YLH +VV+R+ K N++LD + + ++D GL
Sbjct: 249 --RARFYGAEIVS----ALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300
Query: 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ T G Y APE Y D + GVVM E++ GR P
Sbjct: 301 KDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 27/138 (19%), Positives = 55/138 (39%), Gaps = 8/138 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+ L+ L + LS N + +P ++P L L + N + + + + +
Sbjct: 96 FAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154
Query: 163 NSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L S F + L+ + ++ N + +P +++ L+L N++T
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKITKVDAAS 211
Query: 220 FSGLP-LTTLNVANNHFS 236
GL L L ++ N S
Sbjct: 212 LKGLNNLAKLGLSFNSIS 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 32/165 (19%), Positives = 56/165 (33%), Gaps = 36/165 (21%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNF-------------------SG 143
+ L ++ +I TIP LPP+LT L+L N S
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 144 NLPYSI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N ++ A+ L L+++ N L + + + + L NN S N F
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 199 ------SLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANN 233
++ S + L +N V + F + + + N
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 29/144 (20%), Positives = 59/144 (40%), Gaps = 14/144 (9%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSIASMV 153
+ + L + +L N + + + L+ + +A N + +P +
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSS---GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PP 192
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213
SL+ L++ N +T+ L LA L LSFN+ S S + ++ L+L NN++
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 214 TGSLNVFSGLP-LTTLNVANNHFS 236
+ + + + NN+ S
Sbjct: 253 VKVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 32/161 (19%), Positives = 59/161 (36%), Gaps = 27/161 (16%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
LR S + +P LPP+ L+L +N + ++ +L L + N +++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 168 SIGDIFGNLAGLATLDLSFNN--------FSG----DL---------PNSFISLSNISSL 206
F L L L LS N + + F L+ + +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 150
Query: 207 YLQNNQVTGSL---NVFSGLP-LTTLNVANNHFSGWIPREL 243
L N + S F G+ L+ + +A+ + + IP+ L
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL 190
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 33/142 (23%), Positives = 58/142 (40%), Gaps = 8/142 (5%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
+ L +L D+S + +L L +A N+F N I + +L++
Sbjct: 121 VFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
L++S+ L Q F +L+ L L++S NNF + L+++ L N +
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 239
Query: 217 LNVFSGLP--LTTLNVANNHFS 236
P L LN+ N F+
Sbjct: 240 KQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 30/134 (22%), Positives = 56/134 (41%), Gaps = 7/134 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT- 166
S + + + ++P +P + T L L SN + L+ L++S N L+
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 167 QSIGD-IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGL 223
+ L LDLSFN + ++F+ L + L Q++ + +VF L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 224 P-LTTLNVANNHFS 236
L L++++ H
Sbjct: 126 RNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 31/142 (21%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 103 LSDLLSLRKFDLSGNSIH--DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L K LS N + +L L+L+ N + + + L +L
Sbjct: 48 FDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106
Query: 159 NVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++L Q S +F +L L LD+S + F LS++ L + N +
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166
Query: 218 --NVFSGLP-LTTLNVANNHFS 236
++F+ L LT L+++
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 32/128 (25%), Positives = 49/128 (38%), Gaps = 4/128 (3%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNL 145
DIS + + L SL ++GNS + + NLT L+L+
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 191
Query: 146 PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-SNIS 204
P + S+ SL LN+S N+ + L L LD S N+ S+++
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 251
Query: 205 SLYLQNNQ 212
L L N
Sbjct: 252 FLNLTQND 259
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 37/174 (21%), Positives = 63/174 (36%), Gaps = 27/174 (15%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLS 156
L L+ + + +LP L +L LA N LP SIAS+ L
Sbjct: 100 AFRLSHLQHMTIDAAGLM-----ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 157 YLNVSR-NSLTQ---SIG-----DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY 207
L++ LT+ + L L +L L + LP S +L N+ SL
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 208 LQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE---LISIRTF-IYDGNSF 256
++N+ ++ LP L L++ P ++ + D ++
Sbjct: 213 IRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 32/160 (20%), Positives = 57/160 (35%), Gaps = 27/160 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP-----YQLPP------NLTSLNLASNNFSGNLPYSIAS 151
++ L LR+ + +P NL SL L +LP SIA+
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204
Query: 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ +L L + + L+ ++G +L L LDL + P F + + L L++
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 212 QVTGSLNVFSGLP--------LTTLNVANNHFSGWIPREL 243
+ LP L L++ +P +
Sbjct: 264 ------SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 11/116 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLS 156
+++L +L+ + + + L P L L+L N P L
Sbjct: 202 IANLQNLKSLKIRNSPLS-----ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L + S ++ L L LDL LP+ L + + +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 26/155 (16%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+L + Q P +L + + + LP ++ L L
Sbjct: 80 QPGRVALELRSVPLP-----QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLT 133
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---------ISLSNISSLYLQN 210
++RN L ++ +L L L + +LP L N+ SL L+
Sbjct: 134 LARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 211 NQVTGSL-NVFSGLP-LTTLNVANNHFSGWIPREL 243
+ SL + L L +L + N+ S + +
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 16/104 (15%), Positives = 30/104 (28%), Gaps = 7/104 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPY---QLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L L + DL G + P L L L + LP I + L L+
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFN---NFSGDLPNSFISL 200
+ + + L + + + P + +
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 15/137 (10%), Positives = 33/137 (24%), Gaps = 26/137 (18%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI----------------- 172
+L + ++ + +R +
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATA 72
Query: 173 ----FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-LT 226
G L+L P+ LS++ + + + L + L
Sbjct: 73 DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130
Query: 227 TLNVANNHFSGWIPREL 243
TL +A N +P +
Sbjct: 131 TLTLARNPLRA-LPASI 146
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKI-DNAALSLQEEDNFLEAVSNMSRLR 466
+ F E + G+G+ G V + G +A+KK+ + +E L+ + +++ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77
Query: 467 HPNIVTLAGYCAEHGQR-------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
HPNIV L Y G+R +V EYV + LH ++V L
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFL 135
Query: 520 -GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC--GLA----ALTPNTERQV 572
R++ LH + +V HR+ K N+L+++ + L C G A PN
Sbjct: 136 FQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 573 STQMVGAFGYSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
S Y APE + YT D++S G + E++ G +P+
Sbjct: 194 SRY------YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 39/179 (21%), Positives = 64/179 (35%), Gaps = 21/179 (11%)
Query: 448 SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH---FADD 504
S D + M N V + + + NL D ++ +D
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 505 SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-- 562
+ + + A A+E+LH ++HR+ K +NI + + D GL
Sbjct: 161 REHGVCL----HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 563 ---------ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG 612
LTP T VG Y +PE Y+ K D++S G+++ ELL
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 21/102 (20%), Positives = 34/102 (33%), Gaps = 6/102 (5%)
Query: 412 FSQEF----LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
+ +F +G G G V+ A+ + A+K+I L E E V +++L
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLE 62
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN 508
HP IV E E + + S
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSP 104
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 32/214 (14%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + K+ A+K + + + F E M+ P +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
Y + + L +V EY+ G+L + + V AR AL
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+ +H + +HR+ K N+LLD + L+D G VG Y +P
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 586 EFALS----GIYTVKSDVYSFGVVMLELLTGRKP 615
E S G Y + D +S GV + E+L G P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 56/276 (20%), Positives = 95/276 (34%), Gaps = 30/276 (10%)
Query: 355 MHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQ 414
+ + +S PP + + + LQ N+
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 415 EF-----LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RH 467
++ ++G G G+V + + A+K + + + +E V R +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-------VELHWRASQC 114
Query: 468 PNIVTLAGYCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
P+IV + L+V E + G L D + T +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGE 172
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPH----LSDCGLAALTPNTERQVSTQMVGA 579
A++YLH + ++ HR+ K N+L + P+ L+D G A T T T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNSLTTPCYT 226
Query: 580 FGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y APE Y D++S GV+M LL G P
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 10/143 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L +LR DL+ N + + P++ +L+ A+NN S + S + ++
Sbjct: 76 LESLSTLRTLDLNNNYVQ-ELLV--GPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N +T G + + LDL N + S + L LQ N + +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
Query: 222 GLP-LTTLNVANNHFSGWIPREL 243
L TL++++N + ++ E
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 33/161 (20%), Positives = 60/161 (37%), Gaps = 14/161 (8%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146
++ L + L ++++ DLSGN + L L LNL+SN
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL 74
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
+ S+ +L L+++ N + + + TL + NN S + N +
Sbjct: 75 -DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRVSCSRGQGKKN---I 125
Query: 207 YLQNNQVTG-SLNVFSGLP-LTTLNVANNHFSGWIPRELIS 245
YL NN++T + L++ N EL +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 30/147 (20%), Positives = 57/147 (38%), Gaps = 13/147 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ + + ++ +S+ + N+ L+L+ N S +A L LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLN 218
+S N L D +L+ L TLDL+ N + +I +L+ NN ++ S +
Sbjct: 65 LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCS 117
Query: 219 VFSGLPLTTLNVANNHFSGWIPRELIS 245
G + +ANN + +
Sbjct: 118 RGQG--KKNIYLANNKITM-LRDLDEG 141
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 30/154 (19%), Positives = 51/154 (33%), Gaps = 8/154 (5%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSG 143
+I ++ ++ ++ DL N I +L L LNL N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNI 203
++ L L++S N L +G F + AG+ + L N + + N+
Sbjct: 183 DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 204 SSLYLQNNQ-VTGSLNVFSGLPLTTLNVANNHFS 236
L+ N G+L F VA
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 25/138 (18%), Positives = 47/138 (34%), Gaps = 3/138 (2%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
L + +L +L N I+D + L +L+L+SN + + S +++++
Sbjct: 162 AELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD-LPNSFISLSNISSLYLQNNQVTGSLN 218
+ N L I L DL N F L + F + ++ Q + N
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 219 VFSGLPLTTLNVANNHFS 236
T +
Sbjct: 280 EEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 9/120 (7%)
Query: 118 SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
+IH+ Q + ++ L S ++ L++S N L+Q
Sbjct: 1 AIHEIK--QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS 236
L L+LS N SLS + +L L NN + P + TL+ ANN+ S
Sbjct: 59 KLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 13/156 (8%), Positives = 35/156 (22%), Gaps = 9/156 (5%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN-------NF 141
++ + G + + +P L +L + +
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCC-EDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 142 SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
+ L + ++ + I + TL+ + N + +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
Query: 202 NISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNHFS 236
+ Q + PL L +
Sbjct: 385 ELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 55/215 (25%), Positives = 83/215 (38%), Gaps = 31/215 (14%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ G V + K+ A+K ++ L E F E + I TL
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR--------AL 525
Y + L LV +Y G+L + + R+ AR A+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDL--LTLLS---------KFEDRLPEEMARFYLAEMVIAI 188
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
+ +H++ VHR+ K NIL+D + L+D G S+ VG Y +P
Sbjct: 189 DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 586 E-----FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E G Y + D +S GV M E+L G P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 73/270 (27%), Positives = 106/270 (39%), Gaps = 50/270 (18%)
Query: 368 DLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFL--IGEGSLGR 425
D P E L + SG +++ K + AS F + L IG GS +
Sbjct: 11 DYDIPTTENLYFQGAMGSG-IEEEKEAMNTRESGKASSSLGLQDF--DLLRVIGRGSYAK 67
Query: 426 VYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
V +I A++ + D +Q E + E SN HP +V L C
Sbjct: 68 VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPFLVGLH-SC 121
Query: 478 AEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR-----VALGTARAL 525
+ RL V EYV G+L M H ++ R ++L AL
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE---------HARFYSAEISL----AL 166
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAP 585
YLHE +++R+ K N+LLD E + L+D G+ ST G Y AP
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAP 222
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
E Y D ++ GV+M E++ GR P
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 35/163 (21%), Positives = 63/163 (38%), Gaps = 15/163 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + L+ D+ NS+ +P LPP+L + +N LP + ++ L+ +
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLP-DLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADN 204
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
NSL + L ++ N +L ++++Y NN + +
Sbjct: 205 NSLK----KLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK---TLPDL 255
Query: 223 LP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPP 264
P L LNV +N+ + +P S+ N F PP
Sbjct: 256 PPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 35/165 (21%), Positives = 67/165 (40%), Gaps = 25/165 (15%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
+ +L+ + ++P +LPP+L SL + N+ + LP S+ SL N + +L
Sbjct: 70 DRQAHELELNNLGLS-SLP-ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 166 TQ-------------SIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+ + + N + L +D+ N+ LP+ ++ + N
Sbjct: 127 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPD---LPPSLEFIAAGN 182
Query: 211 NQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
NQ+ L LP LT + NN +P +S+ + + N
Sbjct: 183 NQLE-ELPELQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGNN 225
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 33/170 (19%), Positives = 56/170 (32%), Gaps = 33/170 (19%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L +L L N + T+P LPP+L +LN+ N + +LP S+ L
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLP-DLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIF 289
Query: 163 NSLTQSIG-------------DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQ 209
+ L++ + L L++S N +LP + L
Sbjct: 290 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIAS 345
Query: 210 NNQVTGSLNVFSGLP-----LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
N + +P L L+V N P S+ + +
Sbjct: 346 FNH-------LAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSH 387
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 37/153 (24%), Positives = 55/153 (35%), Gaps = 19/153 (12%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
LSL N + + Q P LT++ +N LP SL LNV N L
Sbjct: 214 PLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYL 269
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP- 224
T + ++ +L L + F+ S N+ L +N+ + LP
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSE-------LPPNLYYLNASSNE----IRSLCDLPP 317
Query: 225 -LTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
L LNV+NN +P + I N
Sbjct: 318 SLEELNVSNNKLIE-LPALPPRLERLIASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 26/152 (17%), Positives = 52/152 (34%), Gaps = 27/152 (17%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L SL + ++S N + +P LPP L L + N+ + +P +L L+V
Sbjct: 312 LCDLPPSLEELNVSNNKL-IELP-ALPPRLERLIASFNHLA-EVPELPQ---NLKQLHVE 365
Query: 162 RNSLTQ---------------SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
N L + + ++ L L + N + P+ ++ L
Sbjct: 366 YNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD---IPESVEDL 421
Query: 207 YLQNNQVTGSLNV-FSGLPLTTLNV-ANNHFS 236
+ + +V +V ++H
Sbjct: 422 RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 27/183 (14%), Positives = 53/183 (28%), Gaps = 39/183 (21%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMV---------- 153
L++ +++ +P + + T A + + N P
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 154 ---SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
L ++ L+ + L +L S N+ + +LP SL ++
Sbjct: 69 LDRQAHELELNNLGLS----SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 211 NQVTG----------SLNVFSGLP-------LTTLNVANNHFSGWIPRELISIRTFIYDG 253
++ S N LP L ++V NN +P S+
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGN 182
Query: 254 NSF 256
N
Sbjct: 183 NQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 19/131 (14%), Positives = 43/131 (32%), Gaps = 13/131 (9%)
Query: 145 LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS 204
+ S L ++LT + N+ +++ + + P ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 205 SLYLQNNQVTG------SLNVFSGLP-----LTTLNVANNHFSGWIPRELISIRTFIYDG 253
L++ + S LP L +L + N + +P S+++ + D
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTE-LPELPQSLKSLLVDN 120
Query: 254 NSFDNGPAPPP 264
N+ PP
Sbjct: 121 NNLKALSDLPP 131
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 64/223 (28%), Positives = 91/223 (40%), Gaps = 47/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
+ L IG GS +V +I A+K + D +Q E + E SN
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--- 68
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP +V L C + RL V EYV G+L M H ++ R
Sbjct: 69 --HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE---------HARF 114
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
++L AL YLHE +++R+ K N+LLD E + L+D G+
Sbjct: 115 YSAEISL----ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
ST G Y APE Y D ++ GV+M E++ GR P
Sbjct: 168 ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 60/261 (22%), Positives = 100/261 (38%), Gaps = 70/261 (26%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRA-EFANGKIMAVKKI-DNAALSLQEEDNFLEAVSNM 462
L+T++ +S +G GS G V + +GK A+KK+ + +E + M
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE-------LDIM 54
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-------------------------------------- 484
L H NI+ L Y G
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLHEVCLPSVVHRNFKS 543
++ EYV + LH +L S +++ + + + RA+ ++H + + HR+ K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKP 169
Query: 544 ANILLD---DELNPHLSDCGLA----ALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTV 595
N+L++ + L L D G A P+ + ++ Y APE L YT
Sbjct: 170 QNLLVNSKDNTLK--LCDFGSAKKLIPSEPSVA-YICSRF-----YRAPELMLGATEYTP 221
Query: 596 KSDVYSFGVVMLELLTGRKPL 616
D++S G V EL+ G KPL
Sbjct: 222 SIDLWSIGCVFGELILG-KPL 241
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 6e-16
Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++L S+ + + + I Q PN+T L L N + ++ + ++ +L +L +
Sbjct: 39 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDE 96
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N + D+ +L L +L L N S D+ + L + SLYL NN++T + V
Sbjct: 97 NKIK----DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVL 149
Query: 221 SGLP-LTTLNVANN 233
S L L TL++ +N
Sbjct: 150 SRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 31/134 (23%), Positives = 57/134 (42%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
K +L S+ D + ++ + +++ ++ I + +++ L ++
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N LT DI NL L L L N DL + L + SL L++N ++ +N
Sbjct: 75 NKLT----DIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 127
Query: 221 SGLP-LTTLNVANN 233
LP L +L + NN
Sbjct: 128 VHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 27/156 (17%), Positives = 48/156 (30%), Gaps = 8/156 (5%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L L L N I D L +L+L N S ++ +A + L L +S+
Sbjct: 127 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 184
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N ++ D+ L L L+L N +L +++ + + +
Sbjct: 185 NHIS----DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
Query: 221 SGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
NV + I +
Sbjct: 241 DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 23/129 (17%), Positives = 49/129 (37%), Gaps = 8/129 (6%)
Query: 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168
+ + I P NL + + + + S+ + + + + S
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-S 57
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTT 227
+ I L + L L+ N + D+ +L N+ L+L N++ L+ L L +
Sbjct: 58 VQGI-QYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSSLKDLKKLKS 113
Query: 228 LNVANNHFS 236
L++ +N S
Sbjct: 114 LSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 34/196 (17%), Positives = 63/196 (32%), Gaps = 3/196 (1%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
LS L L L N I D +P L +L L+ N+ S +L ++A + +L L +
Sbjct: 149 LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 206
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ NL T+ + + S ++ + T ++ F
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS-FIF 265
Query: 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHR 282
T+ A F G + + L + T YD + P + +
Sbjct: 266 YQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFK 325
Query: 283 QGSHSPSGSQSSSSDK 298
+G + +
Sbjct: 326 GWYTEKNGGHEWNFNT 341
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 6/131 (4%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S + + ++ +P LP + T L+L+ N ++ L+ LN+ R LT+
Sbjct: 11 SHLEVNCDKRNL-TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-L 225
+ G L L TLDLS N LP +L ++ L + N++T L GL L
Sbjct: 70 L--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126
Query: 226 TTLNVANNHFS 236
L + N
Sbjct: 127 QELYLKGNELK 137
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 34/149 (22%), Positives = 53/149 (35%), Gaps = 15/149 (10%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNV 160
L L DLS N + ++P P LT L+++ N + +LP + L L +
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L + L L L+ NN + L N+ +L LQ N +
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGF 191
Query: 220 FSGLPLTTLNVANN---------HFSGWI 239
F L + N +F W+
Sbjct: 192 FGSHLLPFAFLHGNPWLCNCEILYFRRWL 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 22/207 (10%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
IG G+ G V A + + +A+KK+ + + M + H NI+ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
E Q + +V E + NL ++ L + R+ L +++LH
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELD-HERMSYLLYQMLCGIKHLH 144
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K +NI++ + + D GLA + + T V Y APE L
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 199
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y D++S G +M E++ G L
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 34/132 (25%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L S++ DL+ I D P NL L L N + N+ +A + +L YL++
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGN 160
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
++ NL+ L TL N S D+ SL N+ ++L+NNQ++ ++ +
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSPLAN 215
Query: 223 LP-LTTLNVANN 233
L + + N
Sbjct: 216 TSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 34/133 (25%), Positives = 59/133 (44%), Gaps = 8/133 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + G + Q NL L L N + +L + ++ ++ L +S
Sbjct: 37 QADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSG 94
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N L ++ L + TLDL+ + D+ LSN+ LYL NQ+T +++ +G
Sbjct: 95 NPLK-NV-SAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT-NISPLAG 149
Query: 223 LP-LTTLNVANNH 234
L L L++ N
Sbjct: 150 LTNLQYLSIGNAQ 162
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 28/134 (20%), Positives = 55/134 (41%), Gaps = 12/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + K +++ DT+ +T+L+ + + + + +L L +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N +T D+ NL + L+LS N ++ L +I +L L + Q+T +
Sbjct: 73 NQIT----DLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT-DVTPL 125
Query: 221 SGLP-LTTLNVANN 233
+GL L L + N
Sbjct: 126 AGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 25/128 (19%), Positives = 53/128 (41%), Gaps = 8/128 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
+I+ P N + +N + + A + ++ L+ +T +I +
Sbjct: 4 TQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGV 59
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L L L+L N + DL +L+ I+ L L N + +++ +GL + TL++ +
Sbjct: 60 QYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTS 116
Query: 233 NHFSGWIP 240
+ P
Sbjct: 117 TQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 25/131 (19%), Positives = 51/131 (38%), Gaps = 15/131 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L+ + + D P LT+L N S ++ +AS+ +L +++
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKN 204
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ N + L + L+ ++N Y N V + SG
Sbjct: 205 NQISDVSP--LANTSNLFIVTLTNQT-----------ITNQPVFYNNNLVVPNVVKGPSG 251
Query: 223 LPLTTLNVANN 233
P+ +++N
Sbjct: 252 APIAPATISDN 262
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 12/121 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L +L + L N I D P NL + L + + N P + +L NV +
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTIT-NQPVFYNN--NLVVPNVVK 247
Query: 163 NSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
I + A+ +L++N S ++N+S + Q+ + FS
Sbjct: 248 GPSGAPIAPATISDNGTYASPNLTWNLTS--------FINNVSYTFNQSVTFKNTTVPFS 299
Query: 222 G 222
G
Sbjct: 300 G 300
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 29/136 (21%), Positives = 52/136 (38%), Gaps = 9/136 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
S L L+K +S N + IP LP +L L + N + + +++ + +
Sbjct: 98 FSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 163 NSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNV 219
N L S F L L L +S +G + ++ L+L +N++ L
Sbjct: 157 NPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQAIELED 212
Query: 220 FSGLP-LTTLNVANNH 234
L L + +N
Sbjct: 213 LLRYSKLYRLGLGHNQ 228
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 26/160 (16%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
LR S + +P ++ P+ T L+L +N+ S + L L + N +++
Sbjct: 34 HLRVVQCSDLGL-KAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 168 SIGDIFGNLAGLATLDLSFNN--------FSG----DL---------PNSFISLSNISSL 206
F L L L +S N+ S + F L N++ +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 207 YLQNNQVTGSL---NVFSGLPLTTLNVANNHFSGWIPREL 243
+ N + S F GL L L ++ +G IP++L
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 30/161 (18%), Positives = 49/161 (30%), Gaps = 36/161 (22%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNF-------------------SGNLPY 147
L L +S + IP LP L L+L N N
Sbjct: 172 LKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230
Query: 148 SI-----ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF----- 197
I + + +L L++ N L+ + +L L + L NN + N F
Sbjct: 231 MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF 289
Query: 198 -ISLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANN 233
+ + + + L NN V F + + N
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 24/143 (16%), Positives = 53/143 (37%), Gaps = 13/143 (9%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPP------NLTSLNLASNNFSGNLPYSIASMVS 154
+ S L ++ ++ GN + ++ P L L ++ + +P + +
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSG---FEPGAFDGLKLNYLRISEAKLT-GIPKDLPE--T 194
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214
L+ L++ N + + + L L L N S L + L+L NN+++
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
Query: 215 GSLNVFSGLP-LTTLNVANNHFS 236
L L + + N+ +
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 22/123 (17%), Positives = 44/123 (35%), Gaps = 13/123 (10%)
Query: 101 YLLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSY 157
L L + L N I + LP L L+L +N S +P + + L
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLP-TLRELHLDNNKLS-RVPAGLPDLKLLQV 268
Query: 158 LNVSRNSLTQSIGDIFGNLAG------LATLDLSFNNFSGDL--PNSFISLSNISSLYLQ 209
+ + N++T+ + F + + L N P +F +++ ++
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 210 NNQ 212
N +
Sbjct: 329 NYK 331
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 51/209 (24%), Positives = 81/209 (38%), Gaps = 17/209 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+IG G+ V + G++ A+K ++ L E F E + I L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 475 GYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
+ + L LV EY G+L + + + AR +A A++ +H +
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRL-- 181
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPE------- 586
VHR+ K NILLD + L+D G S VG Y +PE
Sbjct: 182 -GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+G Y + D ++ GV E+ G+ P
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 35/179 (19%), Positives = 65/179 (36%), Gaps = 22/179 (12%)
Query: 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTIPYQLPPNLTSLNLA 137
AC + +++ GL+ L L + + N++ ++P LPP L +L ++
Sbjct: 36 ACLNNGNAVLNVGESGLT----TLPDCLPAHITTLVIPDNNL-TSLP-ALPPELRTLEVS 89
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
N + +LP ++ LS + L GL L + N + LP
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPV-- 138
Query: 198 ISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
+ L + +NQ+ + S L L NN + +P ++ N
Sbjct: 139 -LPPGLQELSVSDNQLASLPALPSE--LCKLWAYNNQLTS-LPMLPSGLQELSVSDNQL 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 12/130 (9%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+ L K N + ++P LP L L + S N +LP + L L VS N
Sbjct: 198 TLPSELYKLWAYNNRLT-SLP-ALPSGLKELIV-SGNRLTSLPVLPSE---LKELMVSGN 251
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL 223
LT + +GL +L + N + LP S I LS+ +++ L+ N ++ + +
Sbjct: 252 RLTS----LPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR 305
Query: 224 PLTTLNVANN 233
+T+ +
Sbjct: 306 EITSAPGYSG 315
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 37/150 (24%), Positives = 57/150 (38%), Gaps = 23/150 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L K N + ++P LP L L+++ N + +LP + + L N
Sbjct: 156 LPALPSELCKLWAYNNQLT-SLP-MLPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNR 212
Query: 162 RNSLTQSIG-----DIFGN--------LAGLATLDLSFNNFSGDLPNSFISLSNISSLYL 208
SL + GN + L L +S N + LP S + SL +
Sbjct: 213 LTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPM---LPSGLLSLSV 268
Query: 209 QNNQVTGSL-NVFSGLP-LTTLNVANNHFS 236
NQ+T L L TT+N+ N S
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 28/123 (22%), Positives = 53/123 (43%), Gaps = 10/123 (8%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L++ +SGN + ++P LP L L ++ N + +LP + L L+V
Sbjct: 216 LPALPSGLKELIVSGNRLT-SLP-VLPSELKELMVSGNRLT-SLPMLPSG---LLSLSVY 269
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
RN LT + + +L+ T++L N S + + I+S + + +
Sbjct: 270 RNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQAL--REITSAPGYSGPIIRFDMAGA 325
Query: 222 GLP 224
P
Sbjct: 326 SAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 22/108 (20%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
L++ +SGN + ++P LP L SL++ N + LP S+ + S + +N+ N L++
Sbjct: 242 ELKELMVSGNRL-TSLP-MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298
Query: 168 SIGDIFGNLAGLATLD---LSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ + F+ P +L ++ +L +
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 49/300 (16%)
Query: 338 RSSAGSFPVSTNNMNTEMHEQRVKSVAAVTDLTPPPAEKLVIERVAKSGSLKKIKSPITA 397
++ + + E V + + + +K + I+
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 398 TSYTVASLQTATNSFSQEFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAAL 447
+ F FL +G+GS G+V +E ++ AVK + D+
Sbjct: 329 FDNNGNRDRMKLTDF--NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE 386
Query: 448 SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------ 500
E L + P + L C + RL V EYV G+L M H
Sbjct: 387 CTMVEKRVLALPG-----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGR 438
Query: 501 FADDSSKNLTWNARVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555
F + +A+ L +L +++R+ K N++LD E +
Sbjct: 439 FKEP---------HAVFYAAEIAI----GLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482
Query: 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
++D G+ T G Y APE Y D ++FGV++ E+L G+ P
Sbjct: 483 IADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 36/163 (22%), Positives = 56/163 (34%), Gaps = 17/163 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSI-------HDTIPYQLPPNLTSLNLASN 139
+ I+ + +L DLS N P + P L L L +
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP-TLQVLALRNA 211
Query: 140 NF---SGNLPYSIASMVSLSYLNVSRNSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPN 195
SG A+ V L L++S NSL + G + L +L+LSF
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271
Query: 196 SFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSG 237
+ +S L L N++ LP + L++ N F
Sbjct: 272 LP---AKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 37/192 (19%), Positives = 66/192 (34%), Gaps = 20/192 (10%)
Query: 82 GSAVVSIDISGLGLSGTMGYLLS----DLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLN 135
G + +++ + + +L L+ ++ + Q+ P L++L+
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 136 LASNNFSGNLPYSIA----SMVSLSYLNVSRNSLTQ---SIGDIFGNLAGLATLDLSFNN 188
L+ N G A +L L + + + L LDLS N+
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 189 FSGDLPN-SFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVANNHFSGW-IPRELI 244
S S ++SL L + V GLP L+ L+++ N P EL
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPAKLSVLDLSYNRLDRNPSPDELP 296
Query: 245 SIRTFIYDGNSF 256
+ GN F
Sbjct: 297 QVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 28/151 (18%), Positives = 49/151 (32%), Gaps = 17/151 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLP-----PNLTSLNLASNNFSGNLPYSIASMV--SL 155
+ LSL++ + I I + L L L + +G P + L
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 156 SYLNVSRNSLT---QSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+ LN+ S + ++ L GL L ++ + +S+L L +N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 212 QVTGSLNVFSGLP------LTTLNVANNHFS 236
G + S L L L + N
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 33/174 (18%), Positives = 60/174 (34%), Gaps = 19/174 (10%)
Query: 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL----PPNLTSLNLASNNFS 142
+ I L G + L + L++ L + T P L P+L LNL + +++
Sbjct: 77 AARIPSRILFGALRVL--GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 143 GNLPY----SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-- 196
+ L L++++ + L+TLDLS N G+
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 197 --FISLSNISSLYLQNNQVTGSLNVFSGL-----PLTTLNVANNHFSGWIPREL 243
+ + L L+N + V S L L L++++N
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
L +LS + +P LP L+ L+L+ N P S + + L++ N
Sbjct: 254 QLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
Query: 168 S 168
S
Sbjct: 311 S 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 22/134 (16%), Positives = 44/134 (32%), Gaps = 12/134 (8%)
Query: 130 NLTSLNLASNNFSGNLPYS-IASMVSLSYLNVSRNSLTQSIGDI---FGNLAGLATLDLS 185
+L L + + ++ I +SL L V + I ++GL L L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 186 FNNFSGDLPNSFISLS--NISSLYLQNNQVTGSLNVFSGLP------LTTLNVANNHFSG 237
+G P + + +++ L L+N + L L L++A H
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 238 WIPRELISIRTFIY 251
+ ++
Sbjct: 164 FSCEQVRVFPALST 177
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 48/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
++L +G+G+ G+V A G+ A+K + + E L+
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT----- 62
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
RHP + L Y + RL V EY G L H F ++ R R
Sbjct: 63 -RHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEE---------RARF 109
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ ALEYLH VV+R+ K N++LD + + ++D GL + +
Sbjct: 110 YGAEIVS----ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
T G Y APE Y D + GVVM E++ GR P
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 49/222 (22%), Positives = 78/222 (35%), Gaps = 41/222 (18%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSN---------MSRLRHP 468
I GS G V + G +A+K++ N + + ++ ++ HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 469 NIVTL-----AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTA 522
NI+ L + LV E + +L ++H + + ++ +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH----DQRIVISPQHIQYFMYHIL 144
Query: 523 RALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLAALTPNTERQVSTQ 575
L LHE VVHR+ NILL + LA T
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLA-------DNNDITICDFNLAREDTADAN--KTH 192
Query: 576 MVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
V Y APE + +T D++S G VM E+ RK L
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 39/167 (23%), Positives = 57/167 (34%), Gaps = 15/167 (8%)
Query: 104 SDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160
L L L+GN S+ L +L L N + + I + +L LNV
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 161 SRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN----ISSLYLQNNQVTG 215
+ N + + + F NL L LDLS N L SL L N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 216 -SLNVFSGLPLTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
F + L L + N +P L S++ N +D
Sbjct: 192 IQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 28/137 (20%), Positives = 47/137 (34%), Gaps = 17/137 (12%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
S + DLS N + L L L+L+ + S+ LS L
Sbjct: 29 STKNLDLSFNPLR-----HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSL 217
++ N + F L+ L L N + L + L + +N +
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 218 NVFSGLP-LTTLNVANN 233
FS L L L++++N
Sbjct: 143 EYFSNLTNLEHLDLSSN 159
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 33/117 (28%), Positives = 50/117 (42%), Gaps = 4/117 (3%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
IP LP + +L+L+ N YS S L L++SR + + +L+ L+TL
Sbjct: 22 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 81
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
L+ N +F LS++ L + SL L L LNVA+N
Sbjct: 82 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 104 SDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
L+ DLS +I D L +L++L L N +L + + SL L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLILTGNPIQ-SLALGAFSGLSSLQKLV 106
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNF-SGDLPNSFISLSNISSLYLQNNQVTGSL 217
+L S+ G+L L L+++ N S LP F +L+N+ L L +N++ S+
Sbjct: 107 AVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SI 164
Query: 218 --NVFSGLP-LTTLN 229
L + LN
Sbjct: 165 YCTDLRVLHQMPLLN 179
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 47/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
FL +G+GS G+V +E ++ AVK + D+ E L
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--- 79
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
P + L C + RL V EYV G+L M H F +
Sbjct: 80 --PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP---------HAVF 125
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+A+ L +L +++R+ K N++LD E + ++D G+
Sbjct: 126 YAAEIAI----GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
T G Y APE Y D ++FGV++ E+L G+ P
Sbjct: 179 KT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 415 EFL--IGEGSLGRVYRAEFANGK----IMAVKKIDNAALSLQEED--------NFLEAVS 460
E L +G+G G+V++ G I A+K + A + +D N LE V
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV- 78
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNA 513
+HP IV L Y + G +L L+ EY+ G L + F +D
Sbjct: 79 -----KHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMED--------- 121
Query: 514 RVR-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568
+++ AL +LH+ +++R+ K NI+L+ + + L+D GL + +
Sbjct: 122 TACFYLAEISM----ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174
Query: 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
T G Y APE + + D +S G +M ++LTG P
Sbjct: 175 GTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 60/223 (26%), Positives = 90/223 (40%), Gaps = 47/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
EF+ +G+GS G+V A G + AVK + D+ E L N
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--- 82
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP + L C + RL V E+V G+L M H F + R R
Sbjct: 83 --HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA---------RARF 128
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ AL +LH+ +++R+ K N+LLD E + L+D G+
Sbjct: 129 YAAEIIS----ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+T G Y APE +Y D ++ GV++ E+L G P
Sbjct: 182 AT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
+G+GS G+V+ AEF + A+K + D+ E L
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--- 76
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP + + + + L V EY+ G+L M H F R
Sbjct: 77 --HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLS---------RATF 122
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ L L++LH +V+R+ K NILLD + + ++D G+ + +
Sbjct: 123 YAAEIIL----GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+T G Y APE L Y D +SFGV++ E+L G+ P
Sbjct: 176 NT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++L S+ + + + I Q PN+T L L N + ++ +A++ +L +L +
Sbjct: 42 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDE 99
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N + +L L +L L N S D+ + L + SLYL NN++T + V S
Sbjct: 100 NKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVLSR 154
Query: 223 LP-LTTLNVANN 233
L L TL++ +N
Sbjct: 155 LTKLDTLSLEDN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 12/135 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
K +L S+ D + ++ + +++ ++ I + +++ L ++
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77
Query: 163 NSLTQSIGDIFG--NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N LT DI NL L L L N DL + L + SL L++N ++ +N
Sbjct: 78 NKLT----DIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 130
Query: 221 SGLP-LTTLNVANNH 234
LP L +L + NN
Sbjct: 131 VHLPQLESLYLGNNK 145
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 37/143 (25%), Positives = 57/143 (39%), Gaps = 7/143 (4%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L DL L+ L N I D P L SL L +N + ++ ++ + L L++
Sbjct: 108 LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLED 165
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N ++ I L L L LS N+ S DL L N+ L L + + + +
Sbjct: 166 NQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECL-NKPINHQ 220
Query: 223 LPLTTLNVANNHFSGWIPRELIS 245
L N N + E+IS
Sbjct: 221 SNLVVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 23/124 (18%), Positives = 46/124 (37%), Gaps = 8/124 (6%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I NL + + + + S+ + + + + S+ I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGI- 64
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
L + L L+ N + D+ +L N+ L+L N+V L+ L L +L++ +
Sbjct: 65 QYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEH 121
Query: 233 NHFS 236
N S
Sbjct: 122 NGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 31/142 (21%), Positives = 49/142 (34%), Gaps = 17/142 (11%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
LS L L L N I D +P L +L L+ N+ S +L ++A + +L L +
Sbjct: 152 LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLY-LQNNQVTGSLNVFS 221
+ NL T+ + S ++ IS + V L F+
Sbjct: 210 QECLNKPINHQSNLVVPNTVK--------NTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 261
Query: 222 GLP------LTTLNVANNHFSG 237
T+ A F G
Sbjct: 262 NEVSFIFYQPVTIGKAKARFHG 283
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 50/225 (22%)
Query: 415 EFL--IGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQE------EDNFLEAVSNM 462
E L +G+GS G+V+ + + ++ A+K + A L +++ E + L V
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV--- 83
Query: 463 SRLRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARV 515
HP IV L Y + +L L+ +++ G+L F ++ V
Sbjct: 84 ---NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEE---------DV 128
Query: 516 R-----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+ +AL AL++LH + +++R+ K NILLD+E + L+D GL+ + + E+
Sbjct: 129 KFYLAELAL----ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ + G Y APE +T +D +SFGV+M E+LTG P
Sbjct: 182 KAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 34/213 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG G+ G V A + + +A+KK+ N A + M + H NI
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNI 123
Query: 471 VTL-----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTAR 523
++L E Q + LV E + NL ++ L + R+ L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELD-HERMSYLLYQMLC 175
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
+++LH ++HR+ K +NI++ + + D GLA + + T V Y
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYR 230
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L Y D++S G +M E++ K L
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 10/135 (7%)
Query: 108 SLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRN 163
++ DLS + ++ ++ +L L LA N + + + + L LN+S+N
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFT-DLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFS 221
L +F NL L LDLS+N+ SF+ L N+ L L NQ+ S+ +F
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
Query: 222 GLP-LTTLNVANNHF 235
L L + + N +
Sbjct: 393 RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 5/113 (4%)
Query: 127 LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG-DIFGNLAGLATLDLS 185
LP ++ ++L+ N+ + S + + L +L V + + I + F L+ L L L
Sbjct: 28 LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 186 FNNFSGDLPNSFISLSNISSLYLQNNQVTGSL---NVFSGLP-LTTLNVANNH 234
+N F +F L+N+ L L + G++ N F L L L + +N+
Sbjct: 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 36/165 (21%), Positives = 58/165 (35%), Gaps = 14/165 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S L L+ + + I L +L L L N F L + +L
Sbjct: 50 FSRLQDLQFLKVEQQTPGLVIRNNTFRGL-SSLIILKLDYNQFL-QLETGAFNGLANLEV 107
Query: 158 LNVSRNSLTQSI--GDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVT 214
L +++ +L ++ G+ F L L L L NN P S F+++ L L N+V
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 215 ----GSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNS 255
L F G T L +++ L + N+
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 31/143 (21%), Positives = 50/143 (34%), Gaps = 20/143 (13%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
+ DLS NSI +L +L L + + + + SL L
Sbjct: 31 HVNYVDLSLNSIA-----ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNF-SGDLP-NSFISLSNISSLYLQNNQVTGSL 217
+ N Q F LA L L L+ N L N F L+++ L L++N + +
Sbjct: 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KI 144
Query: 218 N---VFSGLP-LTTLNVANNHFS 236
F + L++ N
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 31/168 (18%), Positives = 62/168 (36%), Gaps = 21/168 (12%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLAS---------- 138
D++ L S+ DLSGN +++ + + + S
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 139 -----NNFSG--NLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191
NF N + + ++S++ + + +F + L L L+ N +
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK 313
Query: 192 DLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
N+F L+++ L L N + S+ +F L L L+++ NH
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 24/147 (16%), Positives = 48/147 (32%), Gaps = 23/147 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMV 153
+ L +L L+ ++ + L +L L L NN P S +M
Sbjct: 98 AFNGLANLEVLTLTQCNLDGAV---LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR 154
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLA----------TLDLSFNNFSGDLPNSFISLSNI 203
L+++ N + + N G D++ + + ++I
Sbjct: 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 204 SSLYLQNNQVTGSL--NVFSGLPLTTL 228
++L L N S+ F + T +
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKI 241
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 32/165 (19%), Positives = 54/165 (32%), Gaps = 30/165 (18%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFS----------GNLPYS 148
L SL L N+I P + L+L N ++
Sbjct: 124 FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183
Query: 149 IASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF---ISLSNISS 205
+ + S++ +++ L + TLDLS N F + F I+ + I S
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 206 LYLQNNQVTGSL-----------NVFSGLP---LTTLNVANNHFS 236
L L N+ GS F GL + T +++ +
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 65/276 (23%), Positives = 109/276 (39%), Gaps = 54/276 (19%)
Query: 368 DLTPPPAEKLVIERVAKSGSLKKIKSPITATSYTVASLQTATNSFSQEFL--IGEGSLGR 425
+ A + L +K + + T + + +F E L +G G+ G+
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENF--ELLKVLGTGAYGK 69
Query: 426 VYRAEFA----NGKIMAVKKIDNAALSLQEED--------NFLEAVSNMSRLRHPNIVTL 473
V+ GK+ A+K + A + + + LE + P +VTL
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTL 124
Query: 474 AGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR-----VALGT 521
Y + +L L+ +Y+ G L H F + V+ + L
Sbjct: 125 H-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEH---------EVQIYVGEIVL-- 170
Query: 522 ARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG 581
ALE+LH++ +++R+ K NILLD + L+D GL+ E + + G
Sbjct: 171 --ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 582 YSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKP 615
Y AP+ G + D +S GV+M ELLTG P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 32/158 (20%), Positives = 48/158 (30%), Gaps = 7/158 (4%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S N + +P L T LN++ N S I S+ L L +S N + +
Sbjct: 6 DRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F L LDLS N + N+ L L N F + L L
Sbjct: 65 FKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPS 267
++ H + + + P
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG 159
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 40/231 (17%), Positives = 89/231 (38%), Gaps = 7/231 (3%)
Query: 11 LPFSTSRLIDAFVLILSIFLTLSLVQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDP 70
+ S L LTL+ ++ T +S V +T++ S+ + D
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 71 CGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPN 130
+ G + + ++ + G + Y + ++++ F +SG + +
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325
Query: 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT--QSIGDIFGNLAGLATLDLSFNN 188
L+ ++N + + + + L L + N L I ++ + L LD+S N+
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385
Query: 189 FSGDLP-NSFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVANNHFS 236
S D ++ SL + +N +T + +F LP + L++ +N
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDT--IFRCLPPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 31/139 (22%), Positives = 54/139 (38%), Gaps = 14/139 (10%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQ-----LPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
L L L N + + +L L+++ N+ S + + SL LN
Sbjct: 347 LTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-- 217
+S N LT +I + LDL N +P + L + L + +NQ+ S+
Sbjct: 406 MSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD 461
Query: 218 NVFSGLP-LTTLNVANNHF 235
+F L L + + N +
Sbjct: 462 GIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 31/173 (17%), Positives = 60/173 (34%), Gaps = 17/173 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L L R FD SG S+ L+ + S+ F Y +++ N +
Sbjct: 259 LQGQLDFRDFDYSGTSLK---------ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ---VTGSLNV 219
+ ++ LD S N + + + L+ + +L LQ NQ ++ +
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369
Query: 220 FSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNGPAPPPPPS 267
+ + L L+++ N S + S+ + N + PP
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR 422
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 26/138 (18%), Positives = 47/138 (34%), Gaps = 10/138 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+ L LR +S N I + ++ L L+L+ N + V+L +L+
Sbjct: 41 ILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLD 96
Query: 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GS 216
+S N+ I FGN++ L L LS + L+ L +
Sbjct: 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156
Query: 217 LNVFSGLPLTTLNVANNH 234
+L++
Sbjct: 157 PEGLQDFNTESLHIVFPT 174
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 21/141 (14%), Positives = 48/141 (34%), Gaps = 10/141 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI---ASMVSLSYLN 159
LS++ + + + + Q P L++L L + + N I ++ Y +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 160 VSRNSLT-----QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214
+S L + +L L+ + + F + SN++ +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 215 G-SLNVFSGLP-LTTLNVANN 233
+ S + L+ +NN
Sbjct: 314 MVHMLCPSKISPFLHLDFSNN 334
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 37/129 (28%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLP--YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
+P LP L+L+ NN S L ++ + +L L +S N L + F + L
Sbjct: 32 NVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL 90
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
LDLS N+ F L + L L NN + + N F + L L ++ N S
Sbjct: 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 237 GWIPRELIS 245
P ELI
Sbjct: 150 -RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 12/139 (8%)
Query: 108 SLRKFDLSGNSIH----DTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSR 162
DLS N++ + P +L NL SL L+ N+ + + + +L YL++S
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLT-NLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFS 221
N L +F +L L L L N+ N+F ++ + LYL NQ++ + +
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK 157
Query: 222 GLP----LTTLNVANNHFS 236
L L++++N
Sbjct: 158 DGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 32/148 (21%), Positives = 56/148 (37%), Gaps = 15/148 (10%)
Query: 100 GYLLSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVS 154
+ + L +L LS N ++ I + PNL L+L+SN+ L + + + +
Sbjct: 57 EWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV-PNLRYLDLSSNHLH-TLDEFLFSDLQA 113
Query: 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL---YLQNN 211
L L + N + + F ++A L L LS N S + + L L +N
Sbjct: 114 LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN 173
Query: 212 QVT----GSLNVFSGLPLTTLNVANNHF 235
++ L L + NN
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 62/223 (27%), Positives = 85/223 (38%), Gaps = 47/223 (21%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKI-------DNAALSLQEEDNFLEAVSNMSR 464
FL IG+GS G+V A A AVK + + E N L
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--- 97
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP +V L + + +L V +Y+ G L H F + R R
Sbjct: 98 --HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEP---------RARF 143
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+A AL YLH + ++V+R+ K NILLD + + L+D GL
Sbjct: 144 YAAEIAS----ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
ST G Y APE Y D + G V+ E+L G P
Sbjct: 197 ST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + G +AVKK+ S+ + + ++H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
E + LV +G +L++++ + LT + V+ + R L+Y+H
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGA-DLNNIVK-----CQKLT-DDHVQFLIYQILRGLKYIH 149
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM---VGAFGYSAPE 586
++HR+ K +N+ ++++ + D GLA R + +M V Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTADEMTGYVATRWYRAPE 199
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
L+ Y D++S G +M ELLTG + L
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 33/218 (15%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH 467
+ F + +G GS GRV + +G A+K +D + L++ ++ L + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 468 PNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDML----HFADDSSKNLTWNARVR-----V 517
P +V L + + L +V EYV G + L F++ R +
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---------HARFYAAQI 150
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMV 577
L EYLH + +++R+ K N+L+D + ++D G A + +
Sbjct: 151 VL----TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLC 199
Query: 578 GAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
G APE LS Y D ++ GV++ E+ G P
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + +G+ +A+KK+ S + + ++H N++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
+ LV ++ +L ++ + +++ + + L+Y+H
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFS-EEKIQYLVYQMLKGLKYIH 143
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM---VGAFGYSAPE 586
VVHR+ K N+ ++++ + D GLA R +M V Y APE
Sbjct: 144 SA---GVVHRDLKPGNLAVNEDCELKILDFGLA-------RHADAEMTGYVVTRWYRAPE 193
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
LS Y D++S G +M E+LTG K L
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL--- 473
+G G+ G V A + G +A+KK+ S + + +RH N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 474 --AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALEYLH 529
+ LV ++G +L ++ + L R++ + + L Y+H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGT-DLGKLMK-----HEKLG-EDRIQFLVYQMLKGLRYIH 145
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM---VGAFGYSAPE 586
++HR+ K N+ ++++ + D GLA RQ ++M V Y APE
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLA-------RQADSEMTGYVVTRWYRAPE 195
Query: 587 FALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
L+ YT D++S G +M E++TG K L
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 29/134 (21%), Positives = 58/134 (43%), Gaps = 13/134 (9%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L + K +L S+ D + + + + N ++N +L + +L L++S
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSH 72
Query: 163 NSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N ++ D+ +L L L ++ N +L I + +S L+L NN++ +
Sbjct: 73 NQIS----DLSPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELR-DTDSL 124
Query: 221 SGLP-LTTLNVANN 233
L L L++ NN
Sbjct: 125 IHLKNLEILSIRNN 138
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 11/134 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+L ++ F+ ++I Q NL L+L+ N S +L + + L L+V+R
Sbjct: 37 QKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNR 94
Query: 163 NSLTQSIGDIFG-NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
N L ++ G A L+ L L N D + I L N+ L ++NN++ S+ +
Sbjct: 95 NRLK----NLNGIPSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SIVMLG 147
Query: 222 GLP-LTTLNVANNH 234
L L L++ N
Sbjct: 148 FLSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 24/120 (20%), Positives = 43/120 (35%), Gaps = 7/120 (5%)
Query: 114 LSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIF 173
I+ P N NL + + + + + N +++ S+ +
Sbjct: 4 QRPTPINQVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGM- 59
Query: 174 GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANN 233
L L LS N S DL L+ + L + N++ +LN L+ L + NN
Sbjct: 60 QFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNN 116
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 45/210 (21%), Positives = 84/210 (40%), Gaps = 33/210 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAG 475
+G G V+ A N + + VK + ++ + + LR PNI+TLA
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 476 --YCAEHGQRLLVYEYVGNGNLHDMLH-FADDSSKNLTWNARVRVALGTARALEYLHEVC 532
LV+E+V N + + D + + +AL+Y H +
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKALDYCHSM- 149
Query: 533 LPSVVHRNFKSANILLDDEL-NPHLSDCGLA----ALTPNTERQVSTQMVGAFGYSAPEF 587
++HR+ K N+++D E L D GLA R V+++ + PE
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRY-----FKGPEL 201
Query: 588 ALSG-IYTVKSDVYSFGVVMLELLTGRKPL 616
+ +Y D++S G ++ ++ ++P
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 27/172 (15%), Positives = 59/172 (34%), Gaps = 17/172 (9%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L S L L+ + I + L L + +++ P S+ S+ ++S+L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL 203
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLS--------FNNFSGDLPNSFISLSNISSLYLQN 210
+ + + + L+L F+ S NS I ++ + +
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 211 NQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFD 257
+ + + + + L L + N +P L S++ N +D
Sbjct: 264 ESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 4/132 (3%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
S S+ ++IP L + SL+L++N + + V+L L ++ N + D
Sbjct: 37 KGSSGSL-NSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLN 229
F +L L LDLS+N S + F LS+++ L L N G ++FS L L L
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 230 VANNHFSGWIPR 241
V N I R
Sbjct: 156 VGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 21/149 (14%), Positives = 46/149 (30%), Gaps = 14/149 (9%)
Query: 102 LLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
L SL +L GN ++ +T + L L + + + + A + L
Sbjct: 119 WFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-- 215
L + + L ++ ++ L L L S++ L L++ +
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238
Query: 216 ----SLNVFSGLP----LTTLNVANNHFS 236
S + L + + +
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 12/172 (6%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS 142
+ + S+D ++ G + L L K + N+I T+ NLT L SN +
Sbjct: 42 ATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNI-TTLDLSQNTNLTYLACDSNKLT 98
Query: 143 GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
NL + + L+YLN N LT+ L L+ + N + ++ S +
Sbjct: 99 -NLD--VTPLTKLTYLNCDTNKLTK---LDVSQNPLLTYLNCARNTLT-EIDVS--HNTQ 149
Query: 203 ISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGN 254
++ L N+ L+V LTTL+ + N + + + D N
Sbjct: 150 LTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTN 201
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 12/135 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L L + N + + P LT LN A N + + ++ L+ L+
Sbjct: 102 VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHL 157
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N + L TLD SFN + +L S ++ L N +T L+ +
Sbjct: 158 NKKITKLD--VTPQTQLTTLDCSFNKIT-ELDVS--QNKLLNRLNCDTNNIT-KLD-LNQ 210
Query: 223 LP-LTTLNVANNHFS 236
LT L+ ++N +
Sbjct: 211 NIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 34/150 (22%), Positives = 55/150 (36%), Gaps = 10/150 (6%)
Query: 91 SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
+ + T L +L D +SI D + LT L SNN + L ++
Sbjct: 26 AAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-TLD--LS 82
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210
+L+YL N LT ++ L L L+ N + L S ++ L
Sbjct: 83 QNTNLTYLACDSNKLT-NL--DVTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCAR 136
Query: 211 NQVTGSLNVFSGLPLTTLNVANNHFSGWIP 240
N +T ++V LT L+ N +
Sbjct: 137 NTLT-EIDVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 28/153 (18%), Positives = 54/153 (35%), Gaps = 12/153 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+S L + + N++ I LT L+ N L + L+ L+ S
Sbjct: 123 VSQNPLLTYLNCARNTL-TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N +T+ L L+ NN + L + ++ L +N++T ++ +
Sbjct: 180 NKITELD---VSQNKLLNRLNCDTNNIT-KLDLN--QNIQLTFLDCSSNKLT-EID-VTP 231
Query: 223 LP-LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
L LT + + N + L + T
Sbjct: 232 LTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 23/134 (17%), Positives = 49/134 (36%), Gaps = 10/134 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+S L + + N+I + LT L+ +SN + + + + L+Y + S
Sbjct: 187 VSQNKLLNRLNCDTNNI-TKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSV 242
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
N LT + L+ L TL + ++ + + + + + L+V
Sbjct: 243 NPLT-EL--DVSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKELDVTHN 296
Query: 223 LPLTTLNVANNHFS 236
L L+ +
Sbjct: 297 TQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 19/135 (14%), Positives = 41/135 (30%), Gaps = 10/135 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
L+ L F G + L L+ + + L ++ L YL ++
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNN 327
Query: 163 NSLTQSIGDI-FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
LT ++ + L +L + D S + +++ + Q
Sbjct: 328 TELT----ELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETL 381
Query: 222 GLPLTTLNVANNHFS 236
T+ V+ +
Sbjct: 382 TNNSLTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 32/140 (22%), Positives = 55/140 (39%), Gaps = 11/140 (7%)
Query: 117 NSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
S +D P N S A+ S + +L+ L+ +S+T G L
Sbjct: 9 QSFNDWFP---DDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKL 63
Query: 177 AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHF 235
GL L + NN + L S +N++ L +N++T +L+ + L LT LN N
Sbjct: 64 TGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDTNKL 118
Query: 236 SGWIPRELISIRTFIYDGNS 255
+ + + N+
Sbjct: 119 TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 15/122 (12%), Positives = 39/122 (31%), Gaps = 8/122 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
++ L D I + + P L L L + + L ++ L L+
Sbjct: 293 VTHNTQLYLLDCQAAGITE-LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348
Query: 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG 222
+ G + L + +P ++ +++ ++ + + + N +
Sbjct: 349 AHIQ-DF-SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNI 404
Query: 223 LP 224
P
Sbjct: 405 EP 406
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 37/124 (29%), Positives = 51/124 (41%), Gaps = 5/124 (4%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S IP +P + L+L SN S + + L L ++ N L I
Sbjct: 22 DCSSKK-LTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI 80
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLN 229
F L L TL ++ N F L N++ L L NQ+ SL VF L LT L+
Sbjct: 81 FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 230 VANN 233
+ N
Sbjct: 140 LGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 10/137 (7%)
Query: 104 SDLLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
+L +L ++ N + +P + NL L L N +LP + S+ L+YL+
Sbjct: 82 KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 160 VSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SL 217
+ N L QS+ +F L L L L N +F L+ + +L L NNQ+
Sbjct: 140 LGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198
Query: 218 NVFSGLP-LTTLNVANN 233
F L L L + N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 11/144 (7%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181
IP LP +T + L N P + + L +++S N +++ D F L L +
Sbjct: 25 EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84
Query: 182 LDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFSG 237
L L N + +LP S F L ++ L L N++ L + F L L L++ +N
Sbjct: 85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 238 WIPRE----LISIRTFIYDGNSFD 257
I + L +I+T N F
Sbjct: 143 -IAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 33/146 (22%), Positives = 62/146 (42%), Gaps = 25/146 (17%)
Query: 113 DLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNS 164
L N+I +PP L ++L++N S L + SL+ L + N
Sbjct: 38 RLEQNTIK-----VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGL 223
+T+ +F L L L L+ N + ++F L N++ L L +N++ + FS L
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 224 P-LTTLNVANN---------HFSGWI 239
+ T+++A N + ++
Sbjct: 152 RAIQTMHLAQNPFICDCHLKWLADYL 177
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 8/114 (7%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S LR+ DLS N I + L +L SL L N + LP S+ + SL
Sbjct: 52 FSPYKKLRRIDLSNNQIS-ELAPDAFQGLR-SLNSLVLYGNKIT-ELPKSLFEGLFSLQL 108
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
L ++ N + D F +L L L L N +F L I +++L N
Sbjct: 109 LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPNI 470
IGEG+ G V A + N +A+KKI +L+E + + R RH NI
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-------IKILLRFRHENI 87
Query: 471 VTL-----AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
+ + A + +V + + +L+ +L +++L+ N + L R
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-----TQHLS-NDHICYFLYQILRG 140
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA--ALTPNTERQVSTQMVGAFGY 582
L+Y+H +V+HR+ K +N+LL+ + + D GLA A + T+ V Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 583 SAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
APE L+ YT D++S G ++ E+L+ +P+
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 47/223 (21%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 404 SLQTATNSFSQEF-----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLE 457
LQ N+ ++ ++G G G+V + + A+K + + + +E
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE------ 60
Query: 458 AVSNMSRL-RHPNIVTLAGYCAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWN 512
V R + P+IV + L+V E + G L + D + T
Sbjct: 61 -VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTER 117
Query: 513 ARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
+ A++YLH + ++ HR+ K N+L + PN
Sbjct: 118 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSK-------------RPN----- 156
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ + FG+ A E Y D++S GV+M LL G P
Sbjct: 157 AILKLTDFGF-AKET-TGEKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 33/145 (22%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 122 TIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180
IP +P L L +N F+ I + L +N S N +T F +G+
Sbjct: 25 KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84
Query: 181 TLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANNHFS 236
+ L+ N ++ + F L ++ +L L++N++T + + F GL + L++ +N +
Sbjct: 85 EILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 237 GWIPRE----LISIRTFIYDGNSFD 257
+ L S+ T N F+
Sbjct: 143 T-VAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 34/143 (23%), Positives = 60/143 (41%), Gaps = 18/143 (12%)
Query: 113 DLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQS 168
L+ N ++ P L +N ++N + ++ ++ + ++ N L
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENV 96
Query: 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-L 225
+F L L TL L N + +SFI LS++ L L +NQ+T ++ F L L
Sbjct: 97 QHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSL 155
Query: 226 TTLNVANNHF---------SGWI 239
+TLN+ N F W+
Sbjct: 156 STLNLLANPFNCNCYLAWLGEWL 178
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 29/159 (18%), Positives = 43/159 (27%), Gaps = 31/159 (19%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
S R F + + IP LP N L + + L + +S+N + +
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 168 SIG--------------------------DIFGNLAGLATLDLSFNNFSGDLPNSFISLS 201
I + F NL L L +S I
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 202 NISSLYLQ-NNQVTG-SLNVFSGLP--LTTLNVANNHFS 236
L +Q N + N F GL L + N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 31/207 (14%), Positives = 58/207 (28%), Gaps = 14/207 (6%)
Query: 101 YLLSDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS 156
L D+ N +I L L L N + S + L
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLD 180
Query: 157 YLNVSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
LN+S N+L + D+F +G LD+S +L + + N +
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK--- 237
Query: 216 SLNVFSGLP-LTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGR 274
L L L ++ + R I + + N +
Sbjct: 238 KLPTLEKLVALMEASLTYP----SHCCAFANWRRQISELHPICNKSILRQEVDYMTQARG 293
Query: 275 SHNNRSHRQGSHSPSGSQSSSSDKELP 301
++ + S G + ++ +
Sbjct: 294 QRSSLAEDNESSYSRGFDMTYTEFDYD 320
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 24/141 (17%), Positives = 44/141 (31%), Gaps = 9/141 (6%)
Query: 104 SDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
S+L L + + I+ LP NL L +++ + L+
Sbjct: 76 SNLPKLHEIRIEKANNLLYINPEAFQNLP-NLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 160 VSRNSLTQSIGD-IFGNLAG-LATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-S 216
+ N +I F L+ L L+ N ++F NN +
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 217 LNVFSGLP-LTTLNVANNHFS 236
+VF G L+++
Sbjct: 195 NDVFHGASGPVILDISRTRIH 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 8e-13
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 415 EFL--IGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQE------EDNFLEAVSNMSR 464
+ L +G GS GRV+ NG+ A+K + + L++ E L V
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV----- 63
Query: 465 LRHPNIVTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------FADDSSKNLTWNARVR- 516
HP I+ + + Q++ ++ +Y+ G L F + +
Sbjct: 64 -THPFIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNP---------VAKF 110
Query: 517 ----VALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572
V L ALEYLH +++R+ K NILLD + ++D G A P+
Sbjct: 111 YAAEVCL----ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T 160
Query: 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
T + G Y APE + Y D +SFG+++ E+L G P
Sbjct: 161 YT-LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKI--DNAALS---LQEEDNFLEAVSNMSRLRHPNIV 471
+G G G V+ A + K +A+KKI + L+E + + RL H NIV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-------IKIIRRLDHDNIV 71
Query: 472 TL-------AGYCAEHGQRL-------LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+ + L +V EY+ +L ++L L R+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLL-EEHARL 124
Query: 518 AL-GTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC--GLA--ALTPNTERQV 572
+ R L+Y+H +V+HR+ K AN+ ++ E + L GLA + +
Sbjct: 125 FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE-DLVLKIGDFGLARIMDPHYSHKGH 180
Query: 573 STQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616
++ + Y +P LS YT D+++ G + E+LTG K L
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 34/158 (21%), Positives = 57/158 (36%), Gaps = 24/158 (15%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
+ N + L + L L N S +LP ++ ++ L ++
Sbjct: 32 AWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEIT 88
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
+N+L S+ ++ + L LD N S LP SL + L + NNQ +
Sbjct: 89 QNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKH---LDVDNNQ-------LT 133
Query: 222 GLP-----LTTLNVANNHFSGWIPRELISIRTFIYDGN 254
LP L +N NN + +P S+ N
Sbjct: 134 MLPELPALLEYINADNNQLTM-LPELPTSLEVLSVRNN 170
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 28/155 (18%), Positives = 51/155 (32%), Gaps = 12/155 (7%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLS----Y 157
L SL + N + +P +LP +L +L++++N +LP +
Sbjct: 155 LPELPTSLEVLSVRNNQLT-FLP-ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIF 211
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N +T I + +L T+ L N S +S Y
Sbjct: 212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRI---YF 266
Query: 218 NVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYD 252
++ G T + + W P S + I+
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWH 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 19/131 (14%), Positives = 44/131 (33%), Gaps = 12/131 (9%)
Query: 103 LSDLL-SLRKFDLSGNSIHDTIP------YQLPPNLTSLNLASNNFSGNLPYSIASMVSL 155
L +L SL D+S N + ++P + N + ++P +I S+
Sbjct: 175 LPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPT 232
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATL---DLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ + N L+ I + + F+ G L++ + + N+
Sbjct: 233 CTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENK 292
Query: 213 VTGSLNVFSGL 223
+ ++
Sbjct: 293 QSDVSQIWHAF 303
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 52/251 (20%), Positives = 89/251 (35%), Gaps = 74/251 (29%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG GS G VY A + K +A+KK++ ++ ++ ++ ++RL+ I
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYI 87
Query: 471 VTLAG-YCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG-TARA 524
+ L + + +V E + +L + + LT ++ L
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK----TPIFLT-EEHIKTILYNLLLG 141
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLA-ALTPNTERQVSTQM 576
++HE ++HR+ K AN LL+ DC GLA + + + +
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLN-------QDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 577 VGAFG--------------------YSAPEFAL-SGIYTVKSDVYSFGVVMLELLTG--- 612
Y APE L YT D++S G + ELL
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 613 -------RKPL 616
R PL
Sbjct: 252 HINDPTNRFPL 262
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 27/149 (18%), Positives = 57/149 (38%), Gaps = 12/149 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
S+L ++ + +S + + Y L +T + + + + + L +
Sbjct: 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLS-KVTHIEIRNTRNLTYIDPDALKELPLLKF 109
Query: 158 LNVSRNSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLP-NSFISLSNIS-SLYLQNNQV 213
L + L D+ + L+++ N + +P N+F L N + +L L NN
Sbjct: 110 LGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
Query: 214 TG-SLNVFSGLPLTTLNVANNHFSGWIPR 241
T F+G L + + N + I +
Sbjct: 169 TSVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 26/145 (17%), Positives = 52/145 (35%), Gaps = 15/145 (10%)
Query: 104 SDLLSLRKFDLSGN----SIHDTIPYQLPPNLTSLNLASNNFSGNLP--YSIASMVSLSY 157
+L + ++ I +LP L L + + P + S
Sbjct: 77 YNLSKVTHIEIRNTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFI 134
Query: 158 LNVSRNSLTQSI-GDIFGNL-AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L ++ N SI + F L TL L N F+ + + + + ++YL N+
Sbjct: 135 LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
Query: 216 SL--NVFSGLP--LTTLNVANNHFS 236
+ + F G+ + L+V+ +
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 26/133 (19%), Positives = 48/133 (36%), Gaps = 30/133 (22%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
F ++ I IP LPP+ +L L + +I S
Sbjct: 12 QEEDFRVTCKDIQ-RIP-SLPPSTQTLKLIETHLR-----TIPS---------------- 48
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL--NVFSGLP 224
F NL ++ + +S + L +SF +LS ++ + ++N + + + LP
Sbjct: 49 ---HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105
Query: 225 -LTTLNVANNHFS 236
L L + N
Sbjct: 106 LLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 23/115 (20%), Positives = 47/115 (40%), Gaps = 10/115 (8%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQ----LPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
+ +++ N +IP L +L L +N F+ ++ + L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 159 NVSRNSLTQSI-GDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
+++N I D FG + G + LD+S + + LP+ L ++ L +N
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 55/229 (24%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPNI 470
+GEG+ G V A G+I+A+KKI+ A +L+E + + +H NI
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE-------IKILKHFKHENI 71
Query: 471 VTLAG-YCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
+T+ + + ++ E + +LH ++ S++ L+ + ++ + T RA
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQMLS-DDHIQYFIYQTLRA 124
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLAALTPNTERQVSTQMV 577
++ LH +V+HR+ K +N+L++ S+C GLA + + S
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLIN-------SNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 578 GAFG---------YSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPL 616
G Y APE L+ Y+ DV+S G ++ EL R+P+
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 53/249 (21%), Positives = 90/249 (36%), Gaps = 65/249 (26%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLRHPNI 470
IG GS G V A + +++A+KKI ++ ++ ++ ++RL H ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVF------EDLIDCKRILREIAILNRLNHDHV 114
Query: 471 VTL----AGYCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARA 524
V + E L +V E + + + + LT ++ L
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----TPVYLT-ELHIKTLLYNLLVG 168
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFG--- 581
++Y+H ++HR+ K AN L++ + + + D GLA E S +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 582 -----------------------YSAPEFAL-SGIYTVKSDVYSFGVVMLELLT------ 611
Y APE L YT DV+S G + ELL
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 612 ----GRKPL 616
R PL
Sbjct: 286 AYHADRGPL 294
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 43/156 (27%), Positives = 64/156 (41%), Gaps = 23/156 (14%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSYLN 159
+ LS NSI +L L L L+ N +L + + L YL+
Sbjct: 53 RTKALSLSQNSIS-----ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLD 106
Query: 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS--FISLSNISSLYLQNNQVT-GS 216
VS N L Q+I +A L LDLSFN+F LP F +L+ ++ L L +
Sbjct: 107 VSHNRL-QNIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 217 LNVFSGLPLTT--LNVANNHFSGWIPRELISIRTFI 250
L + L L+ L++ + H G L T +
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV 198
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 30/124 (24%), Positives = 50/124 (40%), Gaps = 7/124 (5%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI 172
D S ++ +P LPP +L+L+ N+ S I+ + L L +S N + +
Sbjct: 37 DYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHV 95
Query: 173 FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ--VTGSLNVFSGLP-LTTLN 229
F L LD+S N + ++++ L L N V F L LT L
Sbjct: 96 FLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152
Query: 230 VANN 233
++
Sbjct: 153 LSAA 156
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 29/167 (17%), Positives = 57/167 (34%), Gaps = 12/167 (7%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGN-----LPYSIASMVSLSYLNVS 161
++L+ + + + P + LN+ + + YS ++ SL +V
Sbjct: 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS-LNVF 220
S ++ A + LS ++ S S+ + L N T S
Sbjct: 314 NQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGC 373
Query: 221 SGLP-LTTLNVANNHFSGW-----IPRELISIRTFIYDGNSFDNGPA 261
S L L TL + N + + + + S+ T NS ++
Sbjct: 374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 96 SGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSL 155
S + S+ +LS N + ++ LPP + L+L +N ++P + + +L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQAL 475
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189
LNV+ N L +F L L + L N +
Sbjct: 476 QELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 33/141 (23%), Positives = 54/141 (38%), Gaps = 18/141 (12%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQ--LPPNLTSLNLASNNFSGNLPYSIASMV-----SLSYL 158
L L+ L N + + N++SL + +L S+ L
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLET-LDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 159 NVSRNSLTQSIGDIFGNL-AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
N+S N LT S+ F L + LDL N +P L + L + +NQ+ S+
Sbjct: 434 NLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488
Query: 218 --NVFSGLP-LTTLNVANNHF 235
VF L L + + +N +
Sbjct: 489 PDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 26/167 (15%), Positives = 46/167 (27%), Gaps = 17/167 (10%)
Query: 107 LSLRKFDLSGNSIHD----TIPYQLPPNLTSLNLASNNFSGNLPYSIASMV---SLSYLN 159
L L L+ + P L ++ L + + + YLN
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282
Query: 160 VSRNSLTQSIGDIFGN-----LAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214
+ ++T+ I L L + F + + ++ L +
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342
Query: 215 GSLNVFSGLP--LTTLNVANNHFS---GWIPRELISIRTFIYDGNSF 256
V P T LN N F+ L ++T I N
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 4e-11
Identities = 25/107 (23%), Positives = 42/107 (39%), Gaps = 6/107 (5%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R L+ + + +T L+L+ N LP ++A++ L L S N+L ++
Sbjct: 444 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 170 GDIFGNLAGLATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVT 214
+ NL L L L N +S + L LQ N +
Sbjct: 502 DGV-ANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 3e-10
Identities = 28/144 (19%), Positives = 51/144 (35%), Gaps = 10/144 (6%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQL-----PPNLTSLNLASNNFSGNLPYSIASMVSL 155
LL+ +L +R D + P L+ + F +
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L+++ LT + + L + LDLS N LP + +L + L +N +
Sbjct: 444 RVLHLAHKDLT-VLCHL-EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 216 SLNVFSGLP-LTTLNVANNHFSGW 238
+++ + LP L L + NN
Sbjct: 500 NVDGVANLPRLQELLLCNNRLQQS 523
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 33/120 (27%), Positives = 52/120 (43%), Gaps = 4/120 (3%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
D++P +P + L+L S + + + L++LN+ N L +F +L L
Sbjct: 26 LDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGL-PLTTLNVANNHFS 236
TL L+ N + F L+ + LYL NQ+ SL VF L L L + N
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 53/197 (26%), Positives = 77/197 (39%), Gaps = 31/197 (15%)
Query: 71 CGESWKGVACEGSAVVSI------DISGLGLSGTMGYLLSD-----LLSLRKFDLSGNSI 119
C E K V C+G ++ S+ D L L T LSD L L +L N +
Sbjct: 12 CNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL 71
Query: 120 HDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIFGN 175
T+ + L +L LA+N + +LP + + L L + N L +F
Sbjct: 72 -QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDR 129
Query: 176 LAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVAN 232
L L L L+ N +P F L+N+ +L L NQ+ F L L T+ +
Sbjct: 130 LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
Query: 233 NHF----------SGWI 239
N F S WI
Sbjct: 189 NQFDCSRCEILYLSQWI 205
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPN 469
+IG+GS G+V +A + +A+K + N A EE LE + + N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQDKDNTMN 160
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYL 528
++ + + +E + NL++++ +L VR A + L+ L
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP---LVRKFAHSILQCLDAL 216
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
H+ ++H + K NILL + + D G + V T + F Y APE
Sbjct: 217 HK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRF-YRAPE 269
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
L Y + D++S G ++ ELLTG PL
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTG-YPL 298
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 28/126 (22%), Positives = 46/126 (36%), Gaps = 10/126 (7%)
Query: 113 DLSGNSIHDTIPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVSRNSLTQSIG 170
L+ I Y L+L NL A++ ++ S N + +
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLG---ATLDQFDAIDFSDNEIR-KLD 58
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTT 227
F L L TL ++ N +L +++ L L NN + G L+ + L LT
Sbjct: 59 G-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
Query: 228 LNVANN 233
L + N
Sbjct: 118 LCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 29/138 (21%), Positives = 54/138 (39%), Gaps = 17/138 (12%)
Query: 103 LSDLLSLRKFDLSGNSIHDT--IPYQLPPNLTSLNLASNNFS--GNLPYSIASMVSLSYL 158
++ + R+ DL G I + L +++ + N P + L L
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATL-DQFDAIDFSDNEIRKLDGFP----LLRRLKTL 69
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISLSNISSLYLQNNQVTGS 216
V+ N + + + L L L L+ N+ GDL + SL +++ L + N VT
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVTNK 128
Query: 217 LN----VFSGLP-LTTLN 229
+ V +P + L+
Sbjct: 129 KHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L D S N I + L L +L + +N ++ L+ L ++
Sbjct: 37 LGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96
Query: 162 RNSLTQSIGDI--FGNLAGLATLDLSFN 187
NSL +GD+ +L L L + N
Sbjct: 97 NNSLV-ELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 21/105 (20%), Positives = 38/105 (36%), Gaps = 8/105 (7%)
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217
+ ++ + Q+ + N LDL + N +L ++ +N++ L
Sbjct: 2 VKLTAELIEQAAQ--YTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 218 NVFSGLP-LTTLNVANNHFS---GWIPRELISIRTFIYDGNSFDN 258
+ F L L TL V NN + + L + I NS
Sbjct: 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 63/238 (26%)
Query: 418 IGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEA------VSNMSRLR-HPN 469
+G+G+ G V+++ + G+++AVKKI +A N +A + ++ L H N
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF------QNSTDAQRTFREIMILTELSGHEN 70
Query: 470 IVTLAG-YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL-GTARALE 526
IV L A++ + + LV++Y+ +LH ++ + L + + + ++
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR-----ANILE-PVHKQYVVYQLIKVIK 123
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDC-------GLAALTPNTERQVSTQMVGA 579
YLH ++HR+ K +NILL+ ++C GL+ N R + +
Sbjct: 124 YLHSG---GLLHRDMKPSNILLN-------AECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 580 FG--------------------YSAPEFAL-SGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L S YT D++S G ++ E+L KP+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 44/222 (19%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHP---- 468
+G G V+ A+ N +A+K + + + ++E L+ V++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 469 -NIVTL------AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALG 520
+I+ L G H ++V+E +G NL ++ + L V+ ++
Sbjct: 86 NHILKLLDHFNHKGPNGVH--VVMVFEVLGE-NLLALIKKYEHRGIPLI---YVKQISKQ 139
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPH------LSDCGLAALTPNTERQVST 574
L+Y+H C ++H + K N+L++ +P ++D G A +
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTN 194
Query: 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+ Y +PE L + +D++S ++ EL+TG L
Sbjct: 195 SIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITG-DFL 234
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-10
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 6/119 (5%)
Query: 119 IHDTIPYQLPPNLTSLNL-ASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
IH + + P + L L + G + A V+L +L++ L S+ L
Sbjct: 14 IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLP 71
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLNVANN 233
L L+LS N G L L N++ L L N++ +L L L +L++ N
Sbjct: 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 32/109 (29%), Positives = 43/109 (39%), Gaps = 14/109 (12%)
Query: 129 PNLTSLNLASNNFS--GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186
NL L+L + NLP + L L +S N + + + L L L+LS
Sbjct: 49 VNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG 104
Query: 187 NNFS--GDLPNSFISLSNISSLYLQNNQVTGSLN----VFSGLP-LTTL 228
N L L + SL L N +VT + VF LP LT L
Sbjct: 105 NKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L ++ ++L L + P L L L+ N G L + +L++LN+S
Sbjct: 44 LTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 162 RNSLTQSIGDI--FGNLAGLATLDLSFN 187
N L + I + L L +LDL
Sbjct: 104 GNKL-KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 2/100 (2%)
Query: 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLPNS 196
+ + + + + + +L+ L + Q + L L L + + P++
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 197 FISLSNISSLYLQNNQVTG-SLNVFSGLPLTTLNVANNHF 235
F +S L L N + S GL L L ++ N
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 7/68 (10%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIP----YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
L L LR + + + + + P L+ LNL+ N +L + +SL L
Sbjct: 52 LRGLGELRNLTIVKSGL-RFVAPDAFHFTP-RLSRLNLSFNALE-SLSWKTVQGLSLQEL 108
Query: 159 NVSRNSLT 166
+S N L
Sbjct: 109 VLSGNPLH 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-10
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 6/119 (5%)
Query: 119 IHDTIPYQLPPNLTSLNLASNNFS-GNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177
IH + + P ++ L L ++ + G L L +L+ LT SI L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP-LTTLNVANN 233
L L+LS N SG L N++ L L N++ ++ L L +L++ N
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 20/88 (22%), Positives = 31/88 (35%), Gaps = 3/88 (3%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L + L + L L L+ N SG L +L++LN+S
Sbjct: 37 LTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96
Query: 162 RNSLTQSIGDI--FGNLAGLATLDLSFN 187
N + + + I L L +LDL
Sbjct: 97 GNKI-KDLSTIEPLKKLENLKSLDLFNC 123
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 418 IGEGSLGRVYRAE-----FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIV 471
+G G+ G+V A+ K+ + E + + + + H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 472 TLAGYCAEHGQRLLV-YEYVGNGNLHDMLH 500
L G C + G L+V E+ GNL L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 19/129 (14%)
Query: 496 HDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPH 555
+ D LT + + A+ +E+L +HR+ + NILL ++
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 233
Query: 556 LSDCGLAALTPNTERQVSTQ--------MVGAFGYSAPEFALSGIYTVKSDVYSFGVVML 607
+ D GLA V M APE +YT++SDV+SFGV++
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWM-------APETIFDRVYTIQSDVWSFGVLLW 286
Query: 608 ELLT-GRKP 615
E+ + G P
Sbjct: 287 EIFSLGASP 295
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 1e-09
Identities = 35/238 (14%), Positives = 64/238 (26%), Gaps = 55/238 (23%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKI------------DNAALSLQEEDNFLEAVSNMSRL 465
IGEG G V++ A+ +A+K I + E + +S +S
Sbjct: 28 IGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 466 ---RHPNIVTL------AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDS----------- 505
R + L G + + G+ +D F D
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 506 --------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557
+K + + +L HR+ N+LL L
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLH 204
Query: 558 DCGLAALTPNTERQVSTQMVGAFGYSAP--EFALSGIYTVKSDVYSFGVVMLELLTGR 613
+ + + G ++ LS + V+ + +L TG
Sbjct: 205 YTLNG----------KSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPN 469
LIG+GS G+V +A + +A+K I N A E LE ++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKYY 117
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYL 528
IV L + LV+E + NL+D+L + +L R A AL +L
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLN---LTRKFAQQMCTALLFL 173
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQMVGAFGYSAPE 586
L S++H + K NILL + + D G + + + F Y +PE
Sbjct: 174 ATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRF-YRSPE 228
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
L Y + D++S G +++E+ TG +PL
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTG-EPL 257
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 29/128 (22%), Positives = 46/128 (35%), Gaps = 6/128 (4%)
Query: 99 MGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYL 158
M LS L + + LS N+I NL L+L N + A +L L
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98
Query: 159 NVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGS 216
+S N + S+ I L L L +S N + + + +L + L L N +
Sbjct: 99 WISYNQIA-SLSGI-EKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYND 155
Query: 217 LNVFSGLP 224
+
Sbjct: 156 YKENNATS 163
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 36/133 (27%), Positives = 57/133 (42%), Gaps = 20/133 (15%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181
IP +P + T L L N + + L L + RN LT + F + +
Sbjct: 23 IPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82
Query: 182 LDLSFNNFSGDLPN-SFISLSNISSLYLQNNQVT----GSLNVFSGLP-LTTLNVANN-- 233
L L N ++ N F+ L + +L L +NQ++ GS F L LT+LN+A+N
Sbjct: 83 LQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGS---FEHLNSLTSLNLASNPF 138
Query: 234 -------HFSGWI 239
F+ W+
Sbjct: 139 NCNCHLAWFAEWL 151
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 157 YLNVSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215
L ++ N L + S +FG L L L+L N +G PN+F S+I L L N++
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 216 SL--NVFSGLP-LTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFD 257
+ +F GL L TLN+ +N S + L S+ + N F+
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFN 139
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 6/118 (5%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
++P +P T L+L +N+ + SL+ L + N L +F L L
Sbjct: 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 180 ATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANN 233
L+LS N LPN F L+ + L L NQ+ SL VF L L L + N
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-09
Identities = 32/129 (24%), Positives = 59/129 (45%), Gaps = 14/129 (10%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
+P +P ++T L L N F+ +P +++ L+ +++S N ++ F N+ L TL
Sbjct: 25 LPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL 83
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP-LTTLNVANN------ 233
LS+N P +F L ++ L L N ++ + F+ L L+ L + N
Sbjct: 84 ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142
Query: 234 ---HFSGWI 239
S W+
Sbjct: 143 NMQWLSDWV 151
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
K +L S+ D + ++ + +++ ++ I + ++ YL + N L
Sbjct: 20 ETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKL-H 76
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGLP- 224
I L L L L+ N F L+N+ L L NQ+ SL VF L
Sbjct: 77 DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN 134
Query: 225 LTTLNVANN 233
LT LN+A+N
Sbjct: 135 LTYLNLAHN 143
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 36/131 (27%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L S+ + + + I Q PN+ L L N ++ ++ + +L+YL ++ N L
Sbjct: 40 LNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQL 97
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSGL 223
+F L L L L N F L+N++ L L +NQ+ SL VF L
Sbjct: 98 QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKL 156
Query: 224 P-LTTLNVANN 233
LT L+++ N
Sbjct: 157 TNLTELDLSYN 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 40/132 (30%), Positives = 57/132 (43%), Gaps = 6/132 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRNS 164
L ++R L GN +HD + NLT L L N +LP + + +L L + N
Sbjct: 62 LPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120
Query: 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL--NVFSG 222
L +F L L L+L+ N F L+N++ L L NQ+ SL VF
Sbjct: 121 LQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDK 179
Query: 223 LP-LTTLNVANN 233
L L L + N
Sbjct: 180 LTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 22/116 (18%), Positives = 39/116 (33%), Gaps = 8/116 (6%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
P NL + + + + S+ + + + + G L +
Sbjct: 10 KQIFPDDAFAETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYLPNV 65
Query: 180 ATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG-SLNVFSGLP-LTTLNVANN 233
L L N D+ + L+N++ L L NQ+ VF L L L + N
Sbjct: 66 RYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 35/112 (31%), Positives = 52/112 (46%), Gaps = 8/112 (7%)
Query: 106 LLSLRKFDLSGNSIHDTIP---YQLPPNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVS 161
L +L L+GN + ++P + NL L L N +LP + + +L+YLN++
Sbjct: 84 LTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQ 212
N L +F L L LDLS+N LP F L+ + L L NQ
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQ 192
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 30/166 (18%), Positives = 45/166 (27%), Gaps = 34/166 (20%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFS-------------G 143
L L LS N+ T L L L L +N
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 144 NLPYSIASMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD-----LP 194
+ + L + RN L + F + L T+ + N + L
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 195 NSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNH 234
+ L LQ+N T GS + L L L + +
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 36/242 (14%), Positives = 68/242 (28%), Gaps = 49/242 (20%)
Query: 44 VQALQVLYTSLNSPSVLT--NWKGNE-GDPCGESWKGVACEGSA------VVSIDISG-- 92
+A + L ++ S L + G E + + A + ++ +S
Sbjct: 46 TEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105
Query: 93 LGLSG--TMGYLLSDLLSLRKFDLSGNSI---------------HDTIPYQLPPNLTSLN 135
G + + LS L L N + + P L S+
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165
Query: 136 LASNNFSGNLPYSIASMV----SLSYLNVSRNSLT-----QSIGDIFGNLAGLATLDLSF 186
N A L + + +N + + + L LDL
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 187 NNFSGD----LPNSFISLSNISSLYLQNNQVTG--------SLNVFSGLPLTTLNVANNH 234
N F+ L + S N+ L L + ++ + + + L TL + N
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285
Query: 235 FS 236
Sbjct: 286 IE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 27/132 (20%), Positives = 45/132 (34%), Gaps = 22/132 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHD-----TIPYQLPPN--LTSLNLASNNFSGNLPYSIASMV-- 153
L + N I + L L L+L N F+ ++A +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 154 --SLSYLNVSRNSLT----QSIGDIFGNLA--GLATLDLSFNNFSGD----LPNSFIS-L 200
+L L ++ L+ ++ D F L GL TL L +N D L +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302
Query: 201 SNISSLYLQNNQ 212
++ L L N+
Sbjct: 303 PDLLFLELNGNR 314
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 25/174 (14%), Positives = 49/174 (28%), Gaps = 41/174 (23%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFSGNLP-------YSI 149
L + S+++ LSGN+I L +L S+ F+G + +
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF-SDIFTGRVKDEIPEALRLL 86
Query: 150 ASMV----SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFS----------- 190
+ L + +S N+ + + D L L L N
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 191 --GDLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNHFS 236
+ + + S+ N++ L T+ + N
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 22/168 (13%), Positives = 42/168 (25%), Gaps = 39/168 (23%)
Query: 107 LSLRKFDLSGNSIHDT------IPYQLPPNLTSLNLASNNFSGNLPYSIASMV----SLS 156
S+ L ++I ++ + L+ N ++ + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 157 YLNVSRNSL----------TQSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
S + + L T+ LS N F L + +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 203 ISSLYLQNNQVT--GSLNVFSGLP-------------LTTLNVANNHF 235
+ LYL NN + + L L ++ N
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 24/119 (20%), Positives = 40/119 (33%), Gaps = 17/119 (14%)
Query: 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTSLNLASNNFS 142
I G+ + L+ L+ DL N+ + L PNL L L S
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 143 GNLPYSIASMV------SLSYLNVSRNSLT----QSIGD-IFGNLAGLATLDLSFNNFS 190
++ L L + N + +++ I + L L+L+ N FS
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 25/153 (16%), Positives = 51/153 (33%), Gaps = 23/153 (15%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPP---NLTSLNLASNNFS----GNLPYSIASMVSLSYLN 159
L ++ D+ + D +L P + L + ++ ++ +L+ LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 160 VSRNSLT----QSIGDIFGNL-AGLATLDLSFNNFS----GDLPNSFISLSNISSLYLQN 210
+ N L + + L L + G L ++ +L + L+L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 211 NQVT--GSLNVFSGL-----PLTTLNVANNHFS 236
N + G + GL L L + S
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 35/183 (19%), Positives = 56/183 (30%), Gaps = 32/183 (17%)
Query: 86 VSIDISGLGLSGT------MGYLLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTS 133
+S+DI L + LL L + L + + I L P L
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 134 LNLASNNFSGNLPYSIASMV-----SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDL 184
LNL SN + + + + L++ LT + L L L L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 185 SFNNFSGD----LPNSFISL-SNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANN 233
S N L + + L L+ ++ + S L L V+NN
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 234 HFS 236
+
Sbjct: 181 DIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 29/161 (18%), Positives = 59/161 (36%), Gaps = 27/161 (16%)
Query: 103 LSDLLSLRKFDLSGNSIHDT-----IPYQLPPN--LTSLNLASNNFSGNLPYSIASMV-- 153
++ SLR+ L N + D P L P+ L +L + + + ++
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 154 --SLSYLNVSRNSLT----QSIGD-IFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
SL L+++ N L + + + + L +L + +F+ +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 203 ISSLYLQNNQVT--GSLNVFSGLP-----LTTLNVANNHFS 236
+ L + NN++ G + GL L L +A+ S
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 29/162 (17%), Positives = 57/162 (35%), Gaps = 27/162 (16%)
Query: 102 LLSDLLSLRKFDLSGNSIHD----TIPYQL---PPNLTSLNLASNNFSGNLPYSIASMV- 153
L +L + +L N + D + L + L+L + +G ++S +
Sbjct: 51 ALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 110
Query: 154 ---SLSYLNVSRNSLT----QSIGDIFG-NLAGLATLDLSFNNFS----GDLPNSFISLS 201
+L L++S N L Q + + L L L + + S L + +
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 170
Query: 202 NISSLYLQNNQV--TGSLNVFSGLP-----LTTLNVANNHFS 236
+ L + NN + G + GL L L + + +
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 30/162 (18%), Positives = 58/162 (35%), Gaps = 27/162 (16%)
Query: 102 LLSDLLSLRKFDLSGNSIHDT----IPYQLPPN---LTSLNLASNNFS----GNLPYSIA 150
+L ++ +S N I++ + L + L +L L S + +L +A
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 151 SMVSLSYLNVSRNSLT----QSIGDIFGN-LAGLATLDLSFNNFSGD----LPNSFISLS 201
S SL L + N L + + + L TL + + L +
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 202 NISSLYLQNNQVT--GSLNVFSGL-----PLTTLNVANNHFS 236
++ L L N++ G+ + L L +L V + F+
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 30/164 (18%), Positives = 48/164 (29%), Gaps = 32/164 (19%)
Query: 102 LLSDLLSLRKFDLSGNSIHDT----IPYQLP--PNLTSLNLASNNFSGNLPYSIASMV-- 153
LL LR + I + L +L L+LA N + +
Sbjct: 251 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE 310
Query: 154 ---SLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD--------LPNSFI 198
L L V S T + L L +S N L
Sbjct: 311 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP-- 368
Query: 199 SLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNHFS 236
S + L+L + V+ ++ + L L L+++NN
Sbjct: 369 -GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 32/116 (27%), Positives = 52/116 (44%), Gaps = 3/116 (2%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
H ++P +P N L L N + P S+++L L + N L +F +L L
Sbjct: 31 HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 180 ATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANN 233
LDL N + LP++ F L ++ L++ N++T L LT L + N
Sbjct: 91 TVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 15/115 (13%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPP-------NLTSLNLASNNFSGNLPYSI-ASMVSLSY 157
L++L++ L N + LP LT L+L +N + LP ++ +V L
Sbjct: 63 LINLKELYLGSNQLG-----ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKE 116
Query: 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
L + N L + L L L L N +F LS+++ YL N
Sbjct: 117 LFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 29/164 (17%)
Query: 102 LLSDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIASMV- 153
S + DLS N+++ +L P ++TSLNL+ N+ + ++
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 154 ----SLSYLNVSRNSLT----QSIGDIF-GNLAGLATLDLSFNNFSGD----LPNSFISL 200
+++ LN+S N L+ + + LDL +N+FS +F +L
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 201 -SNISSLYLQNNQVT--GSLNVFSGLP-----LTTLNVANNHFS 236
++I+SL L+ N + S + L + +LN+ N+ +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 34/185 (18%), Positives = 62/185 (33%), Gaps = 35/185 (18%)
Query: 87 SIDISGLGLSGTMGYLLSDLL-----SLRKFDLSGNSIHDT-------IPYQLPPNLTSL 134
+D+ S S+ +L GN + I +P N+ SL
Sbjct: 113 VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL 172
Query: 135 NLASNNFSGNLPYSIASMV-----SLSYLNVSRNSLT----QSIGDIF-GNLAGLATLDL 184
NL NN + +A + S++ L++S N L + IF + +L+L
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNL 232
Query: 185 SFNNFSGD----LPNSFISLSNISSLYLQNNQVT-----GSLNVFSGLP----LTTLNVA 231
N G L SL ++ ++YL + V + + P + ++
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292
Query: 232 NNHFS 236
Sbjct: 293 GKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 24/130 (18%), Positives = 43/130 (33%), Gaps = 23/130 (17%)
Query: 108 SLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSG----NLPYSIASMVSLS 156
S+ DLS N + +L P ++ SLNL N G NL S+ L
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 157 YLNVSRNSLT-------QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISL-----SNIS 204
+ + + + +++G F N+ + +D + +L
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKAD 316
Query: 205 SLYLQNNQVT 214
L N +
Sbjct: 317 VPSLLNQCLI 326
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 41/229 (17%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHPN 469
+G+G+ GRV + N K AVK + N +A + E + L+ + N + N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQNDDINNN-N 97
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEYL 528
IV G + L++E +G +L++++ + + ++ ++ + +AL YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIE---DIKLYCIEILKALNYL 153
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGA----FG--- 581
++ S+ H + K NILLDD + T+ G FG
Sbjct: 154 RKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 582 --------------YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
Y APE L+ + V SD++SFG V+ EL TG L
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLL 258
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG GS G +Y A G+ +A+K + L E + + I T+
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQG-----GVGIPTIR 71
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
AE ++V E +G +L D+ +F S+ + + +A +EY+H
Sbjct: 72 WCGAEGDYNVMVMELLGP-SLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK--- 124
Query: 535 SVVHRNFKSANILLDDELNPH---LSDCGLAA--LTPNTERQV----STQMVGAFGYSAP 585
+ +HR+ K N L+ + + D GLA T + + + + G Y A
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-AS 183
Query: 586 EFALSGI-YTVKSDVYSFGVVMLELLTGRKP 615
GI + + D+ S G V++ G P
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 48/262 (18%), Positives = 86/262 (32%), Gaps = 74/262 (28%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE----EDNFLEAVSNMSRLRHPN---I 470
+G G V+ + GK K+ +A E E L++V N PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP-NDPNREMV 103
Query: 471 VTL------AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
V L +G H +V+E +G+ +L + ++ + L ++ +
Sbjct: 104 VQLLDDFKISGVNGTH--ICMVFEVLGH-HLLKWIIKSNY--QGLPLPCVKKIIQQVLQG 158
Query: 525 LEYLHEVCLPSVVHRNFKSANILL------------------------------------ 548
L+YLH C ++H + K NILL
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 549 -------------DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
++L ++D G A T+ + Y + E + Y
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNT 272
Query: 596 KSDVYSFGVVMLELLTGRKPLD 617
+D++S + EL TG +
Sbjct: 273 PADIWSTACMAFELATGDYLFE 294
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 48/225 (21%), Positives = 80/225 (35%), Gaps = 37/225 (16%)
Query: 417 LIGEGSLGRVYRA--EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHP 468
+GEG+ G+V +A+K I N AA + E N L+ + +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIKEKDKENKF 82
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVR-VALGTARALEY 527
V ++ + HG + +E +G N + L + L VR +A AL +
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLP---HVRHMAYQLCHALRF 138
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER----------------Q 571
LHE + H + K NIL + L + + + +
Sbjct: 139 LHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 572 VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
+T + Y PE L + DV+S G ++ E G L
Sbjct: 196 HTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTL 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 31/153 (20%), Positives = 62/153 (40%), Gaps = 20/153 (13%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IGEGS G ++ N + +A+K + A L++E + ++ I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG-----CTGIPNVY 72
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G +L D+L + + A ++ +HE
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK--- 125
Query: 535 SVVHRNFKSANILLDDELNP-----HLSDCGLA 562
S+V+R+ K N L+ + ++ D G+
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 35/165 (21%), Positives = 55/165 (33%), Gaps = 26/165 (15%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVK--------KIDNAALSLQEEDNFLEAV---------S 460
+ G +Y A + K+D L E NF +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 461 NMSRLRHPNIVTLAGYCAEHGQ-RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+ I T G+ + R LV +G +L L+ + ++VA
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSA--LDVSPKHVLSERSVLQVAC 166
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILL--DDELNPHLSDCGLA 562
ALE+LHE VH N + NI + +D+ L+ G A
Sbjct: 167 RLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 8e-06
Identities = 20/109 (18%), Positives = 36/109 (33%), Gaps = 18/109 (16%)
Query: 102 LLSDLLSLRKFDL---SGNSIHDTIPYQLP--------PNLTSLNLASNNFSGNLPYSIA 150
L SDL +L K L + D PNL L + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 151 S---MVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGD 192
+ L +++S LT + + D + L +++ +N S +
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 2e-05
Identities = 24/177 (13%), Positives = 61/177 (34%), Gaps = 23/177 (12%)
Query: 61 TNWKGNEGDPCGESWKGVACEGSAV-VSIDISGLGLSGTMGYLLSDLLS--LRKFDLSGN 117
W + + SW + ++ L + GT + L+ ++
Sbjct: 144 LFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISG 203
Query: 118 SIHDTIPYQL----PPNLTSLNL--ASNNFSGNLP-------YSIASMVSLSYLNVSRNS 164
+ D++ + PNL L L ++ + +S +L +L +
Sbjct: 204 GLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263
Query: 165 LTQSIGDIFGN---LAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVT 214
+ ++F L L T+D+S + + L + + ++ + ++ N ++
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 45/211 (21%), Positives = 81/211 (38%), Gaps = 26/211 (12%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG GS G +Y + +A+K + L E + I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG-----GTGIPNVR 69
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G +L D+ + S+ L+ + +A +E++H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLF---NFCSRKLSLKTVLMLADQMINRVEFVHSK--- 122
Query: 535 SVVHRNFKSANILLDDELNPH---LSDCGLAAL--TPNTERQV----STQMVGAFGYSAP 585
S +HR+ K N L+ + + D GLA +T + + + + G Y A
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-AS 181
Query: 586 EFALSGI-YTVKSDVYSFGVVMLELLTGRKP 615
GI + + D+ S G V++ L G P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 33/167 (19%), Positives = 69/167 (41%), Gaps = 28/167 (16%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVK-----KIDNA-ALSLQEEDNFL---------EAVSN 461
IG+G G +Y A+ + + + K++ + L E F +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 462 MSRLRHPNIVTLAGYCAEHGQ----RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+L++ + G R ++ + G+ +L + + ++K + +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY---EANAKRFSRKTVLQL 157
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLA 562
+L LEY+HE VH + K++N+LL+ + +L D GLA
Sbjct: 158 SLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 25/181 (13%), Positives = 59/181 (32%), Gaps = 27/181 (14%)
Query: 83 SAVVSIDISGLGLSGTMGYLLSDLL-----SLRKFDLSGNSIHDTIPYQLPP---NLTSL 134
S++ ++++G+ ++ +++ +L +L + +L+ + L P L
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL 131
Query: 135 NLASNNFSGNLPYSIASM-----VSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLS 185
L N+ + + ++ L +S N LT + + + L L
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLL 191
Query: 186 FNNFSGD----LPNSFISLSNISSLYLQNNQVT--GSLNVFSGLP----LTTLNVANNHF 235
+ L + L + N +L + L L++ N
Sbjct: 192 HTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
Query: 236 S 236
S
Sbjct: 252 S 252
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 29/153 (18%), Positives = 60/153 (39%), Gaps = 20/153 (13%)
Query: 418 IGEGSLGRVYRAE-FANGKIMAVK--KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
IG G+ G + + + +A+K + + A L E F + + + I +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS-----GDGIPQVY 71
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ +V E +G +L D+ + + + +A+ +EY+H
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK--- 124
Query: 535 SVVHRNFKSANILLDDELNP-----HLSDCGLA 562
++++R+ K N L+ N H+ D LA
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
+ +L+L S + V L+ + +L + I + L +L+LS N
Sbjct: 127 GSQQALDL-KGLRSDPDLVAQNIDVVLNRRSCMAATL-RIIEENIPELL---SLNLSNNR 181
Query: 189 FSG--DLPNSFISLSNISSLYLQNNQVT--GSLNVFSGLPLTTLNVANN 233
D+ + N+ L L N++ L+ GL L L + N
Sbjct: 182 LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 47/232 (20%), Positives = 81/232 (34%), Gaps = 51/232 (21%)
Query: 417 LIGEGSLGRVYRA--EFANGKIMAVKKIDN------AALSLQEEDNFLEAVSNMSRLRHP 468
+GEG+ G+V A G+ +AVK + N AA + E LE ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---RSEIQVLEHLNTTDPNSTF 77
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR----- 523
V + + HG +V+E +G + +D + K N + L R
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGL-STYDFI-------KE---NGFLPFRLDHIRKMAYQ 126
Query: 524 ---ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER---------- 570
++ +LH + H + K NIL + +
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 571 ------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616
ST + Y APE L+ ++ DV+S G +++E G +
Sbjct: 184 ATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG-FTV 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 36/165 (21%), Positives = 62/165 (37%), Gaps = 27/165 (16%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVK--KIDNAALS-LQEEDNFLEAVS---------NMS 463
IG G G +Y A + A K++ L E F + V+
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 464 RLRHPNIVTLAGY----CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVAL 519
+L + I G R +V E +G +L + + + +++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS----GQNGTFKKSTVLQLGI 158
Query: 520 GTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLA 562
LEY+HE VH + K+AN+LL + +L+D GL+
Sbjct: 159 RMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 14/130 (10%)
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATL 182
+P +P + T L L SN + L+ L++S+N + +F L L L
Sbjct: 22 VPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81
Query: 183 DLSFNNFSGDLPNS-FISLSNISSLYLQNNQVTGSLN-VFSGLP-LTTLNVANN------ 233
L N LPN F L+ + L L NQ+ + +F L L + + N
Sbjct: 82 YLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140
Query: 234 ----HFSGWI 239
+ S W+
Sbjct: 141 PRIDYLSRWL 150
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 4e-04
Identities = 38/301 (12%), Positives = 86/301 (28%), Gaps = 91/301 (30%)
Query: 349 NNMNTEMHEQRVKSVAAVTDLTPPPAEKL-------VIERVAKSGSLKKI---KSPITAT 398
++M+ E E + + ++ + + + + + I K ++ T
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64
Query: 399 SYTVASLQTATNSFSQEFLIGEGSLGRVY-------RAE------------------FAN 433
+L + Q+F+ E L Y + E + +
Sbjct: 65 LRLFWTLLSKQEEMVQKFV--EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 434 GKIMA---------VKKIDNAALSLQEEDNF--------------LEAVSNMSRLRHP-- 468
++ A K+ A L L+ N L+ +
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 469 NI--VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNL---TWNARVRVALGTAR 523
I + L C L L +L+ D + + + N ++R+ A
Sbjct: 183 KIFWLNL-KNCNSPETVLE--------MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD-----CGLAALTPNTERQVSTQMVG 578
L + +++ ++L + N + C + T +QV+ +
Sbjct: 234 LRRLLK--------SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF--KQVTDFLSA 283
Query: 579 A 579
A
Sbjct: 284 A 284
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 618 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.9 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.88 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.88 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.87 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.87 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.87 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.86 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.85 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.85 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.85 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.84 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.83 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.83 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.83 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.83 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.83 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.82 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.82 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.82 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.82 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.82 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.81 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.81 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.81 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.81 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.8 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.8 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.8 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.8 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.8 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.8 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.8 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.8 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.79 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.79 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.79 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.78 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.78 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.78 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.78 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.78 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.78 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.78 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.77 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.76 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.75 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.75 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.75 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.74 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.74 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.74 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.73 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.73 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.73 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.73 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.73 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.72 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.71 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.69 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.69 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.69 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.64 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.64 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.63 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.63 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.62 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.62 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.61 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.61 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.61 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.53 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.5 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.48 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.37 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.14 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.01 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.88 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.85 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.84 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.71 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.63 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.52 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.66 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.64 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.56 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.48 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.43 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.1 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.07 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.06 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.04 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.03 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.96 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.82 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.76 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.54 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.49 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.16 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 95.49 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.02 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.29 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.07 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.88 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.58 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.4 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.09 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=398.14 Aligned_cols=202 Identities=25% Similarity=0.430 Sum_probs=177.2
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|++.+.||+|+||.||+|++. +|+.||||++..........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999875 59999999998776666677889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
||++|+|.++++.. ....+++..++.|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999632 345678999999999999999999999 9999999999999999999999999999876432
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||.
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 223345689999999999999999999999999999999999999996
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=388.65 Aligned_cols=203 Identities=29% Similarity=0.484 Sum_probs=174.0
Q ss_pred hhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
+...+++...+.||+|+||+||+|++. ..||||+++......+..+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 445577888999999999999999875 358999998766667777899999999999999999999998864 56899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
|||||++|+|.++++. ....+++.++..|+.||++||+|||++ +||||||||+|||+++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999973 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-cccccceeccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTE-RQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 4332 223345689999999999964 458999999999999999999999996
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=389.68 Aligned_cols=201 Identities=24% Similarity=0.379 Sum_probs=180.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||+||+|+.. +|+.||||++.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999875 599999999975432 2233567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++. .+.+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999973 45799999999999999999999999 999999999999999999999999999987653
Q ss_pred CC-cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 32 333456799999999999999999999999999999999999999996
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=388.37 Aligned_cols=205 Identities=27% Similarity=0.481 Sum_probs=178.3
Q ss_pred hcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
.++|...+.||+|+||.||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 457888899999999999999874 4788999999754 34567789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC
Q 007103 483 RLLVYEYVGNGNLHDMLHFAD---------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN 553 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 553 (618)
.++|||||++|+|.++++... .....+++.++.+|+.||++||+|||++ +||||||||+|||+++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997532 2345799999999999999999999999 9999999999999999999
Q ss_pred cEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 554 PHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
+||+|||+|+........ ......||++|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999865433322 2334679999999999999999999999999999999999 9999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=390.79 Aligned_cols=198 Identities=28% Similarity=0.420 Sum_probs=178.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
...|+..+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456889999999999999999876 5999999999654322 3456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
|||++|+|.++++. ..+++.++..++.||+.||+|||++ +||||||||+|||++.++++||+|||+|+....
T Consensus 151 Ey~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 151 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 99999999999962 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus 223 ~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 223 EV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp SS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 32 23345789999999999999999999999999999999999999996
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=378.62 Aligned_cols=196 Identities=27% Similarity=0.418 Sum_probs=172.0
Q ss_pred cccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee----CCeEEEEE
Q 007103 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLVY 487 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 487 (618)
...+.||+|+||.||+|.+. +++.||+|++..........+.|.+|++++++++|||||++++++.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55668999999999999876 48899999998776666677889999999999999999999999865 34689999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCcEEeeccccccCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTP 566 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~ 566 (618)
|||++|+|.++++. ...+++..+..++.||+.||+|||++. ++||||||||+|||++ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999973 457899999999999999999999981 1399999999999998 47999999999998654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 32 3345789999999998865 69999999999999999999999995
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=386.52 Aligned_cols=205 Identities=26% Similarity=0.455 Sum_probs=176.7
Q ss_pred cCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++...+.||+|+||.||+|.+. +++.||||+++... .....++|++|+.++++++|||||+++|+|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 44566778999999999999873 46889999997554 333467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 484 LLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
++|||||++|+|.++++.... ....+++.++.+|+.||++||+|||++ +||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 999999999999999964321 124689999999999999999999999 99999999999999999
Q ss_pred CCcEEeeccccccCCCCC-cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
+.+||+|||+++...... ........||++|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 999999999998654332 223345689999999999999999999999999999999999 8999963
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=387.14 Aligned_cols=205 Identities=29% Similarity=0.488 Sum_probs=172.4
Q ss_pred hcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
.++|...+.||+|+||.||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 356778889999999999999874 4789999999754 34567789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 483 RLLVYEYVGNGNLHDMLHFADD-----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
.++|||||++|+|.++++.... ...++++.++.+|+.||++||+|||++ +||||||||+|||++++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999975332 235699999999999999999999999 99999999999999999
Q ss_pred CCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
+.+||+|||+++....... .......||++|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence 9999999999986643332 23345689999999999999999999999999999999999 9999963
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=387.08 Aligned_cols=200 Identities=28% Similarity=0.412 Sum_probs=172.0
Q ss_pred cCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
++|++.+.||+|+||+||+|+.. .++.||+|+++...........+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999763 37889999997655444445578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.++++. .+.+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999973 45799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC
Confidence 4332 22345789999999999999999999999999999999999999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=392.83 Aligned_cols=199 Identities=28% Similarity=0.419 Sum_probs=179.1
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..+.|+..+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 3467999999999999999999876 5999999999654322 345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
||||++|+|.++++. ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+...
T Consensus 227 mEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 999999999999962 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus 299 ~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 299 KEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp SSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 432 23346799999999999999999999999999999999999999996
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=383.74 Aligned_cols=196 Identities=25% Similarity=0.318 Sum_probs=171.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.+.|...+.||+|+||.||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..++||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 346788889999999999999875 589999999975432 246899999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEeeccccccCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAALTP 566 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~ 566 (618)
|||++|+|.++++. .+.+++..+..++.||+.||+|||++ +||||||||+|||++.++ ++||+|||+|+...
T Consensus 130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999973 35799999999999999999999999 999999999999999887 69999999998765
Q ss_pred CCCcc----cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 567 NTERQ----VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 567 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
..... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 258 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 33211 12346899999999999999999999999999999999999999963
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=370.92 Aligned_cols=199 Identities=29% Similarity=0.486 Sum_probs=162.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|++.+.||+|+||+||+|... +|+.||+|++.+.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 5999999999755432 233567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+ +|+|.+++. ..+.+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 579999986 346799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.. .....+||+.|||||++.+..| +.++||||+||++|||+||+.||+.
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 22 2345789999999999998876 5799999999999999999999963
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=377.76 Aligned_cols=211 Identities=25% Similarity=0.425 Sum_probs=181.7
Q ss_pred hhhhhhhcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCC-Ccccccce
Q 007103 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAG 475 (618)
Q Consensus 403 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~ 475 (618)
..++...++|+..+.||+|+||.||+|.+.. ++.||||+++... .....+.|.+|++++.+++| ||||+++|
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 3455667889999999999999999998653 3689999997654 33456789999999999965 89999999
Q ss_pred EEeeC-CeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 007103 476 YCAEH-GQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542 (618)
Q Consensus 476 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 542 (618)
+|.++ +..++|||||++|+|.++++..+. ....+++.++..++.||++||+|||++ +|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 99765 568999999999999999975332 134589999999999999999999999 99999999
Q ss_pred CCCeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 543 SANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 543 p~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+|||+++++.+||+|||+|+....... .......||++|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999987654333 23345689999999999999999999999999999999998 999996
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=368.92 Aligned_cols=198 Identities=27% Similarity=0.371 Sum_probs=163.5
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC----eEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QRLL 485 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 485 (618)
++|.+.+.||+|+||.||+|++ +|+.||||++.... .....+..|+..+.+++|||||++++++.+++ ..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4677888999999999999998 48999999986432 12223345666777899999999999998754 5799
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-----CLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
|||||++|+|.++++. ..+++..+.+++.|+++||+|||++ +.++||||||||+|||+++++++||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999973 4689999999999999999999975 23589999999999999999999999999
Q ss_pred ccccCCCCCcc---cccceeccccccCccccccC------CCCcccchhhHHHHHHHHHhCCCCC
Q 007103 561 LAALTPNTERQ---VSTQMVGAFGYSAPEFALSG------IYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 561 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~Pf 616 (618)
+++........ .....+||+.|||||++.+. .|+.++|||||||++|||+||+.||
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 99866443322 22346899999999999764 4788999999999999999998765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=363.67 Aligned_cols=200 Identities=25% Similarity=0.393 Sum_probs=162.0
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-------
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------- 481 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 481 (618)
++|+..+.||+|+||.||+|++. +|+.||||+++... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46889999999999999999875 68999999987543 3345578999999999999999999999987644
Q ss_pred -----eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEE
Q 007103 482 -----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (618)
Q Consensus 482 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 556 (618)
..++||||+++|+|.++++... .....++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 3689999999999999997322 223456777899999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCCCcc-----------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 557 SDCGLAALTPNTERQ-----------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 557 ~Dfgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 999999876433211 1234689999999999999999999999999999999996 774
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=369.39 Aligned_cols=200 Identities=27% Similarity=0.417 Sum_probs=175.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee------CCe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------HGQ 482 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 482 (618)
++|++.+.||+|+||.||+|.+. +|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999875 69999999998776666667889999999999999999999998764 357
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.|+|||||+ |+|.+++. ..+.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 68999986 456899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCC---CcccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNT---ERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+..... ........+||+.|||||++.+.. |+.++||||+||++|||++|+.||.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 866432 122334579999999999988754 6899999999999999999999995
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.35 Aligned_cols=199 Identities=26% Similarity=0.379 Sum_probs=170.6
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
++...++|++.+.||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++++.+ +||||+++++++.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 3445678999999999999999999753 46889999986543 345678899999888 69999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-CCcEEee
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSD 558 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~D 558 (618)
.+..++||||+++|+|.++++ .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 999999999999999999884 488999999999999999999999 99999999999999876 7999999
Q ss_pred ccccccCCCCCc---------------------------ccccceeccccccCccccccC-CCCcccchhhHHHHHHHHH
Q 007103 559 CGLAALTPNTER---------------------------QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELL 610 (618)
Q Consensus 559 fgl~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell 610 (618)
||+|+....... ......+||+.|||||++.+. .|+.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999975533211 112345799999999999875 5899999999999999999
Q ss_pred hCCCCCC
Q 007103 611 TGRKPLD 617 (618)
Q Consensus 611 tg~~Pf~ 617 (618)
||+.||.
T Consensus 242 ~G~~Pf~ 248 (361)
T 4f9c_A 242 SGRYPFY 248 (361)
T ss_dssp HTCSSSS
T ss_pred HCCCCCC
Confidence 9999994
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=377.51 Aligned_cols=199 Identities=30% Similarity=0.410 Sum_probs=173.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHH-HHH---HHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ-EED---NFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.+...... ... ..+.++++++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999876 599999999975432111 122 233446777888999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
|+||||++||+|.++++. .+.+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999973 45799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 765332 235689999999999975 579999999999999999999999995
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=367.72 Aligned_cols=199 Identities=24% Similarity=0.380 Sum_probs=178.5
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|+++|+.++||||+++++++.+++..++||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 467999999999999999999875 59999999987543 334677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC--CCcEEeeccccccC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE--LNPHLSDCGLAALT 565 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfgl~~~~ 565 (618)
|||++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 234 E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 234 EFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp ECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred eecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999998852 345799999999999999999999999 99999999999999854 89999999999877
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.
T Consensus 308 ~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 308 DPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp CTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 5432 2345689999999999999999999999999999999999999996
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.23 Aligned_cols=219 Identities=38% Similarity=0.721 Sum_probs=194.3
Q ss_pred cceehhhhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEE
Q 007103 398 TSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477 (618)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 477 (618)
..++..+++...++|...+.||+|+||.||+|...+|+.||+|++...... .....+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 457788899999999999999999999999999888999999999754422 2233688999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEe
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 557 (618)
...+..++||||+++|+|.++++........+++..+..++.|++.||+|||+.+.++|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998665556679999999999999999999999866689999999999999999999999
Q ss_pred eccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|||+++..............||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999998776555444555679999999999999999999999999999999999999995
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.46 Aligned_cols=210 Identities=26% Similarity=0.329 Sum_probs=182.6
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
+.++....++|+..+.||+|+||.||+|+..+ ++.||+|++++.... ......+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34455667889999999999999999998875 789999998653221 1122348889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
.+..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999973 246799999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||.
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 999876554444445578999999999997 5678999999999999999999999995
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=329.89 Aligned_cols=201 Identities=28% Similarity=0.434 Sum_probs=181.0
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|...+.||+|+||.||+|.+ .+|+.||+|++..........+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456799999999999999999987 4799999999987766666778899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999963 35689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcccccceeccccccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYT-VKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||+
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 215 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 332 23456899999999999988875 89999999999999999999996
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.07 Aligned_cols=207 Identities=23% Similarity=0.325 Sum_probs=180.4
Q ss_pred hhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 403 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
.++....++|+..+.||+|+||.||+|+.. +++.||+|++++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345566788999999999999999999886 488999999864321 111234578899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
+..++||||+++|+|.++++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999862 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGI----YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++.............+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 99877654443445678999999999998765 8899999999999999999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.49 Aligned_cols=201 Identities=27% Similarity=0.379 Sum_probs=177.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++.... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357889999999999999999876 589999999975432 222356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999863 35689999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCC
Confidence 322 22345689999999999999999999999999999999999999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.61 Aligned_cols=214 Identities=37% Similarity=0.717 Sum_probs=187.4
Q ss_pred ceehhhhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEe
Q 007103 399 SYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (618)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 478 (618)
.+...+++...++|+..+.||+|+||.||+|.+.+|+.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 345556677889999999999999999999998889999999987553 234677899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
..+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999975444445799999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCC-cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+++...... ........||+.|+|||++.+..++.++||||||+++|||+||+.||.
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence 99997654322 222344579999999999999999999999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=339.15 Aligned_cols=210 Identities=23% Similarity=0.298 Sum_probs=182.2
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
+.+.....++|+..+.||+|+||.||+|+.. +|+.||+|++++... .....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4445566788999999999999999999885 699999999965332 12233457889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
.+..++||||+++|+|.++++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999732 34789999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcccccceeccccccCccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFAL-------SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||.
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 999876554443344568999999999997 4568999999999999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.15 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=174.1
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+.+|+..+++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4567999999999999999999865 589999999854332 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999963 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
............||+.|+|||++.+..++.++||||||+++|||+||+.||+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 5443333445679999999999999999999999999999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.94 Aligned_cols=202 Identities=24% Similarity=0.381 Sum_probs=172.5
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
..++|+..+.||+|+||.||+|+.. +|+.||+|+++.... .......+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3467999999999999999999876 589999999975432 223346678889999887 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999973 35689999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 225 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCC
Confidence 43222 22345689999999999999999999999999999999999999996
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=318.17 Aligned_cols=199 Identities=27% Similarity=0.428 Sum_probs=177.5
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|+..+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 456899999999999999999986 46899999998654322 356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 96 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999999999963 3589999999999999999999999 99999999999999999999999999997665
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 217 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4332 2334679999999999999999999999999999999999999995
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=321.35 Aligned_cols=208 Identities=35% Similarity=0.522 Sum_probs=173.7
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.......+|+..+.||+|+||.||+|+. .|+.||+|++..........+.+.+|++++++++||||+++++++...+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3445567899999999999999999987 588999999987766666778899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeecCCCCcEEeeccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
++||||+++|+|.++++... ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999997321 112389999999999999999999999 7 99999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 97554322 22334679999999999999999999999999999999999999996
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.70 Aligned_cols=201 Identities=25% Similarity=0.407 Sum_probs=175.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH-HHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
.++|+..+.||+|+||.||+|+.. +++.||+|++++..... ...+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467889999999999999999876 47899999997654322 2334577888888776 89999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999873 35689999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 3222 22345689999999999999999999999999999999999999994
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=321.50 Aligned_cols=198 Identities=28% Similarity=0.457 Sum_probs=176.5
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999876 589999999975432 112356678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999973 45689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 204 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 32 234679999999999999999999999999999999999999995
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=323.62 Aligned_cols=201 Identities=26% Similarity=0.408 Sum_probs=177.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357888999999999999999876 489999999976543 334456788899999887 89999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.++++. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999863 35689999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 3222 22345689999999999999999999999999999999999999995
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.32 Aligned_cols=203 Identities=24% Similarity=0.411 Sum_probs=175.8
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 483 (618)
...++|...+.||+|+||.||+|+.. +|+.||+|+++.... .......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999886 589999999975432 112345677888888766 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999973 35689999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCC
Confidence 643222 22345689999999999999999999999999999999999999996
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=325.38 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=180.3
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|...+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999875 58999999998766666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC---CCcEEeecccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfgl~ 562 (618)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999999886 345789999999999999999999999 99999999999999864 45999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 179 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 179 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp BCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 77653322 234679999999999999999999999999999999999999995
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=327.08 Aligned_cols=200 Identities=29% Similarity=0.428 Sum_probs=176.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467889999999999999999876 488999999865432 222356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+.+|+|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999997 346799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcccccceeccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 332 2345689999999999974 458999999999999999999999995
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.50 Aligned_cols=205 Identities=18% Similarity=0.240 Sum_probs=174.2
Q ss_pred hhhhhcCCcccceeccCccceEEEEE------EcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC---CCcccccce
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAG 475 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~ 475 (618)
++...++|...+.||+|+||.||+|. ...++.||+|+++... ..++..|++.+.+++ |+||+++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 34456789999999999999999993 4468999999997543 345666666666665 999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC----
Q 007103 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADD-SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---- 550 (618)
Q Consensus 476 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---- 550 (618)
++...+..++||||+++|+|.++++..+. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence 99999999999999999999999975433 356799999999999999999999999 9999999999999998
Q ss_pred -------CCCcEEeeccccccCCC-CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 551 -------ELNPHLSDCGLAALTPN-TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 551 -------~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++.+||+|||+++.... .........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 89999999999965431 12233345689999999999999999999999999999999999999984
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=323.94 Aligned_cols=201 Identities=24% Similarity=0.341 Sum_probs=178.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH----HHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
..+.|...+.||+|+||.||+|... +|+.||+|.++...... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4567999999999999999999876 58999999987654321 134678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC----CcEEee
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSD 558 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~D 558 (618)
.++||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999996 345799999999999999999999999 999999999999998776 799999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99998765432 2234679999999999999999999999999999999999999995
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.42 Aligned_cols=201 Identities=26% Similarity=0.480 Sum_probs=176.7
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|...+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 467888999999999999999876 5899999988543 3456778999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 87 EYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp ECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999973 245799999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccc-------------ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQV-------------STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....||+.|+|||++.+..++.++||||||+++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~ 223 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSST
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCc
Confidence 32211 114579999999999999999999999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=318.85 Aligned_cols=205 Identities=26% Similarity=0.398 Sum_probs=175.5
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.+...++|+..+.||+|+||.||+|+..+|+.||+|++............+.+|++++++++||||+++++++.+.+..+
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 34456789999999999999999999988999999999765544445677889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 99999985 88887753 345689999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 169 FGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp TTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 643322 2234578999999999976 568999999999999999999999995
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.12 Aligned_cols=206 Identities=29% Similarity=0.494 Sum_probs=178.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc--------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (618)
..++|...+.||+|+||.||+|++. ++..||+|+++... .....+.+.+|+++++++ +||||+++++++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 4577899999999999999999763 35679999997653 444567899999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANI 546 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Ni 546 (618)
..+..++||||+++|+|.++++.... ....+++.++..++.||+.||+|||++ +|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 99999999999999999999975432 124589999999999999999999999 999999999999
Q ss_pred eecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 547 LLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 547 ll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999986543322 12233467889999999999999999999999999999999 999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=323.88 Aligned_cols=202 Identities=22% Similarity=0.348 Sum_probs=176.4
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
..++|+..+.||+|+||.||+|+... |+.||+|+++.... .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34679999999999999999998875 78999999975432 122346678889999887 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++. .+.+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999973 34689999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 222 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCC
Confidence 43222 22345689999999999999999999999999999999999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.28 Aligned_cols=203 Identities=26% Similarity=0.369 Sum_probs=179.5
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|+..+.||+|+||.||+|... +|+.+|+|++..........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34577999999999999999999765 68999999998766666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec---CCCCcEEeecccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgl~ 562 (618)
||||+++|+|.+.+. ....+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999999886 345699999999999999999999999 999999999999998 5678999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.
T Consensus 161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 77654322 2234689999999999999999999999999999999999999995
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=322.71 Aligned_cols=198 Identities=24% Similarity=0.376 Sum_probs=177.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.++|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467899999999999999999876 589999999865432 222356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999973 35689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 239 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence 32 234689999999999999999999999999999999999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=324.19 Aligned_cols=205 Identities=25% Similarity=0.346 Sum_probs=177.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc---HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS---LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|+..+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999875 5899999998643211 113567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC---cEEeeccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGL 561 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfgl 561 (618)
+||||+++++|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988865444455689999999999999999999999 9999999999999986554 99999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 98765432 22344679999999999999999999999999999999999999995
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.80 Aligned_cols=201 Identities=29% Similarity=0.494 Sum_probs=179.2
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..++|+..+.||+|+||.||+|.+.+++.||+|++...... .+++.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 34678889999999999999999988999999999865433 456899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 85 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp ECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999963 345689999999999999999999999 999999999999999999999999999986654
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 43333344567889999999999999999999999999999999 999996
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=316.34 Aligned_cols=199 Identities=19% Similarity=0.273 Sum_probs=177.1
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|...+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 3467999999999999999999876 5889999998743 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC--CCCcEEeecccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--ELNPHLSDCGLAAL 564 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~ 564 (618)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999862 335789999999999999999999999 9999999999999987 78999999999987
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 154 LKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 65432 2234679999999999999889999999999999999999999995
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.69 Aligned_cols=195 Identities=28% Similarity=0.413 Sum_probs=174.3
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEec
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
|+..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 666778999999999999886 699999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 570 (618)
++++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 125 ~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 125 QGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp CSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 9999999985 34689999999999999999999999 999999999999999999999999999976654322
Q ss_pred ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 571 QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 571 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 197 -KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2234679999999999999999999999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.96 Aligned_cols=201 Identities=25% Similarity=0.406 Sum_probs=167.0
Q ss_pred hcCCcccceeccCccceEEEEEE----cCCcEEEEEEcCcccc--cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
.++|+..+.||+|+||.||+|+. .+|+.||+|+++.... .......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999987 4689999999976532 22344567889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999963 34688999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCC
Confidence 7543222 22234579999999999999999999999999999999999999996
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.56 Aligned_cols=202 Identities=27% Similarity=0.391 Sum_probs=168.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHH-hhcCCCCcccccceEEeeCCeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSN-MSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
..++|+..+.||+|+||.||+|+.. +++.||+|++++.... ......+..|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3467999999999999999999886 4889999999765432 2334556667666 57789999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 116 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999999973 35688999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 43222 22345689999999999999999999999999999999999999995
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.95 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=171.9
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
++|+..+.||+|+||.||+|...+|+.||+|++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999988899999999976544433456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 985 89888863 345789999999999999999999999 99999999999999999999999999997654322
Q ss_pred cccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1 22345789999999999764 58999999999999999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.34 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=173.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 467999999999999999999876 689999999864432 223467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 9999999999986 345699999999999999999999999 999999999999999999999999999976532
Q ss_pred CC-cccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TE-RQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||+
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 209 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 22 222334689999999999988776 789999999999999999999996
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.39 Aligned_cols=206 Identities=24% Similarity=0.391 Sum_probs=181.2
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|+.. +|+.||+|++...... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3467899999999999999999886 5999999999754322 1234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999875444456799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~ 390 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence 54322 2234589999999999999999999999999999999999999995
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.28 Aligned_cols=204 Identities=26% Similarity=0.445 Sum_probs=178.0
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.....++|+..+.||+|+||.||+|.+.++..||+|+++..... .+++.+|++++.+++||||+++++++.+.+..+
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 34556789999999999999999999998999999999865433 456889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++++|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 96 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 96 IITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred EEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999973 235689999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.............+|+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~ 223 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 65443333334467888999999999999999999999999999998 999996
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.20 Aligned_cols=202 Identities=27% Similarity=0.454 Sum_probs=180.2
Q ss_pred hhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...++|+..+.||+|+||.||+|++.++..||+|+++..... .+++.+|++.+.+++||||+++++++.+.+..++|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 345778999999999999999999998889999999765433 45688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 9999999999999642 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
...........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence 544443444567788999999999999999999999999999999 999996
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.51 Aligned_cols=203 Identities=29% Similarity=0.464 Sum_probs=175.2
Q ss_pred hhcCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
..++|...+.||+|+||.||+|.+. .+..||||+++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 4567899999999999999999875 35569999997543 444567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999963 345799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 76543221 2223456788999999999999999999999999999999 999995
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.41 Aligned_cols=200 Identities=31% Similarity=0.473 Sum_probs=174.5
Q ss_pred hcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccH-HHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.++|...+.||+|+||.||+|.+ .+|+.||+|++....... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999987 468999999986543221 1235788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+ +|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6799998863 35689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
... .....+||+.|+|||++.+..+ ++++|||||||++|||++|+.||+.
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 432 2234579999999999998876 6899999999999999999999963
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=309.93 Aligned_cols=199 Identities=23% Similarity=0.372 Sum_probs=173.9
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|+||.||+|... +|+.||+|++............+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46889999999999999999876 58999999997666555566788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 56555542 346799999999999999999999999 9999999999999999999999999999866433
Q ss_pred CcccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf 616 (618)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 22 223457899999999998766 799999999999999999998885
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.33 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=177.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH----HHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
..+.|...+.||+|+||.||+|... +|+.||+|.+....... ...+.+.+|++++++++||||+++++++...+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4467889999999999999999876 58999999987543221 135678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC----CcEEee
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSD 558 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~D 558 (618)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999999996 345799999999999999999999999 999999999999999887 799999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 162 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 162 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 999987643322 234579999999999999999999999999999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=321.60 Aligned_cols=205 Identities=23% Similarity=0.326 Sum_probs=180.1
Q ss_pred hhcCCcccceeccC--ccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 408 ATNSFSQEFLIGEG--SLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
..++|+..+.||+| +||.||+|+.. +|+.||||++..........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999886 6999999999877666667788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999999742 235689999999999999999999999 999999999999999999999999998864
Q ss_pred CCCCC------cccccceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTE------RQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 32111 111223478999999999987 678999999999999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.35 Aligned_cols=203 Identities=26% Similarity=0.394 Sum_probs=169.4
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe---
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ--- 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 482 (618)
..++|+..+.||+|+||.||+|.. .+++.||+|+++.... .......+.+|++.+++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 456899999999999999999987 4689999999976533 33445678999999999999999999999876543
Q ss_pred -EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 483 -RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 483 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
.++||||+++++|.++++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 4999999999999999973 35689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++........ ......||+.|+|||++.+..++.++||||||+++|||+||+.||.
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9765433221 2234579999999999999999999999999999999999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=309.65 Aligned_cols=200 Identities=23% Similarity=0.356 Sum_probs=168.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH------------------------HHHHHHHHHHHHhh
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL------------------------QEEDNFLEAVSNMS 463 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~ 463 (618)
.++|...+.||+|+||.||+|... +|+.||+|++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467899999999999999999875 58899999986543211 12356889999999
Q ss_pred cCCCCcccccceEEee--CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 007103 464 RLRHPNIVTLAGYCAE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNF 541 (618)
Q Consensus 464 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 541 (618)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 568899999999999988663 45799999999999999999999999 9999999
Q ss_pred CCCCeeecCCCCcEEeeccccccCCCCCcccccceeccccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 542 KSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 542 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654322 223457999999999998765 4788999999999999999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.63 Aligned_cols=204 Identities=27% Similarity=0.420 Sum_probs=179.4
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
...++|...+.||+|+||.||+|... +|+.||+|++..... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34567999999999999999999876 699999999975432 2223566889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 261 lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999998632 234589999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~ 386 (576)
T 2acx_A 336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386 (576)
T ss_dssp CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSS
T ss_pred cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 654322 234589999999999999999999999999999999999999996
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.25 Aligned_cols=203 Identities=26% Similarity=0.460 Sum_probs=165.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
...+|...+.||+|+||.||+|++. ++..||||+++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 3467899999999999999999875 47789999997643 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.++++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 999999999999999973 345799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccc--ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 765332211 122346788999999999999999999999999999998 999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=322.18 Aligned_cols=202 Identities=27% Similarity=0.426 Sum_probs=165.6
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCC--e
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHG--Q 482 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 482 (618)
...++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999865 5899999999766656667788889999999997 999999999997644 6
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||++ ++|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999998 589998862 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCC--------------------CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNT--------------------ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+..... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 765321 1112234689999999999987 678999999999999999999999995
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.52 Aligned_cols=202 Identities=26% Similarity=0.382 Sum_probs=167.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|... +|+.||+|+++.... .......+.+|+++++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999875 589999999975432 23345677889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999863 3568999999999999999999998 7 999999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 43322 22344689999999999999999999999999999999999999995
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.16 Aligned_cols=199 Identities=22% Similarity=0.342 Sum_probs=176.2
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999876 58899999986543 334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC--CCCcEEeeccccccC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--ELNPHLSDCGLAALT 565 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~ 565 (618)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 128 E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 128 EFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp ECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999998862 345799999999999999999999999 9999999999999974 578999999999876
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 202 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 202 NPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp CTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 54322 234579999999999999999999999999999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=313.48 Aligned_cols=204 Identities=24% Similarity=0.354 Sum_probs=172.1
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 481 (618)
..++|+..+.||+|+||.||+|++. +|+.||||+++... .....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3467889999999999999999886 69999999987544 3335678999999999999999999999986543
Q ss_pred ----------------------------------------------------eEEEEEEecCCCChhhhhhcccCCCCCC
Q 007103 482 ----------------------------------------------------QRLLVYEYVGNGNLHDMLHFADDSSKNL 509 (618)
Q Consensus 482 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l 509 (618)
..++||||+++|+|.++++... .....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~ 161 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDR 161 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGS
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccch
Confidence 3799999999999999997432 23345
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCc-----------ccccceec
Q 007103 510 TWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-----------QVSTQMVG 578 (618)
Q Consensus 510 ~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~g 578 (618)
++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 7778899999999999999999 999999999999999999999999999987654321 12234579
Q ss_pred cccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 579 t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
|+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999999998875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.96 Aligned_cols=201 Identities=24% Similarity=0.341 Sum_probs=171.8
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCC--CcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH--PNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|...+++.||+|++.......+..+.+.+|++++.+++| |||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456799999999999999999998889999999998766666677889999999999976 999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||| +.+++|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 567899999973 45789999999999999999999999 999999999999997 568999999999876
Q ss_pred CCCCcc-cccceeccccccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQ-VSTQMVGAFGYSAPEFALS-----------GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 543322 2335679999999999865 678999999999999999999999996
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.59 Aligned_cols=204 Identities=26% Similarity=0.382 Sum_probs=172.4
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC---
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--- 481 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 481 (618)
+....++|+..+.||+|+||.||+|++. ++.||||++.... .....+..|+..+++++||||+++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 3445678999999999999999999886 7999999996442 23445567899999999999999999998754
Q ss_pred -eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------CCCCceecCCCCCCeeecCCCC
Q 007103 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV-------CLPSVVHRNFKSANILLDDELN 553 (618)
Q Consensus 482 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~~iiH~Dlkp~Nill~~~~~ 553 (618)
..++||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +.++|+||||||+|||++.++.
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred ceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 47999999999999999963 4589999999999999999999986 1237999999999999999999
Q ss_pred cEEeeccccccCCCCCc-ccccceeccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 554 PHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 99999999976543322 22234679999999999987 356778999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.29 Aligned_cols=204 Identities=25% Similarity=0.467 Sum_probs=178.3
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.+...++|...+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++. .+..+
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 4456678899999999999999999998899999999986443 3567999999999999999999999986 56789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 9999999999999997321 23578899999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.............+|+.|+|||++....++.++|||||||++|||+| |+.||.
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 65433222334457789999999999999999999999999999999 999996
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.70 Aligned_cols=204 Identities=25% Similarity=0.424 Sum_probs=177.2
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|...+.||+|+||.||+|.+. +++.||+|.++... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 34567888999999999999999886 68999999987543 34455678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999973 234589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcccc-cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 566 PNTERQVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........ ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~ 317 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP 317 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43221111 12346788999999999999999999999999999998 999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=316.29 Aligned_cols=210 Identities=28% Similarity=0.465 Sum_probs=180.1
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEE
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 477 (618)
.+....++|...+.||+|+||.||+|++. +++.||+|.++... .....+.+.+|++++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34556788999999999999999999875 34889999997554 344567899999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADDS--------------------SKNLTWNARVRVALGTARALEYLHEVCLPSVV 537 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii 537 (618)
.+.+..++||||+++|+|.++++..... ...+++.+++.++.||++||+|||+. +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 9999999999999999999999753211 25789999999999999999999999 999
Q ss_pred ecCCCCCCeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCC
Q 007103 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKP 615 (618)
Q Consensus 538 H~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P 615 (618)
||||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999975532221 12233568899999999999999999999999999999999 9999
Q ss_pred CC
Q 007103 616 LD 617 (618)
Q Consensus 616 f~ 617 (618)
|.
T Consensus 277 ~~ 278 (343)
T 1luf_A 277 YY 278 (343)
T ss_dssp TT
T ss_pred CC
Confidence 85
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.98 Aligned_cols=203 Identities=23% Similarity=0.390 Sum_probs=160.9
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|... +|+.||+|+++... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357888999999999999999875 58999999986543 2223466889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 488 EYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||++ |+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59999886432 2234689999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 43222 2234578999999999976 468999999999999999999999995
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.27 Aligned_cols=214 Identities=25% Similarity=0.437 Sum_probs=180.5
Q ss_pred eehhhhhhhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccc
Q 007103 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVT 472 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 472 (618)
+.....+...++|...+.||+|+||.||+|++. +++.||||+++... .....+.+.+|++++.++ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 334455667789999999999999999999742 46889999997543 344567899999999999 7999999
Q ss_pred cceEEeeCC-eEEEEEEecCCCChhhhhhcccCC----------------------------------------------
Q 007103 473 LAGYCAEHG-QRLLVYEYVGNGNLHDMLHFADDS---------------------------------------------- 505 (618)
Q Consensus 473 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------- 505 (618)
+++++.+.+ ..++||||+++|+|.++++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998765 489999999999999999753321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 506 ----------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 506 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12289999999999999999999999 99999999999999999999999999998654332
Q ss_pred c-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 570 R-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 570 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 297 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCC
Confidence 2 23344678999999999999999999999999999999998 999995
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=315.89 Aligned_cols=199 Identities=26% Similarity=0.415 Sum_probs=161.3
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
....++|+..+.||+|+||.||+|... +++.||+|+++... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 345678999999999999999999886 47899999987532 3466889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCcEEeeccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGL 561 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl 561 (618)
+||||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 125 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 125 LVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 9999999999999986 345689999999999999999999999 9999999999999975 88999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 198 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 198 SKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 97654322 2234679999999999999999999999999999999999999995
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.00 Aligned_cols=202 Identities=27% Similarity=0.482 Sum_probs=177.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+++++.++||||+++++++...+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3467889999999999999999876 6999999999754321 1234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.+++. ..+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 94 v~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 94 VMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 999999999999996 346799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||+.
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 167 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp CTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 5432 2234579999999999998776 6899999999999999999999963
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.25 Aligned_cols=200 Identities=26% Similarity=0.302 Sum_probs=169.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||+||+|... +|+.||||++............+..|+..+.++ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4467999999999999999999886 699999999876655555555666666655554 89999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 56998888642 45699999999999999999999999 9999999999999999999999999998766
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4332 2234579999999999876 78999999999999999999976653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.49 Aligned_cols=200 Identities=26% Similarity=0.398 Sum_probs=172.3
Q ss_pred cCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|+||.||+|.... |+.||+|++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578899999999999999998864 8999999997766565667788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999998886 345689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 22 2234578999999999976 668999999999999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.59 Aligned_cols=203 Identities=25% Similarity=0.388 Sum_probs=174.7
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC--eEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~ 484 (618)
..++|...+.||+|+||.||+|.... |+.||+|++..... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 34678999999999999999998864 89999999975432 223567789999999999999999999988765 789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----cCCCCcEEeecc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCG 560 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfg 560 (618)
+||||+++++|.++++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 86 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999997432 233489999999999999999999999 99999999999999 778889999999
Q ss_pred ccccCCCCCcccccceeccccccCccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFAL--------SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||.
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred CceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9987654332 23457999999999986 5778999999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=312.57 Aligned_cols=211 Identities=24% Similarity=0.446 Sum_probs=163.8
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEcCCc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFANGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
+.....++|+..+.||+|+||.||+|.+.... .||+|+++.........+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 44456678999999999999999999876432 79999998765555667889999999999999999999999987
Q ss_pred CCeE------EEEEEecCCCChhhhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 480 HGQR------LLVYEYVGNGNLHDMLHFADD--SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 480 ~~~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
.... ++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 999999999999999964332 223689999999999999999999999 99999999999999999
Q ss_pred CCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 241 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9999999999976543322 12223457889999999999999999999999999999999 999996
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=314.42 Aligned_cols=198 Identities=18% Similarity=0.252 Sum_probs=173.2
Q ss_pred hcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 486 (618)
.++|...+.||+|+||.||+|.. .+|+.||||.+..... .+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46789999999999999999986 4689999999864432 24578899999999 999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC-----cEEeeccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-----PHLSDCGL 561 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfgl 561 (618)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9999 89999999742 45799999999999999999999999 9999999999999998887 99999999
Q ss_pred cccCCCCCcc------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~ 218 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence 9865433221 1235689999999999999999999999999999999999999996
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.53 Aligned_cols=209 Identities=29% Similarity=0.467 Sum_probs=180.2
Q ss_pred hhhhhcCCcccceeccCccceEEEEEE------cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEe
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 478 (618)
.+...++|...+.||+|+||.||+|.. .+++.||+|+++... .....+.+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 445567899999999999999999976 245889999997543 4455678999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADD--------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVH 538 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH 538 (618)
..+..++||||+++++|.++++.... ....+++.+++.++.|+++||+|||+. +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 99999999999999999999975432 123489999999999999999999999 9999
Q ss_pred cCCCCCCeeecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 007103 539 RNFKSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPL 616 (618)
Q Consensus 539 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf 616 (618)
|||||+||++++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999866443322 2233467889999999999999999999999999999999 99998
Q ss_pred C
Q 007103 617 D 617 (618)
Q Consensus 617 ~ 617 (618)
.
T Consensus 254 ~ 254 (314)
T 2ivs_A 254 P 254 (314)
T ss_dssp T
T ss_pred C
Confidence 6
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.88 Aligned_cols=198 Identities=23% Similarity=0.306 Sum_probs=169.2
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (618)
..++|+..+.||+|+||.||+|... +|+.||||++..........+.+.+|+++++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999765 589999999987665666778899999999999999999999999654
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++||||+++ ++.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 357999999986 5666664 2489999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 99866432 22345689999999999999999999999999999999999999996
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=306.23 Aligned_cols=204 Identities=26% Similarity=0.395 Sum_probs=164.8
Q ss_pred hhhhcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
+...++|+..+.||+|+||.||+|.+.. +..||+|.++... .....+.+.+|+..+++++||||+++++++. ++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 3455789999999999999999998753 5579999987543 3445678999999999999999999999984 56
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence 78999999999999999963 234689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++..............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 98765443333334467889999999999999999999999999999997 999996
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.61 Aligned_cols=206 Identities=26% Similarity=0.388 Sum_probs=175.8
Q ss_pred hhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
..++|...+.||+|+||.||+|.+. +++.||||+++... .......+.+|+.++++++||||+++++++...+
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4567899999999999999999853 46789999997543 4455667899999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC---CcE
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPH 555 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~k 555 (618)
..++||||+++|+|.++++..+. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999975432 235689999999999999999999999 999999999999999554 599
Q ss_pred EeeccccccCCCCC-cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 556 LSDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 556 l~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~ 288 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999997432111 112233568899999999999999999999999999999998 999996
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.19 Aligned_cols=208 Identities=28% Similarity=0.470 Sum_probs=179.9
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc--------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY 476 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 476 (618)
+...++|...+.||+|+||.||+|++. .+..||+|+++... .......+.+|+++++++ +||||++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 445678999999999999999999863 24679999997653 445567899999999999 89999999999
Q ss_pred EeeCCeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 477 CAEHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
+...+..++||||+++|+|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 9999999999999999999999975432 124689999999999999999999999 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|||+++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999986643322 22334567899999999999999999999999999999999 999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.50 Aligned_cols=200 Identities=25% Similarity=0.344 Sum_probs=171.6
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC--CCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 486 (618)
.++|...+.||+|+||.||+|...+++.||||++..........+.+.+|++++.+++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999999888999999999766556667788999999999996 59999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|| +.+++|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 567899999973 34788999999999999999999999 999999999999996 5799999999998765
Q ss_pred CCCcc-cccceeccccccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQ-VSTQMVGAFGYSAPEFALS-----------GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 33222 2344679999999999875 468999999999999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.03 Aligned_cols=207 Identities=26% Similarity=0.363 Sum_probs=180.0
Q ss_pred cceehhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-----CCccc
Q 007103 398 TSYTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----HPNIV 471 (618)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv 471 (618)
..+.........++|...+.||+|+||.||+|... +++.||+|+++.. ......+..|++++++++ ||||+
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 34556666777889999999999999999999875 5889999999742 334556777888888886 99999
Q ss_pred ccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-
Q 007103 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD- 550 (618)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~- 550 (618)
++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||+++
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 88999999743 234589999999999999999999999 9999999999999975
Q ss_pred ------------------------CCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHH
Q 007103 551 ------------------------ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVM 606 (618)
Q Consensus 551 ------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 606 (618)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 7899999999997654322 345789999999999999999999999999999
Q ss_pred HHHHhCCCCCC
Q 007103 607 LELLTGRKPLD 617 (618)
Q Consensus 607 ~elltg~~Pf~ 617 (618)
|||++|+.||.
T Consensus 250 ~ell~g~~pf~ 260 (360)
T 3llt_A 250 AELYTGSLLFR 260 (360)
T ss_dssp HHHHHSSCSCC
T ss_pred HHHHHCCCCCC
Confidence 99999999995
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=330.11 Aligned_cols=205 Identities=26% Similarity=0.472 Sum_probs=180.6
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.+....+|...+.||+|+||.||+|.+.. ++.||||.++.... ..+.|.+|++++++++||||+++++++...+..
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 34456678899999999999999998875 88999999976543 356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.++++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 292 ~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999999743 345689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..............+++.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence 765443333334567789999999999999999999999999999999 999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.47 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=179.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999876 589999999987766666778899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC---cEEeeccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfgl~~ 563 (618)
|||+++++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999988863 35689999999999999999999999 9999999999999986655 9999999997
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 6653322 234579999999999999999999999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=306.41 Aligned_cols=203 Identities=25% Similarity=0.361 Sum_probs=167.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++.+++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3467999999999999999999876 688999999976543 33345788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999973 35689999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
............||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 5443333344679999999999999999999999999999999999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.56 Aligned_cols=196 Identities=26% Similarity=0.382 Sum_probs=158.5
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----Ce
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (618)
.++|+..+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999765 689999999987665666778899999999999999999999998443 57
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||++ ++|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 68999886 356799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCc--------------------------ccccceeccccccCcccc-ccCCCCcccchhhHHHHHHHHHhC
Q 007103 563 ALTPNTER--------------------------QVSTQMVGAFGYSAPEFA-LSGIYTVKSDVYSFGVVMLELLTG 612 (618)
Q Consensus 563 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg 612 (618)
+....... ......+||+.|+|||++ .+..|+.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 86642211 123446889999999986 456799999999999999999993
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.46 Aligned_cols=198 Identities=25% Similarity=0.374 Sum_probs=165.6
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|...+.||+|+||.||+|+.. +++.||+|++...... .+.+.+|+..+++++||||+++++++.+.+..++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 4567999999999999999999876 6899999999754322 35678999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC--cEEeecccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLSDCGLAAL 564 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfgl~~~ 564 (618)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.
T Consensus 95 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 95 MEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999863 35689999999999999999999999 9999999999999987765 99999999874
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcc-cchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVK-SDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 33221 2234579999999999988887655 899999999999999999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=305.06 Aligned_cols=214 Identities=36% Similarity=0.626 Sum_probs=184.5
Q ss_pred cceehhhhhhhhcCCccc------ceeccCccceEEEEEEcCCcEEEEEEcCccc--ccHHHHHHHHHHHHHhhcCCCCc
Q 007103 398 TSYTVASLQTATNSFSQE------FLIGEGSLGRVYRAEFANGKIMAVKKIDNAA--LSLQEEDNFLEAVSNMSRLRHPN 469 (618)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~------~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~n 469 (618)
..++..++..+++.|... +.||+|+||.||+|.. +++.||+|++.... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457777888888888777 8999999999999987 58899999986532 22334678999999999999999
Q ss_pred ccccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec
Q 007103 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (618)
Q Consensus 470 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~ 549 (618)
|+++++++...+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999986432 245689999999999999999999999 999999999999999
Q ss_pred CCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 550 DELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 550 ~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 999999999999976643322 22234579999999998865 58899999999999999999999996
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.55 Aligned_cols=202 Identities=23% Similarity=0.352 Sum_probs=176.1
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH------HHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL------QEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
...++|...+.||+|+||.||+|... +|+.||+|++....... .....+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34578999999999999999999864 58999999987553211 123457789999999999999999999999
Q ss_pred CCeEEEEEEecCCC-ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 480 HGQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 480 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
.+..++||||+..| +|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence 99999999999777 9999986 345799999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.
T Consensus 174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 999987654322 234679999999999998877 889999999999999999999995
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.27 Aligned_cols=202 Identities=26% Similarity=0.381 Sum_probs=173.6
Q ss_pred hcCCcccceeccCccceEEEEEE----cCCcEEEEEEcCcccc--cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCC
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF----ANGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHG 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 481 (618)
.++|+..+.||+|+||.||+|+. .+|+.||||+++.... .......+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46799999999999999999987 3689999999875432 112334567788888888 6999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999973 34689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 98765444444445689999999999986 347899999999999999999999995
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.51 Aligned_cols=195 Identities=27% Similarity=0.397 Sum_probs=166.8
Q ss_pred cccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecC
Q 007103 413 SQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVG 491 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 491 (618)
...+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 34668999999999999875 58999999987543 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee--cCCCCcEEeeccccccCCCCC
Q 007103 492 NGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL--DDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 492 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill--~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 170 ~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 170 GGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp TCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999998863 234689999999999999999999999 99999999999999 567889999999998765433
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 244 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 244 K--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp B--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred c--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 2 233579999999999999999999999999999999999999996
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.44 Aligned_cols=201 Identities=26% Similarity=0.368 Sum_probs=171.7
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----C
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----G 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 481 (618)
..++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3568999999999999999999875 488999999987666666778899999999999999999999999776 5
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||++ |+|.++++ ....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 7899999987 59999986 346799999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc---------------------ccccceeccccccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 562 AALTPNTER---------------------QVSTQMVGAFGYSAPEFA-LSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 562 ~~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
++....... ......+||+.|+|||++ ....|+.++|||||||++|||++|..||
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 987643321 123456899999999986 5567999999999999999999866655
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.62 Aligned_cols=190 Identities=27% Similarity=0.435 Sum_probs=151.1
Q ss_pred cceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEEEEecCC
Q 007103 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
.+.||+|+||.||+|... +|+.||+|++... ....+.+|++.++.+. ||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 368999999999999876 5899999998643 3456778999999997 99999999999999999999999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC---CcEEeeccccccCCCCC
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL---NPHLSDCGLAALTPNTE 569 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfgl~~~~~~~~ 569 (618)
|+|.++++. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 91 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 91 GELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999973 46799999999999999999999999 999999999999998665 79999999998664432
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 164 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 164 Q-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred C-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 2 2234578999999999999999999999999999999999999996
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.18 Aligned_cols=200 Identities=30% Similarity=0.485 Sum_probs=177.8
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.++|...+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 4678889999999999999999988999999999865433 3578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999963 235689999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.........+++.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCC
Confidence 2222334467889999999998999999999999999999999 899996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.84 Aligned_cols=205 Identities=29% Similarity=0.446 Sum_probs=178.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCeEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLL 485 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 485 (618)
.++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999876 68999999998766566677889999999999999999999998754 578999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----ceecCCCCCCeeecCCCCcEEeecc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS-----VVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
||||+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976544556699999999999999999999999 7 9999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 217 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 997664332 22234578999999999999999999999999999999999999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.78 Aligned_cols=211 Identities=27% Similarity=0.316 Sum_probs=173.4
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc---cHHHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL---SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
++....++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566788999999999999999999875 588999999865432 23456789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDS------------------------------------SKNLTWNARVRVALGTAR 523 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~ 523 (618)
.+..++||||+++|+|.++++..... ...+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521111 122467788899999999
Q ss_pred HHHHHhhcCCCCceecCCCCCCeeecCCC--CcEEeeccccccCCCC---CcccccceeccccccCcccccc--CCCCcc
Q 007103 524 ALEYLHEVCLPSVVHRNFKSANILLDDEL--NPHLSDCGLAALTPNT---ERQVSTQMVGAFGYSAPEFALS--GIYTVK 596 (618)
Q Consensus 524 ~L~~LH~~~~~~iiH~Dlkp~Nill~~~~--~~kl~Dfgl~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 596 (618)
||+|||+. +|+||||||+||+++.++ .+||+|||+++..... .........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 8999999999754321 1112344679999999999975 678999
Q ss_pred cchhhHHHHHHHHHhCCCCCC
Q 007103 597 SDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 597 ~DvwslG~il~elltg~~Pf~ 617 (618)
+|||||||++|||++|+.||.
T Consensus 257 ~DiwslG~il~el~~g~~pf~ 277 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFP 277 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999995
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=299.75 Aligned_cols=198 Identities=20% Similarity=0.367 Sum_probs=174.4
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 485 (618)
..++|...+.||+|+||.||+|.+. |+.||+|+++.........+.+.+|++++++++||||+++++++.+. +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3467889999999999999999985 89999999987766667778899999999999999999999999887 78899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
||||+++|+|.++++.. ....+++..+..++.|++.||+|||+. + |+||||||+||++++++.++|.|||++.
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 99999999999999732 233689999999999999999999998 7 9999999999999999999999998875
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCc---ccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTV---KSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.
T Consensus 162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 4322 2346899999999998766544 7999999999999999999996
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.58 Aligned_cols=202 Identities=22% Similarity=0.348 Sum_probs=176.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
..++|+..+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567999999999999999999876 488899999975432 222345677888888877 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999973 35699999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC
Confidence 43322 22345789999999999999999999999999999999999999996
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=314.13 Aligned_cols=197 Identities=23% Similarity=0.366 Sum_probs=169.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----- 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 481 (618)
..++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+++++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3567999999999999999999875 5999999999766555566778999999999999999999999997653
Q ss_pred -eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 482 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
..++||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 7799999862 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 99875432 234578999999999987 679999999999999999999999996
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.97 Aligned_cols=196 Identities=27% Similarity=0.425 Sum_probs=165.0
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhc--CCCCcccccceEEeeC----C
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEH----G 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~ 481 (618)
..++|+..+.||+|+||.||+|.+ +|+.||||++... ....+..|.+++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999988 5899999998643 23445556665555 7999999999987553 4
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCceecCCCCCCeeecCCCC
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--------EVCLPSVVHRNFKSANILLDDELN 553 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiH~Dlkp~Nill~~~~~ 553 (618)
..++||||+++|+|.++++ ...+++..+.+++.|++.||+||| +. +|+||||||+|||++.++.
T Consensus 80 ~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred eeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 5899999999999999995 357999999999999999999999 77 9999999999999999999
Q ss_pred cEEeeccccccCCCCCccc---ccceeccccccCccccccC------CCCcccchhhHHHHHHHHHhC----------CC
Q 007103 554 PHLSDCGLAALTPNTERQV---STQMVGAFGYSAPEFALSG------IYTVKSDVYSFGVVMLELLTG----------RK 614 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~ 614 (618)
+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999997654332221 2234799999999999877 566899999999999999999 88
Q ss_pred CCC
Q 007103 615 PLD 617 (618)
Q Consensus 615 Pf~ 617 (618)
||.
T Consensus 232 pf~ 234 (301)
T 3q4u_A 232 PFY 234 (301)
T ss_dssp TTT
T ss_pred ccc
Confidence 884
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.89 Aligned_cols=203 Identities=32% Similarity=0.528 Sum_probs=171.5
Q ss_pred hhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
+...++|...+.||+|+||.||+|.+.++..||||+++..... .+.|.+|++++++++||||+++++++.+ +..++
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 4456778899999999999999999988889999999865433 4678999999999999999999999876 67899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.++++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 256 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999999999632 234589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
............+++.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence 5433333334567889999999999999999999999999999999 999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=303.37 Aligned_cols=203 Identities=29% Similarity=0.359 Sum_probs=172.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|...+.||+|+||.||+|... +++.+|+|++..... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 3467889999999999999999875 588999999875542 22457789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---cCCCCcEEeeccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~ 563 (618)
|||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999865444457799999999999999999999999 99999999999999 456789999999997
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ......||+.|+|||++. ..++.++||||||+++|||++|+.||.
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 654332 223457999999999885 568999999999999999999999996
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=307.25 Aligned_cols=201 Identities=23% Similarity=0.335 Sum_probs=177.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH----HHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
..++|...+.||+|+||.||+|... +|+.||+|.+....... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567899999999999999999876 58999999987543221 135678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC----CcEEee
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSD 558 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~D 558 (618)
.++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999999999996 345789999999999999999999999 999999999999999887 799999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 999977654322 234579999999999999999999999999999999999999995
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.19 Aligned_cols=201 Identities=24% Similarity=0.407 Sum_probs=173.6
Q ss_pred hcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|.... |+.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4678899999999999999998764 899999998766656666778899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988765 345699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 322 22345789999999999875 68999999999999999999999996
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.01 Aligned_cols=203 Identities=20% Similarity=0.295 Sum_probs=168.4
Q ss_pred hhcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHH---------HHHHHHHHHhhcCCCCcccc
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEE---------DNFLEAVSNMSRLRHPNIVT 472 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~ 472 (618)
..++|...+.||+|+||.||+|.+.. ++.||+|++.........+ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998865 4789999986543221111 22345566778889999999
Q ss_pred cceEEeeC----CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 007103 473 LAGYCAEH----GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL 548 (618)
Q Consensus 473 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill 548 (618)
+++++... ...++||||+ +++|.++++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4579999999 8999999963 346799999999999999999999999 99999999999999
Q ss_pred c--CCCCcEEeeccccccCCCCCcc------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 549 D--DELNPHLSDCGLAALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 549 ~--~~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9 8899999999999765432211 1133469999999999999999999999999999999999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=301.17 Aligned_cols=200 Identities=30% Similarity=0.460 Sum_probs=173.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4567899999999999999999776 4778999998654322 1235678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999863 35689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 208 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCC
Confidence 4322 234578999999999999999999999999999999999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.41 Aligned_cols=198 Identities=33% Similarity=0.487 Sum_probs=173.1
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..+.|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 345688899999999999999986 4689999999875432 33345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+. |+|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++...
T Consensus 132 v~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 999997 688888753 245789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... ....||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 432 2357999999999985 5678999999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.56 Aligned_cols=202 Identities=26% Similarity=0.434 Sum_probs=170.4
Q ss_pred hhcCCcccceeccCccceEEEEEE-----cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-- 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-- 480 (618)
..++|+..+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 346788999999999999999985 258999999987543 44567899999999999999999999998653
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++||||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence 5689999999999999999742 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++........ ......++..|+|||.+.+..++.++||||||+++|||+||..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 99876433221 1223457788999999999999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=303.58 Aligned_cols=205 Identities=25% Similarity=0.463 Sum_probs=182.4
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.+...++|...+.||+|+||.||+|.+.. ++.||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 44566789999999999999999998875 8899999997543 2456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++++|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999742 345689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
..............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~ 214 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 776554444455678899999999999999999999999999999999 999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.69 Aligned_cols=203 Identities=29% Similarity=0.409 Sum_probs=166.9
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH---HHHHHHHHHHHHhhcC---CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL---QEEDNFLEAVSNMSRL---RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~ 479 (618)
...++|+..+.||+|+||.||+|... +|+.||+|++....... .....+.+|+++++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34678999999999999999999864 68999999986433211 1123455566655554 59999999999987
Q ss_pred CC-----eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCc
Q 007103 480 HG-----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 480 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
.. ..++||||++ ++|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 65 5799999997 5999998732 234499999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999999998664332 2234679999999999999999999999999999999999999995
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=301.65 Aligned_cols=204 Identities=30% Similarity=0.502 Sum_probs=177.6
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.+...++|...+.||+|+||.||+|...+++.||+|.++..... .+.+.+|++++++++||||+++++++. .+..+
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 44456789999999999999999999988889999999754432 467889999999999999999999886 45689
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 999999999999999632 123689999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 212 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCc
Confidence 65443333344567889999999998899999999999999999999 999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=300.21 Aligned_cols=203 Identities=30% Similarity=0.457 Sum_probs=156.5
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|... +|+.||+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3467899999999999999999874 6899999998644321 1224678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999863 335789999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 43222 1223578999999999999999999999999999999999999996
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.96 Aligned_cols=208 Identities=28% Similarity=0.455 Sum_probs=179.6
Q ss_pred hhhhcCCcccceeccCccceEEEEEE------cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEe
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCA 478 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 478 (618)
+...++|...+.||+|+||.||+|.+ .+++.||+|+++... .....+.+.+|+++++++ +||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 44567899999999999999999975 246889999997553 334567899999999999 9999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADD--------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
..+..++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 99999999999999999999975321 123589999999999999999999999 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876544322 2234567889999999999999999999999999999999 999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=303.57 Aligned_cols=203 Identities=32% Similarity=0.512 Sum_probs=166.0
Q ss_pred hhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
+...++|...+.||+|+||.||+|.+. ..+|+|+++.........+.+.+|++++++++||||+++++++ ..+..++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 455678999999999999999999864 4599999987766777778899999999999999999999965 4567899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 9999999999999863 346789999999999999999999999 9999999999999999999999999999755
Q ss_pred CCCC-cccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTE-RQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ........||+.|+|||++. +..++.++||||||+++|||++|+.||.
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 4321 22223457999999999987 5678899999999999999999999996
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=300.33 Aligned_cols=201 Identities=33% Similarity=0.540 Sum_probs=163.5
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCccccc--HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS--LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|.+. |+.||+|+++..... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3567889999999999999999985 899999998754322 2234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC--------CCCcEEe
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD--------ELNPHLS 557 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~--------~~~~kl~ 557 (618)
||||+++++|.++++ ...+++..+..++.|++.||+|||+....+|+||||||+||+++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999985 457899999999999999999999992222999999999999986 7789999
Q ss_pred eccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|||++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 159 Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 159 DFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred cCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999976543222 24579999999999999999999999999999999999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=309.59 Aligned_cols=202 Identities=22% Similarity=0.348 Sum_probs=164.8
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|...+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34567999999999999999999765 68999999998665555556678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-----CCCCcEEeecc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-----DELNPHLSDCG 560 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-----~~~~~kl~Dfg 560 (618)
||||+++ +|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999985 99999863 45689999999999999999999999 999999999999994 45569999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9976543222 22345789999999999875 48999999999999999999999996
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=301.02 Aligned_cols=202 Identities=22% Similarity=0.299 Sum_probs=176.2
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|... +++.||+|++............+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999886 699999999987655556677888999999988 99999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC--------------
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-------------- 551 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-------------- 551 (618)
||||+++++|.++++........+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999975444446789999999999999999999999 99999999999999844
Q ss_pred -----CCcEEeeccccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 552 -----LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 552 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|+.|+.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999997765432 23589999999999876 56789999999999999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.93 Aligned_cols=202 Identities=22% Similarity=0.382 Sum_probs=178.4
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|...+ ++.+|+|.+..... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 45678899999999999999998864 78899999865432 34456788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999998863 35689999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 43222 2234579999999999999999999999999999999999999996
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=304.02 Aligned_cols=212 Identities=25% Similarity=0.449 Sum_probs=170.8
Q ss_pred hhhhhhhcCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEe
Q 007103 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (618)
Q Consensus 403 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 478 (618)
.......++|...+.||+|+||.||+|.+. .++.||+|+++.........+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344556678999999999999999999765 2458999999876666666788999999999999999999999998
Q ss_pred eCC-----eEEEEEEecCCCChhhhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 479 EHG-----QRLLVYEYVGNGNLHDMLHFAD--DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 479 ~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
..+ ..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 755 3499999999999999985432 2346799999999999999999999999 99999999999999999
Q ss_pred CCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 251 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP 251 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence 9999999999976543322 12233467889999999999999999999999999999999 999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.75 Aligned_cols=198 Identities=26% Similarity=0.394 Sum_probs=173.3
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee----CCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 483 (618)
.+.|...+.||+|+||.||+|... ++..||+|.+..........+.+.+|++++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345777889999999999999875 57889999998776667778889999999999999999999999875 3468
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeec-CCCCcEEeecc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLD-DELNPHLSDCG 560 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nill~-~~~~~kl~Dfg 560 (618)
++||||+++++|.++++. ...+++..+..++.|++.||+|||+. + |+||||||+||+++ +++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 999999999999999973 35689999999999999999999998 7 99999999999998 78999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++....... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||.
T Consensus 178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 178 LATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp GGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred Ccccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 997654332 234579999999998864 58999999999999999999999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=311.61 Aligned_cols=209 Identities=28% Similarity=0.465 Sum_probs=175.7
Q ss_pred hhhhhcCCcccceeccCccceEEEEEE------cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
.+...++|...+.||+|+||.||+|.+ .+++.||+|.+.... .....+.+.+|++++.++ +||||+++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344567899999999999999999986 246689999997543 233456789999999999 899999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADDS-------------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVH 538 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH 538 (618)
...+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999743211 13479999999999999999999999 9999
Q ss_pred cCCCCCCeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 007103 539 RNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPL 616 (618)
Q Consensus 539 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf 616 (618)
|||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||+| |+.||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999976543322 22334578899999999999999999999999999999998 99999
Q ss_pred C
Q 007103 617 D 617 (618)
Q Consensus 617 ~ 617 (618)
.
T Consensus 276 ~ 276 (344)
T 1rjb_A 276 P 276 (344)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=297.79 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=175.9
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 467889999999999999999876 689999999865432 234577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999886 345689999999999999999999999 999999999999999999999999999976532
Q ss_pred CC-cccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TE-RQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 209 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 22 122334579999999999988775 789999999999999999999996
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=306.87 Aligned_cols=203 Identities=22% Similarity=0.380 Sum_probs=179.3
Q ss_pred hhhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
...++|...+.||+|+||.||++...+ ++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 345789999999999999999998764 78999999875432 3445677899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 118 lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 118 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 99999999999998863 35689999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus 191 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 191 VEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp CCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCC
Confidence 643222 2234579999999999999999999999999999999999999996
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.69 Aligned_cols=201 Identities=27% Similarity=0.471 Sum_probs=166.3
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|+..+.||+|+||.||+|.+. +++ +||+|.+.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence 457889999999999999999865 344 35888876433 334457899999999999999999999999875 47
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++|+||+.+|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 899999999999999974 345789999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 65433222 2233467889999999999999999999999999999999 999996
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.19 Aligned_cols=214 Identities=24% Similarity=0.402 Sum_probs=182.5
Q ss_pred eehhhhhhhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCccccc
Q 007103 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTL 473 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 473 (618)
+...+++...++|...+.||+|+||.||+|.+. .++.||+|.+.... .......+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 334456667788999999999999999999764 37889999997543 34456678999999999999999999
Q ss_pred ceEEeeCCeEEEEEEecCCCChhhhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 007103 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADD------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (618)
Q Consensus 474 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 547 (618)
++++.+.+..++||||+++|+|.++++..+. ....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 9999999999999999999999999964321 124678999999999999999999999 9999999999999
Q ss_pred ecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 548 LDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 548 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 99999999999999975533221 12233467899999999999999999999999999999999 899986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=298.09 Aligned_cols=198 Identities=28% Similarity=0.378 Sum_probs=174.3
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|...+.||+|+||.||+|.... ++.+|+|++...... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 45678999999999999999998764 778999998754432 356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---cCCCCcEEeeccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~ 563 (618)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 85 MELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999998863 35689999999999999999999999 99999999999999 788999999999997
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ......||+.|+|||++.+. ++.++||||||+++|||++|+.||.
T Consensus 158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 158 RFKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp ECCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCC
Confidence 665332 22345799999999998665 8999999999999999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=306.95 Aligned_cols=208 Identities=28% Similarity=0.485 Sum_probs=177.6
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc--------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY 476 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 476 (618)
....++|...+.||+|+||.||+|++. +++.||+|+++... .....+.+.+|+++++++ +||||++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 334578999999999999999999873 46789999997543 444567889999999999 89999999999
Q ss_pred EeeCCeEEEEEEecCCCChhhhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDS------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
+...+..++||||+++|+|.++++..... ...+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 99999999999999999999999753321 23489999999999999999999999 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 999999999999999999866543321 2233467889999999999999999999999999999999 999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=314.04 Aligned_cols=195 Identities=23% Similarity=0.332 Sum_probs=159.4
Q ss_pred hcCCccc-ceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHh-hcCCCCcccccceEEee----CC
Q 007103 409 TNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNM-SRLRHPNIVTLAGYCAE----HG 481 (618)
Q Consensus 409 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~ 481 (618)
.++|... +.||+|+||.||+|... +|+.||||+++.. ..+.+|++++ +..+||||+++++++.. .+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3456555 68999999999999876 5889999998632 3456677776 44589999999999876 56
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCcEEee
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSD 558 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~D 558 (618)
..++||||+++|+|.++++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 789999999999999999732 234689999999999999999999999 9999999999999997 78999999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 208 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 208 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp CTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 99998654322 2234679999999999999999999999999999999999999995
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.67 Aligned_cols=206 Identities=24% Similarity=0.396 Sum_probs=169.8
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccc-ccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...+|...+.||+|+||.||+|... +|+.||+|++.... ........+.+|++++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4467999999999999999999874 68999999987532 244556788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999975544567799999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 43322 2234578999999999999999999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=320.13 Aligned_cols=197 Identities=31% Similarity=0.492 Sum_probs=171.8
Q ss_pred hhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-eEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG-QRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~l 485 (618)
...++|...+.||+|+||.||+|.+. |+.||||.++... ..+.|.+|++++++++||||+++++++...+ ..++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 34567888999999999999999886 7899999997543 3467899999999999999999999987765 7999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.++++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 265 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 99999999999999743 233478999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 340 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 340 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3221 22357889999999999999999999999999999998 999996
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=308.69 Aligned_cols=202 Identities=25% Similarity=0.380 Sum_probs=172.5
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-------- 479 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 479 (618)
.++|+..+.||+|+||.||+|... +|+.||+|++............+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467999999999999999999874 68999999987655444445678899999999999999999999877
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
.+..++||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999985 77777752 345699999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCC---cccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTE---RQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 9997654222 122234578999999999976 458999999999999999999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.96 Aligned_cols=201 Identities=24% Similarity=0.381 Sum_probs=164.1
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc------HHHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
...++|...+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999775 5899999998754321 122335789999999999999999999975
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC---CCcEE
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHL 556 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl 556 (618)
.+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 456899999999999999886 356799999999999999999999999 99999999999999754 45999
Q ss_pred eeccccccCCCCCcccccceeccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 557 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+|||+++..... .......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~ 345 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999876432 22345689999999999864 668899999999999999999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.89 Aligned_cols=198 Identities=31% Similarity=0.526 Sum_probs=169.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHH-----HHHHHHHHHhhcCCCCcccccceEEeeCC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEE-----DNFLEAVSNMSRLRHPNIVTLAGYCAEHG 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 481 (618)
..++|+..+.||+|+||.||+|.+. +++.||+|++.......... +.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3467889999999999999999875 68999999986543322211 67899999999999999999999987655
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeecCCCC-----c
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDELN-----P 554 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~-----~ 554 (618)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 699999999999988862 345799999999999999999999999 7 999999999999988776 9
Q ss_pred EEeeccccccCCCCCcccccceeccccccCccccc--cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL--SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+|||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||+
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999999975432 223457999999999994 4567899999999999999999999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=301.63 Aligned_cols=206 Identities=26% Similarity=0.387 Sum_probs=164.7
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|+..+.||+|+||.||+|... +|+.||+|+++.........+.+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 44578999999999999999999874 68999999998665444445556666666888999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||++ |+|.++++........+++..+..++.|++.||+|||++. +|+||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999997 4888888654445678999999999999999999999853 8999999999999999999999999999766
Q ss_pred CCCCcccccceeccccccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFA----LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....||+.|+|||++ .+..++.++||||||+++|||+||+.||+
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 43322 2334799999999996 56678999999999999999999999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.59 Aligned_cols=196 Identities=28% Similarity=0.379 Sum_probs=169.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|... +|+.||+|++...... ..+|++++.++ +||||+++++++.+.+..++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4567899999999999999999876 5899999999754322 34567777776 79999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC----CCcEEeeccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE----LNPHLSDCGL 561 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfgl 561 (618)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+
T Consensus 94 v~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 94 VTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 999999999999986 345699999999999999999999999 99999999999998543 3599999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+........ .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 167 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 167 AKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp CEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 986643322 2234578999999999998889999999999999999999999996
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=311.07 Aligned_cols=197 Identities=25% Similarity=0.409 Sum_probs=157.6
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------ 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 480 (618)
..++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999764 589999999987655666678889999999999999999999998654
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++|+|++ +++|.++++ ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 579998885 25699999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99765432 234679999999999987 678999999999999999999999995
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=301.44 Aligned_cols=199 Identities=19% Similarity=0.275 Sum_probs=173.1
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|.. .+|+.||+|++.... ..+.+.+|++.++++ +|+|++++++++......++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 456799999999999999999986 468999999986433 234577888999888 79999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC-----cEEeecc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-----PHLSDCG 560 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfg 560 (618)
||||+ +++|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 84 v~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999 89999999742 34699999999999999999999999 9999999999999987776 9999999
Q ss_pred ccccCCCCCcc------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 99866433221 2234579999999999999999999999999999999999999996
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=306.02 Aligned_cols=211 Identities=19% Similarity=0.304 Sum_probs=179.3
Q ss_pred eehhhhhhhhcCCccc-ceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceE
Q 007103 400 YTVASLQTATNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGY 476 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 476 (618)
..+...+...++|... +.||+|+||.||+|... +|+.||+|+++...........+.+|+.++.++ .||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444556667778777 88999999999999876 589999999987655555567889999999988 46999999999
Q ss_pred EeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCC
Q 007103 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELN 553 (618)
Q Consensus 477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~ 553 (618)
+...+..++||||+++|+|.+++.. .....+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999998852 2346789999999999999999999999 9999999999999997 789
Q ss_pred cEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 554 PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 173 ~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999987643322 234579999999999999999999999999999999999999995
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=323.32 Aligned_cols=200 Identities=27% Similarity=0.435 Sum_probs=174.6
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|...+.||+|+||.||+|... +|+.||+|++............+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999876 689999999875544444567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec---CCCCcEEeeccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgl~~ 563 (618)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998863 35689999999999999999999999 999999999999995 55679999999997
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ......||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 664332 2234579999999999876 58999999999999999999999995
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=323.63 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=170.9
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|...+.||+|+||.||+|... +++.||+|++............+.+|+++++.++||||+++++++.+.+..++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45567999999999999999999876 58899999997665444456778999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCcEEeecccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl~ 562 (618)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999998863 35689999999999999999999999 9999999999999975 455999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... ......||+.|+|||++. ..|+.++||||+||++|+|++|+.||.
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 8765332 223467999999999986 569999999999999999999999996
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.95 Aligned_cols=201 Identities=27% Similarity=0.442 Sum_probs=168.1
Q ss_pred hcCCcccceeccCccceEEEEEEcC-CcE----EEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GKI----MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|+..+.||+|+||.||+|.+.. ++. ||+|.+.... .......+.+|+..+++++||||+++++++. ++..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 4578889999999999999998753 443 7788775432 2223345778899999999999999999886 5678
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999999963 235688999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 76544322 2344578889999999999999999999999999999999 999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.32 Aligned_cols=197 Identities=23% Similarity=0.309 Sum_probs=165.5
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (618)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999765 5899999999765555566778899999999999999999999997654
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+++ +|.++++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 7888775 3488999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9765432 12234679999999999999999999999999999999999999996
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.91 Aligned_cols=202 Identities=17% Similarity=0.249 Sum_probs=166.2
Q ss_pred hhhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCccc-ccHHHHHHHHHHH---HHhhcCCCCcccccc-------
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAA-LSLQEEDNFLEAV---SNMSRLRHPNIVTLA------- 474 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~niv~l~------- 474 (618)
...++|...+.||+|+||.||+|.+ .+|+.||||++.... ......+.+.+|+ +.+++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999999986 469999999987442 2334567888999 556666899999998
Q ss_pred eEEeeCC-----------------eEEEEEEecCCCChhhhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 007103 475 GYCAEHG-----------------QRLLVYEYVGNGNLHDMLHFADDS---SKNLTWNARVRVALGTARALEYLHEVCLP 534 (618)
Q Consensus 475 ~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 534 (618)
+++.+.+ ..++||||+ +|+|.++++..... ...+++..+..++.||+.||+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 225 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 225 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 6665543 278999999 57999999743211 12344588889999999999999999
Q ss_pred CceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccceeccccccCccccccC-----------CCCcccchhhHH
Q 007103 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-----------IYTVKSDVYSFG 603 (618)
Q Consensus 535 ~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG 603 (618)
+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 999999999999999999999999999985432 2234567 999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCC
Q 007103 604 VVMLELLTGRKPLD 617 (618)
Q Consensus 604 ~il~elltg~~Pf~ 617 (618)
|++|||++|+.||.
T Consensus 301 ~il~elltg~~Pf~ 314 (377)
T 3byv_A 301 LVIYWIWCADLPIT 314 (377)
T ss_dssp HHHHHHHHSSCCC-
T ss_pred HHHHHHHHCCCCCc
Confidence 99999999999995
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.04 Aligned_cols=199 Identities=28% Similarity=0.429 Sum_probs=175.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.++|...+.||+|+||.||+|... +++.||+|.+...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467889999999999999999876 5788999998654321 12246788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999973 34689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 213 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence 322 234578999999999999999999999999999999999999996
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=308.08 Aligned_cols=199 Identities=25% Similarity=0.387 Sum_probs=164.4
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46888999999999999999876 689999999865431 1122245678999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 998 589888863 345689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (324)
T 3mtl_A 154 TK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 22 2234578999999999977 568999999999999999999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.04 Aligned_cols=204 Identities=32% Similarity=0.525 Sum_probs=177.3
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.+...++|...+.||+|+||.||+|.+.++..||||+++..... .+.|.+|++++++++||||+++++++.+ +..+
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34456778899999999999999999988889999999865433 4678999999999999999999999876 6789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 999999999999999632 234589999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.............++..|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~ 466 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSST
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 65332222233457789999999999999999999999999999999 999996
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.87 Aligned_cols=201 Identities=25% Similarity=0.410 Sum_probs=173.4
Q ss_pred hcCCcccc-eeccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEF-LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~-~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|...+ .||+|+||.||+|.+. +++.||+|+++... .....+.+.+|++++++++||||+++++++ ..+..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 45566665 8999999999999764 57889999997653 345567899999999999999999999999 556799
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 99999999999999862 345699999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccc--ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........ .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 215 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 65433221 223457889999999998899999999999999999999 999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.42 Aligned_cols=200 Identities=26% Similarity=0.387 Sum_probs=173.3
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH----HHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|+..+.||+|+||.||+|... +|+.||+|.++...... ...+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356889999999999999999886 58999999987543221 1357789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC----CcEEeec
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSDC 559 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Df 559 (618)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999963 35689999999999999999999999 999999999999999877 8999999
Q ss_pred cccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 99976643322 234568999999999999999999999999999999999999996
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.54 Aligned_cols=207 Identities=26% Similarity=0.370 Sum_probs=174.6
Q ss_pred hhhhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee----C
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----H 480 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~ 480 (618)
....++|...+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|++++++++||||+++++++.. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34567899999999999999999987 46899999988643 34456788999999999999999999999873 3
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
...++||||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence 478999999999999999986555567899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcc--------cccceeccccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQ--------VSTQMVGAFGYSAPEFALSGI---YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 98755321111 012245799999999997654 6889999999999999999999984
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=298.62 Aligned_cols=203 Identities=27% Similarity=0.419 Sum_probs=171.5
Q ss_pred hhhcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
...++|...+.||+|+||.||+|.+.+ +..||+|.+.... .....+.+.+|++++++++||||+++++++.+ +.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 345788999999999999999997653 3469999987653 34456789999999999999999999999865 45
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp CEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred CEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence 6899999999999999963 235689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
...............+|+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 8765443333344567889999999999999999999999999999998 999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.42 Aligned_cols=200 Identities=24% Similarity=0.421 Sum_probs=175.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|+..+.||+|+||.||+|.+. +|+.||+|++.... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 3567899999999999999999876 58999999987543 445567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++. ...+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++....
T Consensus 110 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp ECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999973 346899999999999999999999842 79999999999999999999999999986442
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 184 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 184 D---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp H---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred c---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 12234579999999999999999999999999999999999999995
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.29 Aligned_cols=200 Identities=28% Similarity=0.367 Sum_probs=167.5
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC----
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH---- 480 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 480 (618)
+...++|...+.||+|+||.||+|... +|+.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 445678999999999999999999764 689999999864432 234689999999999999999998543
Q ss_pred ----------------------------------CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 007103 481 ----------------------------------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526 (618)
Q Consensus 481 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~ 526 (618)
...++||||++ |+|.+.++........+++..+..++.|+++||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34789999998 5888887654445678999999999999999999
Q ss_pred HHhhcCCCCceecCCCCCCeeec-CCCCcEEeeccccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHH
Q 007103 527 YLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGV 604 (618)
Q Consensus 527 ~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~ 604 (618)
|||+. +|+||||||+|||++ +++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 999999999999998 688999999999986644332 2345789999999998875 4899999999999
Q ss_pred HHHHHHhCCCCCC
Q 007103 605 VMLELLTGRKPLD 617 (618)
Q Consensus 605 il~elltg~~Pf~ 617 (618)
++|||++|+.||.
T Consensus 231 il~ell~g~~pf~ 243 (383)
T 3eb0_A 231 VFGELILGKPLFS 243 (383)
T ss_dssp HHHHHHHSSCSSC
T ss_pred HHHHHHhCCCCCC
Confidence 9999999999996
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.24 Aligned_cols=197 Identities=31% Similarity=0.519 Sum_probs=163.3
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
.++|+..+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|++.+++++||||+++++++. +..++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence 357888899999999999999885 788999999643 34577899999999999999999999887 34789999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC-cEEeeccccccCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-PHLSDCGLAALTPN 567 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-~kl~Dfgl~~~~~~ 567 (618)
|+++|+|.++++... ....+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred cCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999997422 1235788999999999999999999932228999999999999998886 79999999975532
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....||+.|+|||++.+..++.++||||||+++|||+||+.||+
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 204 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCch
Confidence 2 123468999999999999999999999999999999999999996
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.85 Aligned_cols=211 Identities=25% Similarity=0.438 Sum_probs=179.1
Q ss_pred hhhhhhhcCCcccceeccCccceEEEEEE------cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccce
Q 007103 403 ASLQTATNSFSQEFLIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAG 475 (618)
Q Consensus 403 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 475 (618)
...+...++|...+.||+|+||.||+|.+ .+++.||+|+++... .....+.+.+|++++.++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 34455678899999999999999999975 246899999997654 344567789999999999 7999999999
Q ss_pred EEeeCC-eEEEEEEecCCCChhhhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 007103 476 YCAEHG-QRLLVYEYVGNGNLHDMLHFADDS------------SKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFK 542 (618)
Q Consensus 476 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 542 (618)
++...+ ..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 987754 589999999999999999743221 12388999999999999999999999 99999999
Q ss_pred CCCeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 543 SANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 543 p~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999986643322 22334578999999999999999999999999999999998 999995
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.78 Aligned_cols=197 Identities=28% Similarity=0.425 Sum_probs=172.2
Q ss_pred CcccceeccCccceEEEEEEc-----CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--CeEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-----NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--GQRL 484 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 484 (618)
|...+.||+|+||.||++.+. +|+.||+|+++... .....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488899999999999998653 58899999997653 445667899999999999999999999999884 5789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999962 3489999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... ......||+.|+|||++.+..++.++||||||+++|||+||+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 6543321 2234568889999999999999999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=315.34 Aligned_cols=203 Identities=25% Similarity=0.387 Sum_probs=174.1
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC--eEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG--QRL 484 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~ 484 (618)
..++|...+.||+|+||.||+|.+.. |+.||+|++..... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 34678999999999999999998864 89999999975432 223567789999999999999999999998765 779
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----cCCCCcEEeecc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELNPHLSDCG 560 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfg 560 (618)
+||||+++|+|.++++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 86 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999997432 233489999999999999999999999 99999999999999 777889999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc--------CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS--------GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp GCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred CceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9987654322 234579999999999875 567889999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.47 Aligned_cols=200 Identities=24% Similarity=0.370 Sum_probs=166.4
Q ss_pred hcCCccc-ceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEE
Q 007103 409 TNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 409 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 485 (618)
.+.|.+. +.||+|+||.||+|... +++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4567774 78999999999999865 689999999865432 2356788999999884 79999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC---cEEeecccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfgl~ 562 (618)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999973 35689999999999999999999999 9999999999999998766 999999998
Q ss_pred ccCCCCCc------ccccceeccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTER------QVSTQMVGAFGYSAPEFALS-----GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 75532211 11123469999999999975 558899999999999999999999995
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=302.35 Aligned_cols=202 Identities=24% Similarity=0.420 Sum_probs=172.3
Q ss_pred hcCCcccceeccCccceEEEEEE-----cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC--C
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH--G 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 481 (618)
.+.|+..+.||+|+||.||+|++ .+++.||+|+++... .....+.+.+|++++++++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 45688899999999999999984 358999999997543 223457789999999999999999999999876 6
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred eEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 68999999999999999953 245689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc--ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTER--QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+........ .......||..|+|||++.+..++.++||||||+++|||+||+.|+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 987654432 22234568888999999999999999999999999999999998863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=297.41 Aligned_cols=200 Identities=27% Similarity=0.449 Sum_probs=177.1
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..+.|...+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3456889999999999999999765 5899999998754422 3457789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 99 MEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999999985 35789999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 171 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 171 DTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp TTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 332 12234579999999999999999999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.72 Aligned_cols=202 Identities=26% Similarity=0.380 Sum_probs=172.7
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH-----------HHHHHHHHHHHHhhcCCCCccccc
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL-----------QEEDNFLEAVSNMSRLRHPNIVTL 473 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l 473 (618)
....++|...+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345678999999999999999999876 47899999987544221 234678899999999999999999
Q ss_pred ceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-
Q 007103 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL- 552 (618)
Q Consensus 474 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~- 552 (618)
++++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCC
Confidence 9999999999999999999999998863 35689999999999999999999999 999999999999998775
Q ss_pred --CcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 553 --NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 553 --~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+||+|||++....... ......||+.|+|||++. ..|+.++||||+||++|+|++|+.||.
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp CSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 69999999998765432 223457999999999987 468999999999999999999999996
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.72 Aligned_cols=202 Identities=29% Similarity=0.420 Sum_probs=171.3
Q ss_pred hhcCCcccc-eeccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 408 ATNSFSQEF-LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 408 ~~~~~~~~~-~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
..++|...+ .||+|+||.||+|.+. .++.||+|+++.........+.+.+|++++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 446777777 9999999999999653 368899999986654555567899999999999999999999999 56778
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999973 45689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccc--ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 222 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence 765443322 122356789999999999899999999999999999999 999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=322.52 Aligned_cols=201 Identities=28% Similarity=0.474 Sum_probs=176.6
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
...++|...+.||+|+||.||+|... +|+.||||++..... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567999999999999999999876 689999999865432 2334677899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---cCCCCcEEeeccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGL 561 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl 561 (618)
+||||+.+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 103 LVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999999886 346799999999999999999999999 99999999999999 5678999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++....... .....||+.|+|||++.+ .|+.++||||+||++|||++|+.||.
T Consensus 176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 176 STHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp HHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 977654322 234579999999999876 68999999999999999999999996
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.27 Aligned_cols=201 Identities=29% Similarity=0.477 Sum_probs=161.6
Q ss_pred cCCcccceeccCccceEEEEEEcC--C--cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-CCeEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFAN--G--KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRL 484 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 484 (618)
..|...+.||+|+||.||+|.+.+ + ..||+|.++... .....+.+.+|++++++++||||+++++++.. ++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 456777899999999999997642 2 468999987533 33456789999999999999999999998754 56789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 168 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence 99999999999999963 345688999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcc---cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQ---VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....... ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 5432211 1233467889999999999999999999999999999999 777875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.35 Aligned_cols=203 Identities=27% Similarity=0.452 Sum_probs=169.5
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
...+|...+.||+|+||.||+|.+.. +..||+|.++... .......+.+|++++++++||||+++++++...+.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 44678888999999999999997653 2459999997543 34456678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999963 345789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 563 ALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 766433221 1222356789999999999999999999999999999999 999995
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.15 Aligned_cols=203 Identities=27% Similarity=0.420 Sum_probs=175.8
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc--c----HHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL--S----LQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
....++|...+.||+|+||.||+|.+. +|+.||||++..... . ....+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445577999999999999999999886 699999999864431 1 12245678899999998 799999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEe
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 557 (618)
...+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999863 35689999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCcccccceeccccccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALS------GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 243 DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 243 DFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 9999977654322 234679999999999863 358899999999999999999999995
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=305.45 Aligned_cols=207 Identities=25% Similarity=0.322 Sum_probs=170.7
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccc---------cHHHHHHHHHHHHHhhcCCCCcccc
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL---------SLQEEDNFLEAVSNMSRLRHPNIVT 472 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~niv~ 472 (618)
..++....++|...+.||+|+||.||+|...+|+.||||++..... .....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4567778899999999999999999999988899999999865332 2223478899999999999999999
Q ss_pred cceEEee-----CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 007103 473 LAGYCAE-----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (618)
Q Consensus 473 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 547 (618)
+++++.. ....++||||++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 9999854 336899999998 588888862 345799999999999999999999999 9999999999999
Q ss_pred ecCCCCcEEeeccccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 548 LDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 548 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 9999999999999997543322 2234578999999999987 678999999999999999999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.33 Aligned_cols=198 Identities=27% Similarity=0.437 Sum_probs=172.8
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|...+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3567889999999999999999876 689999999975432 2345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---cCCCCcEEeeccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~ 563 (618)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 85 MQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp ECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999998863 34689999999999999999999999 99999999999999 788999999999987
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 158 MEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 65432 2233568999999999999999999999999999999999999995
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.62 Aligned_cols=201 Identities=21% Similarity=0.250 Sum_probs=164.9
Q ss_pred hcCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccccHHH---------HHHHHHHHHHhhcCCCCcccccce
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQE---------EDNFLEAVSNMSRLRHPNIVTLAG 475 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~ 475 (618)
.++|...+.||+|+||.||+|... .+..+|+|+.......... ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999886 5788999998754322111 124567888899999999999999
Q ss_pred EEee----CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 476 YCAE----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 476 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9988 67889999999 8999999963 23789999999999999999999999 99999999999999987
Q ss_pred C--CcEEeeccccccCCCCCc------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 552 L--NPHLSDCGLAALTPNTER------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 552 ~--~~kl~Dfgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 7 999999999976542211 11234579999999999999999999999999999999999999994
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.52 Aligned_cols=203 Identities=29% Similarity=0.412 Sum_probs=167.0
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHH---HHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ---EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
...++|...+.||+|+||.||+|... +|+.||+|++........ ..+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999876 589999999975432211 12467899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 88888852 345688899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 87643322 22345789999999999764 58999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=293.83 Aligned_cols=201 Identities=28% Similarity=0.479 Sum_probs=168.2
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|... +|+.||+|.+..... .....+.+.+|++.++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4467899999999999999999886 689999999865432 12234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999963 34689999999999999999999999 9999999999999999999999999999776
Q ss_pred CCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 4332 2234578999999999988765 689999999999999999999996
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.85 Aligned_cols=204 Identities=19% Similarity=0.368 Sum_probs=176.4
Q ss_pred hhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHH---------------HHHHHHHHHHHhhcCCCCccc
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQ---------------EEDNFLEAVSNMSRLRHPNIV 471 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~niv 471 (618)
...++|...+.||+|+||.||+|.. +|+.||+|++........ ..+.+.+|++++++++||||+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3457899999999999999999998 899999999875432211 117789999999999999999
Q ss_pred ccceEEeeCCeEEEEEEecCCCChhhhhhc----ccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCe
Q 007103 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHF----ADDSSKNLTWNARVRVALGTARALEYLHE-VCLPSVVHRNFKSANI 546 (618)
Q Consensus 472 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dlkp~Ni 546 (618)
++++++.+.+..++||||+++|+|.++++. .......+++..+..++.|++.||+|||+ . +|+||||||+||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 999999999999999999999999998321 11225679999999999999999999999 8 999999999999
Q ss_pred eecCCCCcEEeeccccccCCCCCcccccceeccccccCccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCC
Q 007103 547 LLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTV-KSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 547 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~Pf~ 617 (618)
+++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||.
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999765433 22345799999999999887 6666 9999999999999999999996
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=296.26 Aligned_cols=203 Identities=29% Similarity=0.471 Sum_probs=170.3
Q ss_pred hhcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEe-eCCe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-EHGQ 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~ 482 (618)
...+|...+.||+|+||.||+|.+.+ +..+|+|.+.... .....+.+.+|++++++++||||+++++++. .++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 34568888999999999999998653 2358999887533 4455678999999999999999999999865 4567
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 102 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred eEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 8999999999999999963 346689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCc---ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 563 ALTPNTER---QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+....... .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 234 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence 76643322 12234567889999999999999999999999999999999 566664
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=313.53 Aligned_cols=197 Identities=28% Similarity=0.388 Sum_probs=165.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------C
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 481 (618)
..+|...+.||+|+||.||+|.+. +|+.||||++.... ..+.+|++++++++||||+++++++... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 346888999999999999999886 58999999986432 1234689999999999999999988542 1
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-CCcEEeecc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-LNPHLSDCG 560 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg 560 (618)
..++||||+++ ++.++++........+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 36799999986 67776654444567899999999999999999999999 99999999999999955 678999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++....... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9986643322 2345789999999999765 78999999999999999999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=306.36 Aligned_cols=209 Identities=26% Similarity=0.433 Sum_probs=178.3
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
.+...++|...+.||+|+||.||+|.... ++.||+|.+.... .....+.+.+|+++++++ +||||+++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34456789999999999999999998753 2479999997554 344567899999999999 899999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADD----------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANIL 547 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 547 (618)
...+..++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999964321 134689999999999999999999999 9999999999999
Q ss_pred ecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 548 LDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 548 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 99999999999999976533222 22234567889999999999999999999999999999999 999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.38 Aligned_cols=200 Identities=26% Similarity=0.416 Sum_probs=166.9
Q ss_pred cCCcccc-eeccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 410 NSFSQEF-LIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 410 ~~~~~~~-~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
.++...+ .||+|+||.||+|.+. ++..||||+++... .....+.+.+|++++++++||||+++++++.. +..++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 3444444 7999999999999774 46779999998653 23356789999999999999999999999976 56899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.++++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 413 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999999963 345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccc--cceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 566 PNTERQVS--TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........ ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 54332221 22346689999999999999999999999999999998 999996
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=305.47 Aligned_cols=196 Identities=23% Similarity=0.370 Sum_probs=170.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE---
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR--- 483 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 483 (618)
..++|...+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3568999999999999999999875 589999999987665666678899999999999999999999999877654
Q ss_pred ---EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 484 ---LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 484 ---~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999998 58888773 3489999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 99765432 234578999999999987 678999999999999999999999996
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.45 Aligned_cols=201 Identities=27% Similarity=0.464 Sum_probs=165.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcE----EEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKI----MAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|+..+.||+|+||.||+|.+. +++. |++|.+.... .....+.+.+|++++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 467999999999999999999865 3443 5777775433 2334677899999999999999999999998754 8
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++|+||+.+|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred eEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 899999999999999974 345689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 6643322 22233467889999999999999999999999999999999 999996
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.60 Aligned_cols=203 Identities=30% Similarity=0.492 Sum_probs=170.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEE--EEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIM--AVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~v--avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
.++|...+.||+|+||.||+|... +|..+ |+|.++... .....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 467889999999999999999765 46544 899886432 333456789999999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 485 LVYEYVGNGNLHDMLHFAD------------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
+||||+++|+|.++++... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997432 2235799999999999999999999999 999999999999999999
Q ss_pred CcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 99999999987443211 1223457889999999999899999999999999999998 999995
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=311.12 Aligned_cols=198 Identities=15% Similarity=0.123 Sum_probs=153.7
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHH---HHhhcCCCCcccccc-------e
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAV---SNMSRLRHPNIVTLA-------G 475 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~ 475 (618)
....|...+.||+|+||.||+|.+. +|+.||+|++..... .....+.+.+|+ +.++. +||||++++ +
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence 3456889999999999999999876 689999999987554 334456677774 45555 799988754 4
Q ss_pred EEeeC-----------------CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHhhcC
Q 007103 476 YCAEH-----------------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNAR------VRVALGTARALEYLHEVC 532 (618)
Q Consensus 476 ~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~ 532 (618)
++... ...++||||++ |+|.++++... ..+.+..+ ..++.||+.||+|||++
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~- 213 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK- 213 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence 54433 23799999999 89999997432 23344455 67789999999999999
Q ss_pred CCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccceeccccccCcccccc--CCCCcccchhhHHHHHHHHH
Q 007103 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELL 610 (618)
Q Consensus 533 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell 610 (618)
+|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 99999999999999999999999999998664322 13457799999999987 67999999999999999999
Q ss_pred hCCCCCC
Q 007103 611 TGRKPLD 617 (618)
Q Consensus 611 tg~~Pf~ 617 (618)
||+.||.
T Consensus 288 tg~~Pf~ 294 (371)
T 3q60_A 288 CLFLPFG 294 (371)
T ss_dssp HSSCSTT
T ss_pred hCCCCCC
Confidence 9999996
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=301.09 Aligned_cols=209 Identities=27% Similarity=0.468 Sum_probs=171.0
Q ss_pred eehhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
+....+....++|+..+.||+|+||.||+|.+. +|+.||+|++..... ....+.+|+++++++ +||||+++++++
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 445556667889999999999999999999875 689999999864432 346788899999988 799999999999
Q ss_pred ee------CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC
Q 007103 478 AE------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE 551 (618)
Q Consensus 478 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 551 (618)
.. .+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCC
Confidence 77 46789999999999999999743 235689999999999999999999999 99999999999999999
Q ss_pred CCcEEeeccccccCCCCCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp CCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 9999999999876543221 223457999999999997 5668999999999999999999999995
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.64 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=165.5
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe-----
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ----- 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 482 (618)
...+|...+.||+|+||.||+|+..++..+|+|++..... ...+|+++++.++||||+++++++...+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3457999999999999999999998877899998864332 12368999999999999999999865443
Q ss_pred -EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCcEEeecc
Q 007103 483 -RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCG 560 (618)
Q Consensus 483 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg 560 (618)
.++||||++++ +.+.+.........+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 78999999874 4444433233456799999999999999999999999 999999999999999 79999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++....... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.
T Consensus 188 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 188 SAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp TCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9987643332 2345789999999999765 58999999999999999999999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=297.54 Aligned_cols=200 Identities=29% Similarity=0.491 Sum_probs=170.9
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|+..+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34567999999999999999999876 48999999986543 24568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999999863 245789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 176 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 176 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp BTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred hhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 43321 2234578999999999999999999999999999999999999996
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.85 Aligned_cols=194 Identities=29% Similarity=0.435 Sum_probs=166.5
Q ss_pred ceeccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||.||+|.+. .++.||||+++.........+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999664 46789999998766555567889999999999999999999999864 568899999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcc-
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ- 571 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 571 (618)
|+|.++++ ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999996 345789999999999999999999999 9999999999999999999999999999876543322
Q ss_pred -cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 572 -VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 572 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2233457889999999999999999999999999999998 999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.58 Aligned_cols=199 Identities=26% Similarity=0.393 Sum_probs=171.7
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----Ce
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (618)
.++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 467999999999999999999875 58899999997533 344557789999999999999999999999765 36
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||++ |+|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999998 49999886 24689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc--cccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQ--VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 866533221 1234589999999998765 458999999999999999999999995
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.68 Aligned_cols=195 Identities=27% Similarity=0.409 Sum_probs=168.7
Q ss_pred hcCCcccceeccCccceEEEEEEcC-C-------cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-G-------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
.++|...+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4678899999999999999997653 3 479999986543 33457799999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC-------
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN------- 553 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~------- 553 (618)
+..++||||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999973 233489999999999999999999999 9999999999999998877
Q ss_pred -cEEeeccccccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhC-CCCC
Q 007103 554 -PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTG-RKPL 616 (618)
Q Consensus 554 -~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg-~~Pf 616 (618)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++| ..||
T Consensus 159 ~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp EEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 999999998655322 23468899999999987 6789999999999999999995 4454
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.58 Aligned_cols=198 Identities=26% Similarity=0.394 Sum_probs=162.6
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhc--CCCCcccccceEEeeC-
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAEH- 480 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~- 480 (618)
......++|+..+.||+|+||.||+|++. |+.||+|++.... ...+..|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 34556678999999999999999999886 8999999985332 3334445555444 4899999999999887
Q ss_pred ---CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceecCCCCCCeeecCCC
Q 007103 481 ---GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-----LPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 481 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~Dlkp~Nill~~~~ 552 (618)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 789999999999999999962 46899999999999999999999761 23899999999999999999
Q ss_pred CcEEeeccccccCCCCCccc---ccceeccccccCccccccCCCCcc------cchhhHHHHHHHHHhC
Q 007103 553 NPHLSDCGLAALTPNTERQV---STQMVGAFGYSAPEFALSGIYTVK------SDVYSFGVVMLELLTG 612 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg 612 (618)
.+||+|||+++......... .....||+.|+|||++.+..+..+ +|||||||++|||+||
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999999997654332221 124579999999999988766654 9999999999999999
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=294.03 Aligned_cols=201 Identities=29% Similarity=0.438 Sum_probs=169.9
Q ss_pred hcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE-
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR- 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~- 483 (618)
...|...+.||+|+||.||+|.+.+ +..+|+|.+.... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 3456677899999999999997643 2379999987533 444567889999999999999999999999876655
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+.+|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 99 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp EEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred EEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 999999999999999963 346789999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCc---ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 564 LTPNTER---QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 564 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 6543221 1122346889999999999999999999999999999999955554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.63 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=174.9
Q ss_pred hcCCcccceeccCccceEEEEEE-----cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEe--eCC
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA--EHG 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~ 481 (618)
.++|+..+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 46788899999999999999984 358899999997543 445677999999999999999999999886 456
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+++++|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred eEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 789999999999999999742 24589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 9876543322 2233568889999999999999999999999999999999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=299.87 Aligned_cols=200 Identities=24% Similarity=0.388 Sum_probs=167.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc------HHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
..++|...+.||+|+||.||+|... +++.||||.+...... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999875 4889999998754321 12234588999999999999999999998765
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC---cEEe
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLS 557 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~ 557 (618)
. .++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999886 346789999999999999999999999 9999999999999987654 9999
Q ss_pred eccccccCCCCCcccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|||++....... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 999998764322 223457899999999974 5678999999999999999999999995
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.16 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=155.1
Q ss_pred hcCCcc-cceeccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCe
Q 007103 409 TNSFSQ-EFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQ 482 (618)
Q Consensus 409 ~~~~~~-~~~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 482 (618)
.+.|+. .++||+|+||.||+|.+. +++.||+|++...... ..+.+|++++++++||||+++++++.. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 344555 447999999999999876 4789999999754422 457789999999999999999999954 678
Q ss_pred EEEEEEecCCCChhhhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----cCCCC
Q 007103 483 RLLVYEYVGNGNLHDMLHFADD-----SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL----DDELN 553 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~ 553 (618)
.++||||+++ +|.+++...+. ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 9999999975 88887753321 223589999999999999999999999 99999999999999 67789
Q ss_pred cEEeeccccccCCCCCc--ccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 554 PHLSDCGLAALTPNTER--QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 554 ~kl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999987643221 222346899999999999874 58999999999999999999999995
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.42 Aligned_cols=207 Identities=27% Similarity=0.423 Sum_probs=158.3
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|...+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++.+++++||||+++++++...+..++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34578999999999999999999764 689999999865432 2345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 486 VYEYVGNGNLHDMLHFAD----DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
||||+++++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999986421 1245689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc----ccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTER----QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 228 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 876543221 11234579999999999976 568999999999999999999999996
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.68 Aligned_cols=203 Identities=27% Similarity=0.414 Sum_probs=170.0
Q ss_pred hhhcCCcccceeccCccceEEEEEE--cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC---CCCcccccceEEe---
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVTLAGYCA--- 478 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--- 478 (618)
...++|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|+++++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4557899999999999999999987 3688999999875443222223455666655544 8999999999987
Q ss_pred --eCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEE
Q 007103 479 --EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (618)
Q Consensus 479 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 556 (618)
.....++||||++ |+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence 4567899999998 6999998743 234589999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 557 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 9999997654322 2334678999999999999999999999999999999999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.58 Aligned_cols=198 Identities=22% Similarity=0.313 Sum_probs=169.6
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC------CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL------RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~ 479 (618)
....+|+..+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.+ .|+||+++++++..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 34567999999999999999999776 48999999997532 2344566666666555 67899999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC--cEEe
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN--PHLS 557 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~ 557 (618)
.+..++||||++ ++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEEC
T ss_pred CCeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEe
Confidence 999999999996 5999988643 234589999999999999999999999 9999999999999999887 9999
Q ss_pred eccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 558 DCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 245 DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 245 DFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 99999765432 223578999999999999999999999999999999999999996
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=294.46 Aligned_cols=199 Identities=21% Similarity=0.315 Sum_probs=166.8
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEE-eeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC-AEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+++++.++|++++..++++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 457899999999999999999986 468999999865433 223577899999999998888777766 55678899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---cCCCCcEEeecccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~ 562 (618)
||||+ +++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||++
T Consensus 83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 99999 8899999863 245699999999999999999999999 99999999999999 78899999999999
Q ss_pred ccCCCCCc------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTER------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 86643322 12234579999999999999999999999999999999999999996
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=294.02 Aligned_cols=197 Identities=24% Similarity=0.417 Sum_probs=171.9
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee------
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------ 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 479 (618)
....+|+..+.||+|+||.||+|.+. +|+.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34567899999999999999999886 69999999986543 346689999999999999999998864
Q ss_pred ----------CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec
Q 007103 480 ----------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD 549 (618)
Q Consensus 480 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~ 549 (618)
....++||||+++++|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 44579999999999999999743 235789999999999999999999999 999999999999999
Q ss_pred CCCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 550 DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 550 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
+++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..||
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred CCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 999999999999977654322 23356999999999999999999999999999999999999886
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=298.32 Aligned_cols=209 Identities=24% Similarity=0.334 Sum_probs=174.3
Q ss_pred eehhhhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC--CCcccccceEE
Q 007103 400 YTVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYC 477 (618)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~ 477 (618)
+....+....++|...+.||+|+||.||+|...+++.||+|++..........+.+.+|++++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444556667889999999999999999999888999999999766656667788999999999997 59999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEe
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLS 557 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 557 (618)
...+..++||| +.+++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++ +.+||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 99999999999 567899999973 35789999999999999999999999 9999999999999965 799999
Q ss_pred eccccccCCCCCcc-cccceeccccccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 558 DCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALS-----------GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 558 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|||++......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 99999766433221 2234579999999999875 468889999999999999999999996
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=299.57 Aligned_cols=207 Identities=26% Similarity=0.390 Sum_probs=172.1
Q ss_pred hhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
...++|...+.||+|+||.||+|.+. +++.||+|++.... ......++.+|+.++++++||||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34578999999999999999999742 47789999997443 445567889999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADD---SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNP 554 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~ 554 (618)
+..++||||+++++|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999975432 124589999999999999999999999 9999999999999984 4569
Q ss_pred EEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 555 HLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999865422211 12233467899999999999999999999999999999998 999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=296.17 Aligned_cols=192 Identities=23% Similarity=0.400 Sum_probs=168.8
Q ss_pred hcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEee--CCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAE--HGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~ 484 (618)
.++|+..+.||+|+||.||+|.. .+++.||+|+++... .+.+.+|++++++++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 36789999999999999999976 468999999987432 466889999999997 9999999999988 56789
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEeeccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAA 563 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~ 563 (618)
+||||+++++|.++++ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 110 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 9999999999999885 378899999999999999999999 999999999999999766 89999999998
Q ss_pred cCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 6643322 234578999999999987 668999999999999999999999983
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.31 Aligned_cols=195 Identities=24% Similarity=0.371 Sum_probs=169.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe-----
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ----- 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 482 (618)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999875 58999999998765555567788999999999999999999999987654
Q ss_pred -EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 483 -RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 483 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 58887774 3489999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9765432 234578999999999987 678999999999999999999999996
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=306.42 Aligned_cols=196 Identities=21% Similarity=0.274 Sum_probs=168.0
Q ss_pred hcCCcccceeccCccceEEEEEEcC---------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccc-------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN---------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT------- 472 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------- 472 (618)
.++|...+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4679999999999999999998764 789999998643 35778999999999999987
Q ss_pred --------cceEEee-CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 007103 473 --------LAGYCAE-HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKS 543 (618)
Q Consensus 473 --------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp 543 (618)
+++++.. ++..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 5667766 67889999999 89999999742 235799999999999999999999999 999999999
Q ss_pred CCeeecCCC--CcEEeeccccccCCCCCcc------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 007103 544 ANILLDDEL--NPHLSDCGLAALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615 (618)
Q Consensus 544 ~Nill~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P 615 (618)
+||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 8999999999766432211 11334799999999999999999999999999999999999999
Q ss_pred CC
Q 007103 616 LD 617 (618)
Q Consensus 616 f~ 617 (618)
|.
T Consensus 268 f~ 269 (352)
T 2jii_A 268 WT 269 (352)
T ss_dssp TG
T ss_pred cc
Confidence 95
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=299.77 Aligned_cols=202 Identities=28% Similarity=0.429 Sum_probs=171.4
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhc--CCCCcccccceEEee
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR--LRHPNIVTLAGYCAE 479 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~ 479 (618)
........++|...+.||+|+||.||+|.+ +|+.||+|++... ....+.+|.+++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 333455667899999999999999999988 4899999998643 34567778888776 789999999999988
Q ss_pred CC----eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCceecCCCCCCee
Q 007103 480 HG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--------EVCLPSVVHRNFKSANIL 547 (618)
Q Consensus 480 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiH~Dlkp~Nil 547 (618)
.. ..++||||+++|+|.++++. ..+++..++.++.|++.||+||| +. +|+||||||+||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 76 78999999999999999962 46899999999999999999999 77 9999999999999
Q ss_pred ecCCCCcEEeeccccccCCCCCcc---cccceeccccccCccccccC------CCCcccchhhHHHHHHHHHhC------
Q 007103 548 LDDELNPHLSDCGLAALTPNTERQ---VSTQMVGAFGYSAPEFALSG------IYTVKSDVYSFGVVMLELLTG------ 612 (618)
Q Consensus 548 l~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg------ 612 (618)
++.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999765433322 22345799999999999876 345789999999999999999
Q ss_pred ----CCCCC
Q 007103 613 ----RKPLD 617 (618)
Q Consensus 613 ----~~Pf~ 617 (618)
+.||.
T Consensus 260 ~~~~~~p~~ 268 (342)
T 1b6c_B 260 HEDYQLPYY 268 (342)
T ss_dssp CCCCCCTTT
T ss_pred ccccccCcc
Confidence 78885
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=293.39 Aligned_cols=199 Identities=21% Similarity=0.308 Sum_probs=170.4
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEE-eeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC-AEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|.. .+|+.||+|++..... .+.+.+|+++++.++|++++..+.++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 356899999999999999999987 5699999999865432 24578899999999998877776665 55677899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---cCCCCcEEeecccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~ 562 (618)
||||+ +++|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||++
T Consensus 83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 99999 8899999963 245699999999999999999999999 99999999999999 48889999999999
Q ss_pred ccCCCCCcc------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
......... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 766443221 1234579999999999999999999999999999999999999996
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=299.56 Aligned_cols=206 Identities=22% Similarity=0.362 Sum_probs=159.4
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEe----
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCA---- 478 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~---- 478 (618)
++....+|...+.||+|+||.||+|.+. +|+.||+|++... .....+.+.+|+..+.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 3445568999999999999999999875 6899999998543 3445677889999999996 999999999984
Q ss_pred ----eCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeecCCC
Q 007103 479 ----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS--VVHRNFKSANILLDDEL 552 (618)
Q Consensus 479 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~ 552 (618)
.....++||||++ |+|.++++... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence 3345799999996 69999886432 345699999999999999999999998 7 99999999999999999
Q ss_pred CcEEeeccccccCCCCCccc-----------ccceeccccccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 553 NPHLSDCGLAALTPNTERQV-----------STQMVGAFGYSAPEFA---LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+||+|||+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 99999999997664332211 1134689999999998 56678999999999999999999999996
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=291.51 Aligned_cols=201 Identities=28% Similarity=0.412 Sum_probs=174.4
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-------cHHHHHHHHHHHHHhhcCC-CCcccccceEEe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-------SLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCA 478 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 478 (618)
..++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4568999999999999999999876 589999999864421 1223467789999999995 999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
..+..++||||+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999973 35689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccceeccccccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFAL------SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||.
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 999976643322 23457899999999985 4568899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.82 Aligned_cols=208 Identities=21% Similarity=0.328 Sum_probs=172.3
Q ss_pred ehhhhhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 401 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
.....+...++|+..+.||+|+||.||+|.+.+ .+|+|+++.........+.+.+|++++++++||||+++++++...
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344555667889999999999999999998853 589999876544444445678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
+..++||||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence 999999999999999999963 345689999999999999999999999 999999999999998 6799999999
Q ss_pred ccccCCCCC----cccccceeccccccCcccccc---------CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTE----RQVSTQMVGAFGYSAPEFALS---------GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 244 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 986543211 112223469999999999875 357889999999999999999999996
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=293.25 Aligned_cols=197 Identities=31% Similarity=0.504 Sum_probs=164.8
Q ss_pred hhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-CeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-GQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~l 485 (618)
...++|+..+.||+|+||.||+|+.. |+.||+|.++... ..+.+.+|++++++++||||+++++++... +..++
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 34578999999999999999999875 8899999997543 456788999999999999999999987654 47899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 999999999999996321 22378899999999999999999999 9999999999999999999999999998755
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.... ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 168 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 168 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred cccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 4322 22357889999999999999999999999999999998 999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=291.46 Aligned_cols=201 Identities=27% Similarity=0.441 Sum_probs=175.2
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|...+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999876 68999999997655544556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC---CCcEEeecccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE---LNPHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfgl~ 562 (618)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998863 34689999999999999999999999 99999999999999754 47999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
........ .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCC
Confidence 76643322 1234689999999998764 8999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=291.38 Aligned_cols=203 Identities=26% Similarity=0.342 Sum_probs=169.8
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc--HHHHHHHHHHHHHhhcCCCCcccccceEEe--eCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS--LQEEDNFLEAVSNMSRLRHPNIVTLAGYCA--EHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 483 (618)
.++|...+.||+|+||.||+|... +++.||+|+++..... ......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 467999999999999999999875 5889999999754321 234678999999999999999999999984 45678
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||++++ |.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 77777532 345789999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCC-cccccceeccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTE-RQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 654322 22223457999999999998644 4789999999999999999999996
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.30 Aligned_cols=202 Identities=25% Similarity=0.378 Sum_probs=170.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|.....||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 345566679999999999999875 58899999987543 234577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-CCCcEEeeccccccCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDCGLAALTP 566 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~ 566 (618)
||+++++|.++++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++....
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 99 EQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp ECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 9999999999997432 234567889999999999999999999 9999999999999987 8999999999997664
Q ss_pred CCCcccccceeccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGI--YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.
T Consensus 175 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 175 GINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 3221 223457899999999997654 7899999999999999999999984
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=298.94 Aligned_cols=200 Identities=26% Similarity=0.408 Sum_probs=170.5
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----C
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----G 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 481 (618)
..++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|++++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4568999999999999999999876 58999999996433 344566788999999999999999999988654 6
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 7899999997 589998862 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcc---------cccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQ---------VSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 9866432211 1123578999999998765 678999999999999999999999996
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.65 Aligned_cols=205 Identities=25% Similarity=0.372 Sum_probs=159.3
Q ss_pred hhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 404 SLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 404 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
......++|...+.||+|+||.||+|... +|+.||||++...... ...+.++++.+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 34556788999999999999999999875 5899999988644322 2345667777888899999999999976443
Q ss_pred -------EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCceecCCCCCCeeecC-CC
Q 007103 483 -------RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH--EVCLPSVVHRNFKSANILLDD-EL 552 (618)
Q Consensus 483 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~iiH~Dlkp~Nill~~-~~ 552 (618)
.++||||+++ +|.+.+.........+++..+..++.|++.||+||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999986 555554433335667899999999999999999999 87 9999999999999996 89
Q ss_pred CcEEeeccccccCCCCCcccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 999999999987654332 23457899999999997654 8999999999999999999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.45 Aligned_cols=199 Identities=26% Similarity=0.368 Sum_probs=163.8
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEe--------
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA-------- 478 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-------- 478 (618)
..++|...+.||+|+||.||+|.... |+.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 34679999999999999999998875 899999998644 3445678899999999999999999999873
Q ss_pred ------eCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CC
Q 007103 479 ------EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DE 551 (618)
Q Consensus 479 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~ 551 (618)
.....++||||++ |+|.++++ .+.+++..+..++.|++.||+|||+. +|+||||||+||+++ ++
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 3467899999998 69999885 35689999999999999999999999 999999999999997 56
Q ss_pred CCcEEeeccccccCCCCCc--ccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTER--QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.+||+|||+++....... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence 7999999999986643211 11233467899999998876 678999999999999999999999996
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=295.20 Aligned_cols=201 Identities=25% Similarity=0.433 Sum_probs=169.1
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..++|+..+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4577999999999999999999886 48899999987543 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999998863 245689999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ........||+.|+|||++. +..++.++||||||+++|||++|+.||.
T Consensus 169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 223 (302)
T 2j7t_A 169 KT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223 (302)
T ss_dssp HH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence 11 11122357899999999983 6678999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.35 Aligned_cols=205 Identities=26% Similarity=0.392 Sum_probs=172.7
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH 480 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 480 (618)
.+...++|+..+.||+|+||.||+|.+.. +..||+|.++... .....+.+.+|+.++++++||||+++++++. +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34456789999999999999999998743 5679999987543 3445678999999999999999999999985 4
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
+..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 568999999999999999973 234689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
+++..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 998765443333334567889999999999999999999999999999997 999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.93 Aligned_cols=202 Identities=26% Similarity=0.441 Sum_probs=173.5
Q ss_pred hhcCCcccceeccCccceEEEEEE-----cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC-
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-----ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG- 481 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 481 (618)
..++|+..+.||+|+||.||+|.+ .+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 346688899999999999999984 358999999987542 345678999999999999999999999987654
Q ss_pred -eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 482 -QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 482 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
..++||||+++++|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred CceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence 68999999999999999974 235689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccc--ccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQV--STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++.......... .....++..|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 998765443221 223457788999999999999999999999999999999998874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=300.09 Aligned_cols=198 Identities=27% Similarity=0.444 Sum_probs=159.6
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHH--HHHHHhhcCCCCcccccceEEee-----C
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFL--EAVSNMSRLRHPNIVTLAGYCAE-----H 480 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~-----~ 480 (618)
..++|...+.||+|+||.||+|+. +++.||+|++.... ...+. .|+..+..++||||+++++.+.. .
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 346788999999999999999977 58999999986432 23333 34444556899999999986543 2
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeecCCCCc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------LPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
...++||||+++|+|.++++. ...++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 357899999999999999963 34588999999999999999999862 2389999999999999999999
Q ss_pred EEeeccccccCCCCC-------cccccceeccccccCcccccc-------CCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 555 HLSDCGLAALTPNTE-------RQVSTQMVGAFGYSAPEFALS-------GIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 999999997654321 112223579999999999987 45678999999999999999997775
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=293.71 Aligned_cols=198 Identities=21% Similarity=0.334 Sum_probs=170.8
Q ss_pred hhhcCCcccceeccCccceEEEEEE--cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCC------cccccceEEe
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEF--ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP------NIVTLAGYCA 478 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~ 478 (618)
...++|+..+.||+|+||.||+|.. .+|+.||+|+++.. ....+.+.+|+++++.++|+ +++++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 4457899999999999999999986 36889999999743 23456677888888777655 5999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC--------
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-------- 550 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-------- 550 (618)
..+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccC
Confidence 999999999999 78999998642 234689999999999999999999999 9999999999999987
Q ss_pred -----------CCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 551 -----------ELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 551 -----------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6789999999997654322 23578999999999999999999999999999999999999995
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.69 Aligned_cols=199 Identities=20% Similarity=0.299 Sum_probs=168.3
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC--------CCcccccceEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--------HPNIVTLAGYC 477 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~ 477 (618)
...++|...+.||+|+||.||+|... +++.||+|+++.. ....+.+.+|++++++++ |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 34578999999999999999999765 5889999999743 334567888999888885 78899999998
Q ss_pred e----eCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-
Q 007103 478 A----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL- 552 (618)
Q Consensus 478 ~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~- 552 (618)
. .....++||||+. +++.+++.. .....+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLG-HHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEETTEEEEEEEECCCC-CBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHH
T ss_pred eecCCCCceEEEEEeccC-ccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccch
Confidence 7 4557899999995 566666542 23356999999999999999999999963 799999999999999775
Q ss_pred ------------------------------------------------CcEEeeccccccCCCCCcccccceeccccccC
Q 007103 553 ------------------------------------------------NPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584 (618)
Q Consensus 553 ------------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 584 (618)
.+||+|||+++..... .....||+.|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~a 261 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccC
Confidence 7999999999766432 234578999999
Q ss_pred ccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 585 PE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++.+..++.++|||||||++|||+||+.||+
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence 999999999999999999999999999999996
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.35 Aligned_cols=202 Identities=27% Similarity=0.425 Sum_probs=163.3
Q ss_pred hcCCcccceeccCccceEEEEEEc--CCc--EEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA--NGK--IMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|+..+.||+|+||.||+|.+. +++ .||+|+++.... .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467899999999999999999864 233 689999875432 2345678899999999999999999999998765 8
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999742 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 564 LTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 226 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 76543322 2233467889999999999899999999999999999999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=305.48 Aligned_cols=199 Identities=23% Similarity=0.331 Sum_probs=168.9
Q ss_pred hhcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCC-cccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP-NIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~l 485 (618)
..++|.+.+.||+|+||.||+|.+ .+++.||||++..... ..++..|+++++.++|+ +|..+..++...+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 346799999999999999999986 4689999998764432 23477899999999875 45555666677788999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---cCCCCcEEeecccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL---DDELNPHLSDCGLA 562 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~ 562 (618)
||||+ +++|.++++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 81 vme~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 99999 88999999742 45799999999999999999999999 99999999999999 58899999999999
Q ss_pred ccCCCCCcc------cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQ------VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 866543221 1224679999999999999999999999999999999999999996
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=292.88 Aligned_cols=204 Identities=28% Similarity=0.412 Sum_probs=152.3
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHH-HhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVS-NMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|...+.||+|+||.||+|... +|+.||+|++...... ....++..|+. +++.++||||+++++++...+..++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 4567889999999999999999885 6899999999765432 33444555555 7788899999999999999999999
Q ss_pred EEEecCCCChhhhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 486 VYEYVGNGNLHDMLHFAD-DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
||||+++ +|.+++.... .....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999985 8888775321 23567899999999999999999999962 799999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFA----LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.
T Consensus 176 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (327)
T 3aln_A 176 LVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred cccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 643221 2234799999999999 45678999999999999999999999995
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=297.58 Aligned_cols=206 Identities=25% Similarity=0.304 Sum_probs=171.5
Q ss_pred ehhhhhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CC-----ccccc
Q 007103 401 TVASLQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HP-----NIVTL 473 (618)
Q Consensus 401 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l 473 (618)
.+...+...++|...+.||+|+||.||+|... +++.||||+++... .....+..|+.+++.++ |+ +|+++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 33444556789999999999999999999876 58899999997432 33455667777777664 44 49999
Q ss_pred ceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec--CC
Q 007103 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DE 551 (618)
Q Consensus 474 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~ 551 (618)
++++...+..++||||++ ++|.+++... ....+++..+..++.|++.||+|||+.. .+|+||||||+|||++ .+
T Consensus 122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp EEEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTS
T ss_pred eeeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCC
Confidence 999999999999999996 5999998743 2346899999999999999999999521 2899999999999995 47
Q ss_pred CCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 552 LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 552 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 198 ~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp CCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 78999999999876432 234578999999999999999999999999999999999999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.40 Aligned_cols=203 Identities=22% Similarity=0.341 Sum_probs=172.3
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH----HHHHHHHHHHHHhhcCC--CCcccccceEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLR--HPNIVTLAGYC 477 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~ 477 (618)
.+...++|...+.||+|+||.||+|... +|+.||+|++....... .....+.+|++++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445678999999999999999999764 68999999987543221 12345667888888885 59999999999
Q ss_pred eeCCeEEEEEEecCC-CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCcE
Q 007103 478 AEHGQRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPH 555 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~k 555 (618)
...+..++|+|++.+ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999986 899999863 35689999999999999999999999 999999999999999 789999
Q ss_pred EeeccccccCCCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007103 556 LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 556 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||+
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 99999998765332 234579999999999987766 788999999999999999999996
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.43 Aligned_cols=194 Identities=27% Similarity=0.446 Sum_probs=161.8
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-------- 479 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 479 (618)
.++|+..+.||+|+||.||+|... +|+.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 467889999999999999999875 6899999998642 3456778999999999999999999998865
Q ss_pred -----CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCc
Q 007103 480 -----HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP 554 (618)
Q Consensus 480 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 554 (618)
.+..++||||+++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 3567999999999999999973 234678899999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCCC-------------cccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHh
Q 007103 555 HLSDCGLAALTPNTE-------------RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLT 611 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt 611 (618)
||+|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999997654221 1122345799999999999864 68999999999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.66 Aligned_cols=199 Identities=25% Similarity=0.328 Sum_probs=156.2
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 488 (618)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 345567889999999998777778999999998643 234577899998875 89999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC-------------C
Q 007103 489 YVGNGNLHDMLHFADDSSKN---LTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE-------------L 552 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-------------~ 552 (618)
|++ |+|.+++......... ..+..++.++.||+.||+|||+. +|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence 996 6999999743222111 13335678999999999999999 99999999999999754 4
Q ss_pred CcEEeeccccccCCCCCcc---cccceeccccccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 553 NPHLSDCGLAALTPNTERQ---VSTQMVGAFGYSAPEFALS-------GIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 8999999999876543322 1234579999999999976 568999999999999999999 999996
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=289.35 Aligned_cols=204 Identities=24% Similarity=0.381 Sum_probs=155.6
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
....++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.++..+++.++||||+++++++...+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 344578899999999999999999886 6899999999765544444455566666788889999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+ ++.+..+... ....+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++..
T Consensus 101 lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999 4455555432 2457899999999999999999999832 899999999999999999999999999976
Q ss_pred CCCCCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||++. ...++.++||||||+++|||++|+.||+
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 175 LVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 54322 223457999999999994 4568899999999999999999999996
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=291.68 Aligned_cols=196 Identities=22% Similarity=0.333 Sum_probs=146.0
Q ss_pred hhcCCccc-ceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee----CC
Q 007103 408 ATNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HG 481 (618)
Q Consensus 408 ~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~ 481 (618)
..++|... +.||+|+||.||+|... +|+.||+|++.... ... .+....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 45678874 46999999999999876 58999999986432 112 222334566789999999999876 44
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCcEEee
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSD 558 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~D 558 (618)
..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred eEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 589999999999999999732 235799999999999999999999999 9999999999999986 45599999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 175 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 175 FGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99997654322 234578999999999999999999999999999999999999995
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.43 Aligned_cols=202 Identities=23% Similarity=0.341 Sum_probs=163.6
Q ss_pred hhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH----HHHHHHHHHHHHhhcC----CCCcccccceE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRL----RHPNIVTLAGY 476 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~~ 476 (618)
+...++|...+.||+|+||.||+|... +|+.||+|++....... .....+.+|++.+.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445678999999999999999999774 68899999997543321 1233456788888877 89999999999
Q ss_pred EeeCCeEEEEEEe-cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCc
Q 007103 477 CAEHGQRLLVYEY-VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNP 554 (618)
Q Consensus 477 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~ 554 (618)
+...+..++|+|| +.+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999973 34689999999999999999999999 999999999999999 88999
Q ss_pred EEeeccccccCCCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007103 555 HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 555 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||+
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 999999998765432 234568999999999987776 458999999999999999999996
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=291.16 Aligned_cols=200 Identities=21% Similarity=0.321 Sum_probs=169.9
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CC-cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCc------ccccceE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NG-KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN------IVTLAGY 476 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~ 476 (618)
.....++|...+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.++++
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 3445678999999999999999999875 34 78999999743 234567788888888887665 8999999
Q ss_pred EeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee--------
Q 007103 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILL-------- 548 (618)
Q Consensus 477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill-------- 548 (618)
+...+..++||||+ ++++.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence 99999999999999 55777766532 235689999999999999999999999 99999999999999
Q ss_pred -----------cCCCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 549 -----------DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 549 -----------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999997654322 34579999999999999999999999999999999999999996
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.83 Aligned_cols=193 Identities=16% Similarity=0.150 Sum_probs=157.7
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccc------cHHHHHHHHHHHHHhhcCC---------C------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAAL------SLQEEDNFLEAVSNMSRLR---------H------ 467 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h------ 467 (618)
.++|+..+.||+|+||.||+|+. +|+.||||++..... .....+.+.+|++++++++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999988 689999999975532 1222356777887777765 5
Q ss_pred -----------CcccccceEEee-------------CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHH
Q 007103 468 -----------PNIVTLAGYCAE-------------HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523 (618)
Q Consensus 468 -----------~niv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 523 (618)
|||+++++++.+ .+..++||||+++|++.+.+. ...+++..+..++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 455555554443 678999999999997766663 256899999999999999
Q ss_pred HHHHHh-hcCCCCceecCCCCCCeeecCCC--------------------CcEEeeccccccCCCCCcccccceeccccc
Q 007103 524 ALEYLH-EVCLPSVVHRNFKSANILLDDEL--------------------NPHLSDCGLAALTPNTERQVSTQMVGAFGY 582 (618)
Q Consensus 524 ~L~~LH-~~~~~~iiH~Dlkp~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 582 (618)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ..+||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999865432 35799999
Q ss_pred cCccccccCCCCcccchhhHHHH-HHHHHhCCCCCC
Q 007103 583 SAPEFALSGIYTVKSDVYSFGVV-MLELLTGRKPLD 617 (618)
Q Consensus 583 ~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~Pf~ 617 (618)
+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998766 889999998776 788999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=317.03 Aligned_cols=194 Identities=24% Similarity=0.394 Sum_probs=167.8
Q ss_pred hhhcCCcccceeccCccceEEEEEEc--CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCe--
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ-- 482 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 482 (618)
...++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|++++++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34578999999999999999999875 58999999987543 34456778999999999999999999999987665
Q ss_pred ---EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 483 ---RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 483 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
.++||||+++++|.+++. ..+++..++.++.||+.||+|||++ +|+||||||+|||++++ .+||+||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp CEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence 799999999999988774 2689999999999999999999999 99999999999999986 8999999
Q ss_pred cccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||.
T Consensus 226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 226 GAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp TTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEET
T ss_pred ccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCc
Confidence 999876433 3457999999999987654 889999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.79 Aligned_cols=198 Identities=22% Similarity=0.313 Sum_probs=158.1
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 486 (618)
...+|...+.||+|+||+||.....+|+.||||++...... .+.+|+++++++ +||||+++++++.+....++|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 34568889999999999976666667999999998654322 245788999888 799999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-----CCCcEEeeccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-----ELNPHLSDCGL 561 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfgl 561 (618)
|||++ |+|.+++... .....+..+..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+
T Consensus 97 ~E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 97 IELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99997 5999998732 23344556678999999999999999 9999999999999953 23578999999
Q ss_pred cccCCCCCc--ccccceeccccccCccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 562 AALTPNTER--QVSTQMVGAFGYSAPEFAL---SGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
++....... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||.
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 987653321 2234467999999999997 4567889999999999999999 999985
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=283.88 Aligned_cols=220 Identities=26% Similarity=0.443 Sum_probs=200.4
Q ss_pred CCChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCceeEeeC----CCEEEEEcCCCCCcc--cccccccCCCCCCE
Q 007103 38 TTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEG----SAVVSIDISGLGLSG--TMGYLLSDLLSLRK 111 (618)
Q Consensus 38 ~~~~~~~~al~~~~~~~~~~~~~~~w~~~~~~~c~~~w~gv~c~~----~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~ 111 (618)
.|.++|++||++||+++.+|..+.+|.. +.+||.+.|.||.|+. .+|+.|+|++|++.| .+|..|.++++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 4678999999999999988878999975 4578855699999985 689999999999999 99999999999999
Q ss_pred EEecC-CCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCc
Q 007103 112 FDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (618)
Q Consensus 112 L~L~~-N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 188 (618)
|+|++ |.+.+.+|..+. ++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..|..+++|++|+|++|+
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 99995 999999998886 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccCC-CcCeeeeccccccccccc-cCCCCccEEEcccccccccCchhh---hcccchhccCCcCCC
Q 007103 189 FSGDLPNSFISLS-NISSLYLQNNQVTGSLNV-FSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDN 258 (618)
Q Consensus 189 l~g~~p~~~~~l~-~L~~L~l~~N~l~~~~~~-~~~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~ 258 (618)
++|.+|..+..++ +|++|+|++|++++.++. +...+|+.|+|++|.+++.+|..+ .+|+.|++++|.+..
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceee
Confidence 9999999999998 999999999999986654 444569999999999999988765 567788999998863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.24 Aligned_cols=197 Identities=19% Similarity=0.338 Sum_probs=167.3
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-----------CCcccccceE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----------HPNIVTLAGY 476 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~ 476 (618)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 467999999999999999999874 68999999997432 34566778888887775 8999999999
Q ss_pred EeeCC----eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec---
Q 007103 477 CAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--- 549 (618)
Q Consensus 477 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~--- 549 (618)
+...+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 88654 789999999 78999998743 2345899999999999999999999953 899999999999994
Q ss_pred ---CCCCcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 550 ---DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 550 ---~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 4457999999999766432 223578999999999999999999999999999999999999996
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.61 Aligned_cols=202 Identities=28% Similarity=0.440 Sum_probs=173.2
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee------CC
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE------HG 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 481 (618)
.++|...+.||+|+||.||+|.+. +|+.||+|++.... .....+.+.+|++++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 367999999999999999999875 58999999987543 45566789999999999999999999998765 66
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC---cEEee
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN---PHLSD 558 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~D 558 (618)
..++||||+++|+|.++++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred eEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 7899999999999999997432 234688999999999999999999999 9999999999999997765 89999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 168 FG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 168 LGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 99998765432 2234679999999999999999999999999999999999999994
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=273.78 Aligned_cols=173 Identities=16% Similarity=0.174 Sum_probs=152.2
Q ss_pred hhcCCcccceeccCccceEEEEEEcC-CcEEEEEEcCccccc-HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
..++|+..+.||+|+||.||+|.... |+.||+|++...... ....+.+.+|++.+.+++||||+++++++...+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34679999999999999999998864 899999999865433 4455788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++++|.++++. + ....++.+++.|++.||+|||++ +|+||||||+|||+++++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999852 2 35567889999999999999999 99999999999999999999998443
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|++| ++.++|||||||++|||+||+.||.
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~ 203 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLP 203 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3333 6889999999999999999999996
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-33 Score=294.19 Aligned_cols=204 Identities=18% Similarity=0.245 Sum_probs=156.9
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccc-ccHHHHHHHHHHHHHhhcCCC-Ccccccc-------
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAA-LSLQEEDNFLEAVSNMSRLRH-PNIVTLA------- 474 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~l~------- 474 (618)
+......|...+.||+|+||.||+|.+. +|+.||||++.... ......+.+.+|+.+++.++| +|.....
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3344556888899999999999999865 69999999987332 233345778999999999987 3222111
Q ss_pred --eE------------Eee-----CCeEEEEEEecCCCChhhhhhcc---cCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 007103 475 --GY------------CAE-----HGQRLLVYEYVGNGNLHDMLHFA---DDSSKNLTWNARVRVALGTARALEYLHEVC 532 (618)
Q Consensus 475 --~~------------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 532 (618)
+. +.. ....+++|+++ +++|.++++.. ......+++..+..++.|+++||+|||++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 230 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY- 230 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 11 111 12356677655 57999988532 22345678889999999999999999999
Q ss_pred CCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccceeccccccCcccc----------ccCCCCcccchhhH
Q 007103 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA----------LSGIYTVKSDVYSF 602 (618)
Q Consensus 533 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvwsl 602 (618)
+|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999999999999999998765432 334567 999999999 55668899999999
Q ss_pred HHHHHHHHhCCCCCC
Q 007103 603 GVVMLELLTGRKPLD 617 (618)
Q Consensus 603 G~il~elltg~~Pf~ 617 (618)
||++|||+||+.||.
T Consensus 304 Gvil~elltg~~Pf~ 318 (413)
T 3dzo_A 304 GLAIYWIWCADLPNT 318 (413)
T ss_dssp HHHHHHHHHSSCCCC
T ss_pred HHHHHHHHHCCCCCC
Confidence 999999999999996
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=265.27 Aligned_cols=174 Identities=23% Similarity=0.367 Sum_probs=148.7
Q ss_pred hcCCccc-ceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHh-hcCCCCcccccceEEee----CC
Q 007103 409 TNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNM-SRLRHPNIVTLAGYCAE----HG 481 (618)
Q Consensus 409 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~ 481 (618)
.++|... +.||+|+||.||+|... +++.||+|+++.. ..+.+|++.+ +..+||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3456665 78999999999999874 6899999998632 3456777776 56689999999999887 66
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCcEEee
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSD 558 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~D 558 (618)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred eEEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 789999999999999999742 235699999999999999999999999 9999999999999997 78999999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++.... +..++.++|||||||++|||+||+.||.
T Consensus 164 fg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 164 FGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp CTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99885432 2346789999999999999999999995
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=285.60 Aligned_cols=185 Identities=16% Similarity=0.100 Sum_probs=130.0
Q ss_pred eccCccceEEEEE-EcCCcEEEEEEcCcccc--------cHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEEEEE
Q 007103 418 IGEGSLGRVYRAE-FANGKIMAVKKIDNAAL--------SLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 418 Lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.+.|+.|.+..++ .--|+.+++|.+..... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666555542 22388999999864321 223456799999999999 6999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||++|++|.++++ ..++++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999997 34566654 5889999999999999 999999999999999999999999999987654
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRK 614 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 614 (618)
.. ......+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 392 ~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 33 23345789999999999876 46778999999999888766543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-29 Score=284.62 Aligned_cols=213 Identities=17% Similarity=0.329 Sum_probs=158.5
Q ss_pred CChHHHHHHHHHHHhCCCCCCCCCCCCCC----CCCCCCCC------------ceeEeeC-CCEEEEEcCCCCCcccccc
Q 007103 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNE----GDPCGESW------------KGVACEG-SAVVSIDISGLGLSGTMGY 101 (618)
Q Consensus 39 ~~~~~~~al~~~~~~~~~~~~~~~w~~~~----~~~c~~~w------------~gv~c~~-~~v~~l~l~~~~l~~~~~~ 101 (618)
+...|++||++||+++++| +|+.+. .+||+|.| .||.|+. ++|+.|+|++++|.|.+|+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred cchHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 4467999999999999887 787553 57766699 9999984 7999999999999999999
Q ss_pred cccCCCCCCEEEe-cCCCccCC----------------------------------------------------------
Q 007103 102 LLSDLLSLRKFDL-SGNSIHDT---------------------------------------------------------- 122 (618)
Q Consensus 102 ~l~~l~~L~~L~L-~~N~l~~~---------------------------------------------------------- 122 (618)
.|++|++|+.|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 88877665
Q ss_pred ------------------CCCCCC--CCccEEecccccccc-----------------cCCcccc--CCCCccEEEeecC
Q 007103 123 ------------------IPYQLP--PNLTSLNLASNNFSG-----------------NLPYSIA--SMVSLSYLNVSRN 163 (618)
Q Consensus 123 ------------------~p~~~~--~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~L~~N 163 (618)
+|..+. ++|+.|+|++|+|+| .+|..++ ++++|++|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 444443 677777777777777 3777766 7777777777777
Q ss_pred CCCCccchhhcCCCCCCeEEcccCc-CCC-CCCCCcccCC-------CcCeeeecccccccccc--ccCC-CCccEEEcc
Q 007103 164 SLTQSIGDIFGNLAGLATLDLSFNN-FSG-DLPNSFISLS-------NISSLYLQNNQVTGSLN--VFSG-LPLTTLNVA 231 (618)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~l~-------~L~~L~l~~N~l~~~~~--~~~~-~~L~~L~l~ 231 (618)
++.+.+|..|+++++|+.|+|++|+ |+| .+|..++.++ +|++|+|++|+|+..+. .+.. .+|+.|+|+
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls 581 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECT
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECC
Confidence 7777777777777777777777776 776 6666555544 77777777777773333 2333 347777777
Q ss_pred cccccccCchhh---hcccchhccCCcCC
Q 007103 232 NNHFSGWIPREL---ISIRTFIYDGNSFD 257 (618)
Q Consensus 232 ~N~l~g~ip~~~---~~l~~l~~~~N~~~ 257 (618)
+|+++ .+| .+ .+|+.|++++|.+.
T Consensus 582 ~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 582 HNKVR-HLE-AFGTNVKLTDLKLDYNQIE 608 (876)
T ss_dssp TSCCC-BCC-CCCTTSEESEEECCSSCCS
T ss_pred CCCcc-cch-hhcCCCcceEEECcCCccc
Confidence 77776 666 33 34556666666665
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=277.62 Aligned_cols=219 Identities=24% Similarity=0.323 Sum_probs=170.1
Q ss_pred hccCCChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCceeEeeCCCEEEEEcCCCCCccc---cc-----------
Q 007103 35 VQCTTDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGT---MG----------- 100 (618)
Q Consensus 35 ~~~~~~~~~~~al~~~~~~~~~~~~~~~w~~~~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~---~~----------- 100 (618)
+++.+.++|++||++||+++.||..+++|+ .+.||| .|+||.|+.++|+.|+|+++++.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~~l~~W~-~~~~~C--~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKNLLPDWS-SNKNPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTTSSTTCC-TTSCGG--GSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcccccCCC-CCCCCc--CCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 334446789999999999998877899997 345666 8999999988999999999999987 55
Q ss_pred ------------ccccCCCCCCEEEecCCCccCCCCC--CCC--CCccEEecccccccccCCccc-cCCCCccEEEeecC
Q 007103 101 ------------YLLSDLLSLRKFDLSGNSIHDTIPY--QLP--PNLTSLNLASNNFSGNLPYSI-ASMVSLSYLNVSRN 163 (618)
Q Consensus 101 ------------~~l~~l~~L~~L~L~~N~l~~~~p~--~~~--~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N 163 (618)
..++.+++|++|+|++|.++|.+|. .+. ++|++|+|++|++++.+|..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 4566777777777777777777776 554 677788888777777777665 67778888888888
Q ss_pred CCCCccchh---hcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccccC
Q 007103 164 SLTQSIGDI---FGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWI 239 (618)
Q Consensus 164 ~l~~~~p~~---~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~i 239 (618)
++++..|.. +.++++|++|+|++|++++.+|. ..+++|++|+|++|++++.++.+.. .+|+.|+|++|.++|.+
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 239 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDF 239 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCH
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcc
Confidence 887777766 67788888888888888776653 6788888888888888887766544 35889999999998888
Q ss_pred chhhh---cccchhccCCcCCC
Q 007103 240 PRELI---SIRTFIYDGNSFDN 258 (618)
Q Consensus 240 p~~~~---~l~~l~~~~N~~~~ 258 (618)
|..+. +|+.|++.+|.+..
T Consensus 240 ~~~l~~l~~L~~L~Ls~n~l~~ 261 (768)
T 3rgz_A 240 SRAISTCTELKLLNISSNQFVG 261 (768)
T ss_dssp HHHTTTCSSCCEEECCSSCCEE
T ss_pred cHHHhcCCCCCEEECCCCcccC
Confidence 87664 45677888887753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=274.63 Aligned_cols=213 Identities=18% Similarity=0.312 Sum_probs=181.5
Q ss_pred ChHHHHHHHHHHHhCCCCCCC---------CCCCCCCCCCCCCCC---ceeEeeC-CCEEEEEcCCCCCcccccccccCC
Q 007103 40 DSSDVQALQVLYTSLNSPSVL---------TNWKGNEGDPCGESW---KGVACEG-SAVVSIDISGLGLSGTMGYLLSDL 106 (618)
Q Consensus 40 ~~~~~~al~~~~~~~~~~~~~---------~~w~~~~~~~c~~~w---~gv~c~~-~~v~~l~l~~~~l~~~~~~~l~~l 106 (618)
...|++||.+++.+++++.|- .+|+.+ .++| .| .||.|+. ++|+.|+|++++++|.+|++|++|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c--~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L 104 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELD--MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQL 104 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGG--GTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGC
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcc--cccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcC
Confidence 356999999999999877532 379753 5666 89 9999975 599999999999999999999999
Q ss_pred CCCCEEEecCCCc-------------------------------------------------------------------
Q 007103 107 LSLRKFDLSGNSI------------------------------------------------------------------- 119 (618)
Q Consensus 107 ~~L~~L~L~~N~l------------------------------------------------------------------- 119 (618)
++|++|+|++|.+
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 9999999999943
Q ss_pred -----------cCCCCCCCC--CCccEEeccccccccc-----------------CCcccc--CCCCccEEEeecCCCCC
Q 007103 120 -----------HDTIPYQLP--PNLTSLNLASNNFSGN-----------------LPYSIA--SMVSLSYLNVSRNSLTQ 167 (618)
Q Consensus 120 -----------~~~~p~~~~--~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~ 167 (618)
+| +|..+. ++|++|+|++|+|+|. +|..++ ++++|++|+|++|++++
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 34 676665 8999999999999986 999999 99999999999999999
Q ss_pred ccchhhcCCCCCCeEEcccCc-CCC-CCCCCcccC------CCcCeeeecccccccccc--ccCC-CCccEEEccccccc
Q 007103 168 SIGDIFGNLAGLATLDLSFNN-FSG-DLPNSFISL------SNISSLYLQNNQVTGSLN--VFSG-LPLTTLNVANNHFS 236 (618)
Q Consensus 168 ~~p~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~~~~~--~~~~-~~L~~L~l~~N~l~ 236 (618)
.+|..|+++++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+++..+. .+.. .+|+.|+|++|+++
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~ 343 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCE
T ss_pred cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCc
Confidence 999999999999999999998 998 889888776 899999999999994444 3444 35999999999999
Q ss_pred ccCchhh---hcccchhccCCcCC
Q 007103 237 GWIPREL---ISIRTFIYDGNSFD 257 (618)
Q Consensus 237 g~ip~~~---~~l~~l~~~~N~~~ 257 (618)
|.+| .+ .+|+.|++++|.+.
T Consensus 344 g~ip-~~~~l~~L~~L~L~~N~l~ 366 (636)
T 4eco_A 344 GKLP-AFGSEIKLASLNLAYNQIT 366 (636)
T ss_dssp EECC-CCEEEEEESEEECCSSEEE
T ss_pred cchh-hhCCCCCCCEEECCCCccc
Confidence 9888 55 45667888888776
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=243.94 Aligned_cols=214 Identities=19% Similarity=0.252 Sum_probs=184.2
Q ss_pred CChHHHHHHHHHHHhCC-CC-CCCCCCC---CCCCCCCCCCCceeEeeC----------CCEEEEEcCCCCCcccccccc
Q 007103 39 TDSSDVQALQVLYTSLN-SP-SVLTNWK---GNEGDPCGESWKGVACEG----------SAVVSIDISGLGLSGTMGYLL 103 (618)
Q Consensus 39 ~~~~~~~al~~~~~~~~-~~-~~~~~w~---~~~~~~c~~~w~gv~c~~----------~~v~~l~l~~~~l~~~~~~~l 103 (618)
...+|.+||++||.++. ++ .++.+|. ....++| .|.|+.|.. .+|+.|+|++|++. .+|..+
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~--~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE--TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC--CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhccccccccccc--ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 44679999999999873 43 4678884 2334555 799999952 68999999999998 778889
Q ss_pred cCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcC------
Q 007103 104 SDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGN------ 175 (618)
Q Consensus 104 ~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------ 175 (618)
+++++|++|+|++|.|+ .+|..+. ++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 8888776 89999999999999 88999999999999999999999999987765
Q ss_pred ---CCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccccCchhh---hcccc
Q 007103 176 ---LAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPREL---ISIRT 248 (618)
Q Consensus 176 ---l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~ 248 (618)
+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++.++.+.. .+|+.|+|++|++.+.+|..+ .+|+.
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 257 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence 999999999999999 8999999999999999999999987665544 459999999999999999876 45667
Q ss_pred hhccCCcCCC
Q 007103 249 FIYDGNSFDN 258 (618)
Q Consensus 249 l~~~~N~~~~ 258 (618)
|++.+|.+..
T Consensus 258 L~L~~n~~~~ 267 (328)
T 4fcg_A 258 LILKDCSNLL 267 (328)
T ss_dssp EECTTCTTCC
T ss_pred EECCCCCchh
Confidence 8888877643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=257.82 Aligned_cols=187 Identities=13% Similarity=0.189 Sum_probs=149.1
Q ss_pred cccceeccCccceEEEEEEcCCcEEEEEEcCccccc------HHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS------LQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...+.||+|+||.||+|.. .++.+++|+....... ....+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4456899999999999955 4778888876433221 11245689999999999999999777777788888999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999962 457999999999999999 9999999999999999 99999999998876
Q ss_pred CCCccc------ccceeccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQV------STQMVGAFGYSAPEFALS--GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... .....||+.|||||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 543221 235689999999999987 668888999999999999988888775
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=245.99 Aligned_cols=179 Identities=28% Similarity=0.394 Sum_probs=134.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccc-----------
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI----------- 149 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~----------- 149 (618)
..++.|+|++|.+++.+|..++.+++|++|+|++|+++|.+|..+. ++|+.|+|++|+++|.+|..+
T Consensus 490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~ 569 (768)
T 3rgz_A 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence 3566666666666666666666666666666666666666666554 677777777777776666543
Q ss_pred -----------------------------------------------------------cCCCCccEEEeecCCCCCccc
Q 007103 150 -----------------------------------------------------------ASMVSLSYLNVSRNSLTQSIG 170 (618)
Q Consensus 150 -----------------------------------------------------------~~l~~L~~L~L~~N~l~~~~p 170 (618)
..+++|++|||++|+++|.+|
T Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip 649 (768)
T 3rgz_A 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649 (768)
T ss_dssp TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence 234667788888888888888
Q ss_pred hhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc-CC-CCccEEEcccccccccCch--hhhcc
Q 007103 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLNVANNHFSGWIPR--ELISI 246 (618)
Q Consensus 171 ~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~L~l~~N~l~g~ip~--~~~~l 246 (618)
..|+++++|+.|+|++|+|+|.+|..|+++++|++|+|++|+++|.+|.. .. ..|+.|||++|+|+|.||. .+.++
T Consensus 650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~ 729 (768)
T 3rgz_A 650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGS
T ss_pred HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccC
Confidence 88888888888888888888888888888888888888888888877653 22 3588888888888888886 46777
Q ss_pred cchhccCCcCCCCCC
Q 007103 247 RTFIYDGNSFDNGPA 261 (618)
Q Consensus 247 ~~l~~~~N~~~~~~~ 261 (618)
....+.||+..|+..
T Consensus 730 ~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 730 PPAKFLNNPGLCGYP 744 (768)
T ss_dssp CGGGGCSCTEEESTT
T ss_pred CHHHhcCCchhcCCC
Confidence 778888888888753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=209.60 Aligned_cols=187 Identities=22% Similarity=0.269 Sum_probs=156.6
Q ss_pred CCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEeccccc
Q 007103 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (618)
Q Consensus 74 ~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (618)
.|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++|.|+...+..+. ++|++|+|++|+
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~ 96 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSC
T ss_pred CCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCc
Confidence 456677753 2478899999999988888999999999999999999955444433 899999999999
Q ss_pred ccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-
Q 007103 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV- 219 (618)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~- 219 (618)
+++..+..+.++++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+.
T Consensus 97 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 176 (270)
T 2o6q_A 97 LQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGA 176 (270)
T ss_dssp CCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred CCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhH
Confidence 9987777889999999999999999998888999999999999999999966666689999999999999999987664
Q ss_pred cCC-CCccEEEcccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 220 FSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 220 ~~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
+.. .+|+.|+|++|++++..+..+ .+|+.|++.+|+|.|.+
T Consensus 177 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 177 FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred hccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 333 469999999999996555444 56778999999999865
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=204.13 Aligned_cols=175 Identities=21% Similarity=0.251 Sum_probs=153.1
Q ss_pred CCCCCCCceeEeeCC-----------CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEe
Q 007103 69 DPCGESWKGVACEGS-----------AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (618)
Q Consensus 69 ~~c~~~w~gv~c~~~-----------~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~ 135 (618)
+.|.|.|.+|.|... +++.|+|++|++++..+..|..+++|++|+|++|+|++..+..+. ++|++|+
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 467779999999742 588999999999988888899999999999999999966554444 8999999
Q ss_pred cccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc
Q 007103 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 136 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
|++|+|++..+..+.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|.+++
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 99999997777778999999999999999998888889999999999999999997666678999999999999999886
Q ss_pred cccccCCCCccEEEcccccccccCchhhhcccc
Q 007103 216 SLNVFSGLPLTTLNVANNHFSGWIPRELISIRT 248 (618)
Q Consensus 216 ~~~~~~~~~L~~L~l~~N~l~g~ip~~~~~l~~ 248 (618)
..+ .|+.|+++.|+++|.+|+.+.++..
T Consensus 163 ~~~-----~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 TCP-----GIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CTT-----TTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CCC-----CHHHHHHHHHhCCceeeccCccccC
Confidence 543 5889999999999999998887653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-24 Score=216.50 Aligned_cols=174 Identities=29% Similarity=0.391 Sum_probs=134.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCC-CccEEE
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMV-SLSYLN 159 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ 159 (618)
.+++.|+|++|++++.+|..|.++++|++|+|++|.|++.+|..+. ++|++|+|++|++++.+|..+..++ +|++|+
T Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~ 180 (313)
T 1ogq_A 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180 (313)
T ss_dssp TTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEE
T ss_pred CCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEE
Confidence 4688899999999999999999999999999999999988887775 8899999999999888888888887 888888
Q ss_pred eecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEccccccccc
Q 007103 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGW 238 (618)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~ 238 (618)
|++|++++.+|..|..++ |+.|+|++|++++.+|..|..+++|++|+|++|++++.++.+.. .+|+.|+|++|+|+|.
T Consensus 181 L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 259 (313)
T 1ogq_A 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp CCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEEC
T ss_pred CcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCc
Confidence 888888888888887776 88888888888777777777777777777777777765554333 2366666666666666
Q ss_pred Cchhhh---cccchhccCCcCC
Q 007103 239 IPRELI---SIRTFIYDGNSFD 257 (618)
Q Consensus 239 ip~~~~---~l~~l~~~~N~~~ 257 (618)
+|..+. +|+.|++++|++.
T Consensus 260 ~p~~l~~l~~L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 260 LPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEE
T ss_pred CChHHhcCcCCCEEECcCCccc
Confidence 665443 3345555555554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-23 Score=202.57 Aligned_cols=183 Identities=22% Similarity=0.263 Sum_probs=155.3
Q ss_pred CCceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccC
Q 007103 74 SWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIAS 151 (618)
Q Consensus 74 ~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~ 151 (618)
.|.|+.|.. ..+.+++++++++. +|..+. ++|+.|+|++|.+++..+..+. ++|++|+|++|+|++..|..|.+
T Consensus 6 ~~~gC~C~~-~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 81 (251)
T 3m19_A 6 TVTGCTCNE-GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81 (251)
T ss_dssp HHHSSEEEG-GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred CCCceEcCC-CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhcc
Confidence 799999963 24468999999975 455554 6899999999999988877665 89999999999999988888999
Q ss_pred CCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEE
Q 007103 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLN 229 (618)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ 229 (618)
+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++.++. +.. .+|+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 99999999999999988888999999999999999999976666788999999999999999987763 433 4699999
Q ss_pred cccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 230 VANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 230 l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
|++|+|++..|..+ .+|+.|++.+|+|.|.+
T Consensus 162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 99999997766554 56778899999999863
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=208.99 Aligned_cols=161 Identities=14% Similarity=0.077 Sum_probs=127.9
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccH----------------HHHHHHHHHHHHhhcCCCCcccc
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSL----------------QEEDNFLEAVSNMSRLRHPNIVT 472 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~niv~ 472 (618)
...|...+.||+|+||.||+|.+.+|+.||+|.++...... .....+.+|++++++++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 44566778999999999999998779999999996433211 23567899999999998 5 77
Q ss_pred cceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 473 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
+.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++ ++
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TT
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CC
Confidence 7776544 55699999999999988 421 12446999999999999999 999999999999999 99
Q ss_pred CcEEeeccccccCCCCCcccccceeccccccCcccccc----------CCCCcccchhhH
Q 007103 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS----------GIYTVKSDVYSF 602 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvwsl 602 (618)
.+||+|||+++. +..|+|||++.+ .+|..++|+|.+
T Consensus 230 ~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 230 GIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp EEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred cEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999999999853 344788998864 456677788763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=204.18 Aligned_cols=176 Identities=22% Similarity=0.181 Sum_probs=157.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
..++.|+|++|.+++..+..|..+++|++|+|++|.|++..+....++|+.|+|++|+|+ .+|..+..+++|++|+|++
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~ 109 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC
Confidence 468999999999999999999999999999999999997666655599999999999999 7889999999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc-C-CCCccEEEcccccccccCc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~L~l~~N~l~g~ip 240 (618)
|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++.. . ..+|+.|+|++|+|+ .+|
T Consensus 110 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip 188 (290)
T 1p9a_G 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (290)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred CcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccC
Confidence 9999988899999999999999999999777777899999999999999999876643 3 346999999999999 778
Q ss_pred hhhh---cccchhccCCcCCCCC
Q 007103 241 RELI---SIRTFIYDGNSFDNGP 260 (618)
Q Consensus 241 ~~~~---~l~~l~~~~N~~~~~~ 260 (618)
..+. +|+.+.+.+|+|.|.+
T Consensus 189 ~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 189 KGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TTTTTTCCCSEEECCSCCBCCSG
T ss_pred hhhcccccCCeEEeCCCCccCcC
Confidence 7653 4778899999999964
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=202.89 Aligned_cols=134 Identities=22% Similarity=0.239 Sum_probs=116.7
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
.++.|+|++|++++..+..|.++++|++|+|++|.+++..+..+. ++|++|+|++|++++..+..+.++++|++|+|+
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 588999999999988888899999999999999999876665555 789999999999998888889999999999999
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCC-CCCCcccCCCcCeeeeccccccccc
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGD-LPNSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
+|++++..+..++.+++|+.|+|++|++++. +|..+..+++|++|+|++|+|++..
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~ 165 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCC
Confidence 9999988777888999999999999999863 6888999999999999999888754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4.1e-22 Score=213.48 Aligned_cols=186 Identities=18% Similarity=0.176 Sum_probs=151.4
Q ss_pred CCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEeccccc
Q 007103 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (618)
Q Consensus 74 ~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (618)
.|..|.|.. .+++.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+. ++|++|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 467899974 3589999999999999999999999999999999999988777776 899999999999
Q ss_pred ccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCC-CCcccCCCcCeeeeccccccccccc
Q 007103 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNV 219 (618)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~ 219 (618)
|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+..+.++ ..|..+++|++|+|++|+|++....
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 214 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNL 214 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCC
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccc
Confidence 998777889999999999999999998777788888899999988844333444 4577888888888888888876443
Q ss_pred cCCCCccEEEcccccccccCchhh---hcccchhccCCcCCCC
Q 007103 220 FSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 220 ~~~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~ 259 (618)
....+|+.|+|++|+|++..|..+ .+|+.|++.+|.+...
T Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (452)
T 3zyi_A 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257 (452)
T ss_dssp TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence 334458888888888887777655 3455677777776543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=204.15 Aligned_cols=191 Identities=23% Similarity=0.312 Sum_probs=142.4
Q ss_pred CCCCCCCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCC--CC-----------
Q 007103 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT--IP----------- 124 (618)
Q Consensus 69 ~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p----------- 124 (618)
+.|.|.|.+|.|.. .+++.|+|++|+++...+..|.++++|++|+|++|.++.. +|
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 56777999999975 3588999999999876666688888899999888887632 11
Q ss_pred ------------CCC--CCCccEEecccccccccCC-ccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcC
Q 007103 125 ------------YQL--PPNLTSLNLASNNFSGNLP-YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (618)
Q Consensus 125 ------------~~~--~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 189 (618)
..+ .++|++|+|++|++++..+ ..+..+++|++|+|++|++++..+..|..+++|+.|+|++|.+
T Consensus 83 L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 162 (306)
T 2z66_A 83 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162 (306)
T ss_dssp EECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred EECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence 111 1567777777777775544 5677888888888888888888888888888888888888888
Q ss_pred CC-CCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCchhh---hcccchhccCCcCCCC
Q 007103 190 SG-DLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 190 ~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~ 259 (618)
++ .+|..+..+++|++|+|++|+|++..+. +.. .+|+.|+|++|++++..+..+ .+|+.|++++|.+...
T Consensus 163 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 238 (306)
T 2z66_A 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238 (306)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC
T ss_pred ccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc
Confidence 76 5777788888888888888888876543 322 358888888888876555443 5667777888877653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.9e-22 Score=198.64 Aligned_cols=176 Identities=21% Similarity=0.228 Sum_probs=151.2
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEeccccc-ccccCCccccCCCCccEEEe
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN-FSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L 160 (618)
.++.|+|++|++++..+..|..+++|++|+|++|.+++..|..+. ++|++|+|++|+ ++...|..+..+++|++|+|
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 588999999999988888899999999999999999987777776 899999999997 77777888999999999999
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEccccccccc
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGW 238 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ 238 (618)
++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+. +.. .+|+.|+|++|.+++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 99999988888999999999999999999976667788999999999999999986654 333 4599999999999988
Q ss_pred Cchhh---hcccchhccCCcCCCC
Q 007103 239 IPREL---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 239 ip~~~---~~l~~l~~~~N~~~~~ 259 (618)
.|..+ .+|+.|++++|.+...
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~ 216 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSAL 216 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CHhHccCcccccEeeCCCCcCCcC
Confidence 78766 4667888888887653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.9e-22 Score=198.15 Aligned_cols=178 Identities=22% Similarity=0.243 Sum_probs=158.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCC-ccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEE
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
.+++.|+|++|.+++..+..|..+++|++|+|++|. ++...|..+. ++|++|+|++|++++..|..+.++++|++|+
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 579999999999999999999999999999999998 7766676665 8999999999999998899999999999999
Q ss_pred eecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccc
Q 007103 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSG 237 (618)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g 237 (618)
|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..+. +.. .+|+.|+|++|++++
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 215 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence 999999988888899999999999999999976666799999999999999999997554 333 469999999999997
Q ss_pred cCchhh---hcccchhccCCcCCCCC
Q 007103 238 WIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 238 ~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
..+..+ .+|+.|++.+|+|.|.+
T Consensus 216 ~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 216 LPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCHHHcccCcccCEEeccCCCccCCC
Confidence 666545 56778999999999864
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-21 Score=192.30 Aligned_cols=167 Identities=23% Similarity=0.279 Sum_probs=149.3
Q ss_pred CCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEeccccc
Q 007103 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (618)
Q Consensus 74 ~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (618)
.+..+.|.. ..++.|+|++|++.+..+..|.++++|++|+|++|.|++..|..+. ++|+.|+|++|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 577788863 3588999999999999999999999999999999999988776665 899999999999
Q ss_pred ccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-
Q 007103 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV- 219 (618)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~- 219 (618)
|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++.++.
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 174 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA 174 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHH
Confidence 9988888899999999999999999988888899999999999999999976677899999999999999999987764
Q ss_pred cCC-CCccEEEcccccccccCc
Q 007103 220 FSG-LPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 220 ~~~-~~L~~L~l~~N~l~g~ip 240 (618)
+.. .+|+.|+|++|++++..+
T Consensus 175 ~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 175 FDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TTTCTTCCEEECCSCCBCTTST
T ss_pred HhCCCCCCEEEeeCCceeCCcc
Confidence 433 469999999999997633
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.4e-22 Score=226.76 Aligned_cols=179 Identities=19% Similarity=0.205 Sum_probs=124.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|++.+..+..|..+++|++|+|++|.+++..|..+. ++|+.|+|++|++++..+..|.++++|++|+|
T Consensus 290 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 369 (844)
T 3j0a_A 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369 (844)
T ss_dssp CCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEE
T ss_pred CCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEEC
Confidence 3566667777777666666667777777777777776665555544 56666666666666555555555555555555
Q ss_pred ecCCCCCc------------------------------------------------------------------------
Q 007103 161 SRNSLTQS------------------------------------------------------------------------ 168 (618)
Q Consensus 161 ~~N~l~~~------------------------------------------------------------------------ 168 (618)
++|.+++.
T Consensus 370 s~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 449 (844)
T 3j0a_A 370 RDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449 (844)
T ss_dssp ETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCS
T ss_pred CCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccccc
Confidence 55554431
Q ss_pred ----------------------cchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCcc
Q 007103 169 ----------------------IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLT 226 (618)
Q Consensus 169 ----------------------~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~ 226 (618)
.+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.....+|+
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~ 529 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLE 529 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhcccc
Confidence 1122444556666666666666666666777888888888888888776665557799
Q ss_pred EEEcccccccccCchhhhcccchhccCCcCCCCCC
Q 007103 227 TLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPA 261 (618)
Q Consensus 227 ~L~l~~N~l~g~ip~~~~~l~~l~~~~N~~~~~~~ 261 (618)
.|+|++|+|++.+|..+.+++.|++.+|+|.|.+.
T Consensus 530 ~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 530 ILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp EEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred EEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 99999999999999999999999999999999653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=199.95 Aligned_cols=172 Identities=19% Similarity=0.272 Sum_probs=129.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccC---------
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIAS--------- 151 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~--------- 151 (618)
.+++.|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..+. ++|++|+|++|++.+.+|..+..
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 46788888888887 77778888888888888888888 6676665 78888888888888788777654
Q ss_pred CCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc-CC-CCccEEE
Q 007103 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLN 229 (618)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~L~ 229 (618)
+++|++|+|++|+|+ .+|..++.+++|+.|+|++|+++ .+|..+..+++|++|+|++|++.+.++.. .. .+|+.|+
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 788888888888887 67777888888888888888888 46667778888888888888877766543 22 3488888
Q ss_pred cccccccccCchhhh---cccchhccCCcCCC
Q 007103 230 VANNHFSGWIPRELI---SIRTFIYDGNSFDN 258 (618)
Q Consensus 230 l~~N~l~g~ip~~~~---~l~~l~~~~N~~~~ 258 (618)
|++|++.+.+|..+. +|+.|++++|++..
T Consensus 260 L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp CTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred CCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 888888878876554 45566777776544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5.2e-21 Score=190.37 Aligned_cols=175 Identities=21% Similarity=0.236 Sum_probs=121.0
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|++++|.+... +.+..+++|++|+|++|.+++.....-.++|++|+|++|++++..+..+.++++|++|+|++
T Consensus 41 ~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 118 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118 (272)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC
Confidence 4577777777777542 34677777777777777777532222226777777777777766666677777777777777
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc-C-CCCccEEEcccccccccCc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~L~l~~N~l~g~ip 240 (618)
|++++..+..|+.+++|++|+|++|+|++..+..|..+++|++|+|++|+|++.++.. . ..+|+.|+|++|++++..|
T Consensus 119 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 7777777777777777777777777777665666677777777777777777655542 2 2457777777777776665
Q ss_pred hhh---hcccchhccCCcCCCC
Q 007103 241 REL---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 241 ~~~---~~l~~l~~~~N~~~~~ 259 (618)
..+ .+|+.|++.+|+|.|.
T Consensus 199 ~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 199 GVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp TTTTTCTTCCEEECCSSCBCCC
T ss_pred HHHhCCcCCCEEEccCCCcccc
Confidence 443 4566677777777764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=205.34 Aligned_cols=185 Identities=18% Similarity=0.194 Sum_probs=146.5
Q ss_pred CCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEeccccc
Q 007103 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (618)
Q Consensus 74 ~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (618)
.|..|.|.. ..++.|+|++|++.+..+..|.++++|++|+|++|.|++..+..+. ++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 467899974 3578899999999999999999999999999999999977666665 899999999999
Q ss_pred ccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCC-CCcccCCCcCeeeeccccccccccc
Q 007103 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNV 219 (618)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~ 219 (618)
|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+..+.++ ..|.++++|++|+|++|+|+.....
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 203 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNL 203 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCC
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccccc
Confidence 997777789999999999999999998777788888888888888844333444 4677888888888888888865443
Q ss_pred cCCCCccEEEcccccccccCchhh---hcccchhccCCcCCC
Q 007103 220 FSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDN 258 (618)
Q Consensus 220 ~~~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~ 258 (618)
....+|+.|+|++|+|++..|..+ .+|+.|++.+|.+..
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 245 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE
Confidence 333458888888888877666655 345566777776654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-20 Score=193.03 Aligned_cols=195 Identities=18% Similarity=0.224 Sum_probs=157.9
Q ss_pred CCCCCCCCCCCCCCCCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC
Q 007103 60 LTNWKGNEGDPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP 128 (618)
Q Consensus 60 ~~~w~~~~~~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 128 (618)
...|.......|.|.|+.+.|.. ..++.|+|++|++++..+..|.++++|++|+|++|++++..|..+.
T Consensus 18 i~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (330)
T 1xku_A 18 IEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 97 (330)
T ss_dssp ----CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred cccccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhc
Confidence 34554433456777899999963 3578899999999998888999999999999999999988888776
Q ss_pred --CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCC--CCCCCcccCCCcC
Q 007103 129 --PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG--DLPNSFISLSNIS 204 (618)
Q Consensus 129 --~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~ 204 (618)
++|++|+|++|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|+|++|.+.. ..+..+..+++|+
T Consensus 98 ~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~ 174 (330)
T 1xku_A 98 PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174 (330)
T ss_dssp TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcC
Confidence 89999999999999 6676654 789999999999998888889999999999999999963 6778888999999
Q ss_pred eeeeccccccccccccCCCCccEEEcccccccccCchhh---hcccchhccCCcCCC
Q 007103 205 SLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDN 258 (618)
Q Consensus 205 ~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~ 258 (618)
+|++++|.++..+... ..+|+.|+|++|++++..|..+ .+|+.|++++|.+..
T Consensus 175 ~L~l~~n~l~~l~~~~-~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 175 YIRIADTNITTIPQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230 (330)
T ss_dssp EEECCSSCCCSCCSSC-CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred EEECCCCccccCCccc-cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence 9999999988644333 3668888888888887777665 456677788887654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.5e-21 Score=206.36 Aligned_cols=188 Identities=20% Similarity=0.221 Sum_probs=152.7
Q ss_pred CCCCCCCceeEeeC----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCC-CCC--CCccEEe
Q 007103 69 DPCGESWKGVACEG----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY-QLP--PNLTSLN 135 (618)
Q Consensus 69 ~~c~~~w~gv~c~~----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~--~~L~~L~ 135 (618)
+.|.|.+..|.|.. .+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.++. .+. ++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 34543444588875 3589999999999999999999999999999999999877754 344 8999999
Q ss_pred cccccccccCCccccCCCCccEEEeecCCCCCccchh--hcCCCCCCeEEcccCcCCCCCCCC-cccCCCcCeeeecccc
Q 007103 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQNNQ 212 (618)
Q Consensus 136 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~l~~N~ 212 (618)
|++|++++..|..|+++++|++|+|++|++++.+|.. |..+++|++|+|++|++++..|.. +..+++|++|+|++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999999999999999999999999999977665 999999999999999999887877 8899999999999999
Q ss_pred ccccccccC------------------------------------CCCccEEEcccccccccCchhh------hcccchh
Q 007103 213 VTGSLNVFS------------------------------------GLPLTTLNVANNHFSGWIPREL------ISIRTFI 250 (618)
Q Consensus 213 l~~~~~~~~------------------------------------~~~L~~L~l~~N~l~g~ip~~~------~~l~~l~ 250 (618)
+++..+... ..+|+.|+|++|++++.+|..+ .+++.|.
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~ 245 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEe
Confidence 998654311 1236667777777766666554 3445555
Q ss_pred ccCCcC
Q 007103 251 YDGNSF 256 (618)
Q Consensus 251 ~~~N~~ 256 (618)
+.+|..
T Consensus 246 l~~~~~ 251 (455)
T 3v47_A 246 LSNSYN 251 (455)
T ss_dssp CTTCTT
T ss_pred eccccc
Confidence 555543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=5e-21 Score=186.66 Aligned_cols=190 Identities=17% Similarity=0.228 Sum_probs=157.9
Q ss_pred CCCCCCC-ce--eEeeC--------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCC-ccCCCCCCCC--CCccEE
Q 007103 69 DPCGESW-KG--VACEG--------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IHDTIPYQLP--PNLTSL 134 (618)
Q Consensus 69 ~~c~~~w-~g--v~c~~--------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~--~~L~~L 134 (618)
+.|.|.+ .+ |.|.. ..++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..+. ++|++|
T Consensus 6 ~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L 85 (239)
T 2xwt_C 6 PPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI 85 (239)
T ss_dssp SSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEE
T ss_pred CCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEE
Confidence 4455543 44 55953 579999999999999888899999999999999997 8865555554 899999
Q ss_pred eccc-ccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCC---eEEcccC-cCCCCCCCCcccCCCcC-eeee
Q 007103 135 NLAS-NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA---TLDLSFN-NFSGDLPNSFISLSNIS-SLYL 208 (618)
Q Consensus 135 ~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~ls~N-~l~g~~p~~~~~l~~L~-~L~l 208 (618)
+|++ |++++..+..|.++++|++|+|++|++++ +|. |..+++|+ .|+|++| ++++..+..|..+++|+ +|+|
T Consensus 86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 9999 99998777899999999999999999997 665 88899998 9999999 99976667799999999 9999
Q ss_pred ccccccccccc-cCCCCccEEEccccc-ccccCchhh----hcccchhccCCcCCCCC
Q 007103 209 QNNQVTGSLNV-FSGLPLTTLNVANNH-FSGWIPREL----ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 209 ~~N~l~~~~~~-~~~~~L~~L~l~~N~-l~g~ip~~~----~~l~~l~~~~N~~~~~~ 260 (618)
++|+++...+. +...+|+.|+|++|+ +++..+..+ .+|+.|++++|++...+
T Consensus 164 ~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~ 221 (239)
T 2xwt_C 164 YNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP 221 (239)
T ss_dssp CSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCC
T ss_pred CCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCC
Confidence 99999964443 344569999999995 986555554 56778899999987543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-21 Score=184.96 Aligned_cols=151 Identities=23% Similarity=0.249 Sum_probs=124.9
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCC-C--CCCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-L--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 87 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~--~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
.+++++|+++. +|..+. ..+++|+|++|+|++..|.. + .++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 56677777765 455543 35689999999999776644 3 289999999999999888888999999999999999
Q ss_pred CCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCc
Q 007103 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip 240 (618)
+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+. +.. .+|+.|+|++|.+++..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99988888899999999999999999988889999999999999999999987554 333 359999999999987655
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-20 Score=194.15 Aligned_cols=171 Identities=22% Similarity=0.218 Sum_probs=145.8
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC---CCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 87 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
.+++++++|+. +|..+. ..|+.|+|++|+|++..+..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 46777788865 455443 4589999999999977776553 89999999999999888889999999999999999
Q ss_pred CCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccC-----CCCccEEEccccccccc
Q 007103 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS-----GLPLTTLNVANNHFSGW 238 (618)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~~L~~L~l~~N~l~g~ 238 (618)
+|++..+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+... ..+|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 9998888899999999999999999998889999999999999999999998665532 34699999999999965
Q ss_pred Cchhhhcc-----cchhccCCcCCCCC
Q 007103 239 IPRELISI-----RTFIYDGNSFDNGP 260 (618)
Q Consensus 239 ip~~~~~l-----~~l~~~~N~~~~~~ 260 (618)
.+..+..+ ..|++.+|+|.|.+
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred CHHHhhhccHhhcceEEecCCCccCCc
Confidence 55666555 55889999999975
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.84 E-value=5.2e-21 Score=179.78 Aligned_cols=171 Identities=20% Similarity=0.240 Sum_probs=131.7
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCC-CC--CCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 87 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
.|++++|+|. .+|..+.. +|+.|+|++|+|++..+.. +. ++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4566777774 45655543 8899999999998766643 33 88999999999999888899999999999999999
Q ss_pred CCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCC-CccEEEcccccccccCchh
Q 007103 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL-PLTTLNVANNHFSGWIPRE 242 (618)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l~~N~l~g~ip~~ 242 (618)
+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+..... -++...+..+......|..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~ 168 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChH
Confidence 999888888999999999999999999888888999999999999999988765421111 1233344555555566777
Q ss_pred hhcccchhccCCcCCCCC
Q 007103 243 LISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 243 ~~~l~~l~~~~N~~~~~~ 260 (618)
+.......+..+.+.|..
T Consensus 169 l~~~~l~~l~~~~~~C~~ 186 (192)
T 1w8a_A 169 VRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp TTTSBGGGSCTTTCCCCC
T ss_pred HcCCChhhCcHhhcCcCC
Confidence 777777777777777753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=180.34 Aligned_cols=156 Identities=26% Similarity=0.323 Sum_probs=124.5
Q ss_pred CCCCCCCceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCC
Q 007103 69 DPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146 (618)
Q Consensus 69 ~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p 146 (618)
..|.|.|..|.|. +++++. +|..+. ++|+.|+|++|+|++..+..+. ++|+.|+|++|+|++..|
T Consensus 7 ~~C~C~~~~v~c~----------~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~ 73 (220)
T 2v9t_B 7 AACTCSNNIVDCR----------GKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAP 73 (220)
T ss_dssp TTSEEETTEEECT----------TSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECT
T ss_pred CCCEECCCEEEcC----------CCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCH
Confidence 4465566665554 455543 344443 6889999999999876665555 789999999999998888
Q ss_pred ccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CC
Q 007103 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LP 224 (618)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~ 224 (618)
..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+. +.. .+
T Consensus 74 ~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 153 (220)
T 2v9t_B 74 DAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153 (220)
T ss_dssp TTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred HHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCC
Confidence 8999999999999999999977777788899999999999999988888899999999999999999987664 333 45
Q ss_pred ccEEEcccccccc
Q 007103 225 LTTLNVANNHFSG 237 (618)
Q Consensus 225 L~~L~l~~N~l~g 237 (618)
|+.|+|++|++..
T Consensus 154 L~~L~L~~N~~~c 166 (220)
T 2v9t_B 154 IQTMHLAQNPFIC 166 (220)
T ss_dssp CCEEECCSSCEEC
T ss_pred CCEEEeCCCCcCC
Confidence 8999999999874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.83 E-value=9.7e-21 Score=188.39 Aligned_cols=171 Identities=23% Similarity=0.270 Sum_probs=148.4
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEE
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
-.+++.|+|++|.+.+. +.+..+++|++|+|++|.+++..+..+. ++|++|+|++|++++..+..+..+++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 35799999999999874 5899999999999999999977775554 8999999999999988888899999999999
Q ss_pred eecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccccc-C-CCCccEEEcccccccc
Q 007103 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSG 237 (618)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~L~l~~N~l~g 237 (618)
|++|++++..+..|+.+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++.++.. . ..+|+.|+|++|.+++
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9999999988888999999999999999999877777899999999999999999977653 3 3469999999999998
Q ss_pred cCchhhhcccchhccCCcCCC
Q 007103 238 WIPRELISIRTFIYDGNSFDN 258 (618)
Q Consensus 238 ~ip~~~~~l~~l~~~~N~~~~ 258 (618)
..| ++..+.+..|.+..
T Consensus 220 ~~~----~l~~l~~~~n~~~g 236 (272)
T 3rfs_A 220 TCP----GIRYLSEWINKHSG 236 (272)
T ss_dssp CTT----TTHHHHHHHHHTGG
T ss_pred cCc----HHHHHHHHHHhCCC
Confidence 766 45666666666553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-20 Score=202.19 Aligned_cols=184 Identities=16% Similarity=0.185 Sum_probs=161.2
Q ss_pred CCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEeccccc
Q 007103 74 SWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (618)
Q Consensus 74 ~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (618)
.|..|.|.. ..++.|+|++|+|++..+..|.++++|++|+|++|.|++..|..+. ++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 578899974 3578999999999999999999999999999999999988887776 899999999999
Q ss_pred ccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-
Q 007103 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV- 219 (618)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~- 219 (618)
+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 9977777789999999999999999999999999999999999999999988899999999999999999999986653
Q ss_pred cC-CCCccEEEcccccccccCchhh---hcccchhccCCcCC
Q 007103 220 FS-GLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFD 257 (618)
Q Consensus 220 ~~-~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~ 257 (618)
+. ..+|+.|+|++|.+++..+..+ .+|+.|++++|++.
T Consensus 172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC
T ss_pred hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc
Confidence 33 3469999999999997766554 45667777777643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.6e-21 Score=195.52 Aligned_cols=175 Identities=18% Similarity=0.172 Sum_probs=108.7
Q ss_pred CCEEEEEcCCCCCcccccccc--cCCCCCCEEEecCCCccCCCCCCCC-------CCccEEecccccccccCCccccCCC
Q 007103 83 SAVVSIDISGLGLSGTMGYLL--SDLLSLRKFDLSGNSIHDTIPYQLP-------PNLTSLNLASNNFSGNLPYSIASMV 153 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~p~~~~-------~~L~~L~L~~N~l~~~~p~~~~~l~ 153 (618)
.+++.|+|++|++++.+|..+ ..+++|++|+|++|++++. |..+. ++|++|+|++|++++..|..|++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 356667777777776666655 6677777777777777655 43322 5677777777777766666677777
Q ss_pred CccEEEeecCCCCCc--cchhh--cCCCCCCeEEcccCcCCC--CCC-CCcccCCCcCeeeecccccccccc--ccC-CC
Q 007103 154 SLSYLNVSRNSLTQS--IGDIF--GNLAGLATLDLSFNNFSG--DLP-NSFISLSNISSLYLQNNQVTGSLN--VFS-GL 223 (618)
Q Consensus 154 ~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~ls~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~-~~ 223 (618)
+|++|+|++|++++. +|..+ ..+++|++|+|++|+|++ .++ ..+..+++|++|+|++|+|++.++ .+. ..
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 777777777776654 23333 666777777777777662 112 223355667777777777766542 222 23
Q ss_pred CccEEEcccccccccCchhhh-cccchhccCCcCCCC
Q 007103 224 PLTTLNVANNHFSGWIPRELI-SIRTFIYDGNSFDNG 259 (618)
Q Consensus 224 ~L~~L~l~~N~l~g~ip~~~~-~l~~l~~~~N~~~~~ 259 (618)
+|+.|+|++|+|+ .+|..+. +|+.|++++|.+...
T Consensus 254 ~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDRN 289 (312)
T ss_dssp TCCEEECTTSCCS-SCCSSCCSEEEEEECCSSCCCSC
T ss_pred CCCEEECCCCccC-hhhhhccCCceEEECCCCCCCCC
Confidence 4777777777776 5665553 666677777766543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.5e-21 Score=193.22 Aligned_cols=175 Identities=19% Similarity=0.258 Sum_probs=148.2
Q ss_pred eCCCEEEEEcCCCCCcccccccccCC-----CCCCEEEecCCCccCCCCCCCC--CCccEEeccccccccc--CCccc--
Q 007103 81 EGSAVVSIDISGLGLSGTMGYLLSDL-----LSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN--LPYSI-- 149 (618)
Q Consensus 81 ~~~~v~~l~l~~~~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~--~p~~~-- 149 (618)
...+++.|+|++|++++. |..+..+ ++|++|+|++|+|++..|..+. ++|+.|+|++|++.+. +|..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 345799999999999998 8888887 9999999999999988877776 8999999999999876 34455
Q ss_pred cCCCCccEEEeecCCCCCc--cc-hhhcCCCCCCeEEcccCcCCCCCC-CCcccCCCcCeeeeccccccccccccCCCCc
Q 007103 150 ASMVSLSYLNVSRNSLTQS--IG-DIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNVFSGLPL 225 (618)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~--~p-~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L 225 (618)
..+++|++|+|++|+|++. ++ ..+..+++|+.|+|++|+|++.+| ..+..+++|++|+|++|+|+..+..+. .+|
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~-~~L 276 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP-AKL 276 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC-SEE
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc-CCc
Confidence 8999999999999999942 23 456789999999999999998776 456778999999999999995444344 779
Q ss_pred cEEEcccccccccCch--hhhcccchhccCCcCCC
Q 007103 226 TTLNVANNHFSGWIPR--ELISIRTFIYDGNSFDN 258 (618)
Q Consensus 226 ~~L~l~~N~l~g~ip~--~~~~l~~l~~~~N~~~~ 258 (618)
+.|||++|+|++. |. .+.+|+.|++.+|++..
T Consensus 277 ~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 277 SVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred eEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence 9999999999975 54 45677889999999875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-20 Score=190.48 Aligned_cols=186 Identities=18% Similarity=0.241 Sum_probs=156.7
Q ss_pred CCCCCCCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEe
Q 007103 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (618)
Q Consensus 69 ~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~ 135 (618)
..|.|.|+.+.|.. .+++.|+|++|++.+..+..|.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 45666899999964 3588999999999998888999999999999999999988787776 8999999
Q ss_pred cccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCC--CCCCCCcccCCCcCeeeeccccc
Q 007103 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS--GDLPNSFISLSNISSLYLQNNQV 213 (618)
Q Consensus 136 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--g~~p~~~~~l~~L~~L~l~~N~l 213 (618)
|++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|+.|+|++|.++ +..|..+..+ +|++|++++|++
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 9999999 6676665 89999999999999888888999999999999999996 4778888888 999999999999
Q ss_pred cccccccCCCCccEEEcccccccccCchhh---hcccchhccCCcCCCC
Q 007103 214 TGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 214 ~~~~~~~~~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~ 259 (618)
++.+..+ ..+|+.|+|++|.+++..|..+ .+|+.|++++|.+...
T Consensus 185 ~~l~~~~-~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (332)
T 2ft3_A 185 TGIPKDL-PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232 (332)
T ss_dssp SSCCSSS-CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC
T ss_pred CccCccc-cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC
Confidence 8744333 3678899999999987766654 4567788888877653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-20 Score=178.96 Aligned_cols=155 Identities=23% Similarity=0.250 Sum_probs=129.8
Q ss_pred CCCCceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccc
Q 007103 72 GESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSI 149 (618)
Q Consensus 72 ~~~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~ 149 (618)
.|+|++|.|...+ +. .+|..+. ++|++|+|++|+|++..|..+. ++|+.|+|++|+|+...+..|
T Consensus 18 ~Cs~~~v~c~~~~----------l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 84 (229)
T 3e6j_A 18 SCSGTTVDCRSKR----------HA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF 84 (229)
T ss_dssp EEETTEEECTTSC----------CS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred EEeCCEeEccCCC----------cC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc
Confidence 3489999997544 32 3444333 8899999999999988887665 899999999999986666778
Q ss_pred cCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccE
Q 007103 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTT 227 (618)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~ 227 (618)
..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+. +.. .+|+.
T Consensus 85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 163 (229)
T 3e6j_A 85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163 (229)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence 99999999999999999888888999999999999999999 8899999999999999999999987654 333 46999
Q ss_pred EEcccccccccCc
Q 007103 228 LNVANNHFSGWIP 240 (618)
Q Consensus 228 L~l~~N~l~g~ip 240 (618)
|+|++|.+++..+
T Consensus 164 L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 164 AYLFGNPWDCECR 176 (229)
T ss_dssp EECTTSCBCTTBG
T ss_pred EEeeCCCccCCcc
Confidence 9999999986554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=195.15 Aligned_cols=187 Identities=18% Similarity=0.220 Sum_probs=158.2
Q ss_pred CCCCCceeEeeC-------------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEe
Q 007103 71 CGESWKGVACEG-------------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (618)
Q Consensus 71 c~~~w~gv~c~~-------------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~ 135 (618)
|.|.|.|+ |+. .+++.|+|++|++++..+..|.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 28 ~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 28 LSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 33478887 642 3689999999999998888999999999999999999988777665 8999999
Q ss_pred cccccccccCCccccCCCCccEEEeecCCCCCccc-hhhcCCCCCCeEEcccC-cCCCCCCCCcccCCCcCeeeeccccc
Q 007103 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG-DIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQNNQV 213 (618)
Q Consensus 136 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~l~~N~l 213 (618)
|++|++++..+..+.++++|++|+|++|++++..+ ..|..+++|+.|+|++| .+.+..|..|..+++|++|++++|++
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence 99999996655569999999999999999996555 58999999999999999 57766678899999999999999999
Q ss_pred cccccc-cCC-CCccEEEcccccccccCchh----hhcccchhccCCcCCCC
Q 007103 214 TGSLNV-FSG-LPLTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNG 259 (618)
Q Consensus 214 ~~~~~~-~~~-~~L~~L~l~~N~l~g~ip~~----~~~l~~l~~~~N~~~~~ 259 (618)
++..+. +.. .+|+.|++++|.++ .+|.. +.+|+.|++++|.+...
T Consensus 187 ~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~ 237 (353)
T 2z80_A 187 QSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237 (353)
T ss_dssp CEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTC
T ss_pred CccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccc
Confidence 997554 333 35999999999997 55543 46788999999988754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.6e-21 Score=192.25 Aligned_cols=173 Identities=18% Similarity=0.208 Sum_probs=108.2
Q ss_pred CEEEEEcCCCCCcccccccc--cCCCCCCEEEecCCCccCCCCC------CCCCCccEEecccccccccCCccccCCCCc
Q 007103 84 AVVSIDISGLGLSGTMGYLL--SDLLSLRKFDLSGNSIHDTIPY------QLPPNLTSLNLASNNFSGNLPYSIASMVSL 155 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~p~------~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 155 (618)
+++.|+|++|++.+..|..+ ..+++|++|+|++|.+++..+. ...++|++|+|++|++++..|..++++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 47778888888777777776 7777777777777777765441 123677777777777777767777777777
Q ss_pred cEEEeecCCCCCc--cc--hhhcCCCCCCeEEcccCcCCCCCCC----CcccCCCcCeeeecccccccccc-ccCC----
Q 007103 156 SYLNVSRNSLTQS--IG--DIFGNLAGLATLDLSFNNFSGDLPN----SFISLSNISSLYLQNNQVTGSLN-VFSG---- 222 (618)
Q Consensus 156 ~~L~L~~N~l~~~--~p--~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~~~~~-~~~~---- 222 (618)
++|+|++|++++. ++ ..++.+++|++|+|++|+|+ .+|. .+..+++|++|+|++|+|++..| .+..
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 7777777776642 21 12355666666666666665 2322 13455666666666666666532 2211
Q ss_pred CCccEEEcccccccccCchhh-hcccchhccCCcCCC
Q 007103 223 LPLTTLNVANNHFSGWIPREL-ISIRTFIYDGNSFDN 258 (618)
Q Consensus 223 ~~L~~L~l~~N~l~g~ip~~~-~~l~~l~~~~N~~~~ 258 (618)
.+|+.|+|++|+|+ .+|..+ .+|+.|++++|.+..
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNR 286 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCS
T ss_pred CcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCC
Confidence 24666666666666 445433 456666666666654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=207.08 Aligned_cols=132 Identities=20% Similarity=0.251 Sum_probs=95.2
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
+++.|++++|.+....+..+..+++|++|+|++|.|++..|..+. ++|+.|+|++|.|++..|..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 356677777777666666677777777777777777766665554 677777777777777666677777777777777
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
+|.|++..+..|+++++|++|+|++|.|++..|..|..+++|++|+|++|.|++
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 777776666666777777777777777776666677777777777777777665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.9e-20 Score=198.24 Aligned_cols=105 Identities=18% Similarity=0.292 Sum_probs=63.0
Q ss_pred CccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcc
Q 007103 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVA 231 (618)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~ 231 (618)
+|++|+|++|++++.+|..|+.+++|+.|+|++|++++..|..|..+++|++|+|++|.|++..+. +.. .+|+.|+|+
T Consensus 276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 355 (455)
T 3v47_A 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS 355 (455)
T ss_dssp CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECC
T ss_pred CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECC
Confidence 455555555555555666666666666666666666666666666666666666666666655432 222 346666666
Q ss_pred cccccccCchhh---hcccchhccCCcCCC
Q 007103 232 NNHFSGWIPREL---ISIRTFIYDGNSFDN 258 (618)
Q Consensus 232 ~N~l~g~ip~~~---~~l~~l~~~~N~~~~ 258 (618)
+|++++..|..+ .+|+.|++++|.+..
T Consensus 356 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 356 YNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCcccccChhhccccccccEEECCCCcccc
Confidence 666666555544 344556666666554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.4e-20 Score=196.24 Aligned_cols=178 Identities=19% Similarity=0.210 Sum_probs=115.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|+|.+..+..|.++++|++|+|++|+|++..+..+. ++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167 (440)
T ss_dssp SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence 5788999999999988888899999999999999999866554454 78888888888888666656666666666666
Q ss_pred ecCCCCCcc-chhhcCCCCCCeEE----------------------cccCcCCCCCCCCcccCCCcCeeeeccccccccc
Q 007103 161 SRNSLTQSI-GDIFGNLAGLATLD----------------------LSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 161 ~~N~l~~~~-p~~~~~l~~L~~L~----------------------ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
++|+..+.+ +..|.++++|+.|+ |++|+|++..|..|..+++|+.|+|++|+|++..
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 247 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE 247 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCccccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEC
Confidence 663332232 33455555555555 5555555444555555555555555555555543
Q ss_pred cc-cCC-CCccEEEcccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 218 NV-FSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 218 ~~-~~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
+. +.. .+|+.|+|++|+|++..+..+ .+|+.|++.+|+|.|.+
T Consensus 248 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp TTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred hhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence 32 222 347777777777775444333 45566677777777754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-20 Score=204.24 Aligned_cols=177 Identities=23% Similarity=0.341 Sum_probs=113.2
Q ss_pred CCCCCCCCCCCCCC---CCcee-EeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEe
Q 007103 60 LTNWKGNEGDPCGE---SWKGV-ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLN 135 (618)
Q Consensus 60 ~~~w~~~~~~~c~~---~w~gv-~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~ 135 (618)
+.+|.. +.++|.. .|.|+ .|..++++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| .+.++|+.|+
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip-~~l~~L~~L~ 106 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP-ELPASLEYLD 106 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC-CCCTTCCEEE
T ss_pred HHHHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc-cccCCCCEEE
Confidence 345653 3467754 59999 7887889999999999987 666553 67888888888888 566 6667888888
Q ss_pred cccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc
Q 007103 136 LASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 136 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++
T Consensus 107 Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 107 ACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred ccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence 88888876 666 554 77777777777776 444 45666666666666664 554 34566666666666665
Q ss_pred cccccCCCCccEEEcccccccccCchhhhcc-------cchhccCCcCC
Q 007103 216 SLNVFSGLPLTTLNVANNHFSGWIPRELISI-------RTFIYDGNSFD 257 (618)
Q Consensus 216 ~~~~~~~~~L~~L~l~~N~l~g~ip~~~~~l-------~~l~~~~N~~~ 257 (618)
.+. +. .+|+.|+|++|+|+ .+|....+| +.|++++|.+.
T Consensus 175 lp~-l~-~~L~~L~Ls~N~L~-~lp~~~~~L~~~~~~L~~L~Ls~N~l~ 220 (571)
T 3cvr_A 175 LPE-LP-ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT 220 (571)
T ss_dssp CCC-CC-TTCCEEECCSSCCS-SCCCCC--------CCEEEECCSSCCC
T ss_pred cch-hh-CCCCEEECcCCCCC-chhhHHHhhhcccccceEEecCCCcce
Confidence 333 22 44555555555555 444411234 44555555544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=6.3e-20 Score=206.90 Aligned_cols=174 Identities=24% Similarity=0.307 Sum_probs=153.7
Q ss_pred CCCCCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecc
Q 007103 71 CGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137 (618)
Q Consensus 71 c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~ 137 (618)
|.|.++.|.|.. .+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..+. ++|++|+|+
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 81 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence 555667777853 3689999999999999888999999999999999999988887765 899999999
Q ss_pred cccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccc
Q 007103 138 SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
+|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|++|+|++|++++..
T Consensus 82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 99999666668999999999999999999988899999999999999999999999999999999999999999999876
Q ss_pred cc----cCCCCccEEEcccccccccCchhhh
Q 007103 218 NV----FSGLPLTTLNVANNHFSGWIPRELI 244 (618)
Q Consensus 218 ~~----~~~~~L~~L~l~~N~l~g~ip~~~~ 244 (618)
+. ....+|+.|+|++|++++..|..+.
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~ 192 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFH 192 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCCBCTTGGG
T ss_pred HHHhhccccccccEEECCCCcccccChhhhh
Confidence 53 2335699999999999988887554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=204.87 Aligned_cols=184 Identities=20% Similarity=0.231 Sum_probs=158.4
Q ss_pred CCceeEeeC-------------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEeccc
Q 007103 74 SWKGVACEG-------------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLAS 138 (618)
Q Consensus 74 ~w~gv~c~~-------------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~ 138 (618)
.|.|+ |+. ..++.|+|++|++++..|..|.++++|++|+|++|++++..|..+. ++|++|+|++
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 78887 763 2699999999999999999999999999999999999988877776 8999999999
Q ss_pred ccccccCCccccCCCCccEEEeecCCCCCc-cchhhcCCCCCCeEEcccCcCCCCCC-CCcccCCCcCeeeecccccccc
Q 007103 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQS-IGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGS 216 (618)
Q Consensus 139 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~ 216 (618)
|++++..|..|+++++|++|+|++|++++. +|..|+++++|+.|+|++|++.+.+| ..|..+++|++|+|++|++++.
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 163 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence 999988888899999999999999999974 67789999999999999999655665 6899999999999999999996
Q ss_pred ccc-cCC-CCccEEEcccccccccCchh----hhcccchhccCCcCCCC
Q 007103 217 LNV-FSG-LPLTTLNVANNHFSGWIPRE----LISIRTFIYDGNSFDNG 259 (618)
Q Consensus 217 ~~~-~~~-~~L~~L~l~~N~l~g~ip~~----~~~l~~l~~~~N~~~~~ 259 (618)
++. +.. .+|+.|++++|.+. .+|.. +.+|+.|++++|.+...
T Consensus 164 ~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~ 211 (549)
T 2z81_A 164 QSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARF 211 (549)
T ss_dssp CTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTC
T ss_pred ChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccc
Confidence 654 333 35999999999986 55543 56888999999988764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.1e-20 Score=197.12 Aligned_cols=178 Identities=22% Similarity=0.229 Sum_probs=114.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+. ++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 99 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 178 (452)
T 3zyi_A 99 HHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL 178 (452)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC
Confidence 5789999999999999889999999999999999999966665554 79999999999998666656666666666666
Q ss_pred ecC-CCCCccchhhcCCCCCCeEEcccCcCC----------------------CCCCCCcccCCCcCeeeeccccccccc
Q 007103 161 SRN-SLTQSIGDIFGNLAGLATLDLSFNNFS----------------------GDLPNSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 161 ~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~----------------------g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
++| .++...+..|.++++|++|+|++|+|+ +..|..|..+++|+.|+|++|+|++..
T Consensus 179 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 258 (452)
T 3zyi_A 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258 (452)
T ss_dssp CCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEEC
T ss_pred CCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceEC
Confidence 663 333222334555555555555555555 444444445555555555555555433
Q ss_pred cc-cCC-CCccEEEcccccccccCchh---hhcccchhccCCcCCCCC
Q 007103 218 NV-FSG-LPLTTLNVANNHFSGWIPRE---LISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 218 ~~-~~~-~~L~~L~l~~N~l~g~ip~~---~~~l~~l~~~~N~~~~~~ 260 (618)
+. +.. .+|+.|+|++|+|++..+.. +.+|+.|++.+|+|.|.+
T Consensus 259 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred HHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 32 222 23666666666666443332 244555666666666654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2e-19 Score=172.75 Aligned_cols=149 Identities=21% Similarity=0.254 Sum_probs=113.9
Q ss_pred CCCCCCCceeEeeCC-----------CEEEEEcCCCCCccccc-ccccCCCCCCEEEecCCCccCCCCCCCC--CCccEE
Q 007103 69 DPCGESWKGVACEGS-----------AVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSL 134 (618)
Q Consensus 69 ~~c~~~w~gv~c~~~-----------~v~~l~l~~~~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L 134 (618)
..|.|.|..+.|+.. .++.|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..+. ++|+.|
T Consensus 7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 456667888888642 35678888888877754 4577888888888888888866665554 778888
Q ss_pred ecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccc
Q 007103 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (618)
Q Consensus 135 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (618)
+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|.++
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 88888888777777888888888888888888777788888888888888888888777778888888888888888877
Q ss_pred ccc
Q 007103 215 GSL 217 (618)
Q Consensus 215 ~~~ 217 (618)
+..
T Consensus 167 c~c 169 (220)
T 2v70_A 167 CNC 169 (220)
T ss_dssp CSG
T ss_pred CCC
Confidence 643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-20 Score=201.59 Aligned_cols=167 Identities=20% Similarity=0.172 Sum_probs=117.5
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
+++.|+|++|.+++..| +..+++|++|+|++|.|++..+. ++|+.|+|++|+|++..+. .+++|+.|+|++|
T Consensus 59 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~---~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N 130 (487)
T 3oja_A 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG---PSIETLHAANNNISRVSCS---RGQGKKNIYLANN 130 (487)
T ss_dssp TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC---TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSS
T ss_pred CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC---CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCC
Confidence 44444444444444333 44444445555544444432211 4555555555555544332 4578899999999
Q ss_pred CCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcc-cCCCcCeeeeccccccccccccCCCCccEEEcccccccccCch-
Q 007103 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR- 241 (618)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~- 241 (618)
+|++..|..|+.+++|+.|+|++|.|++.+|..+. .+++|++|+|++|.|++..+.....+|+.|+|++|.|++..|.
T Consensus 131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 210 (487)
T 3oja_A 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEF 210 (487)
T ss_dssp CCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGG
T ss_pred CCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCCCHhH
Confidence 99988888889999999999999999988888876 7899999999999999876665566799999999999975553
Q ss_pred -hhhcccchhccCCcCCC
Q 007103 242 -ELISIRTFIYDGNSFDN 258 (618)
Q Consensus 242 -~~~~l~~l~~~~N~~~~ 258 (618)
.+.+|+.|++++|.+..
T Consensus 211 ~~l~~L~~L~Ls~N~l~~ 228 (487)
T 3oja_A 211 QSAAGVTWISLRNNKLVL 228 (487)
T ss_dssp GGGTTCSEEECTTSCCCE
T ss_pred cCCCCccEEEecCCcCcc
Confidence 23567788889998875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.3e-20 Score=204.62 Aligned_cols=175 Identities=22% Similarity=0.187 Sum_probs=154.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..|..+. ++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 4689999999999999999999999999999999999988887776 89999999999999988999999999999999
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCC-CCCCCcccCCCcCeeeeccccccccccccC-CC-----CccEEEcccc
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS-GL-----PLTTLNVANN 233 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~-----~L~~L~l~~N 233 (618)
++|++++..+..|+++++|++|+|++|++.+ .+|..|+++++|++|+|++|++++..+... .. .+..|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999999888899999999999999999986 679999999999999999999998665322 11 1558999999
Q ss_pred cccccCchhhh--cccchhccCCcCC
Q 007103 234 HFSGWIPRELI--SIRTFIYDGNSFD 257 (618)
Q Consensus 234 ~l~g~ip~~~~--~l~~l~~~~N~~~ 257 (618)
.+++..+..+. +|+.|++.+|.+.
T Consensus 192 ~l~~~~~~~~~~~~L~~L~L~~n~~~ 217 (606)
T 3vq2_A 192 PIDFIQDQAFQGIKLHELTLRGNFNS 217 (606)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSC
T ss_pred CcceeCcccccCceeeeeeccCCccc
Confidence 99866555443 6788888888764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.9e-20 Score=204.23 Aligned_cols=175 Identities=20% Similarity=0.197 Sum_probs=115.9
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCC-CCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
+++.|+|++|.+.+ +|..+..+++|+.|+|++|.+++..| ..+. ++|+.|+|++|++++..|..+.++++|++|+|
T Consensus 377 ~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 455 (606)
T 3vq2_A 377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455 (606)
T ss_dssp CCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred cccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEEC
Confidence 44555555555544 33556666666666666666666655 2332 67777777777777777777777777777777
Q ss_pred ecCCCCC-ccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccc
Q 007103 161 SRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSG 237 (618)
Q Consensus 161 ~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g 237 (618)
++|++++ .+|..|+.+++|+.|+|++|++++..|..|..+++|++|+|++|++++.++. +.. .+|+.|+|++|+|+
T Consensus 456 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~- 534 (606)
T 3vq2_A 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE- 534 (606)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-
T ss_pred CCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-
Confidence 7777776 3666777777777777777777776677777777777777777777776443 332 34777777777777
Q ss_pred cCchhhh----cccchhccCCcCCCCC
Q 007103 238 WIPRELI----SIRTFIYDGNSFDNGP 260 (618)
Q Consensus 238 ~ip~~~~----~l~~l~~~~N~~~~~~ 260 (618)
.+|..+. +|+.|++.+|+|.|.+
T Consensus 535 ~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 535 TSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred ccCHhHhhhcccCcEEEccCCCcccCC
Confidence 5665442 3566777777777754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.6e-20 Score=191.90 Aligned_cols=172 Identities=22% Similarity=0.232 Sum_probs=140.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+++++.+....+..+..+++|++|+|++|.+++..+..+. ++|++|+|++|++++..|..++++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 3578899999999887777789999999999999999977776665 89999999999999888889999999999999
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEccccccccc-C
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGW-I 239 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~-i 239 (618)
++|+++...+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++.. .....+|+.|++++|.+++. .
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~L~~L~l~~n~l~~~~~ 203 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-LSLIPSLFHANVSYNLLSTLAI 203 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC-GGGCTTCSEEECCSSCCSEEEC
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc-cccccccceeecccccccccCC
Confidence 999999766667899999999999999999888888999999999999999998742 22234567777777776642 2
Q ss_pred chhhhcccchhccCCcCCC
Q 007103 240 PRELISIRTFIYDGNSFDN 258 (618)
Q Consensus 240 p~~~~~l~~l~~~~N~~~~ 258 (618)
| .+++.|++++|.+..
T Consensus 204 ~---~~L~~L~l~~n~l~~ 219 (390)
T 3o6n_A 204 P---IAVEELDASHNSINV 219 (390)
T ss_dssp C---SSCSEEECCSSCCCE
T ss_pred C---CcceEEECCCCeeee
Confidence 2 245556666665544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=173.71 Aligned_cols=150 Identities=22% Similarity=0.267 Sum_probs=133.1
Q ss_pred CEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcC
Q 007103 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (618)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 189 (618)
+.+++++|.++ .+|..+.++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp TEEECTTSCCS-SCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred CEEEcCCCCcC-cCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 57899999999 68888889999999999999988888999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 190 SGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
++..+..|..+++|++|+|++|+|++..+. +.. .+|+.|+|++|+|++..+..+ .+|+.|++.+|+|.|.+
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 965556678999999999999999997654 333 469999999999998776655 56778999999999854
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2e-19 Score=173.98 Aligned_cols=151 Identities=22% Similarity=0.242 Sum_probs=132.6
Q ss_pred CCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCc
Q 007103 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (618)
Q Consensus 109 L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 188 (618)
.+.++.++|+++ .+|..+.++|+.|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCEeEccCCCcC-ccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 356788899988 7888889999999999999999999999999999999999999998888889999999999999999
Q ss_pred CCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
|++..+..|..+++|++|+|++|+|+..+..+.. .+|+.|+|++|+|++..+..+ .+|+.|++.+|+|.|.+
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 9977777789999999999999999965544433 469999999999996655544 57788999999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=202.21 Aligned_cols=177 Identities=23% Similarity=0.200 Sum_probs=144.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCC-CC--CCccEEecccccccccCCccccCCCCccEEE
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
.+++.|++++|.+.+..|..+..+++|+.|+|++|.+++..|.. +. ++|+.|+|++|.+++..|..+..+++|++|+
T Consensus 376 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 455 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455 (606)
T ss_dssp TTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence 46788888888888888888888888888888888888776654 33 7889999999999888888888899999999
Q ss_pred eecCCCCCc---cchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEccccc
Q 007103 160 VSRNSLTQS---IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNH 234 (618)
Q Consensus 160 L~~N~l~~~---~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~ 234 (618)
|++|++++. .+..+..+++|+.|+|++|++++..|..|..+++|++|+|++|++++.++. +.. ..| .|+|++|+
T Consensus 456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~ 534 (606)
T 3t6q_A 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534 (606)
T ss_dssp CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSC
T ss_pred CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCc
Confidence 999998873 235688889999999999999988888899999999999999999886653 333 347 89999999
Q ss_pred ccccCchhh---hcccchhccCCcCCCCC
Q 007103 235 FSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 235 l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
+++.+|..+ .+|+.|++.+|+|.|.+
T Consensus 535 l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 535 ISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred ccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 998777654 56678889999998854
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-20 Score=200.70 Aligned_cols=169 Identities=17% Similarity=0.190 Sum_probs=147.5
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
...++.|+|++|.|++..+ .++|+.|+|++|.|++..+.. .++|+.|+|++|+|++..|..++++++|++|+|+
T Consensus 79 l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (487)
T 3oja_A 79 LSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (487)
T ss_dssp CTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEECC-CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECT
T ss_pred CCCCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCccc-cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECC
Confidence 3589999999999987543 389999999999999766644 4899999999999999999999999999999999
Q ss_pred cCCCCCccchhhc-CCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccccC
Q 007103 162 RNSLTQSIGDIFG-NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWI 239 (618)
Q Consensus 162 ~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~i 239 (618)
+|.|++.+|..+. .+++|+.|+|++|.|++. |. +..+++|++|+|++|+|++.++.+.. .+|+.|+|++|.|++ +
T Consensus 153 ~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-l 229 (487)
T 3oja_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-I 229 (487)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-E
T ss_pred CCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-c
Confidence 9999999998886 799999999999999965 33 34689999999999999998776554 459999999999996 6
Q ss_pred chhh---hcccchhccCCcCCCC
Q 007103 240 PREL---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 240 p~~~---~~l~~l~~~~N~~~~~ 259 (618)
|..+ .+|..|++.+|++.|+
T Consensus 230 p~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 230 EKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTCCCCTTCCEEECTTCCBCHH
T ss_pred chhhccCCCCCEEEcCCCCCcCc
Confidence 7655 5677899999999985
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-20 Score=208.14 Aligned_cols=175 Identities=21% Similarity=0.297 Sum_probs=158.1
Q ss_pred CCCEEEEEcCCCCCccc-----------------cccccc--CCCCCCEEEecCCCccCCCCCCCC--CCccEEeccccc
Q 007103 82 GSAVVSIDISGLGLSGT-----------------MGYLLS--DLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNN 140 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~-----------------~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~ 140 (618)
-.+++.|+|++|.++|. +|..++ ++++|++|+|++|++.|.+|..+. ++|+.|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 36899999999999996 999999 999999999999999999998887 899999999999
Q ss_pred -ccc-cCCccccCC------CCccEEEeecCCCCCccch--hhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecc
Q 007103 141 -FSG-NLPYSIASM------VSLSYLNVSRNSLTQSIGD--IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210 (618)
Q Consensus 141 -l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~ 210 (618)
++| .+|..++++ ++|++|+|++|+++ .+|. .|+++++|+.|+|++|+++|.+| .|..+++|++|+|++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 999 899999887 99999999999999 7888 99999999999999999999999 999999999999999
Q ss_pred ccccccccccCC-CC-ccEEEcccccccccCchhhh-----cccchhccCCcCCCC
Q 007103 211 NQVTGSLNVFSG-LP-LTTLNVANNHFSGWIPRELI-----SIRTFIYDGNSFDNG 259 (618)
Q Consensus 211 N~l~~~~~~~~~-~~-L~~L~l~~N~l~g~ip~~~~-----~l~~l~~~~N~~~~~ 259 (618)
|+++..+..+.. .+ |+.|+|++|+++ .+|..+. +|+.|++++|.+...
T Consensus 363 N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 363 NQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp SEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred CccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 999954444333 45 999999999999 8887653 678899999988753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.5e-19 Score=182.60 Aligned_cols=176 Identities=21% Similarity=0.234 Sum_probs=128.3
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
-.+++.|+|++|++++..|..|.++++|++|+|++|+++ .+|..+.++|++|+|++|++++..+..+.++++|+.|+|+
T Consensus 77 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 155 (332)
T 2ft3_A 77 LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155 (332)
T ss_dssp CTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECC
T ss_pred CCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECC
Confidence 357999999999999999999999999999999999999 7787777999999999999997777789999999999999
Q ss_pred cCCCC--CccchhhcCC--------------------CCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc
Q 007103 162 RNSLT--QSIGDIFGNL--------------------AGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219 (618)
Q Consensus 162 ~N~l~--~~~p~~~~~l--------------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 219 (618)
+|.++ +..|..|..+ ++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+.
T Consensus 156 ~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 235 (332)
T 2ft3_A 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENG 235 (332)
T ss_dssp SCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTT
T ss_pred CCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChh
Confidence 99996 3667777665 2445555555555544445555666666666666666654432
Q ss_pred -cC-CCCccEEEcccccccccCchhh---hcccchhccCCcCCCC
Q 007103 220 -FS-GLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 220 -~~-~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~ 259 (618)
+. ..+|+.|+|++|+++ .+|..+ .+|+.|++.+|++...
T Consensus 236 ~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~ 279 (332)
T 2ft3_A 236 SLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279 (332)
T ss_dssp GGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBC
T ss_pred HhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCcc
Confidence 22 234666666666666 555544 2344555666665543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=182.65 Aligned_cols=177 Identities=23% Similarity=0.249 Sum_probs=157.5
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCC-CCCC--CCccEEecccccccccCCccccCCCCccEEE
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP-YQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
.+++.|+|++|.+.+ +|..+..+++|++|+|++|++++..+ ..+. ++|++|+|++|++++..|..+..+++|++|+
T Consensus 78 ~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp SCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 679999999999985 67779999999999999999997665 3343 8999999999999999999999999999999
Q ss_pred eecCCCCC-ccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEccccccc
Q 007103 160 VSRNSLTQ-SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFS 236 (618)
Q Consensus 160 L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~ 236 (618)
|++|++++ .+|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+. +.. .+|+.|+|++|+++
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 99999997 6889999999999999999999988899999999999999999999986653 333 46999999999999
Q ss_pred ccCchhhh----cccchhccCCcCCCCC
Q 007103 237 GWIPRELI----SIRTFIYDGNSFDNGP 260 (618)
Q Consensus 237 g~ip~~~~----~l~~l~~~~N~~~~~~ 260 (618)
+..|..+. +|+.|++++|++.|.+
T Consensus 237 ~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 237 TSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp BCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred ccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 98887653 6778999999999864
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=2.2e-19 Score=181.95 Aligned_cols=171 Identities=18% Similarity=0.292 Sum_probs=141.7
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
..+++.|+|++|.+.+..+ +..+++|++|+|++|.+++.....-.++|+.|+|++|++++. + .+..+++|++|+|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~ 137 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLD 137 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECC
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECC
Confidence 4579999999999987655 999999999999999998653223338999999999999964 4 38999999999999
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP- 240 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip- 240 (618)
+|++++..+ +..+++|+.|+|++|++++ ++. +..+++|++|+|++|++++..+.....+|+.|+|++|++++..|
T Consensus 138 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~l 213 (308)
T 1h6u_A 138 LNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSPL 213 (308)
T ss_dssp SSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGGG
T ss_pred CCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCccccc
Confidence 999997655 8899999999999999995 444 88999999999999999987664445679999999999997554
Q ss_pred hhhhcccchhccCCcCCCCC
Q 007103 241 RELISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 241 ~~~~~l~~l~~~~N~~~~~~ 260 (618)
..+.+|+.|++.+|++.+.+
T Consensus 214 ~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 214 ANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp TTCTTCCEEEEEEEEEECCC
T ss_pred cCCCCCCEEEccCCeeecCC
Confidence 34567788999999997744
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=201.63 Aligned_cols=174 Identities=21% Similarity=0.255 Sum_probs=114.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|.+++..|..|+++++|++|+|++|.|++..+..+. ++|++|+|++|+|++..|..|+++++|++|+|
T Consensus 99 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 178 (597)
T 3oja_B 99 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178 (597)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEEC
Confidence 3577777777777777777777777777777777777744333332 67777777777777776667777777777777
Q ss_pred ecCCCCCccc-----------------------------------------------------------hhhcCCCCCCe
Q 007103 161 SRNSLTQSIG-----------------------------------------------------------DIFGNLAGLAT 181 (618)
Q Consensus 161 ~~N~l~~~~p-----------------------------------------------------------~~~~~l~~L~~ 181 (618)
++|++++..+ ..++.+++|+.
T Consensus 179 ~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~~~l~~l~~L~~ 258 (597)
T 3oja_B 179 SSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVE 258 (597)
T ss_dssp TTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCCGGGGGCTTCSE
T ss_pred cCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCCChhhccCCCCCE
Confidence 7776664321 23556677777
Q ss_pred EEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccccCchhh---hcccchhccCCcCC
Q 007103 182 LDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFD 257 (618)
Q Consensus 182 L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~ 257 (618)
|+|++|.|++.+|..|..+++|+.|+|++|.|++.+..... .+|+.|+|++|.++ .+|..+ .+|+.|++.+|++.
T Consensus 259 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~ 337 (597)
T 3oja_B 259 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337 (597)
T ss_dssp EECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC
T ss_pred EECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCC
Confidence 78888888777777777777777777777777775443332 34677777777666 455432 34445555555543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.8e-19 Score=200.46 Aligned_cols=178 Identities=20% Similarity=0.239 Sum_probs=136.6
Q ss_pred CCEEEEEcCCCCCccccc-ccccCCCCCCEEEecCCCccC--------------------------CCCCCCC--CCccE
Q 007103 83 SAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHD--------------------------TIPYQLP--PNLTS 133 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~-~~l~~l~~L~~L~L~~N~l~~--------------------------~~p~~~~--~~L~~ 133 (618)
.+++.|+|++|.+.+.+| ..+.++++|++|+|++|++++ .+|..+. ++|+.
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 467778888888877655 567777777777777777653 3444443 67888
Q ss_pred EecccccccccCCccccCCCCccEEEeecCCCCCccc--------hhhcCCCCCCeEEcccCcCCCCCC-CCcccCCCcC
Q 007103 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG--------DIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNIS 204 (618)
Q Consensus 134 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~ 204 (618)
|+|++|++++..|..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+|+ .+| ..|..+++|+
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELK 563 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcc
Confidence 8888888887777778888888888888888876532 23677888888888888888 455 4688999999
Q ss_pred eeeecccccccccccc-CC-CCccEEEcccccccccCch----hhhcccchhccCCcCCCCCC
Q 007103 205 SLYLQNNQVTGSLNVF-SG-LPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDNGPA 261 (618)
Q Consensus 205 ~L~l~~N~l~~~~~~~-~~-~~L~~L~l~~N~l~g~ip~----~~~~l~~l~~~~N~~~~~~~ 261 (618)
+|+|++|+|++.++.. .. .+|+.|+|++|+|++..|. .+.+++.+++.+|||.|.+.
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 9999999999866653 23 5699999999999987776 45678899999999999764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.5e-20 Score=208.29 Aligned_cols=158 Identities=19% Similarity=0.285 Sum_probs=142.0
Q ss_pred ccccccCCCCCCEEEecCCCccC-----------------CCCCCCC----CCccEEecccccccccCCccccCCCCccE
Q 007103 99 MGYLLSDLLSLRKFDLSGNSIHD-----------------TIPYQLP----PNLTSLNLASNNFSGNLPYSIASMVSLSY 157 (618)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~N~l~~-----------------~~p~~~~----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 157 (618)
+|..|++|++|+.|+|++|+|+| .+|..+. ++|+.|+|++|++.+.+|..|+++++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 88899999999999999999998 3888874 89999999999999999999999999999
Q ss_pred EEeecCC-CCC-ccchhhcCCC-------CCCeEEcccCcCCCCCCC--CcccCCCcCeeeeccccccccccccCCC-Cc
Q 007103 158 LNVSRNS-LTQ-SIGDIFGNLA-------GLATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVTGSLNVFSGL-PL 225 (618)
Q Consensus 158 L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L 225 (618)
|+|++|+ ++| .+|..++.++ +|+.|+|++|+|+ .+|. .|..+++|+.|+|++|+|+ .+|.+... +|
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L 597 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKL 597 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcc
Confidence 9999998 999 8998877766 9999999999999 8999 9999999999999999999 56555443 59
Q ss_pred cEEEcccccccccCchhhh---c-ccchhccCCcCCCC
Q 007103 226 TTLNVANNHFSGWIPRELI---S-IRTFIYDGNSFDNG 259 (618)
Q Consensus 226 ~~L~l~~N~l~g~ip~~~~---~-l~~l~~~~N~~~~~ 259 (618)
+.|+|++|+++ .+|..+. + |+.|++++|.+...
T Consensus 598 ~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~l 634 (876)
T 4ecn_A 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYI 634 (876)
T ss_dssp SEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSC
T ss_pred eEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcC
Confidence 99999999999 8997764 4 77789999998743
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=209.18 Aligned_cols=186 Identities=20% Similarity=0.146 Sum_probs=158.5
Q ss_pred CCCceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCC-CCCCC--CCccEEecccccccccCCccc
Q 007103 73 ESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTI-PYQLP--PNLTSLNLASNNFSGNLPYSI 149 (618)
Q Consensus 73 ~~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~--~~L~~L~L~~N~l~~~~p~~~ 149 (618)
+.|..|.+...+++.|||++|.+++..+..|.++++|++|+|++|.+.+.+ |..+. ++|++|+|++|++++..|..|
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 356677664578999999999999999999999999999999999877777 55555 899999999999999999999
Q ss_pred cCCCCccEEEeecCCCCCccchh--hcCCCCCCeEEcccCcCCCCCC-CCcccCCCcCeeeecccccccccccc-CC---
Q 007103 150 ASMVSLSYLNVSRNSLTQSIGDI--FGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSLNVF-SG--- 222 (618)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~-~~--- 222 (618)
+++++|++|+|++|++++.+|.. |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..+.. ..
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~ 173 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence 99999999999999999977765 9999999999999999997655 57899999999999999998865432 21
Q ss_pred CCccEEEcccccccccCchhhhc---------ccchhccCCcCCC
Q 007103 223 LPLTTLNVANNHFSGWIPRELIS---------IRTFIYDGNSFDN 258 (618)
Q Consensus 223 ~~L~~L~l~~N~l~g~ip~~~~~---------l~~l~~~~N~~~~ 258 (618)
.+|+.|+|++|.+++.+|..+.. |+.|++++|.+..
T Consensus 174 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~ 218 (844)
T 3j0a_A 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTV 218 (844)
T ss_dssp CSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSST
T ss_pred CccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCch
Confidence 56899999999999888765433 6778888886653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.1e-19 Score=198.41 Aligned_cols=180 Identities=19% Similarity=0.135 Sum_probs=153.3
Q ss_pred CceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccc
Q 007103 75 WKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNF 141 (618)
Q Consensus 75 w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l 141 (618)
+..+.|.. ..++.|+|++|.|++..|..|.++++|++|+|++|++++..|..+. ++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 56688853 3689999999999999999999999999999999999988888776 8999999999999
Q ss_pred cccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-c
Q 007103 142 SGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-F 220 (618)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~ 220 (618)
++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|++|+|++|++++..+. +
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 999999999999999999999999998888999999999999999999974444555699999999999999987553 3
Q ss_pred C-CCCcc--EEEcccccccccCchhhh--cccchhccCC
Q 007103 221 S-GLPLT--TLNVANNHFSGWIPRELI--SIRTFIYDGN 254 (618)
Q Consensus 221 ~-~~~L~--~L~l~~N~l~g~ip~~~~--~l~~l~~~~N 254 (618)
. ..+|+ .|++++|.+++..|..+. +++.|++.+|
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~ 212 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTC
T ss_pred hhhcccceeEEecCCCccCccChhHhhhccccccccCCc
Confidence 2 33477 899999999988776653 2344444443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=8.2e-20 Score=189.43 Aligned_cols=168 Identities=23% Similarity=0.229 Sum_probs=144.2
Q ss_pred CCCCCCCceeEeeCC-----------CEEEEEcCCCCCccccccccc-CCCCCCEEEecCCCccCCCCCCCC--CCccEE
Q 007103 69 DPCGESWKGVACEGS-----------AVVSIDISGLGLSGTMGYLLS-DLLSLRKFDLSGNSIHDTIPYQLP--PNLTSL 134 (618)
Q Consensus 69 ~~c~~~w~gv~c~~~-----------~v~~l~l~~~~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L 134 (618)
..|.|.+..+.|... .++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..+. ++|+.|
T Consensus 14 ~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 93 (361)
T 2xot_A 14 ANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL 93 (361)
T ss_dssp TTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEE
Confidence 447778999999742 477899999999998888888 999999999999999987776665 899999
Q ss_pred ecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCC-c---ccCCCcCeeeecc
Q 007103 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-F---ISLSNISSLYLQN 210 (618)
Q Consensus 135 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~---~~l~~L~~L~l~~ 210 (618)
+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++ +|.. | ..+++|+.|+|++
T Consensus 94 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~ 172 (361)
T 2xot_A 94 DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSS 172 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCS
T ss_pred ECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCC
Confidence 999999998888889999999999999999999999999999999999999999995 5554 4 5799999999999
Q ss_pred ccccccccc-cCCC---CccEEEcccccccc
Q 007103 211 NQVTGSLNV-FSGL---PLTTLNVANNHFSG 237 (618)
Q Consensus 211 N~l~~~~~~-~~~~---~L~~L~l~~N~l~g 237 (618)
|+|++.... +... .++.|+|++|.+.-
T Consensus 173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp SCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 999975532 2222 25889999999973
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=9.8e-19 Score=173.67 Aligned_cols=156 Identities=21% Similarity=0.260 Sum_probs=139.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|.++...+..|..+++|++|+|++|++++..+..+. ++|+.|+|++|++++..+..|..+++|++|+|
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 5799999999999988777889999999999999999976655554 89999999999999888888999999999999
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEccccccccc
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGW 238 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ 238 (618)
++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++.++. +.. .+|+.|+|++|++...
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 99999988888899999999999999999977777799999999999999999987664 333 4699999999999754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.6e-19 Score=167.24 Aligned_cols=151 Identities=17% Similarity=0.273 Sum_probs=128.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|++++|++.. +| .+..+++|++|+|++|.++...+..-.++|++|+|++|++++..|..++.+++|++|+|++
T Consensus 44 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 121 (197)
T 4ezg_A 44 NSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121 (197)
T ss_dssp HTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred CCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence 468999999999984 45 6999999999999999887443333348999999999999998899999999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCc-CCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNN-FSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSG 237 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g 237 (618)
|++++..|..++.+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++..+.....+|+.|++++|++.+
T Consensus 122 n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 122 SAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred CccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99999899999999999999999998 65 676 689999999999999999986544444569999999999864
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=8.6e-19 Score=179.45 Aligned_cols=174 Identities=17% Similarity=0.241 Sum_probs=151.0
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
-.+++.|+|++|.+++..|..|..+++|++|+|++|.++ .+|..+.++|+.|+|++|++++..+..+.++++|++|+|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 153 (330)
T 1xku_A 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153 (330)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred CCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECC
Confidence 357999999999999999999999999999999999999 6788888999999999999998888889999999999999
Q ss_pred cCCCCC--ccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccc
Q 007103 162 RNSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSG 237 (618)
Q Consensus 162 ~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g 237 (618)
+|+++. ..+..|..+++|+.|++++|+++ .+|..+. ++|++|+|++|++++..+. +.. .+|+.|+|++|++++
T Consensus 154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230 (330)
T ss_dssp SSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred CCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence 999974 77889999999999999999999 5777664 7899999999999986543 333 459999999999998
Q ss_pred cCchhh---hcccchhccCCcCCCC
Q 007103 238 WIPREL---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 238 ~ip~~~---~~l~~l~~~~N~~~~~ 259 (618)
..|..+ .+|+.|++++|.+...
T Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~~l 255 (330)
T 1xku_A 231 VDNGSLANTPHLRELHLNNNKLVKV 255 (330)
T ss_dssp ECTTTGGGSTTCCEEECCSSCCSSC
T ss_pred eChhhccCCCCCCEEECCCCcCccC
Confidence 776555 4677888999988744
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=5e-19 Score=197.53 Aligned_cols=171 Identities=21% Similarity=0.214 Sum_probs=136.4
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
.++.|||++|+|++..+..|.++++|++|+|++|+|++..|..|. ++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 578999999999988888999999999999999999977676665 899999999999997777788999999999999
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCC-CCCCCcccCCCcCeeeeccccccccccccC----C--CCccEEEccccc
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNVFS----G--LPLTTLNVANNH 234 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~----~--~~L~~L~l~~N~ 234 (618)
+|+|++..+..|+++++|++|+|++|++++ .+|..+..+++|++|+|++|+|++..+... . ..+..++++.|.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 999998888889999999999999999975 467788889999999999999988654311 1 125578888888
Q ss_pred ccccCchhhhcc--cchhccCC
Q 007103 235 FSGWIPRELISI--RTFIYDGN 254 (618)
Q Consensus 235 l~g~ip~~~~~l--~~l~~~~N 254 (618)
++...|..+..+ ..+.+.+|
T Consensus 213 l~~i~~~~~~~~~~~~l~l~~n 234 (635)
T 4g8a_A 213 MNFIQPGAFKEIRLHKLTLRNN 234 (635)
T ss_dssp CCEECTTTTTTCEEEEEEEESC
T ss_pred ccccCcccccchhhhhhhhhcc
Confidence 876555444332 34444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=184.17 Aligned_cols=176 Identities=20% Similarity=0.200 Sum_probs=127.6
Q ss_pred CCCEEEEEcCCCCCccccc----ccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEeccccccccc--C--CccccC
Q 007103 82 GSAVVSIDISGLGLSGTMG----YLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGN--L--PYSIAS 151 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~----~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~--~--p~~~~~ 151 (618)
..+++.|+|++|.+.+..+ ..+..+++|++|+|++|++++..|..+. ++|++|+|++|++.+. + +..+..
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 3467788888888877544 3455788888888888888777666654 7888888888887652 2 223367
Q ss_pred CCCccEEEeecCCCCCccc--h-hhcCCCCCCeEEcccCcCCCCCCCCcccC---CCcCeeeeccccccccccccCCCCc
Q 007103 152 MVSLSYLNVSRNSLTQSIG--D-IFGNLAGLATLDLSFNNFSGDLPNSFISL---SNISSLYLQNNQVTGSLNVFSGLPL 225 (618)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p--~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~~L 225 (618)
+++|++|+|++|+++...+ . .++.+++|++|+|++|+|++.+|..+..+ ++|++|+|++|+|+.. |.....+|
T Consensus 196 l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~l-p~~~~~~L 274 (310)
T 4glp_A 196 FPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQV-PKGLPAKL 274 (310)
T ss_dssp SCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSC-CSCCCSCC
T ss_pred CCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCch-hhhhcCCC
Confidence 8888888888888873222 1 35677888888888888887777777666 5888888888888844 33333678
Q ss_pred cEEEcccccccc-cCchhhhcccchhccCCcCCC
Q 007103 226 TTLNVANNHFSG-WIPRELISIRTFIYDGNSFDN 258 (618)
Q Consensus 226 ~~L~l~~N~l~g-~ip~~~~~l~~l~~~~N~~~~ 258 (618)
+.|+|++|+|++ .++..+.+|+.|++++|++..
T Consensus 275 ~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 275 RVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp SCEECCSCCCCSCCCTTSCCCCSCEECSSTTTSC
T ss_pred CEEECCCCcCCCCchhhhCCCccEEECcCCCCCC
Confidence 888888888887 566777788888888888764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-20 Score=213.30 Aligned_cols=207 Identities=23% Similarity=0.199 Sum_probs=104.6
Q ss_pred hHHHHHHHHHHHhCCCCC--CCCCCCCCCCCCCCCCCceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCC
Q 007103 41 SSDVQALQVLYTSLNSPS--VLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS 118 (618)
Q Consensus 41 ~~~~~al~~~~~~~~~~~--~~~~w~~~~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~ 118 (618)
..++++|.+++.++..+. .-..|.......+ .|.++.++..+++.|+|.+|++... +..+ |+.++|+.|.
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~~~ 202 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSG--TATNSAVSTPLTPKIELFANGKDEA-NQAL-----LQHKKLSQYS 202 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccc--cCCCceecCCccceEEeeCCCCCcc-hhhH-----hhcCccCccc
Confidence 457788999987764432 2345654433333 7999999998999999988888663 3222 2333333333
Q ss_pred ccC---------CCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccC
Q 007103 119 IHD---------TIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFN 187 (618)
Q Consensus 119 l~~---------~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 187 (618)
|.+ ..|..+. ++|+.|+|++|++. .+|..+.++++|++|+|++|+|+ .+|..|+++++|++|+|++|
T Consensus 203 i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N 280 (727)
T 4b8c_D 203 IDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHN 280 (727)
T ss_dssp -------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTS
T ss_pred ccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCC
Confidence 332 2233333 67778888888877 66777777788888888888887 67777777888888888888
Q ss_pred cCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccccCchhhhccc----chhccCCcCCC
Q 007103 188 NFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSGWIPRELISIR----TFIYDGNSFDN 258 (618)
Q Consensus 188 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g~ip~~~~~l~----~l~~~~N~~~~ 258 (618)
+|+ .+|..|+.|++|++|+|++|.|+..+..+.. .+|+.|+|++|.|+|.+|..+..+. .+++.+|.+..
T Consensus 281 ~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 281 RLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp CCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred cCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence 887 6777777788888888888877754444433 3477888888888877777664432 35566776653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.4e-19 Score=196.21 Aligned_cols=174 Identities=21% Similarity=0.296 Sum_probs=111.4
Q ss_pred CEEEEEcCCCCCcccccccc-----cCCC--------------------------CCCEEEecCCCccCCCCCCCCCCcc
Q 007103 84 AVVSIDISGLGLSGTMGYLL-----SDLL--------------------------SLRKFDLSGNSIHDTIPYQLPPNLT 132 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l-----~~l~--------------------------~L~~L~L~~N~l~~~~p~~~~~~L~ 132 (618)
.++.|++++|.+.|.+|..+ .+++ +|+.|++++|.+.........++|+
T Consensus 277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~ 356 (562)
T 3a79_B 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356 (562)
T ss_dssp SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred cccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCce
Confidence 68888888888887777765 2222 3555555555554222113336777
Q ss_pred EEecccccccccCCccccCCCCccEEEeecCCCCC--ccchhhcCCCCCCeEEcccCcCCCCCCCC-cccCCCcCeeeec
Q 007103 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQ 209 (618)
Q Consensus 133 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~l~ 209 (618)
+|+|++|++++.+|..+.++++|++|+|++|++++ .+|..|.++++|+.|+|++|++++.+|.. +..+++|++|+|+
T Consensus 357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~ 436 (562)
T 3a79_B 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436 (562)
T ss_dssp EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECC
T ss_pred EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECC
Confidence 77777777777677777777777777777777775 33456677777777777777777645543 5666777777777
Q ss_pred cccccccccccCCCCccEEEcccccccccCchhh---hcccchhccCCcCCC
Q 007103 210 NNQVTGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDN 258 (618)
Q Consensus 210 ~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~ 258 (618)
+|+|++.++.....+|+.|+|++|+|+ .+|..+ .+|+.|++++|.+..
T Consensus 437 ~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 437 SNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp SSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC
T ss_pred CCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC
Confidence 777766554433345677777777766 555543 345566666666654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=174.14 Aligned_cols=169 Identities=18% Similarity=0.237 Sum_probs=145.2
Q ss_pred CCEEEEEcCCCC-CcccccccccCCCCCCEEEecC-CCccCCCCCCCC--CCccEEecccccccccCCccccCCCCcc--
Q 007103 83 SAVVSIDISGLG-LSGTMGYLLSDLLSLRKFDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLS-- 156 (618)
Q Consensus 83 ~~v~~l~l~~~~-l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~-- 156 (618)
.+++.|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..+. ++|+.|+|++|++++ +|. +..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 579999999997 8888788999999999999999 999966655554 899999999999996 676 88888888
Q ss_pred -EEEeecC-CCCCccchhhcCCCCCC-eEEcccCcCCCCCCCCcccCCCcCeeeecccc-ccccccc-cCC--CCccEEE
Q 007103 157 -YLNVSRN-SLTQSIGDIFGNLAGLA-TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ-VTGSLNV-FSG--LPLTTLN 229 (618)
Q Consensus 157 -~L~L~~N-~l~~~~p~~~~~l~~L~-~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~-~~~--~~L~~L~ 229 (618)
+|+|++| ++++..+..|..+++|+ .|+|++|+++ .+|......++|+.|+|++|+ +++..+. +.. .+|+.|+
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 9999999 99988888899999999 9999999999 677655455899999999995 9976544 444 4699999
Q ss_pred cccccccccCchhhhcccchhccCC
Q 007103 230 VANNHFSGWIPRELISIRTFIYDGN 254 (618)
Q Consensus 230 l~~N~l~g~ip~~~~~l~~l~~~~N 254 (618)
|++|+|++..+..+.+++.|.+.++
T Consensus 212 l~~N~l~~l~~~~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 212 VSQTSVTALPSKGLEHLKELIARNT 236 (239)
T ss_dssp CTTCCCCCCCCTTCTTCSEEECTTC
T ss_pred CCCCccccCChhHhccCceeeccCc
Confidence 9999999655566889998888765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-19 Score=196.41 Aligned_cols=176 Identities=18% Similarity=0.236 Sum_probs=130.5
Q ss_pred CEEEEEcCCCCCcccccccc-----cCCCCCCEEEecCCCc--------------------------cCCCCCCCCCCcc
Q 007103 84 AVVSIDISGLGLSGTMGYLL-----SDLLSLRKFDLSGNSI--------------------------HDTIPYQLPPNLT 132 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l-----~~l~~L~~L~L~~N~l--------------------------~~~~p~~~~~~L~ 132 (618)
+++.|++++|.+.|.+|..+ ..+++|+.|++++|.+ .+..-....++|+
T Consensus 248 ~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~ 327 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327 (520)
T ss_dssp SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred cccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCccc
Confidence 56777777777777777666 5555555555554444 3211113347888
Q ss_pred EEecccccccccCCccccCCCCccEEEeecCCCCC--ccchhhcCCCCCCeEEcccCcCCCCCCCC-cccCCCcCeeeec
Q 007103 133 SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSGDLPNS-FISLSNISSLYLQ 209 (618)
Q Consensus 133 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~l~ 209 (618)
+|+|++|++++.+|..++++++|++|+|++|++++ .+|..++.+++|+.|+|++|++++.+|.. +..+++|++|+|+
T Consensus 328 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls 407 (520)
T 2z7x_B 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407 (520)
T ss_dssp EEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECC
T ss_pred EEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECc
Confidence 99999999988888888888999999999999887 56678888889999999999988756654 7788888888888
Q ss_pred cccccccccccCCCCccEEEcccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 210 NNQVTGSLNVFSGLPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 210 ~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
+|++++.++.....+|+.|+|++|+|+ .+|..+ .+|+.|++.+|.+...+
T Consensus 408 ~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~ 460 (520)
T 2z7x_B 408 SNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460 (520)
T ss_dssp SSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCC
T ss_pred CCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccC
Confidence 888887766554567888888888888 777654 45667788888877543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=183.75 Aligned_cols=169 Identities=20% Similarity=0.163 Sum_probs=102.1
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
..+++.|+|++|.+++..+ +..+++|++|+|++|+|++..+. ++|+.|+|++|++++..+. .+++|++|+|+
T Consensus 57 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~---~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~ 128 (317)
T 3o53_A 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG---PSIETLHAANNNISRVSCS---RGQGKKNIYLA 128 (317)
T ss_dssp CTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEEC---TTCCEEECCSSCCSEEEEC---CCSSCEEEECC
T ss_pred CCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCC---CCcCEEECCCCccCCcCcc---ccCCCCEEECC
Confidence 3567788888888876654 77778888888888877743321 5566666666665544332 24556666666
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcc-cCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI-SLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip 240 (618)
+|++++..+..|+.+++|++|+|++|++++..|..+. .+++|++|+|++|+|++........+|+.|+|++|++++..|
T Consensus 129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 208 (317)
T 3o53_A 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGP 208 (317)
T ss_dssp SSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECG
T ss_pred CCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCcchh
Confidence 6666666565666666666666666666655555443 556666666666666655433334456666666666664322
Q ss_pred h--hhhcccchhccCCcCCC
Q 007103 241 R--ELISIRTFIYDGNSFDN 258 (618)
Q Consensus 241 ~--~~~~l~~l~~~~N~~~~ 258 (618)
. .+.+|+.|++++|.+..
T Consensus 209 ~~~~l~~L~~L~L~~N~l~~ 228 (317)
T 3o53_A 209 EFQSAAGVTWISLRNNKLVL 228 (317)
T ss_dssp GGGGGTTCSEEECTTSCCCE
T ss_pred hhcccCcccEEECcCCcccc
Confidence 2 12445556666666553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-18 Score=164.99 Aligned_cols=172 Identities=23% Similarity=0.266 Sum_probs=143.1
Q ss_pred eeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCC
Q 007103 77 GVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVS 154 (618)
Q Consensus 77 gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~ 154 (618)
+..|.. +.++.++++++.. |..+ .++|++|+|++|++++..+..+. ++|++|+|++|++++..+..|..+++
T Consensus 4 ~C~C~~---~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 77 (208)
T 2o6s_A 4 RCSCSG---TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS 77 (208)
T ss_dssp TCEEET---TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred CCEECC---CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCC
Confidence 456754 3678899988754 3333 46899999999999976665554 89999999999999777777899999
Q ss_pred ccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEccc
Q 007103 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVAN 232 (618)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~ 232 (618)
|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++.++. +.. .+|+.|+|++
T Consensus 78 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 157 (208)
T 2o6s_A 78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD 157 (208)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred cCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecC
Confidence 99999999999988888899999999999999999977777789999999999999999987764 333 4699999999
Q ss_pred ccccccCchhhhcccchhccCCcCCC
Q 007103 233 NHFSGWIPRELISIRTFIYDGNSFDN 258 (618)
Q Consensus 233 N~l~g~ip~~~~~l~~l~~~~N~~~~ 258 (618)
|.+.+..| +++.|.+..|.+..
T Consensus 158 N~~~~~~~----~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 158 NPWDCTCP----GIRYLSEWINKHSG 179 (208)
T ss_dssp CCBCCCTT----TTHHHHHHHHHCTT
T ss_pred CCeecCCC----CHHHHHHHHHhCCc
Confidence 99987654 56777777777664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=182.67 Aligned_cols=110 Identities=24% Similarity=0.255 Sum_probs=98.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|.+.+..+..|..+++|++|+|++|.+++..|..+. ++|++|+|++|+++...+..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 4789999999999998888999999999999999999987777665 89999999999999555555789999999999
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCCC
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD 192 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 192 (618)
++|++++..|..|..+++|+.|+|++|++++.
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 99999998888999999999999999999854
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.1e-19 Score=189.63 Aligned_cols=178 Identities=22% Similarity=0.208 Sum_probs=129.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCC--------
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASM-------- 152 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l-------- 152 (618)
.+++.|+|++|.+.+..+..|.++++|+.|+|++|++++..+..+. ++|+.|+|++|++++..+..|..+
T Consensus 128 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 207 (477)
T 2id5_A 128 YNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEI 207 (477)
T ss_dssp TTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEE
T ss_pred ccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeC
Confidence 4577777777777777777777777777777777777644332222 455555555555554444444444
Q ss_pred ----------------CCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccc
Q 007103 153 ----------------VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGS 216 (618)
Q Consensus 153 ----------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 216 (618)
.+|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 287 (477)
T 2id5_A 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287 (477)
T ss_dssp ECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEE
T ss_pred CCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceE
Confidence 4566666666777766556788899999999999999987778889999999999999999987
Q ss_pred ccc-cCC-CCccEEEcccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 217 LNV-FSG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 217 ~~~-~~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
.+. +.. .+|+.|+|++|+|++..+..+ .+|+.|++.+|+|.|.+
T Consensus 288 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 288 EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 553 333 459999999999997665544 56788999999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.7e-19 Score=175.33 Aligned_cols=139 Identities=20% Similarity=0.175 Sum_probs=106.6
Q ss_pred CcccceeccCccceEEEEEE-cCCcE--EEEEEcCccccc----------------------HHHHHHHHHHHHHhhcCC
Q 007103 412 FSQEFLIGEGSLGRVYRAEF-ANGKI--MAVKKIDNAALS----------------------LQEEDNFLEAVSNMSRLR 466 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~ 466 (618)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ......+.+|++.+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999988 67999 999987543211 112346788999999998
Q ss_pred CCcc--cccceEEeeCCeEEEEEEecCC-C----ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCcee
Q 007103 467 HPNI--VTLAGYCAEHGQRLLVYEYVGN-G----NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-EVCLPSVVH 538 (618)
Q Consensus 467 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiH 538 (618)
|+++ ..++++ +..++||||+++ | +|.++... .++..+..++.|++.||+||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 333322 356899999942 4 66665431 224457789999999999999 88 9999
Q ss_pred cCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 539 RNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 539 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||||+|||+++ .++|+|||++....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999998 99999999997653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-19 Score=182.74 Aligned_cols=169 Identities=20% Similarity=0.145 Sum_probs=145.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+|++|++++..|..|..+++|++|+|++|.+++..|..-.++|++|+|++|++++.. .+++|++|++++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~ 108 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELL-----VGPSIETLHAAN 108 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEEETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCS
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchhhhhcCCCCEEECcCCcccccc-----CCCCcCEEECCC
Confidence 368999999999999988999999999999999999998777544589999999999999542 448999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cC--CCCccEEEcccccccccC
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS--GLPLTTLNVANNHFSGWI 239 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~--~~~L~~L~l~~N~l~g~i 239 (618)
|++++..+.. +++|+.|+|++|++++..|..+..+++|++|+|++|.|++..+. +. ..+|+.|+|++|.+++..
T Consensus 109 n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 185 (317)
T 3o53_A 109 NNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK 185 (317)
T ss_dssp SCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE
T ss_pred CccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc
Confidence 9999877654 68899999999999988788999999999999999999986543 32 356999999999999652
Q ss_pred ch-hhhcccchhccCCcCCCC
Q 007103 240 PR-ELISIRTFIYDGNSFDNG 259 (618)
Q Consensus 240 p~-~~~~l~~l~~~~N~~~~~ 259 (618)
+. .+.+|+.|++++|.+...
T Consensus 186 ~~~~l~~L~~L~Ls~N~l~~l 206 (317)
T 3o53_A 186 GQVVFAKLKTLDLSSNKLAFM 206 (317)
T ss_dssp CCCCCTTCCEEECCSSCCCEE
T ss_pred cccccccCCEEECCCCcCCcc
Confidence 22 368899999999998754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.4e-18 Score=172.55 Aligned_cols=153 Identities=21% Similarity=0.214 Sum_probs=135.2
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEE
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
..+++.|+|++|.|++..+. ..+++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+
T Consensus 54 l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp CTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 36899999999999876543 89999999999999999 6776654 8999999999999988888999999999999
Q ss_pred eecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-CCccEEEcccccccc
Q 007103 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-LPLTTLNVANNHFSG 237 (618)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l~~N~l~g 237 (618)
|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+..+..+.. ..|+.|+|++|++.-
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccC
Confidence 999999998888999999999999999999965556678899999999999999976655443 469999999999973
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.2e-19 Score=184.50 Aligned_cols=156 Identities=22% Similarity=0.258 Sum_probs=134.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCC-ccccCCCCccEEE
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP-YSIASMVSLSYLN 159 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ 159 (618)
.+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..+. ++|++|+|++|++++..+ ..+.++++|++|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~ 155 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEE
Confidence 5799999999999999899999999999999999999965443243 899999999999995433 4789999999999
Q ss_pred eecC-CCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccC--CCCccEEEccccccc
Q 007103 160 VSRN-SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS--GLPLTTLNVANNHFS 236 (618)
Q Consensus 160 L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~L~~L~l~~N~l~ 236 (618)
|++| .+++..+..|.++++|+.|+|++|++++..|..+..+++|++|++++|+++.....+. ..+|+.|+|++|.++
T Consensus 156 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred CCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccc
Confidence 9999 5777778899999999999999999999889999999999999999999976554332 356899999999988
Q ss_pred cc
Q 007103 237 GW 238 (618)
Q Consensus 237 g~ 238 (618)
+.
T Consensus 236 ~~ 237 (353)
T 2z80_A 236 TF 237 (353)
T ss_dssp TC
T ss_pred cc
Confidence 74
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-18 Score=173.52 Aligned_cols=169 Identities=21% Similarity=0.261 Sum_probs=140.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|++++|++... +.+..+++|+.|+|++|++++..+..-.++|+.|+|++|++++ + +.+..+++|++|+|++
T Consensus 46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~ 121 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEH 121 (291)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTT
T ss_pred CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcccccCCCCCEEECCCCcCCC-C-hhhccCCCCCEEECCC
Confidence 4688999999999765 3588999999999999999987664444899999999999986 3 3489999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCch-
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR- 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~- 241 (618)
|++++. +.+..+++|+.|+|++|++++. ..+..+++|++|+|++|+|++..+.....+|+.|+|++|.|++ +|.
T Consensus 122 n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~~l 196 (291)
T 1h6t_A 122 NGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRAL 196 (291)
T ss_dssp SCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGGG
T ss_pred CcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Chhh
Confidence 999975 5688899999999999999954 5788999999999999999987774444569999999999985 443
Q ss_pred -hhhcccchhccCCcCCCCC
Q 007103 242 -ELISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 242 -~~~~l~~l~~~~N~~~~~~ 260 (618)
.+.+|+.|++.+|++.+.+
T Consensus 197 ~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 197 AGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp TTCTTCSEEEEEEEEEECCC
T ss_pred ccCCCCCEEECcCCcccCCc
Confidence 3466778889999887644
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.9e-19 Score=194.05 Aligned_cols=177 Identities=24% Similarity=0.281 Sum_probs=147.3
Q ss_pred CCEEEEEcCCCCCcccc--cccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCC-ccccCCCCccE
Q 007103 83 SAVVSIDISGLGLSGTM--GYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~ 157 (618)
.+++.|++++|.+++.. +..+..+++|++|+|++|.+++..+. +. ++|+.|+|++|++++..| ..+.++++|++
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 46888888888888764 67788899999999999988865443 43 789999999999997766 56889999999
Q ss_pred EEeecCCCCCccchhhcCCCCCCeEEcccCcCC-CCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEccccc
Q 007103 158 LNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFS-GDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNH 234 (618)
Q Consensus 158 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~ 234 (618)
|+|++|++++..|..|..+++|+.|+|++|+++ +.+|..+..+++|++|+|++|++++..+. +.. .+|+.|+|++|+
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 999999999888999999999999999999997 67888999999999999999999987554 333 459999999999
Q ss_pred ccccCchhh---hcccchhccCCcCCCCC
Q 007103 235 FSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 235 l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
+++..|..+ .+|+.|++.+|++.|.+
T Consensus 506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 998777655 56678889999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-18 Score=159.63 Aligned_cols=149 Identities=24% Similarity=0.298 Sum_probs=127.5
Q ss_pred CEEEecCCCccCCCCCCCCCCccEEecccccccccCCc-cccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCc
Q 007103 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY-SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (618)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 188 (618)
+.|++++|+|+ .+|..+..+|+.|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 89 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CEEEcCCCCcC-cCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence 78999999996 78988889999999999999977665 48999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCch-hh-hcccchhccCCcCCCC
Q 007103 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPR-EL-ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip~-~~-~~l~~l~~~~N~~~~~ 259 (618)
|++..|..|..+++|++|+|++|+|++.++. +.. .+|+.|+|++|++++..+- .+ ..+....+.++...|.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 9988888899999999999999999997664 333 4699999999999987663 22 2244445556655564
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.6e-18 Score=185.95 Aligned_cols=156 Identities=21% Similarity=0.332 Sum_probs=131.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +..+|+.|+|++|+|++ +|. .+++|+.|+|++
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 149 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPASLKHLDVDNNQLTM-LPE---LPALLEYINADN 149 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhcCCCEEECCCCcCCC-CCC---cCccccEEeCCC
Confidence 57999999999998 456 568999999999999997 777 77899999999999997 676 689999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCc-------cEEEcccccc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPL-------TTLNVANNHF 235 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L-------~~L~l~~N~l 235 (618)
|+|++ +|. .+++|+.|+|++|+|++ +|. |. ++|++|+|++|+|+..+. +.. +| +.|+|++|+|
T Consensus 150 N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~-~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 150 NQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV-RNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC---------CCEEEECCSSCC
T ss_pred CccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH-hhhcccccceEEecCCCcc
Confidence 99997 555 57899999999999996 887 66 899999999999996554 433 67 9999999999
Q ss_pred cccCchhhh---cccchhccCCcCCCC
Q 007103 236 SGWIPRELI---SIRTFIYDGNSFDNG 259 (618)
Q Consensus 236 ~g~ip~~~~---~l~~l~~~~N~~~~~ 259 (618)
+ .+|..+. +|+.|++++|++.+.
T Consensus 220 ~-~lp~~l~~l~~L~~L~L~~N~l~~~ 245 (571)
T 3cvr_A 220 T-HIPENILSLDPTCTIILEDNPLSSR 245 (571)
T ss_dssp C-CCCGGGGGSCTTEEEECCSSSCCHH
T ss_pred e-ecCHHHhcCCCCCEEEeeCCcCCCc
Confidence 9 6887654 566788999998763
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.2e-18 Score=185.68 Aligned_cols=151 Identities=21% Similarity=0.284 Sum_probs=120.0
Q ss_pred CCCEEEecCCCccCCCCCCC-----C--CCccEEecccccccccCCc-------------------------c-ccCCCC
Q 007103 108 SLRKFDLSGNSIHDTIPYQL-----P--PNLTSLNLASNNFSGNLPY-------------------------S-IASMVS 154 (618)
Q Consensus 108 ~L~~L~L~~N~l~~~~p~~~-----~--~~L~~L~L~~N~l~~~~p~-------------------------~-~~~l~~ 154 (618)
+|++|+|++|+++|.+|..+ . ++|+.|++++|.+ .+|. . +..+++
T Consensus 248 ~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~ 325 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325 (520)
T ss_dssp SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCC
T ss_pred cccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCc
Confidence 56777777777777777665 2 3444444444444 2220 1 268899
Q ss_pred ccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCC--CCCCCcccCCCcCeeeeccccccccccc--cCC-CCccEEE
Q 007103 155 LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG--DLPNSFISLSNISSLYLQNNQVTGSLNV--FSG-LPLTTLN 229 (618)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~-~~L~~L~ 229 (618)
|++|+|++|++++.+|..++.+++|+.|+|++|++++ .+|..+..+++|++|+|++|++++.++. +.. .+|+.|+
T Consensus 326 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~ 405 (520)
T 2z7x_B 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405 (520)
T ss_dssp CCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEE
T ss_pred ccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEE
Confidence 9999999999999999999999999999999999997 5677899999999999999999985543 333 4699999
Q ss_pred cccccccccCchhh-hcccchhccCCcCCCCC
Q 007103 230 VANNHFSGWIPREL-ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 230 l~~N~l~g~ip~~~-~~l~~l~~~~N~~~~~~ 260 (618)
|++|++++.+|..+ .+|+.|++++|.+...+
T Consensus 406 Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ip 437 (520)
T 2z7x_B 406 MSSNILTDTIFRCLPPRIKVLDLHSNKIKSIP 437 (520)
T ss_dssp CCSSCCCGGGGGSCCTTCCEEECCSSCCCCCC
T ss_pred CcCCCCCcchhhhhcccCCEEECCCCcccccc
Confidence 99999999999888 59999999999988543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=6.5e-18 Score=171.04 Aligned_cols=170 Identities=23% Similarity=0.315 Sum_probs=144.5
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+++++++... + .+..+++|++|+|++|.+++..+..-.++|+.|+|++|++++. +.+..+++|++|+|++
T Consensus 41 ~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 41 DGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTS 116 (308)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTT
T ss_pred CCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChhHccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCC
Confidence 4799999999999864 3 6899999999999999999766633348999999999999964 4799999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-h
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~ 241 (618)
|++++..+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|++++..+.....+|+.|+|++|++++..+ .
T Consensus 117 n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~l~ 192 (308)
T 1h6u_A 117 TQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192 (308)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred CCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChhhc
Confidence 99997543 8999999999999999995443 88999999999999999987664444569999999999996544 3
Q ss_pred hhhcccchhccCCcCCCCC
Q 007103 242 ELISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 242 ~~~~l~~l~~~~N~~~~~~ 260 (618)
.+.+|+.|++++|.+...+
T Consensus 193 ~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 193 SLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp GCTTCCEEECTTSCCCBCG
T ss_pred CCCCCCEEEccCCccCccc
Confidence 4567889999999987653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=6.9e-18 Score=168.07 Aligned_cols=178 Identities=21% Similarity=0.229 Sum_probs=157.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|.+.+..+..|.++++|++|+|++|.+++..+..+. ++|+.|+|++|++++..+..+.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 5799999999999998888999999999999999999987776665 89999999999999887778999999999999
Q ss_pred ecCCCCCc-cchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcC----eeeecccccccccccc-CCCCccEEEccccc
Q 007103 161 SRNSLTQS-IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS----SLYLQNNQVTGSLNVF-SGLPLTTLNVANNH 234 (618)
Q Consensus 161 ~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~----~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~ 234 (618)
++|++++. +|..|..+++|+.|+|++|++++..+..+..+.+|+ .|++++|++++..+.. ...+|+.|+|++|+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~ 211 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQ 211 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCc
Confidence 99999985 699999999999999999999987777888877777 8999999999876543 44579999999999
Q ss_pred ccccCchh---hhcccchhccCCcCCCCC
Q 007103 235 FSGWIPRE---LISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 235 l~g~ip~~---~~~l~~l~~~~N~~~~~~ 260 (618)
+++..+.. +.+|+.|++.+|+|.|.+
T Consensus 212 l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 212 LKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp CSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred eeecCHhHhcccccccEEEccCCcccccC
Confidence 99665544 456788999999999976
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.7e-18 Score=155.88 Aligned_cols=134 Identities=20% Similarity=0.289 Sum_probs=66.9
Q ss_pred CCCCCCCceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCC
Q 007103 69 DPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLP 146 (618)
Q Consensus 69 ~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p 146 (618)
+.|.|+|+++.|... ++.. +|..+ .++|+.|+|++|++++..+..+. ++|++|+|++|+|++..+
T Consensus 3 ~~C~C~~~~l~~~~~----------~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK----------GLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp TTCEEETTEEECCSS----------CCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CCCEeCCCEEEecCC----------CCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 456667887777644 3322 22221 24556666666666543333322 455555555555554444
Q ss_pred ccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc
Q 007103 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|++|+|++|++++
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 444555555555555555554444445555555555555555553333333444444444444444443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.4e-18 Score=187.61 Aligned_cols=174 Identities=20% Similarity=0.204 Sum_probs=152.5
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..|..+. ++|++|+|++|++++..|..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 3689999999999999999999999999999999999987776665 89999999999999888899999999999999
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCC-CCCCCcccCCCcCeeeeccccccccccc-cCC-CCc----cEEEcccc
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPL----TTLNVANN 233 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L----~~L~l~~N 233 (618)
++|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+. +.. .+| ..|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999998777789999999999999999997 4799999999999999999999986543 221 234 79999999
Q ss_pred cccccCchhhh--cccchhccCCcC
Q 007103 234 HFSGWIPRELI--SIRTFIYDGNSF 256 (618)
Q Consensus 234 ~l~g~ip~~~~--~l~~l~~~~N~~ 256 (618)
.+++..|..+. +++.|++.+|..
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~~ 212 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNFD 212 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCS
T ss_pred CceecCHHHhccCcceeEecccccc
Confidence 99988887664 477888888743
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.7e-18 Score=185.38 Aligned_cols=111 Identities=22% Similarity=0.236 Sum_probs=97.9
Q ss_pred cCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCC--CCCCCcccCCCcCeeeeccccccccccc--cCC-CC
Q 007103 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG--DLPNSFISLSNISSLYLQNNQVTGSLNV--FSG-LP 224 (618)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~-~~ 224 (618)
..+++|++|+|++|++++.+|..++++++|+.|+|++|++++ .+|..+..+++|++|+|++|++++.++. +.. .+
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 678999999999999999999999999999999999999996 3356789999999999999999985543 333 46
Q ss_pred ccEEEcccccccccCchhh-hcccchhccCCcCCCCC
Q 007103 225 LTTLNVANNHFSGWIPREL-ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 225 L~~L~l~~N~l~g~ip~~~-~~l~~l~~~~N~~~~~~ 260 (618)
|+.|+|++|++++.+|..+ .+|+.|++++|.+...+
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip 466 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIP 466 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCC
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccC
Confidence 9999999999999999988 59999999999988543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=179.53 Aligned_cols=167 Identities=27% Similarity=0.392 Sum_probs=86.8
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCC
Q 007103 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (618)
Q Consensus 85 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (618)
++.|++++|.+.+. +.+..+++|+.|+|++|.+++..|....++|+.|+|++|++++..+ +..+++|+.|+|++|+
T Consensus 223 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~ 298 (466)
T 1o6v_A 223 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298 (466)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred CCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchhhhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCc
Confidence 44444444444432 2344555555555555555544443333555555555555554322 5555555555555555
Q ss_pred CCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-hhh
Q 007103 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-REL 243 (618)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~~~ 243 (618)
+++..+ ++.+++|+.|+|++|++++..| +..+++|+.|++++|++++........+|+.|++++|++++..| ..+
T Consensus 299 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~l 374 (466)
T 1o6v_A 299 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTPLANL 374 (466)
T ss_dssp CSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGGGTTC
T ss_pred ccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccchhhcC
Confidence 555433 4555556666666666554433 45555666666666665554322223346666666666665554 223
Q ss_pred hcccchhccCCcCCCC
Q 007103 244 ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 244 ~~l~~l~~~~N~~~~~ 259 (618)
.+|+.|++.+|+|...
T Consensus 375 ~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 375 TRITQLGLNDQAWTNA 390 (466)
T ss_dssp TTCCEEECCCEEEECC
T ss_pred CCCCEEeccCCcccCC
Confidence 4455556666666553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.5e-18 Score=187.54 Aligned_cols=161 Identities=22% Similarity=0.255 Sum_probs=138.0
Q ss_pred cccccCCCCCCEEEecCCCccCCCCCCCC---CCccEEecccccccccCCccccCCCCccEEEeecCCCC-CccchhhcC
Q 007103 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT-QSIGDIFGN 175 (618)
Q Consensus 100 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~ 175 (618)
+..+..+++|+.+++++|++....+.... ++|+.++++.|++++..|..+..+++|+.|+|++|++. +.+|..|..
T Consensus 413 ~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~ 492 (635)
T 4g8a_A 413 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 492 (635)
T ss_dssp CSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred cccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhh
Confidence 34456677777777777777666554433 78999999999999999999999999999999999854 567889999
Q ss_pred CCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCchhh----hcccch
Q 007103 176 LAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPREL----ISIRTF 249 (618)
Q Consensus 176 l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip~~~----~~l~~l 249 (618)
+++|++|+|++|+|++..|..|.++++|++|+|++|+|++.++. +.. .+|+.|||++|+|++..|..+ .+|+.|
T Consensus 493 l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L 572 (635)
T 4g8a_A 493 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 572 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEE
T ss_pred ccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEE
Confidence 99999999999999999999999999999999999999997764 444 469999999999999999876 457789
Q ss_pred hccCCcCCCCC
Q 007103 250 IYDGNSFDNGP 260 (618)
Q Consensus 250 ~~~~N~~~~~~ 260 (618)
++++|||.|.+
T Consensus 573 ~L~~Np~~C~C 583 (635)
T 4g8a_A 573 NLTQNDFACTC 583 (635)
T ss_dssp ECTTCCBCCSG
T ss_pred EeeCCCCcccC
Confidence 99999999975
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-17 Score=166.47 Aligned_cols=149 Identities=23% Similarity=0.278 Sum_probs=129.7
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
-.+++.|+|++|++++..+ +..+++|++|+|++|.+++..+..-.++|+.|+|++|++++. +.+..+++|++|+|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~ 142 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLG 142 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECC
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEcc
Confidence 4689999999999998765 999999999999999999744333348999999999999974 578999999999999
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEccccccccc
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGW 238 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ 238 (618)
+|++++. ..+..+++|+.|+|++|++++..| +..+++|++|+|++|.|++........+|+.|+|++|+++..
T Consensus 143 ~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 143 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEEEEEEEEECC
T ss_pred CCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCChhhccCCCCCEEECcCCcccCC
Confidence 9999986 678999999999999999996554 899999999999999999865433445699999999999853
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2e-17 Score=181.55 Aligned_cols=174 Identities=24% Similarity=0.287 Sum_probs=149.7
Q ss_pred EeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCcc
Q 007103 79 ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLS 156 (618)
Q Consensus 79 ~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (618)
.|....+ .|+++++++. +|..+. ++|++|+|++|++++..|..+. ++|++|+|++|++++..|..|+++++|+
T Consensus 3 ~C~~~~~--c~~~~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 77 (549)
T 2z81_A 3 SCDASGV--CDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77 (549)
T ss_dssp EECTTSE--EECTTSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cCCCCce--EECCCCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCC
Confidence 5777776 7999999985 555554 7999999999999988887776 8999999999999999899999999999
Q ss_pred EEEeecCCCCCccchhhcCCCCCCeEEcccCcCCC-CCCCCcccCCCcCeeeecccccccccc--ccCC-CCccEEEccc
Q 007103 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG-DLPNSFISLSNISSLYLQNNQVTGSLN--VFSG-LPLTTLNVAN 232 (618)
Q Consensus 157 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~-~~L~~L~l~~ 232 (618)
+|+|++|++++..|..|+++++|++|+|++|++++ .+|..+.++++|++|+|++|++.+.++ .+.. .+|+.|+|++
T Consensus 78 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~ 157 (549)
T 2z81_A 78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157 (549)
T ss_dssp EEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred EEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccC
Confidence 99999999999999999999999999999999996 467889999999999999999655443 3443 3599999999
Q ss_pred ccccccCchhhh---cccchhccCCcCC
Q 007103 233 NHFSGWIPRELI---SIRTFIYDGNSFD 257 (618)
Q Consensus 233 N~l~g~ip~~~~---~l~~l~~~~N~~~ 257 (618)
|++++.+|..+. +|+.|++.+|...
T Consensus 158 n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 158 LSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CcccccChhhhhccccCceEecccCccc
Confidence 999999998775 4567778887753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=172.47 Aligned_cols=191 Identities=20% Similarity=0.188 Sum_probs=152.5
Q ss_pred CCCCCCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC---CCcc-EE
Q 007103 70 PCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLT-SL 134 (618)
Q Consensus 70 ~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~~L~-~L 134 (618)
.|.|+|..|.|+. ..++.|+|++|+|+...+..|.+|++|++|+|++|++.+.+|.... ++|+ .+
T Consensus 6 ~C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 6 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp SSEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred ccEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 3777999999974 2578999999999987778999999999999999999888876443 4544 57
Q ss_pred ecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEccc-CcCCCCCCCCcccCC-CcCeeeecccc
Q 007103 135 NLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF-NNFSGDLPNSFISLS-NISSLYLQNNQ 212 (618)
Q Consensus 135 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~-~L~~L~l~~N~ 212 (618)
+++.|+|+...|..|.++++|++|++++|+|++..+..+....++..|++++ |++....+..|..+. .++.|+|++|+
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred cccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence 8888999988899999999999999999999988887888888888999865 567744455666664 68889999999
Q ss_pred ccccccc-cCCCCccEEEcccccccccCch-h---hhcccchhccCCcCCCCC
Q 007103 213 VTGSLNV-FSGLPLTTLNVANNHFSGWIPR-E---LISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 213 l~~~~~~-~~~~~L~~L~l~~N~l~g~ip~-~---~~~l~~l~~~~N~~~~~~ 260 (618)
|+...+. +...+|+.|++++|+.-+.+|. . +.+|+.|++++|.+...+
T Consensus 166 i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp 218 (350)
T 4ay9_X 166 IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 218 (350)
T ss_dssp CCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred ccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccC
Confidence 9876554 4455689999976444346664 2 356778889999887654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=183.78 Aligned_cols=148 Identities=24% Similarity=0.293 Sum_probs=103.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+|++|.|.+..+ +..|++|+.|+|++|.|++.....-.++|+.|+|++|+|++. +.+..|++|+.|+|++
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~ 140 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGN 140 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCS
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCC
Confidence 467777777777776554 777777777777777777533222236777777777777753 4577777777777777
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEccccccccc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGW 238 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ 238 (618)
|+|++. ..|..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++........+|+.|+|++|++++.
T Consensus 141 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 141 NKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp SCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCSEEEECC
T ss_pred CccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCChHHccCCCCCEEEccCCcCcCC
Confidence 777765 567777777777777777776555 777777777777777777653333334577777777777754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-17 Score=157.87 Aligned_cols=154 Identities=14% Similarity=0.205 Sum_probs=126.8
Q ss_pred cccCCCCCCEEEecCCCccCCCC-CCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCC
Q 007103 102 LLSDLLSLRKFDLSGNSIHDTIP-YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180 (618)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~~~~p-~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 180 (618)
....+++|+.|+|++|.|+ .+| ....++|++|+|++|.++. +..+..+++|++|+|++|++++..+..|+.+++|+
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCTTGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred ChhhcCCccEEeccCCCcc-ChHHHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 3467889999999999999 444 2334899999999997763 35899999999999999999998899999999999
Q ss_pred eEEcccCcCCCCCCCCcccCCCcCeeeecccc-ccccccccCCCCccEEEcccccccccCc-hhhhcccchhccCCcCCC
Q 007103 181 TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ-VTGSLNVFSGLPLTTLNVANNHFSGWIP-RELISIRTFIYDGNSFDN 258 (618)
Q Consensus 181 ~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~~~~~l~~l~~~~N~~~~ 258 (618)
+|+|++|++++..|..+..+++|++|+|++|+ ++...+.....+|+.|+|++|++++..+ ..+.+|+.|++.+|++..
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99999999998888999999999999999998 6554333334569999999999996422 456778899999998753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.5e-17 Score=173.86 Aligned_cols=162 Identities=22% Similarity=0.343 Sum_probs=120.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|++++|++++ +| .++++++|++|+|++|++++ +|.. ..+|++|+|++|++++ +| .++++++|++|++++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~-~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL-PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN 204 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC-CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC-cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence 467777788787776 55 57888888888888888875 5543 3588888888888886 55 578888888888888
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCchh
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~ 242 (618)
|++++ +|.. .++|+.|++++|+++ .+|. ++.+++|++|++++|++++.... ..+|+.|++++|++++ +|..
T Consensus 205 N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~l~~~--~~~L~~L~l~~N~l~~-l~~~ 275 (454)
T 1jl5_A 205 NSLKK-LPDL---PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTLPDL--PPSLEALNVRDNYLTD-LPEL 275 (454)
T ss_dssp SCCSS-CCCC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSCCSC--CTTCCEEECCSSCCSC-CCCC
T ss_pred CcCCc-CCCC---cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCccccc--ccccCEEECCCCcccc-cCcc
Confidence 88886 3332 257888888888888 6774 77888888888888888874332 2568888888888885 6776
Q ss_pred hhcccchhccCCcCCCC
Q 007103 243 LISIRTFIYDGNSFDNG 259 (618)
Q Consensus 243 ~~~l~~l~~~~N~~~~~ 259 (618)
+.+++.|++++|.+...
T Consensus 276 ~~~L~~L~ls~N~l~~l 292 (454)
T 1jl5_A 276 PQSLTFLDVSENIFSGL 292 (454)
T ss_dssp CTTCCEEECCSSCCSEE
T ss_pred cCcCCEEECcCCccCcc
Confidence 77788888888877653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=7.8e-17 Score=172.11 Aligned_cols=163 Identities=21% Similarity=0.236 Sum_probs=85.0
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+|++|++++. | .+..+++|++|+|++|+|++. |..-.++|++|+|++|+|++. | ++++++|++|+|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~ 115 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-DLSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDT 115 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCS
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-ccccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCC
Confidence 3556666666666553 2 455666666666666666642 333335666666666666643 2 55566666666666
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCchh
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~ 242 (618)
|++++. | ++.+++|++|+|++|+|++ ++ ++.+++|++|++++|+..+.++.....+|+.|++++|++++.-...
T Consensus 116 N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l~l~~ 189 (457)
T 3bz5_A 116 NKLTKL-D--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQ 189 (457)
T ss_dssp SCCSCC-C--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCCCCTT
T ss_pred CcCCee-c--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccceecccc
Confidence 666653 2 5555666666666666654 22 4455555555555554444333222233555555555555422223
Q ss_pred hhcccchhccCCcCC
Q 007103 243 LISIRTFIYDGNSFD 257 (618)
Q Consensus 243 ~~~l~~l~~~~N~~~ 257 (618)
+.+|+.|.+.+|.+.
T Consensus 190 l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 190 NKLLNRLNCDTNNIT 204 (457)
T ss_dssp CTTCCEEECCSSCCS
T ss_pred CCCCCEEECcCCcCC
Confidence 334444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=164.91 Aligned_cols=147 Identities=20% Similarity=0.225 Sum_probs=101.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|++++|+++.. + .+..+++|+.|+|++|+|++..|..-.++|+.|+|++|++++ +|.. .. ++|++|+|++
T Consensus 41 ~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~ 115 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDN 115 (263)
T ss_dssp TTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCS
T ss_pred CcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChhhccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccC
Confidence 4677788888877653 3 677778888888888888766553333778888888888775 3332 22 7788888888
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEccccccccc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGW 238 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ 238 (618)
|++++. +.+..+++|+.|+|++|+|++ ++ .+..+++|++|+|++|+|++........+|+.|+|++|.+++.
T Consensus 116 N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 116 NELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp SCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence 887764 347777888888888888774 44 5777778888888888877762222234577777777777744
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.2e-17 Score=178.71 Aligned_cols=170 Identities=21% Similarity=0.258 Sum_probs=146.5
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+|++|++... +.+..|++|+.|+|++|.|++..|..-.++|+.|+|++|+|++ +| .+..|++|+.|+|++
T Consensus 43 ~~L~~L~l~~n~i~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~ 118 (605)
T 1m9s_A 43 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEH 118 (605)
T ss_dssp TTCCCCBCTTCCCCCC--TTGGGCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTT
T ss_pred CCCCEEECcCCCCCCC--hHHccCCCCCEEEeeCCCCCCChhhccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecC
Confidence 5788999999999765 3689999999999999999987774555999999999999996 34 799999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCch-
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR- 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~- 241 (618)
|+|++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++.++.....+|+.|+|++|+|++. |.
T Consensus 119 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~~l 193 (605)
T 1m9s_A 119 NGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-RAL 193 (605)
T ss_dssp SCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-GGG
T ss_pred CCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-hHH
Confidence 999974 4589999999999999999964 67899999999999999999988844456799999999999964 42
Q ss_pred -hhhcccchhccCCcCCCCCC
Q 007103 242 -ELISIRTFIYDGNSFDNGPA 261 (618)
Q Consensus 242 -~~~~l~~l~~~~N~~~~~~~ 261 (618)
.+.+|+.|++.+|++...+.
T Consensus 194 ~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 194 AGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp TTCTTCSEEECCSEEEECCCC
T ss_pred ccCCCCCEEEccCCcCcCCcc
Confidence 45678889999999877543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=7.3e-17 Score=151.40 Aligned_cols=123 Identities=24% Similarity=0.408 Sum_probs=78.3
Q ss_pred EEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCC
Q 007103 112 FDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191 (618)
Q Consensus 112 L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 191 (618)
+++++|.|+ .+|..+.++|+.|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++
T Consensus 15 l~~~~~~l~-~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~ 92 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92 (193)
T ss_dssp EECTTSCCS-SCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred EEcCCCCCC-cCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCE
Confidence 334444444 445455556666666666666 566667777777777777777776666677777777777777777776
Q ss_pred CCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEccccccc
Q 007103 192 DLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFS 236 (618)
Q Consensus 192 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~ 236 (618)
..|..|..+++|++|+|++|+|++.++. +.. .+|+.|+|++|.+.
T Consensus 93 i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 6666677777777777777777665443 222 23666666666664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.70 E-value=6e-17 Score=166.88 Aligned_cols=169 Identities=20% Similarity=0.266 Sum_probs=126.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
..++.|++++|.+.+..+ +..+++|+.|+|++|.+++..+....++|+.|++++|++++..+ +..+++|++|+|++
T Consensus 155 ~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~ 230 (347)
T 4fmz_A 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN 230 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred CCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccccccccCCCccceeecccCCCCCCch--hhcCCcCCEEEccC
Confidence 468888888888876554 78888888888888888865554444788888888888886544 77888888888888
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCchh
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~ 242 (618)
|++++..+ +..+++|+.|+|++|.+++ + ..+..+++|++|++++|++++........+|+.|+|++|++++..|..
T Consensus 231 n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 306 (347)
T 4fmz_A 231 NKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEV 306 (347)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHH
T ss_pred CccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcChhH
Confidence 88886554 7788888888888888874 3 357778888888888888887533233345888888888888777765
Q ss_pred h---hcccchhccCCcCCCC
Q 007103 243 L---ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 243 ~---~~l~~l~~~~N~~~~~ 259 (618)
+ .+|+.|++++|++...
T Consensus 307 l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 307 IGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp HHTCTTCSEEECCSSSCCCC
T ss_pred hhccccCCEEEccCCccccc
Confidence 4 4566777888877654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3e-17 Score=150.48 Aligned_cols=130 Identities=22% Similarity=0.257 Sum_probs=73.7
Q ss_pred CEEEEEcCCCCCc-ccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 84 AVVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 84 ~v~~l~l~~~~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
+++.|+|++|+++ +.+|..+..+++|+.|+|++|.|++. ..+. ++|+.|+|++|++++.+|..+.++++|++|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 4666666666665 55566666666666666666666644 2222 55666666666666555555555666666666
Q ss_pred ecCCCCCcc-chhhcCCCCCCeEEcccCcCCCCCC---CCcccCCCcCeeeeccccccc
Q 007103 161 SRNSLTQSI-GDIFGNLAGLATLDLSFNNFSGDLP---NSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 161 ~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l~~L~~L~l~~N~l~~ 215 (618)
++|++++.. +..+..+++|+.|+|++|.+++..+ ..+..+++|++|++++|.+..
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 666665432 2455555666666666666653222 245555555555555555543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.9e-17 Score=152.57 Aligned_cols=125 Identities=26% Similarity=0.269 Sum_probs=109.9
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCC
Q 007103 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (618)
Q Consensus 87 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (618)
.+++++|+|+. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 45667777764 455443 68999999999998 6776665 899999999999998888899999999999999999
Q ss_pred CCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc
Q 007103 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999999999999999999999999996666679999999999999999975
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.7e-17 Score=149.20 Aligned_cols=134 Identities=22% Similarity=0.187 Sum_probs=112.5
Q ss_pred CCCCCCEEEecCCCcc-CCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCe
Q 007103 105 DLLSLRKFDLSGNSIH-DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181 (618)
Q Consensus 105 ~l~~L~~L~L~~N~l~-~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 181 (618)
..++|+.|+|++|.++ +.+|..+. ++|+.|+|++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 4578999999999998 77887654 8999999999999966 78889999999999999999888888888999999
Q ss_pred EEcccCcCCCCC-CCCcccCCCcCeeeecccccccccc----ccCC-CCccEEEcccccccccCch
Q 007103 182 LDLSFNNFSGDL-PNSFISLSNISSLYLQNNQVTGSLN----VFSG-LPLTTLNVANNHFSGWIPR 241 (618)
Q Consensus 182 L~ls~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~-~~L~~L~l~~N~l~g~ip~ 241 (618)
|+|++|+|++.. +..+..+++|++|+|++|++++.++ .+.. .+|+.|++++|.+. .+|+
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 999999998532 2678899999999999999998766 3443 45999999999887 5554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.70 E-value=9e-17 Score=172.57 Aligned_cols=169 Identities=24% Similarity=0.337 Sum_probs=134.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
..++.|++++|.+.+. +.+..+++|++|+|++|.+++..|....++|+.|+|++|++++. ..+..+++|++|+|++
T Consensus 177 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~ 252 (466)
T 1o6v_A 177 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 252 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCC
Confidence 4678888888888764 34788888999999999888877755568899999999988854 4678888999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-h
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~ 241 (618)
|++++..+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|++++..+.....+|+.|+|++|++++..| .
T Consensus 253 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 328 (466)
T 1o6v_A 253 NQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS 328 (466)
T ss_dssp SCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGG
T ss_pred Cccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchhhc
Confidence 99887765 7888889999999998885443 78888899999999988887664444568899999999887665 3
Q ss_pred hhhcccchhccCCcCCCC
Q 007103 242 ELISIRTFIYDGNSFDNG 259 (618)
Q Consensus 242 ~~~~l~~l~~~~N~~~~~ 259 (618)
.+.+|+.|++.+|++...
T Consensus 329 ~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 329 SLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp GCTTCCEEECCSSCCCCC
T ss_pred cCccCCEeECCCCccCCc
Confidence 456777888888887654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-16 Score=148.12 Aligned_cols=131 Identities=20% Similarity=0.261 Sum_probs=117.6
Q ss_pred CCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCc
Q 007103 109 LRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (618)
Q Consensus 109 L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 188 (618)
.+.+++++|+++ .+|..+.++|+.|+|++|++++..+..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCEEEecCCCCc-cCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 578999999998 6788888999999999999998777788999999999999999998888889999999999999999
Q ss_pred CCCCCCCCcccCCCcCeeeecccccccccccc-C-CCCccEEEcccccccccCc
Q 007103 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNVF-S-GLPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~L~~L~l~~N~l~g~ip 240 (618)
|++..+..|..+++|++|+|++|+|++.++.. . ..+|+.|+|++|++++..|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99777777899999999999999999877653 3 3469999999999998766
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-16 Score=169.55 Aligned_cols=164 Identities=20% Similarity=0.238 Sum_probs=132.7
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+|++|.+++. + ++++++|++|+|++|++++ +|..-.++|+.|+|++|++++. + ++.+++|++|++++
T Consensus 85 ~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~ 157 (457)
T 3bz5_A 85 TNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LDVSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHL 157 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CCCTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTT
T ss_pred CCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ecCCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCC
Confidence 5799999999999985 3 8999999999999999997 5655558999999999999974 3 88899999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-h
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~ 241 (618)
|+..+.+ .++.+++|+.|+|++|+|++ +| +..+++|+.|++++|+|++. +.....+|+.|+|++|++++ +| .
T Consensus 158 n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip~~ 230 (457)
T 3bz5_A 158 NKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-IDVT 230 (457)
T ss_dssp CSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CCCT
T ss_pred CCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cCcc
Confidence 9766666 47788899999999999985 55 77888889999999988875 33333568888888888887 45 4
Q ss_pred hhhcccchhccCCcCCCCC
Q 007103 242 ELISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 242 ~~~~l~~l~~~~N~~~~~~ 260 (618)
.+.+|+.|++++|.+...+
T Consensus 231 ~l~~L~~L~l~~N~l~~~~ 249 (457)
T 3bz5_A 231 PLTQLTYFDCSVNPLTELD 249 (457)
T ss_dssp TCTTCSEEECCSSCCSCCC
T ss_pred ccCCCCEEEeeCCcCCCcC
Confidence 4567778888888877643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=164.74 Aligned_cols=167 Identities=23% Similarity=0.332 Sum_probs=99.8
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|++++|.....++. +..+++|++|++++|.+.+..+..-.++|+.|++++|++++..+ +..+++|+.|++++
T Consensus 132 ~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~ 208 (347)
T 4fmz_A 132 TKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV 208 (347)
T ss_dssp TTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred CceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchhhccCCCCCEEEccCCccccccc--ccCCCccceeeccc
Confidence 3566666666654443333 66666677777777666655443333667777777776664322 66666677777777
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc--
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-- 240 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-- 240 (618)
|.+++..+ +..+++|+.|+|++|++++ ++. +..+++|++|++++|.+++........+|+.|++++|++++. |
T Consensus 209 n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~~~ 283 (347)
T 4fmz_A 209 NQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI-SVL 283 (347)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-GGG
T ss_pred CCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC-hhh
Confidence 76665544 5666667777777776663 332 666666777777777666542222233466777777766643 3
Q ss_pred hhhhcccchhccCCcCC
Q 007103 241 RELISIRTFIYDGNSFD 257 (618)
Q Consensus 241 ~~~~~l~~l~~~~N~~~ 257 (618)
..+.+|+.|++++|++.
T Consensus 284 ~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 284 NNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp GGCTTCSEEECCSSCCC
T ss_pred cCCCCCCEEECcCCcCC
Confidence 23355566666666654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-18 Score=182.50 Aligned_cols=178 Identities=19% Similarity=0.237 Sum_probs=141.8
Q ss_pred CCCEEEEEcCCCCCcc----cccccccCCCCCCEEEecCCCccCCCCCCCC---------------CCccEEeccccccc
Q 007103 82 GSAVVSIDISGLGLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---------------PNLTSLNLASNNFS 142 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---------------~~L~~L~L~~N~l~ 142 (618)
..+++.|+|++|.+.+ .++..+..+++|++|+|++|.|++..+..+. ++|++|+|++|+++
T Consensus 93 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~ 172 (386)
T 2ca6_A 93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172 (386)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence 3678899999999987 5778888999999999999998744333332 68999999999998
Q ss_pred -ccCC---ccccCCCCccEEEeecCCCC--C---ccchhhcCCCCCCeEEcccCcCC----CCCCCCcccCCCcCeeeec
Q 007103 143 -GNLP---YSIASMVSLSYLNVSRNSLT--Q---SIGDIFGNLAGLATLDLSFNNFS----GDLPNSFISLSNISSLYLQ 209 (618)
Q Consensus 143 -~~~p---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----g~~p~~~~~l~~L~~L~l~ 209 (618)
+.+| ..+..+++|++|+|++|+++ | ..|..+..+++|+.|+|++|.|+ +.+|..+..+++|++|+|+
T Consensus 173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~ 252 (386)
T 2ca6_A 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252 (386)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence 4455 46778899999999999998 3 34557888999999999999996 5778888899999999999
Q ss_pred ccccccc----ccc-c---CCCCccEEEcccccccc----cCchhh----hcccchhccCCcCCCC
Q 007103 210 NNQVTGS----LNV-F---SGLPLTTLNVANNHFSG----WIPREL----ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 210 ~N~l~~~----~~~-~---~~~~L~~L~l~~N~l~g----~ip~~~----~~l~~l~~~~N~~~~~ 259 (618)
+|.|++. ++. + ...+|+.|+|++|.+++ .+|..+ .+|+.|++.+|++...
T Consensus 253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 9999874 222 2 24569999999999997 488655 6778888999888753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=157.84 Aligned_cols=167 Identities=22% Similarity=0.269 Sum_probs=133.4
Q ss_pred EEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCC
Q 007103 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (618)
Q Consensus 85 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (618)
++.++++++++++.. .+..+++|+.|+|++|.|+........++|+.|+|++|+|++..| +.++++|++|+|++|+
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~ 96 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNR 96 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSC
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccchHHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCc
Confidence 455677888887654 688999999999999999853322233899999999999996544 9999999999999999
Q ss_pred CCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-hhh
Q 007103 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-REL 243 (618)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~~~ 243 (618)
+++. |. +.. ++|+.|+|++|+|++ ++ .+..+++|++|+|++|+|++........+|+.|+|++|++++.-. ..+
T Consensus 97 l~~l-~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~~~l~~l 171 (263)
T 1xeu_A 97 LKNL-NG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNTGGLTRL 171 (263)
T ss_dssp CSCC-TT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBCTTSTTC
T ss_pred cCCc-Cc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcchHHhccC
Confidence 9974 33 233 899999999999995 44 588999999999999999987543444569999999999997611 245
Q ss_pred hcccchhccCCcCCCCC
Q 007103 244 ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 244 ~~l~~l~~~~N~~~~~~ 260 (618)
.+|+.|++.+|++.+.+
T Consensus 172 ~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 172 KKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp CCCCEEEEEEEEEECCC
T ss_pred CCCCEEeCCCCcccCCc
Confidence 67788899999998764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.3e-17 Score=176.09 Aligned_cols=160 Identities=22% Similarity=0.256 Sum_probs=91.3
Q ss_pred CEEEEEcCCCCCcccccccccCCCCC-------------CEEEecCCCccCCCCCCCCCCccEEecccccccccCCcccc
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSL-------------RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L-------------~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~ 150 (618)
+++.|++++|++.|.+|..++++++| ++|++++|.+++ +|. +.++|+.|+|++|++++ +|..
T Consensus 35 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~-~~~~L~~L~l~~n~l~~-lp~~-- 109 (454)
T 1jl5_A 35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE-LPPHLESLVASCNSLTE-LPEL-- 109 (454)
T ss_dssp CHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS-CCTTCSEEECCSSCCSS-CCCC--
T ss_pred chhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC-CcCCCCEEEccCCcCCc-cccc--
Confidence 44445555555555555555555443 555555555553 222 33567777777777775 5543
Q ss_pred CCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEc
Q 007103 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNV 230 (618)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l 230 (618)
+++|++|++++|++++. |.. .++|++|+|++|++++ +| .|+.+++|++|++++|++++.+... .+|+.|++
T Consensus 110 -~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~--~~L~~L~L 180 (454)
T 1jl5_A 110 -PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP--PSLEFIAA 180 (454)
T ss_dssp -CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC--TTCCEEEC
T ss_pred -cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc--ccccEEEC
Confidence 25566666666666542 111 1567777777777774 66 4777777777777777777632211 25667777
Q ss_pred ccccccccCch--hhhcccchhccCCcCCC
Q 007103 231 ANNHFSGWIPR--ELISIRTFIYDGNSFDN 258 (618)
Q Consensus 231 ~~N~l~g~ip~--~~~~l~~l~~~~N~~~~ 258 (618)
++|++++ +|. .+.+|+.|++++|.+..
T Consensus 181 ~~n~l~~-l~~~~~l~~L~~L~l~~N~l~~ 209 (454)
T 1jl5_A 181 GNNQLEE-LPELQNLPFLTAIYADNNSLKK 209 (454)
T ss_dssp CSSCCSS-CCCCTTCTTCCEEECCSSCCSS
T ss_pred cCCcCCc-CccccCCCCCCEEECCCCcCCc
Confidence 7776665 442 23445555666666554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.8e-17 Score=146.57 Aligned_cols=126 Identities=20% Similarity=0.177 Sum_probs=81.6
Q ss_pred CEEEEEcCCCCCc-ccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 84 AVVSIDISGLGLS-GTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 84 ~v~~l~l~~~~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
+++.|++++|+++ +.+|..+..+++|+.|+|++|.+++.....-.++|+.|+|++|++++.+|..+..+++|++|+|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~ 97 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCCTTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTT
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCchhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCC
Confidence 5667777777776 666666777777777777777777551111126677777777777766666666677777777777
Q ss_pred CCCCCc-cchhhcCCCCCCeEEcccCcCCCCCC---CCcccCCCcCeeeec
Q 007103 163 NSLTQS-IGDIFGNLAGLATLDLSFNNFSGDLP---NSFISLSNISSLYLQ 209 (618)
Q Consensus 163 N~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l~~L~~L~l~ 209 (618)
|++++. .+..++.+++|+.|++++|.+++..+ ..+..+++|++|+++
T Consensus 98 N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 98 NKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp SCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 777653 34666667777777777777764333 356666666666665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-17 Score=169.81 Aligned_cols=140 Identities=14% Similarity=0.160 Sum_probs=98.7
Q ss_pred CCcccceeccCccceEEEEEEcCCcEEEEEEcCccccc------------HHHHHHH--------HHHHHHhhcCCCCcc
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS------------LQEEDNF--------LEAVSNMSRLRHPNI 470 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------~~~~~~~--------~~e~~~l~~l~h~ni 470 (618)
-|.+...||+|++|.||+|...+|+.||||+++..... ....... .+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38899999999999999999999999999987543211 0001111 234444555533333
Q ss_pred cccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC
Q 007103 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD 550 (618)
Q Consensus 471 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~ 550 (618)
.-..-+.. ...++||||+++++|.++.. . .....++.|++.+|.|||+. |||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 21111111 12379999999988876542 1 12356889999999999998 9999999999999987
Q ss_pred CCC----------cEEeeccccccC
Q 007103 551 ELN----------PHLSDCGLAALT 565 (618)
Q Consensus 551 ~~~----------~kl~Dfgl~~~~ 565 (618)
++. +.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 763 889999987544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=175.84 Aligned_cols=176 Identities=22% Similarity=0.351 Sum_probs=119.4
Q ss_pred CCCCCCCCCCCCCCCCCcee--------EeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCC
Q 007103 59 VLTNWKGNEGDPCGESWKGV--------ACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPN 130 (618)
Q Consensus 59 ~~~~w~~~~~~~c~~~w~gv--------~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~ 130 (618)
.+.+|... .++| .|+|. .|...+++.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|. ..++
T Consensus 11 ~w~~W~~~-~~~~--~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~-~l~~ 82 (622)
T 3g06_A 11 VWSAWRRA-APAE--ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-LPPE 82 (622)
T ss_dssp HHHHHHHT-CCGG--GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC-CCTT
T ss_pred HHHHHHhc-CCcc--hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC-cCCC
Confidence 34556532 3444 68653 344457889999999998 5666665 78999999999998 5665 5689
Q ss_pred ccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecc
Q 007103 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210 (618)
Q Consensus 131 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~ 210 (618)
|++|+|++|+|+ .+|. .+++|++|+|++|+|++..+ .+++|+.|+|++|+|+ .+|.. +++|++|+|++
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~ 150 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSD 150 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCS
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCC-cCCCC---CCCCCEEECcC
Confidence 999999999988 4665 67889999999999886433 4677888888888888 46654 36788888888
Q ss_pred ccccccccccCCCCccEEEcccccccccCchhhhcccchhccCCcCC
Q 007103 211 NQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257 (618)
Q Consensus 211 N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~~N~~~ 257 (618)
|+|++.... ..+|+.|+|++|.|++ +|..+.+|+.|++++|.+.
T Consensus 151 N~l~~l~~~--~~~L~~L~L~~N~l~~-l~~~~~~L~~L~Ls~N~l~ 194 (622)
T 3g06_A 151 NQLASLPAL--PSELCKLWAYNNQLTS-LPMLPSGLQELSVSDNQLA 194 (622)
T ss_dssp SCCSCCCCC--CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred CcCCCcCCc--cCCCCEEECCCCCCCC-CcccCCCCcEEECCCCCCC
Confidence 887764321 1235555555555552 4444444455555555444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=142.43 Aligned_cols=126 Identities=20% Similarity=0.182 Sum_probs=97.4
Q ss_pred CCCCCCEEEecCCCcc-CCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCe
Q 007103 105 DLLSLRKFDLSGNSIH-DTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLAT 181 (618)
Q Consensus 105 ~l~~L~~L~L~~N~l~-~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 181 (618)
..++|+.|+|++|.++ +.+|..+. ++|+.|+|++|++++. ..+..+++|++|+|++|++++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3467888889988888 77776554 7888888888888866 77888888888888888888878888888888888
Q ss_pred EEcccCcCCCC-CCCCcccCCCcCeeeecccccccccc----ccC-CCCccEEEccc
Q 007103 182 LDLSFNNFSGD-LPNSFISLSNISSLYLQNNQVTGSLN----VFS-GLPLTTLNVAN 232 (618)
Q Consensus 182 L~ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~-~~~L~~L~l~~ 232 (618)
|+|++|++++. .+..+..+++|++|++++|++++..+ .+. ..+|+.||+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 88888888852 34778888888888888888887654 222 24577777653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-18 Score=185.42 Aligned_cols=151 Identities=18% Similarity=0.183 Sum_probs=101.7
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCC-------------ccCCCCCCCC----------------------
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-------------IHDTIPYQLP---------------------- 128 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~-------------l~~~~p~~~~---------------------- 128 (618)
+++.|+|++|+|. .+|..+++|++|+.|++++|. +.+.+|..+.
T Consensus 350 ~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l 428 (567)
T 1dce_A 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428 (567)
T ss_dssp TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHH
T ss_pred cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhh
Confidence 4556788888885 678889999999999987764 3444442211
Q ss_pred ------------CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCC
Q 007103 129 ------------PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196 (618)
Q Consensus 129 ------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 196 (618)
..|+.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .
T Consensus 429 ~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~ 503 (567)
T 1dce_A 429 FLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-G 503 (567)
T ss_dssp HHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred hhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-c
Confidence 246667777777774 454 777777777777777777 566677777777777777777774 56 6
Q ss_pred cccCCCcCeeeeccccccccc--cccCC-CCccEEEcccccccccCc
Q 007103 197 FISLSNISSLYLQNNQVTGSL--NVFSG-LPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 197 ~~~l~~L~~L~l~~N~l~~~~--~~~~~-~~L~~L~l~~N~l~g~ip 240 (618)
++.+++|++|+|++|+|++.+ ..+.. .+|+.|+|++|+|++..|
T Consensus 504 l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 504 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred cCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 677777777777777777653 33333 347777777777775544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.5e-17 Score=184.52 Aligned_cols=154 Identities=23% Similarity=0.168 Sum_probs=121.1
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCC
Q 007103 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165 (618)
Q Consensus 88 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 165 (618)
+++..|.+. ..+..+..++.|+.|+|++|.|. .+|..+. ++|++|+|++|+|+ .+|..|++|++|++|+|++|+|
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 333334333 45778999999999999999999 6776665 89999999999999 8999999999999999999999
Q ss_pred CCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCC-C--CccEEEcccccccccCchh
Q 007103 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSG-L--PLTTLNVANNHFSGWIPRE 242 (618)
Q Consensus 166 ~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~--~L~~L~l~~N~l~g~ip~~ 242 (618)
+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|+|++.++.... . .+..|+|++|.++|.+|..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 9 77999999999999999999998 8999999999999999999999997765332 2 2345889999999999987
Q ss_pred hhcc
Q 007103 243 LISI 246 (618)
Q Consensus 243 ~~~l 246 (618)
+..+
T Consensus 361 l~~l 364 (727)
T 4b8c_D 361 RRFI 364 (727)
T ss_dssp ----
T ss_pred ccee
Confidence 6654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=140.50 Aligned_cols=107 Identities=24% Similarity=0.356 Sum_probs=87.6
Q ss_pred CEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcC
Q 007103 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (618)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 189 (618)
+.|++++|.|+ .+|..+.++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CEEEeCCCCcC-ccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 34555556665 46666678888888888888888888899999999999999999988888889999999999999999
Q ss_pred CCCCCCCcccCCCcCeeeeccccccccc
Q 007103 190 SGDLPNSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
++..+..|..+++|++|+|++|+++...
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9766667888889988888888887543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.1e-17 Score=170.08 Aligned_cols=176 Identities=22% Similarity=0.279 Sum_probs=124.0
Q ss_pred CCEEEEEcCCCCCccccc----ccccCCC-CCCEEEecCCCccCCCCCCC-------CCCccEEecccccccccCCcccc
Q 007103 83 SAVVSIDISGLGLSGTMG----YLLSDLL-SLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIA 150 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~----~~l~~l~-~L~~L~L~~N~l~~~~p~~~-------~~~L~~L~L~~N~l~~~~p~~~~ 150 (618)
..++.|||++|.+++..+ ..|..++ +|++|+|++|.|++..+..+ .++|++|+|++|++++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 458888888888887766 6777787 78888888888886655333 26788888888888876666444
Q ss_pred C----C-CCccEEEeecCCCCCccchhhc----C-CCCCCeEEcccCcCCCCCCC----CcccCC-CcCeeeeccccccc
Q 007103 151 S----M-VSLSYLNVSRNSLTQSIGDIFG----N-LAGLATLDLSFNNFSGDLPN----SFISLS-NISSLYLQNNQVTG 215 (618)
Q Consensus 151 ~----l-~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~ls~N~l~g~~p~----~~~~l~-~L~~L~l~~N~l~~ 215 (618)
. + ++|++|+|++|+|++..+..+. . .++|++|+|++|+|++..+. .+..++ +|++|+|++|+|++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 3 3 7888888888888876665543 3 25888888888888854333 334444 88888888888876
Q ss_pred ccc-----ccCC--CCccEEEccccccccc----Cchhh----hcccchhccCCcCCC
Q 007103 216 SLN-----VFSG--LPLTTLNVANNHFSGW----IPREL----ISIRTFIYDGNSFDN 258 (618)
Q Consensus 216 ~~~-----~~~~--~~L~~L~l~~N~l~g~----ip~~~----~~l~~l~~~~N~~~~ 258 (618)
..+ .+.. .+|+.|||++|.|++. ++..+ .+|+.|++++|.+..
T Consensus 182 ~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 239 (362)
T 3goz_A 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239 (362)
T ss_dssp SCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred hhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence 543 1111 3688888888888762 44444 357788888887665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.4e-15 Score=165.67 Aligned_cols=35 Identities=20% Similarity=0.349 Sum_probs=23.6
Q ss_pred CccEEEcccccccccCchhhhcccchhccCCcCCCC
Q 007103 224 PLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNG 259 (618)
Q Consensus 224 ~L~~L~l~~N~l~g~ip~~~~~l~~l~~~~N~~~~~ 259 (618)
+|+.|+|++|+|++ +|..+.+|+.|++++|.+...
T Consensus 222 ~L~~L~Ls~N~L~~-lp~~l~~L~~L~Ls~N~L~~l 256 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LPVLPSELKELMVSGNRLTSL 256 (622)
T ss_dssp TCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCC
T ss_pred CCCEEEccCCccCc-CCCCCCcCcEEECCCCCCCcC
Confidence 46777777777774 666666777777777766643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-17 Score=170.25 Aligned_cols=170 Identities=16% Similarity=0.227 Sum_probs=81.0
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCC-CCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT-IPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
+++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+. ++|++|+|++|++++..|..++.+++|++|+|
T Consensus 71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 445555555555544333 33455555555555555433 332222 45555555555555555555555555555555
Q ss_pred ecC-CCCCc-cchhhcCCCCCCeEEcccC-cCCCC-CCCCcccCC-CcCeeeeccc--ccc-ccccc-c-CCCCccEEEc
Q 007103 161 SRN-SLTQS-IGDIFGNLAGLATLDLSFN-NFSGD-LPNSFISLS-NISSLYLQNN--QVT-GSLNV-F-SGLPLTTLNV 230 (618)
Q Consensus 161 ~~N-~l~~~-~p~~~~~l~~L~~L~ls~N-~l~g~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~~~-~-~~~~L~~L~l 230 (618)
++| .+++. ++..+..+++|+.|+|++| ++++. ++..+..++ +|++|+|++| .++ +.++. + ...+|+.|+|
T Consensus 150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l 229 (336)
T 2ast_B 150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 229 (336)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeC
Confidence 555 44432 4444555555555555555 55432 344444555 5555555555 233 11111 1 1233555555
Q ss_pred cccc-ccccCchhh---hcccchhccCC
Q 007103 231 ANNH-FSGWIPREL---ISIRTFIYDGN 254 (618)
Q Consensus 231 ~~N~-l~g~ip~~~---~~l~~l~~~~N 254 (618)
++|. +++..+..+ .+|+.|++.+|
T Consensus 230 ~~~~~l~~~~~~~l~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 230 SDSVMLKNDCFQEFFQLNYLQHLSLSRC 257 (336)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred CCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence 5555 444444333 23344444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.61 E-value=8e-17 Score=167.02 Aligned_cols=172 Identities=22% Similarity=0.259 Sum_probs=140.4
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCC----CCCC--C-CccEEecccccccccCCccccCC-----CC
Q 007103 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIP----YQLP--P-NLTSLNLASNNFSGNLPYSIASM-----VS 154 (618)
Q Consensus 87 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p----~~~~--~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 154 (618)
..+|+.|+++|.+|..+...++|++|+|++|.|++..+ ..+. + +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46889999999999999888899999999999997665 2222 4 89999999999998888888775 99
Q ss_pred ccEEEeecCCCCCccchhhcC----C-CCCCeEEcccCcCCCCCCCCccc-----CCCcCeeeecccccccccc-----c
Q 007103 155 LSYLNVSRNSLTQSIGDIFGN----L-AGLATLDLSFNNFSGDLPNSFIS-----LSNISSLYLQNNQVTGSLN-----V 219 (618)
Q Consensus 155 L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~ls~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~~~~~-----~ 219 (618)
|++|+|++|++++..+..+.. + ++|+.|+|++|+|++..+..+.. .++|++|+|++|+|++... .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999887775444 4 89999999999999766655443 3699999999999996321 1
Q ss_pred cC-C-CCccEEEcccccccccCchhh--------hcccchhccCCcCCC
Q 007103 220 FS-G-LPLTTLNVANNHFSGWIPREL--------ISIRTFIYDGNSFDN 258 (618)
Q Consensus 220 ~~-~-~~L~~L~l~~N~l~g~ip~~~--------~~l~~l~~~~N~~~~ 258 (618)
+. . .+|+.|+|++|++++..+..+ .+|+.|++++|.+..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 11 2 379999999999998777543 378889999998764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=138.68 Aligned_cols=107 Identities=23% Similarity=0.317 Sum_probs=86.0
Q ss_pred CEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcC
Q 007103 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (618)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 189 (618)
+.+++++|+++ .+|..+.++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l 93 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL 93 (174)
T ss_dssp SEEECCSSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cEEEeCCCCCC-ccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence 34566666664 56766778888888888888888888889999999999999999987777788899999999999999
Q ss_pred CCCCCCCcccCCCcCeeeeccccccccc
Q 007103 190 SGDLPNSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 190 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
++..+..|..+++|++|+|++|++....
T Consensus 94 ~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 94 KSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9655556888888888888888887543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.6e-17 Score=169.78 Aligned_cols=176 Identities=21% Similarity=0.217 Sum_probs=100.9
Q ss_pred CCEEEEEcCCC---CCcccccccc-------cCCCCCCEEEecCCCccC----CCCCCCC--CCccEEecccccccccCC
Q 007103 83 SAVVSIDISGL---GLSGTMGYLL-------SDLLSLRKFDLSGNSIHD----TIPYQLP--PNLTSLNLASNNFSGNLP 146 (618)
Q Consensus 83 ~~v~~l~l~~~---~l~~~~~~~l-------~~l~~L~~L~L~~N~l~~----~~p~~~~--~~L~~L~L~~N~l~~~~p 146 (618)
.+++.|+|++| ++.+.+|..+ ..+++|++|+|++|.|++ .+|..+. ++|+.|+|++|+|++..+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 45666666664 3444444443 566667777777776665 2333332 567777777776654333
Q ss_pred cccc----CC---------CCccEEEeecCCCC-Cccc---hhhcCCCCCCeEEcccCcCC--C---CCCCCcccCCCcC
Q 007103 147 YSIA----SM---------VSLSYLNVSRNSLT-QSIG---DIFGNLAGLATLDLSFNNFS--G---DLPNSFISLSNIS 204 (618)
Q Consensus 147 ~~~~----~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~ls~N~l~--g---~~p~~~~~l~~L~ 204 (618)
..+. .+ ++|++|+|++|+++ +.++ ..+..+++|+.|+|++|+|+ | .+|..+..+++|+
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence 3332 23 66777777777766 3344 35556667777777777666 2 3344566666777
Q ss_pred eeeecccccc----ccccc-c-CCCCccEEEccccccccc----Cchh-----hhcccchhccCCcCCC
Q 007103 205 SLYLQNNQVT----GSLNV-F-SGLPLTTLNVANNHFSGW----IPRE-----LISIRTFIYDGNSFDN 258 (618)
Q Consensus 205 ~L~l~~N~l~----~~~~~-~-~~~~L~~L~l~~N~l~g~----ip~~-----~~~l~~l~~~~N~~~~ 258 (618)
+|+|++|.|+ +.++. + ...+|+.|+|++|.|++. +|.. +.+|+.|++++|.+..
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 7777777765 22222 2 223477777777777654 4443 3446666666666554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.8e-17 Score=168.50 Aligned_cols=180 Identities=17% Similarity=0.198 Sum_probs=147.7
Q ss_pred CCceeEeeCCCEEEEEcCCCCCcccccccccCC--CCCCEEEecCCCccCCCCCCCC-CCccEEeccccccccc-CCccc
Q 007103 74 SWKGVACEGSAVVSIDISGLGLSGTMGYLLSDL--LSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGN-LPYSI 149 (618)
Q Consensus 74 ~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~p~~~~-~~L~~L~L~~N~l~~~-~p~~~ 149 (618)
.|.++.|+...++.|+++++++. +..+..+ ++|+.|++++|.+++..+..+. ++|+.|+|++|++++. +|..+
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~ 114 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGIL 114 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHH
Confidence 68888887777889999999886 4667777 8999999999999987776444 8999999999999876 88888
Q ss_pred cCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccC-cCCCC-CCCCcccCCCcCeeeeccc-ccccc-ccc-c-CCC
Q 007103 150 ASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFN-NFSGD-LPNSFISLSNISSLYLQNN-QVTGS-LNV-F-SGL 223 (618)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~g~-~p~~~~~l~~L~~L~l~~N-~l~~~-~~~-~-~~~ 223 (618)
..+++|++|+|++|++++..+..++.+++|++|+|++| .+++. ++..+..+++|++|+|++| .+++. ++. + ...
T Consensus 115 ~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~ 194 (336)
T 2ast_B 115 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 194 (336)
T ss_dssp TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSC
T ss_pred hhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcc
Confidence 99999999999999999888999999999999999999 68753 6777888999999999999 88863 222 2 234
Q ss_pred -CccEEEcccc--ccc-ccCchh---hhcccchhccCCcC
Q 007103 224 -PLTTLNVANN--HFS-GWIPRE---LISIRTFIYDGNSF 256 (618)
Q Consensus 224 -~L~~L~l~~N--~l~-g~ip~~---~~~l~~l~~~~N~~ 256 (618)
+|+.|+|++| .++ +.+|.. +.+|+.|++++|..
T Consensus 195 ~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 195 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred cCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 7999999999 565 456654 46778888998883
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=7.1e-16 Score=142.47 Aligned_cols=131 Identities=18% Similarity=0.219 Sum_probs=81.1
Q ss_pred cccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCC
Q 007103 102 LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (618)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (618)
.+.++.+|+.|+|++|+++. +|.... ++|+.|+|++|+|++. ..+..+++|++|+|++|+|++..+..|..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 34556666666666666663 332111 3677777777776654 566667777777777777775544555667777
Q ss_pred CeEEcccCcCCCCCCC--CcccCCCcCeeeeccccccccccc----c-CCCCccEEEccccccc
Q 007103 180 ATLDLSFNNFSGDLPN--SFISLSNISSLYLQNNQVTGSLNV----F-SGLPLTTLNVANNHFS 236 (618)
Q Consensus 180 ~~L~ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~~----~-~~~~L~~L~l~~N~l~ 236 (618)
++|+|++|+|+ .+|. .+..+++|++|+|++|.++..... + ...+|+.||+++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777775 4554 566677777777777777654331 2 2234677777777665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.58 E-value=3.1e-15 Score=138.12 Aligned_cols=129 Identities=19% Similarity=0.224 Sum_probs=109.6
Q ss_pred CCEEEEEcCCCCCcccccccccCCC-CCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLL-SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
..++.|+|++|+++.. +. +..+. +|++|+|++|.|++.....-.++|+.|+|++|+|++..+..+..+++|++|+|+
T Consensus 19 ~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 96 (176)
T 1a9n_A 19 VRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96 (176)
T ss_dssp TSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcccccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence 4789999999999864 44 55555 999999999999976222223899999999999996655556999999999999
Q ss_pred cCCCCCccch--hhcCCCCCCeEEcccCcCCCCCCCC----cccCCCcCeeeeccccccc
Q 007103 162 RNSLTQSIGD--IFGNLAGLATLDLSFNNFSGDLPNS----FISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 162 ~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~----~~~l~~L~~L~l~~N~l~~ 215 (618)
+|+|+. +|. .+..+++|+.|+|++|.++ .+|.. +..+++|++|++++|.+..
T Consensus 97 ~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 97 NNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp SCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 999974 555 8999999999999999999 67775 8899999999999999875
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.6e-17 Score=155.33 Aligned_cols=128 Identities=25% Similarity=0.290 Sum_probs=79.2
Q ss_pred EEEEEcCCCCCcccccc------cccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCcc
Q 007103 85 VVSIDISGLGLSGTMGY------LLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLS 156 (618)
Q Consensus 85 v~~l~l~~~~l~~~~~~------~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (618)
++.++++.+.+.|.+|. .+..+++|++|+|++|.|++ +| .+. ++|+.|+|++|+++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 44444555555555544 67777777777777777765 44 333 66777777777766 5566666666777
Q ss_pred EEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCC-CCcccCCCcCeeeeccccccccc
Q 007103 157 YLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLP-NSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 157 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
+|+|++|++++ +| .+..+++|+.|+|++|+|++..+ ..+..+++|++|++++|++++.+
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 77777777665 33 46666667777777776663211 24566666666666666666543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=132.37 Aligned_cols=102 Identities=23% Similarity=0.240 Sum_probs=90.6
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCC
Q 007103 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (618)
Q Consensus 87 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (618)
.|++++|+|+. +|..+ .++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 56777788875 55555 38999999999999988887775 899999999999998877788999999999999999
Q ss_pred CCCccchhhcCCCCCCeEEcccCcCCC
Q 007103 165 LTQSIGDIFGNLAGLATLDLSFNNFSG 191 (618)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~ls~N~l~g 191 (618)
|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 999888889999999999999999984
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=9e-17 Score=151.57 Aligned_cols=134 Identities=24% Similarity=0.314 Sum_probs=116.6
Q ss_pred ccCCCCCCEEEecCCCccCCCCC------CCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhc
Q 007103 103 LSDLLSLRKFDLSGNSIHDTIPY------QLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFG 174 (618)
Q Consensus 103 l~~l~~L~~L~L~~N~l~~~~p~------~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 174 (618)
+.....++.++|+.|.++|.+|. .+. ++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 56678899999999999999886 444 899999999999996 67 9999999999999999999 5788888
Q ss_pred CCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccccccc--ccCC-CCccEEEcccccccccCch
Q 007103 175 NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN--VFSG-LPLTTLNVANNHFSGWIPR 241 (618)
Q Consensus 175 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~-~~L~~L~l~~N~l~g~ip~ 241 (618)
.+++|+.|+|++|+|++ +| .+..+++|++|+|++|+|++... .+.. .+|+.|++++|++++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 88999999999999995 66 68899999999999999997443 3433 4699999999999988765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.8e-14 Score=155.99 Aligned_cols=118 Identities=22% Similarity=0.273 Sum_probs=103.7
Q ss_pred CCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcc
Q 007103 108 SLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLS 185 (618)
Q Consensus 108 ~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 185 (618)
.|+.|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++ +| .|+.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 57889999999996 565 54 89999999999999 889999999999999999999998 56 89999999999999
Q ss_pred cCcCCCCC-CCCcccCCCcCeeeeccccccccccccC-----CCCccEEEc
Q 007103 186 FNNFSGDL-PNSFISLSNISSLYLQNNQVTGSLNVFS-----GLPLTTLNV 230 (618)
Q Consensus 186 ~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~~L~~L~l 230 (618)
+|+|++.. |..|+.+++|+.|+|++|+|++.++... ..+|+.|+|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999876 9999999999999999999999876432 235777764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.50 E-value=6.8e-16 Score=165.40 Aligned_cols=175 Identities=17% Similarity=0.197 Sum_probs=110.2
Q ss_pred CEEEEEcCCCCCccc----ccccccCCCCCCEEEecCCCccCCCC----CC---CCCCccEEeccccccccc----CCcc
Q 007103 84 AVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIP----YQ---LPPNLTSLNLASNNFSGN----LPYS 148 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p----~~---~~~~L~~L~L~~N~l~~~----~p~~ 148 (618)
+++.|+|++|++++. ++..+..+++|++|+|++|.+++... .. -.++|+.|+|++|+++.. ++..
T Consensus 200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 279 (461)
T 1z7x_W 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279 (461)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence 566666666666553 45556666777777777776653211 11 125677777777777753 5566
Q ss_pred ccCCCCccEEEeecCCCCCccchhhcC-----CCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeecccccccccc-
Q 007103 149 IASMVSLSYLNVSRNSLTQSIGDIFGN-----LAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSLN- 218 (618)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~~- 218 (618)
+..+++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. ++..+..+++|++|+|++|++++...
T Consensus 280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 666777777777777776554444432 25777777777777754 45556666788888888887776321
Q ss_pred ----ccC--CCCccEEEcccccccc----cCchhh---hcccchhccCCcCCC
Q 007103 219 ----VFS--GLPLTTLNVANNHFSG----WIPREL---ISIRTFIYDGNSFDN 258 (618)
Q Consensus 219 ----~~~--~~~L~~L~l~~N~l~g----~ip~~~---~~l~~l~~~~N~~~~ 258 (618)
.+. ..+|+.|+|++|.+++ .+|..+ .+|+.|++++|++..
T Consensus 360 ~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 111 3458888888888875 666554 456677777777654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=5.9e-14 Score=129.13 Aligned_cols=106 Identities=19% Similarity=0.204 Sum_probs=93.3
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 86 VSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 86 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
+.+++++|+|. .+|..+. ++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56899999995 4666654 8999999999999988887775 89999999999999876677899999999999999
Q ss_pred CCCCccchhhcCCCCCCeEEcccCcCCCCCCC
Q 007103 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPN 195 (618)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 195 (618)
+|++..+..|..+++|+.|+|++|.+. ..+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD-CECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC-TTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc-cccc
Confidence 999888778999999999999999999 4444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.50 E-value=5.6e-14 Score=144.77 Aligned_cols=172 Identities=16% Similarity=0.158 Sum_probs=137.9
Q ss_pred CCCEEEEEcCCCCCcccccc-cccCCCCCCE-EEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccE
Q 007103 82 GSAVVSIDISGLGLSGTMGY-LLSDLLSLRK-FDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSY 157 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~-~l~~l~~L~~-L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 157 (618)
-.+++.|+|++|.+.+.+|. .|.+|++|+. +++++|+|+...|..+. ++|++|++++|+|++..+..+....++..
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 35899999999999876664 7889999876 67778999977777665 89999999999999877777888889999
Q ss_pred EEeec-CCCCCccchhhcCCC-CCCeEEcccCcCCCCCCCCcccCCCcCeeeecc-ccccccccc-cCC-CCccEEEccc
Q 007103 158 LNVSR-NSLTQSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSLYLQN-NQVTGSLNV-FSG-LPLTTLNVAN 232 (618)
Q Consensus 158 L~L~~-N~l~~~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~~~-~~~-~~L~~L~l~~ 232 (618)
|++.+ |+++...+..|..+. .|+.|+|++|+|+ .+|.......+|+.|++++ |.++...+. +.. .+|+.|||++
T Consensus 133 l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~ 211 (350)
T 4ay9_X 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 211 (350)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTT
T ss_pred hhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCC
Confidence 99976 577766667777765 6899999999999 6777666778999999986 556655443 344 3599999999
Q ss_pred ccccccCchhhhcccchhccCC
Q 007103 233 NHFSGWIPRELISIRTFIYDGN 254 (618)
Q Consensus 233 N~l~g~ip~~~~~l~~l~~~~N 254 (618)
|+|+...+..+.+|+.|...++
T Consensus 212 N~l~~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 212 TRIHSLPSYGLENLKKLRARST 233 (350)
T ss_dssp SCCCCCCSSSCTTCCEEECTTC
T ss_pred CCcCccChhhhccchHhhhccC
Confidence 9999544456788888876655
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.48 E-value=1.6e-15 Score=162.50 Aligned_cols=174 Identities=21% Similarity=0.226 Sum_probs=140.9
Q ss_pred CEEEEEcCCCCCcc----cccccccCCCCCCEEEecCCCccCCCCCCC-------CCCccEEeccccccccc----CCcc
Q 007103 84 AVVSIDISGLGLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSGN----LPYS 148 (618)
Q Consensus 84 ~v~~l~l~~~~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-------~~~L~~L~L~~N~l~~~----~p~~ 148 (618)
+++.|+|++|+++. .++..+..+++|++|+|++|.+++..+..+ .++|+.|+|++|++++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 69999999999984 678899999999999999999985433322 24799999999999974 4667
Q ss_pred ccCCCCccEEEeecCCCCCccchhhc-----CCCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeeccccccccc--
Q 007103 149 IASMVSLSYLNVSRNSLTQSIGDIFG-----NLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL-- 217 (618)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~-- 217 (618)
+..+++|++|+|++|.+++..+..+. .+++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++..
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 77889999999999999876655554 367999999999999964 5777888999999999999998732
Q ss_pred ---ccc--CCCCccEEEccccccccc----Cchhh---hcccchhccCCcCC
Q 007103 218 ---NVF--SGLPLTTLNVANNHFSGW----IPREL---ISIRTFIYDGNSFD 257 (618)
Q Consensus 218 ---~~~--~~~~L~~L~l~~N~l~g~----ip~~~---~~l~~l~~~~N~~~ 257 (618)
+.+ ...+|+.|+|++|.+++. ++..+ .+|+.|++++|.+.
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 297 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence 222 245699999999999874 56654 56788899998764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=3e-13 Score=139.10 Aligned_cols=112 Identities=20% Similarity=0.261 Sum_probs=74.1
Q ss_pred CC-CCCCceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecC-CCccCCCCCCCCCCccEEecccccccccCCc
Q 007103 70 PC-GESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSG-NSIHDTIPYQLPPNLTSLNLASNNFSGNLPY 147 (618)
Q Consensus 70 ~c-~~~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~ 147 (618)
.| .|.|.+|.|.+. |+|++ +|. |..+++|+.|+|++ |+|+ +..|.
T Consensus 4 ~c~~C~~~~v~~~~~---------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~----------------------~~~~~ 50 (347)
T 2ifg_A 4 ACCPHGSSGLRCTRD---------GALDS-LHH-LPGAENLTELYIENQQHLQ----------------------HLELR 50 (347)
T ss_dssp SSCCSSSSCEECCSS---------CCCTT-TTT-SCSCSCCSEEECCSCSSCC----------------------EECGG
T ss_pred cCccccCCEEEcCCC---------CCCCc-cCC-CCCCCCeeEEEccCCCCCC----------------------CcChh
Confidence 35 557777766532 15654 455 77666666666664 5555 34456
Q ss_pred cccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc
Q 007103 148 SIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 148 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 215 (618)
.|.+|++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..++ |+.|+|++|+|..
T Consensus 51 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 51 DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 677777777777777777777777777777777777777777754444444444 7788888777764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=135.00 Aligned_cols=126 Identities=17% Similarity=0.102 Sum_probs=101.5
Q ss_pred EEecccc-cccccCCccccCCCCccEEEeec-CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecc
Q 007103 133 SLNLASN-NFSGNLPYSIASMVSLSYLNVSR-NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQN 210 (618)
Q Consensus 133 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~ 210 (618)
.++++++ +|+ .+|. |..+++|+.|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|.+|++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4677777 787 5788 99999999999996 999999999999999999999999999998899999999999999999
Q ss_pred ccccccccc-cCCCCccEEEcccccccccCc-hhhhc---ccchhccCCcCCCCC
Q 007103 211 NQVTGSLNV-FSGLPLTTLNVANNHFSGWIP-RELIS---IRTFIYDGNSFDNGP 260 (618)
Q Consensus 211 N~l~~~~~~-~~~~~L~~L~l~~N~l~g~ip-~~~~~---l~~l~~~~N~~~~~~ 260 (618)
|+|++.++. +...+|+.|+|++|.|...-. ..|.. .....+..+.+.|..
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~ 144 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHG 144 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSS
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCC
Confidence 999987764 444569999999999984322 22222 123334456666653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.4e-14 Score=147.13 Aligned_cols=163 Identities=14% Similarity=0.161 Sum_probs=122.9
Q ss_pred CCEEEEEcCCCCCcccccccccCC-----CCCCEEEecCCCccCCCCCCCC---CCccEEecccccccccCCccc-----
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDL-----LSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNFSGNLPYSI----- 149 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~---~~L~~L~L~~N~l~~~~p~~~----- 149 (618)
..++.|+|++|.|+......+..+ ++|+.|+|++|.|+......+. ++|+.|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 568999999999987555554433 7999999999998754333333 689999999999986544444
Q ss_pred cCCCCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeeccccccccc----
Q 007103 150 ASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL---- 217 (618)
Q Consensus 150 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~---- 217 (618)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++. ++..+...++|++|+|++|.|+..-
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2468899999999999853 455667889999999999999753 3556677889999999999998632
Q ss_pred c-cc-CCCCccEEEcccccccccCchhhhc
Q 007103 218 N-VF-SGLPLTTLNVANNHFSGWIPRELIS 245 (618)
Q Consensus 218 ~-~~-~~~~L~~L~l~~N~l~g~ip~~~~~ 245 (618)
. .+ ...+|+.|||++|.|+..-...+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 1 11 2356999999999998655555544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=120.79 Aligned_cols=144 Identities=12% Similarity=0.054 Sum_probs=110.3
Q ss_pred hcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 487 (618)
...|.....++.|+.+.||++... ++.+++|........ ....+.+|++.++.+. +..+.++++++...+..++||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 346777778888999999999764 688999998643211 1235778888888774 677888999999889999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC----------------------------------- 532 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 532 (618)
||++|.+|.+.+. +......++.+++++|+.||+..
T Consensus 90 e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999887531 11123467889999999999820
Q ss_pred ---------------------CCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 533 ---------------------LPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 533 ---------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 02589999999999998766667999998753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.16 E-value=5.5e-11 Score=121.19 Aligned_cols=95 Identities=18% Similarity=0.125 Sum_probs=66.1
Q ss_pred CCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcC-eeeeccccccccc-cccCC-CCccEE
Q 007103 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNIS-SLYLQNNQVTGSL-NVFSG-LPLTTL 228 (618)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~-~~~~~-~~L~~L 228 (618)
+++|+.|+|++|+++.+.+.+|.++++|+.|+|.+| +...-+..|.++.+|+ .|++.+ +++... ..|.. .+|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 677888888888888666667888888888888887 6645556677888888 888877 565433 23444 358888
Q ss_pred EcccccccccCchhhhcccc
Q 007103 229 NVANNHFSGWIPRELISIRT 248 (618)
Q Consensus 229 ~l~~N~l~g~ip~~~~~l~~ 248 (618)
++++|+++..-+..|.++..
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~ 322 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVP 322 (329)
T ss_dssp EECSSCCCEECTTTTCTTCC
T ss_pred EeCCCccCccchhhhcCCcc
Confidence 88888887544455555443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=3.7e-11 Score=117.93 Aligned_cols=138 Identities=18% Similarity=0.171 Sum_probs=99.3
Q ss_pred CCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCc--ccccceEEeeCCeEEEEEE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN--IVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e 488 (618)
.+....+.+.|..+.||++...+|+.+++|...... ...+.+|++.++.+.+.+ +.+++++....+..++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 344433334566799999988778889999876431 234667788777775444 5568888887788999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------------------------------------ 532 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 532 (618)
|+++.++. .. . .+ ...++.++++.|+.||+..
T Consensus 96 ~i~G~~l~--~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998874 21 0 11 2256778888888888752
Q ss_pred -------------------CCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 533 -------------------LPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 533 -------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
.+.++|+|++|.||++++++.+.|+|||.+...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 012899999999999988766779999987543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.5e-12 Score=134.85 Aligned_cols=155 Identities=18% Similarity=0.195 Sum_probs=113.7
Q ss_pred CCEEEEEcCCCCCcccccccc-cCCCCCCEEEecCCCccCCCCCCC-------CCCccEEecccccccc----cCCcccc
Q 007103 83 SAVVSIDISGLGLSGTMGYLL-SDLLSLRKFDLSGNSIHDTIPYQL-------PPNLTSLNLASNNFSG----NLPYSIA 150 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p~~~-------~~~L~~L~L~~N~l~~----~~p~~~~ 150 (618)
..++.|+|++|+|+......+ ..+++|+.|+|++|.|+......+ .++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 589999999999976544444 356789999999999974433222 3789999999999985 3555667
Q ss_pred CCCCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeeccccccccc----c
Q 007103 151 SMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL----N 218 (618)
Q Consensus 151 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~----~ 218 (618)
.+++|++|+|++|+|+.. ++..+...++|+.|+|++|.|++. ++..+...++|++|+|++|.|+..- .
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 899999999999999854 356778889999999999999853 3344556789999999999998632 1
Q ss_pred ccCCCC---ccEEE--cccccccc
Q 007103 219 VFSGLP---LTTLN--VANNHFSG 237 (618)
Q Consensus 219 ~~~~~~---L~~L~--l~~N~l~g 237 (618)
...... |+.+. +..|.++.
T Consensus 261 ~~~~~~~~~L~~l~~ll~~~~~~~ 284 (372)
T 3un9_A 261 DLGGAAEGGARVVVSLTEGTAVSE 284 (372)
T ss_dssp HCC------CEEECCCC----CHH
T ss_pred HHhcCCCccchhhHhhhcCCccCH
Confidence 122222 67776 67776653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.04 E-value=8e-12 Score=138.11 Aligned_cols=175 Identities=18% Similarity=0.095 Sum_probs=90.9
Q ss_pred CCEEEEEcCCCCCccccc-ccccCCCCCCEEEecCCCccCCCCCCC---CCCccEEecc-----------ccccccc-CC
Q 007103 83 SAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNLA-----------SNNFSGN-LP 146 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~~L~~L~L~-----------~N~l~~~-~p 146 (618)
.+++.|+|++|.+++... ..+..+++|+.|+|+ |.++......+ .++|+.|+|+ .|.+++. ++
T Consensus 293 ~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~ 371 (592)
T 3ogk_B 293 AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLI 371 (592)
T ss_dssp GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHH
T ss_pred CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHH
Confidence 378999999999866444 345677777777776 33332111111 1455555555 2444432 11
Q ss_pred ccccCCCCccEEEeecCCCCCccchhhcC-CCCCCeEEcc----cCcCC-------------------------------
Q 007103 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGN-LAGLATLDLS----FNNFS------------------------------- 190 (618)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~ls----~N~l~------------------------------- 190 (618)
..+..+++|++|+|+.|++++..+..++. +++|+.|+|+ .|+++
T Consensus 372 ~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~ 451 (592)
T 3ogk_B 372 ALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLT 451 (592)
T ss_dssp HHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCC
T ss_pred HHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCcc
Confidence 12233455555555555555444444433 4445555553 34444
Q ss_pred CCCCCCcc-cCCCcCeeeeccccccc-cccc-cC-CCCccEEEcccccccccCch----hhhcccchhccCCcCCC
Q 007103 191 GDLPNSFI-SLSNISSLYLQNNQVTG-SLNV-FS-GLPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSFDN 258 (618)
Q Consensus 191 g~~p~~~~-~l~~L~~L~l~~N~l~~-~~~~-~~-~~~L~~L~l~~N~l~g~ip~----~~~~l~~l~~~~N~~~~ 258 (618)
+..+..+. .+++|++|+|++|++++ .++. .. ..+|+.|+|++|.|++.... .+.+|+.|++++|++..
T Consensus 452 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 452 DLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred HHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 32222222 25566666666666665 2222 12 24477777777777654222 23556677777776543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=7.6e-10 Score=114.14 Aligned_cols=143 Identities=16% Similarity=0.253 Sum_probs=105.0
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcC--cccccHHHHHHHHHHHHHhhcCC--CCcccccceEEeeC---CeEEEEE
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKID--NAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEH---GQRLLVY 487 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 487 (618)
.+.++.|.++.||+....+ ..+++|+.. .... ......+.+|+++++.+. +..+.+++.++.+. +..++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999998764 678888876 3221 122456778888888876 44578888888776 4589999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC----------------------------------- 532 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 532 (618)
||+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999997775421 234678888899999999999999731
Q ss_pred --------------------CCCceecCCCCCCeeecCCCC--cEEeeccccccC
Q 007103 533 --------------------LPSVVHRNFKSANILLDDELN--PHLSDCGLAALT 565 (618)
Q Consensus 533 --------------------~~~iiH~Dlkp~Nill~~~~~--~kl~Dfgl~~~~ 565 (618)
.+.++|+|+++.||++++++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 136899999999999997753 689999988643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.5e-10 Score=113.17 Aligned_cols=144 Identities=18% Similarity=0.236 Sum_probs=118.9
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCC-------------CCCCC----------------------
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT-------------IPYQL---------------------- 127 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-------------~p~~~---------------------- 127 (618)
..++.|+|++ +++.+.+.+|.++++|+.|+|++|.++.. +|...
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 5788999998 88888888999999999999999976311 11111
Q ss_pred ---------------------------------------------CCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 128 ---------------------------------------------PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 128 ---------------------------------------------~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.++|+.|+|++|+++...+..|.+|++|+.|+|.+
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 36899999999999977777899999999999999
Q ss_pred CCCCCccchhhcCCCCCC-eEEcccCcCCCCCCCCcccCCCcCeeeecccccccccc-ccCCC-CccEEE
Q 007103 163 NSLTQSIGDIFGNLAGLA-TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSGL-PLTTLN 229 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~-~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~-~L~~L~ 229 (618)
| ++.+.+.+|.++++|+ .|+|.+ +++..-+..|.++++|+.|++++|+++...+ .|... +|+.|+
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 8 8877788999999999 999999 7875667899999999999999999998665 34444 588775
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.97 E-value=1.7e-10 Score=127.47 Aligned_cols=102 Identities=12% Similarity=0.120 Sum_probs=71.2
Q ss_pred CEEEEEcCCCC-Ccc-cccccccCCCCCCEEEecCCCccCCCCCC------CCCCccEEeccccccc----ccCCccccC
Q 007103 84 AVVSIDISGLG-LSG-TMGYLLSDLLSLRKFDLSGNSIHDTIPYQ------LPPNLTSLNLASNNFS----GNLPYSIAS 151 (618)
Q Consensus 84 ~v~~l~l~~~~-l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~------~~~~L~~L~L~~N~l~----~~~p~~~~~ 151 (618)
+++.|+|+++. +.. .++.....+++|++|+|++|.+++.-... -.++|+.|+|++|.++ +.++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 38888888775 211 12333447788888888888877552211 1278888888888887 345555667
Q ss_pred CCCccEEEeecCCCCCccchhhcCCCCCCeEEccc
Q 007103 152 MVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186 (618)
Q Consensus 152 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 186 (618)
+++|+.|+|++|.+.+ +|..+..+++|+.|+++.
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 8888888888888875 567777778888887764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=2.7e-10 Score=114.69 Aligned_cols=186 Identities=19% Similarity=0.237 Sum_probs=119.9
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCc--ccccceEEeeCC---eEEEEEE
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPN--IVTLAGYCAEHG---QRLLVYE 488 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e 488 (618)
.+.++.|....||+.. +.+++|..... .....+.+|.+.++.+. +.. +.+++......+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3468999999999863 56888886532 34567888998887763 333 334444433332 3488999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC------------------------------------ 532 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 532 (618)
+++|.++.+... ..++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 97 KIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred ccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999988765332 24667777888888888888888621
Q ss_pred -------------------CCCceecCCCCCCeeecC--CCCcEEeeccccccCCCCCccccc-------------ceec
Q 007103 533 -------------------LPSVVHRNFKSANILLDD--ELNPHLSDCGLAALTPNTERQVST-------------QMVG 578 (618)
Q Consensus 533 -------------------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~-------------~~~g 578 (618)
.+.++|+|++|.||++++ +..+.|+||+.+...+...+-... ....
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 135799999999999998 556789999988654321110000 0001
Q ss_pred cccccC-ccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 579 AFGYSA-PEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 579 t~~y~a-PE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
..+... |+..... ..-.+.|++|.++|++.+|..||
T Consensus 251 ~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 111111 2221111 12258999999999999998775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.2e-11 Score=120.51 Aligned_cols=116 Identities=18% Similarity=0.180 Sum_probs=52.5
Q ss_pred CCceeEeeCC--CEEEEEcCC---CCCcccc-cccccCCCCCCEEEecCCCccCCCCCC-CC--CCccE--Eeccccccc
Q 007103 74 SWKGVACEGS--AVVSIDISG---LGLSGTM-GYLLSDLLSLRKFDLSGNSIHDTIPYQ-LP--PNLTS--LNLASNNFS 142 (618)
Q Consensus 74 ~w~gv~c~~~--~v~~l~l~~---~~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~--~~L~~--L~L~~N~l~ 142 (618)
.|.|+.|+.. +|..+-..+ ..+.+.+ |+.+..++. .|...+|.-++.++.+ +. +.|.. ++++.|+..
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 6999999754 555444433 2222323 223333322 2333333333332221 11 33443 455555332
Q ss_pred ---ccCCccccCCCCccEEEeecCCCCC--ccchhhcCCCCCCeEEcccCcCCC
Q 007103 143 ---GNLPYSIASMVSLSYLNVSRNSLTQ--SIGDIFGNLAGLATLDLSFNNFSG 191 (618)
Q Consensus 143 ---~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g 191 (618)
+.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~ 210 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 210 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC
Confidence 1111122345556666666666555 333445555555555555555553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.85 E-value=2.5e-10 Score=126.06 Aligned_cols=171 Identities=15% Similarity=0.077 Sum_probs=116.1
Q ss_pred CCEEEEEcCCCCCccccc-ccccCCCCCCEEEecCCCccCCCCCCC---CCCccEEec---------ccccccccCCccc
Q 007103 83 SAVVSIDISGLGLSGTMG-YLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLNL---------ASNNFSGNLPYSI 149 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~~L~~L~L---------~~N~l~~~~p~~~ 149 (618)
.+++.|+|++|.+++... ..+..+++|+.|+|++| ++......+ .++|+.|+| +.|.+++.....+
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l 367 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence 578999999999876433 34668899999999988 442211111 378999988 4456665433344
Q ss_pred c-CCCCccEEEeecCCCCCccchhhc-CCCCCCeEEcc--c----CcCCCCCCC------CcccCCCcCeeeeccccccc
Q 007103 150 A-SMVSLSYLNVSRNSLTQSIGDIFG-NLAGLATLDLS--F----NNFSGDLPN------SFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 150 ~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls--~----N~l~g~~p~------~~~~l~~L~~L~l~~N~l~~ 215 (618)
. ++++|++|+++.|++++..+..+. .+++|+.|+|+ + |++++ .|. .+..+++|+.|+|++ .+++
T Consensus 368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 3 488899998888888877666665 58889999998 3 55652 221 255677888888876 5555
Q ss_pred cc-cccC--CCCccEEEcccccccccCchh----hhcccchhccCCcC
Q 007103 216 SL-NVFS--GLPLTTLNVANNHFSGWIPRE----LISIRTFIYDGNSF 256 (618)
Q Consensus 216 ~~-~~~~--~~~L~~L~l~~N~l~g~ip~~----~~~l~~l~~~~N~~ 256 (618)
.. ..+. ..+|+.|+|++|.+++..+.. +.+|+.|++.+|++
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 32 2211 345888888888887655533 46778888888876
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.84 E-value=7.7e-11 Score=130.17 Aligned_cols=172 Identities=14% Similarity=0.114 Sum_probs=123.8
Q ss_pred CCEEEEEcCCCCCccc-ccccccCCCCCCEEEecC---------CCccCCCCCCC---CCCccEEecccccccccCCccc
Q 007103 83 SAVVSIDISGLGLSGT-MGYLLSDLLSLRKFDLSG---------NSIHDTIPYQL---PPNLTSLNLASNNFSGNLPYSI 149 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~-~~~~l~~l~~L~~L~L~~---------N~l~~~~p~~~---~~~L~~L~L~~N~l~~~~p~~~ 149 (618)
.+++.|+++++ +... ++.....+++|+.|+|++ |.+++.....+ .++|+.|+++.|++++..+..+
T Consensus 314 ~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l 392 (594)
T 2p1m_B 314 PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392 (594)
T ss_dssp TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence 57899999988 5432 233334689999999944 45543222121 3799999999999997766666
Q ss_pred c-CCCCccEEEee--c----CCCCCc-----cchhhcCCCCCCeEEcccCcCCCCCCCCccc-CCCcCeeeecccccccc
Q 007103 150 A-SMVSLSYLNVS--R----NSLTQS-----IGDIFGNLAGLATLDLSFNNFSGDLPNSFIS-LSNISSLYLQNNQVTGS 216 (618)
Q Consensus 150 ~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~-l~~L~~L~l~~N~l~~~ 216 (618)
. .+++|+.|+|+ + |.+++. ++..+..+++|+.|+|++ .+++..+..+.. +++|++|+|++|.+++.
T Consensus 393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~ 471 (594)
T 2p1m_B 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL 471 (594)
T ss_dssp HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence 5 58999999999 4 667632 333467789999999977 677655555655 88999999999999764
Q ss_pred cc-c--cCCCCccEEEcccccccccCch----hhhcccchhccCCcC
Q 007103 217 LN-V--FSGLPLTTLNVANNHFSGWIPR----ELISIRTFIYDGNSF 256 (618)
Q Consensus 217 ~~-~--~~~~~L~~L~l~~N~l~g~ip~----~~~~l~~l~~~~N~~ 256 (618)
.. . ....+|+.|+|++|.+++..+. .+.+|+.|++.+|+.
T Consensus 472 ~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 472 GMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 32 1 1245699999999999764443 456788888888876
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.71 E-value=4.5e-09 Score=107.75 Aligned_cols=160 Identities=16% Similarity=0.203 Sum_probs=89.7
Q ss_pred CCEEEEEcCCCCC---------cccccccccCCCCCCEEEecCCC-ccCCCCCCCCCCccEEecccccccccCCcccc--
Q 007103 83 SAVVSIDISGLGL---------SGTMGYLLSDLLSLRKFDLSGNS-IHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA-- 150 (618)
Q Consensus 83 ~~v~~l~l~~~~l---------~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~-- 150 (618)
.+++.|.+.++.. .+.+...+..+++|+.|+|++|. +. ++.--.++|+.|+|..|.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~~~~~~L~~L~L~~~~l~~~~l~~l~~~ 216 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGKKPRPNLKSLEIISGGLPDSVVEDILGS 216 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCSCBCTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--eccccCCCCcEEEEecCCCChHHHHHHHHc
Confidence 4677777765432 12244555667778888887763 21 2221136788888877776644333443
Q ss_pred CCCCccEEEeec--CCCCCc-----cchhh--cCCCCCCeEEcccCcCCCCCCCCcc---cCCCcCeeeeccccccccc-
Q 007103 151 SMVSLSYLNVSR--NSLTQS-----IGDIF--GNLAGLATLDLSFNNFSGDLPNSFI---SLSNISSLYLQNNQVTGSL- 217 (618)
Q Consensus 151 ~l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~ls~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~~~~- 217 (618)
.+++|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+.+..+..+. .+++|++|+|+.|.|++.-
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 677788777753 221111 11122 2467788888877777643332222 4667788888777776521
Q ss_pred -cccC----CCCccEEEcccccccccCchhhh
Q 007103 218 -NVFS----GLPLTTLNVANNHFSGWIPRELI 244 (618)
Q Consensus 218 -~~~~----~~~L~~L~l~~N~l~g~ip~~~~ 244 (618)
.... ..+|+.|+|++|.|+...-..+.
T Consensus 297 ~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~ 328 (362)
T 2ra8_A 297 RLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328 (362)
T ss_dssp HHHHTTHHHHTTCSEEECCSBBCCHHHHHHHH
T ss_pred HHHHhhcccCCcceEEECCCCcCCHHHHHHHH
Confidence 1111 13577788877777644333333
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.63 E-value=2.2e-08 Score=102.66 Aligned_cols=172 Identities=14% Similarity=0.140 Sum_probs=116.1
Q ss_pred CCEEEEEcCCCCCcc-c-------ccccccCCCCCCEEEecCCCccC-----CCCCCC------CCCccEEecccccccc
Q 007103 83 SAVVSIDISGLGLSG-T-------MGYLLSDLLSLRKFDLSGNSIHD-----TIPYQL------PPNLTSLNLASNNFSG 143 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~-~-------~~~~l~~l~~L~~L~L~~N~l~~-----~~p~~~------~~~L~~L~L~~N~l~~ 143 (618)
.+|+.|.+...+..| . +..++..+++|+.|.+..+.... .-...+ .++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 467888888776553 2 23446678999999998764321 101112 279999999988311
Q ss_pred cCCccccCCCCccEEEeecCCCCCccchhhc--CCCCCCeEEccc--CcCCCC-----CCCCc--ccCCCcCeeeecccc
Q 007103 144 NLPYSIASMVSLSYLNVSRNSLTQSIGDIFG--NLAGLATLDLSF--NNFSGD-----LPNSF--ISLSNISSLYLQNNQ 212 (618)
Q Consensus 144 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~ 212 (618)
.++. + .+++|+.|+|..|.++......++ .+++|+.|+|+. |...|. +...+ ..+++|++|+|++|.
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2333 4 389999999999998865555554 789999999964 332221 11122 257899999999999
Q ss_pred cccccc-----ccCCCCccEEEccccccccc----Cch---hhhcccchhccCCcCC
Q 007103 213 VTGSLN-----VFSGLPLTTLNVANNHFSGW----IPR---ELISIRTFIYDGNSFD 257 (618)
Q Consensus 213 l~~~~~-----~~~~~~L~~L~l~~N~l~g~----ip~---~~~~l~~l~~~~N~~~ 257 (618)
+++... .....+|+.|+|+.|.|++. ++. .+.+|+.|++.+|.+.
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 985321 11234699999999999874 333 3567888888888755
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.62 E-value=1.4e-09 Score=100.67 Aligned_cols=23 Identities=17% Similarity=0.221 Sum_probs=15.0
Q ss_pred cccccccCCCCCCEEEecCC-Ccc
Q 007103 98 TMGYLLSDLLSLRKFDLSGN-SIH 120 (618)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~N-~l~ 120 (618)
.+...+...+.|++|+|++| .|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~ 50 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIP 50 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCC
Confidence 44455666677777777777 665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.62 E-value=1.8e-07 Score=97.56 Aligned_cols=167 Identities=11% Similarity=0.110 Sum_probs=109.3
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
..++.++|++|+++.....+|. ..+|+.+.|.+| ++..-...|. ++|+.++|..| ++..-...|.+ .+|+.+.|
T Consensus 180 ~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 180 YNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp TTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE
T ss_pred ccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe
Confidence 4688889998888876666666 588888888754 5533333443 67888888764 55455556666 67888888
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCC-----CCCCCCcccCCCcCeeeecccccccccc-ccCC-CCccEEEcccc
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFS-----GDLPNSFISLSNISSLYLQNNQVTGSLN-VFSG-LPLTTLNVANN 233 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~-~~L~~L~l~~N 233 (618)
.|.++.+-..+|.++++|+.+++.+|.+. ..-+..|.++++|+.++|. |+++.... .|.+ .+|+.|+|.+|
T Consensus 256 -p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 256 -PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp -ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred -CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 45566566677888888888888777764 2345667778888888887 34554332 3444 45888888554
Q ss_pred cccccCchhhh--cccchhccCCcC
Q 007103 234 HFSGWIPRELI--SIRTFIYDGNSF 256 (618)
Q Consensus 234 ~l~g~ip~~~~--~l~~l~~~~N~~ 256 (618)
++..-+..|. +|+.+.+.+|..
T Consensus 334 -l~~I~~~aF~~~~L~~l~l~~n~~ 357 (401)
T 4fdw_A 334 -VTQINFSAFNNTGIKEVKVEGTTP 357 (401)
T ss_dssp -CCEECTTSSSSSCCCEEEECCSSC
T ss_pred -ccEEcHHhCCCCCCCEEEEcCCCC
Confidence 5422233332 566666776643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.60 E-value=1.9e-07 Score=97.26 Aligned_cols=163 Identities=13% Similarity=0.141 Sum_probs=109.7
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC-CCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP-PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.++.++|.+ ++...-+.+|.++++|+.++|++|+++..-...|. .+|+.+.|..| ++..-...|.++++|+.++|..
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence 466777775 66666667888888888888888888743333333 78888888744 6656667788888888888886
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccc----cc--cccCC-CCccEEEcccccc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG----SL--NVFSG-LPLTTLNVANNHF 235 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~----~~--~~~~~-~~L~~L~l~~N~l 235 (618)
| ++.+-..+|.+ .+|+.++| .|.++..-...|.++++|+.+++.+|.+.. .+ ..|.+ .+|+.++|.+ .+
T Consensus 236 ~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i 311 (401)
T 4fdw_A 236 N-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SI 311 (401)
T ss_dssp T-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TC
T ss_pred C-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ce
Confidence 5 56555667777 78888888 455664556778888888888888887751 12 23333 3588888884 46
Q ss_pred cccCchhhh---cccchhcc
Q 007103 236 SGWIPRELI---SIRTFIYD 252 (618)
Q Consensus 236 ~g~ip~~~~---~l~~l~~~ 252 (618)
+..-...|. +|+.+.+.
T Consensus 312 ~~I~~~aF~~c~~L~~l~lp 331 (401)
T 4fdw_A 312 RILGQGLLGGNRKVTQLTIP 331 (401)
T ss_dssp CEECTTTTTTCCSCCEEEEC
T ss_pred EEEhhhhhcCCCCccEEEEC
Confidence 633333443 34445443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=6e-08 Score=94.39 Aligned_cols=102 Identities=22% Similarity=0.217 Sum_probs=73.2
Q ss_pred ccCCCCCCE--EEecCCCccCCCCC------CCCCCccEEecccccccc--cCCccccCCCCccEEEeecCCCCCccchh
Q 007103 103 LSDLLSLRK--FDLSGNSIHDTIPY------QLPPNLTSLNLASNNFSG--NLPYSIASMVSLSYLNVSRNSLTQSIGDI 172 (618)
Q Consensus 103 l~~l~~L~~--L~L~~N~l~~~~p~------~~~~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 172 (618)
|...+.|.. ++++.|... .++. +..++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence 444445554 667777433 1221 123789999999999987 5667788999999999999999976 33
Q ss_pred hcCCC--CCCeEEcccCcCCCCCCC-------CcccCCCcCeee
Q 007103 173 FGNLA--GLATLDLSFNNFSGDLPN-------SFISLSNISSLY 207 (618)
Q Consensus 173 ~~~l~--~L~~L~ls~N~l~g~~p~-------~~~~l~~L~~L~ 207 (618)
+..+. +|+.|+|++|.+.+.+|. .+..+++|+.||
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 44444 899999999999987763 256778888776
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=1.6e-08 Score=93.58 Aligned_cols=108 Identities=21% Similarity=0.345 Sum_probs=60.6
Q ss_pred CCCEEEEEcCCC-CCccc----ccccccCCCCCCEEEecCCCccCCCCCCC----C--CCccEEeccccccccc----CC
Q 007103 82 GSAVVSIDISGL-GLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIPYQL----P--PNLTSLNLASNNFSGN----LP 146 (618)
Q Consensus 82 ~~~v~~l~l~~~-~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----~--~~L~~L~L~~N~l~~~----~p 146 (618)
...++.|+|++| .|... +...+...++|++|+|++|.|+..-...+ . ++|++|+|++|+|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 457999999999 88653 45566677888888888888863211111 1 4555666666655532 23
Q ss_pred ccccCCCCccEEEe--ecCCCCCc----cchhhcCCCCCCeEEcccCcC
Q 007103 147 YSIASMVSLSYLNV--SRNSLTQS----IGDIFGNLAGLATLDLSFNNF 189 (618)
Q Consensus 147 ~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l 189 (618)
..+...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 34444455555555 44555432 122233334444444444444
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.4e-06 Score=85.67 Aligned_cols=138 Identities=19% Similarity=0.147 Sum_probs=94.4
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCC---cccccceEEe-eCCeEEEEEEec
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP---NIVTLAGYCA-EHGQRLLVYEYV 490 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 490 (618)
.+.++.|....||+. |+.+++|.... ......+.+|.+.++.+.+. .|.+++.+.. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 346788999999988 56788887532 23456788999999888653 2556666664 345678999999
Q ss_pred CCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------
Q 007103 491 GNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV--------------------------------------- 531 (618)
Q Consensus 491 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------- 531 (618)
+|..+.+... ..++..+...++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 96 QGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9988765321 1234445555555555555555543
Q ss_pred ------------------CCCCceecCCCCCCeeecC---CCCc-EEeeccccccCC
Q 007103 532 ------------------CLPSVVHRNFKSANILLDD---ELNP-HLSDCGLAALTP 566 (618)
Q Consensus 532 ------------------~~~~iiH~Dlkp~Nill~~---~~~~-kl~Dfgl~~~~~ 566 (618)
..+.++|+|++|.||++++ ++.+ .|+||+.+...+
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 1125699999999999987 4554 799999886543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.9e-06 Score=83.33 Aligned_cols=136 Identities=15% Similarity=0.161 Sum_probs=94.5
Q ss_pred eeccCccc-eEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEEEEecCCC
Q 007103 417 LIGEGSLG-RVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 417 ~Lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.+..|..| .||+.... ++..+++|+-... ....+.+|...++.+. +--|.++++++.+.+..++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 35556655 68988765 4667888876432 3456777888777663 333677888999999999999999998
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC----------------------------------------- 532 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 532 (618)
++.+..... ......+..++++.|+.||+..
T Consensus 106 ~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 106 TAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 877654311 1122345556666666666431
Q ss_pred --------------CCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 533 --------------LPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 533 --------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
.+.++|+|+.+.|||+++++.+-|+||+.+...
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 013789999999999998877779999988644
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=3.4e-05 Score=78.91 Aligned_cols=83 Identities=8% Similarity=-0.013 Sum_probs=52.5
Q ss_pred ccee-ccCccceEEEEEEc-------CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCC-C--CcccccceEEeeC--
Q 007103 415 EFLI-GEGSLGRVYRAEFA-------NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLR-H--PNIVTLAGYCAEH-- 480 (618)
Q Consensus 415 ~~~L-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~-- 480 (618)
.+.| +.|....+|+.... +++.+++|....... .......+.+|+..++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3467 88999999998764 267888888754320 0000123555666665553 2 2466677776654
Q ss_pred -CeEEEEEEecCCCChhh
Q 007103 481 -GQRLLVYEYVGNGNLHD 497 (618)
Q Consensus 481 -~~~~lv~e~~~~gsL~~ 497 (618)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 45689999999876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=6e-05 Score=76.44 Aligned_cols=143 Identities=17% Similarity=0.275 Sum_probs=78.5
Q ss_pred ceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhc-----CCCCcccccc-e--EEeeCCeEEEEE
Q 007103 416 FLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-----LRHPNIVTLA-G--YCAEHGQRLLVY 487 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-----l~h~niv~l~-~--~~~~~~~~~lv~ 487 (618)
+.|+.|..+.||+....+| .+++|+..... ..+..|...++. +..|.++... | +....+..+++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 3566677899999987655 48899887521 112223333222 2334444321 1 223467789999
Q ss_pred EecCCCChh--------------hhhhcccCC---C-------CCCCHHHH-----------------------------
Q 007103 488 EYVGNGNLH--------------DMLHFADDS---S-------KNLTWNAR----------------------------- 514 (618)
Q Consensus 488 e~~~~gsL~--------------~~l~~~~~~---~-------~~l~~~~~----------------------------- 514 (618)
||++|..+. ..+|..... . ..-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 111211110 0 00122211
Q ss_pred --HHHHHHHHHHHHHHhh----------cCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 515 --VRVALGTARALEYLHE----------VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 515 --~~i~~~i~~~L~~LH~----------~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
..+..++..++++|++ ...+.++|+|+++.||+++.++.+.|+||+.+...
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 1111223445667763 01248999999999999988889999999988543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.78 E-value=6.7e-06 Score=74.16 Aligned_cols=83 Identities=5% Similarity=0.100 Sum_probs=52.5
Q ss_pred CccEEecccccccccCCccccCCCCccEEEeecCC-CCCccchhhcCC----CCCCeEEcccCc-CCCCCCCCcccCCCc
Q 007103 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS-LTQSIGDIFGNL----AGLATLDLSFNN-FSGDLPNSFISLSNI 203 (618)
Q Consensus 130 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~ls~N~-l~g~~p~~~~~l~~L 203 (618)
+|+.|||+++.++..--..+.+|++|+.|+|+++. ++..--..++.+ ++|+.|+|+++. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 46666666666654444556677788888888774 665444455554 367788887764 664333445667777
Q ss_pred Ceeeecccc
Q 007103 204 SSLYLQNNQ 212 (618)
Q Consensus 204 ~~L~l~~N~ 212 (618)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777777764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=2.2e-05 Score=82.30 Aligned_cols=77 Identities=8% Similarity=0.070 Sum_probs=48.2
Q ss_pred CCceecCCCCCCeeecCCCCcEEeeccccccCCCCCcccccce-eccccccCccccccC---CCCcccchhhHHHHHHHH
Q 007103 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQM-VGAFGYSAPEFALSG---IYTVKSDVYSFGVVMLEL 609 (618)
Q Consensus 534 ~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el 609 (618)
+.++|+|++|.|||+++++ ++|+||+.+...+...+- .... .-...|++|+..... ......++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3799999999999999876 999999988654322111 1100 011346666655321 112335566788888887
Q ss_pred HhC
Q 007103 610 LTG 612 (618)
Q Consensus 610 ltg 612 (618)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00017 Score=71.91 Aligned_cols=140 Identities=15% Similarity=0.215 Sum_probs=90.3
Q ss_pred ccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC---CCcccccceEEeeCCeEEEEEEec
Q 007103 414 QEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR---HPNIVTLAGYCAEHGQRLLVYEYV 490 (618)
Q Consensus 414 ~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 490 (618)
..+.|+.|....+|+... ++..+++|+.... ....+..|.+.++.+. ...+.+++.+....+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 345689999999999986 4677888886532 2456778887777663 356788888888888999999999
Q ss_pred CCCChh--------h---hhhcccC-C-----------------CCCCCHHHHH---HHHHH----------------HH
Q 007103 491 GNGNLH--------D---MLHFADD-S-----------------SKNLTWNARV---RVALG----------------TA 522 (618)
Q Consensus 491 ~~gsL~--------~---~l~~~~~-~-----------------~~~l~~~~~~---~i~~~----------------i~ 522 (618)
++..+. + .+|.... . ...-+|.+.. ++..+ ++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987642 1 1222211 0 0012444321 11111 11
Q ss_pred H-HHHHHhh-cCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 523 R-ALEYLHE-VCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 523 ~-~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
+ ..+.|.. ...|.++|+|+.+.|++++.++ +.|+|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 1223321 1235799999999999999887 8899984
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00011 Score=76.48 Aligned_cols=77 Identities=17% Similarity=0.110 Sum_probs=46.6
Q ss_pred cceeccCccceEEEEEEc-CCcEEEEEEcCcccc--cH---HHHHHHHHHHHHhhcCCC--Cc-ccccceEEeeCCeEEE
Q 007103 415 EFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL--SL---QEEDNFLEAVSNMSRLRH--PN-IVTLAGYCAEHGQRLL 485 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~---~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 485 (618)
.+.+|.|..+.||++... +++.+++|....... .. ....++..|.+.++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 467899997653211 00 112345667777766532 33 3344543 3455689
Q ss_pred EEEecCCC
Q 007103 486 VYEYVGNG 493 (618)
Q Consensus 486 v~e~~~~g 493 (618)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.64 E-value=2.9e-06 Score=78.01 Aligned_cols=67 Identities=24% Similarity=0.238 Sum_probs=30.6
Q ss_pred cccccCCCCCCEEEecCC-CccCCCC----CCC--CCCccEEeccccccccc----CCccccCCCCccEEEeecCCCC
Q 007103 100 GYLLSDLLSLRKFDLSGN-SIHDTIP----YQL--PPNLTSLNLASNNFSGN----LPYSIASMVSLSYLNVSRNSLT 166 (618)
Q Consensus 100 ~~~l~~l~~L~~L~L~~N-~l~~~~p----~~~--~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 166 (618)
...+.+-+.|+.|+|++| .|...-- ..+ .+.|+.|+|++|+|... +...+..-+.|+.|+|++|.|+
T Consensus 34 ~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 34 NRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 334445566777777664 5542100 011 14455555555555522 2222233344555555555554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00018 Score=71.07 Aligned_cols=78 Identities=22% Similarity=0.292 Sum_probs=53.5
Q ss_pred CcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCC---cccccceEEeeCCeEEEEEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP---NIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e 488 (618)
....+.+|.|..+.||+.+..||+.|++|+....... ....|..|++.|+.+.-. -+.+++++. ..++|||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 4445679999999999999999999999987543322 234567788877766321 234444432 3478999
Q ss_pred ecCCCCh
Q 007103 489 YVGNGNL 495 (618)
Q Consensus 489 ~~~~gsL 495 (618)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00011 Score=63.06 Aligned_cols=56 Identities=20% Similarity=0.310 Sum_probs=36.4
Q ss_pred EEEecCCCcc-CCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCC
Q 007103 111 KFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166 (618)
Q Consensus 111 ~L~L~~N~l~-~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 166 (618)
.++.+++.++ ..+|..+.++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3455555554 3566666677788888888877555556666667777766666654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.48 E-value=2.6e-05 Score=71.72 Aligned_cols=110 Identities=19% Similarity=0.260 Sum_probs=77.1
Q ss_pred eCCCEEEEEcCCC-CCcc----cccccccCCCCCCEEEecCCCccCCCCCCCC------CCccEEeccccccccc----C
Q 007103 81 EGSAVVSIDISGL-GLSG----TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP------PNLTSLNLASNNFSGN----L 145 (618)
Q Consensus 81 ~~~~v~~l~l~~~-~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~------~~L~~L~L~~N~l~~~----~ 145 (618)
.+..++.|+|++| +|.. .+.+.+..-+.|+.|+|++|.|...--..+. +.|+.|+|++|+|... +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3567999999986 7753 3566777889999999999999844333333 7899999999999853 3
Q ss_pred CccccCCCCccEEEeecCC---CCCc----cchhhcCCCCCCeEEcccCcCC
Q 007103 146 PYSIASMVSLSYLNVSRNS---LTQS----IGDIFGNLAGLATLDLSFNNFS 190 (618)
Q Consensus 146 p~~~~~l~~L~~L~L~~N~---l~~~----~p~~~~~l~~L~~L~ls~N~l~ 190 (618)
-..+..-+.|++|+|++|. +... +...+..-+.|+.|+|+.|.+.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 3345555678888887653 3321 3344555567777777766543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00039 Score=72.06 Aligned_cols=131 Identities=12% Similarity=0.178 Sum_probs=69.3
Q ss_pred cccccCCCCCCEEEecCCCccCCCCCCC--CCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCC
Q 007103 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177 (618)
Q Consensus 100 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 177 (618)
..+|.++..|+.+.+.++..+ .-...+ .++|+.+.+. +.++..-...|.+|.+|+.++|..| ++.+-..+|.++.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 445666777777777655432 111222 2667777775 4455444556677777777777644 5544456677777
Q ss_pred CCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccc
Q 007103 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHF 235 (618)
Q Consensus 178 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l 235 (618)
+|+.+.|..+ ++..-...|.++++|+.+++.+|..... ..+....|+.+.+..|.+
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~~-~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQWN-AISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHHH-TCBCCCCC----------
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeehh-hhhccCCCCEEEeCCCCE
Confidence 7777777544 5523345567777777777776654321 112233466665555543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.42 E-value=5.3e-05 Score=68.26 Aligned_cols=37 Identities=16% Similarity=0.098 Sum_probs=25.8
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCC-cc
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNS-IH 120 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~-l~ 120 (618)
+++.|||+++.++..--..+..+++|+.|+|+++. |+
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It 99 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE 99 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC
Confidence 57888888877766555566677777777777764 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.01 Score=59.31 Aligned_cols=145 Identities=15% Similarity=0.181 Sum_probs=76.7
Q ss_pred cceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-----CCCcccccc-e--EEeeCCeEEEE
Q 007103 415 EFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-----RHPNIVTLA-G--YCAEHGQRLLV 486 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv 486 (618)
.+.|+.|....+|+....+| .+++|...... ....+..|...+..+ .-|.++... | +....+..+++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 34577888899999987666 67889876521 112233444444433 223333211 1 12234677999
Q ss_pred EEecCCCChhh--------------hhhcccCC-CC----CC---CHHHHHH------------HHHHHHHHHHHHhhc-
Q 007103 487 YEYVGNGNLHD--------------MLHFADDS-SK----NL---TWNARVR------------VALGTARALEYLHEV- 531 (618)
Q Consensus 487 ~e~~~~gsL~~--------------~l~~~~~~-~~----~l---~~~~~~~------------i~~~i~~~L~~LH~~- 531 (618)
++|++|..+.. .+|..... .. .. .|..... +...+.+.++++++.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99998865321 01111000 00 01 1221100 001134455666532
Q ss_pred ---CCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 532 ---CLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 532 ---~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
..++++|+|+.+.|||++++..+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123689999999999999876568999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0018 Score=66.60 Aligned_cols=128 Identities=14% Similarity=0.159 Sum_probs=70.8
Q ss_pred cccccCCCCCCEEEecCCCccCCCCCCC--CCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCC
Q 007103 100 GYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLA 177 (618)
Q Consensus 100 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 177 (618)
...+....+|+.+.+..+ +.......+ ..+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++......|.+++
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 445556666777766544 221111222 256777776654 44344556666777777776543 4444445666777
Q ss_pred CCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccc-cccCC-CCccEEEcc
Q 007103 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSG-LPLTTLNVA 231 (618)
Q Consensus 178 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~-~~L~~L~l~ 231 (618)
+|+.+.+.+|.++..-...|.++.+|+.+.|..+ ++..- ..|.. .+|+.+.+.
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 7777777766666444456667777777777543 43322 22333 346665543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00073 Score=57.87 Aligned_cols=37 Identities=22% Similarity=0.178 Sum_probs=20.6
Q ss_pred CCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccc
Q 007103 178 GLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (618)
Q Consensus 178 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (618)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4556666666665333344555566666666666553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0052 Score=61.58 Aligned_cols=143 Identities=17% Similarity=0.208 Sum_probs=78.3
Q ss_pred eeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCC--cccccceE-----EeeCCeEEEEEEe
Q 007103 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHP--NIVTLAGY-----CAEHGQRLLVYEY 489 (618)
Q Consensus 417 ~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~ 489 (618)
.++ |....||+....+|+.+++|........ ...+..|...+..+... .+++++.. ....+..++++||
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 466 8888999988777888999998643222 23444555555444211 13334332 2235667899999
Q ss_pred cCCCChh-----hh---------hhcccCC-----CCCCCHHHH----HHH---------------HHHHHHHHHHHhhc
Q 007103 490 VGNGNLH-----DM---------LHFADDS-----SKNLTWNAR----VRV---------------ALGTARALEYLHEV 531 (618)
Q Consensus 490 ~~~gsL~-----~~---------l~~~~~~-----~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~ 531 (618)
+++..+. .+ +|..... ....++... ..+ ...+.+.++.+.+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875432 10 1111000 011222111 001 11111223333321
Q ss_pred ----CCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 532 ----CLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 532 ----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
..+.++|+|+++.||+++ + .+.|+||+.+...
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 123579999999999999 4 8999999887543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0026 Score=65.80 Aligned_cols=142 Identities=14% Similarity=0.154 Sum_probs=100.5
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCC--CCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
.++.+.+.+ .+...-...+..+..|+.+.+..+... .....+ ...|+.+.+..+.+. ...|..+.+|+.+.+.
T Consensus 231 ~l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPD-SFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECT-TCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred CCceEEECC-CceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccc
Confidence 466666654 344445567889999999999887654 222222 377888887766533 3467789999999997
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccc-cccCC-CCccEEEcccc
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSG-LPLTTLNVANN 233 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~-~~L~~L~l~~N 233 (618)
++ ++.+-..+|.++.+|+.++|.++ ++..-...|.++.+|+.+.+..| ++..- ..|.+ .+|+.+++..|
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 65 66566678999999999999754 66444677889999999999876 55432 23544 46999988655
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.001 Score=65.98 Aligned_cols=30 Identities=17% Similarity=0.202 Sum_probs=25.3
Q ss_pred CceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 535 SVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 535 ~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
.++|+|+.+.||+ .+++.+.++||..+...
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 5799999999999 56667899999987644
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0028 Score=63.84 Aligned_cols=33 Identities=30% Similarity=0.293 Sum_probs=27.9
Q ss_pred CCceecCCCCCCeeecCC----CCcEEeeccccccCC
Q 007103 534 PSVVHRNFKSANILLDDE----LNPHLSDCGLAALTP 566 (618)
Q Consensus 534 ~~iiH~Dlkp~Nill~~~----~~~kl~Dfgl~~~~~ 566 (618)
+.++|+|+.+.|||++.+ +.+.|+||+.+...+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 378999999999999874 678999999886544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0031 Score=65.18 Aligned_cols=53 Identities=13% Similarity=0.160 Sum_probs=32.0
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecc
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLA 137 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~ 137 (618)
..++.++|.+ +++.+-..+|.++++|+.++|.+| ++..-...+. ++|+.+.+.
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p 125 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLP 125 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhccc
Confidence 3578888864 466666677888888888888755 4311112222 455555544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0021 Score=66.49 Aligned_cols=124 Identities=14% Similarity=0.170 Sum_probs=84.1
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEee
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
.++.+++.++ +......+|.+++.|+.+.+. +.++..-...|. .+|+.++|..| ++..-...|.+|.+|+.+.|.
T Consensus 266 ~L~~i~lp~~-~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDS-VVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTT-CCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccc-cceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 3455566543 333445678899999999996 445533333343 79999999865 665667789999999999997
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccc
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (618)
.+ ++.+-..+|.++++|+.+++.+|.... ..+....+|+.+.+..|.+.
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 55 776777899999999999999987652 35677789999998877653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0023 Score=66.99 Aligned_cols=73 Identities=14% Similarity=0.152 Sum_probs=47.1
Q ss_pred cceeccCccceEEEEEEcC--------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcc-cccceEEeeCCeEEE
Q 007103 415 EFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-VTLAGYCAEHGQRLL 485 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~l 485 (618)
.+.|+.|....+|++...+ ++.+++|+..... . ...+.+|...++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4468889899999998763 4788899884321 1 1334467777766643333 556665432 38
Q ss_pred EEEecCCCCh
Q 007103 486 VYEYVGNGNL 495 (618)
Q Consensus 486 v~e~~~~gsL 495 (618)
|+||+++.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0056 Score=62.63 Aligned_cols=142 Identities=15% Similarity=0.155 Sum_probs=79.7
Q ss_pred ceeccCccceEEEEEEc--------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEEE
Q 007103 416 FLIGEGSLGRVYRAEFA--------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 486 (618)
+.+..|-...+|+.... +++.+++|+..... .....+.+|..+++.+. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45777888999999875 25788999864321 12344557877776663 2223556665543 299
Q ss_pred EEecCCCChhhh-----------------hhcccC-CCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 007103 487 YEYVGNGNLHDM-----------------LHFADD-SSKNLT--WNARVRVALGTAR-------------------ALEY 527 (618)
Q Consensus 487 ~e~~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~i~~-------------------~L~~ 527 (618)
|||+++..+..- +|.... ...... +.++.++..++.. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999987654310 111110 111122 3444445443321 2333
Q ss_pred Hh----hc-CCCCceecCCCCCCeeecCC----CCcEEeecccccc
Q 007103 528 LH----EV-CLPSVVHRNFKSANILLDDE----LNPHLSDCGLAAL 564 (618)
Q Consensus 528 LH----~~-~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfgl~~~ 564 (618)
|. .. ....++|+|+.+.||+++++ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 21 11258999999999999876 7899999998853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.01 Score=62.44 Aligned_cols=74 Identities=11% Similarity=0.007 Sum_probs=45.3
Q ss_pred cceeccCccceEEEEEEcC-CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcc-cccceEEeeCCeEEEEEEecCC
Q 007103 415 EFLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI-VTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 492 (618)
.+.|+.|-...+|+....+ ++.+++|+........ .+..+|..+++.+...++ .++++.+. + .+|+||+++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4468889999999998875 5788888875322111 112466777766654444 45666652 2 359999987
Q ss_pred CCh
Q 007103 493 GNL 495 (618)
Q Consensus 493 gsL 495 (618)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.012 Score=60.16 Aligned_cols=131 Identities=14% Similarity=0.153 Sum_probs=76.2
Q ss_pred cccCCCCCCEEEecCCCcc-CCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCC
Q 007103 102 LLSDLLSLRKFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLA 180 (618)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~-~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 180 (618)
.+.....+..+.+..+.-. +........+|+.+.+..+ ++......+.++.+|+.+.+..+ ++.+-..+|.++.+|+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 189 SYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp ECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred cccccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 3444455555554443222 1111222266777777554 33344556677777888777665 5555556777777788
Q ss_pred eEEcccCcCCCCCCCCcccCCCcCeeeecccccccccc-ccCC-CCccEEEccccccc
Q 007103 181 TLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN-VFSG-LPLTTLNVANNHFS 236 (618)
Q Consensus 181 ~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~-~~L~~L~l~~N~l~ 236 (618)
.+.+..+ +.......|.++.+|+.+.+.+|.++..-. .|.. .+|+.++|..+ ++
T Consensus 267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~ 322 (379)
T 4h09_A 267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK 322 (379)
T ss_dssp EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc
Confidence 8777644 443344567777788888887777765332 2333 45777777544 44
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.011 Score=59.68 Aligned_cols=32 Identities=19% Similarity=0.283 Sum_probs=27.8
Q ss_pred CCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 534 ~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36899999999999998888999999877543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.015 Score=59.44 Aligned_cols=73 Identities=10% Similarity=0.039 Sum_probs=40.4
Q ss_pred ceeccCccceEEEEEEcC---------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCc-ccccceEEeeCCeEEE
Q 007103 416 FLIGEGSLGRVYRAEFAN---------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN-IVTLAGYCAEHGQRLL 485 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l 485 (618)
+.++.|....+|+....+ ++.+++|+........ .....|.+.++.+...+ +.++++.. . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~---~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL---YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT---SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce---ecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 457788889999998764 2678888875432111 11245555555553223 34555443 2 368
Q ss_pred EEEecCCCCh
Q 007103 486 VYEYVGNGNL 495 (618)
Q Consensus 486 v~e~~~~gsL 495 (618)
||||+++..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=95.49 E-value=0.01 Score=37.94 Aligned_cols=31 Identities=35% Similarity=0.524 Sum_probs=20.8
Q ss_pred CCCcceeehhHHHHHHHHHHHHHHHHHHHHh
Q 007103 299 ELPAGAIVGIVLGAVFLVALALLALYFCIRK 329 (618)
Q Consensus 299 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 329 (618)
....+.|+|+++|.++.+++++.+.++++||
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 3456788999998887776665555555444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.04 E-value=0.031 Score=36.78 Aligned_cols=30 Identities=23% Similarity=0.446 Sum_probs=15.1
Q ss_pred eeehhHHHHHHHHHHHHHHHHHHHHhcccc
Q 007103 304 AIVGIVLGAVFLVALALLALYFCIRKNRRK 333 (618)
Q Consensus 304 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (618)
.|++.+++.+++++++++.+++++|||+++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 455555555555544445545555544443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.98 E-value=0.032 Score=36.85 Aligned_cols=29 Identities=21% Similarity=0.392 Sum_probs=14.1
Q ss_pred eeehhHHHHHHHHHHHHHHHHHHHHhccc
Q 007103 304 AIVGIVLGAVFLVALALLALYFCIRKNRR 332 (618)
Q Consensus 304 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (618)
.|++.+++.+++++++++++++++|||++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 35555555445444444444455554443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.29 E-value=0.12 Score=53.61 Aligned_cols=74 Identities=8% Similarity=-0.038 Sum_probs=44.6
Q ss_pred cceeccCccceEEEEEEcC--------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEE
Q 007103 415 EFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 485 (618)
.+.+..|-...+|+....+ ++.+++|+....... ..+..+|..+++.+. +.-..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 3467788899999998763 578899887543211 111234555555443 22234455433 2 378
Q ss_pred EEEecCCCCh
Q 007103 486 VYEYVGNGNL 495 (618)
Q Consensus 486 v~e~~~~gsL 495 (618)
|+||+++..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998653
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.69 E-value=0.081 Score=34.73 Aligned_cols=28 Identities=21% Similarity=0.371 Sum_probs=13.6
Q ss_pred cceeehhHHHHHHHHHHHHHHHHHHHHhc
Q 007103 302 AGAIVGIVLGAVFLVALALLALYFCIRKN 330 (618)
Q Consensus 302 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (618)
...++++++|.+ +++++.+++.++.|||
T Consensus 11 ~~~Ia~~vVGvl-l~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 11 LTSIISAVVGIL-LVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHHH-HHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHH-HHHHHHHHHHhheehh
Confidence 345777777743 3333333333444443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.07 E-value=0.23 Score=45.83 Aligned_cols=99 Identities=14% Similarity=0.102 Sum_probs=64.4
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
-+|.++++. .+.++++.++|.++.|.+.+|.-+-.... . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 378898874 36789999999999999998877622111 1 1333457899999999887764 1110
Q ss_pred ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh
Q 007103 573 STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT 611 (618)
Q Consensus 573 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 611 (618)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0112366888763 344678889999999998775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.88 E-value=0.21 Score=46.00 Aligned_cols=87 Identities=14% Similarity=0.129 Sum_probs=64.1
Q ss_pred CCCcccccceEEeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 007103 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (618)
Q Consensus 466 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 545 (618)
.||++++. .+-.+++...+.++.-+ +...+-. -..++...+++++.+|+...++++++ +|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888866 56666666666666543 2222221 23478899999999999988777766 888999999
Q ss_pred eeecCCCCcEEeeccccccC
Q 007103 546 ILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 546 ill~~~~~~kl~Dfgl~~~~ 565 (618)
++++.++.+++.=.|+...+
T Consensus 110 L~f~~~~~p~i~~RGik~~l 129 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV 129 (215)
T ss_dssp EEECTTSCEEESCCEETTTB
T ss_pred EEEcCCCCEEEEEccCccCC
Confidence 99999999999977765433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.58 E-value=0.099 Score=53.89 Aligned_cols=29 Identities=24% Similarity=0.384 Sum_probs=24.7
Q ss_pred ceecCCCCCCeee------cCCCCcEEeecccccc
Q 007103 536 VVHRNFKSANILL------DDELNPHLSDCGLAAL 564 (618)
Q Consensus 536 iiH~Dlkp~Nill------~~~~~~kl~Dfgl~~~ 564 (618)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998853
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.40 E-value=1 Score=41.51 Aligned_cols=85 Identities=13% Similarity=0.157 Sum_probs=62.5
Q ss_pred CCCcccccceEEeeCCeEEEEEEecCCC-ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCceecCCCC
Q 007103 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNG-NLHDMLHFADDSSKNLTWNARVRVALGTARALE-YLHEVCLPSVVHRNFKS 543 (618)
Q Consensus 466 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~iiH~Dlkp 543 (618)
.||++ -..+-.+++...+.++.-+++ +.. .+ ..++..++++++.+|+.... +++++ +|--|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i-------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI-------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH-------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH-------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeC
Confidence 67877 444456677777777765333 333 22 24788899999999988777 66665 8889999
Q ss_pred CCeeecCCCCcEEeeccccccC
Q 007103 544 ANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 544 ~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
+|++++.++.++|.-.|+-..+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTB
T ss_pred ceEEEeCCCcEEEEEcCCcccC
Confidence 9999999999999988865433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.09 E-value=0.16 Score=53.44 Aligned_cols=61 Identities=7% Similarity=0.046 Sum_probs=16.8
Q ss_pred ceeccCccceEEEEEEcC-CcEEEE------EEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee
Q 007103 416 FLIGEGSLGRVYRAEFAN-GKIMAV------KKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE 479 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~-g~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 479 (618)
+.+| ||.||+|.+.. ..+||+ |..+......+....+.+|..+++..+|||+++.+++...
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3455 99999998864 357888 7666544444455678888888888999999999888653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 618 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-59
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS G VY+ ++ +AVK ++ A + Q+ F V + + RH NI+ GY
Sbjct: 15 RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
Q +V ++ +L+ LH + +A TA+ ++YLH S+
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFAL---SGI 592
+HR+ KS NI L ++L + D GLA + Q+ G+ + APE
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 593 YTVKSDVYSFGVVMLELLTGRKPLD 617
Y+ +SDVY+FG+V+ EL+TG+ P
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS 210
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 6e-58
Identities = 48/214 (22%), Positives = 98/214 (45%), Gaps = 11/214 (5%)
Query: 405 LQTATNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMS 463
++ + F + +G G+ G V++ +G +MA K I + + + + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLH 59
Query: 464 RLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
P IV G G+ + E++ G+L +L + + +V++ +
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYS 583
L YL E ++HR+ K +NIL++ L D G++ ++ ++ VG Y
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYM 170
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+PE Y+V+SD++S G+ ++E+ GR P+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-57
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 9/199 (4%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G G G V+ + +AVK + + D FL + M +L+H +V L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ EY+ NG+L D L S LT N + +A A + ++ E +
Sbjct: 77 V-TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVK 596
+HR+ ++ANIL+ D L+ ++D GLA L + E ++APE G +T+K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 597 SDVYSFGVVMLELLTGRKP 615
SDV+SFG+++ E++T +
Sbjct: 191 SDVWSFGILLTEIVTHGRI 209
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-55
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IG G G V+ + N +A+K I E++F+E M +L HP +V L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
E LV+E++ +G L D L + + L + YL E C V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L+ + +SD G+ + + ST +++PE Y+ KS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 598 DVYSFGVVMLELLTGRKP 615
DV+SFGV+M E+ + K
Sbjct: 184 DVWSFGVLMWEVFSEGKI 201
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-54
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 9/198 (4%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
+G G G V ++ +A+K I + ED F+E M L H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ ++ EY+ NG L + L + + A+EYL +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ + N L++D+ +SD GL+ + E S +S PE + ++ KS
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 598 DVYSFGVVMLELLTGRKP 615
D+++FGV+M E+ + K
Sbjct: 183 DIWAFGVLMWEIYSLGKM 200
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-53
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 6/206 (2%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS GR + ++GKI+ K++D +++ E+ + V+ + L+HPNIV
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 476 YCAEHGQRLL--VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE--V 531
+ L V EY G+L ++ + L +RV AL+ H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
+V+HR+ K AN+ LD + N L D GLA + N + + VG Y +PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYYMSPEQMNRM 189
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLD 617
Y KSD++S G ++ EL P
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFT 215
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-53
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S E +G+G G V+ + +A+K + + FL+ M +LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 73
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+V L +V EY+ G+L D L ++ K L V +A A + Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ VHR+ ++ANIL+ + L ++D GLA L + E ++APE AL
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
G +T+KSDV+SFG+++ EL T +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV 213
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-51
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
+G+G+ G+VY+A+ + A K ID S +E ++++ + ++ HPNIV L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
++ E+ G + ++ + + LT + V T AL YLH+ +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-----G 591
+HR+ K+ NIL + + L+D G++A T Q +G + APE +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLD 617
Y K+DV+S G+ ++E+ P
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHH 216
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-51
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G G V ++ G +AVK I N FL S M++LRH N+V L G
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 477 CAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
E L +V EY+ G+L D L L + ++ +L A+EYL +
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NN 123
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
VHR+ + N+L+ ++ +SD GL +T+ ++APE ++
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFST 179
Query: 596 KSDVYSFGVVMLELLTGRKP 615
KSDV+SFG+++ E+ + +
Sbjct: 180 KSDVWSFGILLWEIYSFGRV 199
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 9e-51
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 414 QEFLIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
++ +G G+ G V + + K +AVK + N A +D L + M +L +P I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 471 VTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
V + G C E +LV E G L+ L ++++ + + + ++YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN--TERQVSTQMVGAFGYSAPEFA 588
+ VHR+ + N+LL + +SD GL+ + T + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKP 615
++ KSDV+SFGV+M E + +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQK 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 2e-50
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 400 YTVASLQTATNSFSQEF---------LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAA 446
+T A F++E +IG G G V +A+K + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG- 65
Query: 447 LSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSS 506
+ ++ +FL S M + HPN++ L G + +++ E++ NG+L L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QND 122
Query: 507 KNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566
T V + G A ++YL ++ VHR+ + NIL++ L +SD GL+
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 567 NTERQV----STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ + ++APE +T SDV+S+G+VM E+++ +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 5e-50
Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 14/217 (6%)
Query: 405 LQTATNSFS-QEFLIGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVS 460
L ++ + +G G+ G V + + +A+K + + + +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQ 61
Query: 461 NMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALG 520
M +L +P IV L G C + +LV E G G LH L + + + +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 117
Query: 521 TARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP--NTERQVSTQMVG 578
+ ++YL E + VHR+ + N+LL + +SD GL+ ++ +
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 579 AFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ APE ++ +SDV+S+GV M E L+ +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (440), Expect = 5e-50
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 412 FSQEFLIGEGSLGRVYRAE-FANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPN 469
FS IG GS G VY A N +++A+KK+ + S ++ + ++ V + +LRHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+ G LV EY + K L V G + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+++HR+ K+ NILL + L D G A++ VG + APE L
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVIL 184
Query: 590 S---GIYTVKSDVYSFGVVMLELLTGRKPLD 617
+ G Y K DV+S G+ +EL + PL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 6e-50
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 15/206 (7%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG GS VY+ +A ++ + L+ E F E + L+HPNIV
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 477 CAEHGQR----LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ +LV E + +G L L K + + L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 533 LPSVVHRNFKSANILLDDELN-PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSG 591
P ++HR+ K NI + + D GLA L + + ++G + APE
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPE-MYEE 187
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLD 617
Y DVY+FG+ MLE+ T P
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYS 213
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 7e-50
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEA-VSNMSRLRHPNIVTLAGY 476
IG+G G V+R ++ G+ +AVK + +E F EA + LRH NI+
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 477 CAEHG----QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ Q LV +Y +G+L D L+ +T +++AL TA L +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 533 L-----PSVVHRNFKSANILLDDELNPHLSDCGLAAL---TPNTERQVSTQMVGAFGYSA 584
+ P++ HR+ KS NIL+ ++D GLA +T VG Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 585 PEFALSGI------YTVKSDVYSFGVVMLELLTGRKP 615
PE I ++D+Y+ G+V E+
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 2e-49
Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G G VY + +AVK + + ++E FL+ + M ++HPN+V L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLLG 80
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
C ++ E++ GNL D L + + + ++ + +A + A+EYL + +
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KN 135
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+HR+ + N L+ + ++D GL+ L ++APE +++
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 596 KSDVYSFGVVMLELLTGRKP 615
KSDV++FGV++ E+ T
Sbjct: 196 KSDVWAFGVLLWEIATYGMS 215
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-49
Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 12/203 (5%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G+G G VY A + I+A+K + A L E V S LRHPNI+ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
GY + + L+ EY G ++ L A AL Y H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS---K 125
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
V+HR+ K N+LL ++D G + P++ R + G Y PE ++
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHD 182
Query: 595 VKSDVYSFGVVMLELLTGRKPLD 617
K D++S GV+ E L G+ P +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFE 205
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 6e-49
Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 31/240 (12%)
Query: 403 ASLQTATNSFSQEFLIGEGSLGRVYRAE------FANGKIMAVKKIDNAALSLQEEDNFL 456
SL+ N+ IGEG+ GRV++A + ++AVK + A S + +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQ 64
Query: 457 EAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH---------------- 500
+ M+ +PNIV L G CA L++EY+ G+L++ L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 501 ----FADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556
+ L+ ++ +A A + YL E VHR+ + N L+ + + +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKI 181
Query: 557 SDCGLA-ALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+D GL+ + + + PE YT +SDV+++GVV+ E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-49
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 15/213 (7%)
Query: 412 FSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR 466
F +++ +GEG+ G V A + +AVK +D ++ +N + + L
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLN 61
Query: 467 HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALE 526
H N+V G+ E + L EY G L D + + R +
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVV 117
Query: 527 YLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSAP 585
YLH + HR+ K N+LLD+ N +SD GLA N ++ +M G Y AP
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 586 EFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617
E + DV+S G+V+ +L G P D
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 9e-49
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 417 LIGEGSLGRVYRAEFANGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
+IG G G VY + AVK ++ + E FL M HPN+++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 473 LAGYCAEH-GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
L G C G L+V Y+ +G+L + F + + N T + L A+ + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRN---FIRNETHNPTVKDLIGFGLQVAKGM---KFL 146
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE---RQVSTQMVGAFGYSAPEFA 588
VHR+ + N +LD++ ++D GLA + E T + A E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ +T KSDV+SFGV++ EL+T P
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP 233
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 31/226 (13%)
Query: 417 LIGEGSLGRVYRA------EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
++G G+ G+V A + +AVK + A S E + + + M++L H N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHEN 102
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH-------------------FADDSSKNLT 510
IV L G C G L++EY G+L + L ++ LT
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 511 WNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTER 570
+ + A A+ +E+L S VHR+ + N+L+ + D GLA +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 571 QVS-TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
V + APE GIYT+KSDV+S+G+++ E+ +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-48
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG+G+ G VY A A G+ +A+++++ +++ + + M ++PNIV
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +V EY+ G+L D++ + V +ALE+LH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ KS NILL + + L+D G A + + ST MVG + APE Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGP 195
Query: 596 KSDVYSFGVVMLELLTGRKP 615
K D++S G++ +E++ G P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 6e-48
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 26/221 (11%)
Query: 417 LIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPN 469
+G G+ G+V A +AVK + +A L E + + + +S L H N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMN 88
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH--------------FADDSSKNLTWNARV 515
IV L G C G L++ EY G+L + L +D L +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA-LTPNTERQVST 574
+ A+ + +L + +HR+ + NILL + D GLA + ++ V
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 575 QMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ APE + +YT +SDV+S+G+ + EL +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 2e-47
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 10/202 (4%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
++GEGS V A E A + A+K ++ + + MSRL HP V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ + Y NG L + + ALEYLH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG---K 127
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAAL-TPNTERQVSTQMVGAFGYSAPEFALSGIY 593
++HR+ K NILL+++++ ++D G A + +P +++ + VG Y +PE
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 594 TVKSDVYSFGVVMLELLTGRKP 615
SD+++ G ++ +L+ G P
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPP 209
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-47
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANG-----KIMAVKKIDNAALSLQEEDNFLEAVSNMSR 464
+ +++ +IG G G VY+ +A+K + A + ++ +FL M +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 65
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
H NI+ L G +++ +++ EY+ NG + F + + V + G A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENG---ALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVST--QMVGAFGY 582
++YL + VHR+ + NIL++ L +SD GL+ + + T +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 583 SAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+APE +T SDV+SFG+VM E++T +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (417), Expect = 3e-46
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 13/204 (6%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V+R A G A K + +++ + + MS LRHP +V L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + +++YE++ G L + + D ++ + V + L ++HE
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN--- 144
Query: 536 VVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
VH + K NI+ + + L D GL A + T G ++APE A
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPV 202
Query: 594 TVKSDVYSFGVVMLELLTGRKPLD 617
+D++S GV+ LL+G P
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFG 226
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-46
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 12/203 (5%)
Query: 417 LIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVT 472
IGEG G V++ + + +A+K N S + FL+ M + HP+IV
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVK 72
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G E+ ++ E G L F +L + + A + AL YL
Sbjct: 73 LIGVITEN-PVWIIMELCTLGELRS---FLQVRKYSLDLASLILYAYQLSTALAYLES-- 126
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
VHR+ + N+L+ L D GL+ ++ +++ + APE
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 593 YTVKSDVYSFGVVMLELLTGRKP 615
+T SDV+ FGV M E+L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVK 208
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 22/222 (9%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEFANG---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRL- 465
N + +IGEG+ G+V +A A+K++ A S + +F + + +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLG 68
Query: 466 RHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLH------------FADDSSKNLTWNA 513
HPNI+ L G C G L EY +GNL D L A+ ++ L+
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 514 RVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVS 573
+ A AR ++YL + +HR+ + NIL+ + ++D GL+ +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--K 183
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
T + A E +YT SDV+S+GV++ E+++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-45
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 14/205 (6%)
Query: 418 IGEGSLGRVYRAEF----ANGKIMAVKKIDNAALSLQEE-DNFLEAVSNMSRLRHPNIVT 472
+G+GS G V R E+ +AVK + LS E D+F+ V+ M L H N++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L G +V E G+L D L + R A+ A + YL
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ--VSTQMVGAFGYSAPEFALS 590
+HR+ + N+LL + D GL P + + F + APE +
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKP 615
++ SD + FGV + E+ T +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 1e-44
Identities = 40/202 (19%), Positives = 82/202 (40%), Gaps = 9/202 (4%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V+R A G++ K I+ ++ +S M++L HP ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ + +L+ E++ G L D + ++ + L+++HE S
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+VH + K NI+ + + + T ++ ++APE
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 596 KSDVYSFGVVMLELLTGRKPLD 617
+D+++ GV+ LL+G P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFA 229
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (399), Expect = 1e-43
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED----NFLEAVSNMSR 464
N FS +IG G G VY GK+ A+K +D + +++ + N +S +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 465 LRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARA 524
P IV ++ + + + + G+LH L + A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 525 LEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSA 584
LE++H VV+R+ K ANILLD+ + +SD GLA + VG GY A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMA 173
Query: 585 PEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617
PE G+ Y +D +S G ++ +LL G P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 412 FSQEFLIGEGSLGRVYRAEF-ANGKIMAVK---KIDNAALSLQEEDNFLEAVSNMSRLRH 467
F + ++G G+ G VY+ + G+ + + K A S + L+ M+ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
P++ L G C L+ + + G L D + + N+ + + A+ + Y
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPE 586
L + +VHR+ + N+L+ + ++D GLA L E++ + + A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 587 FALSGIYTVKSDVYSFGVVMLELLTGRKP 615
L IYT +SDV+S+GV + EL+T
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-43
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 11/202 (5%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQE--EDNFLEAVSNMSRLRHPNIVTL 473
++G+GS G+V+ AEF + A+K + + + + E +E HP + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 474 AGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL 533
V EY+ G+L + S + A L++LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS--- 121
Query: 534 PSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
+V+R+ K NILLD + + ++D G+ + + +T G Y APE L Y
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKY 180
Query: 594 TVKSDVYSFGVVMLELLTGRKP 615
D +SFGV++ E+L G+ P
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 7e-43
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G+ V AE K++A+K I AL +E + ++ + +++HPNIV L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
G L+ + V G L D + T R+ A++YLH++
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLG--- 127
Query: 536 VVHRNFKSANILL---DDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI 592
+VHR+ K N+L D++ +SD GL+ + V + G GY APE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 593 YTVKSDVYSFGVVMLELLTGRKP 615
Y+ D +S GV+ LL G P
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-42
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 417 LIGEGSLGRVYRAEF--------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RH 467
+GEG+ G+V AE +AVK + + A ++ + + + M + +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKH 78
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHF------------ADDSSKNLTWNARV 515
NI+ L G C + G ++ EY GNL + L + + + L+ V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 516 RVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQ 575
A AR +EYL +HR+ + N+L+ ++ ++D GLA + + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 576 -MVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ APE IYT +SDV+SFGV++ E+ T
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (388), Expect = 1e-42
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
+G GS GRV+ NG+ A+K + + L++ ++ + +S + HP I+ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
G + Q ++ +Y+ G L +L S+ A ALEYLH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS---K 123
Query: 535 SVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYT 594
+++R+ K NILLD + ++D G A P+ + G Y APE + Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYN 179
Query: 595 VKSDVYSFGVVMLELLTGRKP 615
D +SFG+++ E+L G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (385), Expect = 1e-42
Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 7/198 (3%)
Query: 418 IGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYC 477
IGEG+ G VY+A+ G+ A+KKI + +S + L+H NIV L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 478 AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVV 537
+ +LV+E++ + L L + Y H+ V+
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 538 HRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKS 597
HR+ K N+L++ E ++D GLA R+ + ++V + + S Y+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 598 DVYSFGVVMLELLTGRKP 615
D++S G + E++ G
Sbjct: 183 DIWSVGCIFAEMVNGTPL 200
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-42
Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 418 IGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIV 471
+G+GS G VY +A+K ++ AA S++E FL S M ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 86
Query: 472 TLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKN------LTWNARVRVALGTARAL 525
L G ++ L++ E + G+L L + N + + +++A A +
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 526 EYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA-ALTPNTERQVSTQMVGAFGYSA 584
YL+ VHR+ + N ++ ++ + D G+ + + + + + +
Sbjct: 147 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 585 PEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
PE G++T SDV+SFGVV+ E+ T +
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 6e-42
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 7/200 (3%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG+ G VY+A G+++A+KKI + + +S + L HPNIV L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ LV+E++ M + + + L + H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
V+HR+ K N+L++ E L+D GLA R + ++V + + Y+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 596 KSDVYSFGVVMLELLTGRKP 615
D++S G + E++T R
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-42
Identities = 39/204 (19%), Positives = 85/204 (41%), Gaps = 14/204 (6%)
Query: 417 LIGEGSLGRVYRA-EFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G G V+R E ++ K K + + ++ + +S ++ RH NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ ++++E++ ++ + ++ S+ L V AL++LH +
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 536 VVHRNFKSANILLDDELNPH--LSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY 593
+ H + + NI+ + + + G A + + A Y APE +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVV 180
Query: 594 TVKSDVYSFGVVMLELLTGRKPLD 617
+ +D++S G ++ LL+G P
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFL 204
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 23/219 (10%)
Query: 417 LIGEGSLGRVYRAEF------ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNI 470
+G G+ G+V A+ A + +AVK + A + E + H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 471 VTLAGYCAEHGQRL-LVYEYVGNGNLHDMLH------------FADDSSKNLTWNARVRV 517
V L G C + G L ++ E+ GNL L D LT +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV-STQM 576
+ A+ +E+L +HR+ + NILL ++ + D GLA V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 577 VGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ APE +YT++SDV+SFGV++ E+ +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (377), Expect = 2e-41
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLA 474
++G G + V+ A + +AVK + + A F N + L HP IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 475 GYCAEHGQRL----LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
+V EYV L D++H + +T + V +AL + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV--STQMVGAFGYSAPEFA 588
++HR+ K ANI++ + D G+A ++ V + ++G Y +PE A
Sbjct: 130 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+SDVYS G V+ E+LTG P
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (376), Expect = 2e-41
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 28/225 (12%)
Query: 412 FSQEF----LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSL-------QEEDNFLEAV 459
F + + ++G G V R K AVK ID + + L+ V
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 460 SNMSRLR-HPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVA 518
+ ++ HPNI+ L + LV++ + G L D L L+ ++
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIM 116
Query: 519 LGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVG 578
+ LH++ +VHR+ K NILLDD++N L+D G + E+ ++ G
Sbjct: 117 RALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCG 171
Query: 579 AFGYSAPEFALSGI------YTVKSDVYSFGVVMLELLTGRKPLD 617
Y APE + Y + D++S GV+M LL G P
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 411 SFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 469
S++ +IG GS G VY+A+ +G+++A+KK+ E + M +L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------LQIMRKLDHCN 74
Query: 470 IVTLAGYCAEHGQR------LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTAR 523
IV L + G++ LV +YV H+ + + L R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFR 133
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLDDELNPH-LSDCGLAALTPNTERQVSTQMVGAFGY 582
+L Y+H + HR+ K N+LLD + L D G A E VS + + Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYY 188
Query: 583 SAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKP 615
APE YT DV+S G V+ ELL G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-39
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 13/206 (6%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEED---NFLEAVSNMSRLRHPNIVT 472
+GEG VY+A +I+A+KKI S ++ L + + L HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
L LV++++ D+ D+S LT + L T + LEYLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 533 LPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS-G 591
++HR+ K N+LLD+ L+D GLA + + + T V Y APE
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 592 IYTVKSDVYSFGVVMLELLTGRKPLD 617
+Y V D+++ G ++ ELL L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLP 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 51/222 (22%), Positives = 80/222 (36%), Gaps = 27/222 (12%)
Query: 412 FSQEFL---------IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSN 461
F QE + +G G V + + G A K I E +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 462 ----MSRLRHPNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRV 517
+ ++HPN++TL +L+ E V G L D L ++LT
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEF 118
Query: 518 ALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNP----HLSDCGLAALTPNTERQVS 573
+ YLH + + H + K NI+L D P + D GLA
Sbjct: 119 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--F 173
Query: 574 TQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKP 615
+ G + APE +++D++S GV+ LL+G P
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 47/205 (22%), Positives = 79/205 (38%), Gaps = 12/205 (5%)
Query: 418 IGEGSLGRVYRAEFA--NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL---RHPNIVT 472
IGEG+ G+V++A G+ +A+K++ + + V+ + L HPN+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 473 LAGYCAEHGQRLLVYEYVGNGNLH--DMLHFADDSSKNLTWNARVRVALGTARALEYLHE 530
L C + ++ + + + R L++LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 531 VCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS 590
VVHR+ K NIL+ L+D GLA + T +V Y APE L
Sbjct: 135 HR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQ 189
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKP 615
Y D++S G + E+ +
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IGEG+ G V A N +A+KKI L + + R RH NI+ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 73
Query: 476 YCA----EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
E + + + ++ +L+ +L +++L+ + R L+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA 128
Query: 532 CLPSVVHRNFKSANILLDDELNPHLSDCGLAAL--TPNTERQVSTQMVGAFGYSAPEFAL 589
V+HR+ K +N+LL+ + + D GLA + + T+ V Y APE L
Sbjct: 129 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 590 SGI-YTVKSDVYSFGVVMLELLTGRKP 615
+ YT D++S G ++ E+L+ R
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 3e-37
Identities = 44/200 (22%), Positives = 80/200 (40%), Gaps = 8/200 (4%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IGEG+ G V++A+ +I+A+K++ + L + + L+H NIV L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSV 536
+ LV+E+ V + L+ L +V
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 537 VHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVK 596
+HR+ K N+L++ L++ GLA R S ++V + + +Y+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 597 SDVYSFGVVMLELLTGRKPL 616
D++S G + EL +PL
Sbjct: 183 IDMWSAGCIFAELANAGRPL 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 21/209 (10%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
++G G G+V + + A+K + + + +E + A + P+IV +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA------SQCPHIVRIVD 72
Query: 476 YC----AEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEV 531
A L+V E + G L + D + T + A++YLH +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 532 CLPSVVHRNFKSANILLDDELNP---HLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
++ HR+ K N+L + L+D G A T + + Y APE
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 589 LSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y D++S GV+M LL G P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY 214
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 137 bits (345), Expect = 6e-37
Identities = 36/214 (16%), Positives = 71/214 (33%), Gaps = 24/214 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLA 474
IGEGS G ++ N + +A+K + + L I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 475 GYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+ E +LV + +G + D + + A ++ +HE
Sbjct: 68 YFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 535 SVVHRNFKSANILLDDELNPH-----LSDCGLAALTPN------TERQVSTQMVGAFGYS 583
S+V+R+ K N L+ + + + D G+ + + + G Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 584 APEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
+ L + + D+ + G V + L G P
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 3e-36
Identities = 37/208 (17%), Positives = 70/208 (33%), Gaps = 22/208 (10%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG GS G +Y A G+ +A+K + ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 476 YCAEHGQRL-LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLP 534
+C G +V E +G S+ + + +A +EY+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 535 SVVHRNFKSANIL---LDDELNPHLSDCGLAALTPNTE------RQVSTQMVGAFGYSAP 585
+ +HR+ K N L ++ D GLA + + + + G Y++
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 586 EFALSGIYTVKSDVYSFGVVMLELLTGR 613
L + + D+ S G V++ G
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 42/201 (20%), Positives = 76/201 (37%), Gaps = 9/201 (4%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V A G +A+KK+ S + + +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ + L + + + L Y+H +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII- 143
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGI-YT 594
HR+ K N+ ++++ + D GLA + T V Y APE L+ + YT
Sbjct: 144 --HRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT 197
Query: 595 VKSDVYSFGVVMLELLTGRKP 615
D++S G +M E++TG+
Sbjct: 198 QTVDIWSVGCIMAEMITGKTL 218
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 43/210 (20%), Positives = 76/210 (36%), Gaps = 18/210 (8%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALS----LQEEDNFLEAVSNMSRLR--HPN 469
L+G G G VY ++ +A+K ++ +S L V + ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
++ L + +L+ E L A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 530 EVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
V+HR+ K NIL+D + L D G AL +T T G YS PE+
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 589 LSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617
Y + V+S G+++ +++ G P +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 3e-35
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 13/200 (6%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G GS GRV + +G A+K +D + L++ ++ L + + P +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
++ +V EYV G + L + A EYLH +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD--- 161
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
+++R+ K N+L+D + ++D G A + G APE LS Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNK 217
Query: 596 KSDVYSFGVVMLELLTGRKP 615
D ++ GV++ E+ G P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 20/213 (9%)
Query: 418 IGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGY 476
IG+G+ G V++A G+ +A+KK+ L + + L+H N+V L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 477 CAEH--------GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
C G LV+++ + + + T + RV L Y+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA---ALTPNTERQVSTQMVGAFGYSAP 585
H ++HR+ K+AN+L+ + L+D GLA +L N++ T V Y P
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 586 EFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617
E L Y D++ G +M E+ T +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 55/208 (26%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 410 NSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKID-NAALSLQEEDNFLEAVSNMSRLRH 467
N F L+G+G+ G+V A G+ A+K + ++ E + + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 468 PNIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEY 527
P + L H + V EY G L L + T ALEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 528 LHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEF 587
LH VV+R+ K N++LD + + ++D GL + + G Y APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEV 176
Query: 588 ALSGIYTVKSDVYSFGVVMLELLTGRKP 615
Y D + GVVM E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 417 LIGEGSLGRVYRAEFA----NGKIMAVKKIDNAALSLQEE--DNFLEAVSNMSRLRH-PN 469
++G G+ G+V+ GK+ A+K + A + + + ++ + +R P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 470 IVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
+VTL + L+ +Y+ G L L + T + ALE+LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLH 146
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
+ +++R+ K NILLD + L+D GL+ E + + G Y AP+
Sbjct: 147 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 590 SGI--YTVKSDVYSFGVVMLELLTGRKP 615
G + D +S GV+M ELLTG P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (312), Expect = 5e-32
Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 23/206 (11%)
Query: 417 LIGEGSLGRVYRAE-FANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLA 474
+G G V+ A N + + VK + ++ + + LR PNI+TLA
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLA 96
Query: 475 GYCAEHGQRL--LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC 532
+ R LV+E+V N + + + LT +AL+Y H +
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 533 LPSVVHRNFKSANILLDDE-LNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALS- 590
++HR+ K N+++D E L D GLA + V + + PE +
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDY 204
Query: 591 GIYTVKSDVYSFGVVMLELLTGRKPL 616
+Y D++S G ++ ++ ++P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 41/200 (20%), Positives = 79/200 (39%), Gaps = 7/200 (3%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G+ G V A G +AVKK+ S+ + + ++H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPS 535
+ +L + LT + + R L+Y+H +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII- 143
Query: 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTV 595
HR+ K +N+ ++++ + D GLA +T+ +++ + + + Y
Sbjct: 144 --HRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 596 KSDVYSFGVVMLELLTGRKP 615
D++S G +M ELLTGR
Sbjct: 199 TVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 7e-31
Identities = 43/206 (20%), Positives = 74/206 (35%), Gaps = 19/206 (9%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
IG G+ G V A + +A+KK+ + + M + H NI++L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 476 YCA------EHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH 529
E LV E + + D + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 530 EVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFAL 589
++HR+ K +NI++ + + D GLA + T V Y APE L
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 191
Query: 590 SGIYTVKSDVYSFGVVMLELLTGRKP 615
Y D++S G +M E++ +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 2e-27
Identities = 34/216 (15%), Positives = 78/216 (36%), Gaps = 20/216 (9%)
Query: 417 LIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475
+G G V+ A+ N +A+K + + + + + + R+ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDS 76
Query: 476 YCAEHGQRLLVYEYVGNGNL------------HDMLHFADDSSKNLTWNARVRVALGTAR 523
A H +LL + N + + + + +++
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 524 ALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAAL-TPNTERQVSTQMVGAFG 581
L+Y+H ++H + K N+L++ + +L +A L + T +
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 582 YSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617
Y +PE L + +D++S ++ EL+TG +
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.4 bits (200), Expect = 2e-18
Identities = 28/200 (14%), Positives = 57/200 (28%), Gaps = 23/200 (11%)
Query: 417 LIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQE--------EDNFLEAVSNMSRLRHP 468
L+GEG V+ VK S ++ + +F +R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 469 NIVTLAGYCAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYL 528
+ L G + Y GN M + V +
Sbjct: 67 ALQKLQGLA-------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 529 HEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFA 588
+ +VH + N+L+ +E + D + + +++ + +
Sbjct: 120 YHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR---EILERDVRNIITY- 171
Query: 589 LSGIYTVKSDVYSFGVVMLE 608
S Y + D+ S +L+
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.2 bits (196), Expect = 5e-17
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 10/167 (5%)
Query: 40 DSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGSA----VVSIDISGLGL 95
+ D QAL + L +P+ L++W D C +W GV C+ V ++D+SGL L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 96 SGTMG--YLLSDLLSLRKFDLSGN---SIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIA 150
L++L L + G L L + N SG +P ++
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 151 SMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSF 197
+ +L L+ S N+L+ ++ +L L + N SG +P+S+
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 3e-09
Identities = 23/75 (30%), Positives = 29/75 (38%), Gaps = 1/75 (1%)
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179
D L NL L+L +N G LP + + L LNVS N+L I GNL
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRF 293
Query: 180 ATLDLSFNNFSGDLP 194
+ N P
Sbjct: 294 DVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.5 bits (132), Expect = 6e-09
Identities = 14/57 (24%), Positives = 27/57 (47%), Gaps = 1/57 (1%)
Query: 156 SYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+ L++ N + ++ L L +L++SFNN G++P +L NN+
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 51.3 bits (121), Expect = 1e-07
Identities = 16/59 (27%), Positives = 20/59 (33%), Gaps = 1/59 (1%)
Query: 183 DLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIP 240
DL N G LP L + SL + N + G + L ANN P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 3/92 (3%)
Query: 62 NWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHD 121
K + G + +D+ + GT+ L+ L L ++S N++
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 122 TIPY--QLPPNLTSLNLASNNFSGNLPYSIAS 151
IP L A+N P +
Sbjct: 283 EIPQGGNL-QRFDVSAYANNKCLCGSPLPACT 313
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.3 bits (181), Expect = 8e-15
Identities = 35/152 (23%), Positives = 62/152 (40%), Gaps = 26/152 (17%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP---------------- 146
L+ L +L DL+ N I + P LT L L +N S P
Sbjct: 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296
Query: 147 ----YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
I+++ +L+YL + N+++ +L L L + N S +S +L+N
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 203 ISSLYLQNNQVTGSLNVFSGLP-LTTLNVANN 233
I+ L +NQ++ + L +T L + +
Sbjct: 353 INWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.2 bits (160), Expect = 3e-12
Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 7/152 (4%)
Query: 106 LLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSL 165
L +L + N I D P + NL L+L N ++AS+ +L+ L+++ N +
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 166 TQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPL 225
+ L L L L N S P L+ +++L L NQ+ + + L
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 226 TTLNVANNHFSGWIP-RELISIRTFIYDGNSF 256
T L + N+ S P L ++ + N
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRLFFANNKV 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 7e-08
Identities = 16/104 (15%), Positives = 35/104 (33%), Gaps = 4/104 (3%)
Query: 60 LTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSI 119
LT E + + + + +S +S L L++ + N +
Sbjct: 284 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 120 HDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
D N+ L+ N S P +A++ ++ L ++
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 17/75 (22%), Positives = 29/75 (38%), Gaps = 6/75 (8%)
Query: 169 IGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-L 225
I IF LA L N + + + L +++L + S++ L L
Sbjct: 12 INQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNL 68
Query: 226 TTLNVANNHFSGWIP 240
T +N +NN + P
Sbjct: 69 TQINFSNNQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 17/86 (19%), Positives = 33/86 (38%), Gaps = 4/86 (4%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
+ L K L ++ DT+ +T+L ++ + + +L+ +N S N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 76
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNF 189
LT NL L + ++ N
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 2/61 (3%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162
+DL + I + NLT +N ++N + P + ++ L + ++
Sbjct: 40 QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 163 N 163
N
Sbjct: 98 N 98
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.0 bits (149), Expect = 4e-11
Identities = 39/206 (18%), Positives = 70/206 (33%), Gaps = 23/206 (11%)
Query: 70 PCGESWKGVACEGSAVVSI-----------DISGLGLSGTMGYLLSDLLSLRKFDLSGNS 118
C + V C + + D+ ++ +L +L L N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 119 IHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNL 176
I P L L L+ N LP + + L V N +T+ +F L
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQ--ELRVHENEITKVRKSVFNGL 123
Query: 177 AGLATLDLSF--NNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP--LTTLNVAN 232
+ ++L SG +F + +S + + + +T + GLP LT L++
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDG 180
Query: 233 NHFSGWIPRELISIRTFIYDGNSFDN 258
N + L + G SF++
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNS 206
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 6e-11
Identities = 37/154 (24%), Positives = 60/154 (38%), Gaps = 10/154 (6%)
Query: 93 LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
L SG + L ++ +I TIP LPP+LT L+L N + S+ +
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGL 194
Query: 153 VSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
+L+ L +S NS++ N L L L+ N P I +YL NN
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNN 253
Query: 213 VTG-SLNVFSGLP-------LTTLNVANNHFSGW 238
++ N F + +++ +N W
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 28/154 (18%), Positives = 50/154 (32%), Gaps = 8/154 (5%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLT-SLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
LR + + ++ L + L SG + M LSY+ ++ ++T
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163
Query: 167 QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTG----SLNVFSG 222
+ +L L L N + S L+N++ L L N ++ SL
Sbjct: 164 TIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220
Query: 223 LPLTTLNVANNHFSGWIPRELISIRTFIYDGNSF 256
L LN + I+ N+
Sbjct: 221 LRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 3e-09
Identities = 19/105 (18%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 110 RKFDLSGNSIH-DTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ- 167
+ DL+G ++H D L + + + L S + ++++S + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQ 212
++ I + L L L S + N+ SN+ L L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 14/78 (17%), Positives = 30/78 (38%), Gaps = 4/78 (5%)
Query: 85 VVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP---PNLTSLNLASNNF 141
V++ + + S ++ DLS + I + + + L +L+L
Sbjct: 25 VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 142 SGNLPYSIASMVSLSYLN 159
S + ++A +L LN
Sbjct: 84 SDPIVNTLAKNSNLVRLN 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 1e-08
Identities = 13/95 (13%), Positives = 29/95 (30%), Gaps = 12/95 (12%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPP---NLTSLNLASNNFSG----NLPYSIASMVSLSYLN 159
L ++ D+ + D +L P + L + ++ ++ +L+ LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 160 VSRNSLT----QSIGDIFG-NLAGLATLDLSFNNF 189
+ N L + + L L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 2e-08
Identities = 13/86 (15%), Positives = 26/86 (30%), Gaps = 5/86 (5%)
Query: 130 NLTSLNLASNNFSGN-LPYSIASMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDL 184
++ SL++ S + + + + LT + I LA L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 185 SFNNFSGDLPNSFISLSNISSLYLQN 210
N + + S +Q
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQK 88
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 8e-08
Identities = 24/116 (20%), Positives = 40/116 (34%), Gaps = 19/116 (16%)
Query: 115 SGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMV----SLSYLNVSRNSLTQSIG 170
+G Q L L LA + S + S+A+ + SL L++S N L +
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 171 DIFG-----NLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS 221
L L L +S ++ + +L ++ SL V S
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL-------EKDKP---SLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 11/93 (11%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 153 VSLSYLNVSRNSLT-QSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLY 207
+ + L++ L+ ++ L + L + + ++ ++ L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 208 LQNNQVT--GSLNVFSGLPLTTLNVANNHFSGW 238
L++N++ G V GL + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 3e-06
Identities = 18/86 (20%), Positives = 28/86 (32%), Gaps = 7/86 (8%)
Query: 87 SIDISGLGLSGT-MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP------PNLTSLNLASN 139
S+DI LS LL L + L + + + P L LNL SN
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 140 NFSGNLPYSIASMVSLSYLNVSRNSL 165
+ + + + + SL
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 13/101 (12%), Positives = 28/101 (27%), Gaps = 21/101 (20%)
Query: 151 SMVSLSYLNVSRNSLT----QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSL 206
L L ++ ++ S+ L LDLS N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES------ 420
Query: 207 YLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRELISIR 247
++ L L + + ++S + L ++
Sbjct: 421 -VRQPGCL----------LEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 2e-05
Identities = 11/74 (14%), Positives = 23/74 (31%), Gaps = 7/74 (9%)
Query: 179 LATLDLSFNNFS-GDLPNSFISLSNISSLYLQNNQVTGS-----LNVFSGLP-LTTLNVA 231
+ +LD+ S L + L + +T + + P L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 232 NNHFSGWIPRELIS 245
+N ++
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 1e-04
Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 11/103 (10%)
Query: 61 TNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSG 116
+ E E +G+ GS + + ++ +S + + L SLR+ DLS
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 117 NSIHDTIPYQL-------PPNLTSLNLASNNFSGNLPYSIASM 152
N + D QL L L L +S + + ++
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (125), Expect = 4e-08
Identities = 30/218 (13%), Positives = 54/218 (24%), Gaps = 27/218 (12%)
Query: 53 SLNSPSVLTNWKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKF 112
S + LT + L L L
Sbjct: 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110
Query: 113 DLSGNSIHDTIP--YQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIG 170
L + + P ++ L L L N + + +L++L + N ++
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 171 DIFGNLAGLATLDLSFNNFSGDLPNSFISLS------------------------NISSL 206
F L L L L N + P++F L + L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 207 YLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPREL 243
L +N L +++ +P+ L
Sbjct: 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 6e-06
Identities = 35/207 (16%), Positives = 62/207 (29%), Gaps = 34/207 (16%)
Query: 80 CEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN 139
C V+ GL + + + L GN I +P +L +
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRI---FLHGNRIS-HVPAASFRACRNLTILWL 63
Query: 140 NFSGNL----------------------------PYSIASMVSLSYLNVSRNSLTQSIGD 171
+ + P + + L L++ R L +
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123
Query: 172 IFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLP-LTTLN 229
+F LA L L L N ++F L N++ L+L N+++ F GL L L
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 230 VANNHFSGWIPRELISIRTFIYDGNSF 256
+ N + P + +
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFA 210
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 27/134 (20%), Positives = 46/134 (34%), Gaps = 5/134 (3%)
Query: 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188
L +L+L P + +L YL + N+L D F +L L L L N
Sbjct: 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164
Query: 189 FSGDLPNSFISLSNISSLYLQNNQVTGSL-NVFSGLPLTTLNVANNHFSGWI----PREL 243
S +F L ++ L L N+V + F L + + L
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224
Query: 244 ISIRTFIYDGNSFD 257
+++ + N +
Sbjct: 225 RALQYLRLNDNPWV 238
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.001
Identities = 12/68 (17%), Positives = 20/68 (29%), Gaps = 4/68 (5%)
Query: 124 PYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLD 183
L L L N + + + L S + + + LAG
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP---CSLPQRLAGRDLKR 275
Query: 184 LSFNNFSG 191
L+ N+ G
Sbjct: 276 LAANDLQG 283
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 6e-08
Identities = 24/125 (19%), Positives = 43/125 (34%), Gaps = 9/125 (7%)
Query: 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSI 169
R L+ + + +T L+L+ N P ++A++ L L S N+L
Sbjct: 1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 170 GDIFGNLAGLATLDLSFNNF-SGDLPNSFISLSNISSLYLQNNQVTGS----LNVFSGLP 224
G L L N +S + L LQ N + + LP
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 225 -LTTL 228
++++
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 7e-05
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 7/109 (6%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPY-SIASMVSLSYLNVS 161
L LL + DLS N + P L L + + + +A++ L L +
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPP--ALAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73
Query: 162 RNSLTQSIG-DIFGNLAGLATLDLSFNNFSG--DLPNSFIS-LSNISSL 206
N L QS + L L+L N+ + L ++SS+
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 2e-07
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 10/94 (10%)
Query: 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N S + SL LNVS N L + + L L SFN+ + ++P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPEL-- 322
Query: 199 SLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVAN 232
N+ L+++ N + ++ + L + +
Sbjct: 323 -PQNLKQLHVEYNPLREFPDIPES--VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 17/97 (17%), Positives = 34/97 (35%), Gaps = 8/97 (8%)
Query: 63 WKGNEGDPCGESWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDT 122
+ + + ++ +++S L L + L + S N +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASFNHL-AE 318
Query: 123 IPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159
+P +LP NL L++ N P S+ L +N
Sbjct: 319 VP-ELPQNLKQLHVEYNPLRE-FPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 5e-05
Identities = 20/91 (21%), Positives = 31/91 (34%), Gaps = 12/91 (13%)
Query: 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVF 220
N+ + I + L L++S N +LP + L N L
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNH----LAEV 319
Query: 221 SGLP--LTTLNVANNHFSGW--IPRELISIR 247
LP L L+V N + IP + +R
Sbjct: 320 PELPQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 6/60 (10%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167
+ +L+ + ++P +LPP+L SL + N+ + LP SL L V N+L
Sbjct: 39 QAHELELNNLGLS-SLP-ELPPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 8/85 (9%)
Query: 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQV 213
L ++ L+ S+ ++ +L +L S N+ + +LP ++ SL + NN +
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPE---LPQSLKSLLVDNNNL 90
Query: 214 TGSLNVFSGLPLTTLNVANNHFSGW 238
++ L ++
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPE 115
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.004
Identities = 14/82 (17%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 184 LSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFSGWIPRE 242
N S ++ + ++ L + NN++ + + P L L + NH + +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI---ELPALPPRLERLIASFNHLAE-VPEL 322
Query: 243 LISIRTFIYDGNSFDNGPAPPP 264
+++ + N P P
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPE 344
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.004
Identities = 17/65 (26%), Positives = 25/65 (38%), Gaps = 8/65 (12%)
Query: 127 LPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSF 186
L L L + S +LP L L S NSLT + ++ + L +L +
Sbjct: 36 LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS---LKSLLVDN 87
Query: 187 NNFSG 191
NN
Sbjct: 88 NNLKA 92
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 2e-07
Identities = 33/197 (16%), Positives = 57/197 (28%), Gaps = 3/197 (1%)
Query: 104 SDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
S + S + + ++ +P LP + T L+L+ N ++ L+ LN+ R
Sbjct: 7 SKVASHLEVNCDKRNL-TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGL 223
+ + G L L TLDLS N + N + L GL
Sbjct: 66 E--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 224 PLTTLNVANNHFSGWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQ 283
+ +P L++ + + +N P
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 284 GSHSPSGSQSSSSDKEL 300
P G S
Sbjct: 184 LYTIPKGFFGSHLLPFA 200
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 17/73 (23%), Positives = 28/73 (38%), Gaps = 1/73 (1%)
Query: 139 NNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFI 198
N P + L L+++ N+LT+ + L L TL L N+ +P F
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 199 SLSNISSLYLQNN 211
+ +L N
Sbjct: 193 GSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 35/237 (14%), Positives = 62/237 (26%), Gaps = 29/237 (12%)
Query: 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASN-- 139
+ +S L L L + +L + P L +L+L+ N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQL 89
Query: 140 ---------------------NFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAG 178
+ ++ + L L + N L +
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 179 LATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVANNHFS- 236
L L L+ NN + L N+ +L LQ N + F G L + N +
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
Query: 237 ----GWIPRELISIRTFIYDGNSFDNGPAPPPPPSTAPPSGRSHNNRSHRQGSHSPS 289
+ R L +Y + A ++ G P+
Sbjct: 210 NCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPT 266
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 1e-06
Identities = 27/134 (20%), Positives = 45/134 (33%), Gaps = 14/134 (10%)
Query: 107 LSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLT 166
S + DL G + Q LN ++ + L ++ L LN+S N L
Sbjct: 22 GSQQALDLKGLRSDPDLVAQ--NIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLY 78
Query: 167 --QSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN------ 218
+ I L L+LS N + I + L+L N ++ +
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138
Query: 219 --VFSGLP-LTTLN 229
+ P L L+
Sbjct: 139 SAIRERFPKLLRLD 152
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 2e-05
Identities = 29/176 (16%), Positives = 57/176 (32%), Gaps = 27/176 (15%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVS------------- 154
D +G + IP +P + T L L N + +
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 155 ------------LSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSN 202
+ L + N + + +F L L TL+L N S +P SF L++
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 203 ISSLYLQNNQVTGSLNVFSGLPL-TTLNVANNHFSGWIPRELISIRTFIYDGNSFD 257
++SL L +N + ++ ++ P ++ ++ + F
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFK 183
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 4e-05
Identities = 13/79 (16%), Positives = 23/79 (29%)
Query: 134 LNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL 193
L L N + N+L + D+F +G LD+S
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 194 PNSFISLSNISSLYLQNNQ 212
+L + + N +
Sbjct: 218 SYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 9/45 (20%), Positives = 13/45 (28%), Gaps = 1/45 (2%)
Query: 108 SLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASM 152
S R F + + IP LP N L + +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGF 52
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 11/46 (23%), Positives = 15/46 (32%), Gaps = 1/46 (2%)
Query: 101 YLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLP 146
+ D+S IH ++P NL L S LP
Sbjct: 195 DVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLP 239
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 16/59 (27%), Positives = 27/59 (45%), Gaps = 2/59 (3%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161
L++L L N I D P PNL ++L +N S P +A+ +L + ++
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 164 SLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
S+TQ +I IF LA + +N + + + L I++L VT ++
Sbjct: 2 SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG 58
Query: 220 FSGLP-LTTLNVANNHFSGW 238
L L L + +N +
Sbjct: 59 VQYLNNLIGLELKDNQITDL 78
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 4/62 (6%)
Query: 149 IASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYL 208
+A++ L+ L N ++ +L L + L N S P + SN+ + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 209 QN 210
N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 13/56 (23%), Positives = 25/56 (44%), Gaps = 4/56 (7%)
Query: 130 NLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLS 185
LT+L N S P +AS+ +L +++ N ++ N + L + L+
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 7e-05
Identities = 12/108 (11%), Positives = 29/108 (26%), Gaps = 28/108 (25%)
Query: 112 FDLSGNSIHDTIPYQLP--------PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163
L+ + + L +L L N + ++ ++
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV----------- 296
Query: 164 SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNN 211
I + L L+L+ N F + + + + S +
Sbjct: 297 --------IDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 10/70 (14%), Positives = 23/70 (32%), Gaps = 6/70 (8%)
Query: 147 YSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSN 202
+SI SL ++ +S+ + + + LS N + L + S +
Sbjct: 3 FSIEG-KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 203 ISSLYLQNNQ 212
+ +
Sbjct: 61 LEIAEFSDIF 70
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 24/170 (14%), Positives = 47/170 (27%), Gaps = 42/170 (24%)
Query: 103 LSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFS-----GNLPYSIASMVSLSY 157
++L S+ + + + I Q PN+T L L N + NL + +
Sbjct: 42 QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK 101
Query: 158 L----------------------------------NVSRNSLTQSIGDIFGNLAGLATLD 183
+ + +
Sbjct: 102 VKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTL 161
Query: 184 LSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLP-LTTLNVAN 232
+N D+ L+ + +LYL N ++ L +GL L L + +
Sbjct: 162 SLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 15/81 (18%), Positives = 31/81 (38%), Gaps = 8/81 (9%)
Query: 163 NSLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLN 218
++T I IF A +L + + + + L++I + N+ + S+
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ 62
Query: 219 VFSGLP-LTTLNVANNHFSGW 238
LP +T L + N +
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDI 83
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 164 SLTQ--SIGDIF--GNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV 219
++TQ I IF LA L N + + + L +++L + S++
Sbjct: 1 TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG 57
Query: 220 FSGLP-LTTLNVANNHFSGW 238
L LT +N +NN +
Sbjct: 58 VEYLNNLTQINFSNNQLTDI 77
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 618 | |||
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.85 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.8 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.71 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.61 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.6 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.59 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.58 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.2 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.19 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.14 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.06 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.01 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.85 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.63 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.37 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.28 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.71 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.48 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.15 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.22 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.83 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-47 Score=372.18 Aligned_cols=208 Identities=28% Similarity=0.428 Sum_probs=171.9
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--CCeEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE--HGQRLLV 486 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 486 (618)
++|+..+.||+|+||+||+|+.. +|+.||+|++..........+.+.+|++++++++||||+++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999875 58999999998776666677889999999999999999999999865 4568999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--CCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL--PSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
|||+++|+|.++++........+++..++.++.|++.||+|||+++. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999997655556789999999999999999999999721 1399999999999999999999999999987
Q ss_pred CCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
..... .......||+.|||||++.+..|+.++|||||||++|||+||+.||..
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 65432 233457899999999999999999999999999999999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=370.45 Aligned_cols=200 Identities=28% Similarity=0.424 Sum_probs=174.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|+..+.||+|+||+||+|++. +|+.||||++..... .+..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 56889999999999999999875 589999999875432 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+++|+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999996 356799999999999999999999999 9999999999999999999999999999876433
Q ss_pred C-cccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 E-RQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .......+||+.|||||++.+..+ +.++||||+||++|||+||+.||+
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 2 223345789999999999988876 678999999999999999999995
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=365.37 Aligned_cols=199 Identities=29% Similarity=0.458 Sum_probs=177.9
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||+||+|+.. +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56889999999999999999886 588999999865432 2223567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999973 35689999999999999999999999 999999999999999999999999999976653
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.. .....||+.|||||++.+..|+.++|||||||++|||+||+.||+.
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 32 2346799999999999999999999999999999999999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=367.75 Aligned_cols=199 Identities=27% Similarity=0.432 Sum_probs=178.2
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|+..+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 457999999999999999999864 5999999998754322 3567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++ ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 97 Ey~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp ECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999875 24689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
.. ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||..
T Consensus 169 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 169 EQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 32 233456899999999999999999999999999999999999999963
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=368.08 Aligned_cols=202 Identities=31% Similarity=0.514 Sum_probs=172.5
Q ss_pred hhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
...++|+..+.||+|+||+||+|++. ..||||+++......+..+.|.+|++++++++||||+++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 44578899999999999999999874 369999998766666677899999999999999999999998754 568999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.++++. ....+++..+..++.||++||+|||++ +||||||||+|||+++++.+||+|||+|+...
T Consensus 82 ~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 999999999999963 345799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCc-ccccceeccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTER-QVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... .......||+.|||||++.+ ..|+.++|||||||++|||+||+.||.
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 3322 23345689999999999964 358999999999999999999999996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=362.02 Aligned_cols=199 Identities=29% Similarity=0.487 Sum_probs=166.7
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
++|+..+.||+|+||+||+|.+.+++.||||+++..... .++|.+|++++++++||||++++|++..++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 568888999999999999999999999999999764433 46799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++|+|.++++. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999863 346789999999999999999999999 99999999999999999999999999998776554
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG-RKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~Pf~ 617 (618)
........||+.|+|||++.+..|+.++|||||||++|||+|+ ++||+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 4444456899999999999999999999999999999999995 55554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=367.69 Aligned_cols=201 Identities=24% Similarity=0.385 Sum_probs=176.0
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999875 689999999875432 2223567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++ ..+.+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999886 345799999999999999999999999 999999999999999999999999999987653
Q ss_pred CC-cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCC
Confidence 32 223345689999999999999999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=375.98 Aligned_cols=201 Identities=24% Similarity=0.417 Sum_probs=177.4
Q ss_pred hhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
...++|+..+.||+|+||+||+|+.. +|+.||+|+++... .......+.+|++++++++|||||++++++.+++..++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34678999999999999999999875 68999999987543 33446788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.++++. .+.+++..+..++.|++.||+|||+++ +|+||||||+|||+++++++||+|||+|+..
T Consensus 82 VmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 9999999999999973 356899999999999999999999742 8999999999999999999999999999765
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.
T Consensus 156 ~~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 156 ID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp HH---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred CC---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 32 22345689999999999999999999999999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=358.62 Aligned_cols=197 Identities=27% Similarity=0.419 Sum_probs=171.2
Q ss_pred CcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee----CCeEEEE
Q 007103 412 FSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE----HGQRLLV 486 (618)
Q Consensus 412 ~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 486 (618)
|+..+.||+|+||+||+|.+. +++.||+|++..........+.+.+|++++++++||||+++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 355668999999999999876 58899999998766666677889999999999999999999999865 3467999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec-CCCCcEEeeccccccC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD-DELNPHLSDCGLAALT 565 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~ 565 (618)
|||+++|+|.++++. ...+++..+..++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999973 357899999999999999999999981 1399999999999997 5789999999999865
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 432 2335689999999999865 59999999999999999999999996
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-45 Score=364.65 Aligned_cols=204 Identities=25% Similarity=0.435 Sum_probs=181.5
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
++...++|+..+.||+|+||+||+|.+. +|+.||||+++.... ..++|.+|++++++++||||+++++++.+++..
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 3445678899999999999999999886 488999999975543 356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.+++... ....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 89 ~iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 9999999999999998632 346789999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
..............||+.|+|||++.+..|+.++|||||||++|||++|+.||
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 87655555455567999999999999999999999999999999999977765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=362.50 Aligned_cols=202 Identities=28% Similarity=0.472 Sum_probs=177.2
Q ss_pred hhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEE
Q 007103 406 QTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 406 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 485 (618)
+...++|+..+.||+|+||.||+|.+++++.||||+++.... ..+.|.+|++++++++|||||++++++.+ +..++
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 344578889999999999999999999889999999975443 34679999999999999999999998754 56799
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccC
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALT 565 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 565 (618)
||||+++|+|.+++... ....+++..+.+++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 99999999999987632 234689999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
............||+.|+|||++.+..|+.++|||||||++|||+||..|+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 655545555678999999999999999999999999999999999965554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=363.66 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=175.4
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.+.|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 356888999999999999999875 58999999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 Ey~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp ECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred ecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999998753 245699999999999999999999999 999999999999999999999999999975532
Q ss_pred CCcccccceeccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFAL-----SGIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
. ........||+.|+|||++. +..|+.++|||||||++|||+||+.||..
T Consensus 163 ~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 163 T-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp H-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 2 12233568999999999984 45689999999999999999999999963
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=353.55 Aligned_cols=200 Identities=27% Similarity=0.461 Sum_probs=180.7
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
++|+..+.||+|+||+||+|++++++.||||+++..... .++|.+|++++++++||||++++|++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 578889999999999999999998999999999765433 46799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++|+|.+++.. ....+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999998753 345789999999999999999999999 99999999999999999999999999998766554
Q ss_pred cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
........||+.|+|||.+.+..|+.++|||||||++|||+| |+.||+.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 444445679999999999999999999999999999999998 8999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=365.51 Aligned_cols=200 Identities=27% Similarity=0.382 Sum_probs=179.2
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|+..+.||+|+||.||+|+.. +|+.||+|++++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57899999999999999999875 699999999975432 2224577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.++++. ...+++..++.++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999873 45789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCC
Confidence 32 23345789999999999999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-44 Score=363.06 Aligned_cols=200 Identities=28% Similarity=0.460 Sum_probs=162.0
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
..+.|+..+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4567999999999999999999876 5899999999755433 2346688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec---CCCCcEEeeccccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAA 563 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgl~~ 563 (618)
|||+++|+|.+++. ..+.+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++
T Consensus 86 mE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 86 MQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp ECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 99999999999996 356799999999999999999999999 999999999999995 57899999999998
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 664332 2334689999999999999999999999999999999999999996
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-44 Score=360.43 Aligned_cols=202 Identities=27% Similarity=0.472 Sum_probs=165.6
Q ss_pred hcCCcccceeccCccceEEEEEEcC-C---cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-G---KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|+..+.||+|+||+||+|++.. | ..||||++.... .....++|.+|++++++++|||||+++|++..++..+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 3567788899999999999998753 3 358999887544 3445678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.++++. ....+++.++.+++.||++||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 104 iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999999998862 345799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc----cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQ----VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 6533221 1223468999999999999999999999999999999998 899996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-44 Score=362.45 Aligned_cols=197 Identities=28% Similarity=0.465 Sum_probs=177.4
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56889999999999999999875 599999999975432 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999886 456688899999999999999999999 999999999999999999999999999987653
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ...+||+.|||||++.+..|+.++|||||||++|||+||+.||.
T Consensus 157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~ 202 (316)
T d1fota_ 157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202 (316)
T ss_dssp CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence 32 34689999999999999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-44 Score=359.51 Aligned_cols=197 Identities=31% Similarity=0.449 Sum_probs=173.9
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 486 (618)
.+.|+..+.||+|+||.||+|... +|+.||||++..... .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 345888999999999999999865 689999999875543 333456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 94 ~E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99999999876664 346799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcccccceeccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALS---GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 32 24579999999999864 458999999999999999999999995
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=355.99 Aligned_cols=194 Identities=29% Similarity=0.433 Sum_probs=166.5
Q ss_pred ceeccCccceEEEEEEcC---CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEecCC
Q 007103 416 FLIGEGSLGRVYRAEFAN---GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEYVGN 492 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 492 (618)
+.||+|+||+||+|.+.+ ++.||||+++.........++|.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998653 4689999997665555566789999999999999999999999865 467899999999
Q ss_pred CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCCccc
Q 007103 493 GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTERQV 572 (618)
Q Consensus 493 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 572 (618)
|+|.++++ ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997 345799999999999999999999999 99999999999999999999999999998765443322
Q ss_pred --ccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 573 --STQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 573 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
.....||++|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 234579999999999999999999999999999999998 899996
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=355.00 Aligned_cols=202 Identities=25% Similarity=0.422 Sum_probs=174.1
Q ss_pred hcCCcccce-eccCccceEEEEEEc---CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFL-IGEGSLGRVYRAEFA---NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~-Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.++|...+. ||+|+||.||+|.+. ++..||||+++... .....++|.+|++++++++|||||+++|++.+ +..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 345666664 999999999999764 35579999997553 44556789999999999999999999999865 4689
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.+++.. ....+++..+.+++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 99999999999998752 346799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 565 TPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 565 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 6544322 2234578999999999999999999999999999999998 9999963
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-43 Score=361.97 Aligned_cols=199 Identities=24% Similarity=0.379 Sum_probs=178.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
-++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999875 69999999997553 345678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec--CCCCcEEeeccccccC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLAALT 565 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfgl~~~~ 565 (618)
||+++|+|.+++.. ..+.+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 103 E~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 103 EFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999998852 345799999999999999999999999 999999999999996 4678999999999876
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....||+.|||||++.+..|+.++|||||||++|||+||+.||.
T Consensus 177 ~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 177 DPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 54332 244689999999999999999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-43 Score=360.56 Aligned_cols=199 Identities=22% Similarity=0.352 Sum_probs=178.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999875 69999999987543 334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec--CCCCcEEeeccccccC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD--DELNPHLSDCGLAALT 565 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfgl~~~~ 565 (618)
||+++|+|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 106 E~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 106 EFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp ECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999987752 345799999999999999999999999 999999999999998 6789999999999877
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 180 NPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 5432 2344689999999999999999999999999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=353.78 Aligned_cols=201 Identities=24% Similarity=0.353 Sum_probs=177.9
Q ss_pred hhcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH----HHHHHHHHHHHHhhcCCCCcccccceEEeeCCe
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQ 482 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 482 (618)
..++|+..+.||+|+||.||+|+.. +|+.||||+++...... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3467999999999999999999875 68999999986543321 235779999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC----CcEEee
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL----NPHLSD 558 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~D 558 (618)
.++||||+++|+|.++++. .+.+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999973 35799999999999999999999999 999999999999998776 499999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||++........ .....||+.|+|||++.+..++.++||||+||++|||+||+.||.
T Consensus 161 fG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 161 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp CTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 999987654322 234579999999999999999999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-43 Score=361.06 Aligned_cols=197 Identities=24% Similarity=0.380 Sum_probs=177.5
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
++|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 699999999865432 2233567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+.+|+|.+++.. .+.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999863 35699999999999999999999999 999999999999999999999999999987653
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....||+.|||||++.+..|+.++|||||||++|||+||+.||.
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence 2 234689999999999999999999999999999999999999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=350.28 Aligned_cols=201 Identities=26% Similarity=0.426 Sum_probs=167.3
Q ss_pred hcCCcccceeccCccceEEEEEEcCC-----cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFANG-----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
...|+..++||+|+||.||+|.+.+. ..||||++.... ......+|.+|++++++++|||||+++|++.+.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 45688889999999999999987642 469999987544 344566799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+.+|++.+++.. ....+++..+.+++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999999988753 346799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCc--ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 564 LTPNTER--QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 564 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
....... .......||+.|||||++.+..++.++|||||||++|||++|..||
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 7643322 2233457899999999999999999999999999999999965554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=359.80 Aligned_cols=207 Identities=29% Similarity=0.468 Sum_probs=174.1
Q ss_pred hhhcCCcccceeccCccceEEEEEEcC------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFAN------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
...++|+..+.||+|+||+||+|++.. ...||+|.+.... .......+.+|+.++.++ +|||||++++++.+
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 345689999999999999999998753 2368999886543 233456788999999988 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecC
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADD-------------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRN 540 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D 540 (618)
.+..++||||+++|+|.++++..+. ....+++..++.++.||+.||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999974321 123589999999999999999999999 999999
Q ss_pred CCCCCeeecCCCCcEEeeccccccCCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 541 FKSANILLDDELNPHLSDCGLAALTPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 541 lkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|||+|||++.++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865443322 2345678999999999999999999999999999999998 899996
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=351.83 Aligned_cols=200 Identities=30% Similarity=0.493 Sum_probs=168.6
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
..++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.|.+|+.++++++|||||++++++. ++..++||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 3567999999999999999999999888999999975543 3467999999999999999999999985 45689999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPN 567 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 567 (618)
||+++|+|.+++... ....+++.++..++.||+.||+|||+. +|+||||||+|||+++++++||+|||+++....
T Consensus 91 Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999999888632 234699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 007103 568 TERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 568 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf 616 (618)
..........||+.|+|||++....++.++|||||||++|||+||..||
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 4444444567999999999999999999999999999999999976664
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-42 Score=357.32 Aligned_cols=198 Identities=30% Similarity=0.404 Sum_probs=171.1
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHH-HHHHH---HHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ-EEDNF---LEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
++|++.+.||+|+||.||+|+.. +|+.||||++........ ....+ ..++++++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999876 599999999864432211 12233 34477788889999999999999999999
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999963 45688999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... .....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 65432 234679999999999975 568999999999999999999999996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=350.23 Aligned_cols=200 Identities=25% Similarity=0.425 Sum_probs=173.9
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhh-cCCCCcccccceEEeeCCeEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMS-RLRHPNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 486 (618)
++|+..+.||+|+||+||+|... +|+.||||++++... .....+.+..|...+. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47889999999999999999876 599999999975432 1223345556666554 68999999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999973 45689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
... .......||+.|+|||++.+..|+.++||||+||++|||+||+.||.
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 332 22344689999999999999999999999999999999999999996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-43 Score=345.53 Aligned_cols=203 Identities=27% Similarity=0.394 Sum_probs=164.9
Q ss_pred hhcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
..++|+..+.||+|+||.||+|.+.. +..||||.++... .....+.+.+|++++++++||||+++++++. ++..
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 45679999999999999999998753 4568999986543 4445678999999999999999999999986 4678
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|+|.+++.. ....+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999998753 346789999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 564 LTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 564 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
..............||+.|+|||++.+..|+.++|||||||++|||+| |++||..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 765544444455678999999999999999999999999999999998 8999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-42 Score=344.30 Aligned_cols=202 Identities=26% Similarity=0.388 Sum_probs=170.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC----e
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----Q 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 482 (618)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999874 699999999976543 3445678999999999999999999999987654 3
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+++++|.+++. ..+.+++.++..++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999886 345799999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCC--cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTE--RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence 6553322 223345689999999999999999999999999999999999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-42 Score=340.20 Aligned_cols=200 Identities=28% Similarity=0.417 Sum_probs=175.4
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCccccc-------HHHHHHHHHHHHHhhcCC-CCcccccceEEeeC
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALS-------LQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEH 480 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 480 (618)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ....+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57899999999999999999874 6899999998654321 122356889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 481 GQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
+..++||||+++|+|.++++. .+.+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999973 45799999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccceeccccccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 007103 561 LAALTPNTERQVSTQMVGAFGYSAPEFALS------GIYTVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 561 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
+++...... ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 998765432 2345689999999999863 3478899999999999999999999963
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=346.33 Aligned_cols=198 Identities=19% Similarity=0.285 Sum_probs=176.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVY 487 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 487 (618)
.++|++.+.||+|+||+||+|.+. +|+.||+|.++... .....+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 467999999999999999999876 58899999997543 33456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCC--CCcEEeeccccccC
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDE--LNPHLSDCGLAALT 565 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfgl~~~~ 565 (618)
||+++|+|.++++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++..
T Consensus 81 E~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 81 EFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999962 345799999999999999999999999 99999999999999854 58999999999876
Q ss_pred CCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 566 PNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 566 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.... ......||+.|+|||.+.+..|+.++||||+||++|||++|+.||.
T Consensus 155 ~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 155 KPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 4332 2344679999999999999999999999999999999999999996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-42 Score=346.27 Aligned_cols=212 Identities=27% Similarity=0.448 Sum_probs=181.0
Q ss_pred hhhhhhhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccce
Q 007103 402 VASLQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAG 475 (618)
Q Consensus 402 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 475 (618)
+.+++.+.++|+..+.||+|+||.||+|++. +++.||||+++... ..+..++|.+|++++++++||||+++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 3456667889999999999999999999864 35789999997544 4455678999999999999999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 007103 476 YCAEHGQRLLVYEYVGNGNLHDMLHFADD--------------------SSKNLTWNARVRVALGTARALEYLHEVCLPS 535 (618)
Q Consensus 476 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 535 (618)
++...+..++||||+++|+|.++++.... ....+++..+.+|+.|++.||+|||+. +
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence 99999999999999999999999964221 123589999999999999999999999 9
Q ss_pred ceecCCCCCCeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCC-
Q 007103 536 VVHRNFKSANILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR- 613 (618)
Q Consensus 536 iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~- 613 (618)
||||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..|+.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 99999999999999999999999999976543322 2233467899999999999999999999999999999999985
Q ss_pred CCCC
Q 007103 614 KPLD 617 (618)
Q Consensus 614 ~Pf~ 617 (618)
+||.
T Consensus 241 ~p~~ 244 (301)
T d1lufa_ 241 QPYY 244 (301)
T ss_dssp CTTT
T ss_pred CCCC
Confidence 5675
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=343.58 Aligned_cols=196 Identities=30% Similarity=0.387 Sum_probs=165.8
Q ss_pred ccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHH---HHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 414 QEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQ---EEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 414 ~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
..++||+|+||+||+|+.. +|+.||||+++....... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4568999999999999875 589999999975443221 134688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+.++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99887776654 456789999999999999999999999 99999999999999999999999999997765433
Q ss_pred cccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .....+||+.|+|||++.+. .|+.++|||||||++|||+||+.||.
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 2 22346799999999998754 57999999999999999999999995
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-42 Score=345.46 Aligned_cols=200 Identities=28% Similarity=0.473 Sum_probs=167.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCc----EEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGK----IMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 484 (618)
.+|+..+.||+|+||+||+|.+. +|+ +||+|+++... ..+..++|.+|++++++++|||||+++|++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46999999999999999999875 344 58899886543 334567899999999999999999999999764 567
Q ss_pred EEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 485 LVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+++||+.+|+|.+++.. ....+++..+.+++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 88999999999998863 356799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc-cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 565 TPNTERQ-VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 565 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
....... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~ 215 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCC
Confidence 6543332 2334578999999999999999999999999999999999 899986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=345.11 Aligned_cols=195 Identities=24% Similarity=0.337 Sum_probs=167.3
Q ss_pred hcCCccc-ceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhc-CCCCcccccceEEee----CC
Q 007103 409 TNSFSQE-FLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSR-LRHPNIVTLAGYCAE----HG 481 (618)
Q Consensus 409 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~ 481 (618)
.++|.+. +.||+|+||.||+|++. +|+.||||+++.. ..+.+|++++.+ .+||||+++++++.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 4578776 46999999999999874 6899999998632 346678887654 589999999999876 35
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC---CCCcEEee
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD---ELNPHLSD 558 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~D 558 (618)
..++|||||++|+|.++++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++ ++.+||+|
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 689999999999999999732 245799999999999999999999999 9999999999999985 56799999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+++....... .....||+.|||||++.+..|+.++|||||||++|||+||+.||.
T Consensus 158 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 158 FGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp CTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred cceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 999987654332 244689999999999999999999999999999999999999994
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=340.04 Aligned_cols=201 Identities=27% Similarity=0.414 Sum_probs=170.2
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|++.+.||+|+||.||+|.+. +|+.||||+++.........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47899999999999999999874 69999999997654444446788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
|+.++ +.+++.. .....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99764 4444432 2356799999999999999999999999 9999999999999999999999999999766433
Q ss_pred CcccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
. .......||+.|+|||.+.... ++.++||||+||++|||++|+.||.
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 2 2334468999999999987766 4789999999999999999999995
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=335.79 Aligned_cols=197 Identities=32% Similarity=0.515 Sum_probs=164.3
Q ss_pred hhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-CCeEEEE
Q 007103 408 ATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLV 486 (618)
Q Consensus 408 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 486 (618)
..++|+..+.||+|+||.||+|.++ |+.||||+++... ..+.+.+|++++++++||||++++|++.+ .+..++|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 3456888899999999999999985 7899999997543 34678999999999999999999999865 4668999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCC
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTP 566 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 566 (618)
|||+++|+|.++++.. ....+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 9999999999999632 123589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 567 NTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 567 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||+.
T Consensus 155 ~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 155 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CCC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 322 23468899999999999999999999999999999998 7888863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=339.54 Aligned_cols=209 Identities=24% Similarity=0.412 Sum_probs=165.8
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
++...++|+..+.||+|+||.||+|.+. +++.||||+++... .....+.+.+|.+.+.++ +|+||+.+++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3445578999999999999999999864 24689999997544 334456677777777666 689999999988
Q ss_pred eeC-CeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 007103 478 AEH-GQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSA 544 (618)
Q Consensus 478 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 544 (618)
..+ +..++||||+++|+|.++++..+. ....+++.++..++.||++||+|||++ +|+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence 765 468999999999999999974332 134589999999999999999999999 9999999999
Q ss_pred CeeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCC
Q 007103 545 NILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG-RKPLD 617 (618)
Q Consensus 545 Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~Pf~ 617 (618)
|||+++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+|| +.||.
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999986543332 233456899999999999999999999999999999999996 56775
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-41 Score=337.09 Aligned_cols=200 Identities=24% Similarity=0.346 Sum_probs=173.4
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEEe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYEY 489 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 489 (618)
++|+..+.||+|+||+||+|++++|+.||||+++.........+.+.+|+.++++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57889999999999999999999999999999976654444467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+.++.+..+.+ ..+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877766654 457799999999999999999999999 99999999999999999999999999997654332
Q ss_pred cccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 223345789999999999765 46899999999999999999999996
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=335.52 Aligned_cols=203 Identities=26% Similarity=0.402 Sum_probs=163.8
Q ss_pred hcCCcccceeccCccceEEEEEEcC----CcEEEEEEcCcccc-cHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN----GKIMAVKKIDNAAL-SLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 483 (618)
.++|+..+.||+|+||.||+|++.. ...||||+++.... ..+..++|.+|++++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3568899999999999999997642 23789999875443 33445789999999999999999999999975 467
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||||+++|++.+++.. ....+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999988763 234699999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCcc--cccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 564 LTPNTERQ--VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 564 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
........ ......||..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 76544322 2234568889999999999999999999999999999998 8999963
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=336.74 Aligned_cols=200 Identities=23% Similarity=0.354 Sum_probs=170.1
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccH----HHHHHHHHHHHHhhcCC--CCcccccceEEeeCC
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSL----QEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHG 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 481 (618)
.++|++.+.||+|+||.||+|... +|+.||||++....... ....++.+|++++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999875 68999999987543221 12234668899998886 899999999999999
Q ss_pred eEEEEEEecCC-CChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-CCCcEEeec
Q 007103 482 QRLLVYEYVGN-GNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-ELNPHLSDC 559 (618)
Q Consensus 482 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Df 559 (618)
..++||||+.+ +++.++++ ....+++.+++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 57888776 245799999999999999999999999 9999999999999985 579999999
Q ss_pred cccccCCCCCcccccceeccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 007103 560 GLAALTPNTERQVSTQMVGAFGYSAPEFALSGIY-TVKSDVYSFGVVMLELLTGRKPLDR 618 (618)
Q Consensus 560 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~Pf~~ 618 (618)
|+++..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 999865432 2345689999999999987765 6779999999999999999999963
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=333.29 Aligned_cols=196 Identities=29% Similarity=0.470 Sum_probs=169.3
Q ss_pred cceeccCccceEEEEEEcCC----cEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee-CCeEEEEEEe
Q 007103 415 EFLIGEGSLGRVYRAEFANG----KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-HGQRLLVYEY 489 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 489 (618)
.++||+|+||+||+|.+.++ ..||||+++... .....++|.+|++++++++||||++++|++.. ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46899999999999987542 358999987433 45567889999999999999999999999876 5689999999
Q ss_pred cCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCCC
Q 007103 490 VGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNTE 569 (618)
Q Consensus 490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 569 (618)
+++|+|.++++. .....++..+.+++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999873 345678889999999999999999999 99999999999999999999999999998764332
Q ss_pred cc---cccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 570 RQ---VSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 570 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 21 2233578999999999999999999999999999999999888874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=334.75 Aligned_cols=199 Identities=27% Similarity=0.371 Sum_probs=162.9
Q ss_pred cCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC----eEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QRLL 485 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 485 (618)
++|...+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++||||+++++++.+++ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5677888999999999999987 58999999986432 12222334555667789999999999998754 5799
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceecCCCCCCeeecCCCCcEEeecc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVC-----LPSVVHRNFKSANILLDDELNPHLSDCG 560 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 560 (618)
||||+++|+|.++++. ..+++..+.+++.|++.||+|+|+.. .++|+||||||+|||+++++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999973 46899999999999999999999731 2389999999999999999999999999
Q ss_pred ccccCCCCCcc---cccceeccccccCccccccC------CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 561 LAALTPNTERQ---VSTQMVGAFGYSAPEFALSG------IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 561 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+++........ ......||++|+|||++.+. .++.++|||||||++|||+||..||.
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 99866433322 23346899999999998754 36789999999999999999988873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=334.09 Aligned_cols=208 Identities=28% Similarity=0.466 Sum_probs=173.2
Q ss_pred hhhcCCcccceeccCccceEEEEEEcC--------CcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEE
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFAN--------GKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYC 477 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 477 (618)
...++|+..+.||+|+||.||+|+... +..||||+++... ......++.+|...+.++ +||||+++++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 345788999999999999999997642 3479999997654 344567788888888877 899999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 007103 478 AEHGQRLLVYEYVGNGNLHDMLHFADD------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (618)
Q Consensus 478 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 545 (618)
.+++..++||||+++|+|.++++.... ....+++.++.+++.||+.||+|||+. +|+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 999999999999999999999975432 235689999999999999999999999 99999999999
Q ss_pred eeecCCCCcEEeeccccccCCCCC-cccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 007103 546 ILLDDELNPHLSDCGLAALTPNTE-RQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLDR 618 (618)
Q Consensus 546 ill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~~ 618 (618)
||++.++.+||+|||+++...... ........||+.|+|||.+.+..|+.++|||||||++|||++ |+.||..
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 999999999999999998664332 223345679999999999999999999999999999999998 7888863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=333.49 Aligned_cols=209 Identities=24% Similarity=0.395 Sum_probs=180.3
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEe
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCA 478 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 478 (618)
++...++|+..+.||+|+||.||+|.+. +++.||||+++... ..+....|.+|++++++++||||+++++++.
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 4455688999999999999999999764 25789999997543 4556678999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhccc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 479 EHGQRLLVYEYVGNGNLHDMLHFAD------DSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 479 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
.++..++||||+++|+|.++++..+ .....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999986432 1234578999999999999999999999 999999999999999999
Q ss_pred CcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCC
Q 007103 553 NPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTG-RKPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~Pf~ 617 (618)
++||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|| +.||.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 999999999986643332 223345799999999999999999999999999999999998 47775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=335.18 Aligned_cols=203 Identities=29% Similarity=0.465 Sum_probs=169.4
Q ss_pred hcCCcccceeccCccceEEEEEEcC-Cc--EEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEeeCCeEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFAN-GK--IMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAEHGQRL 484 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 484 (618)
.++|+..+.||+|+||.||+|.+.+ |. .||||+++... ..+..+.|.+|+++++++ +||||+++++++.+.+..+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 4678889999999999999998764 44 47788775433 233456799999999998 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhcc------------cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC
Q 007103 485 LVYEYVGNGNLHDMLHFA------------DDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL 552 (618)
Q Consensus 485 lv~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 552 (618)
+||||+++|+|.++++.. ......+++..+.+++.||++||+|||+. +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 999999999999999743 12346799999999999999999999999 999999999999999999
Q ss_pred CcEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCC
Q 007103 553 NPHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGR-KPLD 617 (618)
Q Consensus 553 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~Pf~ 617 (618)
.+||+|||+++...... ......||..|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus 165 ~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 99999999997654222 123457899999999999999999999999999999999965 5675
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=334.57 Aligned_cols=207 Identities=29% Similarity=0.451 Sum_probs=178.5
Q ss_pred hhhcCCcccceeccCccceEEEEEEc------CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcC-CCCcccccceEEee
Q 007103 407 TATNSFSQEFLIGEGSLGRVYRAEFA------NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRL-RHPNIVTLAGYCAE 479 (618)
Q Consensus 407 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 479 (618)
...++|+..+.||+|+||.||+|++. .++.||||+++... .......+.+|+.+++++ +||||+++++++.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 44578889999999999999999762 46789999997654 344567899999999998 69999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADD--------------SSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSAN 545 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 545 (618)
.+..++||||+++|+|.++++.... ....+++..+.+++.||++||+|||++ +|+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999975331 234689999999999999999999999 99999999999
Q ss_pred eeecCCCCcEEeeccccccCCCCCc-ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 007103 546 ILLDDELNPHLSDCGLAALTPNTER-QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLT-GRKPLD 617 (618)
Q Consensus 546 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~Pf~ 617 (618)
|+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |++||+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999987654433 33345689999999999999999999999999999999999 555554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=336.35 Aligned_cols=201 Identities=25% Similarity=0.387 Sum_probs=167.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-C-CcEEEEEEcCcccccHHHHHHHHHHHHHhhc---CCCCcccccceEEee----
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-N-GKIMAVKKIDNAALSLQEEDNFLEAVSNMSR---LRHPNIVTLAGYCAE---- 479 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~---- 479 (618)
.++|++.+.||+|+||+||+|++. + ++.||||+++...........+.+|+.+++. .+||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999874 4 6779999987544333223345566665554 489999999999853
Q ss_pred -CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEee
Q 007103 480 -HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSD 558 (618)
Q Consensus 480 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 558 (618)
....+++|||++++.+..... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346799999999877654443 2456789999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 559 CGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 559 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
||+++..... .......||+.|+|||++.+..|+.++||||+||++|||+||+.||.
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 9998765432 23345689999999999999999999999999999999999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=329.31 Aligned_cols=202 Identities=24% Similarity=0.355 Sum_probs=169.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEee--------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAE-------- 479 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 479 (618)
.++|++.+.||+|+||+||+|.+. +|+.||||++...........++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 467899999999999999999875 69999999987665444456778899999999999999999998855
Q ss_pred CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeec
Q 007103 480 HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDC 559 (618)
Q Consensus 480 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 559 (618)
.+..++||||++++.+..+.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 345799999998876665443 456789999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCc---ccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 560 GLAALTPNTER---QVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 560 gl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+++....... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 99976543321 222345799999999999765 68999999999999999999999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-39 Score=330.08 Aligned_cols=196 Identities=23% Similarity=0.365 Sum_probs=167.6
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC------
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG------ 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 481 (618)
.++|+..+.||+|+||.||+|... +|+.||||+++.........+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999875 5999999999876666666788999999999999999999999997654
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+ +.+|..+.+ ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 457877765 35699999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSG-IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++...... +...||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 98765432 346799999999999764 46899999999999999999999995
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-39 Score=328.26 Aligned_cols=200 Identities=26% Similarity=0.373 Sum_probs=167.9
Q ss_pred hcCCcccceeccCccceEEEEEE-cCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCC----eE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEF-ANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHG----QR 483 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 483 (618)
..+|+..+.||+|+||+||+|.. .+|+.||||++.... .....+.+++|++++++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35699999999999999999976 479999999997543 3445678899999999999999999999997653 34
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++++||+.+|+|.++++. ..+++..++.++.|++.||+|||++ +||||||||+|||+++++.+||+|||+++
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 566677789999999962 4689999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCc--ccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 564 LTPNTER--QVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 564 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
....... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 6543222 22344679999999999855 567899999999999999999999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-40 Score=330.70 Aligned_cols=201 Identities=27% Similarity=0.401 Sum_probs=174.3
Q ss_pred cCCcccceeccCccceEEEEEEc----CCcEEEEEEcCcccc--cHHHHHHHHHHHHHhhcCCC-CcccccceEEeeCCe
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA----NGKIMAVKKIDNAAL--SLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQ 482 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 482 (618)
++|+..+.||+|+||+||+|+.. +|+.||||.++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999752 478999999875432 22234568899999999976 899999999999999
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++||||+.+|+|.++++. ...+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999873 34677889999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcccccceeccccccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSG--IYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+..............|++.|+|||.+.+. .++.++||||+||++|||+||+.||.
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 87765555545567899999999999765 36789999999999999999999996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-39 Score=321.02 Aligned_cols=198 Identities=19% Similarity=0.260 Sum_probs=169.3
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCC-CcccccceEEeeCCeEEEE
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-PNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 486 (618)
.++|++.+.||+|+||+||+|++. +|+.||||.+..... ...+.+|++.++.++| +|++.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 357999999999999999999875 589999998754332 2346677888888865 8999999999999999999
Q ss_pred EEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecC-----CCCcEEeeccc
Q 007103 487 YEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDD-----ELNPHLSDCGL 561 (618)
Q Consensus 487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfgl 561 (618)
|||+ +++|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 80 me~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 9999 5799998863 345789999999999999999999999 9999999999999974 57899999999
Q ss_pred cccCCCCCc------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTER------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
|+....... ......+||+.|||||++.+..+++++|||||||++|||+||+.||.
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 986543221 12234689999999999999999999999999999999999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=317.44 Aligned_cols=199 Identities=23% Similarity=0.344 Sum_probs=176.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeCCeEEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEHGQRLLVYE 488 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 488 (618)
++|++.+.||+|+||+||+|++. +|+.||||+++..........++.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47899999999999999999875 68899999997665555567889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccccccCCCC
Q 007103 489 YVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLAALTPNT 568 (618)
Q Consensus 489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 568 (618)
++.++++..+++ ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888776 456789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCC
Q 007103 569 ERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPL 616 (618)
Q Consensus 569 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf 616 (618)
.. ......+++.|+|||.+.... ++.++||||+||++|||++|+.||
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 32 223456788999999988765 689999999999999999999997
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-39 Score=328.02 Aligned_cols=195 Identities=29% Similarity=0.378 Sum_probs=163.0
Q ss_pred CCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------CeE
Q 007103 411 SFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------GQR 483 (618)
Q Consensus 411 ~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 483 (618)
+|...++||+|+||+||+|++. +|+.||||++..... .+.+|++++++++||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5778889999999999999876 599999999865432 234689999999999999999998643 247
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEeecccc
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLA 562 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~ 562 (618)
++||||++++.+.. +.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 95 ~lv~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 89999998754443 332223456799999999999999999999999 999999999999999765 8999999999
Q ss_pred ccCCCCCcccccceeccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALS-GIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
+....... .....||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||.
T Consensus 171 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 171 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp EECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred hhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 87643322 234689999999998875 568999999999999999999999995
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.9e-38 Score=319.00 Aligned_cols=191 Identities=24% Similarity=0.386 Sum_probs=166.1
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeC--CeEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEH--GQRLL 485 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l 485 (618)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .+++.+|++++++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 57999999999999999999874 68999999987432 456889999999985 99999999998753 56899
Q ss_pred EEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCC-CcEEeecccccc
Q 007103 486 VYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDEL-NPHLSDCGLAAL 564 (618)
Q Consensus 486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~ 564 (618)
||||+++++|.++. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 99999999997754 3589999999999999999999999 999999999999998654 699999999987
Q ss_pred CCCCCcccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... .....||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.
T Consensus 180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 180 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 654322 23467999999999988754 7999999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-38 Score=315.56 Aligned_cols=197 Identities=21% Similarity=0.283 Sum_probs=163.7
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccc-eEEeeCCeEEEEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLA-GYCAEHGQRLLVY 487 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~lv~ 487 (618)
++|++.+.||+|+||.||+|.+. +|+.||||.+..... ..++..|+++++.++|+|++..+ +++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 56999999999999999999874 589999998765432 23577899999999887766554 4556677889999
Q ss_pred EecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeec---CCCCcEEeecccccc
Q 007103 488 EYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLD---DELNPHLSDCGLAAL 564 (618)
Q Consensus 488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgl~~~ 564 (618)
||++ +++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9995 466665542 356799999999999999999999999 999999999999986 455799999999987
Q ss_pred CCCCCc------ccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 565 TPNTER------QVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 565 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
...... .......||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 643322 12234689999999999999999999999999999999999999995
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-38 Score=321.76 Aligned_cols=197 Identities=24% Similarity=0.389 Sum_probs=170.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC-----Ce
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH-----GQ 482 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 482 (618)
.++|+..+.||+|+||+||+|+.. +|+.||||+++....+....+.+.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999864 699999999987766666778899999999999999999999998643 34
Q ss_pred EEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeecccc
Q 007103 483 RLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGLA 562 (618)
Q Consensus 483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 562 (618)
.++++||+.+|+|.++++ .+.+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 577788889999999985 35699999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccceeccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 007103 563 ALTPNTERQVSTQMVGAFGYSAPEFALSGI-YTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 563 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
..... ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 65432 223467999999999877754 6889999999999999999999995
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=320.64 Aligned_cols=197 Identities=22% Similarity=0.289 Sum_probs=163.0
Q ss_pred hcCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCCCcccccceEEeeC------C
Q 007103 409 TNSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVTLAGYCAEH------G 481 (618)
Q Consensus 409 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 481 (618)
.++|++.+.||+|+||+||+|.+. +|+.||||++..........+++.+|++++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999876 599999999987666666677899999999999999999999999643 5
Q ss_pred eEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEEeeccc
Q 007103 482 QRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHLSDCGL 561 (618)
Q Consensus 482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 561 (618)
..++||||+.++.+ +.+. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 78999999976544 4442 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 562 AALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 562 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 8765432 22345679999999999999999999999999999999999999994
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-34 Score=293.04 Aligned_cols=174 Identities=28% Similarity=0.511 Sum_probs=142.7
Q ss_pred CChHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCceeEeeCC----CEEEEEcCCCCCcc--cccccccCCCCCCEE
Q 007103 39 TDSSDVQALQVLYTSLNSPSVLTNWKGNEGDPCGESWKGVACEGS----AVVSIDISGLGLSG--TMGYLLSDLLSLRKF 112 (618)
Q Consensus 39 ~~~~~~~al~~~~~~~~~~~~~~~w~~~~~~~c~~~w~gv~c~~~----~v~~l~l~~~~l~~--~~~~~l~~l~~L~~L 112 (618)
|.++|++||++||+++.+|..+++|.. +.|||.+.|+||+|+.. +|+.|||++++++| .+|+.+++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 688999999999999999989999974 46888778999999752 79999999999998 578999999999999
Q ss_pred EecC-CCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcC
Q 007103 113 DLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNF 189 (618)
Q Consensus 113 ~L~~-N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 189 (618)
+|++ |+++|.+|.++. ++|++|+|++|+|++..|..+..+.+|+++++++|++.+.+|..+++++.|+.+++++|.+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 9997 899999998887 8999999999999988888788888888888888887777777777777777777777777
Q ss_pred CCCCCCCcccCCCc-Ceeeeccccc
Q 007103 190 SGDLPNSFISLSNI-SSLYLQNNQV 213 (618)
Q Consensus 190 ~g~~p~~~~~l~~L-~~L~l~~N~l 213 (618)
.|.+|..+..+.++ +.+++++|++
T Consensus 162 ~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 162 SGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp EEECCGGGGCCCTTCCEEECCSSEE
T ss_pred ccccccccccccccccccccccccc
Confidence 76666555444333 3333444333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=2.5e-32 Score=281.79 Aligned_cols=198 Identities=18% Similarity=0.247 Sum_probs=158.6
Q ss_pred cCCcccceeccCccceEEEEEEc-CCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-----------CCcccccceEE
Q 007103 410 NSFSQEFLIGEGSLGRVYRAEFA-NGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-----------HPNIVTLAGYC 477 (618)
Q Consensus 410 ~~~~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 477 (618)
.+|++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 35999999999999999999874 69999999997543 22355677777776664 57899999987
Q ss_pred ee--CCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCC--
Q 007103 478 AE--HGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELN-- 553 (618)
Q Consensus 478 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-- 553 (618)
.. ....+++++++..+........ ......+++..+..++.||+.||+|||+.. +|+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccc
Confidence 65 3566777777766543333222 234567899999999999999999999832 8999999999999986543
Q ss_pred ----cEEeeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 007103 554 ----PHLSDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGVVMLELLTGRKPLD 617 (618)
Q Consensus 554 ----~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~Pf~ 617 (618)
++++|||.+...... ....+||+.|+|||++....|+.++||||+||+++||++|+.||.
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 899999998755322 234679999999999999999999999999999999999999995
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=8.4e-23 Score=200.24 Aligned_cols=176 Identities=22% Similarity=0.196 Sum_probs=156.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
..++.|+|++|.|++..+..|.++++|++|+|++|+|+...+....++|+.|+|++|+++ .++..+.++++|+.|++++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~ 109 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccc
Confidence 368999999999999888899999999999999999996545555699999999999999 4577899999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIP 240 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip 240 (618)
|.+.+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|++++|+|++.++. +.. .+|+.|+|++|+|+ .+|
T Consensus 110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp 188 (266)
T d1p9ag_ 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (266)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccC
Confidence 999999999999999999999999999977777788999999999999999997764 333 46999999999999 888
Q ss_pred hhh---hcccchhccCCcCCCCC
Q 007103 241 REL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 241 ~~~---~~l~~l~~~~N~~~~~~ 260 (618)
+.+ .+|+.|++.||||.|.+
T Consensus 189 ~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 189 KGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TTTTTTCCCSEEECCSCCBCCSG
T ss_pred hhHCCCCCCCEEEecCCCCCCCc
Confidence 765 45678999999999965
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.3e-23 Score=193.51 Aligned_cols=169 Identities=13% Similarity=0.092 Sum_probs=118.9
Q ss_pred cccceeccCccceEEEEEEcCCcEEEEEEcCccccc----------------HHHHHHHHHHHHHhhcCCCCcccccceE
Q 007103 413 SQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALS----------------LQEEDNFLEAVSNMSRLRHPNIVTLAGY 476 (618)
Q Consensus 413 ~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~niv~l~~~ 476 (618)
...+.||+|+||+||+|...+|+.||||+++..... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999889999999986532111 1112344567888899999999887765
Q ss_pred EeeCCeEEEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeecCCCCcEE
Q 007103 477 CAEHGQRLLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCLPSVVHRNFKSANILLDDELNPHL 556 (618)
Q Consensus 477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 556 (618)
. ..+++|||+++..+.+ ++......++.|++++++|||+. +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2379999998865543 22334567899999999999999 99999999999999976 4899
Q ss_pred eeccccccCCCCCcccccceeccccccCccccccCCCCcccchhhHHH
Q 007103 557 SDCGLAALTPNTERQVSTQMVGAFGYSAPEFALSGIYTVKSDVYSFGV 604 (618)
Q Consensus 557 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 604 (618)
+|||.|........... ....... -.|. ..+.|+.++|+||..-
T Consensus 144 iDFG~a~~~~~~~~~~~--l~rd~~~-~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 144 IDFPQSVEVGEEGWREI--LERDVRN-IITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp CCCTTCEETTSTTHHHH--HHHHHHH-HHHH-HHHHHCCCCCHHHHHH
T ss_pred EECCCcccCCCCCcHHH--HHHHHHH-HHHH-HcCCCCCcccHHHHHH
Confidence 99999976543221100 0000000 0011 2456888999999753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.85 E-value=4.9e-22 Score=184.57 Aligned_cols=170 Identities=21% Similarity=0.266 Sum_probs=144.8
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCC-C--CCccEEecccccccccCCccccCCCCccEEEeecCC
Q 007103 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL-P--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (618)
Q Consensus 88 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (618)
++.++++|+ .+|..+. +++++|+|++|+|++.++... . ++|+.|+|++|++++..+..+..+++|++|+|++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 455566676 4565553 689999999999987665444 3 899999999999999999999999999999999999
Q ss_pred CCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccC-CCCccEEEcccccccccCchhh
Q 007103 165 LTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS-GLPLTTLNVANNHFSGWIPREL 243 (618)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~L~~L~l~~N~l~g~ip~~~ 243 (618)
|+++.|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+... ...++.+.+..|.++...|..+
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l 169 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChhh
Confidence 999999999999999999999999998778889999999999999999987554322 1236677888999998999999
Q ss_pred hcccchhccCCcCCCCC
Q 007103 244 ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 244 ~~l~~l~~~~N~~~~~~ 260 (618)
.+++.+++..|.+.|.+
T Consensus 170 ~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 170 RDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp TTSBGGGSCTTTCCCCC
T ss_pred cCCEeeecCHhhCcCCC
Confidence 99999999999999864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.1e-20 Score=186.80 Aligned_cols=186 Identities=20% Similarity=0.184 Sum_probs=155.8
Q ss_pred CceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCC------------------
Q 007103 75 WKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPY------------------ 125 (618)
Q Consensus 75 w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~------------------ 125 (618)
|.-|.|++ ..++.|+|++|+|+...+..|.++++|++|++++|+|.+..+.
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 44578865 2468899999999988888999999999999999998644331
Q ss_pred -------CCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCC
Q 007103 126 -------QLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS 196 (618)
Q Consensus 126 -------~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 196 (618)
.+. ++|++|+|++|.+....+..+..+.+|+.+++++|+|+++.+..|..+++|+.|+|++|+|++..+..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 222 68999999999998777788888999999999999999888888999999999999999999877888
Q ss_pred cccCCCcCeeeecccccccccccc-CC-CCccEEEcccccccccCchhh---hcccchhccCCcCCCCC
Q 007103 197 FISLSNISSLYLQNNQVTGSLNVF-SG-LPLTTLNVANNHFSGWIPREL---ISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 197 ~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~L~l~~N~l~g~ip~~~---~~l~~l~~~~N~~~~~~ 260 (618)
|.++++|++|++++|++++..+.. .. .+|+.||+++|.+++..|..+ .+|+.|++++|+|.|.+
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 999999999999999999876543 33 469999999999998777766 45778899999999864
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.80 E-value=7.3e-21 Score=190.97 Aligned_cols=177 Identities=27% Similarity=0.377 Sum_probs=143.0
Q ss_pred CCEEEEEcCC-CCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEE
Q 007103 83 SAVVSIDISG-LGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 83 ~~v~~l~l~~-~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
..++.|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+. .+|+.+++++|++.+.+|..+.++++|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 4788999987 899999999999999999999999999988776554 6788888888888888888888888888888
Q ss_pred eecCCCCCccchhhcCC------------------------------------------------CCCCeEEcccCcCCC
Q 007103 160 VSRNSLTQSIGDIFGNL------------------------------------------------AGLATLDLSFNNFSG 191 (618)
Q Consensus 160 L~~N~l~~~~p~~~~~l------------------------------------------------~~L~~L~ls~N~l~g 191 (618)
+++|.+++.+|..+..+ ++|+.|++++|.+.+
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 88887777776655443 445555666666665
Q ss_pred CCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCch--hhhcccchhccCCcCCCCC
Q 007103 192 DLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPR--ELISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 192 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip~--~~~~l~~l~~~~N~~~~~~ 260 (618)
.+| .+..+++|++|+|++|+|+|.+|. +.. .+|+.|||++|+|+|.+|+ .+.+|+.+.+.+|++.|+.
T Consensus 236 ~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 236 DLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp BGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred ccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCC
Confidence 443 466788999999999999998765 333 4599999999999999996 3678888999999998875
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.78 E-value=4.9e-19 Score=176.73 Aligned_cols=74 Identities=19% Similarity=0.251 Sum_probs=62.0
Q ss_pred CCCCCCCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEe
Q 007103 69 DPCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLN 135 (618)
Q Consensus 69 ~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~ 135 (618)
..|.|.|++|.|++ ..++.|+|++|+|+...+..|.++++|++|++++|.+....|..+. ++|+.|+
T Consensus 6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 45777999999974 3578899999999887777899999999999999999977776664 7888888
Q ss_pred ccccccc
Q 007103 136 LASNNFS 142 (618)
Q Consensus 136 L~~N~l~ 142 (618)
|++|+++
T Consensus 86 l~~n~l~ 92 (305)
T d1xkua_ 86 LSKNQLK 92 (305)
T ss_dssp CCSSCCS
T ss_pred ccCCccC
Confidence 8888766
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=5.9e-18 Score=156.59 Aligned_cols=150 Identities=24% Similarity=0.294 Sum_probs=129.2
Q ss_pred CEEEecCCCccCCCCCCCCCCccEEecccccccccC-CccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCc
Q 007103 110 RKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNL-PYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNN 188 (618)
Q Consensus 110 ~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 188 (618)
+.++.++|+|+ .+|..+++++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..|..+++|++|+|++|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CEEEEeCCCcC-ccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 57999999999 789999999999999999998754 6677999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEcccccccccCchh--hhcccchhccCCcCCCCC
Q 007103 189 FSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGWIPRE--LISIRTFIYDGNSFDNGP 260 (618)
Q Consensus 189 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ip~~--~~~l~~l~~~~N~~~~~~ 260 (618)
|++..|..|.++++|++|+|++|+|++..+. +.. .+|+.|+|++|.+....+.. ...+..+.+..|...|..
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCC
Confidence 9987788899999999999999999997765 433 45999999999998644422 234666777778877753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=4.3e-17 Score=158.96 Aligned_cols=152 Identities=20% Similarity=0.203 Sum_probs=134.2
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEE
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
-.+++.|+|++|+|+.. + .++.+++|++|+|++|++++. +..+. ++|+.|++++|.+.+..+..+..+.+|+.|+
T Consensus 54 l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~ 130 (266)
T d1p9ag_ 54 YTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (266)
T ss_dssp CTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred ccccccccccccccccc-c-ccccccccccccccccccccc-ccccccccccccccccccccceeecccccccccccccc
Confidence 36799999999999854 3 467899999999999999965 43443 8999999999999988888999999999999
Q ss_pred eecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccC-CCCccEEEccccccc
Q 007103 160 VSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFS-GLPLTTLNVANNHFS 236 (618)
Q Consensus 160 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~L~~L~l~~N~l~ 236 (618)
+++|.++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+..++.+. ..+|+.|+|++|.+.
T Consensus 131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence 99999999888999999999999999999998778889999999999999999996554444 456999999999986
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.1e-17 Score=164.94 Aligned_cols=176 Identities=18% Similarity=0.186 Sum_probs=146.6
Q ss_pred CEEEEEc-CCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEe
Q 007103 84 AVVSIDI-SGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNV 160 (618)
Q Consensus 84 ~v~~l~l-~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 160 (618)
.+..++. ..+.++...+..|.++++|++|+|++|.+....+..+. ++|+.+++++|+|++..+..|..+++|+.|+|
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 4556655 46677777788999999999999999999866655554 89999999999999877888999999999999
Q ss_pred ecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cCC-CCccEEEccccccccc
Q 007103 161 SRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FSG-LPLTTLNVANNHFSGW 238 (618)
Q Consensus 161 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~l~~N~l~g~ 238 (618)
++|+|++..+..|.++++|+.|++++|++++..|..|..+++|++|++++|++++.++. +.. .+|+.|+|++|++...
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 99999999999999999999999999999999999999999999999999999997754 333 4599999999999864
Q ss_pred Cchh-h-hcccchhccCCcCCCC
Q 007103 239 IPRE-L-ISIRTFIYDGNSFDNG 259 (618)
Q Consensus 239 ip~~-~-~~l~~l~~~~N~~~~~ 259 (618)
-+.. + ..++.+....+...|.
T Consensus 241 C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 241 CRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp GGGHHHHHHHHHCCSEECCCBEE
T ss_pred ccchHHHHHHHhCcCCCCceEeC
Confidence 4421 1 2344555555666663
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.5e-16 Score=147.76 Aligned_cols=157 Identities=24% Similarity=0.358 Sum_probs=130.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+++++++... +.+..+++|++|+|++|+|++..|..-.++|+.|++++|.+.. ++ .+.++++|+.|++++
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFN 115 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCS
T ss_pred cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcccccCCccccccccccccccc-cc-ccccccccccccccc
Confidence 4688999999999764 3588999999999999999987665555899999999999984 43 489999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCchh
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPRE 242 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~~ 242 (618)
|.+.... .+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++..+.....+|+.|+|++|++++ +| .
T Consensus 116 ~~~~~~~--~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~-i~-~ 189 (199)
T d2omxa2 116 NQITDID--PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-IS-V 189 (199)
T ss_dssp SCCCCCG--GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-G
T ss_pred ccccccc--ccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCCC-Cc-c
Confidence 9998654 4788999999999999998 444 588999999999999999986654445679999999999985 44 3
Q ss_pred hhcccch
Q 007103 243 LISIRTF 249 (618)
Q Consensus 243 ~~~l~~l 249 (618)
+.+++.|
T Consensus 190 l~~L~~L 196 (199)
T d2omxa2 190 LAKLTNL 196 (199)
T ss_dssp GGGCTTC
T ss_pred ccCCCCC
Confidence 5555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.7e-16 Score=148.85 Aligned_cols=161 Identities=21% Similarity=0.258 Sum_probs=131.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
..++.|+++++.+.+.. .+..+++|++|+|++|+|++..|....++|+.|++++|+|++ +| .+.++++|+.|++++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccccccCccccccccccccccc-cc-ccccccccccccccc
Confidence 36889999999997643 488899999999999999987766666899999999999995 44 689999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCch-
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIPR- 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip~- 241 (618)
|.++.. ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++..+.....+|+.|+|++|+|+ .+|.
T Consensus 122 ~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~~l 196 (210)
T d1h6ta2 122 NGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRAL 196 (210)
T ss_dssp SCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCGGG
T ss_pred cccccc--ccccccccccccccccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CChhh
Confidence 998753 458889999999999999984 3457789999999999999998655444457999999999998 4552
Q ss_pred -hhhcccchhcc
Q 007103 242 -ELISIRTFIYD 252 (618)
Q Consensus 242 -~~~~l~~l~~~ 252 (618)
.+.+|+.|+++
T Consensus 197 ~~l~~L~~L~Ls 208 (210)
T d1h6ta2 197 AGLKNLDVLELF 208 (210)
T ss_dssp TTCTTCSEEEEE
T ss_pred cCCCCCCEEEcc
Confidence 33445555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=1.1e-15 Score=141.90 Aligned_cols=163 Identities=18% Similarity=0.272 Sum_probs=132.1
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCC
Q 007103 88 IDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQ 167 (618)
Q Consensus 88 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 167 (618)
+.++.+++++.++ ...+.+|++|++++|.++.....+..++|++|+|++|++++..| ++++++|++|++++|.+..
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCccccccCCCcCcCccccccccCccc--ccCCccccccccccccccc
Confidence 3456666666543 35688999999999999865444556999999999999996543 8999999999999999986
Q ss_pred ccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-hhhhcc
Q 007103 168 SIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-RELISI 246 (618)
Q Consensus 168 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~~~~~l 246 (618)
.. .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++..........+|+.|++++|++++..| ..+.+|
T Consensus 99 ~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L 174 (199)
T d2omxa2 99 IT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTL 174 (199)
T ss_dssp CG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGGGTTCTTC
T ss_pred cc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCCccccCCCCC
Confidence 53 488999999999999999843 3478899999999999999875444455679999999999996433 456788
Q ss_pred cchhccCCcCCC
Q 007103 247 RTFIYDGNSFDN 258 (618)
Q Consensus 247 ~~l~~~~N~~~~ 258 (618)
+.|++++|++..
T Consensus 175 ~~L~ls~N~i~~ 186 (199)
T d2omxa2 175 ERLDISSNKVSD 186 (199)
T ss_dssp CEEECCSSCCCC
T ss_pred CEEECCCCCCCC
Confidence 899999998754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.61 E-value=1.5e-15 Score=144.15 Aligned_cols=167 Identities=23% Similarity=0.312 Sum_probs=101.2
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
..++.|++.+++|+.. +.+..+++|++|+|++|++++..|....++|+.|++++|.++. + ..+.++++|+.|++++
T Consensus 41 ~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~ 116 (227)
T d1h6ua2 41 DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTS 116 (227)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTT
T ss_pred CCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccccccccccccccccccccccc-c-cccccccccccccccc
Confidence 3678888888888754 3577888888888888888876665556788888888888773 3 3577788888888888
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-h
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~ 241 (618)
|...+..+ +...+.+..++++++.+.... .+..+++|+.|++++|.+++..+.....+|+.|+|++|++++..+ .
T Consensus 117 ~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~l~~l~ 192 (227)
T d1h6ua2 117 TQITDVTP--LAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192 (227)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred ccccccch--hccccchhhhhchhhhhchhh--hhccccccccccccccccccchhhcccccceecccCCCccCCChhhc
Confidence 87765433 334455555555555554222 244455555555555555543332223345555555555553211 2
Q ss_pred hhhcccchhccCCcCC
Q 007103 242 ELISIRTFIYDGNSFD 257 (618)
Q Consensus 242 ~~~~l~~l~~~~N~~~ 257 (618)
.+.+|+.|++++|++.
T Consensus 193 ~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 193 SLPNLIEVHLKNNQIS 208 (227)
T ss_dssp GCTTCCEEECTTSCCC
T ss_pred CCCCCCEEECcCCcCC
Confidence 3344455555555444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.60 E-value=1.9e-15 Score=155.14 Aligned_cols=164 Identities=26% Similarity=0.365 Sum_probs=114.0
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|++++|.++.. +.+..+++|+.|++++|.+++..+....++|+.|++++|++++.. .+..++.++.+++++
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCcccccccCCEeeccCcccCCCC--ccccccccccccccc
Confidence 3566677777776652 356677777777777777776666555577777777777777542 366677777777777
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-h
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-R 241 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~ 241 (618)
|++++. ..+..+++++.|+|++|++++. + .+..+++|++|+|++|+|++........+|+.|+|++|+|++..| .
T Consensus 295 n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~~l~ 370 (384)
T d2omza2 295 NQLEDI--SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTPLA 370 (384)
T ss_dssp SCCSCC--GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCGGGT
T ss_pred cccccc--cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCCCChhhc
Confidence 777753 3467778888888888888854 3 377888888888888888764433333458888888888886555 3
Q ss_pred hhhcccchhccCC
Q 007103 242 ELISIRTFIYDGN 254 (618)
Q Consensus 242 ~~~~l~~l~~~~N 254 (618)
.+.+|+.|++++|
T Consensus 371 ~l~~L~~L~L~~N 383 (384)
T d2omza2 371 NLTRITQLGLNDQ 383 (384)
T ss_dssp TCTTCSEEECCCE
T ss_pred cCCCCCEeeCCCC
Confidence 4556777777776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.59 E-value=6e-15 Score=146.57 Aligned_cols=150 Identities=23% Similarity=0.346 Sum_probs=112.5
Q ss_pred EEEEEcCCCCC--cccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 85 VVSIDISGLGL--SGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 85 v~~l~l~~~~l--~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
...++...|.. .+..+..+..+++|+.+++++|.++ .+|..+.++|+.|++++|.+++..+..+.+++.+++|++++
T Consensus 126 ~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~ 204 (305)
T d1xkua_ 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204 (305)
T ss_dssp CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS
T ss_pred ccccccccccccccCCCccccccccccCccccccCCcc-ccCcccCCccCEEECCCCcCCCCChhHhhcccccccccccc
Confidence 34455554432 3344556777888888888888887 56767778888888888888888888888888888888888
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccc-cC-------CCCccEEEccccc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNV-FS-------GLPLTTLNVANNH 234 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-------~~~L~~L~l~~N~ 234 (618)
|.+++..+..|.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+..... +. ..+|+.|+|++|.
T Consensus 205 n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~ 283 (305)
T d1xkua_ 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283 (305)
T ss_dssp SCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSS
T ss_pred ccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCc
Confidence 8888887888888888888888888888 6788888888888888888888864321 11 1247788888887
Q ss_pred cc
Q 007103 235 FS 236 (618)
Q Consensus 235 l~ 236 (618)
++
T Consensus 284 ~~ 285 (305)
T d1xkua_ 284 VQ 285 (305)
T ss_dssp SC
T ss_pred Cc
Confidence 74
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.58 E-value=3.6e-15 Score=139.60 Aligned_cols=162 Identities=23% Similarity=0.378 Sum_probs=132.4
Q ss_pred EcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecCCCCCc
Q 007103 89 DISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQS 168 (618)
Q Consensus 89 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 168 (618)
+++.+.+.+.++. ..|.+|+.|++++|.+++..+.+..++|++|+|++|+|++. + .++.+++|++|++++|+|++.
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~l 105 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKDL 105 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCG
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCchhHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccccc
Confidence 4555556555443 35778999999999999766656679999999999999964 3 478999999999999999964
Q ss_pred cchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccccccccCc-hhhhccc
Q 007103 169 IGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNHFSGWIP-RELISIR 247 (618)
Q Consensus 169 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ip-~~~~~l~ 247 (618)
| .+..+++|+.|++++|.+. .+ ..+..+++|+.+++++|.+++........+|+.+++++|++++..| ..+.+|+
T Consensus 106 -~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~ 181 (210)
T d1h6ta2 106 -S-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQ 181 (210)
T ss_dssp -G-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCC
T ss_pred -c-ccccccccccccccccccc-cc-ccccccccccccccccccccccccccccccccccccccccccccccccCCCCCC
Confidence 4 5889999999999999998 44 3588999999999999999976655555679999999999996433 3567888
Q ss_pred chhccCCcCCC
Q 007103 248 TFIYDGNSFDN 258 (618)
Q Consensus 248 ~l~~~~N~~~~ 258 (618)
.|++++|.+..
T Consensus 182 ~L~Ls~N~i~~ 192 (210)
T d1h6ta2 182 NLYLSKNHISD 192 (210)
T ss_dssp EEECCSSCCCB
T ss_pred EEECCCCCCCC
Confidence 99999998864
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1.1e-14 Score=139.42 Aligned_cols=189 Identities=19% Similarity=0.193 Sum_probs=137.2
Q ss_pred CCCCCCceeEeeC-----------CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCC---CCCccEEe
Q 007103 70 PCGESWKGVACEG-----------SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQL---PPNLTSLN 135 (618)
Q Consensus 70 ~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~~L~~L~ 135 (618)
.|.|..+.|.|.. ..++.|+|++|.|+...+..|.++++|++|+|++|.+...++... .++++.|+
T Consensus 5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred cCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence 4777888999973 258889999999987777789999999999999999887665432 27888888
Q ss_pred cc-cccccccCCccccCCCCccEEEeecCCCCCccch-hhcCCCCCCeEEcccCcCCCCCCCCcccCC-CcCeeeecccc
Q 007103 136 LA-SNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGD-IFGNLAGLATLDLSFNNFSGDLPNSFISLS-NISSLYLQNNQ 212 (618)
Q Consensus 136 L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-~L~~L~l~~N~ 212 (618)
+. .|++....+..|.++++|+.|++++|+++...+. .+..++.|..+..+++.+....+..|..++ .++.|++++|+
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~ 164 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 164 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred ccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccc
Confidence 75 4788878888899999999999999998854332 344556666667777777755556666554 67778888888
Q ss_pred ccccccc-cCCCCccE-EEcccccccccCch----hhhcccchhccCCcCCCC
Q 007103 213 VTGSLNV-FSGLPLTT-LNVANNHFSGWIPR----ELISIRTFIYDGNSFDNG 259 (618)
Q Consensus 213 l~~~~~~-~~~~~L~~-L~l~~N~l~g~ip~----~~~~l~~l~~~~N~~~~~ 259 (618)
++..... +....+.. +++++|+++ .+|. .+.+|+.|++.+|++...
T Consensus 165 l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l 216 (242)
T d1xwdc1 165 IQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 216 (242)
T ss_dssp CCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCC
T ss_pred ccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCcc
Confidence 8765443 33344443 456777777 4443 235667778888877654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.1e-14 Score=123.43 Aligned_cols=83 Identities=28% Similarity=0.334 Sum_probs=38.4
Q ss_pred CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCC-CCCcccCCCcCeee
Q 007103 129 PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDL-PNSFISLSNISSLY 207 (618)
Q Consensus 129 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~~L~~L~ 207 (618)
++|++|+|++|+|+ .+|+.++.+++|+.|++++|+|++. | .++.+++|+.|++++|+|+... ...+..+++|++|+
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEE
Confidence 34444444444444 3344455555555555555555532 2 2445555555555555554211 12344445555555
Q ss_pred ecccccc
Q 007103 208 LQNNQVT 214 (618)
Q Consensus 208 l~~N~l~ 214 (618)
+++|+++
T Consensus 97 l~~N~i~ 103 (124)
T d1dcea3 97 LQGNSLC 103 (124)
T ss_dssp CTTSGGG
T ss_pred CCCCcCC
Confidence 5555444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.53 E-value=2.1e-14 Score=147.10 Aligned_cols=144 Identities=24% Similarity=0.327 Sum_probs=126.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
..++.|++++|.+++..+ +..+++|+.|++++|.+++..+....+.++.++++.|++++. ..+..+++|+.|+|++
T Consensus 241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~ 316 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYF 316 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCS
T ss_pred cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccc--cccchhcccCeEECCC
Confidence 468899999999988654 889999999999999999877766668999999999999963 4688999999999999
Q ss_pred CCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEccccc
Q 007103 163 NSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANNH 234 (618)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~ 234 (618)
|++++..+ +..+++|+.|+|++|+|+ .++ .+.++++|++|+|++|+|++.++.....+|+.|+|++|.
T Consensus 317 n~l~~l~~--l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 317 NNISDISP--VSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 384 (384)
T ss_dssp SCCSCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCEE
T ss_pred CCCCCCcc--cccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCCc
Confidence 99998653 888999999999999999 455 699999999999999999998775445679999999984
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=8.7e-15 Score=130.55 Aligned_cols=112 Identities=21% Similarity=0.242 Sum_probs=70.0
Q ss_pred cccCCCCCCEEEecCCCccCCCCCCC--CCCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCC
Q 007103 102 LLSDLLSLRKFDLSGNSIHDTIPYQL--PPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGL 179 (618)
Q Consensus 102 ~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 179 (618)
.+.+..+|++|+|++|+|+.. |..+ .++|+.|||++|+|+. + +.+..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 345566666677777776633 3222 2567777777777663 3 346667777777777777775555556667777
Q ss_pred CeEEcccCcCCCCCC--CCcccCCCcCeeeeccccccccc
Q 007103 180 ATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 180 ~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
+.|+|++|+|+ .++ ..+..+++|++|++++|+++...
T Consensus 90 ~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~ 128 (162)
T d1a9na_ 90 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKK 128 (162)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred ccceecccccc-ccccccccccccccchhhcCCCcccccc
Confidence 77777777776 333 34566677777777777766543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=6e-15 Score=131.59 Aligned_cols=122 Identities=19% Similarity=0.166 Sum_probs=83.5
Q ss_pred CEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeecC
Q 007103 84 AVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN 163 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 163 (618)
++..|||++|+|+.. +..+..+++|+.|+|++|.|+...+....++|++|+|++|+++...+..+..+++|+.|+|++|
T Consensus 19 ~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N 97 (162)
T d1a9na_ 19 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 97 (162)
T ss_dssp SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSC
T ss_pred cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCccCCcccCcchhhhhcccccccCCCccccccccccccceeccc
Confidence 567788888877654 4555677778888888887774422333377888888888877554555567778888888888
Q ss_pred CCCCccc-hhhcCCCCCCeEEcccCcCCCCCCC----CcccCCCcCeee
Q 007103 164 SLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPN----SFISLSNISSLY 207 (618)
Q Consensus 164 ~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~ 207 (618)
+|+.... ..+..+++|+.|++++|.++ ..|. .+..+++|++||
T Consensus 98 ~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 98 SLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 7775422 45677778888888888776 4443 356677777766
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=2.1e-14 Score=121.72 Aligned_cols=115 Identities=23% Similarity=0.275 Sum_probs=94.0
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCC
Q 007103 87 SIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNS 164 (618)
Q Consensus 87 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 164 (618)
.|+|++|+|+.. + .+..+++|++|+|++|+|+ .+|..+. ++|+.|++++|+|++ +| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 689999999854 3 5899999999999999998 5676555 899999999999995 44 59999999999999999
Q ss_pred CCCcc-chhhcCCCCCCeEEcccCcCCCCC--CCC-cccCCCcCee
Q 007103 165 LTQSI-GDIFGNLAGLATLDLSFNNFSGDL--PNS-FISLSNISSL 206 (618)
Q Consensus 165 l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~--p~~-~~~l~~L~~L 206 (618)
|+... ...+..+++|+.|++++|.+++.- +.. ...+++|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 99654 367899999999999999998321 222 2345666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.47 E-value=1.6e-13 Score=129.82 Aligned_cols=170 Identities=18% Similarity=0.262 Sum_probs=134.9
Q ss_pred CCceeEeeCCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCC
Q 007103 74 SWKGVACEGSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMV 153 (618)
Q Consensus 74 ~w~gv~c~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~ 153 (618)
+..|+. .-.+++.|++++|.+.+..+ +..+++|++|++++|.++..-.....++|+.|++++|...+. ..+...+
T Consensus 55 ~l~~l~-~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~ 129 (227)
T d1h6ua2 55 TIEGVQ-YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV--TPLAGLS 129 (227)
T ss_dssp CCTTGG-GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCC--GGGTTCT
T ss_pred cchhHh-cCCCCcEeecCCceeecccc--cccccccccccccccccccccccccccccccccccccccccc--chhcccc
Confidence 345542 34689999999999987654 899999999999999998543344458999999999998865 3477889
Q ss_pred CccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeeccccccccccccCCCCccEEEcccc
Q 007103 154 SLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVTGSLNVFSGLPLTTLNVANN 233 (618)
Q Consensus 154 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N 233 (618)
.+..+.++++.+....+ +.++++|+.|++++|.+.+.. .+.++++|+.|+|++|++++..+.....+|+.|+|++|
T Consensus 130 ~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N 205 (227)
T d1h6ua2 130 NLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN 205 (227)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTS
T ss_pred chhhhhchhhhhchhhh--hccccccccccccccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCC
Confidence 99999999999986543 677899999999999998433 38899999999999999998655444467999999999
Q ss_pred cccccCc-hhhhcccchhcc
Q 007103 234 HFSGWIP-RELISIRTFIYD 252 (618)
Q Consensus 234 ~l~g~ip-~~~~~l~~l~~~ 252 (618)
++++..| ..+.+|+.|+++
T Consensus 206 ~lt~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 206 QISDVSPLANTSNLFIVTLT 225 (227)
T ss_dssp CCCBCGGGTTCTTCCEEEEE
T ss_pred cCCCCcccccCCCCCEEEee
Confidence 9995433 345566666554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.4e-12 Score=115.22 Aligned_cols=73 Identities=21% Similarity=0.237 Sum_probs=49.8
Q ss_pred ccccCCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeecccccc
Q 007103 141 FSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQNNQVT 214 (618)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 214 (618)
|+..-+..|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|+|+ .+|.......+|+.|+|++|.+.
T Consensus 44 l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 44 LQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 44344456777788888888888887777777888888888888888887 55544443445666666666553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.32 E-value=1e-11 Score=124.94 Aligned_cols=78 Identities=26% Similarity=0.378 Sum_probs=55.4
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEeec
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSR 162 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 162 (618)
.+++.|+|++|+|+ .+|.. +.+|+.|++++|+++ .++ .+++.|++|+|++|.++ .+|. ++.+++|+.|++++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~-~lp~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~ 129 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALS-DLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDN 129 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCC-SCCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCS
T ss_pred CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhh-hhccccccccccccccc-cccc-hhhhccceeecccc
Confidence 35778888888887 44544 356777788888777 333 34567888888888887 4553 57788888888888
Q ss_pred CCCCCc
Q 007103 163 NSLTQS 168 (618)
Q Consensus 163 N~l~~~ 168 (618)
|.++..
T Consensus 130 ~~~~~~ 135 (353)
T d1jl5a_ 130 NSLKKL 135 (353)
T ss_dssp SCCSCC
T ss_pred cccccc
Confidence 876643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=3.2e-12 Score=112.74 Aligned_cols=105 Identities=17% Similarity=0.151 Sum_probs=89.8
Q ss_pred ccEEecccccccccCCccccCCCCccEEEeecC-CCCCccchhhcCCCCCCeEEcccCcCCCCCCCCcccCCCcCeeeec
Q 007103 131 LTSLNLASNNFSGNLPYSIASMVSLSYLNVSRN-SLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNSFISLSNISSLYLQ 209 (618)
Q Consensus 131 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~ 209 (618)
.+.+++++++++ ..|..+..+++|++|+|++| .|+.+.++.|.++++|+.|+|++|+|+...|..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 456777777777 66788889999999999876 4888778899999999999999999997778889999999999999
Q ss_pred cccccccccc-cCCCCccEEEccccccc
Q 007103 210 NNQVTGSLNV-FSGLPLTTLNVANNHFS 236 (618)
Q Consensus 210 ~N~l~~~~~~-~~~~~L~~L~l~~N~l~ 236 (618)
+|+|+...+. +...+|+.|+|++|.|.
T Consensus 89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCcccChhhhccccccccccCCCccc
Confidence 9999976654 44457999999999885
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=1.5e-14 Score=133.68 Aligned_cols=114 Identities=25% Similarity=0.278 Sum_probs=86.9
Q ss_pred cccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEEeecCCCCCccchhhcC
Q 007103 98 TMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLNVSRNSLTQSIGDIFGN 175 (618)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 175 (618)
.++..+..|++|++|+|++|+|+.. + .+. ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++.. +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 3456788899999999999999843 3 233 78888999888887 5666666677888888888888854 34777
Q ss_pred CCCCCeEEcccCcCCCCCC--CCcccCCCcCeeeeccccccccc
Q 007103 176 LAGLATLDLSFNNFSGDLP--NSFISLSNISSLYLQNNQVTGSL 217 (618)
Q Consensus 176 l~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~ 217 (618)
+++|+.|+|++|+|+. ++ ..+..+++|+.|+|++|+++...
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~ 156 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred cccccccccccchhcc-ccccccccCCCccceeecCCCccccCc
Confidence 8888888888888873 33 35777888888888888877543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.20 E-value=1.4e-13 Score=126.95 Aligned_cols=121 Identities=25% Similarity=0.233 Sum_probs=98.8
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccccccccCCccccCCCCccEEE
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASNNFSGNLPYSIASMVSLSYLN 159 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (618)
-.+++.|+|++|+|+.. + .|..+++|+.|+|++|.|+ .+|.... ++|+.|++++|+++.. +.+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEEE
T ss_pred ccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccccccccc
Confidence 35799999999999864 3 5899999999999999998 4453322 6899999999999953 4588999999999
Q ss_pred eecCCCCCccc-hhhcCCCCCCeEEcccCcCCCCCCCC----------cccCCCcCeee
Q 007103 160 VSRNSLTQSIG-DIFGNLAGLATLDLSFNNFSGDLPNS----------FISLSNISSLY 207 (618)
Q Consensus 160 L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~----------~~~l~~L~~L~ 207 (618)
|++|+|+.... ..+..+++|+.|+|++|.+....+.. +..+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999996543 57899999999999999987544432 45677888776
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=2.3e-11 Score=115.78 Aligned_cols=169 Identities=17% Similarity=0.174 Sum_probs=128.3
Q ss_pred CCEEEEEcCCCCCcccc-cccccCCCCCCEEEecC-CCccCCCCCCCC--CCccEEecccccccccCC-ccccCCCCccE
Q 007103 83 SAVVSIDISGLGLSGTM-GYLLSDLLSLRKFDLSG-NSIHDTIPYQLP--PNLTSLNLASNNFSGNLP-YSIASMVSLSY 157 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~-~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~ 157 (618)
.+++.|+|++|.+...+ +..|.+++.+++|++.. |++....+..+. ++|+.|++++|+++...+ ..+..+..|..
T Consensus 53 ~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~ 132 (242)
T d1xwdc1 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132 (242)
T ss_dssp TTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEE
T ss_pred chhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccc
Confidence 57999999999998755 45789999999999875 678766665554 899999999999985433 23456788888
Q ss_pred EEeecCCCCCccchhhcCCC-CCCeEEcccCcCCCCCCCCcccCCCcCee-eeccccccccccc-cCC-CCccEEEcccc
Q 007103 158 LNVSRNSLTQSIGDIFGNLA-GLATLDLSFNNFSGDLPNSFISLSNISSL-YLQNNQVTGSLNV-FSG-LPLTTLNVANN 233 (618)
Q Consensus 158 L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~l~~L~~L-~l~~N~l~~~~~~-~~~-~~L~~L~l~~N 233 (618)
+..++++++...+..|..++ .++.|++++|+++ .++.......+++.+ ++++|+|+...+. +.. .+|+.|+|++|
T Consensus 133 ~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp EEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTS
T ss_pred ccccccccccccccccccccccceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCC
Confidence 88889999877777777765 7999999999999 555555556666555 5788889876543 444 56999999999
Q ss_pred cccccCchhhhcccchhcc
Q 007103 234 HFSGWIPRELISIRTFIYD 252 (618)
Q Consensus 234 ~l~g~ip~~~~~l~~l~~~ 252 (618)
+|+...+..+.++..|...
T Consensus 212 ~l~~l~~~~~~~l~~L~~l 230 (242)
T d1xwdc1 212 RIHSLPSYGLENLKKLRAR 230 (242)
T ss_dssp CCCCCCSSSCTTCCEEESS
T ss_pred cCCccCHHHHcCCcccccC
Confidence 9994434456777666543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.14 E-value=2.3e-10 Score=114.77 Aligned_cols=98 Identities=29% Similarity=0.375 Sum_probs=80.0
Q ss_pred CCCEEEEEcCCCCCcccccccccCCCCCCEEEecCCCccCCCCCCCCCCccEEecccccccccCCccccCCCCccEEEee
Q 007103 82 GSAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGNSIHDTIPYQLPPNLTSLNLASNNFSGNLPYSIASMVSLSYLNVS 161 (618)
Q Consensus 82 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 161 (618)
..++++|||++++|+. +|+. +++|++|+|++|+|+ .+|.. ..+|+.|++++|+++ .++.. .+.|++|+|+
T Consensus 37 ~~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~-~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 37 DRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL-PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp HHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC-CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred HcCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc-hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 3468899999999975 5653 578999999999999 67754 479999999999998 44431 2469999999
Q ss_pred cCCCCCccchhhcCCCCCCeEEcccCcCCC
Q 007103 162 RNSLTQSIGDIFGNLAGLATLDLSFNNFSG 191 (618)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 191 (618)
+|.++. +|. ++.+++|+.|++++|.+..
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~ 134 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKK 134 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSC
T ss_pred cccccc-ccc-hhhhccceeeccccccccc
Confidence 999985 454 6789999999999999873
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.06 E-value=7.4e-12 Score=126.05 Aligned_cols=176 Identities=18% Similarity=0.201 Sum_probs=129.7
Q ss_pred CCEEEEEcCCCCCccc----ccccccCCCCCCEEEecCCCccCCCCC---------------CCCCCccEEecccccccc
Q 007103 83 SAVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIPY---------------QLPPNLTSLNLASNNFSG 143 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~---------------~~~~~L~~L~L~~N~l~~ 143 (618)
.+++.|+|++|.+... +...+...++|+.|+|++|.++..... ...+.|+.|++++|+++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 5789999999988764 444566788999999999987521110 112689999999998873
Q ss_pred c----CCccccCCCCccEEEeecCCCCCc-----cchhhcCCCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeecc
Q 007103 144 N----LPYSIASMVSLSYLNVSRNSLTQS-----IGDIFGNLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQN 210 (618)
Q Consensus 144 ~----~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~ 210 (618)
. +...+..++.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 334456788999999999999842 334577889999999999998632 345567889999999999
Q ss_pred ccccccc--------cccCCCCccEEEccccccccc----Cchh----hhcccchhccCCcCCC
Q 007103 211 NQVTGSL--------NVFSGLPLTTLNVANNHFSGW----IPRE----LISIRTFIYDGNSFDN 258 (618)
Q Consensus 211 N~l~~~~--------~~~~~~~L~~L~l~~N~l~g~----ip~~----~~~l~~l~~~~N~~~~ 258 (618)
|.|++.- .......|+.|++++|+|+.. +... ..+|+.|++++|.+..
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 9998631 112234699999999999753 2332 3467888999999864
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=4.8e-11 Score=116.47 Aligned_cols=170 Identities=24% Similarity=0.242 Sum_probs=88.9
Q ss_pred CEEEEEcCCCCCccc-ccccccCCCCCCEEEecCCCccCCCCCCCC--CCccEEecccc-ccccc-CCccccCCCCccEE
Q 007103 84 AVVSIDISGLGLSGT-MGYLLSDLLSLRKFDLSGNSIHDTIPYQLP--PNLTSLNLASN-NFSGN-LPYSIASMVSLSYL 158 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L 158 (618)
+++.|||+++.+.+. +...+..+++|++|+|++|.+++..+..+. ++|+.|+|+++ .++.. +.....++++|++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 577777777776543 344566777777777777777654444443 67777777773 55522 22223467777777
Q ss_pred EeecC-CCCCc-cchhhcC-CCCCCeEEcccC--cCCCC-CCCCcccCCCcCeeeecccc-ccccc-ccc-CCCCccEEE
Q 007103 159 NVSRN-SLTQS-IGDIFGN-LAGLATLDLSFN--NFSGD-LPNSFISLSNISSLYLQNNQ-VTGSL-NVF-SGLPLTTLN 229 (618)
Q Consensus 159 ~L~~N-~l~~~-~p~~~~~-l~~L~~L~ls~N--~l~g~-~p~~~~~l~~L~~L~l~~N~-l~~~~-~~~-~~~~L~~L~ 229 (618)
+|+++ .++.. +...+.. .++|+.|++++. .++.. +...+..+++|++|+|++|. +++.. ..+ ...+|+.|+
T Consensus 127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~ 206 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 206 (284)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEE
Confidence 77764 44421 1222222 355666666543 23321 11222345666666666543 44321 222 223466666
Q ss_pred ccc-ccccccCchhh---hcccchhccC
Q 007103 230 VAN-NHFSGWIPREL---ISIRTFIYDG 253 (618)
Q Consensus 230 l~~-N~l~g~ip~~~---~~l~~l~~~~ 253 (618)
|++ +.+++.....+ .+|+.|++.|
T Consensus 207 L~~C~~i~~~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 207 LSRCYDIIPETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred CCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence 666 34554433333 3344444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=1.7e-10 Score=112.35 Aligned_cols=175 Identities=21% Similarity=0.228 Sum_probs=126.1
Q ss_pred CCEEEEEcCCCCCcccccccccCCCCCCEEEecCC-CccCCCCC---CCCCCccEEecccc-ccccc-CCccccC-CCCc
Q 007103 83 SAVVSIDISGLGLSGTMGYLLSDLLSLRKFDLSGN-SIHDTIPY---QLPPNLTSLNLASN-NFSGN-LPYSIAS-MVSL 155 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~p~---~~~~~L~~L~L~~N-~l~~~-~p~~~~~-l~~L 155 (618)
.+++.|+|+++.+.+..+..++.+++|++|+|+++ .++..--. ...++|++|+|+++ +++.. +...+.. .++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 57999999999999888899999999999999995 56521111 12389999999985 55532 2333444 4789
Q ss_pred cEEEeecC--CCCCc-cchhhcCCCCCCeEEcccC-cCCCCCCCCcccCCCcCeeeecc-ccccccc-cc-cCCCCccEE
Q 007103 156 SYLNVSRN--SLTQS-IGDIFGNLAGLATLDLSFN-NFSGDLPNSFISLSNISSLYLQN-NQVTGSL-NV-FSGLPLTTL 228 (618)
Q Consensus 156 ~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~-~~-~~~~~L~~L 228 (618)
+.|++++. .++.. +...+..+++|+.|+|++| .+++.....+..+++|++|+|++ +.+++.. .. ....+|+.|
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEE
Confidence 99999964 45533 3344567899999999986 58877888899999999999999 4677532 22 233569999
Q ss_pred EcccccccccCchhhhcccchhccCCcCC
Q 007103 229 NVANNHFSGWIPRELISIRTFIYDGNSFD 257 (618)
Q Consensus 229 ~l~~N~l~g~ip~~~~~l~~l~~~~N~~~ 257 (618)
+++++--.+.++.-...++.|.+..+.+.
T Consensus 231 ~l~~~~~d~~l~~l~~~lp~L~i~~~~ls 259 (284)
T d2astb2 231 QVFGIVPDGTLQLLKEALPHLQINCSHFT 259 (284)
T ss_dssp ECTTSSCTTCHHHHHHHSTTSEESCCCSC
T ss_pred eeeCCCCHHHHHHHHHhCccccccCccCC
Confidence 99988323334444456777777655554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.82 E-value=4.5e-10 Score=112.66 Aligned_cols=175 Identities=19% Similarity=0.161 Sum_probs=104.4
Q ss_pred CCEEEEEcCCCCCccc----------ccccccCCCCCCEEEecCCCccCCCCCCC------CCCccEEecccccccccCC
Q 007103 83 SAVVSIDISGLGLSGT----------MGYLLSDLLSLRKFDLSGNSIHDTIPYQL------PPNLTSLNLASNNFSGNLP 146 (618)
Q Consensus 83 ~~v~~l~l~~~~l~~~----------~~~~l~~l~~L~~L~L~~N~l~~~~p~~~------~~~L~~L~L~~N~l~~~~p 146 (618)
..++.|+++++.+... +...+...++|+.|+|++|.++..-...+ .++|+.|+|++|.+...-.
T Consensus 59 ~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~ 138 (344)
T d2ca6a1 59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 138 (344)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccc
Confidence 4677777776544211 22345566778888888887764322111 1678888888777652111
Q ss_pred cc-------------ccCCCCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCCCC-----CCCCcccCCCcC
Q 007103 147 YS-------------IASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD-----LPNSFISLSNIS 204 (618)
Q Consensus 147 ~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~-----~p~~~~~l~~L~ 204 (618)
.. ....+.|+.|++++|+++.. +...+...+.|+.|+|++|++... +...+..+++|+
T Consensus 139 ~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~ 218 (344)
T d2ca6a1 139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 218 (344)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred ccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhc
Confidence 11 13456777888888877633 233455677788888888887632 334566777888
Q ss_pred eeeecccccccc----c-ccc-CCCCccEEEcccccccccCchhh---------hcccchhccCCcCC
Q 007103 205 SLYLQNNQVTGS----L-NVF-SGLPLTTLNVANNHFSGWIPREL---------ISIRTFIYDGNSFD 257 (618)
Q Consensus 205 ~L~l~~N~l~~~----~-~~~-~~~~L~~L~l~~N~l~g~ip~~~---------~~l~~l~~~~N~~~ 257 (618)
.|+|++|.|+.. + ..+ ...+|+.|+|++|.|++.-...+ ..++.|++++|.+.
T Consensus 219 ~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 219 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred ccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 888888887642 1 111 23457888888888775422222 23556666666543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=7.6e-10 Score=114.96 Aligned_cols=158 Identities=22% Similarity=0.195 Sum_probs=72.8
Q ss_pred CEEEEEcCCCCCccc----ccccccCCCCCCEEEecCCCccCCCCC-------CCCCCccEEecccccccccCCc----c
Q 007103 84 AVVSIDISGLGLSGT----MGYLLSDLLSLRKFDLSGNSIHDTIPY-------QLPPNLTSLNLASNNFSGNLPY----S 148 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~-------~~~~~L~~L~L~~N~l~~~~p~----~ 148 (618)
.+..+++++|.+... ....+..++.++.+++++|.++..... .....|+.+++++|.++..... .
T Consensus 256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~ 335 (460)
T d1z7xw1 256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 335 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccc
Confidence 345555555555432 122334455555555555555421110 1113556666666655533222 2
Q ss_pred ccCCCCccEEEeecCCCCCc----cchhhc-CCCCCCeEEcccCcCCCC----CCCCcccCCCcCeeeeccccccccc--
Q 007103 149 IASMVSLSYLNVSRNSLTQS----IGDIFG-NLAGLATLDLSFNNFSGD----LPNSFISLSNISSLYLQNNQVTGSL-- 217 (618)
Q Consensus 149 ~~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~-- 217 (618)
+...++|++|+|++|+|+.. ++..+. ..+.|++|+|++|+|+.. ++..+..+++|++|+|++|+|+...
T Consensus 336 ~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~ 415 (460)
T d1z7xw1 336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415 (460)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHH
T ss_pred cccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHH
Confidence 23344566666666665532 222222 234566666666665521 2333444555666666666655311
Q ss_pred ---ccc--CCCCccEEEcccccccccCch
Q 007103 218 ---NVF--SGLPLTTLNVANNHFSGWIPR 241 (618)
Q Consensus 218 ---~~~--~~~~L~~L~l~~N~l~g~ip~ 241 (618)
..+ ....|+.|++++|.+......
T Consensus 416 ~l~~~l~~~~~~L~~l~l~~~~~~~~~~~ 444 (460)
T d1z7xw1 416 QLVESVRQPGCLLEQLVLYDIYWSEEMED 444 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred HHHHHHHhCCCccCEEECCCCCCCHHHHH
Confidence 111 112356666666665544333
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=7.9e-09 Score=107.01 Aligned_cols=107 Identities=24% Similarity=0.295 Sum_probs=61.9
Q ss_pred CEEEEEcCCCCCcccc-cccccCCCCCCEEEecCCCccCC----CCCC--CCCCccEEeccccccccc----CCcccc-C
Q 007103 84 AVVSIDISGLGLSGTM-GYLLSDLLSLRKFDLSGNSIHDT----IPYQ--LPPNLTSLNLASNNFSGN----LPYSIA-S 151 (618)
Q Consensus 84 ~v~~l~l~~~~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~----~p~~--~~~~L~~L~L~~N~l~~~----~p~~~~-~ 151 (618)
+++.||+++|++++.. ...+..+++|+.|+|++|.|+.. +... -.++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4677888888876632 34455677777777877776621 1111 125677777777766521 112222 1
Q ss_pred CCCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCC
Q 007103 152 MVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFS 190 (618)
Q Consensus 152 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 190 (618)
..+|+.|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 23566666666666643 3445556666666666666665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=1.2e-08 Score=89.98 Aligned_cols=69 Identities=23% Similarity=0.262 Sum_probs=35.8
Q ss_pred CccccCCCCccEEEeecCCCCCc--cchhhcCCCCCCeEEcccCcCCCCCCC-CcccCCCcCeeeeccccccc
Q 007103 146 PYSIASMVSLSYLNVSRNSLTQS--IGDIFGNLAGLATLDLSFNNFSGDLPN-SFISLSNISSLYLQNNQVTG 215 (618)
Q Consensus 146 p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~ 215 (618)
+..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+. ++. .+....+|+.|+|++|.++.
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCc
Confidence 33344566666666666666643 23445556666666666666652 222 22223345555555555544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.28 E-value=1.7e-06 Score=82.10 Aligned_cols=148 Identities=12% Similarity=0.074 Sum_probs=92.8
Q ss_pred hhhhhcCCcccceeccCccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeE
Q 007103 405 LQTATNSFSQEFLIGEGSLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQR 483 (618)
Q Consensus 405 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 483 (618)
+...-..|...+..+.++...||+... +++.+++|+....... ....+.+|...+..+. +--+.+++.+...++..
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 333344555444444444578999865 4566778887543221 1223456666655442 33356778888888899
Q ss_pred EEEEEecCCCChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC------------------------------
Q 007103 484 LLVYEYVGNGNLHDMLHFADDSSKNLTWNARVRVALGTARALEYLHEVCL------------------------------ 533 (618)
Q Consensus 484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~------------------------------ 533 (618)
++||+++++.++.+.... ... ...++.++++.++.||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccc------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999877654320 011 22244455555555654210
Q ss_pred --------------------------CCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 534 --------------------------PSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 534 --------------------------~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999999876667999998754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=1.2e-07 Score=83.22 Aligned_cols=79 Identities=24% Similarity=0.169 Sum_probs=53.7
Q ss_pred CCccEEeccccccccc--CCccccCCCCccEEEeecCCCCCccchhhcCCCCCCeEEcccCcCCCCCCCC-------ccc
Q 007103 129 PNLTSLNLASNNFSGN--LPYSIASMVSLSYLNVSRNSLTQSIGDIFGNLAGLATLDLSFNNFSGDLPNS-------FIS 199 (618)
Q Consensus 129 ~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-------~~~ 199 (618)
++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|.+....... +..
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~ 144 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHH
Confidence 4566666666666632 3345667888888888888888655544555567888888888887554432 446
Q ss_pred CCCcCeee
Q 007103 200 LSNISSLY 207 (618)
Q Consensus 200 l~~L~~L~ 207 (618)
+++|+.||
T Consensus 145 ~P~L~~LD 152 (162)
T d1koha1 145 FPKLLRLD 152 (162)
T ss_dssp STTCCEET
T ss_pred CCCCCEEC
Confidence 77777765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=1.1e-05 Score=76.03 Aligned_cols=131 Identities=20% Similarity=0.189 Sum_probs=82.2
Q ss_pred eeccCcc-ceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCC--CCcccccceEEeeCCeEEEEEEecCCC
Q 007103 417 LIGEGSL-GRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR--HPNIVTLAGYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 417 ~Lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g 493 (618)
.+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++.+..+.+..++|||++++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3445554 678999988888889998764432 23445555554442 223667788888888899999999876
Q ss_pred ChhhhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 007103 494 NLHDMLHFADDSSKNLTWNARVRVALGTARALEYLH-------------------------------------------- 529 (618)
Q Consensus 494 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-------------------------------------------- 529 (618)
++.+.. .... ..+.++++.|+-||
T Consensus 92 ~~~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 92 DLLSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp ETTTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 553211 0100 11122222233333
Q ss_pred -------hcC----CCCceecCCCCCCeeecCCCCcEEeecccccc
Q 007103 530 -------EVC----LPSVVHRNFKSANILLDDELNPHLSDCGLAAL 564 (618)
Q Consensus 530 -------~~~----~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 564 (618)
+.. .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 221 12379999999999999876678999998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.82 E-value=3e-06 Score=74.43 Aligned_cols=85 Identities=16% Similarity=0.068 Sum_probs=45.7
Q ss_pred CCccEEecccccccc----cCCccccCCCCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCCCC-------C
Q 007103 129 PNLTSLNLASNNFSG----NLPYSIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGD-------L 193 (618)
Q Consensus 129 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~-------~ 193 (618)
++|+.|+|++|.+.. .+...+...+.|+.|+|++|.|+.. +-..+...++|+.|+|++|.+... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 345555555555542 2223344556667777777766632 223445556677777777665421 2
Q ss_pred CCCcccCCCcCeeeeccccc
Q 007103 194 PNSFISLSNISSLYLQNNQV 213 (618)
Q Consensus 194 p~~~~~l~~L~~L~l~~N~l 213 (618)
...+...++|+.|+++.+..
T Consensus 124 ~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCccEeeCcCCCc
Confidence 22333456677777766543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.71 E-value=2.6e-06 Score=74.86 Aligned_cols=89 Identities=10% Similarity=0.144 Sum_probs=53.8
Q ss_pred ccccCCCCccEEEeecCCCCCc----cchhhcCCCCCCeEEcccCcCCCCC----CCCcccCCCcCeeeecccccccc--
Q 007103 147 YSIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDLSFNNFSGDL----PNSFISLSNISSLYLQNNQVTGS-- 216 (618)
Q Consensus 147 ~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~~----p~~~~~l~~L~~L~l~~N~l~~~-- 216 (618)
..+...+.|++|+|++|.++.. +...+...+.|+.|+|++|.|+... -..+...++|++|+|++|.+...
T Consensus 38 ~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~ 117 (167)
T d1pgva_ 38 EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGN 117 (167)
T ss_dssp HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCH
T ss_pred HHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccH
Confidence 3455667788888888877632 2334555677888888888776421 22345556788888877765421
Q ss_pred -----cc-c-cCCCCccEEEcccccc
Q 007103 217 -----LN-V-FSGLPLTTLNVANNHF 235 (618)
Q Consensus 217 -----~~-~-~~~~~L~~L~l~~N~l 235 (618)
+. . .....|+.|+++.+..
T Consensus 118 ~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 118 QVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 11 1 1123477777776654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.48 E-value=0.00012 Score=73.27 Aligned_cols=77 Identities=17% Similarity=0.095 Sum_probs=44.9
Q ss_pred ceeccCccceEEEEEEcC-CcEEEEEEcCccccc-----HHHHHHHHHHHHHhhcC-CC--CcccccceEEeeCCeEEEE
Q 007103 416 FLIGEGSLGRVYRAEFAN-GKIMAVKKIDNAALS-----LQEEDNFLEAVSNMSRL-RH--PNIVTLAGYCAEHGQRLLV 486 (618)
Q Consensus 416 ~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~lv 486 (618)
+.||.|....||+....+ ++.+++|.-...... .....+...|.+.++.+ .+ ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 358999999999998765 677888864321100 01122344566665544 22 334555543 45566899
Q ss_pred EEecCCCC
Q 007103 487 YEYVGNGN 494 (618)
Q Consensus 487 ~e~~~~gs 494 (618)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.15 E-value=8.6e-06 Score=71.32 Aligned_cols=12 Identities=8% Similarity=-0.014 Sum_probs=6.7
Q ss_pred CccEEEcccccc
Q 007103 224 PLTTLNVANNHF 235 (618)
Q Consensus 224 ~L~~L~l~~N~l 235 (618)
+|+.|+++.|..
T Consensus 133 ~L~~L~l~~~~~ 144 (166)
T d1io0a_ 133 TLLKFGYHFTQQ 144 (166)
T ss_dssp SCCEEECCCSSH
T ss_pred CcCEEeCcCCCC
Confidence 466666655544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.09 E-value=5e-05 Score=66.24 Aligned_cols=85 Identities=13% Similarity=0.158 Sum_probs=47.4
Q ss_pred CCccEEeccccccccc----CCccccCCCCccEEEeecCCCCCc----cchhhcCCCCCCeEEc--ccCcCCC----CCC
Q 007103 129 PNLTSLNLASNNFSGN----LPYSIASMVSLSYLNVSRNSLTQS----IGDIFGNLAGLATLDL--SFNNFSG----DLP 194 (618)
Q Consensus 129 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l--s~N~l~g----~~p 194 (618)
++|+.|+|++|.++.. +-..+...++|+.|++++|.++.. +...+...++|+.++| ++|.+.. .+.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 4555555555555432 223344566777777777776633 2244556667776444 4555543 233
Q ss_pred CCcccCCCcCeeeeccccc
Q 007103 195 NSFISLSNISSLYLQNNQV 213 (618)
Q Consensus 195 ~~~~~l~~L~~L~l~~N~l 213 (618)
..+...++|+.|+++.|..
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 3445667777777766654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.78 E-value=0.0039 Score=60.17 Aligned_cols=69 Identities=20% Similarity=0.215 Sum_probs=43.4
Q ss_pred ccceEEEEEEcCCcEEEEEEcCcccccHHHHHHHHHHHHHhhcCCC-----Ccccccc--eEEeeCCeEEEEEEecCCC
Q 007103 422 SLGRVYRAEFANGKIMAVKKIDNAALSLQEEDNFLEAVSNMSRLRH-----PNIVTLA--GYCAEHGQRLLVYEYVGNG 493 (618)
Q Consensus 422 ~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv~l~--~~~~~~~~~~lv~e~~~~g 493 (618)
---.||++...+|+.|++|.......+ .+++.+|.+.+..+.. +..+..- ..+...+..+.++++++|.
T Consensus 34 ~EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 34 YENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ccceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 346899999999999999998755433 3445556555544421 2222221 1234566788999999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.22 E-value=0.0068 Score=60.14 Aligned_cols=73 Identities=14% Similarity=0.092 Sum_probs=46.5
Q ss_pred cceeccCccceEEEEEEcCC--------cEEEEEEcCcccccHHHHHHHHHHHHHhhcCC-CCcccccceEEeeCCeEEE
Q 007103 415 EFLIGEGSLGRVYRAEFANG--------KIMAVKKIDNAALSLQEEDNFLEAVSNMSRLR-HPNIVTLAGYCAEHGQRLL 485 (618)
Q Consensus 415 ~~~Lg~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 485 (618)
.+.|+.|-.-.+|++...++ +.|.+++..... . .....+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 34688899999999987643 456666654221 2 233456777776664 3334466776642 68
Q ss_pred EEEecCCCCh
Q 007103 486 VYEYVGNGNL 495 (618)
Q Consensus 486 v~e~~~~gsL 495 (618)
|+||+++..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.83 E-value=0.022 Score=54.17 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=26.4
Q ss_pred CceecCCCCCCeeecCCCCcEEeeccccc
Q 007103 535 SVVHRNFKSANILLDDELNPHLSDCGLAA 563 (618)
Q Consensus 535 ~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 563 (618)
++||+|+.++||+++.+...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 79999999999999988777899999885
|